<SEC-DOCUMENT>0001069530-23-000039.txt : 20230803
<SEC-HEADER>0001069530-23-000039.hdr.sgml : 20230803
<ACCEPTANCE-DATETIME>20230803163509
ACCESSION NUMBER:		0001069530-23-000039
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		68
CONFORMED PERIOD OF REPORT:	20230630
FILED AS OF DATE:		20230803
DATE AS OF CHANGE:		20230803

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CASSAVA SCIENCES INC
		CENTRAL INDEX KEY:			0001069530
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				911911336
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-29959
		FILM NUMBER:		231140691

	BUSINESS ADDRESS:	
		STREET 1:		6801 N CAPITAL OF TEXAS HIGHWAY
		STREET 2:		BUILDING 1; SUITE 300
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78731
		BUSINESS PHONE:		512-501-2444

	MAIL ADDRESS:	
		STREET 1:		6801 N CAPITAL OF TEXAS HIGHWAY
		STREET 2:		BUILDING 1; SUITE 300
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78731

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PAIN THERAPEUTICS INC
		DATE OF NAME CHANGE:	20000309
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>sava-20230630x10q.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Inline XBRL document created by Certent Disclosure Management 1.0.0.0-->
<!--Created on: 08/03/2023 20:29:13 PM-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:sava="http://www.cassavasciences.com/20230630" xmlns:srt="http://fasb.org/srt/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <head>
    <title>sava-20230630x10q</title>
    <meta http-equiv="Content-Type" content="text/html" /></head>
  <body xml:lang="en-US">
    <div style="display:none"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="ct-nonNumeric-12e78671-2cf4-4cfe-8e28-031279a864d7" contextRef="Duration_1_1_2023_To_6_30_2023" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:CurrentFiscalYearEndDate" id="ct-nonNumeric-a196a7f4-fea8-42f9-9d9a-d4d64ea3ef94" contextRef="Duration_1_1_2023_To_6_30_2023">--12-31</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" id="ct-nonNumeric-ac580dec-0f3e-4cb0-a1a8-f217867fb7fe" contextRef="Duration_1_1_2023_To_6_30_2023">Q2</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalYearFocus" id="ct-nonNumeric-c5df03a3-289e-47bd-a31d-389becb4d206" contextRef="Duration_1_1_2023_To_6_30_2023">2023</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="ct-nonNumeric-0c28ee8c-fffe-4ac3-9349-90d40ee0132d" contextRef="Duration_1_1_2023_To_6_30_2023">0001069530</ix:nonNumeric><ix:nonNumeric name="dei:EntityCurrentReportingStatus" id="ct-nonNumeric-7611e968-3bc7-44e8-9f2b-7bb19dff574f" contextRef="Duration_1_1_2023_To_6_30_2023">Yes</ix:nonNumeric><ix:nonNumeric name="dei:EntityInteractiveDataCurrent" id="ct-nonNumeric-92eef08b-0ada-4e53-849a-20931e2e17e7" contextRef="Duration_1_1_2023_To_6_30_2023">Yes</ix:nonNumeric><ix:nonFraction id="ct-nonFraction-f054078c-0570-4d0c-9c55-32ed2826ad26" name="us-gaap:CommitmentsAndContingencies" contextRef="As_Of_12_31_2022" unitRef="Unit12" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-f5fbd7c9-7e72-4ab7-8180-fb220e6f5c8d" name="us-gaap:CommitmentsAndContingencies" contextRef="As_Of_6_30_2023" unitRef="Unit12" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-9456fc3f-d3a1-4567-ad49-a87cc8abe7e8" name="us-gaap:PreferredStockValue" contextRef="As_Of_12_31_2022" unitRef="Unit12" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-6e7f225c-4650-4e5a-853e-ad6507fb9bc1" name="us-gaap:PreferredStockValue" contextRef="As_Of_6_30_2023" unitRef="Unit12" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-cf26586d-83aa-4eed-9015-9e654cf00456" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-a5e09c6a-9923-4b88-9aac-2bab00d80bb7" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="ct-nonFraction-a4ac9c2f-0510-422d-88c4-81f94dcb8f78" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="Unit1" xsi:nil="true"></ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="sava-20230630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2023_To_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2022_To_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_5_5_2022_To_5_5_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_sava_TwoThousandEighteenEquityIncentivePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-05</xbrli:startDate><xbrli:endDate>2022-05-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_sava_StockOptionAndPerformanceAwardActivity2020PlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:StockOptionAndPerformanceAwardActivity2020PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_6_30_2023_us-gaap_PlanNameAxis_sava_TwoThousandEighteenEquityIncentivePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_11_22_2022_us-gaap_PlanNameAxis_sava_RegisteredDirectOffering2022Member_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:RegisteredDirectOffering2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_4_30_2023_To_4_30_2023_us-gaap_PlanNameAxis_sava_AtMarketEquityProgramMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:AtMarketEquityProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-30</xbrli:startDate><xbrli:endDate>2023-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_5_1_2023_To_5_1_2023_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_sava_AtMarketEquityProgramMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:AtMarketEquityProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2023-05-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_3_1_2020_To_3_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_sava_AtMarketEquityProgramMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:AtMarketEquityProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_11_22_2022_To_11_22_2022_us-gaap_PlanNameAxis_sava_RegisteredDirectOffering2022Member_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:RegisteredDirectOffering2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-22</xbrli:startDate><xbrli:endDate>2022-11-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">sava:AustinMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">sava:AustinMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2022_To_6_30_2022_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">sava:AustinMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_6_30_2022_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">sava:AustinMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2023_To_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2022_To_6_30_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_6_30_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_LeaseContractualTermAxis_sava_OperatingLeasesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">sava:AustinMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">sava:OperatingLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_8_4_2021_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_AssetAcquisitionAxis_sava_TwoBuildingOfficeComplexAssetMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">sava:AustinMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">sava:TwoBuildingOfficeComplexAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2023_To_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2022_To_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_11_4_2021_To_11_4_2021_srt_LitigationCaseAxis_sava_ShareholderDerivativeActionsU.s.DistrictCourtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">sava:ShareholderDerivativeActionsU.s.DistrictCourtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-04</xbrli:startDate><xbrli:endDate>2021-11-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_11_4_2021_To_11_4_2021_srt_LitigationCaseAxis_sava_ShareholderDerivativeActionsTexasCourtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">sava:ShareholderDerivativeActionsTexasCourtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-04</xbrli:startDate><xbrli:endDate>2021-11-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_11_4_2021_To_11_4_2021_srt_LitigationCaseAxis_sava_ShareholderDerivativeActionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">sava:ShareholderDerivativeActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-04</xbrli:startDate><xbrli:endDate>2021-11-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_11_4_2021_To_11_4_2021_srt_LitigationCaseAxis_sava_ShareholderDerivativeActionsDelwareCourtMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">sava:ShareholderDerivativeActionsDelwareCourtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-04</xbrli:startDate><xbrli:endDate>2021-11-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_8_28_2021_To_10_26_2021_srt_LitigationCaseAxis_sava_ViolationsOfFederalSecuritiesLawsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">sava:ViolationsOfFederalSecuritiesLawsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-28</xbrli:startDate><xbrli:endDate>2021-10-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_LeaseContractualTermAxis_sava_OperatingLeasesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">sava:AustinMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">sava:OperatingLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2023_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LeasesAcquiredInPlaceMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LeasesAcquiredInPlaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2023_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_sava_LeasingCommissionsAndOtherMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">sava:LeasingCommissionsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LeasesAcquiredInPlaceMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LeasesAcquiredInPlaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_sava_LeasingCommissionsAndOtherMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">sava:LeasingCommissionsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_5_5_2022_us-gaap_PlanNameAxis_sava_TwoThousandEighteenEquityIncentivePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2023_To_6_30_2023_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_6_30_2023_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2022_To_6_30_2022_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_6_30_2022_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_6_30_2023_srt_StatementScenarioAxis_sava_SecondThroughEighthValuationMilestonesMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">sava:SecondThroughEighthValuationMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:CashIncentiveBonusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2023_To_6_30_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2023_To_6_30_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_sava_StockOptionAndPerformanceAwardActivity2020PlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:StockOptionAndPerformanceAwardActivity2020PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_6_30_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_6_30_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2022_To_6_30_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2022_To_6_30_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_6_30_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_6_30_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2023_To_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_3_31_2023"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2022_To_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2023"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2022_To_6_30_2022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_3_31_2022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_6_30_2023_srt_RangeAxis_srt_MinimumMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:CashIncentiveBonusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_6_30_2023_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:CashIncentiveBonusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_6_30_2023_srt_StatementScenarioAxis_sava_ExceedingPerformanceMilestonesMinimum20ConsecutiveDaysMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">sava:ExceedingPerformanceMilestonesMinimum20ConsecutiveDaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:CashIncentiveBonusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_AssetAcquisitionAxis_sava_TwoBuildingOfficeComplexAssetMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">sava:AustinMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">sava:TwoBuildingOfficeComplexAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_5_1_2023_us-gaap_PlanNameAxis_sava_AtMarketEquityProgramMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:AtMarketEquityProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_8_3_2023_To_8_3_2023_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:CashIncentiveBonusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-03</xbrli:startDate><xbrli:endDate>2023-08-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2021_To_12_31_2021"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_6_30_2023_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:CashIncentiveBonusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2022_To_6_30_2022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2023_srt_RangeAxis_srt_MinimumMember_srt_StatementScenarioAxis_sava_Exceeds5BillionMarketCapitalizationMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">sava:Exceeds5BillionMarketCapitalizationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:CashIncentiveBonusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2023_srt_RangeAxis_srt_MaximumMember_srt_StatementScenarioAxis_sava_Exceeds5BillionMarketCapitalizationMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">sava:Exceeds5BillionMarketCapitalizationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:CashIncentiveBonusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_6_30_2023_srt_TitleOfIndividualAxis_sava_IndependentDirectorsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">sava:IndependentDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_srt_StatementScenarioAxis_sava_SecondThroughEighthValuationMilestonesMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">sava:SecondThroughEighthValuationMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:CashIncentiveBonusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_srt_StatementScenarioAxis_sava_SecondThroughEighthValuationMilestonesMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">sava:SecondThroughEighthValuationMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:CashIncentiveBonusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="As_Of_10_31_2020_srt_StatementScenarioAxis_sava_FirstValuationMilestoneMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">sava:FirstValuationMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:CashIncentiveBonusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_4_1_2023_To_6_30_2023"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="As_Of_8_1_2023"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2023_To_6_30_2023"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001069530</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="Unit17"><xbrli:measure>sava:segment</xbrli:measure></xbrli:unit><xbrli:unit id="Unit16"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="Unit15"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Unit14"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="Unit13"><xbrli:measure>sava:item</xbrli:measure></xbrli:unit><xbrli:unit id="Unit12"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Unit1"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit></ix:resources></ix:header></div>
    <div class="headerContainer"></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 14pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.21in;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 14pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">UNITED STATES</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 14pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 14pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">SECURITIES AND EXCHANGE COMMISSION</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Washington, D.C. 20549</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">_____________________</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 16pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 16pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Form </span><ix:nonNumeric name="dei:DocumentType" id="ct-nonNumeric-60e9c6c4-ee9d-46c3-b219-f1ca95b0cd3c" contextRef="Duration_1_1_2023_To_6_30_2023"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 16pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">10-Q</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">_____________________</span></p><div style="text-align:center"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: auto;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 79.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 11.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 79.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 3.20in;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(Mark One)</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 11.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 79.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:DocumentQuarterlyReport" id="ct-nonNumeric-ff02ca1b-02d5-4af4-84c0-74dc076fe405" contextRef="Duration_1_1_2023_To_6_30_2023" format="ixt:booleantrue"><span style="white-space:pre-wrap; font-family: Wingdings;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; font-family: &quot;Wingdings&quot;">&#254;</span></span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;&#160;&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 11.8%;"><p dir="ltr" style="font-family: Wingdings;font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 79.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">OF THE SECURITIES EXCHANGE ACT OF 1934</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 11.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 5pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 5pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">For the Quarterly Period Ended </span><ix:nonNumeric name="dei:DocumentPeriodEndDate" id="ct-nonNumeric-e506cc62-bfbf-4a7e-abea-16a46f566fbe" contextRef="Duration_1_1_2023_To_6_30_2023" format="ixt:datemonthdayyearen"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30, 2023</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">or</span></p><div style="text-align:center"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: auto;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 79.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 11.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 79.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:DocumentTransitionReport" id="ct-nonNumeric-88196bf6-e358-47ec-8e09-0e95bb06d8ea" contextRef="Duration_1_1_2023_To_6_30_2023" format="ixt:booleanfalse"><span style="white-space:pre-wrap; font-family: Wingdings;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; font-family: &quot;Wingdings&quot;">&#168;</span></span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;&#160;&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 11.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 79.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">OF THE SECURITIES EXCHANGE ACT OF 1934</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">For the Transition Period from ___________ to ___________</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 11.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Commission File Number: </span><ix:nonNumeric name="dei:EntityFileNumber" id="ct-nonNumeric-f04001e7-d490-4ad9-bd5e-11bcf2bfe402" contextRef="Duration_1_1_2023_To_6_30_2023"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">000-29959</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">_______________</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 6pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 6pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: Sansation;font-size: 22pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:EntityRegistrantName" id="ct-nonNumeric-08244c28-662f-40b6-a429-f455b8c14917" contextRef="Duration_1_1_2023_To_6_30_2023"><span style="white-space:pre-wrap; color: #1F497D;font-family: Sansation;font-size: 22pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Cassava Sciences, Inc.</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 22pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 22pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">(Exact name of registrant as specified in its charter)</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 3pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 3pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="text-align:center"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: auto;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 22.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 27.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 25.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 24.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 22.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 27.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="ct-nonNumeric-8a600e1b-ea79-427a-8a94-4147bae321cd" contextRef="Duration_1_1_2023_To_6_30_2023" format="ixt-sec:stateprovnameen"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Delaware</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 25.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="ct-nonNumeric-c7fbf5c5-a736-449d-b8e5-a4e850ee29ff" contextRef="Duration_1_1_2023_To_6_30_2023"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">91-1911336</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 24.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 22.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 27.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">(State</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">or</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">other</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">jurisdiction</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">of</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 25.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">(I.R.S.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Employer</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 24.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 22.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 27.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">incorporation</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">or</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">organization)</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 25.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Identification</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Number)</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 24.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 6pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 6pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="ct-nonNumeric-0d15256c-9fa8-4bed-963b-98ca032f7f93" contextRef="Duration_1_1_2023_To_6_30_2023"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">6801 N. Capital of Texas Highway</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, </span><ix:nonNumeric name="dei:EntityAddressAddressLine2" id="ct-nonNumeric-11ecd369-86d4-433b-ba07-d907dd8d17c6" contextRef="Duration_1_1_2023_To_6_30_2023"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Building 1; Suite 300</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, </span><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="ct-nonNumeric-8df5c0f0-b819-4ffd-81da-19b4fdd90c24" contextRef="Duration_1_1_2023_To_6_30_2023"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Austin</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, </span><ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="ct-nonNumeric-935cc672-e61f-485c-b8ec-f83f7c2accfa" contextRef="Duration_1_1_2023_To_6_30_2023"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">TX</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="ct-nonNumeric-033abb89-716f-4f37-b3ea-afa3e5f155f3" contextRef="Duration_1_1_2023_To_6_30_2023"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">78731</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><ix:nonNumeric name="dei:CityAreaCode" id="ct-nonNumeric-a702e3e8-c6aa-4ced-a32c-8983fdeeec9c" contextRef="Duration_1_1_2023_To_6_30_2023"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">512</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">) </span><ix:nonNumeric name="dei:LocalPhoneNumber" id="ct-nonNumeric-286e55ce-cfd2-4214-bc93-17fd9fdaa1dd" contextRef="Duration_1_1_2023_To_6_30_2023"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">501-2444</span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">(Address, including zip code, of registrant&#8217;s principal executive offices and</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">telephone number, including area code)</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 6pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.20in;"><span style="white-space:pre-wrap; font-size: 6pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.20in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Securities registered pursuant to Section 12(b) of the Act:</span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 38.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0</span></p></td><td style="border-bottom: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 6pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 6pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 45.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 38.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Title of each class</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 15.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Trading</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Symbol(s)</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 45.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Name of each exchange on which registered</span></p></td></tr><tr><td style="border-bottom: none;border-left: none;border-right: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-top: 0;vertical-align: top;width: 38.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:Security12bTitle" id="ct-nonNumeric-3d867cd9-69ee-4795-9e9e-16200a8f4295" contextRef="Duration_1_1_2023_To_6_30_2023"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Common Stock, $0.001 par value</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 15.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:TradingSymbol" id="ct-nonNumeric-99b68c09-7500-459d-bb46-dccff4307996" contextRef="Duration_1_1_2023_To_6_30_2023"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">SAVA</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 1.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom: none;border-left: none;border-right: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-top: 0;vertical-align: bottom;width: 45.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><ix:nonNumeric name="dei:SecurityExchangeName" id="ct-nonNumeric-3b6917a5-bef1-4e38-9aff-a79cef51f4a3" contextRef="Duration_1_1_2023_To_6_30_2023" format="ixt-sec:exchnameen"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Nasdaq</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> Capital Market </span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.20in;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.20in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes&#160;</span><span style="white-space:pre-wrap; font-family: Wingdings;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; font-family: &quot;Wingdings&quot;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonNumeric-7611e968-3bc7-44e8-9f2b-7bb19dff574f;">&#254;</span></span></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160; &#160;No&#160;</span><span style="white-space:pre-wrap; font-family: Wingdings;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; font-family: &quot;Wingdings&quot;">&#168;</span></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.20in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes&#160;</span><span style="white-space:pre-wrap; font-family: Wingdings;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; font-family: &quot;Wingdings&quot;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonNumeric-92eef08b-0ada-4e53-849a-20931e2e17e7;">&#254;</span></span></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;&#160;&#160;No&#160;</span><span style="white-space:pre-wrap; font-family: Wingdings;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; font-family: &quot;Wingdings&quot;">&#168;</span></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.20in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See </span><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;">the </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; </span><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;">&#8220;smaller</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> reporting company,</span><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;">&#8221; and &#8220;emerging growth company&#8221;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> in Rule 12b-2 of the Exchange Act.</span></p><div style="padding-left: 0;text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 37.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 62.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 7.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 30.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><ix:nonNumeric name="dei:EntityFilerCategory" id="ct-nonNumeric-90fef519-856f-4f6b-8b26-c4144f737954" contextRef="Duration_1_1_2023_To_6_30_2023"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Large Accelerated Filer</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">  </span><span style="white-space:pre-wrap; font-family: Wingdings;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; font-family: &quot;Wingdings&quot;">&#254;</span></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 62.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Accelerated Filer </span><span style="white-space:pre-wrap; font-family: Wingdings;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; font-family: &quot;Wingdings&quot;">&#168;</span></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 7.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 30.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Non-accelerated Filer  </span><span style="white-space:pre-wrap; font-family: Wingdings;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; font-family: &quot;Wingdings&quot;">&#168;</span></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 62.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Smaller Reporting Company   </span><ix:nonNumeric name="dei:EntitySmallBusiness" id="ct-nonNumeric-f0997658-cc64-4a5f-98f9-bc1b70f8fc5b" contextRef="Duration_1_1_2023_To_6_30_2023" format="ixt:booleanfalse"><span style="white-space:pre-wrap; font-family: Wingdings;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; font-family: &quot;Wingdings&quot;">&#168;</span></span></ix:nonNumeric></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 7.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 30.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 62.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Emerging Growth Company  </span><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="ct-nonNumeric-ec2b4531-722c-42ec-a3df-aa114dcd035e" contextRef="Duration_1_1_2023_To_6_30_2023" format="ixt:booleanfalse"><span style="white-space:pre-wrap; font-family: Wingdings;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; font-family: &quot;Wingdings&quot;">&#168;</span></span></ix:nonNumeric></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 6pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 6pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.20in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span><span style="white-space:pre-wrap; font-family: Wingdings;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; font-family: &quot;Wingdings&quot;">&#168;</span></span></p><p dir="ltr" style="font-family: Wingdings;font-size: 9pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.20in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2</span><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;"> of the Exchange Act</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">). Yes&#160;</span><span style="white-space:pre-wrap; font-family: Wingdings;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; font-family: &quot;Wingdings&quot;">&#168;</span></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;&#160;&#160;No&#160;</span><ix:nonNumeric name="dei:EntityShellCompany" id="ct-nonNumeric-4d6df1e3-f722-44eb-ab65-366f37dbc4b7" contextRef="Duration_1_1_2023_To_6_30_2023" format="ixt:booleanfalse"><span style="white-space:pre-wrap; font-family: Wingdings;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; font-family: &quot;Wingdings&quot;">&#254;</span></span></ix:nonNumeric></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.20in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Indicate the number of shares outstanding of each of</span><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;"> the</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> issuer&#8217;s classes of common stock, as of the latest practicable date.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.20in;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="padding-left: 0;text-align:center"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: auto;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 11.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #FFFFFF;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 39.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #FFFFFF;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 41.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 8.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 11.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 39.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 41.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 8.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 11.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 39.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Common Stock, $0.001 par value</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 41.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;"><ix:nonFraction id="ct-nonFraction-b49d038f-c680-4d45-920a-d2281935cc1e" name="dei:EntityCommonStockSharesOutstanding" contextRef="As_Of_8_1_2023" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">41,969,994</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 8.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 11.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 39.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 41.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Shares&#160;Outstanding&#160;as&#160;of&#160;August 1,&#160;2023</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 8.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 2pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 2pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 2pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 2pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">1</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">CASSAVA SCIENCES, INC.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;text-decoration: underline;">TABLE OF CONTENTS</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="padding-left: 0;text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 74.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 11.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Page No.</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">PART I.</span></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">FINANCIAL INFORMATION</span></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">   Item 1.</span></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Financial Statements</span></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Balance_Sheets" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Condensed C</span><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">onsolidated </span><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Balance Sheets &#8211; </span><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">June</span><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;"> 30, 2023 and December 31, 2022</span></a></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">3</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Statements_of_Operations" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Condensed Consolidated Statements of Operations &#8211; Three</span><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;"> and Six </span><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Months Ended </span><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">June 30</span><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">, 2</span><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">023 and 2022</span></a></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">4</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Stock_Holders_Equity" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Condensed Consolidated Statements of Changes in Stockholders&#8217; Equity - Three a</span><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">nd Six </span><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Months Ended June 30, 2023 and 2022</span></a></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">5</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Statements_of_Cash_Flows" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Condensed Consolidated Statements of Cash Flows &#8211; </span><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Six </span><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Months Ende</span><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">d June 30</span><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">, 2023 and 2022</span></a></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">6</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Notes_To_Financial_Statements" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Notes to Condensed Consolidated Financial Statements</span></a></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">7</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">   Item 2.</span></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#MDA" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">18</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">   Item 3.</span></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Quantitative_And_Qualitative_Disclosures" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">35</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">   Item 4.</span></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Controls_And_Procedures" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Controls and Procedures</span></a></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">36</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">PART II.</span></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">OTHER INFORMATION</span></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">   Item 1.</span></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Legal_Proceedings" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Legal Proceedings</span></a></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">36</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">   Item 1A</span></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Risk_Factors" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Risk Factors</span></a></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">37</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">   Item 2.</span></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Unregistered_Sales" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Unregistered Sales of Equity Securities and Use of Proceeds</span></a></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">37</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">   Item 3.</span></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Defaults_Upon_Senior_Securities" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Defaults Upon Senior Securities</span></a></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">37</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">   Item 4.</span></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Mine_Safety" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Mine Safety Disclosures</span></a></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">38</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">   Item 5.</span></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Other_Information" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Other Information</span></a></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">38</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">   Item 6.</span></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Exhibits" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Exhibits</span></a></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">39</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 12.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 73.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td colspan="3" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 86.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="#Signatures" style="text-decoration: none;"><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Signatures</span></a></p></td><td colspan="2" style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 13.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">40</span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">2</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: Times;font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: Times;font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">PART I.  FINANCIAL</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> INFORMATION</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span id="Balance_Sheets" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item 1. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Financial Statements</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><sub> </sub></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.02in;margin-top: 0;text-align: center;text-indent: -0.19in;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td colspan="6" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">CASSAVA SCIENCES, INC.</span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td colspan="6" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">CONDENSED CONSOLIDATED BALANCE SHEETS</span></p></td></tr><tr><td colspan="6" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(Unaudited, In thousands, except share and par value data)</span></p></td></tr><tr><td colspan="6" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">December 31, </span><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td colspan="6" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">ASSETS</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Current assets:</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Cash and cash equivalents</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-6a51b9e0-3ba9-473b-bfaa-5c763914b3ab" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">168,438</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-abcab2fb-4720-48d1-b813-a449ac46899f" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">201,015</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Prepaid expenses and other current assets</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e6293ab9-4de3-414f-b3e8-8a7f66743608" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">6,095</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d3225e70-c596-46ca-92d9-c4db7637fa93" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">10,211</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total current assets</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1a6d8594-c2c3-48eb-abd0-b25213bad235" name="us-gaap:AssetsCurrent" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">174,533</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-ea04b8ae-11fa-481d-9663-60436f07ecad" name="us-gaap:AssetsCurrent" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">211,226</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Operating lease right-of-use assets</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-fb0b066b-747b-4011-931a-ac2cdac2231d" name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">122</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Property and equipment, net</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-7362e236-cf04-45ed-a3b3-e2796aaad946" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">22,328</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f99dc0e7-eded-4565-b5cb-d7d6e19de09b" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">22,864</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Intangible assets, net</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-008f949c-38bb-437c-96f0-cd093f5333a7" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">387</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-26a00772-49ef-47e2-83ff-85aebc431434" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">622</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total assets</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b03498c9-15fe-42b1-96ad-16a0f56f1ca2" name="us-gaap:Assets" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">197,248</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-80a8d4a6-2b32-48b1-b990-14d389f27449" name="us-gaap:Assets" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">234,834</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td colspan="6" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">LIABILITIES AND STOCKHOLDERS&apos; EQUITY</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Current liabilities:</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Accounts payable and accrued expenses</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1b2ba653-2878-4bf7-a2a1-a4bcd704eec8" name="us-gaap:AccountsPayableCurrent" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">10,338</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-03c23549-fdcc-4296-b1f7-75820c4324b0" name="us-gaap:AccountsPayableCurrent" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">4,017</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Accrued development expense</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-05191533-e517-4f2b-a4d9-778b724eb818" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">7,044</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-6a1a5d3f-4d6e-491b-b920-7714930a8cd7" name="us-gaap:AccruedLiabilitiesCurrent" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">2,280</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Accrued compensation and benefits</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-ff09562a-7ec1-4b9f-a988-78df88b0184a" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">220</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a45a400a-f109-448d-8cf5-a6cf32aa0371" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">170</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Operating lease liabilities, current</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f1ce2c5b-8fdf-418a-8d55-6dfb85126767" name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">104</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Other current liabilities</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-51bc3d17-0a7c-4531-96bb-478bf65e5266" name="us-gaap:OtherLiabilitiesCurrent" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">293</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0ada7fb5-f0ab-44f1-b24b-4369da6ead62" name="us-gaap:OtherLiabilitiesCurrent" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">492</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total current liabilities</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a87ecf75-9520-4142-852d-4572e7e2166a" name="us-gaap:LiabilitiesCurrent" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">17,895</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0349cebb-29ff-4916-9f85-fcea59cee309" name="us-gaap:LiabilitiesCurrent" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">7,063</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Operating lease liabilities, non-current</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-5f063d3d-1ec2-4c12-817f-a08c804aed8c" name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">35</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Other non-current liabilities</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-16c80de4-d802-476d-8d33-ccfe6cbd7385" name="us-gaap:OtherLiabilitiesNoncurrent" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">197</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total liabilities</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-6e71c3bc-215a-4022-af61-5c5ec837f1b6" name="us-gaap:Liabilities" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">17,895</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-2e8c51fa-cb32-4e5a-b76b-e6c685e40c03" name="us-gaap:Liabilities" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">7,295</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Commitments and contingencies (Notes 10, 11 and 12)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-f5fbd7c9-7e72-4ab7-8180-fb220e6f5c8d;">&#160;</span></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-f054078c-0570-4d0c-9c55-32ed2826ad26;">&#160;</span></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Stockholders&apos; equity:</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Preferred stock, $</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e726e997-c49b-434c-b08b-faad05646928" name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="As_Of_12_31_2022" unitRef="Unit15" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="ct-nonFraction-410f0a6b-acab-441b-91f5-180af86cb9ef" name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="As_Of_6_30_2023" unitRef="Unit15" decimals="INF" format="ixt:numdotdecimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> par value; </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c07259f5-c127-40d1-bfb0-0622d64229e6" name="us-gaap:PreferredStockSharesAuthorized" contextRef="As_Of_12_31_2022" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="ct-nonFraction-cdea114c-3c1a-4139-b94f-f4824fe4e909" name="us-gaap:PreferredStockSharesAuthorized" contextRef="As_Of_6_30_2023" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">10,000,000</ix:nonFraction></ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> shares authorized, </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3ffa8e19-1ba7-4bd9-b37d-b9337962a0e8" name="us-gaap:PreferredStockSharesIssued" contextRef="As_Of_12_31_2022" unitRef="Unit1" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="ct-nonFraction-0a4ed798-9d52-4b52-a418-73c5a1057766" name="us-gaap:PreferredStockSharesIssued" contextRef="As_Of_6_30_2023" unitRef="Unit1" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="ct-nonFraction-59e2ed6d-2bc9-436c-96a9-25e42299d6d0" name="us-gaap:PreferredStockSharesOutstanding" contextRef="As_Of_12_31_2022" unitRef="Unit1" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="ct-nonFraction-824b4b10-d1ae-4ead-9228-97de721c6257" name="us-gaap:PreferredStockSharesOutstanding" contextRef="As_Of_6_30_2023" unitRef="Unit1" decimals="INF" format="ixt-sec:numwordsen">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> issued and outstanding</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-6e7f225c-4650-4e5a-853e-ad6507fb9bc1;">&#8212;</span></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-9456fc3f-d3a1-4567-ad49-a87cc8abe7e8;">&#8212;</span></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Common stock, $</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b74d93e6-5e7d-4e07-8f0f-d24dc1723e6b" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="As_Of_12_31_2022" unitRef="Unit15" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="ct-nonFraction-4169f8e9-5866-46e2-81e7-0507a7870ec2" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="As_Of_6_30_2023" unitRef="Unit15" decimals="INF" format="ixt:numdotdecimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> par value; </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-442c3716-6aa6-4b40-9668-c1174046c74a" name="us-gaap:CommonStockSharesAuthorized" contextRef="As_Of_12_31_2022" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="ct-nonFraction-f7ac6b68-9d52-4297-b5ad-1888405f02d0" name="us-gaap:CommonStockSharesAuthorized" contextRef="As_Of_6_30_2023" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">120,000,000</ix:nonFraction></ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> shares authorized; </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-9d6be6d1-226b-4972-b857-94804fac10d7" name="us-gaap:CommonStockSharesIssued" contextRef="As_Of_6_30_2023" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="ct-nonFraction-35a58ac2-a8de-46e4-93dd-06b327cfd50f" name="us-gaap:CommonStockSharesOutstanding" contextRef="As_Of_6_30_2023" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">41,919,527</ix:nonFraction></ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> and </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1f25f47f-f525-454d-bdec-04061b6b063e" name="us-gaap:CommonStockSharesIssued" contextRef="As_Of_12_31_2022" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="ct-nonFraction-5d1c073a-4de1-4b9b-81ab-ca6a60789cd6" name="us-gaap:CommonStockSharesOutstanding" contextRef="As_Of_12_31_2022" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">41,735,557</ix:nonFraction></ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d347c7e2-8000-4114-94ed-f8e614900689" name="us-gaap:CommonStockValue" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">42</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a16418cb-bdb5-4509-b491-c5ede2348f09" name="us-gaap:CommonStockValue" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">42</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Additional paid-in capital</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-4c0e743e-817e-43ca-96b6-118144a473a0" name="us-gaap:AdditionalPaidInCapital" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">513,510</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a63b8005-a15f-48d4-a4ab-a5e8a0a7167e" name="us-gaap:AdditionalPaidInCapital" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">511,049</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Accumulated deficit</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-dcae85da-cdc3-47ed-abd0-47caaf12bcac" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">334,199</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-ed417891-2746-428a-babd-81d79e9bfc41" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">283,552</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total stockholders&apos; equity </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-2adf73a3-7bf0-4596-8479-c8c12c4d55cf" name="us-gaap:StockholdersEquity" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">179,353</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3bcda201-312f-4c4f-885b-f7436fa74111" name="us-gaap:StockholdersEquity" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">227,539</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total liabilities and stockholders&apos; equity</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-edaa00b4-06df-4081-a117-eeda008e63c0" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">197,248</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1a20eec0-3806-4759-b431-a7d98221a948" name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">234,834</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 70.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 12.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.02in;margin-top: 0;text-align: center;text-indent: -0.19in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.19in;margin-right: 0.02in;margin-top: 0;text-align: center;text-indent: -0.19in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> See accompanying notes to condensed consolidated financial statements.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">3</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span id="Statements_of_Operations" style="text-decoration: none;"></span></p><p dir="ltr" style="font-family: Times;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: Times;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: Times;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Enstivity</span></p><p dir="ltr" style="font-family: Times;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 54.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.02in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 54.1%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.22in;"><td colspan="13" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">CASSAVA SCIENCES, INC.</span></p></td></tr><tr style="height: 0.06in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 54.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.22in;"><td colspan="13" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></p></td></tr><tr style="height: 0.18in;"><td colspan="13" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(Unaudited, in thousands, except per share data)</span></p></td></tr><tr style="height: 0.18in;"><td colspan="13" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.15in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 54.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Three months ended</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Six months ended</span></p></td></tr><tr style="height: 0.19in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 54.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p></td></tr><tr style="height: 0.16in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 54.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td></tr><tr style="height: 0.21in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 54.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Operating expenses:</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.21in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 54.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Research and development, net of grant reimbursement</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-44c3deff-fd61-4da9-938f-3af7d896b11e" name="sava:ResearchAndDevelopmentExpenseNetOfGrantReimbursement" contextRef="Duration_4_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">24,969</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-49d63b5b-9e0c-4e10-86dc-6570d78f6fa5" name="sava:ResearchAndDevelopmentExpenseNetOfGrantReimbursement" contextRef="Duration_4_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">16,948</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-fd9736d0-164c-4132-9a6e-a7dd043d435c" name="sava:ResearchAndDevelopmentExpenseNetOfGrantReimbursement" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">47,089</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1ebecc14-7972-46ee-a0b8-58a28e8af70f" name="sava:ResearchAndDevelopmentExpenseNetOfGrantReimbursement" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">31,854</ix:nonFraction></span></p></td></tr><tr style="height: 0.21in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 54.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">General and administrative </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f0147ef6-adc1-41e0-a7f4-b82706826fbf" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="Duration_4_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">3,808</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c16637b0-cd75-4ee2-94db-e2012f47d815" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="Duration_4_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">2,969</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-385473f5-5bd4-44ed-adc7-c8645e2267a0" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">8,200</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d25f93b9-50ec-4e01-8e34-9a3d1a7ff78c" name="us-gaap:GeneralAndAdministrativeExpense" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">5,884</ix:nonFraction></span></p></td></tr><tr style="height: 0.21in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 54.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total operating expenses</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-823ed6cc-3e63-43c3-a3b0-13b64fa3780c" name="us-gaap:OperatingExpenses" contextRef="Duration_4_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">28,777</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3312b4bb-c484-457e-ab77-475fab129909" name="us-gaap:OperatingExpenses" contextRef="Duration_4_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">19,917</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-352039b4-21d3-4ae4-a335-08ee2d48bb8f" name="us-gaap:OperatingExpenses" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">55,289</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e424766f-5311-4dec-9963-55092697a29f" name="us-gaap:OperatingExpenses" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">37,738</ix:nonFraction></span></p></td></tr><tr style="height: 0.21in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 54.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Operating loss</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d8ac2121-69b7-4cdc-b1dd-230494f6d8ce" name="us-gaap:OperatingIncomeLoss" contextRef="Duration_4_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">28,777</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f90edea2-184f-4efa-bc34-1ca4366c50de" name="us-gaap:OperatingIncomeLoss" contextRef="Duration_4_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">19,917</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-98cc70e1-483e-48a7-8503-94d781be4906" name="us-gaap:OperatingIncomeLoss" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">55,289</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-25804fc3-06b7-45dc-a829-29009cae9951" name="us-gaap:OperatingIncomeLoss" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">37,738</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr style="height: 0.21in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 54.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Interest income</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-de4d2112-6962-48aa-b407-259da13bb59b" name="us-gaap:InterestAndOtherIncome" contextRef="Duration_4_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">2,198</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c646d659-2f85-45cb-a87b-68493ea495b0" name="us-gaap:InterestAndOtherIncome" contextRef="Duration_4_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">314</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-494d52eb-5d1f-4dbc-9552-2fb38f3a6348" name="us-gaap:InterestAndOtherIncome" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">4,249</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-59bf2ffa-f4f7-4662-be9f-6e0b175edbb4" name="us-gaap:InterestAndOtherIncome" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">345</ix:nonFraction></span></p></td></tr><tr style="height: 0.21in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 54.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Other income, net</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-cac95c31-35c5-4845-9bfd-e55b22d64f3f" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="Duration_4_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">203</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3c542561-21bc-410c-aab4-16cb08a8c527" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="Duration_4_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">275</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d2ff81b4-7968-423e-a310-b3d2493a4d7a" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">393</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a058eb3f-44a3-41f0-a335-46817ac6523d" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">538</ix:nonFraction></span></p></td></tr><tr style="height: 0.21in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 54.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net loss</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-fe5c3910-137c-45f0-87b3-0f247c5f032f" name="us-gaap:NetIncomeLoss" contextRef="Duration_4_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">26,376</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3de1e787-2ea4-4ae9-a01f-eaaeae04ffa5" name="us-gaap:NetIncomeLoss" contextRef="Duration_4_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">19,328</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f9db00d6-bc3e-4686-8a47-df53dbff9899" name="us-gaap:NetIncomeLoss" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">50,647</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a0e85607-c898-4963-a819-7e6b549d0d50" name="us-gaap:NetIncomeLoss" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">36,855</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr style="height: 0.21in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 54.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net loss per share, basic and diluted</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-6dc65c81-482c-4125-9562-7c1818b67ba2" name="us-gaap:EarningsPerShareDiluted" contextRef="Duration_4_1_2023_To_6_30_2023" unitRef="Unit15" decimals="2" format="ixt:numdotdecimal" sign="-">0.63</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-cba19182-100f-4941-accf-7c22b96c9b6c" name="us-gaap:EarningsPerShareDiluted" contextRef="Duration_4_1_2022_To_6_30_2022" unitRef="Unit15" decimals="2" format="ixt:numdotdecimal" sign="-">0.48</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-202434b2-44cc-4f34-9e78-7abe4f67f24d" name="us-gaap:EarningsPerShareBasic" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit15" decimals="2" format="ixt:numdotdecimal" sign="-">1.21</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b5ccd96a-71b2-46af-8d67-88bd55fab4e9" name="us-gaap:EarningsPerShareBasic" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit15" decimals="2" format="ixt:numdotdecimal" sign="-">0.92</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr style="height: 0.21in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 54.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Shares used in computing net loss per share, basic and diluted</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-5cd14108-6393-4eea-b411-efc30d1ba297" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="Duration_4_1_2023_To_6_30_2023" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">41,793</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-12ac4a9d-72c7-4952-986c-d51e4cd5cb20" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="Duration_4_1_2022_To_6_30_2022" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">40,015</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-acd0e00c-ed32-4416-8177-aae658cf737d" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">41,766</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3c74575c-5a45-4436-ab57-b8e4e8e9cce9" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">39,989</ix:nonFraction></span></p></td></tr><tr style="height: 0.06in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 54.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><p dir="ltr" style="font-family: Times;font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: Times;font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: Times;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">See accompanying notes to condensed </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">consolidated </span><span style="white-space:pre-wrap; font-family: Times;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">financial stateme</span><span style="white-space:pre-wrap; font-family: Times;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">nts.</span></p><p dir="ltr" style="font-family: Times;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: Times;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span id="Stock_Holders_Equity" style="text-decoration: none;"></span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">4</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: Times;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: Times;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td colspan="14" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">CASSAVA SCIENCES, INC.</span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td colspan="14" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&apos; EQUITY</span></p></td></tr><tr><td colspan="14" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(Unaudited, in thousands, except share data)</span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="4" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 7pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Total</span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="4" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 7pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Common stock</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 7pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Additional</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 7pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Accumulated</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 7pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">stockholders&apos;</span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 7pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Shares</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 7pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Par value</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 7pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">paid-in capital</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 7pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">deficit</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 7pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 7pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 7pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">equity</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> Balance at December 31, 2021</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-cc7fb1f1-fecf-4ebb-a6a9-d7dd02e47195" name="us-gaap:SharesIssued" contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">40,016,792</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-502ff467-59aa-463b-a81d-30952deb6fdd" name="us-gaap:StockholdersEquity" contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">40</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b07bb722-78e0-4240-a424-28dde2f784e8" name="us-gaap:StockholdersEquity" contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">461,181</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-2d0a59fb-dcea-4491-944b-628f7b215ee3" name="us-gaap:StockholdersEquity" contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">207,306</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-261f0ae3-9141-4a13-a8fc-adf1f79a1a6f" name="us-gaap:StockholdersEquity" contextRef="As_Of_12_31_2021" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">253,915</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Stock-based compensation for:</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Stock options for employees</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-dabd6634-063c-4889-adf6-2255e68230e3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">471</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-74e5be70-0d07-424c-bd64-d82effbca3c7" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" contextRef="Duration_1_1_2022_To_3_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">471</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Stock options for non-employees</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-917d57f1-154d-4714-9667-08d8c04b3906" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">24</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-9671812d-72a4-4b3d-bd52-42cebf4586c5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="Duration_1_1_2022_To_3_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">24</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Issuance of common stock pursuant to exercise of stock options</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-869676e3-d2cf-4e60-ab5f-3a4b08d6dca9" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">14,488</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-273c0eb5-5bbf-4864-a7e6-3e1948ed78e6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">211</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-18efcbc3-aa0b-496f-b81b-10be4de7d184" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="Duration_1_1_2022_To_3_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">211</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net loss</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1c48af99-494b-4296-8a2e-381620300ecd" name="us-gaap:NetIncomeLoss" contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">17,527</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-15ad3755-890c-4b2e-aa71-18cfcaac16c8" name="us-gaap:NetIncomeLoss" contextRef="Duration_1_1_2022_To_3_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">17,527</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> Balance at March 31, 2022</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-eb40ad74-3ed0-4eff-9366-38abb415b5b5" name="us-gaap:SharesIssued" contextRef="As_Of_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">40,031,280</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-aa72228d-aa35-41af-aaf4-0dfdc5ddba8f" name="us-gaap:StockholdersEquity" contextRef="As_Of_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">40</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-eaf534f8-8ee4-4b8c-b8e6-77ec7f7119ce" name="us-gaap:StockholdersEquity" contextRef="As_Of_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">461,887</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-ef88d86b-19d1-4714-969b-6f1d77071360" name="us-gaap:StockholdersEquity" contextRef="As_Of_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">224,833</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-7a7d0713-ab55-4861-a3ce-d77c346c5a32" name="us-gaap:StockholdersEquity" contextRef="As_Of_3_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">237,094</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Stock-based compensation for:</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Stock options for employees</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-29924d63-b539-4eb2-be1c-207ce249a55f" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" contextRef="Duration_4_1_2022_To_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">462</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-4898dff4-05a9-49e9-9e45-62bec4d30fcf" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" contextRef="Duration_4_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">462</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Stock options for non-employees</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e4f27b11-8ecc-430d-9231-c85d851e860d" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="Duration_4_1_2022_To_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">23</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-7331dba7-40a3-4124-b4e8-9e9fa146c8e0" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="Duration_4_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">23</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Issuance of common stock pursuant to exercise of stock options</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1bf251bb-dec0-4fc9-81a5-8100a18d8386" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="Duration_4_1_2022_To_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">66,637</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-af543458-faf4-4abd-b272-003e8cd0a5a9" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="Duration_4_1_2022_To_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">119</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0409b108-925c-4084-a500-9d33a15aac10" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="Duration_4_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">119</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net loss</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c04e1a8b-63ac-4a69-a90b-456403034caf" name="us-gaap:NetIncomeLoss" contextRef="Duration_4_1_2022_To_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">19,328</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3170b43d-56b6-422a-9b35-9b8fb2df3609" name="us-gaap:NetIncomeLoss" contextRef="Duration_4_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">19,328</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> Balance at June 30, 2022</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3c7b6293-2a41-4988-94f4-09b8425d9cbc" name="us-gaap:SharesIssued" contextRef="As_Of_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">40,097,917</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-9c4769ad-96d4-4938-9583-6fd2ad0b38b7" name="us-gaap:StockholdersEquity" contextRef="As_Of_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">40</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-89c4ffa3-e52f-49f2-b6b0-a6359c4f95ab" name="us-gaap:StockholdersEquity" contextRef="As_Of_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">462,491</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c318f9c2-209e-4948-b52c-614254bfd464" name="us-gaap:StockholdersEquity" contextRef="As_Of_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">244,161</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c9dd330e-14c7-4ebc-ae45-cafa60eb70a9" name="us-gaap:StockholdersEquity" contextRef="As_Of_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">218,370</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> Balance at December 31, 2022</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-65646f5f-c16f-4ce9-bbcb-740c4dbdb69c" name="us-gaap:SharesIssued" contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">41,735,557</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-50466e3c-9d13-4f04-ac33-88ee820381ac" name="us-gaap:StockholdersEquity" contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">42</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e146bb76-2049-451d-8e8c-812c898ae18d" name="us-gaap:StockholdersEquity" contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">511,049</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e659b2a3-2d72-40c3-9de2-a3dc0068eba5" name="us-gaap:StockholdersEquity" contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">283,552</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-2f4593a8-d5b8-4e86-b6c0-bf42554a795e" name="us-gaap:StockholdersEquity" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">227,539</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Stock-based compensation for:</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Stock options for employees</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c4b30589-ee4a-4550-af7c-964eb271d233" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">650</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a69cf9ee-3e50-441c-945a-baf9bb36724d" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" contextRef="Duration_1_1_2023_To_3_31_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">650</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Stock options for non-employees</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-20e8d28e-9eba-44b3-9d22-883e13691dca" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">23</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a90c8793-c1e1-4448-8ffb-e0ba26b4e7d0" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="Duration_1_1_2023_To_3_31_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">23</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Issuance of common stock pursuant to exercise of stock options</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-265442f8-ec94-4f86-a806-bb315219b2e4" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="INF" format="ixt:numdotdecimal">13,878</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-7cfa7bcf-74ba-4c1a-84a0-f2ba6dadcd1d" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">64</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-11a94b40-fd1a-4b1d-b919-a733e4ea911f" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="Duration_1_1_2023_To_3_31_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">64</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net loss</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-914325b7-60b6-48b9-9901-ce54f5ccaaa2" name="us-gaap:NetIncomeLoss" contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">24,271</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-85213c16-5e1e-4cdd-bde3-80505df487a5" name="us-gaap:NetIncomeLoss" contextRef="Duration_1_1_2023_To_3_31_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">24,271</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> Balance at March 31, 2023</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-505d3608-5991-401f-aa8c-986d500fa197" name="us-gaap:SharesIssued" contextRef="As_Of_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">41,749,435</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a8604059-1fe3-4e54-9cc0-440817f77ad9" name="us-gaap:StockholdersEquity" contextRef="As_Of_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">42</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-662c8364-5b1b-4fb3-b87b-35a4a2be6b3b" name="us-gaap:StockholdersEquity" contextRef="As_Of_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">511,786</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e62c8fa3-d8c6-4287-8172-7f9e1c1764c2" name="us-gaap:StockholdersEquity" contextRef="As_Of_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">307,823</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-aaca66b4-f574-4c05-bce0-70d5fd7dd4a4" name="us-gaap:StockholdersEquity" contextRef="As_Of_3_31_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">204,005</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Stock-based compensation for:</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Stock options for employees</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-2afa030f-240a-4710-92dc-2360acd1a4a3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" contextRef="Duration_4_1_2023_To_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">812</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-97d55499-25c6-42ac-96b9-8425ee0c4680" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" contextRef="Duration_4_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">812</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Stock options for non-employees</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-44a931e2-f4f1-47b2-bd35-937fe8ddff1c" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="Duration_4_1_2023_To_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">23</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f5f661f7-04c6-4780-a1a5-b9f3931ea55e" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" contextRef="Duration_4_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">23</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Issuance of common stock pursuant to exercise of stock options</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-5f608138-a807-497b-847d-5385363b1639" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="Duration_4_1_2023_To_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">170,092</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f385e204-783a-4a44-af00-64a5c268932f" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="Duration_4_1_2023_To_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">889</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-4b752bf7-3640-4b77-bac5-e58e77779478" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="Duration_4_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">889</ix:nonFraction></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net loss</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d9c283d1-c087-45a6-89b8-70d3b5a864a7" name="us-gaap:NetIncomeLoss" contextRef="Duration_4_1_2023_To_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">26,376</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e2ac072f-3f2e-4ba7-b95e-a5d5d383dc4d" name="us-gaap:NetIncomeLoss" contextRef="Duration_4_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">26,376</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> Balance at June 30, 2023</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e41210c9-4f3b-4190-a819-9931d19d1828" name="us-gaap:SharesIssued" contextRef="As_Of_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">41,919,527</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-092855f0-77c5-44ab-93a4-a72aa91dd11e" name="us-gaap:StockholdersEquity" contextRef="As_Of_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">42</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a14a9e1c-897f-4c05-9a5a-d17ba503b569" name="us-gaap:StockholdersEquity" contextRef="As_Of_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">513,510</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.00in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-491a3bbd-3797-4c31-a0ee-8b66cdb291d8" name="us-gaap:StockholdersEquity" contextRef="As_Of_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">334,199</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0.05in;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-9978e5ea-e1e4-4641-831e-16cef375add1" name="us-gaap:StockholdersEquity" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">179,353</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 46.8%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 5.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.1%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: Times;font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">See accompanying notes to condensed consolidated financial statements.</span><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><br />&#8206;</span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">5</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span id="Statements_of_Cash_Flows" style="text-decoration: none;"></span></p><div style="border-bottom-style: none;border-left: none;border-right: none;border-top: none;padding-bottom: 0;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.02in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.21in;"><td colspan="6" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">CASSAVA SCIENCES, INC.</span></p></td></tr><tr style="height: 0.07in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.22in;"><td colspan="6" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 12pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></p></td></tr><tr style="height: 0.18in;"><td colspan="6" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(Unaudited, in thousands)</span></p></td></tr><tr style="height: 0.18in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.05in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.26in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Six months ended June 30,</span></p></td></tr><tr style="height: 0.18in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td></tr><tr style="height: 0.21in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Cash flows from operating activities:</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.22in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.08in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net loss</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.00in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e437c07f-3c48-476b-baaf-7eed9db9667f" name="us-gaap:NetIncomeLoss" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">50,647</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.00in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-8adda230-0567-46ff-98d8-0681276b1107" name="us-gaap:NetIncomeLoss" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">36,855</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr style="height: 0.22in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.08in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Adjustments to reconcile net loss to net cash used in operating activities:</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.22in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.17in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Stock-based compensation</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.17in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.05in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-7cdbcdc3-fcda-4dac-8b21-1b33faf064f8" name="us-gaap:ShareBasedCompensation" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">1,508</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.05in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-845b6f44-31ef-48fd-8c81-7059b6fbc46d" name="us-gaap:ShareBasedCompensation" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">980</ix:nonFraction></span></p></td></tr><tr style="height: 0.22in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.17in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Depreciation</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.17in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.05in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-6db29935-b30b-4734-ae4b-ef73607bf0b9" name="us-gaap:Depreciation" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">544</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.05in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-751bdc96-e127-4fd1-ae5f-30a2b3fd3841" name="us-gaap:Depreciation" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">352</ix:nonFraction></span></p></td></tr><tr style="height: 0.22in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.17in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Amortization of intangible assets</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.17in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.05in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-183674fe-397b-4e1b-b9ad-eb928d7be56f" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">238</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.05in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-cbc4a23c-fa1e-45f9-b5a2-7b77e7e94200" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">260</ix:nonFraction></span></p></td></tr><tr style="height: 0.22in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.17in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Changes in operating assets and liabilities:</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.17in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.22in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.25in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Prepaid and other current assets</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.25in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.05in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-493583f7-3c42-48fc-988c-467b518e8ab6" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">4,116</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.05in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-db49ffb6-92b9-4fb0-8684-cc68ad6d355a" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">4,431</ix:nonFraction></span></p></td></tr><tr style="height: 0.22in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.25in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Operating lease right-of-use assets and liabilities</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.25in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.00in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-2d65349c-a047-451c-a61d-b9e88a75ef31" name="sava:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">17</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.05in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-580b0b2b-ffd4-4c6e-bf9e-d902240b5c61" name="sava:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">4</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr style="height: 0.22in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.25in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Accounts payable and accrued expenses</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.25in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.05in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f081a72e-e603-4cc2-87db-5899612d6e0a" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">6,661</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.00in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-95a39044-b6bc-4b52-8d7f-61a8d717c86b" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">2,368</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr style="height: 0.22in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.25in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Accrued development expense</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.25in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.05in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-024a03cd-06c9-4c75-a6d0-4f719c6838e3" name="sava:IncreaseDecreaseInDevelopmentExpense" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">4,764</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.00in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-52e4c40e-7621-46f0-a118-120166cb6942" name="sava:IncreaseDecreaseInDevelopmentExpense" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">515</ix:nonFraction></span></p></td></tr><tr style="height: 0.22in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.25in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Accrued compensation and benefits</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.25in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.05in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a7df4c05-1d54-42c1-8d27-5ea0df04e8cc" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">50</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.25in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.05in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-8a098a6f-fafc-4dba-bc4d-b5b0f9ffd7df" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">1,701</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr style="height: 0.22in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.25in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Other liabilities</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.25in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.00in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-ed3b64c6-ac19-4ea4-a818-e21e189b9a54" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">396</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.00in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d2098c4a-3b7f-41b5-9bff-034eabba97e5" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">254</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr style="height: 0.22in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.33in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net cash used in operating activities</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.33in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.00in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e9424130-f026-4506-bffa-a37ddb20a618" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">33,179</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.33in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.00in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-2dcaeadc-0193-40f2-b5f9-393b6fa8c78a" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">34,644</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr style="height: 0.22in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Cash flows from investing activities:</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.22in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.08in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Purchase of property and equipment</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.08in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.00in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b73eb3c0-4dc7-4f31-a71d-7d0b0189d740" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">351</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.05in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c6c84310-70c0-44d1-88ee-2b65e92be6ac" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">1,891</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr style="height: 0.22in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.33in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net cash used in investing activities</span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.33in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.00in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0e3931e3-a7e2-4f32-904f-14bc34b6110a" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">351</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.05in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d6a87795-f5a4-4713-b9ec-adcb19a54bde" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">1,891</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr style="height: 0.22in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Cash flows from financing activities:</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.22in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.08in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Proceeds from issuance of common stock upon exercise of stock options</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.05in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-54b05005-7888-4936-bc3a-b1fa5e19a1db" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">953</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.05in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a812279d-081d-4652-a59f-6dfe092153fe" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">330</ix:nonFraction></span></p></td></tr><tr style="height: 0.22in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.33in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net cash provided by financing activities</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0.33in;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.05in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d464ba86-8944-4cf3-aa94-39e9aec54323" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">953</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.05in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c39e44ab-73a0-433f-a975-cfabb35df8f6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">330</ix:nonFraction></span></p></td></tr><tr style="height: 0.22in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net decrease in cash and cash equivalents</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.00in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d16a3605-ff87-40af-b93a-7cbc312f1816" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">32,577</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.00in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1ef090d4-5d1e-44cd-bc78-c713f4bcef01" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">36,205</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr style="height: 0.22in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Cash and cash equivalents at beginning of period</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.05in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-42d5b9a2-60ef-4fe6-9707-0ea93025137c" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">201,015</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.00in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b77b32a9-eac1-489e-8483-5776cec4ed85" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="As_Of_12_31_2021" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">233,437</ix:nonFraction></span></p></td></tr><tr style="height: 0.22in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Cash and cash equivalents at end of period</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.05in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c88e0fcd-6634-43de-a434-b7f0c4ec8ffb" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">168,438</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0.00in;margin-top: 0.05pt;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-21586ef4-f845-4d16-a54b-261ad210bc37" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="As_Of_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">197,232</ix:nonFraction></span></p></td></tr><tr style="height: 0.07in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 72.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 11.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: 0.05pt;margin-left: 0;margin-right: 0;margin-top: 0.05pt;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">See accompanying notes to condensed </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">consolidated </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">financial statements.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">6</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Cassava Sciences, Inc.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Notes to Condensed Consolidated Financial Statement</span><span id="Notes_To_Financial_Statements" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">s</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">(Unaudited)</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><ix:nonNumeric name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="ct-nonNumeric-06fe4a74-b07b-44f3-83b3-3feef1ad567b" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true" continuedAt="ct-nonNumeric-06fe4a74-b07b-44f3-83b3-3feef1ad567b-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Note 1.  General and Liquidity</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-06fe4a74-b07b-44f3-83b3-3feef1ad567b-continuation-0"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Cassava Sciences, Inc. and its wholly-owned subsidiary (collectively referred to as the &#8220;Company&#8221;) discover and develop proprietary pharmaceutical product candidates that may offer significant improvements to patients and healthcare professionals. The Company generally focuses its discovery and product development efforts on disorders of the nervous system. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) for interim financial information and pursuant to the instructions to the Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">All intercompany transactions and balances have been eliminated in consolidation.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> Accordingly, the condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete consolidated financial statements. In the opinion of management of the Company, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation have been included. Operating results for the three and six months ended June 30, 2023 are not necessarily indicative of the results that may be expected for any other interim period or for the year 2023</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">For further information, refer to the consolidated financial statements and footnotes thereto included in the Company&#8217;s Annual Report on Form&#160;10-K for the year ended December 31, 2022.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Liquidity</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company has incurred significant net losses and negative cash flows since inception, and as a result has an accumulated deficit of $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-517afb0d-d01e-4ac5-afd4-1fa685560441" name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-5" format="ixt:numdotdecimal" scale="6" sign="-">334.2</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million at June 30, 2023. The Company expects its cash requirements to be significant in the future. The amount and timing of the Company&#8217;s future cash requirements will depend on regulatory and market acceptance of its product candidates and the resources it devotes to researching and developing, formulating, manufacturing, commercializing and supporting its products. The Company may seek additional funding through public or private financing in the future, if such funding is available and on terms acceptable to the Company. There are no assurances that additional financing will be available on favorable terms, or at all. However, management believes that the current working capital position will be sufficient to meet the Company&#8217;s working capital needs for at least the next 12 months.</span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><ix:nonNumeric name="us-gaap:SignificantAccountingPoliciesTextBlock" id="ct-nonNumeric-b9c44816-6c71-4750-ad99-e7da8f52a206" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true" continuedAt="ct-nonNumeric-b9c44816-6c71-4750-ad99-e7da8f52a206-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Note 2.&#160;&#160;Significant Accounting Policies</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-b9c44816-6c71-4750-ad99-e7da8f52a206-continuation-0" continuedAt="ct-nonNumeric-b9c44816-6c71-4750-ad99-e7da8f52a206-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><ix:nonNumeric name="us-gaap:UseOfEstimates" id="ct-nonNumeric-4731bdcf-8ce3-4ca6-a0c4-e141221efb28" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true" continuedAt="ct-nonNumeric-4731bdcf-8ce3-4ca6-a0c4-e141221efb28-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Use of Estimates</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-4731bdcf-8ce3-4ca6-a0c4-e141221efb28-continuation-0"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company makes estimates and assumptions in preparing its condensed consolidated financial statements in conformity with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amount of revenue earned and expenses incurred during the reporting period. The Company evaluates&#160;its estimates on an ongoing basis, including those estimates related to manufacturing agreements and research collaborations. Actual results could differ from these estimates</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> and assumptions.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><ix:nonNumeric name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="ct-nonNumeric-27bed824-293c-461c-accb-1a8e8aff90ba" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true" continuedAt="ct-nonNumeric-27bed824-293c-461c-accb-1a8e8aff90ba-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Cash and Cash Equivalents and Concentration of Credit Risk</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-27bed824-293c-461c-accb-1a8e8aff90ba-continuation-0"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company invests in cash and cash equivalents. The Company considers highly liquid financial instruments with original maturities of three months or less to be cash equivalents. Highly liquid investments that are considered cash equivalents include money market accounts and funds, certificates of deposit, and U.S. Treasury securities.&#160;The Company maintains&#160;its cash and cash equivalents at one financial institution. </span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></ix:continuation></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">7</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <ix:continuation id="ct-nonNumeric-b9c44816-6c71-4750-ad99-e7da8f52a206-continuation-1" continuedAt="ct-nonNumeric-b9c44816-6c71-4750-ad99-e7da8f52a206-continuation-2"><div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><ix:nonNumeric name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="ct-nonNumeric-a6b441e0-ce6e-4495-b317-1f130bc4b25e" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true" continuedAt="ct-nonNumeric-a6b441e0-ce6e-4495-b317-1f130bc4b25e-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Fair Value Measurements </span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-a6b441e0-ce6e-4495-b317-1f130bc4b25e-continuation-0"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company recognizes financial instruments in accordance with the authoritative guidance on fair value measurements and disclosures for financial assets and liabilities. This guidance defines fair value, establishes a framework for measuring fair value in accordance with GAAP, and expands disclosures about fair value measurements. The guidance also establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Level 1 includes quoted prices in active markets.</span></p><p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Level 2 includes significant observable inputs, such as quoted prices for identical or similar securities, or other inputs that are observable and can be corroborated by observable market data for similar securities. The Company uses market pricing and other observable market inputs obtained from third-party providers. It uses the bid price to establish fair value where a bid price is available. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company does not have any financial instruments where the fair value is based on Level 2 inputs.</span></p><p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Level 3 includes unobservable inputs that are supported by little or no market activity. The Company does not have any financial instruments where the fair value is based on Level 3 inputs.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">If a financial instrument uses inputs that fall in different levels of the hierarchy, the instrument will be categorized based upon the lowest level of input that is significant to the fair value calculation. The fair value of cash and cash equivalents was based on Level 1 inputs at </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023 and December 31, 2022.</span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">&#65279;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><ix:nonNumeric name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="ct-nonNumeric-c58ad7df-730f-43a5-833b-2fcdd0ff93ae" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true" continuedAt="ct-nonNumeric-c58ad7df-730f-43a5-833b-2fcdd0ff93ae-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Business Segments</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-c58ad7df-730f-43a5-833b-2fcdd0ff93ae-continuation-0"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company reports segment information based on how it internally evaluates the operating performance of its business units, or segments. The Company&#8217;s operations are confined to </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a6b423f2-1d29-447c-9714-74b6951334cd" name="us-gaap:NumberOfOperatingSegments" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit17" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> business segment: the development of novel drugs and diagnostics.</span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><ix:nonNumeric name="sava:ProceedsFromGrantsPolicyPolicyTextBlock" id="ct-nonNumeric-60246e56-f1ec-4360-b24a-8926515fce87" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true" continuedAt="ct-nonNumeric-60246e56-f1ec-4360-b24a-8926515fce87-continuation-0"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Proceeds from Grants</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-60246e56-f1ec-4360-b24a-8926515fce87-continuation-0"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">&#65279;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During the three and six months ended </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023,&#160;there were </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-69861e31-f6a7-448d-83db-cd34362094cd" name="sava:ReductionToResearchAndDevelopmentExpense" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-6" format="ixt-sec:numwordsen" scale="6">no</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> reimbursements received pursuant to National Institutes of Health (&#8220;NIH&#8221;) research grants. </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During the </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">three and six months ended </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2022</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, the Company received reimbursements totaling $</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-2c520583-023a-4c49-ad2f-03046f24f02e" name="sava:ReductionToResearchAndDevelopmentExpense" contextRef="Duration_1_1_2022_To_3_31_2022" unitRef="Unit12" decimals="-5" format="ixt:numdotdecimal" scale="6">0.4</ix:nonFraction></span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million and $</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f6afe69b-5bfe-479f-b36a-4886995653a2" name="sava:ReductionToResearchAndDevelopmentExpense" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-5" format="ixt:numdotdecimal" scale="6">0.5</ix:nonFraction></span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million, respectively, pursuant to NIH research grants. </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company records the proceeds from these grants as reductions to its research and development expenses.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><ix:nonNumeric name="us-gaap:CompensationRelatedCostsPolicyTextBlock" id="ct-nonNumeric-04d4ea4a-090a-4526-8386-0bdba1ab4dbe" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true" continuedAt="ct-nonNumeric-04d4ea4a-090a-4526-8386-0bdba1ab4dbe-continuation-0"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Stock-based Compensation</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-04d4ea4a-090a-4526-8386-0bdba1ab4dbe-continuation-0"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#65279;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The&#160;Company recognizes non-cash expense for the fair value of all stock options and other share-based awards. The Company uses the Black-Scholes option valuation model (&#8220;Black-Scholes&#8221;) to calculate the fair value of stock options, using the single-option award approach and straight-line attribution method. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">This model requires the input of subjective assumptions including expected stock price volatility, expected life and estimated forfeitures of each </span><span id="_cp_text_1_372" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">award. These assumptions consist of estimates of future market conditions, which are inherently uncertain, and therefore, are subject to management&apos;s judgment. </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">For all options granted, it recognizes the resulting fair value as expense on a straight-line basis over the vesting period of each respective stock option, generally </span><ix:nonNumeric name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="ct-nonNumeric-6b59cda7-718b-4cb2-bb76-14eb4a395ed6" contextRef="Duration_1_1_2023_To_6_30_2023" format="ixt-sec:durwordsen"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">four years</span></ix:nonNumeric><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.25in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#65279;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company has granted share-based awards that vest upon achievement of certain performance criteria (&#8220;Performance Awards&#8221;). The Company multiplies the number of Performance Awards by the fair value of its common stock on the date of grant to calculate the fair value of each award. It estimates an implicit service period for achieving performance criteria for each award. The Company recognizes the resulting fair value as expense over the implicit service period when it concludes that achieving the performance criteria is probable. It periodically reviews and updates as appropriate its estimates of implicit service periods and conclusions on achieving the performance criteria. Performance Awards vest and common stock is issued upon achievement of the performance criteria.</span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">&#65279;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div></ix:continuation>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">8</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <ix:continuation id="ct-nonNumeric-b9c44816-6c71-4750-ad99-e7da8f52a206-continuation-2" continuedAt="ct-nonNumeric-b9c44816-6c71-4750-ad99-e7da8f52a206-continuation-3"><div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><ix:nonNumeric name="us-gaap:EarningsPerSharePolicyTextBlock" id="ct-nonNumeric-b0368df7-2366-430e-8ed3-a6d2ebc0e5f7" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true" continuedAt="ct-nonNumeric-b0368df7-2366-430e-8ed3-a6d2ebc0e5f7-continuation-0"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Net Loss per Share </span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-b0368df7-2366-430e-8ed3-a6d2ebc0e5f7-continuation-0"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">&#65279;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company computes basic net loss per share on the basis of the weighted-average number of common shares outstanding for the reporting period. Diluted net loss per share is computed on the basis of the weighted-average number of common shares outstanding plus potential dilutive common shares outstanding using the treasury-stock </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">method. Potential dilutive common shares consist of outstanding common stock options.&#160;&#160;There is no difference between the Company&#8217;s net loss and comprehensive loss. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The numerators and denominators in the calculation of basic and diluted net loss per share were as follows (in thousands, except net loss per share data):</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><ix:nonNumeric name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="ct-nonNumeric-df189d84-7ccf-40ff-89f2-3fe4057fcee2" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.20in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.31in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Three months ended</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Six months ended</span></p></td></tr><tr style="height: 0.20in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p></td></tr><tr style="height: 0.16in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Numerator:</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.17in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net loss</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-be72c532-e074-48c2-9b68-8289bcc3a17d" name="us-gaap:NetIncomeLoss" contextRef="Duration_4_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">26,376</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-4a022d74-f953-4869-a9f0-c1951411884d" name="us-gaap:NetIncomeLoss" contextRef="Duration_4_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">19,328</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c08662cc-0ba3-4ab1-ac7d-9ed3b45ff024" name="us-gaap:NetIncomeLoss" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">50,647</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f1df0159-42ec-4882-8d4a-a22bfdcd83d1" name="us-gaap:NetIncomeLoss" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3" sign="-">36,855</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Denominator:</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.17in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Shares used in computing net loss per share, basic and diluted</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-5ff515d1-490e-4575-b334-4226ee0416f8" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="Duration_4_1_2023_To_6_30_2023" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3"><ix:nonFraction id="ct-nonFraction-3b0f51a6-7864-4d29-bb5d-9d68d3c11ad5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="Duration_4_1_2023_To_6_30_2023" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">41,793</ix:nonFraction></ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-595430dc-b51b-4a4c-8c56-b2bd98a8da9a" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="Duration_4_1_2022_To_6_30_2022" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3"><ix:nonFraction id="ct-nonFraction-ff753831-e1ea-4f16-902d-f51bec8f2d0b" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="Duration_4_1_2022_To_6_30_2022" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">40,015</ix:nonFraction></ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-dda77587-5062-4fc2-ac49-a95c847d9513" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3"><ix:nonFraction id="ct-nonFraction-5921ed80-29b4-45a4-b1ca-54c81dcd153c" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">41,766</ix:nonFraction></ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-aa92a356-2219-4ddb-ae5d-fa2304ef86d4" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3"><ix:nonFraction id="ct-nonFraction-64ca593e-e850-42f3-a49e-4c2333c0c910" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">39,989</ix:nonFraction></ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net loss per share, basic and diluted</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-ac4c3fef-c11f-4566-82cb-2452a2491baa" name="us-gaap:EarningsPerShareBasic" contextRef="Duration_4_1_2023_To_6_30_2023" unitRef="Unit15" decimals="2" format="ixt:numdotdecimal" sign="-"><ix:nonFraction id="ct-nonFraction-b19c8459-4287-430a-afbf-d0e1a1c59259" name="us-gaap:EarningsPerShareDiluted" contextRef="Duration_4_1_2023_To_6_30_2023" unitRef="Unit15" decimals="2" format="ixt:numdotdecimal" sign="-">0.63</ix:nonFraction></ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-257b83d1-0792-4995-a061-1b3a3b86731c" name="us-gaap:EarningsPerShareBasic" contextRef="Duration_4_1_2022_To_6_30_2022" unitRef="Unit15" decimals="2" format="ixt:numdotdecimal" sign="-"><ix:nonFraction id="ct-nonFraction-89598112-7bcf-4129-ad35-20396a3c2ba5" name="us-gaap:EarningsPerShareDiluted" contextRef="Duration_4_1_2022_To_6_30_2022" unitRef="Unit15" decimals="2" format="ixt:numdotdecimal" sign="-">0.48</ix:nonFraction></ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-5e052eb4-bafe-44fb-a707-0c616ffc2ac9" name="us-gaap:EarningsPerShareBasic" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit15" decimals="2" format="ixt:numdotdecimal" sign="-"><ix:nonFraction id="ct-nonFraction-fcc1589c-5dec-4412-918b-7c8a40a0ebce" name="us-gaap:EarningsPerShareDiluted" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit15" decimals="2" format="ixt:numdotdecimal" sign="-">1.21</ix:nonFraction></ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-bc4b5931-1459-48be-831d-59025bd1e478" name="us-gaap:EarningsPerShareBasic" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit15" decimals="2" format="ixt:numdotdecimal" sign="-"><ix:nonFraction id="ct-nonFraction-195f340f-070f-400c-ad6e-bf6e20cee21e" name="us-gaap:EarningsPerShareDiluted" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit15" decimals="2" format="ixt:numdotdecimal" sign="-">0.92</ix:nonFraction></ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr style="height: 0.08in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> Dilutive common stock options excluded from net loss per share, diluted</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-2802c998-21a0-40fd-8d04-e45001a21226" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="Duration_4_1_2023_To_6_30_2023_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">2,001</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-4a3c00de-927f-4651-8d41-6bed8e24313a" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="Duration_4_1_2022_To_6_30_2022_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">1,937</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-5450853b-bd89-4ea4-b6ea-ee61ae8a1db1" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">2,018</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-dcfa3dad-cefe-48bd-a0d7-2434e4905310" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="Duration_1_1_2022_To_6_30_2022_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit1" decimals="-3" format="ixt:numdotdecimal" scale="3">2,095</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr style="height: 0.07in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div></ix:nonNumeric><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company excluded common stock options outstanding from the calculation of net loss per share, diluted, because the effect of including outstanding options would have been anti</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">-</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">dilutive. The Company also excluded </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-dece492a-d2ff-4f82-92e7-296ec05cc72f" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">57,143</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> restricted stock awards from the calculation of net loss per share, diluted, until their expiration in June 2022 because the effect of including restricted stock awards would have been anti</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">-</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">dilutive.</span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><ix:nonNumeric name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="ct-nonNumeric-2b78b96d-67fb-42d0-9005-fa949686e2ed" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true" continuedAt="ct-nonNumeric-2b78b96d-67fb-42d0-9005-fa949686e2ed-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Fair Value of Financial Instruments</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160; &#160; </span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-2b78b96d-67fb-42d0-9005-fa949686e2ed-continuation-0"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 6pt;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Financial instruments include accounts payable and accrued liabilities. The estimated fair value of certain financial instruments may be determined using available market information or other appropriate valuation methodologies. However, considerable judgment is required in interpreting market data to develop estimates of fair value; therefore, the estimates are not necessarily indicative of the amounts that could be realized or would be paid in a current market exchange. The effect of using different market assumptions and/or estimation methodologies may be material to the estimated fair value amounts. The carrying amounts of accounts payable and accrued liabilities are at cost, which approximates fair value due to the short maturity of those instruments. </span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><ix:nonNumeric name="sava:ResearchContractCostsAndAccrualsPolicyPolicyTextBlock" id="ct-nonNumeric-cf8dbfbd-1fe4-4f8e-a909-80188e65e001" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true" continuedAt="ct-nonNumeric-cf8dbfbd-1fe4-4f8e-a909-80188e65e001-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Research Contract Costs and Accruals </span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-cf8dbfbd-1fe4-4f8e-a909-80188e65e001-continuation-0"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company has entered into various research and development contracts with research institutions and other third-party vendors. These agreements are generally cancelable. Related payments are recorded as research and development expenses as incurred. The Company records prepaids and accruals for estimated ongoing research costs. When evaluating the adequacy of prepaid expenses and accrued liabilities, the Company analyzes progress of the studies including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made in determining the prepaid and accrued balances at the end of any reporting period. Actual results could differ from the Company&#8217;s estimates. The Company&#8217;s historical prepaid and accrual estimates have not been materially different from actual costs.</span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><ix:nonNumeric name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="ct-nonNumeric-e40ee3fb-1a00-48e1-a83d-9322c611086c" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true" continuedAt="ct-nonNumeric-e40ee3fb-1a00-48e1-a83d-9322c611086c-continuation-0"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Incentive Bonus Plan</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-e40ee3fb-1a00-48e1-a83d-9322c611086c-continuation-0"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In 2020, the Company established the 2020 Cash Incentive Bonus Plan (the &#8220;Plan&#8221;) to incentivize Plan participants. Awards under the Plan are accounted for as liability awards under Accounting Standards Codification (ASC) 718 &#8220;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Stock-based Compensation</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#8221;.&#160;The fair value of each&#160;potential Plan&#160;award&#160;will be&#160;determined&#160;once&#160;a&#160;grant date occurs and&#160;will be&#160;remeasured each reporting period.&#160;Compensation expense associated with the Plan&#160;will be&#160;recognized over the expected achievement period for each&#160;Plan award, when&#160;a Performance Condition&#160;(as defined below) is considered probable of being met. See Note 10 for further discussion of the Plan.</span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div></ix:continuation>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">9</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><ix:continuation id="ct-nonNumeric-b9c44816-6c71-4750-ad99-e7da8f52a206-continuation-3" continuedAt="ct-nonNumeric-b9c44816-6c71-4750-ad99-e7da8f52a206-continuation-4"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 1.00in;margin-top: 0;"><ix:nonNumeric name="us-gaap:LesseeLeasesPolicyTextBlock" id="ct-nonNumeric-f71531e7-2332-40ef-a6e4-aee8f817908f" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true" continuedAt="ct-nonNumeric-f71531e7-2332-40ef-a6e4-aee8f817908f-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Leases</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-f71531e7-2332-40ef-a6e4-aee8f817908f-continuation-0"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company recognizes&#160;assets and liabilities that arise from leases.&#160;For operating leases, the Company is required to recognize a right-of-use asset and a lease liability, initially measured at the present value of the lease payments during the lease term, in the&#160;condensed consolidated balance sheets.&#160;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company elected the short-term lease recognition exemption for all leases that qualify. This means, for those leases that qualify, the Company does not recognize right-of-use assets or lease liabilities. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">As the Company`s leases do not provide an implicit rate, it uses its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. Lease expense for lease payments is recognized on a straight-line basis over the lease term.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="ct-nonNumeric-98e8dfad-4451-4387-9f95-a9c8b946ddb8" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true" continuedAt="ct-nonNumeric-98e8dfad-4451-4387-9f95-a9c8b946ddb8-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Property and equipment</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-98e8dfad-4451-4387-9f95-a9c8b946ddb8-continuation-0"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Property and equipment is recorded at cost, net of accumulated depreciation. Depreciation is recorded using the straight-line method over the estimated useful lives of the assets. Owned buildings and related improvements have estimated useful lives of </span><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ct-nonNumeric-b869ba84-c8b6-4a5b-9ed3-7303540baf9e" contextRef="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember" format="ixt-sec:duryear"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">39</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years and approximately </span><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ct-nonNumeric-66408b36-2321-42ba-b62d-5d88650d1f46" contextRef="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember" format="ixt-sec:duryear"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">10</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years, respectively. Tenant improvements are amortized using the straight-line method over the useful lives of the improvements or the remaining term of the corresponding leases, whichever is shorter. The remaining term of the corresponding leases is approximately </span><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ct-nonNumeric-81e89339-39d1-4805-8c56-d729264a993d" contextRef="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember" format="ixt-sec:duryear"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0.9</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Property and equipment are reviewed for impairment when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. If property and equipment are considered to be impaired, an impairment loss is recognized.</span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><ix:nonNumeric name="us-gaap:IntangibleAssetsFiniteLivedPolicy" id="ct-nonNumeric-f6b6655a-6b3e-4ded-9086-f4cb692297c6" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true" continuedAt="ct-nonNumeric-f6b6655a-6b3e-4ded-9086-f4cb692297c6-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Intangible assets</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-f6b6655a-6b3e-4ded-9086-f4cb692297c6-continuation-0"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Acquired intangible assets are recorded at fair value at the date of acquisition and primarily consist of lease-in-place agreements and leasing commissions. Intangible assets are amortized over the estimated life of the lease-in-place agreements, which is approximately </span><ix:nonNumeric name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="ct-nonNumeric-20a9fc5f-95ea-4af5-b513-660f0d5cc33a" contextRef="As_Of_6_30_2023_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LeasesAcquiredInPlaceMember" format="ixt-sec:duryear"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0.8</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years at </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Intangible assets are reviewed for impairment on an annual basis, and when there is reason to believe that their values have been diminished or impaired. If intangible assets are considered</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> to be impaired, an impairment loss is recognized.</span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><ix:nonNumeric name="us-gaap:IncomeTaxPolicyTextBlock" id="ct-nonNumeric-98d79a4d-93ce-402b-ba74-d2a9f88ab40a" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true" continuedAt="ct-nonNumeric-98d79a4d-93ce-402b-ba74-d2a9f88ab40a-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Income Taxes</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-98d79a4d-93ce-402b-ba74-d2a9f88ab40a-continuation-0" continuedAt="ct-nonNumeric-98d79a4d-93ce-402b-ba74-d2a9f88ab40a-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company accounts for income taxes under the asset and liability method. &#160;Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.&#160;Deferred tax balances are adjusted to reflect tax rates based on currently enacted tax laws, which will be in effect in the years in which the temporary differences are expected to reverse.&#160;The Company has accumulated significant deferred tax assets that reflect the tax effects of net operating loss and tax credit carryovers and temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Realization of certain deferred tax assets is dependent upon future earnings. The Company is uncertain about the timing and amount of any future earnings. Accordingly, the Company offsets these deferred tax assets with a valuation allowance.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><ix:continuation id="ct-nonNumeric-98d79a4d-93ce-402b-ba74-d2a9f88ab40a-continuation-1"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company accounts for uncertain tax positions in accordance with ASC 740, &#8220;Income Taxes&#8221;, which clarifies the accounting for uncertainty in tax positions. These provisions require recognition of the impact of a tax position in the Company&#8217;s </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">condensed</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> consolidated financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Any interest and penalties related to uncertain tax positions will be reflected as a component of income tax expense.</span></ix:continuation></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><ix:continuation id="ct-nonNumeric-b9c44816-6c71-4750-ad99-e7da8f52a206-continuation-4"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></ix:continuation></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">10</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><ix:nonNumeric name="sava:PrepaidAndOtherAssetsDisclosureTextBlock" id="ct-nonNumeric-bd33eec4-8f1e-45e3-945c-296b26be5f54" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true" continuedAt="ct-nonNumeric-bd33eec4-8f1e-45e3-945c-296b26be5f54-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;letter-spacing: 0;margin: 0;padding: 0;">Note 3.  Prepaid Expenses and </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Other Current Assets</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-bd33eec4-8f1e-45e3-945c-296b26be5f54-continuation-0" continuedAt="ct-nonNumeric-bd33eec4-8f1e-45e3-945c-296b26be5f54-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Prepaid expenses and other current assets at </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023 and December 31, 2022 consisted of the following (in thousands):</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><ix:nonNumeric name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="ct-nonNumeric-1aef33c9-f0d7-49cf-8f5e-cda08eb881c7" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.17in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.21in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.31in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">December 31,</span><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Prepaid insurance</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-7b145ab6-f045-43a1-99a4-9e476d4fca80" name="us-gaap:PrepaidInsurance" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">5</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-ed0e10d0-bba8-4de7-9369-c099a230bc25" name="us-gaap:PrepaidInsurance" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">874</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr style="height: 0.17in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Contract research organization and other deposits</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a51ff561-62f4-4be1-aa41-84a80fc779a1" name="us-gaap:DepositContractsAssets" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">4,527</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-11066c2a-9835-45d0-bd35-0672c8588ff8" name="us-gaap:DepositContractsAssets" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">9,177</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Interest receivable</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b8a9052f-1110-4db4-9972-dd36eae9c579" name="us-gaap:InterestReceivableCurrent" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">1,328</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td></tr><tr style="height: 0.17in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Other</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b792fda3-4be6-45fa-b754-a6ac8c78785d" name="us-gaap:OtherPrepaidExpenseCurrent" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">235</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-572681b0-203e-4b57-ba76-dedceb3cf4a0" name="us-gaap:OtherPrepaidExpenseCurrent" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">160</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr style="height: 0.21in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">  Total prepaid expenses and other current assets</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-7e8ca0f6-cb8a-4baa-b11f-b68c6dfe7e6e" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">6,095</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-9cfe0acd-b53c-444b-b35c-a727658bc0db" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">10,211</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr></table></div></ix:nonNumeric><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;"> </span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><ix:continuation id="ct-nonNumeric-bd33eec4-8f1e-45e3-945c-296b26be5f54-continuation-1"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Contract research organization and other deposits represent cash payments made to vendors in excess of expenses incurred.</span></ix:continuation></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><ix:nonNumeric name="us-gaap:BusinessCombinationDisclosureTextBlock" id="ct-nonNumeric-3e816cce-1dd2-4462-b0d1-0d786252799a" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true" continuedAt="ct-nonNumeric-3e816cce-1dd2-4462-b0d1-0d786252799a-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;letter-spacing: 0;margin: 0;padding: 0;">Note 4. Real Property</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-3e816cce-1dd2-4462-b0d1-0d786252799a-continuation-0" continuedAt="ct-nonNumeric-3e816cce-1dd2-4462-b0d1-0d786252799a-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company owns a two-building office complex in Austin, Texas, a portion of which serves as its corporate headquarters. This property is intended to accommodate the Company&#8217;s anticipated growth and expansion of its operations in the coming years. Maintenance, physical facilities, leasing, property management and other key responsibilities related to property ownership are being outsourced to professional real-estate managers. The office complex measures approximately </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-8ef94d06-0f1c-4f35-b7e5-47a01f4a19bd" name="us-gaap:NetRentableArea" contextRef="As_Of_8_4_2021_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_AssetAcquisitionAxis_sava_TwoBuildingOfficeComplexAssetMember" unitRef="Unit16" decimals="0" format="ixt:numdotdecimal">90,000</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> rentable square feet. At </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023, the property was over </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-2c47e26d-4a50-4963-8046-709d1ae795f0" name="sava:PercentageOfCurrentlyLeased" contextRef="Duration_1_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_AssetAcquisitionAxis_sava_TwoBuildingOfficeComplexAssetMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal" scale="-2">60</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">% leased. The Company also occupies approximately </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-07d074c2-2c33-426a-84de-286859c99b77" name="sava:PercentageOfOccupancy" contextRef="Duration_1_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_AssetAcquisitionAxis_sava_TwoBuildingOfficeComplexAssetMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal" scale="-2">25</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">% of the property.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company records the net income from building operations and leases as other income, net, as leasing is not core to the Company&#8217;s operations. Building depreciation and amortization for space not occupied by the Company is included in general and administrative expense. Building depreciation and amortization for space occupied by the Company is allocated between general and administrative expense and research and development expense. Components of other income, net, for the periods presented were as follows (in thousands):</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><ix:nonNumeric name="us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" id="ct-nonNumeric-a97ab4c9-686f-41bd-9a9a-3dc9ca3000c3" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.05in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.21in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #FF0000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Three months ended</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Six months ended</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.18in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #FF0000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.16in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #FF0000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.25in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Lease revenue</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #FF0000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-ba660392-94b0-4b81-ada1-074f79c43763" name="us-gaap:OtherNonoperatingIncome" contextRef="Duration_4_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">559</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a6ed5354-4c86-415b-849c-4cd38fc91fef" name="us-gaap:OtherNonoperatingIncome" contextRef="Duration_4_1_2022_To_6_30_2022_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">586</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-843bb95d-ad34-455b-87ea-b81dc7ebd676" name="us-gaap:OtherNonoperatingIncome" contextRef="Duration_1_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">1,116</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-45cba965-23e8-475c-84f6-e1341adfadef" name="us-gaap:OtherNonoperatingIncome" contextRef="Duration_1_1_2022_To_6_30_2022_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">1,160</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.17in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.25in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Property operating expenses</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #FF0000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0828c4f4-3faf-4b22-8561-704b1ab5ac22" name="us-gaap:OtherNonoperatingExpense" contextRef="Duration_4_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">356</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-4251c9f6-0be4-4e0d-a722-e51a742e400e" name="us-gaap:OtherNonoperatingExpense" contextRef="Duration_4_1_2022_To_6_30_2022_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">311</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3ceb9b9e-22bc-4a23-8212-ff539c1a1fb7" name="us-gaap:OtherNonoperatingExpense" contextRef="Duration_1_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">723</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-fd45c941-a043-477c-b936-627944081fbe" name="us-gaap:OtherNonoperatingExpense" contextRef="Duration_1_1_2022_To_6_30_2022_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">622</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.25in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">  Other income, net</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #FF0000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-67edf1cf-962b-4c44-b928-a8fc4d63d96b" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="Duration_4_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">203</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b28db0fb-6e7a-4cf0-a43b-1bc9a4aae456" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="Duration_4_1_2022_To_6_30_2022_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">275</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-757be9ff-cb34-4018-86b2-119d4473afb8" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="Duration_1_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">393</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-2c82ebef-bb65-4eae-b6be-d44f2de89518" name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="Duration_1_1_2022_To_6_30_2022_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">538</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.06in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #FF0000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div></ix:nonNumeric></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><ix:continuation id="ct-nonNumeric-3e816cce-1dd2-4462-b0d1-0d786252799a-continuation-1"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></ix:continuation></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">11</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="ct-nonNumeric-4ef8b207-a6ad-4bb2-b763-9ea683c16c8c" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true" continuedAt="ct-nonNumeric-4ef8b207-a6ad-4bb2-b763-9ea683c16c8c-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;letter-spacing: 0;margin: 0;padding: 0;">Note 5.  Property and equipment</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-4ef8b207-a6ad-4bb2-b763-9ea683c16c8c-continuation-0" continuedAt="ct-nonNumeric-4ef8b207-a6ad-4bb2-b763-9ea683c16c8c-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The components of property and equipment, net, as of </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023&#160;and&#160;December 31, 2022&#160;were as follows (in thousands):</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="ct-nonNumeric-2e63c3fa-9330-4516-8596-e38861f2dde3" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">December 31,</span><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Land</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-086e3294-4e34-4c96-ac8f-f5ce226bb34d" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">3,734</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c42fc924-812e-42da-8362-0678a59c6695" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">3,734</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Buildings</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b4d39502-d0fc-4c57-a65b-269389a7a3f7" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">15,980</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-15e5ef62-d58e-4f37-9acb-ddba6db1ff0d" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">15,980</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Site improvements</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-be4a9adb-1252-43d1-a028-d83db6e40be1" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">470</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1ade08bb-5497-4918-8e1c-75821c17bedd" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">470</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Tenant improvements</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c82b5093-2a36-4257-9c8c-a0f47551bfca" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">3,018</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b5e83336-8da4-45c9-8194-e35f7a7048f5" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">3,016</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Furniture and equipment</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a22f685d-97fa-4bed-afce-969ce1908ec0" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">868</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b3658073-1037-410f-b3a4-7ec77697fdd5" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">851</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Construction in progress</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-9b0d8d3c-c416-4b3b-ae2b-c2ef12b960ef" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">2</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b8a6e4b2-6c6d-4f5a-aca7-2c6686fdfd9e" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">13</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">  Gross property and equipment</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-844a0884-de5a-4aa1-beb0-65cf9050027b" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">24,072</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-5dc2aeae-1886-4c07-9c1d-5dc6b195b058" name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">24,064</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Accumulated depreciation</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-97d08f78-7afd-41ea-a25d-1cac47d1aa3a" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">1,744</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-5ce04f41-43c2-4089-aa4b-ae7ebb936807" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">1,200</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">  Property and equipment, net</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d11483d1-f22c-4aa9-b823-d3c0397f8a8d" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">22,328</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f338ccdc-de1f-4df9-87c9-aca4c1ee9a3d" name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">22,864</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div></ix:nonNumeric><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><ix:continuation id="ct-nonNumeric-4ef8b207-a6ad-4bb2-b763-9ea683c16c8c-continuation-1"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Depreciation expense for property and equipment was&#160;$</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-451dd3d3-bb39-4f72-afbf-e9b3ec9b51f2" name="us-gaap:Depreciation" contextRef="Duration_4_1_2023_To_6_30_2023" unitRef="Unit12" decimals="0" format="ixt:numdotdecimal">272,000</ix:nonFraction></span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;and&#160;$</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-314d86a1-b2e2-473e-b1a9-19c626c959b7" name="us-gaap:Depreciation" contextRef="Duration_4_1_2022_To_6_30_2022" unitRef="Unit12" decimals="0" format="ixt:numdotdecimal">174,000</ix:nonFraction></span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;for the three months ended&#160;June 30, 2023&#160;and 2022, respectively. </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Depreciation expense for property and equipment was $</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-03c5e503-a6c3-46fd-8c0a-b0ad9b471d70" name="us-gaap:Depreciation" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="0" format="ixt:numdotdecimal">544,000</ix:nonFraction></span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> and $</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-641469d8-3950-4251-831e-0338682af4d9" name="us-gaap:Depreciation" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="0" format="ixt:numdotdecimal">352,000</ix:nonFraction></span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> for the six months ended June 30, 2023 and 2022, respectively.</span></ix:continuation></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><ix:nonNumeric name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="ct-nonNumeric-cfddc871-100e-499f-87b1-d80de20c8c86" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true" continuedAt="ct-nonNumeric-cfddc871-100e-499f-87b1-d80de20c8c86-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;letter-spacing: 0;margin: 0;padding: 0;">Note 6.  Intangible assets</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-cfddc871-100e-499f-87b1-d80de20c8c86-continuation-0" continuedAt="ct-nonNumeric-cfddc871-100e-499f-87b1-d80de20c8c86-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The components of intangible assets, net, as of </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023&#160;and&#160;December 31, 2022&#160;were as follows (in thousands):</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><ix:nonNumeric name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="ct-nonNumeric-81c3597a-7a88-4f4c-96b8-96b615c47526" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">December 31,</span><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Lease-in-place agreements</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-eef188b7-6dc3-4186-8515-bebdf86742f2" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="As_Of_6_30_2023_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LeasesAcquiredInPlaceMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">1,053</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-9037892e-5011-4a10-8cf7-443d3b086087" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LeasesAcquiredInPlaceMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">1,053</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Leasing commissions and other</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-aa21e7c2-562e-4c76-82cc-d021970a0f8f" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="As_Of_6_30_2023_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_sava_LeasingCommissionsAndOtherMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">293</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-40271ac9-0ccf-4c12-a257-3c36aec1537e" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_sava_LeasingCommissionsAndOtherMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">290</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">  Gross intangible assets</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-14304140-cae6-4f77-8e7f-fde598865f9d" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">1,346</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3ed16889-7cac-49ef-9feb-b28570a71c53" name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">1,343</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Accumulated amortization</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-219eabfd-9ad5-4145-984e-255742e41cc0" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">959</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-ee7a8b5d-1732-4939-adad-ece58b22c549" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">721</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">  Intangible assets, net</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-9642b871-0929-4c05-ba38-6d65a5af46e3" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">387</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-4d1e020b-5ac4-4772-869f-a759c96cd9c8" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="As_Of_12_31_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">622</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div></ix:nonNumeric><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Amortization expense for intangible assets was&#160;$</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-00da773d-a69c-465a-bdc5-8e8170f08a6a" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="Duration_4_1_2023_To_6_30_2023" unitRef="Unit12" decimals="0" format="ixt:numdotdecimal">119,000</ix:nonFraction></span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> and $</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0a6c331b-640b-4822-8fc1-d44fd318ebdf" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="Duration_4_1_2022_To_6_30_2022" unitRef="Unit12" decimals="0" format="ixt:numdotdecimal">125,000</ix:nonFraction></span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> for the three months ended&#160;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023 and 2022, respectively. Amortization expense for intangible assets was&#160;$</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-9356df7b-af4a-4ef1-bee2-e0319746a92b" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="0" format="ixt:numdotdecimal">238,000</ix:nonFraction></span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> and $</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-91fb453e-a541-4555-847c-47af76e45fcd" name="us-gaap:AmortizationOfIntangibleAssets" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="0" format="ixt:numdotdecimal">260,000</ix:nonFraction></span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> for the six months ended&#160;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023 and 2022, respectively.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Amortization expense for finite-lived intangible assets as of </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023 is expected to be as follows (in thousands):</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><ix:nonNumeric name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="ct-nonNumeric-96750b72-d4dd-4b58-92df-53b2098ca38b" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;text-decoration: underline;">For the year ending December 31,</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2023</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-8e789382-8012-4dcf-99cd-90432c52c825" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">216</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2024</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-cef4c90b-51b0-493c-b1ef-1730a92d0df0" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">167</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2025</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-8cdc8d47-61bd-44a9-bee0-fc4b695fd641" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">4</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total amortization</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-729e3eaa-7d64-482b-994f-05a4679d9f67" name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="As_Of_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">387</ix:nonFraction></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div></ix:nonNumeric></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><ix:continuation id="ct-nonNumeric-cfddc871-100e-499f-87b1-d80de20c8c86-continuation-1"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></ix:continuation></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><ix:nonNumeric name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" id="ct-nonNumeric-ae9f0d21-c45b-4482-8ffb-576f7211369a" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true" continuedAt="ct-nonNumeric-ae9f0d21-c45b-4482-8ffb-576f7211369a-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;letter-spacing: 0;margin: 0;padding: 0;">Note 7.  Stockholders&#8217; Equity and Stock-Based Compensation Expense</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-ae9f0d21-c45b-4482-8ffb-576f7211369a-continuation-0" continuedAt="ct-nonNumeric-ae9f0d21-c45b-4482-8ffb-576f7211369a-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">2022 Registered Direct Offering</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On November&#160;22, 2022, the Company completed a common stock offering pursuant to which certain investors purchased </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-daed6580-6fef-4e77-8d54-effad77d31f4" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="Duration_11_22_2022_To_11_22_2022_us-gaap_PlanNameAxis_sava_RegisteredDirectOffering2022Member_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">1,666,667</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> shares of common stock at a price of $</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c4d036e7-d46c-4448-9159-b963f56517d0" name="us-gaap:SaleOfStockPricePerShare" contextRef="As_Of_11_22_2022_us-gaap_PlanNameAxis_sava_RegisteredDirectOffering2022Member_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember" unitRef="Unit15" decimals="2" format="ixt:numdotdecimal">30.00</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> per share. Net proceeds of the offering were approximately $</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0b9f19f7-fd44-4b5a-98c8-461eb5c1a6c0" name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="Duration_11_22_2022_To_11_22_2022_us-gaap_PlanNameAxis_sava_RegisteredDirectOffering2022Member_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember" unitRef="Unit12" decimals="-5" format="ixt:numdotdecimal" scale="6">47.3</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million after deducting offering expenses.</span></p></ix:continuation></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">12</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <ix:continuation id="ct-nonNumeric-ae9f0d21-c45b-4482-8ffb-576f7211369a-continuation-1" continuedAt="ct-nonNumeric-ae9f0d21-c45b-4482-8ffb-576f7211369a-continuation-2"><div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">At-the-Market Common Stock Offering </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On May 1, 2023, the Company established a new at-the-market offering program (&#8220;ATM&#8221;) to sell, from time to time, shares of Company common stock having an aggregate offering price of up to $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-69238766-1a4e-4aab-9f46-6de3587a1f42" name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="Duration_5_1_2023_To_5_1_2023_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_sava_AtMarketEquityProgramMember" unitRef="Unit12" decimals="-6" format="ixt:numdotdecimal" scale="6">200</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million in common stock pursuant to a shelf registration statement that was filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on May 1, 2023 and became effective immediately upon filing. The Company is obligated to pay a commission of up to </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-2b7197fa-dc41-402b-b05f-126a777bf409" name="sava:PercentageOfCommissionAtmOffering" contextRef="As_Of_5_1_2023_us-gaap_PlanNameAxis_sava_AtMarketEquityProgramMember" unitRef="Unit14" decimals="4" format="ixt:numdotdecimal" scale="-2">3</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">% of the gross proceeds from the sale of shares of common stock in the offering. The Company is not obligated to sell any shares in the offering.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">There were </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-fe4f2380-b2ae-480e-be6d-532f2be4138e" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit1" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> common stock sales under the ATM during the three and six months ended </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In March 2020, the Company established an at-the-market offering program (&#8220;2020 Program&#8221;) to sell, from time to time, shares of Company common stock having an aggregate offering price of up to $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-8a396c8a-8ac0-4ff2-bf47-e453c379fc8d" name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" contextRef="Duration_3_1_2020_To_3_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_sava_AtMarketEquityProgramMember" unitRef="Unit12" decimals="-6" format="ixt:numdotdecimal" scale="6">100</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">in transactions pursuant to a shelf registration statement that was declared effective by the </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">SEC</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> on May 5, 2020</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">. The Company gave notice of termination for the 2020 Program on April 26, 2023, which was effective May 1, 2023. There were </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-75c376b1-edab-45bd-9546-98d7223b7030" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="Duration_4_30_2023_To_4_30_2023_us-gaap_PlanNameAxis_sava_AtMarketEquityProgramMember" unitRef="Unit1" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> common stock sales under the 2020 Program through its termination. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Stock Option and Performance Award Activity in 2023</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During the six months ended </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023, stock options and unvested Performance Awards outstanding under the Company&#8217;s stock option plans changed as follows:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><ix:nonNumeric name="sava:StockOptionAndPerformanceAwardActivity" id="ct-nonNumeric-d03da9ef-c6f2-46ea-9ef3-0307d5584d97" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Stock Options</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Performance Awards</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Outstanding as of December 31, 2022</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-04532607-c292-4ff0-9255-ea2103179de3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">2,529,448</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d44c06e6-fa49-4918-b53a-f9fdc79057fd" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">7,142</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Options granted</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-7be1a46c-20d3-4a7c-b834-1157b5fd4805" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">122,000</ix:nonFraction></span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-a5e09c6a-9923-4b88-9aac-2bab00d80bb7;">&#8212;</span></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Options exercised</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-ffefb78e-d984-4509-bfbc-877ae9df38e6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">281,175</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-a4ac9c2f-0510-422d-88c4-81f94dcb8f78;">&#8212;</span></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Options forfeited/canceled</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-6d017226-1b93-4225-ac6b-fd5c05847e69" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">7,142</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-cf26586d-83aa-4eed-9015-9e654cf00456;">&#8212;</span></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Outstanding as of June 30, 2023</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-761bfd61-3a46-4dc2-bb55-949bc83001c8" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="As_Of_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">2,363,131</ix:nonFraction></span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-dcd09ee0-5584-46be-8e5b-dc7c216e6b80" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" contextRef="As_Of_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">7,142</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div></ix:nonNumeric><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The weighted average exercise price of options outstanding at </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023 was $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3e924ed3-f99e-492c-af70-bbc218fea621" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="As_Of_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_sava_StockOptionAndPerformanceAwardActivity2020PlanMember" unitRef="Unit15" decimals="2" format="ixt:numdotdecimal">12.67</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">. As outstanding options vest over the current remaining vesting period of </span><ix:nonNumeric name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="ct-nonNumeric-824473da-819e-40db-9ff9-e7b005d1aef0" contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_sava_StockOptionAndPerformanceAwardActivity2020PlanMember" format="ixt-sec:duryear"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2.4</span></ix:nonNumeric><span style="white-space:pre-wrap; color: #FF0000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">years, the Company expects to recognize stock-based compensation expense of $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a2b6bdd3-11b5-40d3-8c0a-e3ea09bd1d0a" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_sava_StockOptionAndPerformanceAwardActivity2020PlanMember" unitRef="Unit12" decimals="-5" format="ixt:numdotdecimal" scale="6">8.8</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million. If and when outstanding Performance Awards vest, the Company will recognize stock-based compensation expense of $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-4171778e-a8f8-42ff-b67a-eea0682e4777" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" unitRef="Unit12" decimals="-5" format="ixt:numdotdecimal" scale="6">0.1</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million over the implicit service period.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During the three months ended </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023, there were </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-053f7790-cb34-464b-b13e-a0c868df7e2a" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="Duration_4_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">262,158</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> stock options exercised. </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Of the stock options exercised, </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-90e9f9f0-f84f-4f96-af26-75e12b1a0bba" name="sava:StockOptionsExercisedNetSettledSatisfactionOfExercisePrice" contextRef="Duration_4_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">92,066</ix:nonFraction></span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> stock options were net settled in satisfaction of the exercise price, with </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3a288816-5de9-45ed-9809-3db8fa5940e5" name="sava:ProceedsFromStockOptionsExercisedNetSettledSatisfactionOfExercisePrice" contextRef="Duration_4_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit12" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> cash proceeds received. Cash proceeds</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> to the Company </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">for options not net settled</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> totaled $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-6e7cbf24-77e4-4fe7-b96e-d47704b7ac6c" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="Duration_4_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit12" decimals="0" format="ixt:numdotdecimal">889,000</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> during the three months ended </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During the six months ended </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023, there were </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3aa703da-a540-41af-a5f1-08e3e494664e" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">281,175</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> stock options exercised. Of the stock options exercised, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-1c7213f3-f95f-49b2-aa69-81c3abbd356a" name="sava:StockOptionsExercisedNetSettledSatisfactionOfExercisePrice" contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit1" decimals="INF" format="ixt:numdotdecimal">97,205</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> stock options were net settled in satisfaction of the exercise price, with </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-69a32b1a-ef31-4d64-9e95-25d2956a78d9" name="sava:ProceedsFromStockOptionsExercisedNetSettledSatisfactionOfExercisePrice" contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit12" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> cash proceeds received. Cash proceeds to the Company for options not net settled totaled $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b7ff777c-c213-4bc2-bf38-b23ed8e258a9" name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" unitRef="Unit12" decimals="0" format="ixt:numdotdecimal">953,000</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> during the six months ended </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Stock-based Compensation Expense in 2023</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.21in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During the three and six months ended </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023 and 2022, the Company&#8217;s stock-based compensation expense was as follows (in thousands):</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><ix:nonNumeric name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="ct-nonNumeric-e5c66e48-ac7b-4739-87bb-f38313ce473b" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Three months ended</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Six months ended</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Research and development</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-de7dff0e-c92a-4b41-8fb7-a4722ed9f521" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="Duration_4_1_2023_To_6_30_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">392</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-20e3c239-e8b4-4366-b39d-8a088bc34427" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="Duration_4_1_2022_To_6_30_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">413</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-09692604-833c-41cd-b085-b56e4f8fa98e" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">781</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b3034df3-acd5-4a85-b554-f422f4a5b8d2" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="Duration_1_1_2022_To_6_30_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">835</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">General and administrative</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3bd1c7a6-735b-4742-964c-3968b27ffa34" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="Duration_4_1_2023_To_6_30_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">443</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-139611f3-b4c0-4df5-a62b-d9e984d3b29e" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="Duration_4_1_2022_To_6_30_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">72</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3143c34a-0944-43f4-8941-d0b267a8c923" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">727</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-88325696-02c4-476a-81d8-52a35123ab54" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="Duration_1_1_2022_To_6_30_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">145</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total stock-based compensation expense</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-7daadd49-7643-49e5-bdc1-fd85e5396674" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="Duration_4_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">835</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-7d006d34-6ec4-40b9-a807-2c90f5b9b465" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="Duration_4_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">485</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-61c4086f-6f49-437c-9f1f-060e746566bf" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">1,508</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-92051db0-2a93-4d2d-91a7-d47ac2cffa3a" name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal" scale="3">980</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div></ix:nonNumeric><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div></ix:continuation>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">13</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><ix:continuation id="ct-nonNumeric-ae9f0d21-c45b-4482-8ffb-576f7211369a-continuation-2" continuedAt="ct-nonNumeric-ae9f0d21-c45b-4482-8ffb-576f7211369a-continuation-3"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0.03in;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">2018 Equity Incentive Plan </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company&#8217;s Board of Directors (the &#8220;Board&#8221;) or a designated committee of the Board is responsible for administration of the Company&#8217;s 2018 Omnibus Incentive Plan, as amended (the &#8220;2018 Plan&#8221;) and determines the terms and conditions of each option granted, consistent with the terms of the 2018 Plan. The Company&#8217;s employees, directors, and consultants are eligible to receive awards under the 2018 Plan, including grants of stock options and Performance Awards. Share-based awards generally expire </span><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="ct-nonNumeric-726157a6-4eaa-4f2b-a4a0-31d4e1551c28" contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_PlanNameAxis_sava_TwoThousandEighteenEquityIncentivePlanMember" format="ixt-sec:duryear"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">10</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years from the date of grant. The 2018 Plan, as amended on May 5, 2022, provides for issuance of up to </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-92a56718-81f1-4417-a2c6-11a28064b5e5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" contextRef="Duration_5_5_2022_To_5_5_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_sava_TwoThousandEighteenEquityIncentivePlanMember" unitRef="Unit1" decimals="0" format="ixt:numdotdecimal">5,000,000</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> shares of common stock, par value $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b156ec7f-1444-4ead-a54b-f2a849702291" name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="As_Of_5_5_2022_us-gaap_PlanNameAxis_sava_TwoThousandEighteenEquityIncentivePlanMember" unitRef="Unit15" decimals="INF" format="ixt:numdotdecimal">0.001</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> per share, subject to adjustment as provided in the 2018 Plan. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#65279; </span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><ix:continuation id="ct-nonNumeric-ae9f0d21-c45b-4482-8ffb-576f7211369a-continuation-3"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">When stock options or Performance Awards are exercised net of the exercise price and taxes, the number of shares of stock issued is reduced by the number of shares equal to the amount of taxes owed by the award recipient and that number of shares are cancelled. The Company then uses&#160;its cash to pay tax authorities the amount of statutory taxes owed by and on behalf of the award recipient.</span></ix:continuation></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><ix:nonNumeric name="us-gaap:IncomeTaxDisclosureTextBlock" id="ct-nonNumeric-9a2eceb0-91fb-436a-945e-8582067de29e" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true" continuedAt="ct-nonNumeric-9a2eceb0-91fb-436a-945e-8582067de29e-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Note 8.  Income Taxes</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"> </span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-9a2eceb0-91fb-436a-945e-8582067de29e-continuation-0" continuedAt="ct-nonNumeric-9a2eceb0-91fb-436a-945e-8582067de29e-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company did </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-b0941293-7b5b-4189-9bc9-190e34541391" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="ct-nonFraction-0a0bf506-714b-47f6-9697-d31288203960" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="Duration_4_1_2023_To_6_30_2023" unitRef="Unit12" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">t provide for income taxes during the three and six months ended </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, because it has projected a net loss for the full year 2023 </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">for which any benefit will be offset by an increase in the valuation allowance</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">. There was also </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-4e06ddcb-9bbd-4dcc-bc16-50a0f270580c" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="ct-nonFraction-5ccdc675-a9c4-43d0-b53d-d1e03b72d318" name="us-gaap:IncomeTaxExpenseBenefit" contextRef="Duration_4_1_2022_To_6_30_2022" unitRef="Unit12" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> provision for income taxes for the three and six months ended </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">,</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 2022.</span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><ix:continuation id="ct-nonNumeric-9a2eceb0-91fb-436a-945e-8582067de29e-continuation-1"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></ix:continuation></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><ix:nonNumeric name="us-gaap:CommitmentsDisclosureTextBlock" id="ct-nonNumeric-e0940d7c-06fa-4815-8b5f-ca1899610b0d" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true" continuedAt="ct-nonNumeric-e0940d7c-06fa-4815-8b5f-ca1899610b0d-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Note 9.  </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Commitments</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-e0940d7c-06fa-4815-8b5f-ca1899610b0d-continuation-0" continuedAt="ct-nonNumeric-e0940d7c-06fa-4815-8b5f-ca1899610b0d-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 1.00in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Right-of-use Asset and Liability</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 1.00in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company had an operating lease for approximately </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f85e91ce-39bb-4f84-ad89-3902619a786e" name="us-gaap:NetRentableArea" contextRef="As_Of_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_LeaseContractualTermAxis_sava_OperatingLeasesMember" unitRef="Unit16" decimals="0" format="ixt:numdotdecimal">6,000</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> square feet of office space in Austin, Texas with an expiration of </span><ix:nonNumeric name="us-gaap:LeaseExpirationDate1" id="ct-nonNumeric-95837df1-1e32-4858-98ab-ab2dd4f1ebef" contextRef="Duration_1_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_LeaseContractualTermAxis_sava_OperatingLeasesMember" format="ixt:datemonthdayyearen"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">April 30, 2024</span></ix:nonNumeric><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">. The Company and the landlord consented to early terminate this lease on February 22, 2023 with no continuing obligations.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">There was </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-57556222-df9c-4c13-8015-e336830da7e4" name="us-gaap:OperatingLeaseCost" contextRef="Duration_4_1_2023_To_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember" unitRef="Unit12" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> rent expense for the three months ended June 30, 2023. Rent expense for the </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">three months ended&#160;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2022&#160;totaled $</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-2692d9dc-46c0-4b12-a4a5-ea12dff266bc" name="us-gaap:OperatingLeaseCost" contextRef="Duration_4_1_2022_To_6_30_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember" unitRef="Unit12" decimals="0" format="ixt:numdotdecimal">41,000</ix:nonFraction></span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Rent expense for the six months ended&#160;June&#160;30, 2023&#160;and 2022&#160;totaled $</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-91865e15-f1f5-4a13-baa5-adc8445eb339" name="us-gaap:OperatingLeaseCost" contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember" unitRef="Unit12" decimals="0" format="ixt:numdotdecimal">24,000</ix:nonFraction></span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> and $</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-153eac7b-398f-414f-8919-abbd92f972f9" name="us-gaap:OperatingLeaseCost" contextRef="Duration_1_1_2022_To_6_30_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember" unitRef="Unit12" decimals="0" format="ixt:numdotdecimal">82,000</ix:nonFraction></span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, respectively.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">There was </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-573b1a21-7220-4c6e-93e0-dfb154011663" name="us-gaap:OperatingLeasePayments" contextRef="Duration_4_1_2023_To_6_30_2023" unitRef="Unit12" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> cash paid for operating lease liabilities during the three months ended June 30, 2023. Cash paid for operating lease liabilities during the three months ended </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2022 totaled $</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-92b23ec1-68da-40be-a2ba-c2ef06b37fba" name="us-gaap:OperatingLeasePayments" contextRef="Duration_4_1_2022_To_6_30_2022" unitRef="Unit12" decimals="-3" format="ixt:numdotdecimal">41,000</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Cash paid for operating lease liabilities during the six months ended June&#160;30, 2023 and 2022 totaled $</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-20a95a6b-dc23-4a68-bedd-26658364bc58" name="us-gaap:OperatingLeasePayments" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit12" decimals="0" format="ixt:numdotdecimal">24,000</ix:nonFraction></span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> and $</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c8a84857-cc1f-4c83-80ca-5ef45bdee289" name="us-gaap:OperatingLeasePayments" contextRef="Duration_1_1_2022_To_6_30_2022" unitRef="Unit12" decimals="0" format="ixt:numdotdecimal">82,000</ix:nonFraction></span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, respectively.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Other Commitments</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company conducts its product research and development programs through a combination of internal and collaborative programs that include, among others, arrangements with universities, contract research organizations and clinical research sites. The Company has contractual arrangements with these organizations that are cancelable. The Company&#8217;s obligations under these contracts are largely based on services performed.</span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><ix:continuation id="ct-nonNumeric-e0940d7c-06fa-4815-8b5f-ca1899610b0d-continuation-1"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></ix:continuation></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><ix:nonNumeric name="sava:CashIncentiveBonusPlanTextBlock" id="ct-nonNumeric-3743b548-35cc-4467-93f9-22790f412cc8" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true" continuedAt="ct-nonNumeric-3743b548-35cc-4467-93f9-22790f412cc8-continuation-0"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Note&#160;10.&#160; 2020 Cash Incentive Bonus Plan</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-3743b548-35cc-4467-93f9-22790f412cc8-continuation-0" continuedAt="ct-nonNumeric-3743b548-35cc-4467-93f9-22790f412cc8-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In August 2020, the Board approved the Plan. The Plan was established to promote the long-term success of the Company by creating an &#8220;at-risk&#8221; cash bonus program that rewards&#160;Plan&#160;participants with additional cash compensation in lockstep with significant increases in the Company&#8217;s market capitalization. The Plan is considered &#8220;at-risk&#8221; because Plan participants&#160;will&#160;not receive a cash bonus&#160;unless&#160;the Company&#8217;s market capitalization increases&#160;significantly and&#160;certain&#160;other&#160;conditions specified in the Plan&#160;are met.&#160;Specifically, Plan participants&#160;will&#160;not&#160;be paid&#160;any cash bonuses unless (1) the Company completes a&#160;merger or acquisition transaction that constitutes a sale of ownership of the Company or its assets (a Merger Transaction) or (2) the Compensation Committee of the Board&#160;(the Compensation Committee) determines the Company has sufficient cash on hand, as </span></p></ix:continuation></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">14</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <ix:continuation id="ct-nonNumeric-3743b548-35cc-4467-93f9-22790f412cc8-continuation-1" continuedAt="ct-nonNumeric-3743b548-35cc-4467-93f9-22790f412cc8-continuation-2"><div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">defined in the Plan. Because&#160;of the inherent discretion and uncertainty regarding&#160;these&#160;requirements, the Company has concluded that&#160;a&#160;Plan&#160;grant date has not occurred&#160;as of </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Plan participants will be paid all earned cash bonuses in the event of a Merger Transaction.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">As of December 31, 2022, the Company&#8217;s independent directors were participants in the Plan. However, effective March 16, 2023, the Board of Directors amended the Plan to remove all independent directors as participants in the Plan and the independent directors consented to such removal. The independent directors&#8217; share of potential benefits under the Plan were completely forfeited to the Company and will not be allocated to any other participant under the Plan. The Company&#8217;s independent directors have </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-5bdb431d-85b6-4e4e-b129-296cfd6a5ffc" name="sava:CashIncentiveBonusAward" contextRef="As_Of_6_30_2023_srt_TitleOfIndividualAxis_sava_IndependentDirectorsMember" unitRef="Unit12" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">t received, and as a result of such amendment will never receive, any payments under the Plan.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company&#8217;s market capitalization for purposes of the Plan&#160;is&#160;determined based on either (1) the closing price&#160;of one share&#160;of the Company&#8217;s common stock on the Nasdaq Capital&#160;Market&#160;multiplied by the total issued and outstanding shares and options to purchase shares of the Company, or (2) the aggregate consideration payable to security holders of the Company in a&#160;Merger Transaction.&#160;This constitutes a market condition under applicable accounting guidance.&#160; &#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Plan&#160;triggers a potential cash bonus each time&#160;the&#160;Company&#8217;s market capitalization increases significantly, up to a maximum&#160;$</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-559f096e-356d-4657-9e31-65e274fb57fc" name="sava:PerformancePlanValuationAmount" contextRef="Duration_1_1_2023_To_6_30_2023_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember" unitRef="Unit12" decimals="-9" format="ixt:numdotdecimal" scale="9">5</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;billion in market capitalization. The Plan specifies 14&#160;incremental&#160;amounts&#160;between&#160;$</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d475cd38-dd68-47fc-b04d-e0f5013a1c60" name="sava:PerformancePlanValuationAmount" contextRef="Duration_1_1_2023_To_6_30_2023_srt_RangeAxis_srt_MinimumMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember" unitRef="Unit12" decimals="-6" format="ixt:numdotdecimal" scale="6">200</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million and&#160;$</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-9f477fce-2a4b-4d73-8a25-0252ba7c2b2e" name="sava:PerformancePlanValuationAmount" contextRef="Duration_1_1_2023_To_6_30_2023_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember" unitRef="Unit12" decimals="-9" format="ixt:numdotdecimal" scale="9">5</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;billion&#160;(each increment,&#160;a &#8220;Valuation Milestone&#8221;). Each&#160;Valuation Milestone&#160;triggers&#160;a potential cash bonus award in a pre-set amount defined in the Plan. Each&#160;Valuation&#160;Milestone&#160;must be achieved and maintained for no less than </span><ix:nonNumeric name="sava:MinimumNumberOfDaysValuationMilestoneMustBeAchievedAndMaintained" id="ct-nonNumeric-43b123d5-ee76-4640-b5cc-e6625b80b6c9" contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember" format="ixt-sec:durday"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">20</span></ix:nonNumeric><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> consecutive trading days for&#160;Plan&#160;participants to be eligible for a potential cash bonus award.&#160;Approximately </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0b6e9863-a848-4669-8e83-a44a30d2c374" name="sava:PercentageValuationMilestoneCashBonusAwardSubjectToApprovalAndAdjustment" contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember" unitRef="Unit14" decimals="2" format="ixt:numdotdecimal" scale="-2">67</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">% of each&#160;cash bonus award&#160;associated with a Valuation Milestone&#160;is subject to&#160;adjustment and&#160;approval&#160;by the Compensation Committee.&#160;Any amounts&#160;not awarded by the Compensation Committee&#160;are&#160;no longer available for distribution.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">If the Company were to exceed a $</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c5067883-7d95-41c3-a435-3b3aea67c58a" name="sava:PerformancePlanValuationAmount" contextRef="Duration_1_1_2023_To_6_30_2023_srt_StatementScenarioAxis_sava_ExceedingPerformanceMilestonesMinimum20ConsecutiveDaysMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember" unitRef="Unit12" decimals="-9" format="ixt:numdotdecimal" scale="9">5</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;billion market capitalization&#160;for no less than 20 consecutive trading days, all&#160;Valuation&#160;Milestones would be deemed achieved, in which case cash bonus awards would&#160;range from&#160;a minimum of&#160;$</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-aeb6e182-dbed-4b1e-93de-20f07aaec3d5" name="sava:CashIncentiveBonusAward" contextRef="As_Of_6_30_2023_srt_RangeAxis_srt_MinimumMember_srt_StatementScenarioAxis_sava_Exceeds5BillionMarketCapitalizationMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember" unitRef="Unit12" decimals="-5" format="ixt:numdotdecimal" scale="6">111.4</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million&#160;up to&#160;a hypothetical maximum of&#160;$</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e0e6401c-ad80-4c8a-aabc-212b90554250" name="sava:CashIncentiveBonusAward" contextRef="As_Of_6_30_2023_srt_RangeAxis_srt_MaximumMember_srt_StatementScenarioAxis_sava_Exceeds5BillionMarketCapitalizationMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember" unitRef="Unit12" decimals="-5" format="ixt:numdotdecimal" scale="6">289.7</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million.&#160;Payment of cash bonuses is deferred until such time as&#160;(1)&#160;the Company completes a Merger Transaction, or&#160;(2)&#160;the&#160;Compensation Committee determines the&#160;Company has sufficient cash&#160;on hand&#160;to render payment&#160;(each, a &#8220;Performance Condition&#8221;),&#160;neither&#160;of which may ever occur. Accordingly, there can be no assurance that&#160;Plan&#160;participants will&#160;ever&#160;be&#160;paid a cash bonus that is awarded under the Plan, even if the Company&#8217;s market capitalization increases&#160;significantly.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Plan is accounted for as a liability award.&#160;The fair value of each&#160;Valuation&#160;Milestone&#160;award&#160;will be&#160;determined&#160;once&#160;a&#160;grant date occurs and&#160;will be&#160;remeasured each reporting period.&#160;Compensation expense associated with the Plan&#160;will be&#160;recognized over the expected achievement period for each&#160;of the </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-e0ed36b4-5f9f-49a6-9ad6-31c655c3489f" name="sava:MinimumNumberOfValuationMilestonesToRecognizeCompensationExpense" contextRef="Duration_1_1_2023_To_6_30_2023" unitRef="Unit13" decimals="INF" format="ixt:numdotdecimal">14</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;Valuation&#160;Milestones, when&#160;a Performance Condition&#160;is considered probable of being met. &#160;&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In October 2020, the Company&#160;achieved&#160;the first&#160;Valuation&#160;Milestone.&#160;Subsequently, the Compensation Committee&#160;approved&#160;a potential cash bonus&#160;award&#160;of&#160;$</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-cf30123a-a970-4ed5-a539-0d8625432b4c" name="sava:CashIncentiveBonusAward" contextRef="As_Of_10_31_2020_srt_StatementScenarioAxis_sava_FirstValuationMilestoneMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember" unitRef="Unit12" decimals="-5" format="ixt:numdotdecimal" scale="6">6.5</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million&#160;in total&#160;for&#160;all Plan participants (after the March 2023 Plan amendment), subject to future satisfaction of a Performance Condition.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During the year ended December&#160;31, 2021, the Company achieved </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-bae15d55-397c-4b4c-a1a2-70d2119d49c5" name="sava:NumberOfValuationMilestonesAchieved" contextRef="Duration_1_1_2021_To_12_31_2021" unitRef="Unit13" decimals="INF" format="ixt:numdotdecimal">11</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> additional Valuation Milestones triggering potential Company obligations to all Plan participants from a minimum of $</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-59baea89-eb6e-4e07-9f07-8624efe9ddb5" name="sava:CashIncentiveBonusAward" contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_srt_StatementScenarioAxis_sava_SecondThroughEighthValuationMilestonesMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember" unitRef="Unit12" decimals="-5" format="ixt:numdotdecimal" scale="6">74.9</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million up to a hypothetical maximum of $</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-a146aed8-278b-4be6-97fa-f1b86689e7fc" name="sava:CashIncentiveBonusAward" contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_srt_StatementScenarioAxis_sava_SecondThroughEighthValuationMilestonesMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember" unitRef="Unit12" decimals="-5" format="ixt:numdotdecimal" scale="6">202.3</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million (after the March 2023 Plan amendment), to be determined by the Compensation Committee and contingent upon future satisfaction of a Performance Condition. However,&#160;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-f659cf2c-1c55-4c07-b82d-ff1843ad495a" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" contextRef="Duration_1_1_2023_To_6_30_2023_srt_StatementScenarioAxis_sava_SecondThroughEighthValuationMilestonesMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember" unitRef="Unit12" decimals="-5" format="ixt-sec:numwordsen" scale="6">no</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;compensation expense was recorded&#160;since no&#160;grant date has occurred and no&#160;Performance Conditions are considered probable of being met.&#160;There is no continuing service requirement for Plan participants once&#160;the Compensation Committee approves a cash&#160;bonus award.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">No Valuation Milestones were achieved during 2022 or the six months ended </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-0c1760a2-49a7-49bd-889e-dcafc4b43ce4" name="sava:PaymentsForCashIncentiveBonus" contextRef="Duration_8_3_2023_To_8_3_2023_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember" unitRef="Unit12" decimals="-5" format="ixt-sec:numwordsen" scale="6">No</ix:nonFraction></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> actual cash payments were authorized or made to participants under the Plan through the date of filing of </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">this Form 10-Q</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span></p></div></ix:continuation>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">15</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><ix:continuation id="ct-nonNumeric-3743b548-35cc-4467-93f9-22790f412cc8-continuation-2" continuedAt="ct-nonNumeric-3743b548-35cc-4467-93f9-22790f412cc8-continuation-3"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 5pt;text-align: justify;text-indent: 0.25in;"><ix:continuation id="ct-nonNumeric-3743b548-35cc-4467-93f9-22790f412cc8-continuation-3"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></ix:continuation></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><ix:nonNumeric name="us-gaap:LossContingencyDisclosures" id="ct-nonNumeric-4873d7f1-1f82-44db-bb62-3e1e457330b1" contextRef="Duration_1_1_2023_To_6_30_2023" escape="true" continuedAt="ct-nonNumeric-4873d7f1-1f82-44db-bb62-3e1e457330b1-continuation-0"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Note 11. Contingencies</span></ix:nonNumeric></p><ix:continuation id="ct-nonNumeric-4873d7f1-1f82-44db-bb62-3e1e457330b1-continuation-0" continuedAt="ct-nonNumeric-4873d7f1-1f82-44db-bb62-3e1e457330b1-continuation-1"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 120.0%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">From time to time, the Company may become involved in litigation or other legal proceedings and claims, including U.S. government inquiries, investigations</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">and Citizen Petitions submitted to FDA, and may receive inquiries from government authorities relating to matters arising from the ordinary course of business</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">. The outcome of these proceedings is inherently uncertain. Regardless of outcome, legal proceedings can have an adverse impact on the Company because of defense and settlement costs, diversion of management resources, and other factors. At this time, no assessment can be made as to their likely outcome or whether the outcome will be material to the Company. No information is available to indicate that it is probable that a loss has been incurred or can be reasonably estimated as of the date of the condensed consolidated financial statements and, as such, no accrual for these matters has been recorded within the condensed consolidated financial statements.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Government Investigations</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On November 15, 2021, the Company disclosed that certain government agencies had asked the Company to provide corporate information and documents. These were confidential requests. The Company has been voluntarily cooperating and intends to continue to cooperate with these inquiries. No government agency has informed the Company that it has found evidence of research misconduct or wrongdoing by the Company or its officers, employees or directors. No government agency has filed any claims or charges relating to these inquiries. We cannot predict the outcome or impact of these ongoing matters, including whether a government agency may pursue an enforcement action against the Company or others.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Securities Class Actions and Shareholder Derivative Actions</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Between August 27, 2021 and October 26, 2021, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d162c3fb-03e8-4062-9174-3088f58da73d" name="us-gaap:LossContingencyNewClaimsFiledNumber" contextRef="Duration_8_28_2021_To_10_26_2021_srt_LitigationCaseAxis_sava_ViolationsOfFederalSecuritiesLawsMember" unitRef="Unit13" decimals="INF" format="ixt-sec:numwordsen">four</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> putative class action lawsuits were filed alleging violations of the federal securities laws by the Company and certain named officers. The complaints rely on allegations contained in Citizen Petitions submitted to FDA and allege that various statements made by the defendants regarding simufilam were rendered materially false and misleading. The Citizen Petitions were all subsequently denied by FDA. These actions were filed in the U.S. District Court for </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the Western District of Texas. The complaints seek unspecified compensatory damages and other relief on behalf of a purported class of purchasers.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On June 30, 2022, a federal judge consolidated the four class action lawsuits into one case and appointed a lead plaintiff and a lead counsel. Lead plaintiff filed a consolidated amended complaint on August 18, 2022 on behalf of a putative class of purchasers of the Company&#8217;s securities between September 14, 2020 and July 26, 2022. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On May 11, 2023, the court dismissed with prejudice plaintiffs&#8217; claims against (deceased) defendant Nadav Friedmann, PhD, MD, but otherwise denied defendants&#8217; motion to dismiss. Defendants filed an answer to the consolidated amended complaint on July 3, 2023.   The Company believes the claims are without merit and intends to defend against these lawsuits vigorously. The Company is unable to estimate the possible loss or range of loss, if any, associated with these lawsuits.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On November 4, 2021, a related shareholder derivative action was filed, purportedly on behalf of the Company, in the U.S. District Court for the Western District of Texas, asserting claims under the U.S. securities laws and state fiduciary duty laws against certain named officers and the members of the Company&#8217;s board of directors. This complaint relies on the allegations made in Citizen Petitions that were submitted to </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">(and subsequently denied by) </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">FDA. The complaint alleges, among other things, that the individual defendants exposed the Company to unspecified damages and securities law liability by causing it to make materially false and misleading statements, in violation of the U.S. securities laws and in breach of their fiduciary duties to the Company. The derivative case seeks, among other things, to recover unspecified compensatory damages on behalf of the Company arising out of the individual defendant&#8217;s alleged wrongful conduct. Although the plaintiff in this derivative case does not seek relief against the Company, the Company has certain indemnification obligations to the individual defendants. Since November 4, 2021, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-3b448c9a-3848-4609-b30a-9ac8c9a3e4cb" name="us-gaap:LossContingencyNewClaimsFiledNumber" contextRef="Duration_11_4_2021_To_11_4_2021_srt_LitigationCaseAxis_sava_ShareholderDerivativeActionsMember" unitRef="Unit13" decimals="INF" format="ixt-sec:numwordsen">four</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> additional shareholder derivative actions were filed alleging substantially similar claims, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-4a259f7b-6971-4174-95ab-78c0079f9d58" name="us-gaap:LossContingencyNewClaimsFiledNumber" contextRef="Duration_11_4_2021_To_11_4_2021_srt_LitigationCaseAxis_sava_ShareholderDerivativeActionsU.s.DistrictCourtMember" unitRef="Unit13" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="ct-nonFraction-d4196505-d0d4-4251-8e3d-1ef40124802c" name="us-gaap:LossContingencyNewClaimsFiledNumber" contextRef="Duration_11_4_2021_To_11_4_2021_srt_LitigationCaseAxis_sava_ShareholderDerivativeActionsU.s.DistrictCourtMember" unitRef="Unit13" decimals="INF" format="ixt-sec:numwordsen">two</ix:nonFraction></ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> in the U.S. District Court for the Western District of Texas, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-d4ebadf0-b552-4b33-9695-a25efb07beec" name="us-gaap:LossContingencyNewClaimsFiledNumber" contextRef="Duration_11_4_2021_To_11_4_2021_srt_LitigationCaseAxis_sava_ShareholderDerivativeActionsTexasCourtMember" unitRef="Unit13" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> in Texas state court (Travis County District Court) and </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><ix:nonFraction id="ct-nonFraction-c3a23cb0-6350-4ec7-9251-ba1c18cccea6" name="us-gaap:LossContingencyNewClaimsFiledNumber" contextRef="Duration_11_4_2021_To_11_4_2021_srt_LitigationCaseAxis_sava_ShareholderDerivativeActionsDelwareCourtMember" unitRef="Unit13" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> in the Delaware Court of Chancery. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On July 5, 2022, the three federal court actions were consolidated into a single action.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></ix:continuation></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">16</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><ix:continuation id="ct-nonNumeric-4873d7f1-1f82-44db-bb62-3e1e457330b1-continuation-1"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On August 19, 2022, a shareholder derivative action was filed, purportedly on behalf of the Company, in the Delaware Court of Chancery, asserting claims under state fiduciary duty laws against certain named officers and members of the Company&#8217;s board of directors. The complaint alleges, among other things, that the individual defendants breached their fiduciary duties by approving the 2020 Cash Incentive Bonus Plan in August 2020. The complaints seek unspecified compensatory damages and other relief. On </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">January 6, 2023, the plaintiffs filed an amended complaint. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Defendants filed a partial answer to the amended complaint on March 10, 2023, and moved to partially dismiss the amended complaint on March 14, 2023. Defendants&#8217; motion to dismiss remains pending. </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Although the plaintiffs in this derivative case do</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> not seek relief against the Company, the Company has certain indemnification obligations to the individual defendants. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company is unable to estimate the possible loss or range of loss, if any, associated with these lawsuits.</span></p></ix:continuation><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">17</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.00in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item 2.  </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Management&#8217;s Discu</span><span id="MDA" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">ssion and Analysis of Financial Condition and Results of Operations</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.20in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">This discussion and analysis should be read in conjunction with Cassava Sciences, Inc.&#8217;s (the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221;) condensed consolidated financial statements and accompanying notes included elsewhere in this Quarterly Report on Form 10-Q. </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Operating</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> results are not necessarily indicative of results that may occur in future periods.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">This Quarterly Report on Form 10-Q contains certain statements that are considered forward-looking statements within the meaning of the Private Securities Reform Act of 1995. We intend that such statements be protected by the safe harbor created thereby. Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts. In some cases, you can identify forward-looking statements by terms such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;should,&#8221; &#8220;will&#8221; and &#8220;would&#8221; or the negatives of these terms or other comparable terminology.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. Forward-looking statements involve risks and uncertainties and our actual results and the timing of events may differ significantly from the results discussed in the forward-looking statements. Examples of such forward-looking statements include, but are not limited to statements about:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">number of patients with Alzheimer&#8217;s disease we expect to enroll in our on-going Phase 3 studies, the enrollment rates for these studies, and the length of time to complete patient enrollment for our studies and the expected safety profile or treatment benefits of simufilam for people with Alzheimer&#8217;s disease</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">our reliance on third-party contractors to conduct the clinical trials and make drug supply on a large-scale for our Phase 3 clinical program, or their ability to do so on-time or on-budget;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">limitations around data interpretation from results of our </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Cognition Maintenance Study (CMS) and </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">long-term open-label study, as compared to efficacy results from a fully completed Phase 3 clinical program;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the ability of clinical scales to assess cognition or health in our trials of Alzheimer&#8217;s disease;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">any significant changes we may make, or anticipate making, to the design of any of our on-going studies of simufilam in patients with Alzheimer&#8217;s disease;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">our ability to initiate, conduct or analyze additional clinical and non-clinical studies with our product candidates targeted at Alzheimer&#8217;s disease and other neurodegenerative diseases;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the impact of pre-clinical findings on our ability to develop our product candidates;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the interpretation of results from our  pre-clinical or early clinical studies, such as Phase 1 and Phase 2 studies;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">our plans to </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">further develop </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">SavaDx, our investigational blood-based diagnostic, and to evaluate a non-antibody approach for SavaDx;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">our ability or willingness to expand therapeutic indications for simufilam outside of Alzheimer&#8217;s disease;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the safety, efficacy, or potential therapeutic benefits of our product candidates;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">our ability to file for and obtain regulatory approval of our product candidates;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">our strategy and ability to establish an infrastructure to commercialize any product candidates, if approved;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the potential future revenues of our product candidates, if approved and commercialized;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the market acceptance of our product candidates, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">if approved and commercialized;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the pricing and reimbursement of our product candidates, if approved and commercialized;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the utility of protection, or the sufficiency, of our intellectual property;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">our potential competitors or competitive products for the treatment of Alzheimer&#8217;s disease;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">our need to raise new capital from time to time to continue our operations or to expand our operations;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">our use of multiple third-party vendors, including a Clinical Research Organization (CRO), to conduct clinical studies of our lead product candidate;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">expectations regarding trade secrets, technological innovations, licensing agreements and outsourcing of certain business functions;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">our expenses increasing by unanticipated amounts due to inflation;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">fluctuations in our financial or operating results;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">our operating losses, anticipated operating and capital expenditures and legal expenses;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">expectations regarding the issuance of shares of common stock, options or other equity to employees or directors pursuant to equity compensation awards, net of employment taxes;</span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">18</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the development and maintenance of our internal information systems and infrastructure;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">our need to hire additional personnel and our ability to attract and retain such personnel;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">existing regulations and regulatory developments in the United States and other jurisdictions in which we operate;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">our plans to expand the size and scope of our operations;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the sufficiency of our current resources to continue to fund our operations;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">potential future agreements with third parties in connection with the commercialization of our product candidates;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the accuracy of our estimates regarding expenses, capital requirements, and needs for additional financing;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">assumptions and estimates used for our disclosures regarding stock-based compensation;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the expense, timing and outcome of pending or future litigation or other legal proceedings and claims, including U.S. government inquiries</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">; and</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">litigation, claims or other uncertainties that may arise from allegations made against us or our collaborators.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.25in;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Such forward-looking statements and our business involve risks and uncertainties, including, but not limited to the following: </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We have a limited operating history in our business&#160;targeting Alzheimer&#8217;s disease and no products approved for commercial sale.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Research and development of biopharmaceutical products is a highly uncertain undertaking and involves a substantial degree of risk </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">and our</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> business is heavily dependent on the successful development of our product candidates</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We are concentrating a substantial portion of our research and development efforts on the diagnosis and treatment of Alzheimer&#8217;s disease, an area of research that has recorded many clinical failures.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We may encounter substantial delays in our clinical trials or may not be able to conduct or complete our clinical trials on the timelines we expect, if at all.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our clinical trials may fail to demonstrate evidence of the safety and efficacy of our product candidates, which would prevent, delay, or limit the scope of regulatory approval and the commercialization of our product candidates.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We may need to obtain substantial additional financing to complete the development and any commercialization of our product candidates</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We are a small company with no sales force and may not be successful in our efforts to commercialize any product candidates which are approved.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our CRO and contract manufacturers may fail to perform as anticipated</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We may be unable to protect our intellectual property rights or trade secrets</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We may be subject to third-party claims of intellectual property infringement</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We may not succeed in our maintenance or pursuit of licensing rights or third-party intellectual property necessary for the development of our product candidates</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Enacted or future legislation or regulatory actions may adversely affect our product pricing, or limit the reimbursement we may receive for our products</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">A significant breakdown, security breach or interruption affecting our internal computer systems, or those used by our third-party research collaborators, may compromise the confidentiality of our financial or proprietary information, result in material disruptions of our products and operations and adversely affect our reputation.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We may be&#160;unsuccessful at hiring and retaining qualified personnel</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We and certain of our directors and executive officers have been named as defendants in lawsuits that could result in substantial costs and divert management&#8217;s attention.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Adverse and lingering circumstances caused by disease epidemics or pandemics, such as COVID-19.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Please also refer to the section entitled </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#8220;Risk Factors</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#8221; in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, as such risk factors may be amended, updated or modified periodically in our reports filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) for further information on these and other risks affecting us. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">19</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We caution you not to place undue reliance on forward-looking statements because our future results may differ materially from those expressed or implied by them. We do not intend to update any forward-looking statement, whether written or oral, relating to the matters discussed in this Quarterly Report on Form 10-Q, except as required by law.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">This Form 10-Q may also contain statistical data and drug information based on independent industry publications or other publicly available information. We have not independently verified the accuracy or completeness of the data contained in these publicly available sources of data and information. Accordingly, we make no representations as to the accuracy or completeness of such information. You are cautioned not to give undue weight to such data.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our research programs in neurodegeneration have benefited from longstanding scientific and financial support from the National </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Institutes</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> of Health (&#8220;NIH&#8221;). The contents of this </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Quarterly Report on Form 10-Q</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> are solely our responsibility and do not necessarily represent any official views of NIH, the Department of Health and Human Services, or the United States government.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Overview</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Cassava Sciences, Inc. is a clinical-stage biotechnology company based in Austin, Texas. Our mission is to detect and treat neurodegenerative diseases, such as Alzheimer&#8217;s disease. Our novel science is based on stabilizing &#8211; but not removing &#8211; a critical protein in the brain. Our lead therapeutic drug candidate, simufilam, is being evaluated for the proposed treatment of Alzheimer&#8217;s disease dementia in Phase 3 clinical studies.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">For more than 10 years, we have combined state-of-the-art technology with new insights in neurobiology to develop novel solutions for Alzheimer&#8217;s disease and other neurodegenerative diseases. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our strategy is to leverage our unique scientific/clinical platform to develop a first-in-class program for </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">treating neurodegenerative diseases, such as Alzheimer&#8217;s</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We currently have two </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">biopharmaceutical </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">assets under development: </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">our lead therapeutic product candidate, called simufilam, is a novel oral treatment for Alzheimer&#8217;s disease dementia; and </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">our lead investigational diagnostic product candidate, called SavaDx, is a novel way to detect the presence of Alzheimer&#8217;s disease from a small sample of blood.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our scientific approach for the treatment of Alzheimer&#8217;s disease seeks to simultaneously suppress </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">both</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> neurodegeneration and neuroinflammation. We believe our ability to improve multiple vital functions in the brain represents a new, different and crucial approach to address Alzheimer&#8217;s disease. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our lead product candidate, simufilam, is a proprietary small molecule (oral) drug. Simufilam targets an altered form of a protein called filamin A (FLNA) in the Alzheimer&#8217;s brain. Published studies have demonstrated that the altered form of FLNA causes neuronal dysfunction, neuronal degeneration and neuroinflammation. We are currently conducting </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">a Phase 3 program with simufilam in patients with mild-to-moderate Alzheimer&#8217;s disease dementia.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">  </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We believe simufilam improves brain health by reverting altered FLNA back to its native, healthy conformation, thus countering the downstream toxic effects of altered FLNA. We have generated and published experimental and clinical evidence of improved brain health with simufilam. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Importantly, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">simufilam</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> is not dependent on clearing amyloid from the brain. S</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">ince simufilam has a unique mechanism of action, we believe its potential therapeutic effects may be additive or synergistic with those of other therapeutic candidates aiming to treat neurodegeneration.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Simufilam has demonstrated a multitude of treatment effects in animal models of disease, including normalizing neurotransmission, decreasing neuroinflammation, suppressing neurodegeneration, and restoring memory and cognition.  </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Simufilam was discovered and designed in-house and was characterized by our academic collaborators during research activities that were conducted from approximately 2008 to date. SavaDx is being developed in-house with outside collaborators. We own exclusive, worldwide rights to drug and diagnostic assets and related technologies, without royalty obligations to any third party. </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our patent protection with respect to simufilam and use of simufilam </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">20</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">for Alzheimer&#8217;s disease and other neurodegenerative diseases currently runs through 2039 and includes seven issued U.S. patents. In addition, we have patent protection with respect to simufilam for use in treating certain cancers that runs through 2034. Our patent estate further includes patents and patent applications for related compounds and treatments. Corresponding foreign filings have been made for each of the U.S. filings.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">About Alzheimer&#8217;s Disease</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Alzheimer&#8217;s disease is a progressive neurodegenerative disorder that affects cognition, function and behavior. As of 2021, there were approximately 55&#160;million people worldwide living with dementia, a figure expected to increase to 139&#160;million by 2050 according to outside sources. The annual global cost of dementia is now above $1 trillion, according to Alzheimer&#8217;s Disease International, a charitable organization.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Phase 2a Study</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In 2019, we completed a small, first-in-patient, clinical-proof-of-concept, open-label Phase 2a study of simufilam in the U.S., with substantial support from the National Institute on Aging (NIA), a division of the NIH. Treatment with simufilam for 28 days significantly improved certain key biomarkers of Alzheimer&#8217;s pathology, neurodegeneration and neuroinflammation (p&lt;0.001). Biomarkers effects were seen in all patients in both cerebrospinal fluid (CSF) and plasma.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Phase 2b Study</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In September 2020, we announced final results of a Phase 2b study with simufilam in Alzheimer&#8217;s disease. In this clinical study funded by the NIH, Alzheimer&#8217;s patients treated with 50 mg or 100 mg of simufilam twice-daily for 28 days showed statistically significant (p&lt;0.05) improvements in CSF biomarkers of disease pathology, neurodegeneration and neuroinflammation, versus Alzheimer&#8217;s patients who took placebo. In addition, Alzheimer&#8217;s patients treated with simufilam showed improvements in validated tests of episodic memory and spatial working memory, versus patients on placebo. Cognitive improvements correlated most strongly with decreases in levels of P-tau181, an exploratory &#8216;research use only&#8217; non-safety related biomarker that suggests brain changes from Alzheimer&#8217;s disease. Materials labeled as Research Use Only are intended for products that are still under development and are not commercially distributed.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Open-label Study Strategy</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Much of the value of our open-label study is to support simufilam&#8217;s long-term safety profile in patients. We believe a well-designed, long-term, open-label study is an exercise in prudent risk-management. Clinical results serve as a tool to help inform and manage the inherent risks and uncertainties of drug development for undertaking a large, expensive Phase 3 clinical testing program.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Open-label Study Top-line Results</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In March 2020, we initiated a long-term, open-label study to evaluate&#160;simufilam, our lead drug candidate,&#160;in patients with Alzheimer&#8217;s disease.&#160;This study&#160;was funded in part by a research grant award from NIH. </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The study </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">was designed to evaluate the long-term safety and tolerability of&#160;simufilam&#160;100 mg twice daily for 12 or more months. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Another study objective was to assess exploratory efficacy endpoints, such as changes in cognition, and biomarkers.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In January 2023, we announced positive top-line Phase 2 results for our open-label study. The study enrolled over 200 patients with mild-to-moderate Alzheimer&#8217;s disease (MMSE 16-26). Endpoints were measured at baseline (study entry) and month 12.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Alzheimer&#8217;s is a degenerative disease of the brain. Over time, cognition progressively worsens in the mild-to-moderate stages of Alzheimer&#8217;s as the disease takes its toll. ADAS-Cog scores that change minimally (or improve) over 1 year is a highly desirable outcome in a clinical study of patients with mild-to-moderate Alzheimer&#8217;s disease.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 5pt;margin-left: 0;margin-right: 0;margin-top: 5pt;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Top-line Results &#8211; mean scores, baseline to month 12 </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">(</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">lower is better, except for MMSE)</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">:</span></p><p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">ADAS-Cog11 scores changed from </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">19.1 (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#177;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">9.2) </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">to </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">19.6 (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#177;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">13.3)</span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">21</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">MMSE scores changed from </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">21.5 (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#177;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">3.6) </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">to </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">20.2 (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#177;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">6.4)</span></p><p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">NPI10 scores changed from 3.2 (&#177;4.6) to 2.9 (&#177;4.6)</span></p><p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">GDS scores changed from </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1.8 (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#177;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1.8) </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">to </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1.4 (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#177;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1.9)</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Response Analysis &#8211; baseline to month 12</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">ADAS-Cog scores improved in 47% of patients; this group had a mean change of -4.7 (&#177;3.8) points (lower is better).</span></p><p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In an additional 23% of patients, ADAS-Cog declined less than 5 points; this group had a mean change of 2.5 (&#177;1.4) points.</span></p><p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Patients with an NPI10 score of zero increased from 42% to 54%, indicating reduced dementia-related neuropsychiatric symptoms after 1 year on simufilam.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Analysis of Efficacy Endpoints</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 5pt;margin-left: 0;margin-right: 0;margin-top: 5pt;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Efficacy outcomes were analyzed by an independent, outside biostatistical consulting firm led by Suzanne Hendrix, PhD. The pre-specified primary efficacy endpoint was change in baseline on ADAS-Cog11, a cognitive scale widely used in Alzheimer&#8217;s clinical research. Exploratory endpoints included the Mini-Mental State Examination (MMSE) to assess disease stage by cognitive impairment; the Neuropsychiatric Inventory (NPI10) to assess dementia related behavior; and the Geriatric Depression Scale (GDS). The Full Analysis Set (FAS) population (N=216) was used for the statistical analysis of efficacy endpoints.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 5pt;margin-left: 0;margin-right: 0;margin-top: 5pt;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Alzheimer&#8217;s is a progressive disease. Severity of disease is typically assessed by MMSE score. In this study, mild patients are MMSE 21-26; moderate patients are MMSE 16-20. Mild and moderate sub-groups showed notable differences on changes in ADAS-Cog mean scores, baseline to month 12 (lower is better):</span></p><p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In the </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">mild</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> sub-group, ADAS-Cog scores improved, from </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">15.0 (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#177;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">6.3) </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">to </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">12.6 (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#177;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">7.8)</span></p><p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In the </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">moderate</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> sub-group, ADAS-Cog scores worsened, from </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">25.7 (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#177;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">9.2) </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">to </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">30.1 (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#177;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">13.1)</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 5pt;margin-left: 0;margin-right: 0;margin-top: 5pt;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We believe the improvement in ADAS-Cog over 1 year in mild patients taking simufilam is well outside the expected range of historic placebo decline rates from numerous other studies. Figure 1 presents a model of historical declines on ADAS-Cog in early disease (MCI + mild) and mild disease.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"><img src="sava-20230630x10qg001.jpg" style="width: 6.520139in; height: 2.115972in" alt="Chart&#xA;&#xA;Description automatically generated with low confidence" /></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Figure 1:</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"> Statistical model of simufilam versus historical 1-year placebo declines on ADAS-Cog in early disease and mild disease</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"><sup>1</sup></span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">22</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Safety Data</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Simufilam 100 mg twice daily was generally safe and well tolerated in this open-label study. There were no drug-related serious adverse events. Three treatment-emergent adverse events (TEAEs) occurred in 7% or more of study patients: COVID-19 (12%), urinary tract infection (10%) and headache (9%). Reported TEAEs are based on all study patients who received at least one dose of drug. The top three reasons for patient discontinuations were withdrawal of informed consent (N=14), adverse events (N=13) and patient non-compliance (N=7).</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Biomarker Data</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Exploratory biomarkers were analyzed from cerebrospinal fluid (CSF) collected from 25 patients in the open-label study who agreed to undergo a lumbar puncture at baseline and again after 6 months of treatment. CSF samples were analyzed blind by our academic collaborator at City University of New York. All CSF biomarkers were &#8216;research use only&#8217;, non-safety-related exploratory biomarkers. We previously announced results of this bioanalysis in a press release dated July 29, 2021.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 5pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> P-values shown below are baseline vs. 6-month levels by paired t-test:</span></p><p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">CSF biomarkers of disease pathology, t-tau and p-tau181, decreased 38% and 18%, respectively (both p&lt;0.00001)</span></p><p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">CSF biomarkers of neurodegeneration, neurogranin and neurofilament light chain (NfL), decreased 72% and 55%, respectively (both p&lt;0.00001)</span></p><p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">CSF biomarkers of neuroinflammation, sTREM2 and YKL-40, decreased 65% and 44% (both p&lt;0.00001)</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 6pt;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Limitations of Open-label Study and Top-line Results</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Data results from our open-label safety study do not constitute, and should not be interpreted as, regulatory evidence of safety or efficacy for simufilam in Alzheimer&#8217;s disease. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Rigorous evidence for drug safety and efficacy is derived from one or more large, randomized, placebo-controlled studies. The open-label design and size of this study may introduce clinical or statistical bias or may generate results that may not fully distinguish between drug effects and random variation. Different methods of statistical analysis on clinical data from the same study may lead to objectively different numerical results. These and other statistical and clinical features of our open-label study add complexity or limitations to the scope of data interpretation. In addition, &#8216;top-line data&#8217; is a summary of the clinical data prior to the completion of a full and final audit or quality-control of the clinical database. We communicated top-line data so that stakeholders had timely access to a summary of the study&#8217;s findings prior to us receiving the final dataset. Final data may change from initial top-line data.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">____________________________</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: 5pt;margin-left: 0;margin-right: 0;margin-top: 6pt;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><sup>1 </sup></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Figure 1: Forest plot</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> model by Pentara Corporation. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Data was sourced from non-randomized studies (i.e., ADNI) and randomized, controlled trials </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">conducted by other sponsors in patients with </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">early (i.e., MCI + mild) and mild Alzheimer&#8217;s disease.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">23</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Cognition Maintenance Study</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 5pt;margin-left: 0;margin-right: 0;margin-top: 5pt;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In May 2021, we initiated a Cognition Maintenance Study (CMS). The CMS is a randomized, withdrawal study design. ICH</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><sup>2</sup></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> defines this type of study design as follows: </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">&#8220;In a randomized withdrawal trial, subjects receiving a test&#160;treatment for a specified time are randomly assigned to continued treatment with the test treatment or to placebo (i.e., withdrawal of active therapy)</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"> &#8230;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">&#160;Any difference that emerges between the group receiving continued treatment and the group randomized to placebo would demonstrate the effect of the active treatment</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">&#8221;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The CMS study design is intended to evaluate simufilam&#8217;s effects on cognition and health outcomes in Alzheimer&#8217;s patients who continue with drug treatment versus patients who discontinue drug treatment. It is a double-blind, randomized, placebo-controlled study of simufilam in patients with mild-to-moderate Alzheimer&#8217;s disease. Study patients are randomized (1:1) to simufilam or placebo for six months. To enroll in this study, patients must have previously completed 12 months or more of open-label treatment with simufilam. Final enrollment was 157 patients. See Figure 2.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Figure 2. Cognition Maintenance Study Design</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><img src="sava-20230630x10qg002.jpg" style="width: 6.520139in; height: 2.022917in" alt="Graphical user interface&#xA;&#xA;Description automatically generated with low confidence" /></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Top-line Results</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Simufilam treatment for 6 months slowed cognitive decline by 38% compared to placebo in mild-to-moderate Alzheimer&#8217;s disease (MMSE 16-26). The placebo arm declined 1.5 points on ADAS-Cog, and this arm declined at all measured timepoints. The simufilam arm declined 0.9 points on ADAS-Cog, a 38% difference in favor of drug at month 6 (95% CI, &#8211; 2.1 to 1.0; not significant for sample sizes). See Table 1 and Chart 1.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Table 1: Results of Randomized Withdrawal Study &#8211; cognitive change, full analysis set (FAS)</span></p><div style="padding-left: 0;text-align:center"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: auto;margin-right: auto;"><tr style="height: 0.01in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 87.5pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 114.75pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 2pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 69.75pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 2pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 74.35pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 112.6pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 5.4pt;padding-right: 5.4pt;padding-top: 0;vertical-align: middle;width: 87.5pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 2pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Full Analysis Set</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 5.4pt;padding-right: 5.4pt;padding-top: 0;vertical-align: middle;width: 114.75pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 2pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Simufilam 100 mg</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 2pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(N = 78)</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 5.4pt;padding-right: 5.4pt;padding-top: 0;vertical-align: middle;width: 69.75pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 2pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Placebo</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 2pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(N = 77)</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 5.4pt;padding-right: 5.4pt;padding-top: 0;vertical-align: middle;width: 74.35pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 2pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Numerical Difference</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 5.4pt;padding-right: 5.4pt;padding-top: 0;vertical-align: middle;width: 112.6pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 2pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Percent Difference</span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 5.4pt;padding-right: 5.4pt;padding-top: 0;vertical-align: top;width: 87.5pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">6-month Change in</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">ADAS-Cog</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 5.4pt;padding-right: 5.4pt;padding-top: 0;vertical-align: middle;width: 114.75pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0.9 point</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Decline</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 5.4pt;padding-right: 5.4pt;padding-top: 0;vertical-align: middle;width: 69.75pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1.5 point</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Decline</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 5.4pt;padding-right: 5.4pt;padding-top: 0;vertical-align: middle;width: 74.35pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.30in;margin-right: 0.17in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#8211; 0.6</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 5.4pt;padding-right: 5.4pt;padding-top: 0;vertical-align: middle;width: 112.6pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">38% in favor of drug</span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">____________________________</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 6pt;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><sup>2  </sup></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH), Topic E10, Choice of Control Group in Clinical Trials.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">24</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: Calibri;font-size: 10pt;line-height: 150.0%;margin-bottom: 12pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><img src="sava-20230630x10qg003.jpg" style="width: 6.520139in; height: 4.085417in" alt="A graph showing the difference between a number of different scores&#xA;&#xA;Description automatically generated with medium confidence" /></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Upon randomization into the CMS, mean baseline MMSE scores were 18.6 and 18.1 for the simufilam and placebo arms, respectively. Mean baseline ADAS-Cog scores were 19.3 and 21.9 for the simufilam and placebo arms, respectively.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Simufilam Drug Effects Favored Patients with Mild Alzheimer&#8217;s Disease.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Simufilam treatment for 6 months slowed cognitive decline &gt; 200% compared to placebo in mild Alzheimer&#8217;s disease. CMS patients with mild Alzheimer&#8217;s (MMSE 21-26) on placebo declined 0.6 points on ADAS-Cog over 6 months as a group. CMS patients with mild Alzheimer&#8217;s on simufilam improved 0.6 points over 6 months as a group, a 205% difference in favor of drug (95% CI, &#8211; 2.6 to 0.4; not significant for sample sizes). See Table 2 and Chart 2.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Table 2: Results of Randomized Withdrawal Study &#8211; cognitive change, mild patients</span></p><div style="padding-left: 0;text-align:center"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: auto;margin-right: auto;"><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 93.75pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 121.7pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 74.15pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 79.2pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 119.5pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 93.75pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 121.7pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 74.15pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 79.2pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 119.5pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 5.4pt;padding-right: 5.4pt;padding-top: 0;vertical-align: middle;width: 93.75pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Mild Patients</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 5.4pt;padding-right: 5.4pt;padding-top: 0;vertical-align: top;width: 121.7pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Simufilam 100 mg</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(N= 40)</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 5.4pt;padding-right: 5.4pt;padding-top: 0;vertical-align: top;width: 74.15pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Placebo</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">(N= 36)</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 5.4pt;padding-right: 5.4pt;padding-top: 0;vertical-align: top;width: 79.2pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Numerical</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Difference</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 5.4pt;padding-right: 5.4pt;padding-top: 0;vertical-align: middle;width: 119.5pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Percent Difference</span></p></td></tr><tr><td style="border-bottom: solid windowtext 1.0pt;border-left: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 5.4pt;padding-right: 5.4pt;padding-top: 0;vertical-align: top;width: 93.75pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">6-month Changes in</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">ADAS-Cog</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 5.4pt;padding-right: 5.4pt;padding-top: 0;vertical-align: top;width: 121.7pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0.6 point</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Improvement</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 5.4pt;padding-right: 5.4pt;padding-top: 0;vertical-align: top;width: 74.15pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0.6 point</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Decline</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 5.4pt;padding-right: 5.4pt;padding-top: 0;vertical-align: middle;width: 79.2pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#8211;&#160;1.1</span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left: solid windowtext 1.0pt;border-right: solid windowtext 1.0pt;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 5.4pt;padding-right: 5.4pt;padding-top: 0;vertical-align: middle;width: 119.5pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">205% in favor of drug</span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 150.0%;margin-bottom: 12pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">25</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><img src="sava-20230630x10qg004.jpg" style="width: 6.520139in; height: 4.093056in" alt="A graph showing the results of a patient's recovery&#xA;&#xA;Description automatically generated" /></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Upon randomization into the CMS, mean baseline MMSE scores for mild patients were MMSE 24.0 and MMSE 24.1 for the simufilam and placebo arms, respectively. Mean baseline ADAS-Cog scores for mild patients were 11.0 and 11.2 for the simufilam and placebo arms, respectively.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 150.0%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Simufilam for 18 months stabilized cognition in mild Alzheimer&#8217;s disease.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">After taking open-label simufilam for 12 months, 76 patients with mild Alzheimer&#8217;s disease (MMSE 21-26) enrolled in the CMS and were randomized to receive either simufilam (N=40) or placebo (N=36) for 6 months. Mild patients randomized to simufilam in the CMS showed no material decline in ADAS-Cog scores over 18 months as a group, indicating stable cognition. Mild patients randomized to placebo in the CMS (and therefore withdrawn from simufilam treatment for 6 months) declined by 0.8 points in ADAS-Cog as a group. See Figure 3.</span></p><p dir="ltr" style="font-family: Calibri;font-size: 10pt;line-height: 150.0%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><img src="sava-20230630x10qg005.jpg" style="width: 6.436111in; height: 2.298611in" alt="Picture 19" /></span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">26</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Figure 3. Historical declines on ADAS-Cog over 18 months in Alzheimer&apos;s disease (MMSE 20-30), placebo arms vs simufilam treatment.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"><sup>1</sup></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Notes: results shown for CLARITY P3 trial of lecanemab; EMERGE and ENGAGE P3 studies of aducanumab; and TRAILBLAZER P3 trial of donanemab; in this figure, the CMS is referred to as the &#8216;PTI-125-04&#8217; study; &#8216;Simufilam100mg-Simufilam100mg&#8217; refers to patients who received simufilam in both the open-label phase and the CMS; &#8216;Simufilam100mg-Placebo&#8217; refers to patients who received simufilam in the open-label phase and placebo in the CMS.</span></p><p dir="ltr" style="font-family: Calibri;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Safety Data</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Simufilam 100 mg twice daily was safe and well tolerated in this study. There were no drug-related serious adverse events. No treatment-emergent adverse events (TEAEs) occurred in 5% or more of study participants in the CMS.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #0A0A0A;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Discussion</span></p><p dir="ltr" style="font-family: Calibri;font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The CMS was a randomized withdrawal study. Patients who completed 12 months of open-label simufilam treatment were all invited to participate in the CMS. It is not known how long a washout period may be needed to remove lingering drug effects, if any, from prior treatment with open-label simufilam for 12 months.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In this small study of oral simufilam in patients with mild-to-moderate Alzheimer&#8217;s disease, the pre-specified cognitive endpoint showed a 38% decline in ADAS-Cog over six months in favor of simufilam, with good drug safety. Effects were pronounced in mild patients. Mean baseline MMSE and ADAS-Cog scores were approximately balanced given the small size of each arm.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Analysis of Efficacy Endpoints</span></p><p dir="ltr" style="font-family: Calibri;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The pre-specified cognition endpoints were analyzed by Pentara Corporation, an independent consulting firm that specializes in complex statistical analysis of clinical trial results. Suzanne Hendrix, PhD, CEO of Pentara, has over 150 peer-reviewed publications of clinical trial results and statistical approaches for clinical trials, many focusing on statistical methodology for Alzheimer&#8217;s disease.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: Calibri;font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Chain of Custody for Clinical Data</span></p><p dir="ltr" style="font-family: Calibri;font-size: 12pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 12pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Investigator sites collected clinical data from study participants. Sites entered their clinical data directly into an electronic data capture system managed by an independent, outside data management vendor. The data management vendor also maintains the clinical database. The data management vendor transmitted the clinical database directly to Pentara Corporation for analysis.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Study Limitations</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The CMS is a proof-of-concept study involving a small number of patients and limited data. Top-line clinical CMS results do not constitute, and should not be interpreted as, regulatory evidence of safety or efficacy for simufilam in Alzheimer&#8217;s disease. Rigorous evidence for drug safety and efficacy is derived from one or more large, randomized placebo-controlled Phase 3 studies. The limited size of the CMS may introduce clinical or statistical bias or may generate results that may not fully distinguish between drug effects and random variation. Different methods of statistical analysis on clinical data from the same study may lead to objectively different numerical results. These and other statistical and clinical features of our CMS study add complexity or limitations to the scope of data interpretation. In addition, &#8216;Top-line data&#8217; is a summary of the clinical data prior to the completion of a full and final audit or quality-control of the clinical database. We are communicating top-line data so that stakeholders may have timely access to a summary of the CMS findings prior to us receiving the final dataset. Final data may change from initial top-line data.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: Calibri;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">____________________________</span></p><p dir="ltr" style="font-family: Calibri;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: Calibri;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><sup>1</sup></span><span style="white-space:pre-wrap; font-family: Calibri;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Figure 3: Forest plot by Pentara Corporation. Data was sourced from the placebo groups in randomized, controlled trials of monoclonal antibodies conducted by other sponsors in Alzheimer&#8217;s disease (MMSE 20-30).</span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">27</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">End-of-Phase 2 (EOP2) Meeting with FDA</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In January </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2021</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, we held an End-of-phase 2 (EOP2) meeting for simufilam with the U.S. Food and Drug Administration (FDA). The purpose of this EOP2 meeting was to gain general agreement around key elements of a pivotal Phase 3 program to treat Alzheimer&#8217;s disease dementia. FDA attendees included Robert Temple, MD, Deputy Center Director for Clinical Science and Senior Advisor in the Office of New Drugs; Billy Dunn, MD, Director, Office of Neuroscience; Eric Bastings, MD, Director, Division of Neurology, and others.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In February 2021, we announced the successful completion of our EOP2 meeting. Official meeting minutes confirm that we and FDA are aligned on key elements of a Phase 3 clinical program for simufilam. FDA has agreed that the completed Phase 2 program, together with an ongoing and well-defined Phase 3 clinical program, are sufficient to show evidence of clinical efficacy for simufilam in Alzheimer&#8217;s disease. There is also agreement that the use of separate clinical scales to assess cognition (ADAS-cog</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><sup>1</sup></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">) and function (ADCS-ADL</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><sup>2</sup></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">) are appropriate co-primary endpoints of efficacy. A clinical scale that combines cognition and function, such as iADRS</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><sup>3</sup></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, is a secondary efficacy endpoint.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Special Protocol Assessments</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In August 2021, we announced we had reached agreement with FDA under a Special Protocol Assessment (SPA) for both </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Phase</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 3 studies. These SPA agreements document that FDA has reviewed and agreed upon the key design features of our Phase 3 study protocols of simufilam for the treatment of patients with Alzheimer&#8217;s disease.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">An SPA agreement indicates concurrence by the FDA with the adequacy and acceptability of specific critical elements of overall protocol design (e.g., entry criteria, dose selection, endpoints, etc.). These elements are critical to ensure that our planned Phase 3 studies of simufilam in Alzheimer&#8217;s disease can be considered adequate and well-controlled studies in support of a future regulatory submission and marketing application.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The first clinical study protocol under the SPA is titled &#8220;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">A Phase 3, Randomized, Double-Blind, Placebo-</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Controlled</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">, Parallel-Group, 52-Week Study Evaluating the Safety and Efficacy of One Dose of Simufilam in Subjects with Mild-to-Moderate Alzheimer&apos;s Disease.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#8221;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The second clinical study protocol under the SPA is titled &#8220;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 76-Week Study Evaluating the Safety and Efficacy of Two Doses of Simufilam in Subjects with Mild-to-Moderate Alzheimer&#8217;s Disease.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#8221;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Phase 3 Drug Supply</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We have entered into a drug supply agreement with Evonik Industries AG for simufilam. Under </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> agreement, Evonik supplies and is expected to continue to supply us with large-scale, clinical-grade quantities of simufilam. Evonik is one of the world&#8217;s largest contract development and manufacturing organizations for pharmaceutical ingredients. Other vendors supply excipients, the finished dosage form (i.e., simufilam tablets), drug packaging, package labeling and other critical steps in the supply chain for Phase 3 drug supply.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Phase 3 Clinical Program Overview</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our Phase 3 program consists of two large, double-blind, randomized, placebo-controlled studies of simufilam in patients with mild-to-moderate Alzheimer&#8217;s disease dementia. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Highlights of this clinical program are summarized in Figure 3. In June 2021, we announced the selection of Premier Research International as our CRO to help conduct our Phase 3 clinical program.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 150.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">_____________________________</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"><sup>1</sup></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"> ADAS-Cog = The Alzheimer&#8217;s Disease Assessment Scale &#8211; Cognitive Subscale, a measure of cognition </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"><sup>2</sup></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"> ADCS-ADL = Alzheimer&#8217;s Disease Cooperative Study &#8211; Activities of Daily Living, a measure of health function</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"><sup>3</sup></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"> iADRS =</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">integrated Alzheimer&#8217;s Disease Rating Scale, a composite measure of cognition and health function</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">28</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Figure 4. Summary of Our Phase 3 Clinical Program</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><img src="sava-20230630x10qg006.jpg" style="width: 6.404861in; height: 1.167361in" alt="Graphical user interface&#xA;&#xA;Description automatically generated with medium confidence" /></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">RETHINK-ALZ and REFOCUS-ALZ</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In Fall 2021, we </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">announced initiation of </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">our two Phase 3 studies </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">of simufilam</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">As of August 3, 2023, a total of over 1,587 patients have been enrolled in our Phase 3 program. The target patient enrollment for the Phase 3 program is over 1,750 patients. We anticipate the completion of patient enrollment for both of our Phase 3 studies by yearend 2023. Patients continue to be screened in clinical trial sites in the U.S., Canada, Puerto Rico, Australia, and South Korea.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The first Phase 3 study, called RETHINK-ALZ, is designed to evaluate the safety and efficacy of oral simufilam 100 mg in enhancing cognition and slowing cognitive and functional decline over 52 weeks. Secondary objectives include the assessment of simufilam&apos;s effect on neuropsychiatric symptoms and caregiver burden. </span><span id="_Hlk96769600" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">This randomized, double-blind, placebo-controlled study plans to enroll approximately 750 patients with mild-to-moderate Alzheimer&#8217;s disease.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Details of the RETHINK-ALZ Phase 3 study include:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: CG Times (WN);font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Wingdings;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61656;</span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Approximately 750 patients with mild-to-moderate Alzheimer&#8217;s disease to be enrolled.</span></p><p dir="ltr" style="font-family: CG Times (WN);font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Wingdings;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61656;</span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Patients to be randomized (1:1) to simufilam 100 mg or placebo twice daily. </span></p><p dir="ltr" style="font-family: CG Times (WN);font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Wingdings;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61656;</span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Patients to be treated for 12 months.</span></p><p dir="ltr" style="font-family: CG Times (WN);font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Wingdings;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61656;</span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The co-primary efficacy endpoints are ADAS-Cog12</span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><sup>1</sup></span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, a cognitive scale, and ADCS-ADL</span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><sup>2</sup></span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, a functional scale; both are standard clinical tools in trials of Alzheimer&#8217;s disease. </span></p><p dir="ltr" style="font-family: CG Times (WN);font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Wingdings;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61656;</span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">A secondary efficacy endpoint is iADRS</span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><sup>3</sup></span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, a standard clinical tool in trials of Alzheimer&#8217;s disease that combines cognitive and functional scores from ADAS-Cog &amp; ADCS-ADL. </span></p><p dir="ltr" style="font-family: CG Times (WN);font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Wingdings;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61656;</span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Other secondary endpoints include plasma biomarkers of disease and NPI</span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><sup>4</sup></span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, a clinical tool that assesses the presence and severity of dementia-related behavior.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In November 2021, we announced initiation of a second Phase 3 study, called REFOCUS-ALZ, designed to evaluate the safety and efficacy of oral simufilam 100 mg and 50 mg over 76 weeks. This randomized, double-blind, placebo-controlled study plans to enroll approximately 1,000 patients with mild-to-moderate Alzheimer&#8217;s disease.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Details of the REFOCUS-ALZ Phase 3 study include:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: CG Times (WN);font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Wingdings;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61656;</span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Approximately 1,000 patients with mild-to-moderate Alzheimer&#8217;s disease to be enrolled.</span></p><p dir="ltr" style="font-family: CG Times (WN);font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Wingdings;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61656;</span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Patients to be randomized (1:1:1) to simufilam 100 mg, 50 mg, or placebo BID. </span></p><p dir="ltr" style="font-family: CG Times (WN);font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Wingdings;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61656;</span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Patients to be treated for 76 weeks.</span></p><p dir="ltr" style="font-family: CG Times (WN);font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Wingdings;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61656;</span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The co-primary efficacy endpoints are ADAS-Cog</span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><sup>1</sup></span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, a cognitive scale, and ADCS-ADL</span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><sup>2</sup></span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, a functional scale; both are widely used clinical tools in trials of Alzheimer&#8217;s disease. </span></p><p dir="ltr" style="font-family: CG Times (WN);font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Wingdings;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61656;</span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">A secondary efficacy endpoint is iADRS</span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><sup>3</sup></span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, a widely used clinical tool in trials of Alzheimer&#8217;s disease that combines cognitive and functional scores from ADAS-Cog &amp; ADCS-ADL. </span></p><p dir="ltr" style="font-family: CG Times (WN);font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Wingdings;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61656;</span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Other secondary endpoints include CSF, plasma and imaging biomarkers of disease and NPI</span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><sup>4</sup></span><span style="white-space:pre-wrap; font-family: CG Times (WN);font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, a clinical tool that assesses the presence and severity of dementia-related behavior.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 150.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">_____________________________</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"><sup>1</sup></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"> ADAS-Cog = The Alzheimer&#8217;s Disease Assessment Scale &#8211; Cognitive Subscale, a measure of cognition </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"><sup>2</sup></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"> ADCS-ADL = Alzheimer&#8217;s Disease Cooperative Study &#8211; Activities of Daily Living, a measure of health function</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"><sup>3</sup></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"> iADRS = integrated Alzheimer&#8217;s Disease Rating Scale, a composite measure of cognition and health function</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"><sup>4</sup></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"> Neuropsychiatric Inventory (NPI)</span><span style="white-space:pre-wrap; font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"><br />&#8206;</span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">29</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 150.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Phase 3 Entry Criteria Includes a Plasma Assay for Phosphorylated Tau (p-Tau)</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We believe plasma levels of pTau proteins can provide independent confirmation of Alzheimer&#8217;s  neuropathology. RETHINK-ALZ and REFOCUS-ALZ studies use a &#8216;research use only&#8217;, non-safety related exploratory P-tau181 plasma assay to qualify mild-to-moderate Alzheimer&#8217;s patients. At the </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">15</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"><sup>th</sup></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"> International Conference on Clinical Trials on Alzheimer&#8217;s Disease</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">(CTAD)</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 2022, a poster presentation indicated a 30 ng/L cut-point showed 100% sensitivity and 88% specificity for Alzheimer&#8217;s  diagnosis in 22 autopsy-confirmed samples</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><sup>5</sup></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">. The plasma assay we use does not rely on age, APOE-gene status or complex algorithms to provide a result.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 150.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 150.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Open-label Extension Study for the Phase 3 Program</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In October 2022, we announced the initiation of an open-label extension study for our Phase 3 program. This study is designed to provide no-cost access to simufilam for one year to Alzheimer&#8217;s patients who have successfully completed a Phase 3 study of simufilam.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The open-label extension study is expected to generate long-term safety and tolerability data for (oral) simufilam 100 mg twice daily over 52 weeks. There is no obligation for a patient or a physician to participate in the open-label extension study.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Each clinical investigational site and each patient chooses whether to participate in this open-label extension study. Patient enrollment for this study began November 2022.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 150.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">SavaDx</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our investigational product candidate, called SavaDx, is early-stage program focused on detecting the presence of Alzheimer&#8217;s disease from a small sample of blood. For business, technical and personnel reasons, we continue to prioritize the </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">development of simufilam, our novel drug candidate, over SavaDx, our novel diagnostic candidate. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">SavaDx is a research-use only, non-safety related exploratory biomarker.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The regulatory pathway for SavaDx may eventually include formal analytical validation studies and clinical studies that sup</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">port evidence of sensitivity, specificity and other variables in various healthy and diseased patient populations. We have not conducted such studies and do not expect to conduct such studies in 2023. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.50in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">SavaDx is currently designed as an antibody-based detection system for altered filamin A (FLNA). Working with third parties, we </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">are evaluating the exploratory use of mass spectrometry </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">to detect FLNA, i.e., without the use of antibodies.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span id="_Hlk33446796" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Financial Overview</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We have yet to generate any revenues from product sales. We have an accumulated deficit of $334.2 million at June 30, 2023. These losses have resulted principally from costs incurred in connection with research and development activities, salaries and other personnel-related costs and general corporate expenses. Research and development activities include costs of clinical and preclinical trials as well as clinical supplies associated with our product candidates. Salaries and other personnel-related costs include stock-based compensation associated with stock options and other equity awards granted to employees and non-employees. Our operating results may fluctuate substantially from period to period as a result of enrollment rates of clinical trials for our product candidates, timing of preclinical activities and our need for clinical supplies.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 150.0%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">_____________________________</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 6pt;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"><sup>1</sup></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"> ADAS-Cog = The Alzheimer&#8217;s Disease Assessment Scale &#8211; Cognitive Subscale, a measure of cognition </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 6pt;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"><sup>2</sup></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"> ADCS-ADL = Alzheimer&#8217;s Disease Cooperative Study &#8211; Activities of Daily Living, a measure of health function</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 6pt;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"><sup>3</sup></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"> iADRS = integrated Alzheimer&#8217;s Disease Rating Scale, a composite measure of cognition and health function</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 6pt;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"><sup>4</sup></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"> Neuropsychiatric Inventory (NPI)</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 6pt;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"><sup>5</sup></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> Source: </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">pTau181 Plasma Biomarker Performance as an Inclusion Criterion in the RETHINK-ALZ and REFOCUS-ALZ trials in mild-to-moderate Alzheimer&#8217;s disease, Mammel et al., CTAD 2022</span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">30</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We expect to continue to use significant cash resources in our operations for the next several years. Our cash requirements for operating activities and capital expenditures may increase in the future as we:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">continue our ongoing Phase 3 program with simufilam;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">manufacture large-scale supplies for simufilam;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">conduct other preclinical and clinical studies for our product candidates;&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">seek regulatory approvals for our product candidates; </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">develop, formulate, manufacture and commercialize our product candidates; </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">implement additional internal systems and develop new infrastructure;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">acquire or in-license additional products or technologies, or expand the use of our technology; </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">maintain, defend and expand the scope of our intellectual property;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">incur costs related to </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">legal proceedings and claims, including U.S. government inquiries; and</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">hire additional personnel.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Product revenue will depend on our ability to receive regulatory approvals for, and successfully market, our product candidates. If our development efforts result in regulatory approval and successful commercialization of our product candidates, we expect to generate revenue from direct sales of our drugs and/or, if we license our drugs to future collaborators, from the receipt of license fees and royalties from sales of licensed products. We conduct our research and development programs through a combination of internal and collaborative programs. We rely on arrangements with universities, certain collaborators, </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">contract development and manufacturing organizations (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">CDMOs), CROs and clinical research sites for a significant portion of our product development efforts.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We focus substantially all of our research and development efforts in the area of neurology. The following table summarizes expenses </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">by category for research and development efforts </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">(in thousands): </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.04in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.21in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Three months ended</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Six months ended</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.18in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.18in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.18in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.25in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Compensation</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 1,790&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 1,849&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 3,604&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 3,747&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.18in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.25in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Contractor fees and supplies</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 22,893&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 14,820&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 42,941&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 27,676&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.18in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.25in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Other common costs</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 286&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 279&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 544&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 431&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.18in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 24,969&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 16,948&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 47,089&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 31,854&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.04in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Research and development expenses include compensation, contractor fees and supplies as well as allocated common costs. Contractor fees and supplies generally include expenses for clinical studies and preclinical studies and costs for formulation and manufacturing activities. Other common costs include the allocation of common costs such as facilities.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During the three and six months ended </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023, we did not receive reimbursement from NIH research grants. </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During the three and six months ended </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2022, we received $0.4 million and $0.5 million from NIH research grants, respectively. </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">These reimbursements were recorded as a reduction to our research and development expenses.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our technology has been applied across certain of our product candidates. Data, know-how, personnel, clinical results, research results and other matters related to the research and development of any one of our product candidates also relate to, and further the development of, our other product candidates. As a result, costs allocated to a specific drug candidate may not necessarily reflect the actual costs surrounding research and development of that product candidate due to cross application of the foregoing</span><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;">.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Estimating the dates of completion of clinical development, and the costs to complete development, of our product candidates would be highly speculative, subjective and potentially misleading. Pharmaceutical product candidates take a significant amount of time to research, develop and commercialize. The clinical trial portion of the development of a new drug alone usually spans several years. The cost and pace of our future research and development activities are linked and subject to change</span><span style="white-space:pre-wrap; color: #0000FF;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;">.</span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">31</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Critical Accounting Estimates</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.38in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">This discussion and analysis of our financial condition and results of operations is based on our condensed consolidated financial statements, which have been prepared in accordance with&#160;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">U.S. GAAP</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">. The preparation of these condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, as well as the reported expenses and net loss incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 13.5pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.35in;"><span style="white-space:pre-wrap; color: #000000;font-size: 13.5pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.38in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">There have been no material changes to our critical accounting estimates during the six months ended&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;from those described in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in our Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC on&#160;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">February 28, 2023</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Results of Operations &#8211; Three and Six Months Ended </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">,</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> 2023 and 2022</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Research and Development Expense</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Research and development expenses consist primarily of costs of drug development work associated with our product candidates, including:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">clinical trials,</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">pre-clinical testing,</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">clinical supplies and related formulation and design costs, and</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">compensation and other personnel-related expenses.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Research and development expenses were $25.0 million and $16.9 million during the three months ended June 30, 2023 and 2022, respectively. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">This 47% increase was due primarily to increasing enrollment and costs to conduct the ongoing Phase 3 clinical program and open-label studies in simufilam as well as higher preclinical and drug supply costs compared to the prior year.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Research and development expenses were $47.1 million and $31.9 million during the six months ended June 30, 2023 and 2022, respectively. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">This 48% increase was due primarily to increasing enrollment and costs to conduct the ongoing Phase 3 clinical program and open-label studies in simufilam as well as higher preclinical and drug supply costs compared to the prior year. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We expect research and development expense to increase in 2023 compared to 2022 as we conduct a Phase 3 clinical program and other clinical studies with simufilam, continue to hire new personnel, manufacture drug supply, and continue our development efforts.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">General and Administrative Expense</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">General and administrative expenses consist of personnel costs, allocated expenses and other expenses for outside professional services, including legal, human resources, audit and accounting services. Personnel costs consist of salaries, bonus, benefits and stock-based compensation. </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Allocated expenses consist primarily of facility costs for </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">our Company owned</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> office complex in Austin, Texas</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> Depreciation and amortization for office space leased but not occupied by the Company is included in general and administrative expense. Depreciation and amortization for office space occupied by the Company is allocated between general and administrative expense and research and development expense. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We also incur expenses associated with operating as a public company, including additional legal fees, expenses related to compliance with the rules and regulations of the SEC and Nasdaq, additional insurance and audit expenses, investor relations activities, Sarbanes-Oxley compliance expenses and other administrative expenses and professional services.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">32</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">General and administrative expenses were $3.8 million and $3.0 million during the three months ended June 30, 2023 and 2022, respectively. The 28% increase was due primarily to </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$0.4 million increase in stock-based compensation expense</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> due to new grant awards during the period as well as $0.3 million in </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">higher legal expenses due to ongoing legal matters as compared to the prior year.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">General and administrative expenses were $8.2 million and $5.9 million during the six months ended June 30, 2023 and 2022, respectively. The 39% increase was due primarily to </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$1.2 million in </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">higher legal expenses due to ongoing legal matters, a </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$0.6 million increase in stock-based compensation expense</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> due to new grant awards during the period as well as </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">an increase in headcount and personnel costs compared to the prior year.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We expect general and administrative expense for 2023 will increase compared to 2022 due primarily to stock-based compensation increases due to new grant awards during the period and higher legal and professional fees related to ongoing securities class action and derivative lawsuits, governmental investigations as well the Company&#8217;s lawsuit against a hedge fund and certain individuals who we believe executed a &#8220;short and distort&#8221; campaign against Cassava Sciences.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Interest Income </span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Interest income was $2.2 million and $0.3 million during the three months ended </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023 and 2022, respectively.</span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Interest income was $4.2 million and $0.3 million during the six months ended </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023 and 2022, respectively.</span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The increase in interest income was due to increases in interest rates compared to the prior periods.</span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We expect interest income increases in 2023 compared to 2022 due to increases in interest rates.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Other income, net </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">record the activities related to leasing office space to third parties in buildings we own as other income, net, as leasing is not core to the Company&#8217;s operations. Other income, net, was $203,000 and $275,000 </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">during</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> the three months ended </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023 and 2022, respectively. </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Other income, net, was $0.4 million and $0.5 million </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">during</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> the six months ended </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023 and 2022, respectively. Other income, net, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">was lower in the three and six months ended June 30, 2023 as occupancy related expenses were higher in 2023 compared to the prior year</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> periods as the Company began occupying approximately 25% of the property </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">beginning late August 2022.</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Depreciation and amortization for the office complex is included in general and administrative and research and development expense, and thus not reflected in other income, net.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Liquidity and Capital Resources</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Since inception, we have financed our operations primarily through public and private stock offerings, payments received under collaboration agreements and interest earned on our cash and cash equivalents balances. We intend to continue to use our capital resources to fund research and development activities, capital expenditures, working capital requirements and other general corporate purposes. As of June 30, 2023, cash and cash equivalents were $168.4 million.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">2022 Registered Direct Offering</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On November 22, 2022, we completed a common stock offering pursuant to which certain investors purchased 1,666,667 shares of common stock at a price of $30.00 per share. Net proceeds of the offering were approximately $47.3&#160;million after deducting offering expenses.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">33</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">At-the-Market Common Stock Offering </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On May 1, 2023, we established a new at-the-market offering program (&#8220;ATM&#8221;) to sell, from time to time, shares of our common stock having an aggregate offering price of up to $200 million </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">in common stock pursuant to a shelf registration statement that was filed with the </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">SEC</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> on May 1, 2023 </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">and became effective immediately upon filing</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">. We are obligated to pay a commission of up to 3% of the gross proceeds from the sale of shares of common stock in the offering. We are not obligated to sell any shares in the offering.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">There were no common stock sales under the ATM during the three and six months ended </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In March 2020, we established an at-the-market offering program (&#8220;2020 Program&#8221;) to sell, from time to time, shares of our common stock having an aggregate offering price of up to $100 million </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">in transactions pursuant to a shelf registration statement that was declared effective by the </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">SEC</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> on May 5, 2020</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">. We gave notice of termination for the 2020 Program effective on April 26, 2023, which was effective May 1, 2023. There were no common stock sales under the 2020 Program through its termination. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">2020 Cash Incentive Bonus Plan Obligations</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In August 2020, the Board approved the 2020 Cash Incentive Bonus Plan (the Plan). The Plan was established to promote the long-term success of the Company by creating an &#8220;at-risk&#8221; cash bonus program that rewards&#160;Plan&#160;participants with additional cash compensation in lockstep with significant increases in the Company&#8217;s market capitalization. The Plan is considered &#8220;at-risk&#8221; because Plan participants&#160;will&#160;not receive a cash bonus&#160;unless&#160;the Company&#8217;s market capitalization increases&#160;significantly and&#160;certain&#160;other&#160;conditions specified in the Plan&#160;are met.&#160;Specifically, Plan participants&#160;will&#160;not&#160;be paid&#160;any cash bonuses unless (1) the Company completes a&#160;merger or acquisition transaction that constitutes a sale of ownership of the Company or its assets (a Merger Transaction) or (2) the Compensation Committee&#160;determines the Company has sufficient cash on hand, as defined in the Plan. Plan participants will be paid all earned cash bonuses in the event of a Merger Transaction.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">As of December 31, 2022, the Company&#8217;s independent directors were participants in the Plan. However, effective March 16, 2023, the Board of Directors amended the Plan to remove all independent directors as participants in the Plan and the independent directors consented to such removal. The independent directors&#8217; share of potential benefits under the Plan were completely forfeited to the Company and will not be allocated to any other participant under the Plan. Our independent directors have not received, and as a result of such amendment will never receive, any payments under the Plan.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company&#8217;s market capitalization, including all outstanding stock options, was $89.4&#160;million at the inception of the Plan in August 2020. If the Company were to exceed a $5&#160;billion market capitalization&#160;for no less than 20 consecutive trading days, and conditions noted above for payment are met, all&#160;Plan milestones would be deemed achieved, in which case total cash bonus awards would&#160;range from&#160;a minimum of&#160;$111.4&#160;million&#160;up to&#160;a hypothetical maximum of&#160;$289.7&#160;million.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company&#8217;s potential financial obligation to plan participants at </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023 totaled $6.5&#160;million (after the March 2023 Plan amendment), based upon the achievement of one Plan milestone in the Company&#8217;s market capitalization in 2020. No actual cash bonus payments have been made to any Plan participant, as the Company has not yet satisfied all the conditions necessary for amounts to be paid under the Plan. During the year ended December&#160;31, 2021, the Company&#8217;s market capitalization increased substantially. These increases triggered the achievement of 11 additional Plan milestones. Collectively, the achievement of such milestones could trigger potential Company obligations to Plan participants ranging from a minimum of $74.9&#160;million up to a hypothetical maximum of $202.3&#160;million, with exact amounts to be determined by the Compensation Committee and contingent upon future satisfaction of a Performance Condition.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">No Valuation Milestones were achieved during the 2022 or the six months ended </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">No actual cash payments were authorized or made to participants under the Plan as of </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023, or through the filing date of this Form 10-Q.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">34</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Use of Cash</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net cash used in operating activities was $33.2 million for the six months ended June 30, 2023, resulting primarily from the net loss of $50.6 million, partially offset by an increase in accounts payable and accrued expenses of $6.7 million, an increase in accrued developmental expenses of $4.8 million, a decrease in in prepaid and other current assets of $4.1 million and stock-based compensation expense of $1.5 million.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net cash used in operating activities was $34.6 million for the six months ended June 30, 2022, resulting primarily from the net loss reported of $36.9 million, a decrease in accounts payable and accrued expenses of $2.4 million and accrued compensation and benefits of $1.7 million, partially offset by a decrease in in prepaid and other assets of $4.4 million, an increase in accrued developmental expenses of $0.5 million and stock-based compensation expense of $1.0 million.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net cash used in investing activities during the six months ended June 30, 2023 was $0.4 million as final payment was made on renovations and fixtures for</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> our corporate headquarters</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net cash used in investing activities during the six months ended June 30, 2022 was $1.9 million related to renovations to an owned building in Austin, Texas, a portion of which serves as our corporate headquarters.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net cash provided by financing activities during the six months ended June 30, 2023 was $1.0 million, from the exercise of stock options.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net cash provided by financing activities during the six months ended June 30, 2022 was $0.3 million, from the exercise of stock options.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Property and Leases</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We own an office complex in Austin, Texas, a portion of which serves as our corporate headquarters. This property is intended to accommodate our anticipated growth and expansion of our operations in the coming years. Maintenance, physical facilities, leasing, property management and other key responsibilities related to property ownership are outsourced to professional real-estate managers. The office complex measures approximately 90,000 rentable square feet. The property is currently over 60% leased. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We also occupied approximately 25% of the property beginning late August 2022.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We leased approximately 6,000 square feet of office space pursuant to an operating lease in Austin, Texas expiring in April 2024. We and the landlord consented to early terminate this lease on February 22, 2023 with no continuing obligations.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.00in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.00in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Other Commitments</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We have an accumulated deficit of $334.2 million as of </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023. We expect our cash requirements to be significant in the future. The amount and timing of our future cash requirements will depend on regulatory and market acceptance of our drug candidates, the resources we devote to researching and developing, formulating, manufacturing, commercializing and supporting our products and other corporate needs. We believe that our current cash and cash equivalents will be sufficient to fund our operations for at least the next 12 months. We may seek additional future funding through public or private financing in the future, if such funding is available and on terms acceptable to us. However, there are no assurances that additional financing will be available on favorable terms, or at all.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item 3.  </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Quantitative and Qualitative Disclosures About Market Risk</span><span id="Quantitative_And_Qualitative_Disclosures" style="text-decoration: none;"></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.38in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We are exposed to market risks in the ordinary course of our business, primarily related to interest rate sensitivities and, to a lesser extent, currency fluctuations related to our clinical operations outside the U.S.</span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 13.5pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.38in;"><span style="white-space:pre-wrap; color: #000000;font-size: 13.5pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Interest Rate Sensitivity</span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 13.5pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.38in;"><span style="white-space:pre-wrap; color: #000000;font-size: 13.5pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.38in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We are exposed to market risk related to changes in interest rates. We had cash and cash equivalents of $168.4 million as of June 30, 2023, which consisted primarily of </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">U.S. Treasury securities and money market accounts</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">35</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 13.5pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.38in;"><span style="white-space:pre-wrap; color: #000000;font-size: 13.5pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.38in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The primary objective of our investment activities is to preserve capital to fund our operations. We also seek to maximize income from our investments without assuming significant risk. To achieve our objectives, we maintain investment vehicles with high credit quality and short-term duration, in accordance with our board-approved investment policy. </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Such interest-earning instruments carry a degree of interest rate risk. However, due to the generally short-term maturities and low risk profile of our cash equivalents, an immediate 100 basis point increase or decrease in interest rates </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">during any of the periods presented would increase or decrease our annual net loss by less than $2 million in our condensed consolidated financial statements.</span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.38in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item 4.  </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Controls and Procedures</span><span id="Controls_And_Procedures" style="text-decoration: none;"></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.20in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Evaluation of disclosure controls and procedures. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our Chief Executive Officer (as Principal Executive Officer) and our Chief Financial Officer (as Principal Financial Officer) have concluded that our disclosure controls and procedures are effective to ensure that information we are required to disclose in reports that we file or submit under the Securities Exchange Act of 1934, as amended</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (the &#8220;Exchange Act&#8221;)</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms</span><span style="white-space:pre-wrap; color: black;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;"> and that such information is accumulated and communicated to management as appropriate to allow timely decisions regarding required disclosures</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.20in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Changes in internal control over financial reporting.  </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">There has been no change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) identified during the three months ended </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> that has materially affected, or is reasonable likely to materially affect, our internal control over financial reporting.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">PART II &#8211; OTHER INFORMATION</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span id="Legal_Proceedings" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item 1.  </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Legal Proceedings</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">From time to time, we may become involved in litigation or other legal proceedings and claims, including U.S. government inquiries, investigations</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">and Citizen Petitions submitted to FDA, and may receive inquiries from government authorities relating to matters arising from the ordinary course of business</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">. The outcome of these proceedings is inherently uncertain. Regardless of outcome, legal proceedings can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors. At this time, no assessment can be made as to their likely outcome or whether the outcome will be material to us. No information is available to indicate that it is probable that a loss has been incurred or can be reasonably estimated as of the date of the condensed consolidated financial statements and, as such, no accrual for these matters has been recorded within the condensed consolidated financial statements.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Government Investigations</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On November 15, 2021, the Company disclosed that certain government agencies had asked the Company to provide corporate information and documents. These were confidential requests. The Company has been voluntarily cooperating and intends to continue to cooperate with these inquiries. No government agency has informed the Company that it has found evidence of research misconduct or wrongdoing by the Company or its officers, employees or directors. No government agency has filed any claims or charges relating to these inquiries. We cannot predict the outcome or impact of these ongoing matters, including whether a government agency may pursue an enforcement action against the Company or others.</span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">36</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 105.8%;margin-bottom: 5pt;margin-left: 0;margin-right: 0;margin-top: 5pt;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Securities Class Actions and Shareholder Derivative Actions</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Between August 27, 2021 and October 26, 2021, four putative class action lawsuits were filed alleging violations of the federal securities laws by us and certain named officers. The complaints rely on allegations contained in Citizen Petitions that were submitted to FDA and allege that various statements made by the defendants regarding simufilam were rendered materially false and misleading. The Citizen Petitions were all subsequently denied by FDA. These actions were filed in the U.S. District Court for the Western District of Texas. The complaints seek unspecified compensatory damages and other relief on behalf of a purported class of purchasers.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On June 30, 2022, a federal judge consolidated the four class action lawsuits into one case and appointed a lead plaintiff and a lead counsel. Lead plaintiff filed a consolidated amended complaint on August 18, 2022 on behalf of a putative class of purchasers of our securities between September 14, 2020 and July 26, 2022. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On May 11, 2023, the court dismissed with prejudice plaintiffs&#8217; claims against (deceased) defendant Nadav Friedmann, PhD, MD, but otherwise denied defendants&#8217; motion to dismiss.  Defendants filed an answer to the consolidated amended complaint on July 3, 2023.  </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> We believe the claims are without merit and intend to defend against these lawsuits vigorously. We are unable to estimate the possible loss or range of loss, if any, associated with these lawsuits.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On November 4, 2021, a related shareholder derivative action was filed, purportedly on behalf of the Company, in the U.S. District Court for the Western District of Texas, asserting claims under the U.S. securities laws and state fiduciary duty laws against certain named officers and the members of the Company&#8217;s board of directors. This complaint relies on allegations made in Citizen Petitions that were submitted to</span><span id="OLE_LINK1" style="text-decoration: none;"></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (and subsequently denied by)</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> FDA. The complaint alleges, among other things, that the individual defendants exposed the Company to unspecified damages and securities law liability by causing it to make materially false and misleading statements, in violation of the U.S. securities laws and in breach of their fiduciary duties to the Company. The derivative case seeks, among other things, to recover unspecified compensatory damages on behalf of the Company arising out of the individual defendant&#8217;s alleged wrongful conduct. Although the plaintiff in this derivative case does not seek relief against the Company, the Company has certain indemnification obligations to the individual defendants. Since November 4, 2021, four additional shareholder derivative actions were filed alleging substantially similar claims, two in the U.S. District Court for the Western District of Texas, one in Texas state court (Travis County District Court)</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> and one in the Delaware Court of Chancery</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On July 5, 2022, the three federal court actions were consolidated into a single action.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On August 19, 2022, a shareholder derivative action was filed, purportedly on behalf of the Company, in the Delaware Court of Chancery, asserting claims under state fiduciary duty laws against certain named officers and members of the Company&#8217;s board of directors. The complaint alleges, among other things, that the individual defendants breached their fiduciary duties by approving </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the 2020 Cash Incentive Bonus Plan</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> in August 2020. The complaints seek unspecified compensatory damages and other relief. On </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">January 6, 2023, the plaintiffs filed an amended complaint. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Defendants filed a partial answer to the amended complaint on March 10, 2023, and moved to partially dismiss the amended complaint on March 14, 2023. Defendants&#8217; motion to dismiss remains pending. </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Although the plaintiffs in this derivative case do</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> not seek relief against the Company, the Company has certain indemnification obligations to the individual defendants. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We are unable to estimate the possible loss or range of loss, if any, associated with these lawsuits.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item 1A.  </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Risk Factors</span><span id="Risk_Factors" style="text-decoration: none;"></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span id="_cp_text_1_506" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">There have been no material changes to our risk factors from those disclosed under &#8220;Risk Factors&#8221; in Part I, Item 1A of our 2022 Annual Report</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"> on Form 10</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">-</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">K</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">. The risks and uncertainties described in our 2022&#160;Annual Report </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">on Form 10</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">-</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">K</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"> are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also materially adversely affect our business, financial condition or results of operations.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item 2.  </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Unregistered Sales of Equity Securities and Use of Proceeds</span><span id="Unregistered_Sales" style="text-decoration: none;"></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">None.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item 3.  </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Defaults Upon Senior Securities</span><span id="Defaults_Upon_Senior_Securities" style="text-decoration: none;"></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">None.</span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">37</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><h1 dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item 4.  </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Mine Safety Disclosures</span><span id="Mine_Safety" style="text-decoration: none;"></span></h1><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Not applicable.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><h1 dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item 5.  </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Other Information</span><span id="Other_Information" style="text-decoration: none;"></span></h1><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During the quarter ended June 30, 2023, none of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) informed us of the </span><ix:nonNumeric name="ecd:Rule10b51ArrAdoptedFlag" id="ct-nonNumeric-28a28610-17f8-407c-8ca0-9ff0dc069bcd" contextRef="Duration_4_1_2023_To_6_30_2023" format="ixt:booleanfalse"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">adoption</span></ix:nonNumeric><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> or </span><ix:nonNumeric name="ecd:Rule10b51ArrTrmntdFlag" id="ct-nonNumeric-65374b8f-a867-40bc-8ddb-dcc17ae74bdf" contextRef="Duration_4_1_2023_To_6_30_2023" format="ixt:booleanfalse"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">termination</span></ix:nonNumeric><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> of a &#8220;</span><ix:nonNumeric name="ecd:NonRule10b51ArrAdoptedFlag" id="ct-nonNumeric-9dd4babb-e791-4f8e-a5a9-006c8cb95f08" contextRef="Duration_4_1_2023_To_6_30_2023" format="ixt:booleanfalse"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Rule 10b5-1</span></ix:nonNumeric><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> trading arrangement&#8221; or &#8220;</span><ix:nonNumeric name="ecd:NonRule10b51ArrTrmntdFlag" id="ct-nonNumeric-801dbf81-bfec-42ad-bab7-255cd68dc674" contextRef="Duration_4_1_2023_To_6_30_2023" format="ixt:booleanfalse"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">non-Rule 10b5-1</span></ix:nonNumeric><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> trading arrangement,&#8221; as those terms are defined in Regulation S-K, Item 408.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br />&#8206;</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">38</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Item 6.  </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Exhibits </span><span id="Exhibits" style="text-decoration: none;"></span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 1.69in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -1.54in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The following exhibits have been filed with this report:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 63.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 4.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 9.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 5.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 63.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 19.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Incorporated by</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 63.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 19.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Reference</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Exhibit</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 63.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"> Description</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 4.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 9.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Filing</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 5.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Exhibit</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Filed</span></p></td></tr><tr><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">No.</span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 63.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 4.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Form</span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 9.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Date</span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 5.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">No.</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Herewith</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1069530/000119312505152582/dex31.htm"><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">3.1</span></a></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #0563C1;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 63.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1069530/000119312505152582/dex31.htm"><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Amended and Restated Certificate of Incorporation.</span></a></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 4.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">10-Q</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 9.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">7/29/2005</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 5.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">3.1</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1069530/000106953017000028/ptie-20170508xex3_1.htm"><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">3.2</span></a></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #0563C1;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 63.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1069530/000106953017000028/ptie-20170508xex3_1.htm"><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Certificate of Amendment of Restated Certificate of Incorporation.</span></a></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #0563C1;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 4.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">8-K</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 9.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">5/8/2017</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 5.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">3.1</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1069530/000106953019000019/sava-20181231xex3_3.htm"><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">3.3</span></a></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #0563C1;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 63.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1069530/000106953019000019/sava-20181231xex3_3.htm"><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Certificate of Amendment of Restated Certificate of Incorporation.</span></a></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #0563C1;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 4.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">10-K</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 9.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">3/29/2019</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 5.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">3.3</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1069530/000106953023000009/sava-20221231xex3_4.htm"><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">3.4</span></a></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #0563C1;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 63.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1069530/000106953023000009/sava-20221231xex3_4.htm"><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Amended and Restated Bylaws of Cassava Sciences, Inc.</span></a></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #0563C1;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 4.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">10-K</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 9.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2/28/2023</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 5.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">3.4</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1069530/000149315223015041/ex1-1.htm"><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">10.1</span></a></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #0563C1;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 63.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="http://www.sec.gov/Archives/edgar/data/1069530/000149315223015041/ex1-1.htm"><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Capital On Demand</span><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;"><sup>TM</sup></span><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">&#160;Sales Agreement, dated as of May 1, 2023, between Cassava Sciences, Inc. and JonesTrading Institutional Services LLC</span></a></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #0563C1;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 4.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">8-K</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 9.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">5/1/2023</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 5.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1.1</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="sava-20230630xex10_2.htm"><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">10.</span><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">2</span><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">*</span></a><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">&#8224;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #0563C1;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 63.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="sava-20230630xex10_2.htm"><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Cassava Sciences, Inc. 2020 Cash Incentive Bonus Plan</span><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;"> (As Amended March 16, 2023).</span></a></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #0563C1;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 4.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 9.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 5.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">X</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="sava-20230630xex10_3.htm"><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">10.</span><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">3</span><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">*</span></a></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #0563C1;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 63.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="sava-20230630xex10_3.htm"><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Cassava Sciences Non-Employee Director Compensation Plan</span></a></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #0563C1;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 4.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 9.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 5.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">X</span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="sava-20230630xex31_1.htm"><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">31.1</span></a></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #0563C1;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 63.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="sava-20230630xex31_1.htm"><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.  </span></a></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #0563C1;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 4.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 9.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 5.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">X</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="sava-20230630xex31_2.htm"><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">31.2</span></a></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #0563C1;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 63.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="sava-20230630xex31_2.htm"><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #0563C1;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 4.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 9.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 5.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">X</span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="sava-20230630xex32_1.htm"><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">32.1+</span></a></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #0563C1;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 63.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><a href="sava-20230630xex32_1.htm"><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-decoration: underline;">Certification of the Chief Executive Officer and the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #0563C1;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 4.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 9.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 5.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">X</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">101.INS</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 63.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Inline XBRL Instance Document</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> - </span><span style="white-space:pre-wrap; color: #0563C1;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">(the instant document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 4.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 9.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 5.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">X</span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">101.SCH</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 63.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Inline XBRL Taxonomy Extension Schema Document.</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 4.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 9.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 5.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">X</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">101.CAL</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 63.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 4.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 9.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 5.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">X</span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">101.DEF</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 63.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Inline XBRL Taxonomy Extension Definition Linkbase Document.</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 4.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 9.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 5.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">X</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">101.LAB</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 63.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Inline XBRL Taxonomy Extension Labels Linkbase Document.</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 4.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 9.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 5.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">X</span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">101.PRE</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 63.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 4.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 9.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 5.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">X</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">104.</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 63.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Cover Page Interactive Data File &#8211;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">(formatted as Inline XBRL and contained in Exhibit 101)</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 4.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 9.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 1.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 5.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 0.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: middle;width: 7.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">X</span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><sup>&#8224;</sup></span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Certain confidential portions of this exhibit were omitted by means of marking such portions with asterisks pursuant to Item 601(b)(10)(iv) of Regulation S-K because it is both not material and the type of information that the Company treats as private or confidential.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">* Management contract, compensatory plan or arrangement.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">+The certification furnished in Exhibit&#160;32.1 hereto is deemed to accompany this Quarterly Report on Form&#160;10-Q and will not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Exchange Act of 1934. Such certification will not be deemed to be incorporated by reference into any filings under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.</span><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><br />&#8206;</span></p></div>
    <div><div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">39</span></p></div><hr class="pageBreak" style="margin:18pt 0pt; ct-page-break: true; page-break-after: always;" /><div class="headerContainer"></div></div>
    <div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span id="Signatures" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">SIGNATURES</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="padding-left: 0;text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 297pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 160.75pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 11.8pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.01in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 297pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 172.55pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 297pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 160.75pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Cassava Sciences, Inc.</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 11.8pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 297pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 172.55pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">(Registrant)</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 297pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 172.55pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 297pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 160.75pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">/s/ </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">REMI BARBIER</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 11.8pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 297pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 172.55pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Remi Barbier,</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 297pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 172.55pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Chairman of the Board of Directors,</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 297pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 172.55pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">President and Chief Executive Officer</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 297pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Date: August 3, 2023</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 172.55pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">(Principal Executive Officer)</span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="padding-left: 0;text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 297pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 160.75pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 11.8pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.01in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 297pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 172.55pt;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 297pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 172.55pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 297pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid windowtext 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 160.75pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">/</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">s/ ERIC J. SCHOEN</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 11.8pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 297pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid windowtext 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 172.55pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Eric J. Schoen,</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 297pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 172.55pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Chief Financial Officer</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 297pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Date: August 3, 2023</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: top;width: 172.55pt;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">(Principal Financial and Accounting Officer)</span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div>
    <div class="footerContainer"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;" class="ctHeaderFooterPage">40</span></p></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>2
<FILENAME>sava-20230630xex10_2.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!--HTML document created with Certent Disclosure Management 23.3.2.2-->
<!--Created on: 8/3/2023 3:29:49 PM-->
<html>
	<head>
		<title>
			Exhibit 10.2
		</title>
	</head>
	<body><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:12pt 0pt 0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;color:#000000;text-decoration:underline;">Exhibit 10.</font><font style="display: inline;font-weight:bold;color:#000000;text-decoration:underline;">2</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM IF PUBLICLY DISCLOSED. SUCH PORTIONS ARE MARKED AS INDICATED WITH BRACKETS (&#x201C;[***]&#x201D;) BELOW.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-align:center;font-family:Times New Roman;font-size: 16pt">
			<font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;font-size:16pt;">Cassava Sciences</font><font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;font-size:16pt;">,</font><font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;font-size:16pt;"> Inc. </font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;">2020</font><font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;">&nbsp;</font><font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;">Cash </font><font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;">Incentive</font><font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;"> Bonus Plan</font><br /><font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;">[As Amended by the Board of Directors Effective March 16, 2023]</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">This </font><font style="display: inline;">2020</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">Cash </font><font style="display: inline;">Incentive</font><font style="display: inline;"> Bonus Plan (the &#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;">Plan</font><font style="display: inline;">&#x201D;) is established by </font><font style="display: inline;">Cassava Sciences, Inc.</font><font style="display: inline;">, a Delaware corporation (the &#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;">Company</font><font style="display: inline;">&#x201D;), effective as of </font><font style="display: inline;">August 26</font><font style="display: inline;">, &nbsp;</font><font style="display: inline;">2020</font><font style="display: inline;"> (the &#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;">Effective Date</font><font style="display: inline;">&#x201D;).</font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;">1.</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;"></font><font style="display: inline;font-weight:bold;color:#000000;">Purpose of the Plan.</font><font style="display: inline;color:#000000;"> &nbsp;The Company considers it essential to </font><font style="display: inline;color:#000000;">its </font><font style="display: inline;color:#000000;">operation</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">and future success </font><font style="display: inline;color:#000000;">that em</font><font style="display: inline;color:#000000;">ployees</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">and key service providers of the Company </font><font style="display: inline;color:#000000;">are</font><font style="display: inline;color:#000000;"> retained </font><font style="display: inline;color:#000000;">and incentivized</font><font style="display: inline;color:#000000;"> over the long-term.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">The purpos</font><font style="display: inline;color:#000000;">e of the Plan is to establish a</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">long-term, at-risk </font><font style="display: inline;color:#000000;">bonus </font><font style="display: inline;color:#000000;">plan </font><font style="display: inline;color:#000000;">to incentivize emp</font><font style="display: inline;color:#000000;">loyees </font><font style="display: inline;color:#000000;">and key service providers of the Company </font><font style="display: inline;color:#000000;">to </font><font style="display: inline;color:#000000;">maximize the </font><font style="display: inline;color:#000000;">long-term </font><font style="display: inline;color:#000000;">valuation of t</font><font style="display: inline;color:#000000;">he Company&#x2019;s Common Stock.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">The Plan is meant to achieve the foregoing purposes</font><font style="display: inline;color:#000000;"> by offering inc</font><font style="display: inline;color:#000000;">entive compensation that is</font><font style="display: inline;color:#000000;"> aligned with the interests of stockholders</font><font style="display: inline;color:#000000;"> of the Company</font><font style="display: inline;color:#000000;">.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;">2.</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;"></font><font style="display: inline;font-weight:bold;color:#000000;">Definitions.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;color:#000000;">2.1</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Administrator</font><font style="display: inline;color:#000000;">&#x201D; means the Compensation Committee of the Board. </font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;color:#000000;">2.2</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Aggregate Bonus Payment</font><font style="display: inline;color:#000000;">&#x201D; shall mean the total amount of Bonus Payments payable to Partic</font><font style="display: inline;color:#000000;">ipants upon each Achievement of</font><font style="display: inline;">&nbsp;</font><font style="display: inline;color:#000000;">a &nbsp;</font><font style="display: inline;color:#000000;">Target Valuation Milestone </font><font style="display: inline;color:#000000;">as set forth on Schedule 1.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;color:#000000;">2.3</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Board</font><font style="display: inline;color:#000000;">&#x201D; means the Board of Directors of the Company.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;color:#000000;">2.4</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;font-weight:bold;font-style:italic;color:#1F497D;">&nbsp;</font><font style="display: inline;color:#1F497D;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Bonus Payment</font><font style="display: inline;color:#000000;">&#x201D;</font><font style="display: inline;color:#000000;"> with regard to each Participant for each </font><font style="display: inline;color:#000000;">Target Valuation Milestone</font><font style="display: inline;color:#000000;"> mean</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;"> the amount of cash payment for s</font><font style="display: inline;color:#000000;">uch Target Valuation Milestone </font><font style="display: inline;color:#000000;">determined as set forth in Section 4.1</font><font style="display: inline;color:#000000;">.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;color:#000000;">2.5</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Cause</font><font style="display: inline;color:#000000;">&#x201D; means</font><font style="display: inline;color:#000000;">, with respect to a Participant who is an employee of the Company</font><font style="display: inline;color:#000000;"> and </font><font style="display: inline;color:#000000;">who (A) </font><font style="display: inline;color:#000000;">commits any of the following before such time as he</font><font style="display: inline;color:#000000;"> or she</font><font style="display: inline;color:#000000;"> is owed a Bonus Payment:</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">(i) performance of any act</font><font style="display: inline;color:#000000;">,</font><font style="display: inline;color:#000000;"> or failure to perform any act </font><font style="display: inline;color:#000000;">that is</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">materially injurious</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">to</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">the Company; (ii)&nbsp;</font><font style="display: inline;color:#000000;">demonstrably willful and intentional</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">dishonesty</font><font style="display: inline;color:#000000;">; or</font><font style="display: inline;color:#000000;"> &nbsp;(</font><font style="display: inline;color:#000000;">iii) </font><font style="display: inline;color:#000000;">material breach of any written agreement with the Company</font><font style="display: inline;color:#000000;"> that continues </font><font style="display: inline;color:#000000;">uncured </font><font style="display: inline;color:#000000;">beyond 30 days after written notice to the Participant</font><font style="display: inline;color:#000000;">; or (</font><font style="display: inline;color:#000000;">B</font><font style="display: inline;color:#000000;">)&nbsp;</font><font style="display: inline;color:#000000;">is </font><font style="display: inline;color:#000000;">held </font><font style="display: inline;color:#000000;">criminally responsible </font><font style="display: inline;color:#000000;">by a court of law </font><font style="display: inline;color:#000000;">for the </font><font style="display: inline;color:#000000;">commission of </font><font style="display: inline;color:#000000;">a</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">felony off</font><font style="display: inline;color:#000000;">ense under state or </font><font style="display: inline;color:#000000;">federal law</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">involving </font><font style="display: inline;color:#000000;">financial impropriety</font><font style="display: inline;color:#000000;">, &nbsp;</font><font style="display: inline;color:#000000;">moral turpitude, </font><font style="display: inline;color:#000000;">breach of trust, or physical harm to any person</font><font style="display: inline;color:#000000;">.</font></font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">

			<font style="display: inline;font-weight:bold;font-size:9pt;">Page </font><font style="display: inline;font-weight:bold;font-size:9pt;"></font><font style="display: inline;font-weight:bold;font-size:9pt;">1</font><font style="display: inline;font-weight:bold;font-size:9pt;"></font><font style="display: inline;font-weight:bold;font-size:9pt;"> of </font><font style="display: inline;font-weight:bold;font-size:9pt;">1</font><font style="display: inline;font-weight:bold;font-size:9pt;">0</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;color:#000000;">2.6</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Closing</font><font style="display: inline;color:#000000;">&#x201D; means the initial closing of </font><font style="display: inline;color:#000000;">a &nbsp;</font><font style="display: inline;color:#000000;">Merger </font><font style="display: inline;color:#000000;">Transaction pursuant to the definitive agreement</font><font style="display: inline;color:#000000;"> executed in connection with </font><font style="display: inline;color:#000000;">the</font><font style="display: inline;color:#000000;"> Merger</font><font style="display: inline;color:#000000;"> Transaction.&nbsp; </font><font style="display: inline;color:#000000;">In the case of a series of </font><font style="display: inline;color:#000000;">related </font><font style="display: inline;color:#000000;">transact</font><font style="display: inline;color:#000000;">ions constituting a Merger</font><font style="display: inline;color:#000000;"> Transaction</font><font style="display: inline;color:#000000;">, &nbsp;</font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;color:#000000;">Closing&#x201D; means the final </font><font style="display: inline;color:#000000;">closing that satisfies the threshold of </font><font style="display: inline;color:#000000;">the definition for</font><font style="display: inline;color:#000000;"> a Merger Transaction.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;color:#000000;">2.7</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Code</font><font style="display: inline;color:#000000;">&#x201D; means the Internal Revenue Code of 1986, as amended.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;color:#000000;">2.8</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;font-style:italic;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Common Stock</font><font style="display: inline;font-style:italic;color:#000000;">&#x201D;</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">means the common stock of the Company.</font><font style="display: inline;color:#000000;">&nbsp;</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;color:#000000;">2.9</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Contingent Consideration</font><font style="display: inline;color:#000000;">&#x201D; &nbsp;</font><font style="display: inline;color:#000000;">means the sum of any cash and the Fair Market Value of any securiti</font><font style="display: inline;color:#000000;">es </font><font style="display: inline;color:#000000;">to be received by the Company or the Securityholders after the Closing of a </font><font style="display: inline;color:#000000;">Merger </font><font style="display: inline;color:#000000;">Transaction, the receipt of which is contingent upon the passage of time or the occurrence or non-occurrence of some future events, circumstances and/or conditions, including, without limitation, amounts of consideration paid at a subsequent closing, milestone payments, royalties, and earn-outs and amounts of consideration subject to escrows, </font><font style="display: inline;color:#000000;">or </font><font style="display: inline;color:#000000;">purchase price adj</font><font style="display: inline;color:#000000;">ustments </font><font style="display: inline;color:#000000;">(such </font><font style="display: inline;color:#000000;">passage of time, </font><font style="display: inline;color:#000000;">events, circumstances and conditions, the &#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Conditions</font><font style="display: inline;color:#000000;">&#x201D;).</font><font style="display: inline;color:#000000;">&nbsp;</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:17pt;"><font style="display: inline;font-weight:bold;color:#000000;">2.10</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Exchange Act</font><font style="display: inline;color:#000000;">&#x201D; means </font><font style="display: inline;color:#000000;">the Securities Excha</font><font style="display: inline;color:#000000;">nge Act of 1934, as amended.</font><font style="display: inline;color:#000000;">&nbsp;</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:17pt;"><font style="display: inline;font-weight:bold;color:#000000;">2.11</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Fair Market Value</font><font style="display: inline;color:#000000;">&#x201D; will be the value determined by the Administrator as of the applicable date in its sole discretion in accordance with Section 409A, to the extent applicable, and such determination will be final and binding.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:17pt;"><font style="display: inline;font-weight:bold;color:#000000;">2.12</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;font-weight:bold;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Independent Director</font><font style="display: inline;font-style:italic;color:#000000;">&#x201D; &nbsp;</font><font style="display: inline;color:#000000;">means a director of the Company who is not an executive officer or employee of the Company.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:17pt;"><font style="display: inline;font-weight:bold;color:#000000;">2.13</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Initial Consideration</font><font style="display: inline;color:#000000;">&#x201D;</font><font style="display: inline;font-weight:bold;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">means </font><a name="_DV_M19"></a><a name="_DV_M20"></a><a name="_DV_M29"></a><font style="display: inline;color:#000000;">the sum of any cash and the Fair Market Value of any securities received by the Company or the Security</font><font style="display: inline;color:#000000;">holders upon the Closing of </font><font style="display: inline;color:#000000;">a &nbsp;</font><font style="display: inline;color:#000000;">Merger </font><font style="display: inline;color:#000000;">Transaction.&nbsp; </font><font style="display: inline;color:#000000;">For clarity, the term &#x201C;Initial Consideration&#x201D; is intended to represent the proceeds that are paid to the Company or the Securityholders upon Closing</font><font style="display: inline;color:#000000;"> without deduction for</font><font style="display: inline;color:#000000;"> any transacti</font><font style="display: inline;color:#000000;">on fees related to the </font><font style="display: inline;color:#000000;">Merger </font><font style="display: inline;color:#000000;">T</font><font style="display: inline;color:#000000;">ransaction that are paid by the Company or its Securityholders (such as fees related to legal services, </font><font style="display: inline;color:#000000;">accounting services, </font><font style="display: inline;color:#000000;">financial advisory services, investment banking services or other professional services)</font><font style="display: inline;color:#000000;"> but </font><font style="display: inline;color:#000000;">excluding (a)</font><font style="display: inline;color:#000000;"> any payments to employees or other service providers in the form of severance, change in control </font><font style="display: inline;color:#000000;">payments, or other bonuses paid </font><font style="display: inline;color:#000000;">by the </font><font style="display: inline;color:#000000;">purchaser or other acquirer of the Company&#x2019;s assets or stock </font><font style="display: inline;color:#000000;">in connection with the</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">Merger </font><font style="display: inline;color:#000000;">Transaction</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">and (b) </font><font style="display: inline;color:#000000;">any Contingent Consideration.</font><font style="display: inline;color:#000000;">&nbsp;</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:17pt;"><font style="display: inline;font-weight:bold;color:#000000;">2.14</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Involuntary Termination</font><font style="display: inline;color:#000000;">&#x201D; means, with respect to a Participant that is an employee, a Separation from Service as a result of either (i) a termination by the Company without Cause and other than as a result of such Participant&#x2019;s death or </font><font style="display: inline;color:#000000;">disability</font><font style="display: inline;color:#000000;"> or (ii) such Participant&#x2019;s Resignation for Good Reason. </font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:17pt;"><font style="display: inline;font-weight:bold;color:#000000;">2.15</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Market Price</font><font style="display: inline;color:#000000;">&#x201D; means the closing sale price of the </font><font style="display: inline;color:#000000;">Common Stock </font><font style="display: inline;color:#000000;">on the Nasdaq Capital Market as reported on the website of The Nasdaq Stock Market LLC, currently nasdaq.com (or, if the security is not listed or principally traded on the Nasdaq Capital Market, such other reporting system as the Board may reasonably select) on the relev</font><font style="display: inline;color:#000000;">ant date, or, if no sale of the</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">Common Stock </font><font style="display: inline;color:#000000;">is so reported for such date, the next preceding day for which the</font><font style="display: inline;color:#000000;"> closing sale price is so</font><font style="display: inline;color:#000000;"> reported. </font></font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">

			<font style="display: inline;font-weight:bold;font-size:9pt;">Page </font><font style="display: inline;font-weight:bold;font-size:9pt;"></font><font style="display: inline;font-weight:bold;font-size:9pt;">2</font><font style="display: inline;font-weight:bold;font-size:9pt;"></font><font style="display: inline;font-weight:bold;font-size:9pt;"> of </font><font style="display: inline;font-weight:bold;font-size:9pt;">1</font><font style="display: inline;font-weight:bold;font-size:9pt;">0</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:17pt;"><font style="display: inline;font-weight:bold;color:#000000;">2.16</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Marketable Securities</font><font style="display: inline;color:#000000;">&#x201D; means</font><font style="display: inline;color:#000000;">, for purposes of a Merger Transaction,</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">securities meeting all of the following requirements: (i) the issuer thereof is then subject to the reporting requirements of Section 13 or Section 15(d) of</font><font style="display: inline;color:#000000;"> the Exchange Act</font><font style="display: inline;color:#000000;">, and is then current in its filing of all required reports and other information under the </font><font style="display: inline;color:#000000;">Securities </font><font style="display: inline;color:#000000;">Act and the Exchange Act; (ii) the class and series of </font><font style="display: inline;color:#000000;">such securities is</font><font style="display: inline;color:#000000;">, upon the consummation of the Merger Transaction,</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">then </font><font style="display: inline;color:#000000;">quoted or </font><font style="display: inline;color:#000000;">traded </font><font style="display: inline;color:#000000;">on a </font><font style="display: inline;color:#000000;">nationally recognized securities exchange, inter-dealer quotation system or over-the-counter market</font><font style="display: inline;color:#000000;">, and (iii) </font><font style="display: inline;color:#000000;">the reoffer and resale of such securities after receipt by stockholders of the Company in connection with a Merger Transaction is not subject to restrictions </font><font style="display: inline;color:#000000;">under federal or state securities laws, rules or regulations</font><font style="display: inline;color:#000000;"> or under any agreement or contract entered into in connection with the Merger Transaction</font><font style="display: inline;color:#000000;">.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:17pt;"><font style="display: inline;font-weight:bold;color:#000000;">2.17</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Merger</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Transaction</font><font style="display: inline;color:#000000;">&#x201D; means the consummation</font><font style="display: inline;color:#000000;">, in one or more related transactions: </font><font style="display: inline;color:#000000;">of (i)</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">a merger, combination, consolidation, recapitalization, or other reorganization of the </font><font style="display: inline;color:#000000;">Company </font><font style="display: inline;color:#000000;">with one or more other entities that are not </font><font style="display: inline;color:#000000;">Subsidiaries</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">of the Company </font><font style="display: inline;color:#000000;">in which the </font><font style="display: inline;color:#000000;">Securityholders </font><font style="display: inline;color:#000000;">receive </font><font style="display: inline;color:#000000;">only </font><font style="display: inline;color:#000000;">cash </font><font style="display: inline;color:#000000;">and/</font><font style="display: inline;color:#000000;">or Marketable Securities in exchange for their shares of Common Stock;</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">or (ii) </font><font style="display: inline;color:#000000;">a sale</font><font style="display: inline;color:#000000;">,</font><font style="display: inline;color:#000000;"> transfer</font><font style="display: inline;color:#000000;">, exclusive license or other disposition</font><font style="display: inline;color:#000000;"> of all or substantially all of the </font><font style="display: inline;color:#000000;">Company&#x2019;</font><font style="display: inline;color:#000000;">s business and/or assets as an entirety to an entity that is</font><font style="display: inline;color:#000000;"> not a Subsidiary</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">of the Company </font><font style="display: inline;color:#000000;">in which the </font><font style="display: inline;color:#000000;">Securityholders</font><font style="display: inline;color:#000000;"> receive </font><font style="display: inline;color:#000000;">only </font><font style="display: inline;color:#000000;">cash </font><font style="display: inline;color:#000000;">and/</font><font style="display: inline;color:#000000;">or Marketable Securities in </font><font style="display: inline;color:#000000;">respect of </font><font style="display: inline;color:#000000;">their shares of Common Stock</font><font style="display: inline;color:#000000;">;</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;text-decoration:underline;color:#000000;">provided</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;text-decoration:underline;color:#000000;">that</font><font style="display: inline;color:#000000;"> in each case</font><font style="display: inline;color:#000000;"> of (i) or (ii</font><font style="display: inline;color:#000000;">), such event also constitutes either a &#x201C;change in </font><font style="display: inline;color:#000000;">the </font><font style="display: inline;color:#000000;">ownership of a corporation&#x201D; or a &#x201C;change in</font><font style="display: inline;color:#000000;"> the</font><font style="display: inline;color:#000000;"> ownership of a substantial portion of a corporation&#x2019;s assets&#x201D; (as defined under Treasury Regulations Sections 1.409A-3(i)(5)(</font><font style="display: inline;color:#000000;">v) and (vii))</font><font style="display: inline;color:#000000;">. &nbsp;</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:17pt;"><font style="display: inline;font-weight:bold;color:#000000;">2.18</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Participant</font><font style="display: inline;color:#000000;">&#x201D; means </font><font style="display: inline;color:#000000;">each </font><font style="display: inline;color:#000000;">(i) employee </font><font style="display: inline;color:#000000;">of the Company</font><font style="display: inline;color:#000000;"> and</font><font style="display: inline;color:#000000;"> (ii) </font><font style="display: inline;color:#000000;">other non-employee key service provider of the Company,</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">in each case </font><font style="display: inline;color:#000000;">as </font><font style="display: inline;color:#000000;">set forth on Schedule 2</font><font style="display: inline;color:#000000;">,</font><font style="display: inline;color:#000000;"> or who has been designated </font><font style="display: inline;color:#000000;">from time-to-time </font><font style="display: inline;color:#000000;">as a Participant by the Administrator</font><font style="display: inline;color:#000000;">.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:17pt;"><font style="display: inline;font-weight:bold;color:#000000;">2.19</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Resignation for Good Reason</font><font style="display: inline;color:#000000;">&#x201D;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">means, with respect to a Participant that is an employee, </font><font style="display: inline;color:#000000;">the Participant&#x2019;s resignation from all positions he or she then holds with the Company in a manner that constitutes a Separation from Service, as a result of the occurrence of any of the following events, conditions or actions taken by the Company without Cause and without </font><font style="display: inline;color:#000000;">the </font><font style="display: inline;color:#000000;">Participant&#x2019;s consent: </font><font style="display: inline;color:#000000;">(a)&nbsp;</font><font style="display: inline;color:#000000;">a &nbsp;</font><font style="display: inline;color:#000000;">material reductio</font><font style="display: inline;color:#000000;">n of </font><font style="display: inline;color:#000000;">the </font><font style="display: inline;color:#000000;">Participant&#x2019;s duties, </font><font style="display: inline;color:#000000;">and responsibilities, relative to </font><font style="display: inline;color:#000000;">the </font><font style="display: inline;color:#000000;">Participant&#x2019;s duties</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">and responsibilities at the Company as in effect immediately prior to such reduction; (b)&nbsp;a material reduction in such Participant&#x2019;s level of base salary</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">and</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">benefits (including insurance coverage)</font><font style="display: inline;color:#000000;"> other than in connection with a comparable</font><font style="display: inline;color:#000000;"> proportionate </font><font style="display: inline;color:#000000;">reduction affecting all employees; or (c)&nbsp;a relocation of </font><font style="display: inline;color:#000000;">the </font><font style="display: inline;color:#000000;">Participant&#x2019;s principal place of employment that increases the Participant&#x2019;s one-way commute by more than </font><font style="display: inline;color:#000000;">thirty (30) </font><font style="display: inline;color:#000000;">miles from the location at the time of the execution of an agreement that results in a </font><font style="display: inline;color:#000000;">Merger </font><font style="display: inline;color:#000000;">Transaction (other than reasonable business travel required as part of the job duties associated with such Participant&#x2019;s position); </font><font style="display: inline;font-style:italic;color:#000000;">provided, however</font><font style="display: inline;color:#000000;">, that in each of (a), (b) or (c), the Participant must (i) provide the Company with written notice of the occurrence of such event or condition within 30 days after such event </font><font style="display: inline;color:#000000;">or condition </font><font style="display: inline;color:#000000;">first occurs, (ii) allow the Company 30 days to cure such event, and (iii) if the Company does not cure such event within such period, the Participant&#x2019;s resignation is effective not later than 60 days after the conclusion of such cure period.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:17pt;"><font style="display: inline;font-weight:bold;color:#000000;">2.20</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Section 409A</font><font style="display: inline;color:#000000;">&#x201D; means Section 409A of the Code and the Treasury Regulations and other guidance issued thereunder and any state law of similar effect. </font></font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">

			<font style="display: inline;font-weight:bold;font-size:9pt;">Page </font><font style="display: inline;font-weight:bold;font-size:9pt;"></font><font style="display: inline;font-weight:bold;font-size:9pt;">3</font><font style="display: inline;font-weight:bold;font-size:9pt;"></font><font style="display: inline;font-weight:bold;font-size:9pt;"> of </font><font style="display: inline;font-weight:bold;font-size:9pt;">1</font><font style="display: inline;font-weight:bold;font-size:9pt;">0</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:17pt;"><font style="display: inline;font-weight:bold;color:#000000;">2.21</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Securities Act</font><font style="display: inline;color:#000000;">&#x201D; means the Securities Act of 1933, as amended.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:17pt;"><font style="display: inline;font-weight:bold;color:#000000;">2.22</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Securityholders</font><font style="display: inline;color:#000000;">&#x201D; mean</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;"> the stockholders, </font><font style="display: inline;color:#000000;">option holders</font><font style="display: inline;color:#000000;"> and warrant holders of the Company. </font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:17pt;"><font style="display: inline;font-weight:bold;color:#000000;">2.23</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Separation from Service</font><font style="display: inline;color:#000000;">&#x201D; means a separation from service within the meaning of Treasury Regulations Section 1.409A-1(h), without regard to alternative definitions thereunder. </font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:17pt;"><font style="display: inline;font-weight:bold;color:#000000;">2.24</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Subsidiary</font><font style="display: inline;color:#000000;">&#x201D; means</font><font style="display: inline;color:#000000;">, as to any person, any corporation, association, partnership, limited liability company or other business entity</font><font style="display: inline;color:#000000;"> controlled by such person and</font><font style="display: inline;color:#000000;"> of which 50</font><font style="display: inline;color:#000000;">%</font><font style="display: inline;color:#000000;"> or more of the </font><font style="display: inline;color:#000000;">outstanding voting securities </font><font style="display: inline;color:#000000;">is </font><font style="display: inline;color:#000000;">owned or </font><font style="display: inline;color:#000000;">controlled (directly or indirectly</font><font style="display: inline;color:#000000;"> through one or more intermediaries</font><font style="display: inline;color:#000000;">) by that </font><font style="display: inline;color:#000000;">person</font><font style="display: inline;color:#000000;">.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:17pt;"><font style="display: inline;font-weight:bold;color:#000000;">2.25</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Target Valuation Milestones</font><font style="display: inline;color:#000000;">&#x201D; shall mean the Target Valuation Milestones listed on Schedule 1</font><font style="display: inline;color:#000000;">.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:17pt;"><font style="display: inline;font-weight:bold;color:#000000;">2.26</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Total Consideration</font><font style="display: inline;color:#000000;">&#x201D;</font><font style="display: inline;color:#000000;"> means the sum of the Initial Consideration a</font><font style="display: inline;color:#000000;">nd the Contingent Consideration </font><font style="display: inline;color:#000000;">received (</font><font style="display: inline;color:#000000;">but only to the extent actually received</font><font style="display: inline;color:#000000;">)</font><font style="display: inline;color:#000000;"> by t</font><font style="display: inline;color:#000000;">he Company or the Security</font><font style="display: inline;color:#000000;">h</font><font style="display: inline;color:#000000;">older</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;"> in a Merger Transaction</font><font style="display: inline;color:#000000;">.</font><font style="display: inline;color:#000000;">&nbsp;</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;">3.</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;"></font><font style="display: inline;font-weight:bold;color:#000000;">Interpretation and Administration of the Plan.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;color:#000000;">3.1</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">T</font><font style="display: inline;color:#000000;">he Plan will be interpreted and administered by the Administrator, whose actions in interpreting the terms of the Plan and administration of the Plan will be final and binding on all Participants.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt 36pt;text-indent: -36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref289175668"></a><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;">4.</font><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 28.8pt 0pt 0pt;"></font><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;"></font><font style="display: inline;font-weight:bold;color:#000000;">El</font><font style="display: inline;font-weight:bold;color:#000000;">igibility to Earn a </font><font style="display: inline;font-weight:bold;color:#000000;">Bonus</font><font style="display: inline;font-weight:bold;color:#000000;"> Payment</font><font style="display: inline;font-weight:bold;color:#000000;">.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref289175184"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;color:#000000;">4.1</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Achievement of&nbsp;a Target Valuation Milestone</font><font style="display: inline;color:#000000;">&#x201D;</font><font style="display: inline;color:#000000;"> shall be deemed to occur </font><font style="display: inline;color:#000000;">automatically </font><font style="display: inline;color:#000000;">in the event that (a) the Market Price multiplied by the number of </font><font style="display: inline;color:#000000;">all </font><font style="display: inline;color:#000000;">outstanding shares of Common Stock </font><font style="display: inline;color:#000000;">including shares issuable upon exercise of outstanding stock options</font><font style="display: inline;color:#000000;"> but excluding warrants</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">on such date </font><font style="display: inline;color:#000000;">shall equal or exceed such </font><font style="display: inline;color:#000000;">Target Valuation Milestone for 20 consec</font><font style="display: inline;color:#000000;">utive Trading Days, or (b) the C</font><font style="display: inline;color:#000000;">losing of a Merger Transaction shall occur and the amount of Total Consideration shall equal or exceed such Target Valuation Milestone.</font><font style="display: inline;color:#000000;"> For clarity, </font><font style="display: inline;color:#000000;">upon occurrence of event 4.1(a) or 4.1(b), </font><font style="display: inline;color:#000000;">no further action</font><font style="display: inline;color:#000000;"> or authorization</font><font style="display: inline;color:#000000;"> shall be required </font><font style="display: inline;color:#000000;">for the Administrator to </font><font style="display: inline;color:#000000;">cause</font><font style="display: inline;color:#000000;"> an </font><font style="display: inline;color:#000000;">Achievement of a Target Valuation Milestone</font><font style="display: inline;color:#000000;"> and the consequences thereof.</font><font style="display: inline;color:#000000;">&nbsp;</font></font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">Upon Achievement of a Target Valuation Milestone, </font><font style="display: inline;color:#000000;">and subject to Section</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;"> 4.2 through 4.6 </font><font style="display: inline;color:#000000;">and Section 8 </font><font style="display: inline;color:#000000;">below</font><font style="display: inline;color:#000000;">,</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">Participants shall be entitled to receive a</font><font style="display: inline;color:#000000;"> cash payment (each, a</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Bonus Payment</font><font style="display: inline;color:#000000;">&#x201D;)</font><font style="display: inline;color:#000000;"> equal </font><font style="display: inline;color:#000000;">up </font><font style="display: inline;color:#000000;">to a portion of the Aggregate Bonus Payment for such Target Valuation Milestone as follows:</font>
		</p>
		<p style="margin:12pt 0pt 12pt 72pt;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">(i) </font><font style="display: inline;color:#000000;">the </font><font style="display: inline;color:#000000;">Chairman, President and </font><font style="display: inline;color:#000000;">CEO</font><font style="display: inline;color:#000000;"> (assuming such Participant shall hold all three such offices</font><font style="display: inline;color:#000000;">)</font><font style="display: inline;color:#000000;"> shall be entitled to a Bo</font><font style="display: inline;color:#000000;">nus Payment equal to </font><font style="display: inline;color:#000000;">no less than </font><font style="display: inline;color:#000000;">33.3 % of </font><font style="display: inline;color:#000000;">such Aggregate Bonus Payment</font><font style="display: inline;color:#000000;">,</font><font style="display: inline;color:#000000;"> and</font>
		</p>
		<p style="margin:12pt 0pt 12pt 72pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">

			<font style="display: inline;font-weight:bold;font-size:9pt;">Page </font><font style="display: inline;font-weight:bold;font-size:9pt;"></font><font style="display: inline;font-weight:bold;font-size:9pt;">4</font><font style="display: inline;font-weight:bold;font-size:9pt;"></font><font style="display: inline;font-weight:bold;font-size:9pt;"> of </font><font style="display: inline;font-weight:bold;font-size:9pt;">1</font><font style="display: inline;font-weight:bold;font-size:9pt;">0</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:12pt 0pt 12pt 72pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">(ii) </font><font style="display: inline;color:#000000;">Participants who are </font><font style="display: inline;color:#000000;">then-current</font><font style="display: inline;color:#000000;"> members of the Scientific and Technical team shall be entitled to receive in t</font><font style="display: inline;color:#000000;">he aggregate Bonus Payments of </font><font style="display: inline;color:#000000;">up to </font><font style="display: inline;color:#000000;">a maximum of </font><font style="display: inline;color:#000000;">33.3% of such Aggregate Bonus Amount, which actual </font><font style="display: inline;color:#000000;">aggregate </font><font style="display: inline;color:#000000;">amounts </font><font style="display: inline;color:#000000;">may be less than</font><font style="display: inline;color:#000000;"> 33.3% in the </font><font style="display: inline;color:#000000;">sole </font><font style="display: inline;color:#000000;">discretion of the Administrator</font><font style="display: inline;color:#000000;">, and</font>
		</p>
		<p style="margin:12pt 0pt 12pt 72pt;border-top:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">(i</font><font style="display: inline;color:#000000;">ii</font><font style="display: inline;color:#000000;">) &nbsp;</font><font style="display: inline;color:#000000;">A</font><font style="display: inline;color:#000000;">ll other Participants shall be entitled to receive in the aggregate Bonus Payments of up</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">to </font><font style="display: inline;color:#000000;">a maximum of </font><font style="display: inline;color:#000000;">23.3% of such Aggregate Bonus Payment, which actual </font><font style="display: inline;color:#000000;">aggregate </font><font style="display: inline;color:#000000;">amounts </font><font style="display: inline;color:#000000;">may be less than</font><font style="display: inline;color:#000000;"> 23.3% in the </font><font style="display: inline;color:#000000;">sole </font><font style="display: inline;color:#000000;">discretion of the Administrator</font><font style="display: inline;color:#000000;">, and</font>
		</p>
		<p style="margin:0pt 0pt 12pt 72pt;line-height:100%;text-indent:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">(</font><font style="display: inline;color:#000000;">i</font><font style="display: inline;color:#000000;">v) </font><font style="display: inline;color:#000000;">The</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">actual amount</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">of </font><font style="display: inline;color:#000000;">the </font><font style="display: inline;color:#000000;">Bonus Payment</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">each Participant </font><font style="display: inline;color:#000000;">(other than the</font><font style="display: inline;color:#000000;"> Chairman, President and</font><font style="display: inline;color:#000000;"> CEO) </font><font style="display: inline;color:#000000;">is eligible to receive</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">will be determined by the Administrator </font><font style="display: inline;color:#000000;">taking into account the recommendation of the CEO</font><font style="display: inline;color:#000000;"> at each </font><font style="display: inline;color:#000000;">time of </font><font style="display: inline;color:#000000;">an</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">Achievement of a Target Valuation Milestone</font><font style="display: inline;color:#000000;">.&nbsp;&nbsp;In making such determination, the Administrator </font><font style="display: inline;color:#000000;">and CEO </font><font style="display: inline;color:#000000;">shall consider years of experience, education level, longevity with the Company, intellectual and other contributions</font><font style="display: inline;color:#000000;">,</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">the actual and projected success of the Company, </font><font style="display: inline;color:#000000;">and other factors </font><font style="display: inline;color:#000000;">affecting overall compensation</font><font style="display: inline;color:#000000;">, and</font>
		</p>
		<p style="margin:12pt 0pt 0pt 72pt;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">(v) </font><font style="display: inline;color:#000000;">A Participant&#x2019;s receipt of a</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">Bonus </font><font style="display: inline;color:#000000;">Payment </font><font style="display: inline;color:#000000;">shall not </font><font style="display: inline;color:#000000;">confer upon such</font><font style="display: inline;color:#000000;"> Participant </font><font style="display: inline;color:#000000;">(other than the </font><font style="display: inline;color:#000000;">Chairman, President and </font><font style="display: inline;color:#000000;">CEO) the right to receive </font><font style="display: inline;color:#000000;">in any subsequent </font><font style="display: inline;color:#000000;">Achievement of a Target Valuation Milestone</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">that same</font><font style="display: inline;color:#000000;">,</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">or any, dollar </font><font style="display: inline;color:#000000;">amount</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">of Bonus Payment</font><font style="display: inline;color:#000000;">, or </font><font style="display: inline;color:#000000;">that same, or any, percentage of an Aggregate Bonus Payment</font><font style="display: inline;color:#000000;">, and</font>
		</p>
		<p style="margin:12pt 0pt 0pt 72pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">(v</font><font style="display: inline;color:#000000;">i</font><font style="display: inline;color:#000000;">) &nbsp;</font><font style="display: inline;color:#000000;">Any Aggregate Bonus Payment</font><font style="display: inline;color:#000000;"> that is not </font><font style="display: inline;color:#000000;">awarded</font><font style="display: inline;color:#000000;"> to </font><font style="display: inline;color:#000000;">any </font><font style="display: inline;color:#000000;">Participant</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;"> at the time of </font><font style="display: inline;color:#000000;">Achievement of a Target Valuation Milestone</font><font style="display: inline;color:#000000;"> shall </font><font style="display: inline;color:#000000;">be deemed </font><font style="display: inline;color:#000000;">to be no longer </font><font style="display: inline;color:#000000;">available for distribution</font><font style="display: inline;color:#000000;">, and</font>
		</p>
		<p style="margin:12pt 0pt 0pt 72pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">(vii) In the event two or more </font><font style="display: inline;color:#000000;">Achievement of a Target Valuation Milestone</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">occur </font><font style="display: inline;color:#000000;">simultaneously </font><font style="display: inline;color:#000000;">or</font><font style="display: inline;color:#000000;"> within proximity of </font><font style="display: inline;color:#000000;">one </font><font style="display: inline;color:#000000;">another, each </font><font style="display: inline;color:#000000;">Achievement of a Target Valuation Milestone</font><font style="display: inline;color:#000000;"> shall be deemed to have </font><font style="display: inline;color:#000000;">occurred individually and </font><font style="display: inline;color:#000000;">separately and </font><font style="display: inline;color:#000000;">Participants shall be entitled to receive a Bonus Payment, without limitation, for each individual </font><font style="display: inline;color:#000000;">and separate </font><font style="display: inline;color:#000000;">Achievement of a Target Valuation Milestone</font><font style="display: inline;color:#000000;">, subject to Sections 4.2 through 4.6 below</font><font style="display: inline;color:#000000;">, and</font><font style="display: inline;color:#000000;"> &nbsp; &nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt 72pt;border-top:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">(</font><font style="display: inline;color:#000000;">vii</font><font style="display: inline;color:#000000;">i</font><font style="display: inline;color:#000000;">) F</font><font style="display: inline;color:#000000;">or </font><font style="display: inline;color:#000000;">clarity, no further conditions or </font><font style="display: inline;color:#000000;">approvals </font><font style="display: inline;color:#000000;">shall be required by the Administrator or t</font><font style="display: inline;color:#000000;">he Company </font><font style="display: inline;color:#000000;">for a Participant to receive his/her Bonus Payment upon Achievement of a Target Valuation Milestone</font><font style="display: inline;color:#000000;"> as set forth herein</font><font style="display: inline;color:#000000;">, subject to Section</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;"> 4.2 through 4.6 </font><font style="display: inline;color:#000000;">and Section 8 </font><font style="display: inline;color:#000000;">below.</font><font style="display: inline;color:#000000;"> &nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;color:#000000;">4.2</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">F</font><font style="display: inline;color:#000000;">or each Participant </font><font style="display: inline;color:#000000;">who </font><font style="display: inline;color:#000000;">is an employee of the Comp</font><font style="display: inline;color:#000000;">any</font><font style="display: inline;color:#000000;">,</font><font style="display: inline;color:#000000;"> the receipt of a</font><font style="display: inline;color:#000000;"> Bonus </font><font style="display: inline;color:#000000;">Payment </font><font style="display: inline;color:#000000;">will be subject to the Participant&#x2019;s </font><font style="display: inline;color:#000000;">continued employment</font><font style="display: inline;color:#000000;"> with the Company</font><font style="display: inline;color:#000000;"> (or, in the case of a Merger Transaction, the acquiring, surviving, resulting or successor entity, as the case may be)</font><font style="display: inline;color:#000000;"> &nbsp;t</font><font style="display: inline;color:#000000;">hrough (a) the date of Achievement of </font><font style="display: inline;color:#000000;">a Target Valuation Milestone</font><font style="display: inline;color:#000000;">, &nbsp;</font><font style="display: inline;color:#000000;">other than in a Merger Transaction </font><font style="display: inline;color:#000000;">or (b) in th</font><font style="display: inline;color:#000000;">e event of a Merger Transaction</font><font style="display: inline;color:#000000;">:</font><font style="display: inline;color:#000000;">&nbsp;</font></font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">

			<font style="display: inline;font-weight:bold;font-size:9pt;">Page </font><font style="display: inline;font-weight:bold;font-size:9pt;"></font><font style="display: inline;font-weight:bold;font-size:9pt;">5</font><font style="display: inline;font-weight:bold;font-size:9pt;"></font><font style="display: inline;font-weight:bold;font-size:9pt;"> of </font><font style="display: inline;font-weight:bold;font-size:9pt;">1</font><font style="display: inline;font-weight:bold;font-size:9pt;">0</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:12pt 0pt 12pt 72pt;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref289695797"></a><font style="display: inline;color:#000000;">(i) the </font><font style="display: inline;color:#000000;">date of </font><font style="display: inline;color:#000000;">the Closing</font><font style="display: inline;color:#000000;"> with regard t</font><font style="display: inline;color:#000000;">o the amount of the </font><font style="display: inline;color:#000000;">Bonus </font><font style="display: inline;color:#000000;">P</font><font style="display: inline;color:#000000;">ayment </font><font style="display: inline;color:#000000;">based upon the Initi</font><font style="display: inline;color:#000000;">al Consideration, and</font>
		</p>
		<p style="margin:0pt 0pt 0pt 72pt;border-top:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref289695940"></a><font style="display: inline;color:#000000;">(ii) w</font><font style="display: inline;color:#000000;">ith regard </font><font style="display: inline;color:#000000;">to the amount of the</font><font style="display: inline;color:#000000;"> Bonus </font><font style="display: inline;color:#000000;">payment </font><font style="display: inline;color:#000000;">based upon any Contingent Consideration, the date of receipt of such Contingent Consideration</font><font style="display: inline;color:#000000;"> by the Company or the Security</font><font style="display: inline;color:#000000;">holders (the &#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Receipt Date</font><font style="display: inline;color:#000000;">&#x201D;)</font><font style="display: inline;color:#000000;">;</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;font-style:italic;color:#000000;">provided, however</font><font style="display: inline;color:#000000;">, that, in the case of a Participant who is an employee, if the Participant suffers an Involuntary Termination after the Closing </font><font style="display: inline;color:#000000;">and </font><font style="display: inline;color:#000000;">prior to the Receipt Date and provided that the Participant (a) complies with </font><font style="display: inline;color:#000000;">the </font><font style="display: inline;color:#000000;">Participant&#x2019;s continuing obligations to the Company </font><font style="display: inline;color:#000000;">or the acquiring, surviving, resulting or successor entity, as the case may be, </font><font style="display: inline;color:#000000;">including the return of any Company property</font><font style="display: inline;color:#000000;">,</font><font style="display: inline;color:#000000;"> and (b) resigns from all positions </font><font style="display: inline;color:#000000;">the </font><font style="display: inline;color:#000000;">Participant then holds with the Company</font><font style="display: inline;color:#000000;"> or the acquiring, surviving, resulting or successor entity, as the case may be</font><font style="display: inline;color:#000000;">, the Participant will be treated as having provided the necessary employment through the Receipt Date and will be ent</font><font style="display: inline;color:#000000;">itled to receive the</font><font style="display: inline;color:#000000;"> Bonus</font><font style="display: inline;color:#000000;"> Payment</font><font style="display: inline;color:#000000;"> based upon such Contingent Consideration.</font><font style="display: inline;color:#000000;">&nbsp;</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref289695810"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;color:#000000;">4.3</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">E</font><font style="display: inline;color:#000000;">ach Participant </font><font style="display: inline;color:#000000;">that is not an employee of the Company </font><font style="display: inline;color:#000000;">will be enti</font><font style="display: inline;color:#000000;">tled to receive the </font><font style="display: inline;color:#000000;">Bonus</font><font style="display: inline;color:#000000;"> Payment</font><font style="display: inline;color:#000000;"> subject to the Participant&#x2019;s continued service with the Company through the </font><font style="display: inline;color:#000000;">date of Achievement of </font><font style="display: inline;color:#000000;">a</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">Target Valuation</font><font style="display: inline;color:#000000;"> Milestone</font><font style="display: inline;color:#000000;">.</font><font style="display: inline;color:#000000;"> &nbsp; &nbsp;</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;color:#000000;">4.4</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">Excluding those on disability</font><font style="display: inline;color:#000000;">, maternity</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">or sick </font><font style="display: inline;color:#000000;">leave, workers compensation leave or </font><font style="display: inline;color:#000000;">any </font><font style="display: inline;color:#000000;">other authorized leave of absence,</font><font style="display: inline;color:#000000;"> &nbsp;i</font><font style="display: inline;color:#000000;">f a Participant is not in the employment or service</font><font style="display: inline;color:#000000;"> of the Company upon the date of Achievement of </font><font style="display: inline;color:#000000;">a &nbsp;</font><font style="display: inline;color:#000000;">Target Valuation</font><font style="display: inline;color:#000000;"> Milestone</font><font style="display: inline;color:#000000;">, &nbsp;</font><font style="display: inline;color:#000000;">the </font><font style="display: inline;color:#000000;">Participant w</font><font style="display: inline;color:#000000;">ill not receive any </font><font style="display: inline;color:#000000;">Bonus Payment</font><font style="display: inline;color:#000000;">.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;border-top:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;color:#000000;">4.5</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">Notwithstanding anything to the contrary in the Plan, a Participant will not earn or be entitled to receive any </font><font style="display: inline;color:#000000;">Bonus P</font><font style="display: inline;color:#000000;">ayments under the P</font><font style="display: inline;color:#000000;">lan unless and until </font><font style="display: inline;color:#000000;">such time as the</font><font style="display: inline;color:#000000;"> Achievement of </font><font style="display: inline;color:#000000;">a</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">Target Valuation</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">Milestone </font><font style="display: inline;color:#000000;">actually occurs.</font></font>
		</p>
		<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;color:#000000;">4.6</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">Notwithstanding anything to the contrary in the Plan, </font><font style="display: inline;color:#000000;">other than in connection with a Merger Transaction, </font><font style="display: inline;color:#000000;">the Company will defer actual payment of any Bonus Payments under the Plan until such time as the Company has sufficient cash remaining, after pro forma payment of all such Bonus Payments, to meet the Company&#x2019;s projected cash needs for the subsequent twenty-four (24) months (&#x201C;Remaining Sufficient Cash&#x201D;). In each case, Remaining Sufficient Cash will be based upon the Company&#x2019;s then-current operating plan and budget previously approved by the Board for the subsequent twenty-four (24) months, net of any direct expenses related to ongoing or projected Phase II/III </font><font style="display: inline;color:#000000;">and Phase III </font><font style="display: inline;color:#000000;">clinical studies.</font></font>
		</p>
		<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 36pt;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">If the Company does not have Remaining Sufficient Cash to pay the Bonus Payments in full, the Company shall make partial Bonus Payments to each Participant to the extent it has Remaining Sufficient Cash to do so. Such partial Bonus Payments shall be paid pro rata to each Participant as an equal percentage of the Bonus Payments which each Participant is entitled to receive. </font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">To the extent the Bonus Payments are not paid in full, the Company will be, and shall remain, obligated to pay all Bonus Payments at a future point in time, and each Participant </font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">

			<font style="display: inline;font-weight:bold;font-size:9pt;">Page </font><font style="display: inline;font-weight:bold;font-size:9pt;"></font><font style="display: inline;font-weight:bold;font-size:9pt;">6</font><font style="display: inline;font-weight:bold;font-size:9pt;"></font><font style="display: inline;font-weight:bold;font-size:9pt;"> of </font><font style="display: inline;font-weight:bold;font-size:9pt;">1</font><font style="display: inline;font-weight:bold;font-size:9pt;">0</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:0pt 0pt 12pt 36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;color:#000000;">shall remain entitled to receive any unpaid balance of the Bonus Payments when the Company does have Remaining Sufficient Cash to do so. </font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">A Participant who, having otherwise satisfied all requisite conditions for payment of a Bonus Payment, is owed an unpaid Bonus Payment need not be an employee or in the service of the Company to receive future payment of such owed and unpaid Bonus</font><font style="display: inline;color:#000000;"> Payment.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:72pt;border-top:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">Earned but </font><font style="display: inline;color:#000000;">unpaid Bonus Payments shall be a contractual financial obligation of the Company</font><font style="display: inline;color:#000000;">.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">D</font><font style="display: inline;color:#000000;">octrine</font><font style="display: inline;color:#000000;">s of frustration and </font><font style="display: inline;color:#000000;">force majeure </font><font style="display: inline;color:#000000;">shall not apply to the Company&#x2019;s obligation to pay Participants t</font><font style="display: inline;color:#000000;">he Bonus Payments. </font><a name="_Ref289175026"></a>
		</p>
		<p style="margin:12pt 0pt 0pt 36pt;text-indent: -36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;">5.</font><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 28.8pt 0pt 0pt;"></font><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;"></font><font style="display: inline;font-weight:bold;color:#000000;">P</font><font style="display: inline;font-weight:bold;color:#000000;">ayment of </font><font style="display: inline;font-weight:bold;color:#000000;">Bonus</font><font style="display: inline;font-weight:bold;color:#000000;"> Payments.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_Ref289696141"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;color:#000000;">5.1</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">If the conditi</font><font style="display: inline;color:#000000;">ons for earning </font><font style="display: inline;color:#000000;">a &nbsp;</font><font style="display: inline;color:#000000;">Bonus</font><font style="display: inline;color:#000000;"> Payment</font><font style="display: inline;color:#000000;"> set forth in the Plan are satisfied, including the requireme</font><font style="display: inline;color:#000000;">nt that the Participant must</font><font style="display: inline;color:#000000;"> execute and allow to become effective a Release as provided in Section 8, each Participant will be entitled t</font><font style="display: inline;color:#000000;">o be paid his or her</font><font style="display: inline;color:#000000;"> Bonus </font><font style="display: inline;color:#000000;">Payment</font><font style="display: inline;color:#000000;">&nbsp;</font><a name="_DV_C23"></a><font style="display: inline;color:#000000;">not later than the 30</font><font style="display: inline;color:#000000;font-size:6pt;vertical-align:super;line-height:100%">th</font><font style="display: inline;color:#000000;"> day after the </font><font style="display: inline;color:#000000;">date </font><font style="display: inline;color:#000000;">of </font><font style="display: inline;color:#000000;">the </font><font style="display: inline;color:#000000;">Achievement of Target </font><font style="display: inline;color:#000000;">Valuation </font><font style="display: inline;color:#000000;">Milestone</font><font style="display: inline;color:#000000;">,</font><font style="display: inline;color:#000000;"> subject</font><font style="display: inline;color:#000000;"> to the provision</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;"> of Section 4.</font><font style="display: inline;color:#000000;"> &nbsp;In the event the Company is unable to make such Bonus Payment due</font><font style="display: inline;color:#000000;"> to the provision of Section 4.6, such Bonus P</font><font style="display: inline;color:#000000;">ayment shall be made not later than the 30</font><font style="display: inline;color:#000000;font-size:6pt;vertical-align:super;line-height:100%">th</font><font style="display: inline;color:#000000;"> day after the Company meets </font><font style="display: inline;color:#000000;">the requirements of Section 4.6. N</font><font style="display: inline;color:#000000;">otwithstanding the foregoing</font><font style="display: inline;color:#000000;">,</font><font style="display: inline;color:#000000;"> with respect to a Merger Transaction, Bonus Payments shall be paid </font><font style="display: inline;color:#000000;">not later than the 30</font><font style="display: inline;color:#000000;font-size:6pt;vertical-align:super;line-height:100%">th</font><font style="display: inline;color:#000000;"> day after (i) the Closing, with respect to the Initial Consideration, and (ii) the </font><font style="display: inline;color:#000000;">Receipt Date</font><font style="display: inline;color:#000000;">,</font><font style="display: inline;color:#000000;"> with respect to the Contingent Consideration, wit</font><font style="display: inline;color:#000000;">h the amount of the </font><font style="display: inline;color:#000000;">Bonus </font><font style="display: inline;color:#000000;">Payment </font><font style="display: inline;color:#000000;">to be paid with respect to the Initial Consideration and the Contingent Consideration to be calculated based on the amount of the Initial Consideration and any Contingent Consideration, respectively, that as of such payment date has </font><font style="display: inline;color:#000000;">actually </font><font style="display: inline;color:#000000;">been received by the Company or the Securityholders, no longer subject to Conditions.</font></font>
		</p>
		<p style="margin:0pt;line-height:100%;border-bottom:1pt none #D9D9D9 ;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;border-top:1pt none #D9D9D9 ;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">To the extent that a Condition, when applied to the Bonus Payment, would not constitute a &#x201C;substantial risk of forfeiture&#x201D; (as defined in Treasury Regulations Section 1.409A-1(d)), such that the Bonus Payment related to such Condition would not be reasonably likely to be payable in compliance with either Treasury Regulations Section 1.409A-1(b)(4) or Treasury Regulations Section 1.409A-3(i)(5)(iv)(A), or to the extent the Administrator determines such Bonus Payment is not otherwise payable in compliance with or under an exemption from Section 409A, the Participant will be paid the Bonus Payment related to such Condition, subject to any reduction made by the Administrator based on the Fair Market Value (as of the Closing) of the Bonus Payment&nbsp;&nbsp;as a result of the existence of the Condition (that is, the present value of the Bonus Payment that may be earned upon satisfaction of the Condition), in a lump sum on the 60th day following the effective date of the Achievement of the relevant Valuation Milestone, subject to the requirements of Section 4.</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;color:#000000;">5.2</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">It is intended that each installment of the </font><font style="display: inline;color:#000000;">Bonus P</font><font style="display: inline;color:#000000;">ayments provided under the Plan (the &#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Plan</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Payments</font><font style="display: inline;color:#000000;">&#x201D;) is a separate &#x201C;payment&#x201D; for purposes of Treasury Regulations Section 1.409A-2(b)(2)(i).&nbsp;&nbsp;For clarity, it is intended that the Plan Payments satisfy, to the greatest extent possible, the exemption from the application of Section 409A provided under Treasury Regulations Section 1.409A-1(b)(4) and, to the extent not so exempt, that the Plan Payments </font>
		</font>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">

			<font style="display: inline;font-weight:bold;font-size:9pt;">Page </font><font style="display: inline;font-weight:bold;font-size:9pt;"></font><font style="display: inline;font-weight:bold;font-size:9pt;">7</font><font style="display: inline;font-weight:bold;font-size:9pt;"></font><font style="display: inline;font-weight:bold;font-size:9pt;"> of </font><font style="display: inline;font-weight:bold;font-size:9pt;">1</font><font style="display: inline;font-weight:bold;font-size:9pt;">0</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:12pt 0pt 0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt"><font style="display: inline;color:#000000;">comply, and the Plan be interpreted to the greatest extent possible as consistent, with Treasury Regulations Section 1.409A-3(i)(5)(iv)(A) &#x2013; that is, as &#x201C;transaction-based compensation</font><font style="display: inline;color:#000000;">,&#x201D; which requires all payments to be made prior to the date that is five years following the effective date of </font><font style="display: inline;color:#000000;">a Merger </font><font style="display: inline;color:#000000;">Transaction and otherwise in accordance with Treasury Regulations Section 1.409A-3(i)(5)(iv)(A</font><font style="display: inline;color:#000000;">). </font><font style="display: inline;color:#000000;">To the extent not already incorporated directly into the Plan, the terms and conditions of these sections of the Treasury Regulations are incorporated by reference in the Plan. </font></p><a name="_Ref289178263"></a>
		</p>
		<p style="margin:0pt 0pt 12pt;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;border-top:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;">6.</font><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;"></font><font style="display: inline;font-weight:bold;color:#000000;">Type of Consideration</font><font style="display: inline;color:#000000;">.&nbsp; </font><font style="display: inline;color:#000000;">In the event of a Merger Transaction, the</font><font style="display: inline;color:#000000;"> Bonus </font><font style="display: inline;color:#000000;">Payments </font><font style="display: inline;color:#000000;">will be paid to Participants in the same form and proportion as paid by the acquirer to the Company or the Securityholders as part of the Total Consideration</font><font style="display: inline;color:#000000;">; &nbsp;</font><font style="display: inline;font-style:italic;color:#000000;">provided, that</font><font style="display: inline;color:#000000;"> the Administrator may substitute an equivalent cash payment for any portion of the Total Consideration paid in stock of the acquirer if necessary in order to comply with applicable securities regulations</font><font style="display: inline;color:#000000;">. In addition to any other restrictions imposed on the payments to be made pursuant to the Plan, any securities that are issued to the Participants under the Plan will be subject to the same or similar restrictions as imposed by the acquiring company on the securities distributed</font><font style="display: inline;color:#000000;"> to the Company or the Security</font><font style="display: inline;color:#000000;">holders as part of the Total Consideration on the terms set forth in the definitive agreement executed in c</font><font style="display: inline;color:#000000;">onnection with the</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">Merger </font><font style="display: inline;color:#000000;">Transaction.</font><a name="_Ref289177655"></a>
		</p>
		<p style="margin:12pt 0pt 0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_DV_C252"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;">7.</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;"></font><font style="color:#0000FF;display: inline;font-weight:bold;color:#000000;text-decoration:none;">[Reserved]</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;">8.</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;"></font><font style="display: inline;font-weight:bold;color:#000000;">Release.</font><font style="display: inline;color:#000000;"> &nbsp; &nbsp;</font><font style="display: inline;color:#000000;">Promptly</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">following the </font><font style="display: inline;color:#000000;">Achievement of a Target Valuation Milestone</font><font style="display: inline;color:#000000;">, the Company shall furnish to each Participant a general release of claims in substantially the form of </font><font style="display: inline;font-weight:bold;color:#000000;">Exhibit A</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">(</font><font style="display: inline;color:#000000;">a &nbsp;</font><font style="display: inline;color:#000000;">&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;">Release</font><font style="display: inline;color:#000000;">&#x201D;).&nbsp; </font><font style="display: inline;color:#000000;">As a further condition to earning and receiving</font><font style="display: inline;color:#000000;"> payment of </font><font style="display: inline;color:#000000;">each </font><font style="display: inline;color:#000000;">Bonus Payment,</font><font style="display: inline;color:#000000;"> a Participant must execute and allow to become effective </font><font style="display: inline;color:#000000;">a Release prior to payment of each Bonus Payment</font><font style="display: inline;color:#000000;">.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">If </font><font style="display: inline;color:#000000;">a &nbsp;</font><font style="display: inline;color:#000000;">Partic</font><font style="display: inline;color:#000000;">ipant</font><font style="display: inline;color:#000000;"> fails </font><font style="display: inline;color:#000000;">to execute </font><font style="display: inline;color:#000000;">or allow to become effective a R</font><font style="display: inline;color:#000000;">elease</font><font style="display: inline;color:#000000;"> within thirty (30) calendar days of having been furnished such Release</font><font style="display: inline;color:#000000;">, then </font><font style="display: inline;color:#000000;">the </font><font style="display: inline;color:#000000;">Participant will n</font><font style="display: inline;color:#000000;">ot be eligible to earn such </font><font style="display: inline;color:#000000;">Bonus </font><font style="display: inline;color:#000000;">Payment</font><font style="display: inline;color:#000000;">, and </font><font style="display: inline;color:#000000;">such </font><font style="display: inline;color:#000000;">Bonus </font><font style="display: inline;color:#000000;">Payment </font><font style="display: inline;color:#000000;">otherwise payable to </font><font style="display: inline;color:#000000;">the </font><font style="display: inline;color:#000000;">Participant will be </font><font style="display: inline;color:#000000;">forfeited</font><font style="display: inline;color:#000000;"> an</font><font style="display: inline;color:#000000;">d the Participant shall </font><font style="display: inline;color:#000000;">lose all right </font><font style="display: inline;color:#000000;">such </font><font style="display: inline;color:#000000;">Participant may have</font><font style="display: inline;color:#000000;"> with regard to </font><font style="display: inline;color:#000000;">such</font><font style="display: inline;color:#000000;"> Bonus Payment.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:26pt;"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;">9.</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;"></font><font style="display: inline;font-weight:bold;color:#000000;">Withholding of Compensation.&nbsp; </font><font style="display: inline;color:#000000;">In connection with any Bonus Payment to </font><font style="display: inline;color:#000000;">be made</font><font style="display: inline;color:#000000;"> under the Plan to any </font><font style="display: inline;color:#000000;">Participant</font><font style="display: inline;color:#000000;">, such </font><font style="display: inline;color:#000000;">Participant</font><font style="display: inline;color:#000000;"> shall make</font><font style="display: inline;color:#000000;"> arrangements</font><font style="display: inline;color:#000000;"> reasonably</font><font style="display: inline;color:#000000;"> acceptable to the Administrator for the satisfaction of any non-U.S., federal, state, or local income and employment tax withholding obligations, including, without limitation, obligations incident to the receipt of </font><font style="display: inline;color:#000000;">cash or stock of the acquirer.</font><font style="display: inline;color:#000000;"> &nbsp; &nbsp;</font><font style="display: inline;color:#000000;">Each Participant is encouraged to </font><font style="display: inline;color:#000000;">consult with </font><font style="display: inline;color:#000000;">his or her personal legal or tax advisors with respect to the benefits provided </font><font style="display: inline;color:#000000;">under </font><font style="display: inline;color:#000000;">the Plan.&nbsp;&nbsp;Neither the Company nor any of its employees, directors, officers or agents (i) are authorized to provide any tax advice to Participants with respect to the benefits provided under the Plan or (ii)&nbsp;make or </font><font style="display: inline;color:#000000;">have </font><font style="display: inline;color:#000000;">made any representation about the tax consequences of any payments or benefits offered by the Company to any Participant under </font><font style="display: inline;color:#000000;">the </font><font style="display: inline;color:#000000;">Plan.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;">10.</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;"></font><font style="display: inline;font-weight:bold;color:#000000;">No Guarantee of Employment or Other Service Rights.</font><font style="display: inline;color:#000000;"> &nbsp;The Plan is intended to provide a financial incentive to Participants and is not intended to confer any rights to continued service upon Participants and the employment of an employee will remain at-will and subject to termination by either the Company or Participant at any time, with or without cause or notice.</font></font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">

			<font style="display: inline;font-weight:bold;font-size:9pt;">Page </font><font style="display: inline;font-weight:bold;font-size:9pt;"></font><font style="display: inline;font-weight:bold;font-size:9pt;">8</font><font style="display: inline;font-weight:bold;font-size:9pt;"></font><font style="display: inline;font-weight:bold;font-size:9pt;"> of </font><font style="display: inline;font-weight:bold;font-size:9pt;">1</font><font style="display: inline;font-weight:bold;font-size:9pt;">0</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;">11.</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;"></font><font style="display: inline;font-weight:bold;color:#000000;">No Equity Interest; Status as Creditor.</font><font style="display: inline;color:#000000;"> &nbsp;Neither the Plan nor the allocation of </font><font style="display: inline;color:#000000;">Bonus </font><font style="display: inline;color:#000000;">Payments under the Plan creates or conveys any equity or ownership interest in the Company or any rights commonly associated with any such interest, including, but not limited to, the right to vote on any matters put before the Company&#x2019;s stockholders.&nbsp;&nbsp;A Participant&#x2019;s sole right under the Plan will be as a general unsecured creditor of the Company </font><font style="display: inline;color:#000000;">or </font><font style="display: inline;color:#000000;">the acquiring</font><font style="display: inline;color:#000000;">,</font><font style="display: inline;color:#000000;"> surviving</font><font style="display: inline;color:#000000;">, resulting or successor entity, as the case may be</font><font style="display: inline;color:#000000;">.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;">12.</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;"></font><font style="display: inline;font-weight:bold;color:#000000;">No Assignment or Transfer by Participant.</font><font style="display: inline;color:#000000;"> &nbsp;None of the rights, benefits, obligations or duties under the Plan may </font><font style="display: inline;color:#000000;">be sold or discounted,</font><font style="display: inline;color:#000000;"> assigned or transferred by any Participant except by will or under the laws of descent and distribution.&nbsp;&nbsp;Any purported </font><font style="display: inline;color:#000000;">sale, discount, </font><font style="display: inline;color:#000000;">assignment or transfer by any such Participant will be void.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;">13.</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;"></font><font style="display: inline;font-weight:bold;color:#000000;">Termination of the Plan.</font><font style="display: inline;color:#000000;"> &nbsp;T</font><font style="display: inline;color:#000000;">h</font><font style="display: inline;color:#000000;">e Plan </font><font style="display: inline;color:#000000;">will terminate and no amounts will be earned under the Plan as of and effective on the earliest to occur of (i) any liquidation, dissolution or winding up of the Company</font><font style="display: inline;color:#000000;">, other than in connection with a Merger Transaction,</font><font style="display: inline;color:#000000;"> or at such time as the Company does not have sufficient cash to pay its current obligations, (ii) a</font><font style="display: inline;color:#000000;">t such time a</font><font style="display: inline;color:#000000;">s all earned Bonus P</font><font style="display: inline;color:#000000;">ayments due under the Plan have been paid, including any payments in respect of</font><font style="display: inline;color:#000000;"> Contingent Consideration, and</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">(iii) December 31</font><font style="display: inline;color:#000000;">, 2030</font><font style="display: inline;color:#000000;"> provided that Bonus Payments payable as a result of Contingent Consideration received after the date of termination in connection with a Merger Transaction entered into prior to the date of Termination shall continue to be due and payable after the date of termination</font><font style="display: inline;color:#000000;">. &nbsp;</font><font style="display: inline;color:#000000;">Further, the Company&#x2019;s Board of Directors may elect to extend the Plan for such time period and with any such modifications as it deems in the best interests of the Company.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;">14.</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;"></font><font style="display: inline;font-weight:bold;color:#000000;">Amendment of the Plan</font><font style="display: inline;font-weight:bold;color:#000000;">.</font><font style="display: inline;color:#000000;"> &nbsp; &nbsp;</font><font style="display: inline;color:#000000;">Any material changes to the Plan shall be proposed by the Administrator to the Board of Directors and such changes to the Plan shall require unanimous approval or consent of the Board of Directors for such changes to the Plan to be effective</font><font style="display: inline;color:#000000;">; &nbsp;</font><font style="display: inline;font-style:italic;color:#000000;">provided</font><font style="display: inline;color:#000000;">, &nbsp;</font><font style="display: inline;font-style:italic;color:#000000;">however</font><font style="display: inline;color:#000000;">,</font><font style="display: inline;color:#000000;"> that </font><font style="display: inline;color:#000000;">(i) no amendment to the</font><font style="display: inline;color:#000000;"> Plan may be made after the dat</font><font style="display: inline;color:#000000;">e of a Merger Transaction</font><font style="display: inline;color:#000000;">, and (ii) </font><font style="display: inline;color:#000000;">no amendment will adversely affect the rights of a Participant under the Plan without written consent of </font><font style="display: inline;color:#000000;">the </font><font style="display: inline;color:#000000;">Participant unless </font><font style="display: inline;color:#000000;">(</font><font style="display: inline;color:#000000;">x</font><font style="display: inline;color:#000000;">) &nbsp;</font><font style="display: inline;color:#000000;">such amendment affects the rights of all Participants under the P</font><font style="display: inline;color:#000000;">lan in the same manner</font><font style="display: inline;color:#000000;">,</font><font style="display: inline;color:#000000;"> and (</font><font style="display: inline;color:#000000;">y</font><font style="display: inline;color:#000000;">) Participants entitled to receive a majority of the Bonus Payments consent in writing to such amendment</font><font style="display: inline;color:#000000;">.&nbsp;&nbsp;Notwithstanding the foregoing, </font><font style="display: inline;color:#000000;">any such amendment </font><font style="display: inline;color:#000000;">to the detriment of a Participant </font><font style="display: inline;color:#000000;">in a manner different from the other Participants </font><font style="display: inline;color:#000000;">may only be made</font><font style="display: inline;color:#000000;"> with the written consent of </font><font style="display: inline;color:#000000;">the </font><font style="display: inline;color:#000000;">Participant.</font><font style="display: inline;color:#000000;"> For clarity, all Schedules </font><font style="display: inline;color:#000000;">referenced in the Plan </font><font style="display: inline;color:#000000;">are </font><font style="display: inline;color:#000000;">expressly made an integral</font><font style="display: inline;color:#000000;"> part of the Plan.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;">15.</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;"></font><font style="display: inline;font-weight:bold;color:#000000;">Governing Law.</font><font style="display: inline;color:#000000;"> &nbsp;The rights and obligations of a Participant under the Plan will be governed by and interpreted, construed and enforced in accordance with the laws of the State of Delaware without regard to its or any other jurisdiction&#x2019;s conflicts of laws principles. The parties submit to the jurisdiction of the state or federal courts, as applicable, encompassing the then current location of the Company&#x2019;s (or the acquiring or surviving corporation&#x2019;s, as applicable) principal headquarters at the time of such dispute or claim. </font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;">16.</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;"></font><font style="display: inline;font-weight:bold;color:#000000;">Assumption by Acquirer.&nbsp; </font><font style="display: inline;color:#000000;">The Company&#x2019;s ob</font><font style="display: inline;color:#000000;">ligations to pay the</font><font style="display: inline;color:#000000;"> Bonus Payments</font><font style="display: inline;color:#000000;"> to Participants under the Plan will be deemed to have been appropriately satisfied if the acquiring</font><font style="display: inline;color:#000000;">,</font><font style="display: inline;color:#000000;"> surviving</font><font style="display: inline;color:#000000;">, resulting or successor entity</font><font style="display: inline;color:#000000;"> in a </font><font style="display: inline;color:#000000;">Merger </font><font style="display: inline;color:#000000;">Transaction assumes such oblig</font><font style="display: inline;color:#000000;">ations and pays the </font><font style="display: inline;color:#000000;">Bonus</font><font style="display: inline;color:#000000;"> Payments </font><font style="display: inline;color:#000000;">as provided under the Plan. </font></font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">

			<font style="display: inline;font-weight:bold;font-size:9pt;">Page </font><font style="display: inline;font-weight:bold;font-size:9pt;"></font><font style="display: inline;font-weight:bold;font-size:9pt;">9</font><font style="display: inline;font-weight:bold;font-size:9pt;"></font><font style="display: inline;font-weight:bold;font-size:9pt;"> of </font><font style="display: inline;font-weight:bold;font-size:9pt;">1</font><font style="display: inline;font-weight:bold;font-size:9pt;">0</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;">17.</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;"></font><font style="display: inline;font-weight:bold;color:#000000;">Severability.</font><font style="display: inline;color:#000000;"> If any provision of the Plan is held invalid or unenforceable, its invalidity or unenforceability will not affect any other provision of the Plan, and the Plan will be construed and enforced as if such provision had not been included.</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;border-top:1pt none #D9D9D9 ;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="text-indent:0pt;margin-left:0pt; padding-right:22pt;"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;">18.</font></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;"></font><font style="display: inline;font-weight:bold;color:#000000;">Entire Agreement</font><font style="display: inline;font-weight:bold;color:#000000;">.&nbsp; </font><font style="display: inline;color:#000000;">The Plan</font><font style="display: inline;color:#000000;"> set</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;"> forth all of the agreements and understandings between the Company and Participants with respect to the subject matter of the Plan, and supersede</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;"> and terminate</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;"> all prior agreements and understandings between the Company and Participants with respect to the subject matter of the Plan; </font><font style="display: inline;font-style:italic;color:#000000;">provided, however,</font><font style="display: inline;color:#000000;"> that (i) the Company&#x2019;s </font><font style="display: inline;color:#000000;">equity incentive </font><font style="display: inline;color:#000000;">plans </font><font style="display: inline;color:#000000;">(including the 2018 Omnibus Incentive Plan) </font><font style="display: inline;color:#000000;">and (ii) any other plan, program, agreement or arrangement between any Participant and the Company providing for severance benefits payable in connection with the Participant&#x2019;s termination of employment in connection with a change in control even</font><font style="display: inline;color:#000000;">t</font><font style="display: inline;color:#000000;"> affecting the Company shall remain in effect and any such severance benefits provided thereunder shall b</font><font style="display: inline;color:#000000;">e in addition to the</font><font style="display: inline;color:#000000;"> Bonus </font><font style="display: inline;color:#000000;">Payments </font><font style="display: inline;color:#000000;">payable under </font><font style="display: inline;color:#000000;">the </font><font style="display: inline;color:#000000;">Plan (if any).</font><font style="display: inline;color:#000000;"> &nbsp; &nbsp;</font></font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-indent:0pt;text-align:center;line-height:200%;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;color:#000000;">[intentionally left blank]</font><font style="display: inline;font-weight:bold;font-family:Times New Roman;text-transform:uppercase;color:#000000;">&nbsp;</font>
		</p></div><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:12pt 0pt 0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">

			<font style="display: inline;font-weight:bold;font-size:9pt;">Page </font><font style="display: inline;font-weight:bold;font-size:9pt;"></font><font style="display: inline;font-weight:bold;font-size:9pt;">10</font><font style="display: inline;font-weight:bold;font-size:9pt;"></font><font style="display: inline;font-weight:bold;font-size:9pt;"> of </font><font style="display: inline;font-weight:bold;font-size:9pt;">1</font><font style="display: inline;font-weight:bold;font-size:9pt;">0</font>

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:12pt 0pt 0pt;text-align:center;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;text-transform:uppercase;">Exhibit A</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;">General Release</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">[Omitted pursuant to Item 601(a)(5) of Regulation S-K.]</font>
		</p>
		<p style="margin:12pt 0pt 0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;text-decoration:underline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;">SCHEDULE 1</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:47.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">Target Valuation Milestones</font></p>
				</td>
				<td valign="bottom" style="width:06.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:45.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">Aggregate Bonus Payment</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:47.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$200,000,000 </font></p>
				</td>
				<td valign="bottom" style="width:06.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:45.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;font-size:11pt;">10,0</font><font style="display: inline;color:#000000;font-size:11pt;">00,000 </font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:47.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font><font style="display: inline;color:#000000;font-size:11pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:06.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:45.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font><font style="display: inline;color:#000000;font-size:11pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:47.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font></p>
				</td>
				<td valign="bottom" style="width:06.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:45.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:47.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font></p>
				</td>
				<td valign="bottom" style="width:06.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:45.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:47.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font></p>
				</td>
				<td valign="bottom" style="width:06.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:45.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:47.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font></p>
				</td>
				<td valign="bottom" style="width:06.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:45.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:47.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font></p>
				</td>
				<td valign="bottom" style="width:06.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:45.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:47.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font></p>
				</td>
				<td valign="bottom" style="width:06.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:45.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:47.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font></p>
				</td>
				<td valign="bottom" style="width:06.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:45.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:47.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font></p>
				</td>
				<td valign="bottom" style="width:06.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:45.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:47.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font></p>
				</td>
				<td valign="bottom" style="width:06.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:45.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:47.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font></p>
				</td>
				<td valign="bottom" style="width:06.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:45.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:47.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font></p>
				</td>
				<td valign="bottom" style="width:06.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:45.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:47.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$5,000,000,000 </font></p>
				</td>
				<td valign="bottom" style="width:06.76%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:45.94%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;color:#000000;font-size:11pt;">$5</font><font style="display: inline;color:#000000;font-size:11pt;">0,000,000 </font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">For the avoidance</font><font style="display: inline;"> of doubt, the Aggregate Bonus P</font><font style="display: inline;">ayment shall </font><font style="display: inline;">only </font><font style="display: inline;">be paid once with regard</font><font style="display: inline;"> to achievement of each</font><font style="display: inline;"> Target Valuation Milestone.&nbsp;&nbsp;By way of example</font><font style="display: inline;">,</font><font style="display: inline;"> if the </font><font style="display: inline;font-family:Calibri;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font><font style="display: inline;"> Target Valuation Milestone is achieved and the Company&#x2019;</font><font style="display: inline;">s market capitalization </font><font style="display: inline;">shall thereafter decrease below </font><font style="display: inline;font-family:Calibri;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font><font style="display: inline;"> but shall subsequently increase above </font><font style="display: inline;font-family:Calibri;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font><font style="display: inline;">, a second Aggregate Bonus Payment shall </font><font style="display: inline;">not be </font><font style="display: inline;">paid for th</font><font style="display: inline;">e &nbsp;</font><font style="display: inline;">subsequent achievement </font><font style="display: inline;">of the </font><font style="display: inline;font-family:Calibri;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font><font style="display: inline;"> Target</font><font style="display: inline;"> Valuation Milestone.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Furthermore, achievement of a given Target Valuation Milestone shall imply achievement of all prior Target Valuation Milestones.&nbsp;&nbsp;By way of example, if the Company&#x2019;s market capitalization shall be </font><font style="display: inline;font-family:Calibri;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font><font style="display: inline;">, and the Company shall enter into a Merger Transaction in which the Securityholder shall receive Total Consideration of </font><font style="display: inline;font-family:Calibri;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font><font style="display: inline;">, the Target Valuation Milestones of </font><font style="display: inline;font-family:Calibri;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font><font style="display: inline;"> and </font><font style="display: inline;font-family:Calibri;color:#000000;font-size:11pt;">$</font><font style="display: inline;color:#000000;">[***]</font><font style="display: inline;"> shall also be deemed to be achieved.</font>
		</p></div><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;">SCHEDULE 2</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">Participants</font>
		</p>
		<p style="margin:12pt 0pt 0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">[Omitted pursuant to Item 601(a)(5) of Regulation S-K.]</font>
		</p>
		<p style="margin:0pt;line-height:10pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>3
<FILENAME>sava-20230630xex10_3.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!--HTML document created with Certent Disclosure Management 23.3.2.2-->
<!--Created on: 8/3/2023 3:29:58 PM-->
<html>
	<head>
		<title>
			Exhibit 10.3
		</title>
	</head>
	<body><div style="margin-left:72pt;margin-right:72pt;"><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;font-weight:bold;font-size:11pt;">Exhib</font><font style="display: inline;font-weight:bold;font-size:11pt;">it 10.</font><font style="display: inline;font-weight:bold;font-size:11pt;">3</font>

		</p>

		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 11pt">

			<font style="display: inline;font-weight:bold;font-size:11pt;"><img src="sava-20230630xex10_3g001.jpg" style="width: 4.290909in; height: 1.272727in" alt="A blue text on a white background&#xA;&#xA;Description automatically generated"></font>

		</p>

</div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;font-size:11pt;">non-employee </font><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;font-size:11pt;">DIRECTOR COMPENSATION </font><font style="display: inline;font-weight:bold;text-transform:uppercase;color:#000000;font-size:11pt;">program</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;font-size:11pt;">(Adopted and approved</font><font style="display: inline;color:#000000;font-size:11pt;"> effective </font><font style="display: inline;color:#000000;font-size:11pt;">May 4</font><font style="display: inline;color:#000000;font-size:11pt;">, 2023</font><font style="display: inline;color:#000000;font-size:11pt;">) &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;font-size:11pt;">Each member of the Board of Directors (the &#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">Board</font><font style="display: inline;color:#000000;font-size:11pt;">&#x201D;) of </font><font style="display: inline;color:#000000;font-size:11pt;">Cassava Sciences, Inc</font><font style="display: inline;color:#000000;font-size:11pt;">. (the &#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">Company</font><font style="display: inline;color:#000000;font-size:11pt;">&#x201D;), who is not an employee of the Company (each such member, a &#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">Non-</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">e</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">mployee Director</font><font style="display: inline;color:#000000;font-size:11pt;">&#x201D;), will receive the compensation described in this Director Compensation </font><font style="display: inline;color:#000000;font-size:11pt;">Program</font><font style="display: inline;color:#000000;font-size:11pt;"> (the &#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">Director Compensation </font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">Program</font><font style="display: inline;color:#000000;font-size:11pt;">&#x201D;) for his or her Board service</font><font style="display: inline;color:#000000;font-size:11pt;"> upon and</font><font style="display: inline;color:#000000;font-size:11pt;"> following the date set forth above (the &#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">Effective Date</font><font style="display: inline;color:#000000;font-size:11pt;">&#x201D;)</font><font style="display: inline;color:#000000;font-size:11pt;">, subject to the approval of this Director Compensation Program by the stockholders of the Company at the Company&#x2019;s 2023 </font><font style="display: inline;color:#000000;font-size:11pt;">A</font><font style="display: inline;color:#000000;font-size:11pt;">nnual </font><font style="display: inline;color:#000000;font-size:11pt;">M</font><font style="display: inline;color:#000000;font-size:11pt;">eeting of </font><font style="display: inline;color:#000000;font-size:11pt;">S</font><font style="display: inline;color:#000000;font-size:11pt;">tockholders</font><font style="display: inline;color:#000000;font-size:11pt;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;font-size:11pt;">The Director Compensation </font><font style="display: inline;color:#000000;font-size:11pt;">Program</font><font style="display: inline;color:#000000;font-size:11pt;"> will </font><font style="display: inline;color:#000000;font-size:11pt;">be</font><font style="display: inline;color:#000000;font-size:11pt;"> effective</font><font style="display: inline;color:#000000;font-size:11pt;"> as of</font><font style="display: inline;color:#000000;font-size:11pt;"> the Effective Date and supersedes all prior arrangements with respect to the subject matter hereof. </font><font style="display: inline;color:#000000;font-size:11pt;">S</font><font style="display: inline;color:#000000;font-size:11pt;">tock option grants awarded</font><font style="display: inline;color:#000000;font-size:11pt;"> prior to the Effective Date </font><font style="display: inline;color:#000000;font-size:11pt;">shall</font><font style="display: inline;color:#000000;font-size:11pt;"> not</font><font style="display: inline;color:#000000;font-size:11pt;"> be</font><font style="display: inline;color:#000000;font-size:11pt;"> affected</font><font style="display: inline;color:#000000;font-size:11pt;"> in any way</font><font style="display: inline;color:#000000;font-size:11pt;"> by this Director Compensation Program.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;font-size:11pt;">As </font><font style="display: inline;color:#000000;font-size:11pt;">set forth in this Director Compensation Program</font><font style="display: inline;color:#000000;font-size:11pt;">, &nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">e</font><font style="display: inline;color:#000000;font-size:11pt;">ach person who is a</font><font style="display: inline;color:#000000;font-size:11pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">Non-</font><font style="display: inline;color:#000000;font-size:11pt;">e</font><font style="display: inline;color:#000000;font-size:11pt;">mployee Director</font><font style="display: inline;color:#000000;font-size:11pt;"> on the Effective Date</font><font style="display: inline;color:#000000;font-size:11pt;"> shall </font><font style="display: inline;color:#000000;font-size:11pt;">be eligible to </font><font style="display: inline;color:#000000;font-size:11pt;">receive</font><font style="display: inline;color:#000000;font-size:11pt;"> the following</font><font style="display: inline;color:#000000;font-size:11pt;"> compensation:</font>
		</p>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:0pt 0pt 12pt;">
				<font style="margin:0pt 0pt 12pt;font-family:Symbol;text-align:justify;text-justify:inter-ideograph;color:#000000;font-size:11pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:0pt 0pt 12pt;">
			<font style="display: inline;color:#000000;font-size:11pt;">Annual Cash Retainer: $10,000</font><font style="display: inline;color:#000000;font-size:11pt;">;</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:0pt 0pt 12pt;">
				<font style="margin:0pt 0pt 12pt;font-family:Symbol;text-align:justify;text-justify:inter-ideograph;color:#000000;font-size:11pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:0pt 0pt 12pt;">
			<font style="display: inline;color:#000000;font-size:11pt;">2023 Initial Stock Option Grant:</font><font style="display: inline;color:#000000;font-size:11pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">20,000 </font><font style="display: inline;color:#000000;font-size:11pt;">stock </font><font style="display: inline;color:#000000;font-size:11pt;">options (vesting over 36 months)</font><font style="display: inline;color:#000000;font-size:11pt;">;</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:0pt 0pt 12pt;">
				<font style="margin:0pt 0pt 12pt;font-family:Symbol;text-align:justify;text-justify:inter-ideograph;color:#000000;font-size:11pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:0pt 0pt 12pt;">
			<font style="display: inline;color:#000000;font-size:11pt;">Annual Stock Option Grant in 2024 and 2025: </font><font style="display: inline;color:#000000;font-size:11pt;">10,000 </font><font style="display: inline;color:#000000;font-size:11pt;">stock </font><font style="display: inline;color:#000000;font-size:11pt;">options (vesting over 12 months)</font><font style="display: inline;color:#000000;font-size:11pt;">;</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:0pt 0pt 12pt;">
				<font style="margin:0pt 0pt 12pt;font-family:Symbol;text-align:justify;text-justify:inter-ideograph;color:#000000;font-size:11pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;color:#000000;font-family:Times New Roman;font-size: 11pt;margin:0pt 0pt 12pt;">
			<font style="display: inline;color:#000000;font-size:11pt;">Additional Committee Grant: </font><font style="display: inline;color:#000000;font-size:11pt;">2,500 </font><font style="display: inline;color:#000000;font-size:11pt;">stock </font><font style="display: inline;color:#000000;font-size:11pt;">options for service on one </font><font style="display: inline;color:#000000;font-size:11pt;">standing </font><font style="display: inline;color:#000000;font-size:11pt;">Board committee</font><font style="display: inline;color:#000000;font-size:11pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;text-decoration:underline;">or</font><font style="display: inline;color:#000000;font-size:11pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">5,000 options for service on two or more </font><font style="display: inline;color:#000000;font-size:11pt;">standing </font><font style="display: inline;color:#000000;font-size:11pt;">Board</font><font style="display: inline;color:#000000;font-size:11pt;"> committees</font><font style="display: inline;color:#000000;font-size:11pt;"> (vesting over 12</font><font style="display: inline;color:#000000;font-size:11pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">months)</font><font style="display: inline;color:#000000;font-size:11pt;">.</font></p></td></tr></table></div>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;font-size:11pt;">N</font><font style="display: inline;color:#000000;font-size:11pt;">on-</font><font style="display: inline;color:#000000;font-size:11pt;">e</font><font style="display: inline;color:#000000;font-size:11pt;">mployee </font><font style="display: inline;color:#000000;font-size:11pt;">D</font><font style="display: inline;color:#000000;font-size:11pt;">irector</font><font style="display: inline;color:#000000;font-size:11pt;">s</font><font style="display: inline;color:#000000;font-size:11pt;"> elected or appointed to the Board </font><font style="display: inline;color:#000000;font-size:11pt;">after the Effective Date</font><font style="display: inline;color:#000000;font-size:11pt;"> shall be eligible to receive </font><font style="display: inline;color:#000000;font-size:11pt;">a &nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">stock </font><font style="display: inline;color:#000000;font-size:11pt;">option grant of 20,000 stock options </font><font style="display: inline;color:#000000;font-size:11pt;">on </font><font style="display: inline;color:#000000;font-size:11pt;">the</font><font style="display: inline;color:#000000;font-size:11pt;"> start date</font><font style="display: inline;color:#000000;font-size:11pt;"> of their service to the Company</font><font style="display: inline;color:#000000;font-size:11pt;">, as set forth below,</font><font style="display: inline;color:#000000;font-size:11pt;"> and shall participate in the Director Compensation Program</font><font style="display: inline;color:#000000;font-size:11pt;"> as described below</font><font style="display: inline;color:#000000;font-size:11pt;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;text-decoration:underline;">Annual Cash Compensation</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;font-size:11pt;">Each Non-</font><font style="display: inline;color:#000000;font-size:11pt;">e</font><font style="display: inline;color:#000000;font-size:11pt;">mployee Director will receive </font><font style="display: inline;color:#000000;font-size:11pt;">$10,000 in</font><font style="display: inline;color:#000000;font-size:11pt;"> cash compensation </font><font style="display: inline;color:#000000;font-size:11pt;">per </font><font style="display: inline;color:#000000;font-size:11pt;">twelve (12) </font><font style="display: inline;color:#000000;font-size:11pt;">months</font><font style="display: inline;color:#000000;font-size:11pt;"> of</font><font style="display: inline;color:#000000;font-size:11pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">continuous </font><font style="display: inline;color:#000000;font-size:11pt;">service on the Board</font><font style="display: inline;color:#000000;font-size:11pt;">,</font><font style="display: inline;color:#000000;font-size:11pt;"> with each twelve (12) month period measured from the Effective Date</font><font style="display: inline;color:#000000;font-size:11pt;"> for this purpose</font><font style="display: inline;color:#000000;font-size:11pt;">. The annual cash compensation amount will be payable in arrears, in </font><font style="display: inline;color:#000000;font-size:11pt;">one payment on the </font><font style="display: inline;color:#000000;font-size:11pt;">applicable </font><font style="display: inline;color:#000000;font-size:11pt;">anniversary of </font><font style="display: inline;color:#000000;font-size:11pt;">the</font><font style="display: inline;color:#000000;font-size:11pt;"> Effective Date</font><font style="display: inline;color:#000000;font-size:11pt;">. &nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">In the event</font><font style="display: inline;color:#000000;font-size:11pt;"> that</font><font style="display: inline;color:#000000;font-size:11pt;"> &nbsp;a</font><font style="display: inline;color:#000000;font-size:11pt;"> new </font><font style="display: inline;color:#000000;font-size:11pt;">Non-employee </font><font style="display: inline;color:#000000;font-size:11pt;">Director is appointed to the Board or </font><font style="display: inline;color:#000000;font-size:11pt;">that </font><font style="display: inline;color:#000000;font-size:11pt;">a</font><font style="display: inline;color:#000000;font-size:11pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">Non-employee </font><font style="display: inline;color:#000000;font-size:11pt;">Director </font><font style="display: inline;color:#000000;font-size:11pt;">ceases to be a Non-employee Director</font><font style="display: inline;color:#000000;font-size:11pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">during such </font><font style="display: inline;color:#000000;font-size:11pt;">a &nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">twelve (12) month period</font><font style="display: inline;color:#000000;font-size:11pt;">, &nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">then </font><font style="display: inline;color:#000000;font-size:11pt;">a</font><font style="display: inline;color:#000000;font-size:11pt;">ny amount payable for a partial </font><font style="display: inline;color:#000000;font-size:11pt;">year </font><font style="display: inline;color:#000000;font-size:11pt;">of service will be </font><font style="display: inline;color:#000000;font-size:11pt;">paid </font><font style="display: inline;color:#000000;font-size:11pt;">pro-</font><font style="display: inline;color:#000000;font-size:11pt;">rata </font><font style="display: inline;color:#000000;font-size:11pt;">based on the number </font><font style="display: inline;color:#000000;font-size:11pt;">of</font><font style="display: inline;color:#000000;font-size:11pt;"> quarter</font><font style="display: inline;color:#000000;font-size:11pt;">s</font><font style="display: inline;color:#000000;font-size:11pt;"> in which the</font><font style="display: inline;color:#000000;font-size:11pt;"> Non-employee</font><font style="display: inline;color:#000000;font-size:11pt;"> Director </font><font style="display: inline;color:#000000;font-size:11pt;">served as a </font><font style="display: inline;color:#000000;font-size:11pt;">member of the Board</font><font style="display: inline;color:#000000;font-size:11pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">for at least one day </font><font style="display: inline;color:#000000;font-size:11pt;">during the applicable twelve (12) month period</font><font style="display: inline;color:#000000;font-size:11pt;"> and shall be payable</font><font style="display: inline;color:#000000;font-size:11pt;">, in the case of a departing </font><font style="display: inline;color:#000000;font-size:11pt;">N</font><font style="display: inline;color:#000000;font-size:11pt;">on-employee </font><font style="display: inline;color:#000000;font-size:11pt;">D</font><font style="display: inline;color:#000000;font-size:11pt;">irector, within thirty (30) days of such </font><font style="display: inline;color:#000000;font-size:11pt;">Non-employee D</font><font style="display: inline;color:#000000;font-size:11pt;">irector&#x2019;s separation from service</font><font style="display: inline;color:#000000;font-size:11pt;"> (within the meaning of IRS Code Section 409A)</font><font style="display: inline;color:#000000;font-size:11pt;">.</font><font style="display: inline;color:#000000;font-size:11pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman;font-size: 11pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 9pt">

			<font style="display: inline;font-size:9pt;">6801 N Capital of Texas Highway, Building 1; Suite 300, Austin, TX&nbsp;&nbsp;78731</font><br /><font style="display: inline;font-size:9pt;">Phone:&nbsp;&nbsp;512-501-2444&nbsp;&nbsp;Fax:&nbsp;&nbsp;512-614-0414</font>

		</p>

		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Page </font><font style="display: inline;"></font><font style="display: inline;">2</font><font style="display: inline;"></font>

		</p>

</div>
		<p style="margin:0pt 0pt 12pt;font-family:Times New Roman;;font-size: 11pt"><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;text-decoration:underline;">Equity Compensation</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;font-size:11pt;">The equity awards contemplated by this Director Compensation </font><font style="display: inline;color:#000000;font-size:11pt;">Program</font><font style="display: inline;color:#000000;font-size:11pt;"> will be granted under the Company&#x2019;s </font><font style="display: inline;color:#000000;font-size:11pt;">20</font><font style="display: inline;color:#000000;font-size:11pt;">18</font><font style="display: inline;color:#000000;font-size:11pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">Omnibus</font><font style="display: inline;color:#000000;font-size:11pt;"> Incentive Plan</font><font style="display: inline;color:#000000;font-size:11pt;">, as amended, or any successor equity incentive plan adopted by the Board and the stockholders of the Company (the &#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">Plan</font><font style="display: inline;color:#000000;font-size:11pt;">&#x201D;)</font><font style="display: inline;color:#000000;font-size:11pt;"> and shall be automatic and nondiscretionary</font><font style="display: inline;color:#000000;font-size:11pt;">. In the event of any inconsistency between the Plan and this Director Compensation </font><font style="display: inline;color:#000000;font-size:11pt;">Program</font><font style="display: inline;color:#000000;font-size:11pt;">, this Director Compensation </font><font style="display: inline;color:#000000;font-size:11pt;">Program</font><font style="display: inline;color:#000000;font-size:11pt;"> shall control</font><font style="display: inline;color:#000000;font-size:11pt;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">Automatic Stock Option Grants.&nbsp; </font><font style="display: inline;color:#000000;font-size:11pt;">Automatic stock option grants shall be made</font><font style="display: inline;color:#000000;font-size:11pt;"> to </font><font style="display: inline;color:#000000;font-size:11pt;">Non-employee </font><font style="display: inline;color:#000000;font-size:11pt;">Directors</font><font style="display: inline;color:#000000;font-size:11pt;"> as follows:</font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">Initial Grant for </font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">all </font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">Non-</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">e</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">mployee Directors in 2023</font><font style="display: inline;color:#000000;font-size:11pt;">. &nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">Without any further action of the Board, </font><font style="display: inline;color:#000000;font-size:11pt;">on the Effective Date</font><font style="display: inline;color:#000000;font-size:11pt;">,</font><font style="display: inline;color:#000000;font-size:11pt;"> each </font><font style="display: inline;color:#000000;font-size:11pt;">person who is a </font><font style="display: inline;color:#000000;font-size:11pt;">Non-</font><font style="display: inline;color:#000000;font-size:11pt;">e</font><font style="display: inline;color:#000000;font-size:11pt;">mployee Director</font><font style="display: inline;color:#000000;font-size:11pt;"> on the Effective Date</font><font style="display: inline;color:#000000;font-size:11pt;"> shall be granted </font><font style="display: inline;color:#000000;font-size:11pt;">a stock option award (&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">Initial Option Award</font><font style="display: inline;color:#000000;font-size:11pt;">&#x201D;)</font><font style="display: inline;color:#000000;font-size:11pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">under the Plan covering </font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">2</font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">0,000 </font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">s</font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">hares</font><font style="display: inline;color:#000000;font-size:11pt;"> of the Company&#x2019;s Common Stock (as defined in the Plan). Each </font><font style="display: inline;color:#000000;font-size:11pt;">Initial </font><font style="display: inline;color:#000000;font-size:11pt;">Option Award shall vest monthly</font><font style="display: inline;color:#000000;font-size:11pt;"> on the monthly anniversary of the date of grant</font><font style="display: inline;color:#000000;font-size:11pt;"> in thirty-six (36) equal monthly</font><font style="display: inline;color:#000000;font-size:11pt;"> installments</font><font style="display: inline;color:#000000;font-size:11pt;"> over the following </font><font style="display: inline;color:#000000;font-size:11pt;">thirty-six (36) </font><font style="display: inline;color:#000000;font-size:11pt;">months after the grant date, subject to the applicable Non-</font><font style="display: inline;color:#000000;font-size:11pt;">e</font><font style="display: inline;color:#000000;font-size:11pt;">mployee Director&#x2019;s continued service as a member of the Board through such vesting date</font><font style="display: inline;color:#000000;font-size:11pt;">; provided, however, that the final monthly installment shall vest on the day immediately prior to the upcoming </font><font style="display: inline;color:#000000;font-size:11pt;">a</font><font style="display: inline;color:#000000;font-size:11pt;">nnual </font><font style="display: inline;color:#000000;font-size:11pt;">m</font><font style="display: inline;color:#000000;font-size:11pt;">eeting</font><font style="display: inline;color:#000000;font-size:11pt;"> of the Company&#x2019;s stockholders (&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">Annual Meeting</font><font style="display: inline;color:#000000;font-size:11pt;">&#x201D;)</font><font style="display: inline;color:#000000;font-size:11pt;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">Annual Grant for Continuing Non-</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">e</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">mployee Directors in 2024 and </font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">2025</font><font style="display: inline;color:#000000;font-size:11pt;">. Without any further action of the Board, at the close of business on the date of each </font><font style="display: inline;color:#000000;font-size:11pt;">A</font><font style="display: inline;color:#000000;font-size:11pt;">nnual </font><font style="display: inline;color:#000000;font-size:11pt;">M</font><font style="display: inline;color:#000000;font-size:11pt;">eeting </font><font style="display: inline;color:#000000;font-size:11pt;">in 2024 and 2025</font><font style="display: inline;color:#000000;font-size:11pt;">, each </font><font style="display: inline;color:#000000;font-size:11pt;">person who is a</font><font style="display: inline;color:#000000;font-size:11pt;"> Non-</font><font style="display: inline;color:#000000;font-size:11pt;">e</font><font style="display: inline;color:#000000;font-size:11pt;">mployee Director</font><font style="display: inline;color:#000000;font-size:11pt;"> on such date</font><font style="display: inline;color:#000000;font-size:11pt;"> shall be granted a stock option award (&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">Annual Option Award</font><font style="display: inline;color:#000000;font-size:11pt;">&#x201D;) under the Plan covering </font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">10,000 </font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">s</font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">hares</font><font style="display: inline;color:#000000;font-size:11pt;"> of the Company&#x2019;s Common Stock. Each Annual Option Award shall vest monthly in twelve (12) equal installments</font><font style="display: inline;color:#000000;font-size:11pt;"> on the monthly anniversary of the date of grant</font><font style="display: inline;color:#000000;font-size:11pt;"> over the following twelve (12) months after the grant date, subject to the applicable Non-</font><font style="display: inline;color:#000000;font-size:11pt;">e</font><font style="display: inline;color:#000000;font-size:11pt;">mployee Director&#x2019;s continued service as a member of the Board through such vesting date</font><a name="OLE_LINK1"></a><font style="display: inline;color:#000000;font-size:11pt;">; provided, however, that the final monthly installment shall vest on the day immediately prior to the upcoming Annual Meeting</font><font style="display: inline;color:#000000;font-size:11pt;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">Additional </font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">Annual Grant for Non-</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">e</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">mployee Directors Serving on Standing Committees</font><font style="display: inline;color:#000000;font-size:11pt;">. Without any further action of the Board, </font><font style="display: inline;color:#000000;font-size:11pt;">on the Effective Date and </font><font style="display: inline;color:#000000;font-size:11pt;">at the close of business on the date of each </font><font style="display: inline;color:#000000;font-size:11pt;">Annual Meeting</font><font style="display: inline;color:#000000;font-size:11pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">in 2024 and 2025</font><font style="display: inline;color:#000000;font-size:11pt;">, each </font><font style="display: inline;color:#000000;font-size:11pt;">person who is a</font><font style="display: inline;color:#000000;font-size:11pt;"> Non-</font><font style="display: inline;color:#000000;font-size:11pt;">e</font><font style="display: inline;color:#000000;font-size:11pt;">mployee Director</font><font style="display: inline;color:#000000;font-size:11pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">and</font><font style="display: inline;color:#000000;font-size:11pt;"> member </font><font style="display: inline;color:#000000;font-size:11pt;">of </font><font style="display: inline;color:#000000;font-size:11pt;">a Standing Committee (as defined below)</font><font style="display: inline;color:#000000;font-size:11pt;"> on such date</font><font style="display: inline;color:#000000;font-size:11pt;">,</font><font style="display: inline;color:#000000;font-size:11pt;"> shall be granted a stock option award (&#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">Committee </font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">Option Award</font><font style="display: inline;color:#000000;font-size:11pt;">&#x201D;) under the Plan covering </font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">2,5</font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">0</font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">0 &nbsp;</font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">s</font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">hares</font><font style="display: inline;color:#000000;font-size:11pt;"> of the Company&#x2019;s Common Stock</font><font style="display: inline;color:#000000;font-size:11pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">if such</font><font style="display: inline;color:#000000;font-size:11pt;"> Non-</font><font style="display: inline;color:#000000;font-size:11pt;">e</font><font style="display: inline;color:#000000;font-size:11pt;">mployee Director serves</font><font style="display: inline;color:#000000;font-size:11pt;"> on one Standing Committee </font><font style="display: inline;color:#000000;font-size:11pt;">or</font><font style="display: inline;color:#000000;font-size:11pt;">&nbsp;</font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">5,000 </font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">S</font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">hares</font><font style="display: inline;color:#000000;font-size:11pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">of the Company&#x2019;s Common Stock </font><font style="display: inline;color:#000000;font-size:11pt;">if such Non-</font><font style="display: inline;color:#000000;font-size:11pt;">e</font><font style="display: inline;color:#000000;font-size:11pt;">mployee Director serves on two or more Standing Committees</font><font style="display: inline;color:#000000;font-size:11pt;">. Each </font><font style="display: inline;color:#000000;font-size:11pt;">Committee</font><font style="display: inline;color:#000000;font-size:11pt;"> Option Award shall vest </font><font style="display: inline;color:#000000;font-size:11pt;">monthly</font><font style="display: inline;color:#000000;font-size:11pt;"> on the monthly anniversary of the date of grant</font><font style="display: inline;color:#000000;font-size:11pt;"> in twelve (12) equal installments over the following twelve (12) months after the grant date, subject to the applicable Non-</font><font style="display: inline;color:#000000;font-size:11pt;">e</font><font style="display: inline;color:#000000;font-size:11pt;">mployee Director&#x2019;s continued service as a member of the Board through such vesting date</font><font style="display: inline;color:#000000;font-size:11pt;">; provided, however, that the final monthly installment shall vest on the day immediately prior to the upcoming Annual Meeting</font><font style="display: inline;color:#000000;font-size:11pt;">.</font><font style="display: inline;color:#000000;font-size:11pt;"> &nbsp; &nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">For purposes of this Director Compensation Program, a </font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">&#x201C;Standing Committee&#x201D; </font><font style="display: inline;color:#000000;font-size:11pt;">shall cons</font><font style="display: inline;color:#000000;font-size:11pt;">ist of </font><font style="display: inline;color:#000000;font-size:11pt;">the Audit Committee, the Compensation Committee</font><font style="display: inline;color:#000000;font-size:11pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">or </font><font style="display: inline;color:#000000;font-size:11pt;">the Nominating and Governance Committee</font><font style="display: inline;color:#000000;font-size:11pt;">.</font><font style="display: inline;color:#000000;font-size:11pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">Membership</font><font style="display: inline;color:#000000;font-size:11pt;"> on an </font><font style="display: inline;font-style:italic;color:#000000;font-size:11pt;">ad hoc</font><font style="display: inline;color:#000000;font-size:11pt;"> committee of the Board, regardless of length of time served, </font><font style="display: inline;color:#000000;font-size:11pt;">shall not constitute</font><font style="display: inline;color:#000000;font-size:11pt;"> membership on a Standing Committee for purposes of this Director Compensation Program</font><font style="display: inline;color:#000000;font-size:11pt;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt 36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">Initial Grant for New Non-</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">e</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">mployee Directors</font><font style="display: inline;color:#000000;font-size:11pt;">. Without any further action of the Board, each person who, after the </font><font style="display: inline;color:#000000;font-size:11pt;">Effective Date</font><font style="display: inline;color:#000000;font-size:11pt;">, is elected or appointed for the first time to be a Non-</font><font style="display: inline;color:#000000;font-size:11pt;">e</font><font style="display: inline;color:#000000;font-size:11pt;">mployee Director will automatically, upon the effective date of his or her initial election or appointment to </font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			<font style="display: inline;">Page </font><font style="display: inline;"></font><font style="display: inline;">3</font><font style="display: inline;"></font>

		</p>

</div>
		<p style="margin:0pt 0pt 12pt 36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 11pt"><font style="display: inline;color:#000000;font-size:11pt;">be a Non-</font><font style="display: inline;color:#000000;font-size:11pt;">e</font><font style="display: inline;color:#000000;font-size:11pt;">mployee Director, be granted a stock option award </font><font style="display: inline;color:#000000;font-size:11pt;">(a &#x201C;</font><font style="display: inline;font-weight:bold;font-style:italic;color:#000000;font-size:11pt;">New Director Option Award</font><font style="display: inline;color:#000000;font-size:11pt;">&#x201D;) </font><font style="display: inline;color:#000000;font-size:11pt;">covering </font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">2</font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">0</font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">,000 </font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">s</font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">hares</font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">of the Company&#x2019;s Common Stock</font><font style="display: inline;color:#000000;font-size:11pt;">. Each New Director Option Award </font><font style="display: inline;color:#000000;font-size:11pt;">shall vest monthly</font><font style="display: inline;color:#000000;font-size:11pt;"> on the monthly anniversary of the date of grant</font><font style="display: inline;color:#000000;font-size:11pt;"> in thirty-six (36) equal monthly installments over the following thirty-six (36) months after the grant date, subject to the applicable Non-</font><font style="display: inline;color:#000000;font-size:11pt;">e</font><font style="display: inline;color:#000000;font-size:11pt;">mployee Director&#x2019;s continued service as a member of the Board through such vesting date</font><font style="display: inline;color:#000000;font-size:11pt;">.</font><font style="display: inline;color:#000000;font-size:11pt;"> &nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;">Remaining Terms</font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;"> and Conditions</font><font style="display: inline;color:#000000;font-size:11pt;">. &nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">All options granted under this </font><font style="display: inline;color:#000000;font-size:11pt;">Director Compensation Program</font><font style="display: inline;color:#000000;font-size:11pt;"> shall be Non</font><font style="display: inline;color:#000000;font-size:11pt;">-</font><font style="display: inline;color:#000000;font-size:11pt;">q</font><font style="display: inline;color:#000000;font-size:11pt;">ualified</font><font style="display: inline;color:#000000;font-size:11pt;"> Stock Options (as defined in the Plan) and shall have a term of ten (10) years and an exercise price per share equal to 100% of the </font><font style="display: inline;color:#000000;font-size:11pt;">Fair Market Value (as defined in the Plan)</font><font style="display: inline;color:#000000;font-size:11pt;"> of a share of Common Stock on the date of grant of the option (or if such date is not a trading day, the </font><font style="display: inline;color:#000000;font-size:11pt;">Fair Market Value of a share</font><font style="display: inline;color:#000000;font-size:11pt;"> of the Common Stock on the most recent trading day). Each vested option will be exercisable only while the Non-</font><font style="display: inline;color:#000000;font-size:11pt;">e</font><font style="display: inline;color:#000000;font-size:11pt;">mployee Director remains a Non-</font><font style="display: inline;color:#000000;font-size:11pt;">e</font><font style="display: inline;color:#000000;font-size:11pt;">mployee Director of the Company and for a period of three (3) months thereafter (but in no event later than the expiration of the term of such option as set forth in the option grant agreement); provided, however, that, if a Non-</font><font style="display: inline;color:#000000;font-size:11pt;">e</font><font style="display: inline;color:#000000;font-size:11pt;">mployee Director ceases to be a Non-</font><font style="display: inline;color:#000000;font-size:11pt;">e</font><font style="display: inline;color:#000000;font-size:11pt;">mployee Director as a result of the Non-</font><font style="display: inline;color:#000000;font-size:11pt;">e</font><font style="display: inline;color:#000000;font-size:11pt;">mployee Director&#x2019;s death or Disability (as defined in the Plan), the option will remain exercisable for twelve (12) months following such termination (but in no event later than the expiration of the term of such option as set forth in the option grant agreement). </font><font style="display: inline;color:#000000;font-size:11pt;">The remaining terms and conditions of each stock option award granted under this </font><font style="display: inline;color:#000000;font-size:11pt;">Director Compensation Program</font><font style="display: inline;color:#000000;font-size:11pt;"> will be as set forth in the Plan and the Company&#x2019;s standard form of stock option agreement for Non-</font><font style="display: inline;color:#000000;font-size:11pt;">e</font><font style="display: inline;color:#000000;font-size:11pt;">mployee Directors </font><font style="display: inline;color:#000000;font-size:11pt;">as</font><font style="display: inline;color:#000000;font-size:11pt;"> in effect</font><font style="display: inline;color:#000000;font-size:11pt;"> from time to time</font><font style="display: inline;color:#000000;font-size:11pt;">, &nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">and </font><font style="display: inline;color:#000000;font-size:11pt;">as it may be amended from time to time by the Board.</font><font style="display: inline;color:#000000;font-size:11pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;text-decoration:underline;">Amendments</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;font-size:11pt;">This Director Compensation Policy was adopted by the Board and may be amended or terminated </font><font style="display: inline;color:#000000;font-size:11pt;">only </font><font style="display: inline;color:#000000;font-size:11pt;">by </font><font style="display: inline;color:#000000;font-size:11pt;">a unanimous affirmative vote of </font><font style="display: inline;color:#000000;font-size:11pt;">all members of </font><font style="display: inline;color:#000000;font-size:11pt;">the Board</font><font style="display: inline;color:#000000;font-size:11pt;">, &nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">subject to </font><font style="display: inline;color:#000000;font-size:11pt;">approval by</font><font style="display: inline;color:#000000;font-size:11pt;">&nbsp;</font><font style="display: inline;color:#000000;font-size:11pt;">the </font><font style="display: inline;color:#000000;font-size:11pt;">stockholders of the Company at a</font><font style="display: inline;color:#000000;font-size:11pt;">ny</font><font style="display: inline;color:#000000;font-size:11pt;"> regular</font><font style="display: inline;color:#000000;font-size:11pt;"> Annual Meeting of Stockholders </font><font style="display: inline;color:#000000;font-size:11pt;">that is </font><font style="display: inline;font-size:11pt;">convened, noted, and properly held</font><font style="display: inline;color:#000000;font-size:11pt;">.</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;text-decoration:underline;">Program</font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;text-decoration:underline;">&nbsp;</font><font style="display: inline;font-weight:bold;color:#000000;font-size:11pt;text-decoration:underline;">Term</font>
		</p>
		<p style="margin:0pt 0pt 12pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;color:#000000;font-size:11pt;">This Director Compensation </font><font style="display: inline;color:#000000;font-size:11pt;">Program</font><font style="display: inline;color:#000000;font-size:11pt;"> shall be effective for thirty-six (36) months from the Effective Date.</font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>sava-20230630xex31_1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!--HTML document created with Certent Disclosure Management 23.3.2.2-->
<!--Created on: 8/3/2023 3:29:24 PM-->
<html>
	<head>
		<title>
			Exhibit 31.1
		</title>
	</head>
	<body><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:0pt 0pt 0pt 10.6pt;text-indent: -18pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Exhibit 31.1</font>
		</p>
		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">CERTIFICATION OF THE </font><font style="display: inline;font-size:10pt;">PRINCIPAL </font><font style="display: inline;font-size:10pt;">EXECUTIVE OFFICER</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">PURSUANT TO</font>
		</p>
		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font>
		</p>
		<p style="margin:0pt;text-align:left;font-weight:bold;line-height:100%;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:3pt 0pt 0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">I, Remi Barbier, certify that: </font>
		</p>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:21pt;"><p style="width:21pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
				<font style="margin:3pt 0pt 0pt;font-family:Times New Roman;font-size:10pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;;"> 1.</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
			<font style="display: inline;font-size:10pt;color:#000000;">I have reviewed this </font><font style="display: inline;font-size:10pt;color:#000000;">Quarterly </font><font style="display: inline;font-size:10pt;color:#000000;">Report on Form 10-Q of </font><font style="display: inline;font-size:10pt;color:#000000;">Cassava Sciences</font><font style="display: inline;font-size:10pt;color:#000000;">, Inc.;&nbsp;&nbsp; </font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:21pt;"><p style="width:21pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
				<font style="margin:3pt 0pt 0pt;font-family:Times New Roman;font-size:10pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;;"> 2.</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
			<font style="display: inline;font-size:10pt;color:#000000;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; </font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:21pt;"><p style="width:21pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
				<font style="margin:3pt 0pt 0pt;font-family:Times New Roman;font-size:10pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;;"> 3.</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
			<font style="display: inline;font-size:10pt;color:#000000;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; </font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:21pt;"><p style="width:21pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
				<font style="margin:3pt 0pt 0pt;font-family:Times New Roman;font-size:10pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;;"> 4.</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
			<font style="display: inline;font-size:10pt;color:#000000;">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))</font><font style="color:#0000FF;display: inline;color:#000000;font-size:10pt;text-decoration:none;"> and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) </font><font style="display: inline;font-size:10pt;color:#000000;">for the registrant and have: </font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;"><p style="width:54pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 17.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
				<font style="margin:3pt 0pt 0pt;font-family:Times New Roman;font-size:10pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;;"> a.</font>
			</p>
		</td><td style="width:1pt;"><p style="width:1pt;width:1pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
			<font style="display: inline;font-size:10pt;color:#000000;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; </font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;"><p style="width:54pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 17.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;color:#000000;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
				<font style="margin:3pt 0pt 0pt;font-family:Times New Roman;font-size:10pt;text-align:justify;text-justify:inter-ideograph;color:#000000;line-height:100%;;"> b.</font>
			</p>
		</td><td style="width:1pt;"><p style="width:1pt;width:1pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;color:#000000;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
			<font style="color:#0000FF;display: inline;color:#000000;font-size:10pt;text-decoration:none;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;"><p style="width:54pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 17.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
				<font style="margin:3pt 0pt 0pt;font-family:Times New Roman;font-size:10pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;;"> c.</font>
			</p>
		</td><td style="width:1pt;"><p style="width:1pt;width:1pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
			<font style="display: inline;font-size:10pt;color:#000000;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and </font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;"><p style="width:54pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 17.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
				<font style="margin:3pt 0pt 0pt;font-family:Times New Roman;font-size:10pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;;"> d.</font>
			</p>
		</td><td style="width:1pt;"><p style="width:1pt;width:1pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
			<font style="display: inline;font-size:10pt;color:#000000;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and </font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:21pt;"><p style="width:21pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
				<font style="margin:3pt 0pt 0pt;font-family:Times New Roman;font-size:10pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;;"> 5.</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
			<font style="display: inline;font-size:10pt;color:#000000;">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): </font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;"><p style="width:54pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 17.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
				<font style="margin:3pt 0pt 0pt;font-family:Times New Roman;font-size:10pt;text-align:justify;text-justify:inter-ideograph;border-bottom:1pt none #D9D9D9;line-height:100%;;"> a.</font>
			</p>
		</td><td style="width:1pt;"><p style="width:1pt;width:1pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
			<font style="display: inline;font-size:10pt;color:#000000;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and </font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;"><p style="width:54pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 17.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
				<font style="margin:3pt 0pt 0pt;font-family:Times New Roman;font-size:10pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9;line-height:100%;;"> b.</font>
			</p>
		</td><td style="width:1pt;"><p style="width:1pt;width:1pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
			<font style="display: inline;font-size:10pt;color:#000000;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. </font></p></td></tr></table></div>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;line-height:100%;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:212.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="border-bottom:1pt none #D9D9D9 ;width:166.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-bottom:1pt none #D9D9D9 ;width:90.30pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:212.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:166.60pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:90.30pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:212.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:256.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:212.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:256.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:212.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:166.60pt;border-bottom:1pt solid #000000 ;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">/s/ REMI BARBIER</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:90.30pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:212.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:256.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">Remi Barbier,</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:212.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:256.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">Chairman of the Board of Directors,</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:212.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:256.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">President and Chief Executive Officer</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:212.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:256.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">(Principal Executive Officer)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;color:#000000;">Dat</font><font style="display: inline;font-size:10pt;color:#000000;">e</font><font style="display: inline;font-size:10pt;color:#000000;">: &nbsp;</font><font style="display: inline;font-size:10pt;color:#000000;">August 3</font><font style="display: inline;font-size:10pt;color:#000000;">, 20</font><font style="display: inline;font-size:10pt;color:#000000;">2</font><font style="display: inline;font-size:10pt;color:#000000;">3</font>
		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>sava-20230630xex31_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!--HTML document created with Certent Disclosure Management 23.3.2.2-->
<!--Created on: 8/3/2023 3:29:32 PM-->
<html>
	<head>
		<title>
			Exhibit 31.2
		</title>
	</head>
	<body><div style="margin-left:72pt;margin-right:72pt;">
		<p style="margin:0pt 0pt 0pt 10.6pt;text-indent: -18pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Exhibit 31.</font><font style="display: inline;">2</font>
		</p>
		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">CERTIFICATION OF THE </font><font style="display: inline;font-size:10pt;">PRINCIPAL </font><font style="display: inline;font-size:10pt;">FINANCIAL</font><font style="display: inline;font-size:10pt;"> OFFICER</font><font style="display: inline;font-size:10pt;">&nbsp;</font><font style="display: inline;font-size:10pt;">PURSUANT TO</font>
		</p>
		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font>
		</p>
		<p style="margin:0pt;text-align:left;font-weight:bold;line-height:100%;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<p style="margin:3pt 0pt 0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">I, </font><font style="display: inline;font-size:10pt;">Eric J. Schoen</font><font style="display: inline;font-size:10pt;">, certify that: </font>
		</p>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:21pt;"><p style="width:21pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
				<font style="margin:3pt 0pt 0pt;font-family:Times New Roman;font-size:10pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;;"> 1.</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
			<font style="display: inline;font-size:10pt;color:#000000;">I have reviewed this </font><font style="display: inline;font-size:10pt;color:#000000;">Quarterly </font><font style="display: inline;font-size:10pt;color:#000000;">Report on Form 10-Q of </font><font style="display: inline;font-size:10pt;color:#000000;">Cassava Sciences</font><font style="display: inline;font-size:10pt;color:#000000;">, Inc.;&nbsp;&nbsp; </font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:21pt;"><p style="width:21pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
				<font style="margin:3pt 0pt 0pt;font-family:Times New Roman;font-size:10pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;;"> 2.</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
			<font style="display: inline;font-size:10pt;color:#000000;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; </font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:21pt;"><p style="width:21pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
				<font style="margin:3pt 0pt 0pt;font-family:Times New Roman;font-size:10pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;;"> 3.</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
			<font style="display: inline;font-size:10pt;color:#000000;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; </font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:21pt;"><p style="width:21pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
				<font style="margin:3pt 0pt 0pt;font-family:Times New Roman;font-size:10pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;;"> 4.</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
			<font style="display: inline;font-size:10pt;color:#000000;">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))</font><font style="color:#0000FF;display: inline;color:#000000;font-size:10pt;text-decoration:none;"> and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) </font><font style="display: inline;font-size:10pt;color:#000000;">for the registrant and have: </font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;"><p style="width:54pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 17.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
				<font style="margin:3pt 0pt 0pt;font-family:Times New Roman;font-size:10pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;;"> a.</font>
			</p>
		</td><td style="width:1pt;"><p style="width:1pt;width:1pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
			<font style="display: inline;font-size:10pt;color:#000000;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; </font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;"><p style="width:54pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 17.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;color:#000000;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
				<font style="margin:3pt 0pt 0pt;font-family:Times New Roman;font-size:10pt;text-align:justify;text-justify:inter-ideograph;color:#000000;line-height:100%;;"> b.</font>
			</p>
		</td><td style="width:1pt;"><p style="width:1pt;width:1pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;color:#000000;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
			<font style="color:#0000FF;display: inline;color:#000000;font-size:10pt;text-decoration:none;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;"><p style="width:54pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 17.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
				<font style="margin:3pt 0pt 0pt;font-family:Times New Roman;font-size:10pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;;"> c.</font>
			</p>
		</td><td style="width:1pt;"><p style="width:1pt;width:1pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
			<font style="display: inline;font-size:10pt;color:#000000;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and </font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;"><p style="width:54pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 17.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
				<font style="margin:3pt 0pt 0pt;font-family:Times New Roman;font-size:10pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;;"> d.</font>
			</p>
		</td><td style="width:1pt;"><p style="width:1pt;width:1pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
			<font style="display: inline;font-size:10pt;color:#000000;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and </font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:21pt;"><p style="width:21pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
				<font style="margin:3pt 0pt 0pt;font-family:Times New Roman;font-size:10pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;;"> 5.</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
			<font style="display: inline;font-size:10pt;color:#000000;">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): </font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;"><p style="width:54pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 17.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
				<font style="margin:3pt 0pt 0pt;font-family:Times New Roman;font-size:10pt;text-align:justify;text-justify:inter-ideograph;border-bottom:1pt none #D9D9D9;line-height:100%;;"> a.</font>
			</p>
		</td><td style="width:1pt;"><p style="width:1pt;width:1pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;border-bottom:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
			<font style="display: inline;font-size:10pt;color:#000000;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and </font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:54pt;"><p style="width:54pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 17.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
				<font style="margin:3pt 0pt 0pt;font-family:Times New Roman;font-size:10pt;text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9;line-height:100%;;"> b.</font>
			</p>
		</td><td style="width:1pt;"><p style="width:1pt;width:1pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;border-top:1pt none #D9D9D9 ;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:3pt 0pt 0pt;">
			<font style="display: inline;font-size:10pt;color:#000000;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. </font></p></td></tr></table></div>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;line-height:100%;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:211.95pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="border-bottom:1pt none #D9D9D9 ;width:166.10pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-bottom:1pt none #D9D9D9 ;width:89.95pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:211.95pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:166.10pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:89.95pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:211.95pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:256.05pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:211.95pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:256.05pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:211.95pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:166.10pt;border-bottom:1pt solid #000000 ;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">/s/ </font><font style="display: inline;font-size:10pt;color:#000000;">ERIC J. SCHOEN</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:89.95pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:211.95pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:256.05pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">Eric J. Schoen</font><font style="display: inline;font-size:10pt;color:#000000;">,</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:211.95pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:256.05pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">Chief </font><font style="display: inline;font-size:10pt;color:#000000;">Financial</font><font style="display: inline;font-size:10pt;color:#000000;"> Officer</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:211.95pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:256.05pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">(Principal </font><font style="display: inline;font-size:10pt;color:#000000;">Financial</font><font style="display: inline;font-size:10pt;color:#000000;"> Officer)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;color:#000000;">Dat</font><font style="display: inline;font-size:10pt;color:#000000;">e</font><font style="display: inline;font-size:10pt;color:#000000;">: &nbsp;</font><font style="display: inline;font-size:10pt;color:#000000;">August</font><font style="display: inline;font-size:10pt;color:#000000;">&nbsp;</font><font style="display: inline;font-size:10pt;color:#000000;">3</font><font style="display: inline;font-size:10pt;color:#000000;">, 20</font><font style="display: inline;font-size:10pt;color:#000000;">2</font><font style="display: inline;font-size:10pt;color:#000000;">3</font>
		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>sava-20230630xex32_1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!--HTML document created with Certent Disclosure Management 23.3.2.2-->
<!--Created on: 8/3/2023 3:29:41 PM-->
<html>
	<head>
		<title>
			Exhibit 32.1
		</title>
	</head>
	<body><div style="margin-left:70pt;margin-right:71pt;">
		<p style="margin:0pt;text-align:right;line-height:100%;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Exhibit 32.1</font>
		</p>
		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-size:11pt;">CERTIFICATION</font><font style="display: inline;font-size:11pt;"> OF THE CHIEF EXECUTIVE OFFICER</font><font style="display: inline;font-size:11pt;">&nbsp;</font><font style="display: inline;font-size:11pt;">AND CHIEF FINANCIAL OFFICER</font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-size:11pt;">PURSUANT TO</font>
		</p>
		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font>
		</p>
		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">(18 U.S.C. Section 1350)</font>
		</p>
		<p style="margin:0pt;text-align:center;line-height:100%;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the </font><font style="display: inline;font-size:10pt;">Sarbanes-Oxley Act of 2002, </font><font style="display: inline;font-size:10pt;">each of the undersigned officers</font><font style="display: inline;font-size:10pt;"> of </font><font style="display: inline;font-size:10pt;">Cassava Sciences</font><font style="display: inline;font-size:10pt;">, Inc. (the &#x201C;Company&#x201D;), hereb</font><font style="display: inline;font-size:10pt;">y certif</font><font style="display: inline;font-size:10pt;">ies</font><font style="display: inline;font-size:10pt;"> that to the be</font><font style="display: inline;font-size:10pt;">st of </font><font style="display: inline;font-size:10pt;">such officer&#x2019;s</font><font style="display: inline;font-size:10pt;"> knowledge:</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt;">
				<font style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size:10pt;;"> 1.</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt;">
			<font style="display: inline;font-size:10pt;color:#000000;">The Company&#x2019;s </font><font style="display: inline;font-size:10pt;color:#000000;">Quarterly</font><font style="display: inline;font-size:10pt;color:#000000;"> Report on Form 10-Q for the period ended </font><font style="display: inline;font-size:10pt;color:#000000;">June</font><font style="display: inline;font-size:10pt;color:#000000;"> &nbsp;3</font><font style="display: inline;font-size:10pt;color:#000000;">0</font><font style="display: inline;font-size:10pt;color:#000000;">, 20</font><font style="display: inline;font-size:10pt;color:#000000;">2</font><font style="display: inline;font-size:10pt;color:#000000;">3</font><font style="display: inline;font-size:10pt;color:#000000;">, and to which this certification is attached as Exhibit 32.1 (the &#x201C;Periodic Report&#x201D;), fully complies with the requirements of Section 13</font><font style="display: inline;font-size:10pt;color:#000000;">-</font><font style="display: inline;font-size:10pt;color:#000000;">(a) or 15</font><font style="display: inline;font-size:10pt;color:#000000;">-</font><font style="display: inline;font-size:10pt;color:#000000;">(d) of the Securities Exchange Act of 1934, and</font></p></td></tr></table></div>
		<p style="margin:0pt 0pt 0pt 18pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table style="width:100%; table-layout: fixed;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt;">
				<font style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size:10pt;;"> 2.</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt;margin:0pt;">
			<font style="display: inline;font-size:10pt;color:#000000;">The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></p></td></tr></table></div>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 180pt;text-indent:36pt;line-height:100%;font-family:Times New Roman;font-size: 10pt">
			<font style="display: inline;font-size:10pt;color:#000000;">Date</font><font style="display: inline;font-size:10pt;color:#000000;">: &nbsp;</font><font style="display: inline;font-size:10pt;color:#000000;">August 3</font><font style="display: inline;font-size:10pt;color:#000000;">, 20</font><font style="display: inline;font-size:10pt;color:#000000;">2</font><font style="display: inline;font-size:10pt;color:#000000;">3</font>
		</p>
		<p style="margin:0pt 0pt 0pt 288pt;text-indent:36pt;line-height:100%;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;color:#000000;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;line-height:100%;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:212.75pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="border-bottom:1pt none #D9D9D9 ;width:166.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-bottom:1pt none #D9D9D9 ;width:90.30pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;line-height:100%;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:212.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:166.60pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:90.30pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:212.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:256.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:212.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:256.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:212.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:166.60pt;border-bottom:1pt solid #000000 ;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">/s/ REMI BARBIER</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:90.30pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:212.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:256.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">Remi Barbier,</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:212.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:256.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">Chairman of the Board of Directors,</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:212.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:256.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">President and Chief Executive Officer</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:212.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:256.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;border-bottom:1pt solid #000000 ;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">/s/ ERIC J. SCHOEN</font><font style="display: inline;font-size:10pt;color:#000000;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;color:#000000;"></font><font style="display: inline;font-size:10pt;color:#000000;;font-size: 10pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-size:10pt;color:#000000;"></font><font style="display: inline;font-size:10pt;color:#000000;"></font><font style="display: inline;font-size:10pt;color:#000000;"></font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:212.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:256.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">Eric J. Schoen,</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:212.75pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:256.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;line-height:100%;font-family:Times New Roman;font-size: 10pt">
						<font style="display: inline;font-size:10pt;color:#000000;">Chief Financial Officer</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>sava-20230630x10qg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sava-20230630x10qg001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!:17AI9@  34T *@    @ !0,!  4
M   !    2@,#  $    !     %$0  $    ! 0   %$1  0    !   .PU$2
M  0    !   .PP       8:@  "QC__; $, " 8&!P8%" <'!PD)" H,% T,
M"PL,&1(3#Q0=&A\>'1H<'" D+B<@(BPC'!PH-RDL,#$T-#0?)SD].#(\+C,T
M,O_; $,!"0D)# L,& T-&#(A'"$R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,O_  !$( @4$LP,!(@ "$0$#$0'_
MQ  ?   !!0$! 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#
M!04$!    7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*"
M"0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS
M='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$
MQ<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$!
M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /?Z***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@<_QEG.&_P"^,"A+H#VN>RBEH%% !1110 4444 %%%% !1110 4444 %%%%
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M_P#(]>P44 >/_P#"/?'/_H<M#_[\K_\ (]'_  CWQS_Z'+0_^_*__(]>P44
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA7F>DZ/>S>(=-MUAU>&STRYDG$-Y$!#""&&(Y!_K<EAC/09KTP4= ZBT444
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M@RU_]&35U%<O9?\ )3-8_P"P9:_^C)J .HHHHH **** "BBB@ HHHH ****
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M_P!\"C^SK+_GUA_[X% !_:5E_P _</\ WV*DBN8+C/DRI)MZ[6SBH_[.LO\
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MT6RU6/3+G4H([V3&V)CSSTSV'XT ;%)7/#QCI*:[-H]W<1VUTD@CC61O]:2
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MV#+7_P!&34 =11110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!14$]Y;6I43S)&6Z!CUJ'^UM/_Y^XO\ OJ@"[15+^UM/_P"?N+_OJC^UM/\
M^?N+_OJ@"[15+^UM/_Y^XO\ OJC^UM/_ .?N+_OJ@"[16/J?B;2=*TNZU"XN
ME,%M&99/+&YL#T'K6)X7^)_AGQ=<7$.FW$RM;H'?SXM@P3CB@#LZ*I?VMI__
M #]Q?]]4?VMI_P#S]Q?]]4 7:*I?VMI__/W%_P!]4?VMI_\ S]Q?]]4 7:*I
M?VMI_P#S]Q?]]4HU6P9@HNXB2<  ]30!<HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!**#2<T
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M16UW_A';<:4@:1G_ +0_>"-206V;,9P"<9K:U#Q3;6+Z9MB:1;W:Q.<&*-L
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MN/,)E,H)'S)C 4E6P<^E"U ZVBL+7=9O[*\L]/TJRBNKZY5Y )Y3'&J)C))
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ;,(;X3V=]=NT-A<I',R2N2K*S?+TQD'UK4T;PW>V6H^'9?LLJ0V\5VT_G7
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MYK_WS3Z* &>5'_SS7_OFCRH_^>:_]\T^B@!GE1_\\U_[YH\J/_GFO_?-/HH
M9Y4?_/-?^^:Y?QA\/="\;BT&KI./LF[R_(DV?>QG/'/W175T4 9>@Z!8>'=$
MM=)L4;[-;*5C\T[FP23R?QK1\J/_ )YK_P!\T^B@!GE1_P#/-?\ OFCRH_\
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MIEUI'A6RL+U EQ$&#JK!@,L2.1[$50=-#>HHHI %%%% !1110 4444 %%%%
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MH(M5E77AIEU$B^9;B:"1"2'Q@./P)&/:M:N3M[9_^$ETNR5S(-+LSY\O;<P
M5?J1D_A764"%HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?"?B?5!IVG7<WV@HSCS82BX'7DT =Q15/^U+#_G[B_[ZI?[4L?\ G[B_[ZH
MMT54_M2Q_P"?N+_OJC^U+'_G[B_[ZH MT56CO[2:01QW$;.>BAN35F@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M *,FKJ*Y>R_Y*9K'_8,M?_1DU '3]J**.] '.:QXPL=)U 6(M;V]N0H>5+.
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ME%ZZ]?/;[COQTI:0=*6MSR@HHHH **** "BBB@ HHHH *1E#*58 J1@@TM%
M%?[!:?\ /K#_ -\"C[!:?\^L/_? JQ10!7^P6G_/K#_WP*/L%I_SZP_]\"K%
M% %.;3+.:"2(V\0#J5)"#(R,5P/@_P"#.B^#M>&K6U_>74@B:/R[@)MPV.>!
MG->E44 5OL%I_P ^L/\ WP*7[!:?\^L/_? JQ10!7^P6G_/K#_WP*/L%I_SZ
MP_\ ? JQ10! EI;1N'2")6'0A1D5/110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "&O/=#U>#1[G7
MX;^WO1)/J4TB%;.5PR' !R%(QQ7H5)@9Z"HE&[3.BC75.,HR5T[>6QP7@/6K
M>P\/V6EW4-['=>8R[6LY<#<Y(RVW &"/I7?"D"CT%+3A%Q5FR:]6-6;FE:YD
M^)]3FT7PQJ6I6Z(\UK;O*BOG:2!D9Q7G=I\5=1G^&DVMM96O]M)="U6U&X(6
M8_*<9S]WGK7>^,K.XU#P;K%I:1--<36DB1QKU9B#@5Y5:> -<3Q%I[-92+IH
MTQ9YT^7 NUB* 'GKFGO=,R5M#M/#WC/4]87PU).=+B&I6DLT\.YA*67./+7N
M/7)JQX9\>07OA!=<U^:UL=UU);KMSABKE0 .22<5S/AOPQK=IJ/@:2XTV:-+
M#3[F*Z)(_=,P.T'GJ:J:1X8UW2]*\,ZA-I-Q*VEZI<S3V2;3)LD8[749P2/K
M3W%T.Z\&^*YO$]YKRLL'V>PO3!;R19^=, Y.>_-9WQ#\=ZAX4NK&WTNRANY7
M1KBZ$F?W<"D L,$>M.^'6F:C8WWB>ZOM-DL$O=2:>!)".4(&#Q61=^&/$VO>
M,/$FH;;6RM9;<:?;B]@,ADBQEF7:PQDGO2>Z'W.A\4>)M3L]0\.66BFRSK$C
M+YUTC.JJ%# @*1US4WA[Q%J4WB._\.ZW%;"^M8UGCFM@1'-&W&=I)(((QUKB
M;>P\26VF>")K_1+Z>;1;B:*Y2 *SF,+M1@"PR",=ZZOP]IU_?^.=1\4WEC+8
MV\EJEI:P3X$I )+,P!(')]:I?Y_\ AWM]QVXI:04M(H**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** ,?Q/<0VN@7,L\MW%$H7<]HP64?,/ND_Y
MQFJ&H^,[+3+F:S^RWUU<0JC&.VAWLRL"=PP>@QR34WC6":Z\*WD-O#)-*P7:
MD:EB?F'0"JVEVDR>+]9GD@=8GM[=4D9"%8@/D ]\<5G)N]D=M&%+V?-/7?2_
MH1-\0]'!MWCCO);67:'NHX"8H6/0.W8\]!FK&I^-;+3=1FL/L=]=7<2H_E6T
M/F,X;/(&>@QSG'45B#3;M?A=):BRF%R68^5Y1W_Z[/W<9Z<TCZM+HWC35IUT
MJ[OHS;VZN+5 [J<-CY>,CKSVK/FFEK^1TQP]";ER+:_7?;_,WG\::6NB0ZJO
MGM!+,("HC^='YX9>N>,<9[5'<>-K6ULK6233M3^UW09H[$6V9]JG!8J#P/J:
MPTTO47L[>\GL)(I+S7([LVX7<88^!EL9P>,GZUJ:X]WHOBI-;CTRYU"UDM!;
M2+:H'DC(8D$+GD'/;TI\T[7$\/AU+E6N_7MLOZW+47C739=+:]\JZ3RIT@N(
M)(]LD#,0 64G@<CD9K3N=;M;74X+%PYDEA>8N,;8T7&2QSQUXKF].TRX\0R:
M[?7VGRV-OJ,*010R@"0A0?G8#H<MQ]*KZ1I.J:SI.L3ZE"T%_/:_V?$)5*X5
M5P6^C.2?IBFIR)>'H7=W:WG?>WY:W-.T\?:;=WL</V34(K69@D5[+;%8)"3@
M8;W]P*ZP'(S7C,&BWUQY.F26_BWSU*K(DMRHM5 (R0^T@@=0,'I7LB#" >@I
MTI2E\1GCJ%*DU[/\Q]%%%:G )7+V1Q\3-7S_ - RU_\ 1DU=0:XLZ3IVI?$C
M54OK&WN573K9E$T0?!+R@D9[X _(4M2H\M_>.SW#UI=P]16-_P (CX=_Z >G
M?^ R?X4?\(CX=_Z >G?^ J?X4KLJU/N_N_X)L97U%&1ZBL?_ (1'P[_T ]._
M\!4_PH_X1'P[_P! /3O_  %3_"B["U/N_N_X)L97U%&5]16/_P (CX=_Z >G
M?^ J?X4?\(CX=_Z >G?^ J?X4786I]W]W_!-G(]129'J*Q_^$1\._P#0#T[_
M ,!4_P */^$1\._] /3O_ 5/\*+L+4^[^[_@FQD>HHR/45C_ /"(^'?^@'IW
M_@*G^%'_  B/AW_H!Z=_X"I_A1=A:GW?W?\ !-G</44;AZBL;_A$?#O_ $ ]
M._\  5/\*/\ A$?#O_0#T[_P%3_"B["U/N_N_P"";.1ZBDR/45C_ /"(^'?^
M@'IW_@*G^%)_PB7AW/\ R ]._P# 5/\ "G=A:GW?W?\ !*\WC31K77I='O+C
M[-<)M(:7A&R,\-T'7OBNA5E=0RD$'D$5PEQ\+=(N]?DOYL1V9"A+.W01KP.<
MD>OMCZUVMG9V^GVD=K:0I#!&,(B#  J(.;;YCIQ4<*H0]@VW;6^U_(G%+116
MAQ!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS%]N<G(P,=Z .SI*S="U>/7-'AOXXVCWY5XV/*,I(8>_(/-4=-\40:IXGO\
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M ("I_A5ZG-:GW?W?\$V<CU%)D>HK'_X1'P[_ - /3O\ P%3_  H_X1'P[_T
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MTRUVQQ(%49DF)X''6GJ*2C;1_@=?1113("BBB@ HHHH **** "BBB@ HHHH
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MX5U5,$:*[.% 9NI Z_6GT"%HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M])TJ[U"5'>.VB:5E098@#/%86DZ_K=Q=V/\ :&FVIL;]"T-Q8S-*$.,@294
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MY:?W%_*@"A_;FG?\_'_CIH_MS3O^?C_QTU?\M/[B_E1Y:?W%_*@"A_;FG?\
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ME1>%(9].T^6!K"]BL[JZ;[-',N98D*\F4YR,D'DDGD5E:5IVIRS:'H\^G7$
MT:[>>:Z=?W4JX<+L;/).\9],&JZBZ&Q#XHUC_A(+/2KSPWY!N=S>8E^DA1%Z
MNR@9QG ^IKK!TKG=%LK@^(M:U2[AD1GD6WM]X_Y9(.J^S$_I714N@=1:***
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M6?VSIW_/W'0!?HJA_;.G?\_<=']LZ=_S]QT 7Z*H?VSIW_/W'1_;.G?\_<=
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M<NK+@D'H%'/%=M]F@_YX1_\ ? J6B@"+[-!_SPB_[X%'V:#_ )X1?]\"I:*
M(OLT'_/"+_O@4?9H/^>$7_? J6B@"+[-!_SPB_[X%'V:#_GA%_WP*EHH B^S
M0?\ /"+_ +X%'V:#_GA%_P!\"I:* (OLT'_/"+_O@4?9H/\ GA%_WP*EHH C
M6&*-LI&BGU"@5)110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MN2Y\@L"8PP "DCC/'.#3Z#5B.T\7I+X-M=?GL;@-<)E;6!3*Y;) 7@8'3J<
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MKQ/X]T;PMHK:I=--/$KK&4@7+9/3J1QQ4'A+XCZ'XOTZ>]L_M%O'#+Y16Y0
MDX!R,$\<UI^*/"6E^+=&;2M2206S.LA\E@C9'3G%0>$O!&C>"].FLM*24PS2
M^:WGOO.[ '!QTX% &G_;>F_\_2_D:7^V]-_Y^E_(U<\F+_GDG_?(H\F+_GDG
M_?(H I_VWIO_ #]+^1I5UG3V956Y4L3@#!ZU;\F+_GDG_?(I?)C!R(T'_ 10
M \4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI:XS3?%VHW%[I\MY86\6EZI(\5F\<I:56&2/,&, $*>A-=D* %HHHH ****
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M!2UC6NM&;64LI8?+2XMA<VS\Y8<;@?0C(XK8%,!:*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KE[+_DIFL?]@RU_P#1DU=1
M7+V7_)3-8_[!EK_Z,FH ZBBBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BJUW?6UGM\^3:6Z#&35;^W=/\ ^>Q_[X-
M&E16;_;NG_\ /8_]\&C^W=/_ .>Q_P"^#0!I45YQXQ^,>B>#]4AL9[*]NFEA
M$P>$*  21CYB.>*Z'PYXWTOQ%H%KJT0F@CN Q$<J_,N&(YQQVH Z:BLW^W=/
M_P">Q_[X-']NZ?\ \]C_ -\&@#2HK-_MW3_^>Q_[X-7+6ZANXO-A;<F2,XQ0
M!-1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6([O1;*[L5@M-$,FV[\U6^T@J5&U1RO7)R*I_P#"QO$'_0BZA^<G_P ;I?\
MA8WB#_H1=0_.3_XW3^L0_I,;RO%/HO\ P*/^9I^+D\17NHP65KI,UUHOE[KD
MVUU'%)*W]P[B,+ZXZ]*CN['6;>]AU'3M#7%QI_V*2T\^-3;$$E3G.TJ,]!S6
M?_PL;Q!_T(NH?G)_\;H_X6-X@_Z$74/SD_\ C=)5X+_AF+^R\5V7_@4?\S8U
M'PU=I\-/^$?M-L]VEJD2_-M#,",\G\:36]/U>#6)KW3+!;U;VQ%G*/.6,PL"
M<.=W5?FZ#GBLC_A8WB#_ *$74/SD_P#C='_"QO$'_0BZA^<G_P ;H^L0_I,/
M[*Q79?\ @4?\S4ATYK2\\,Z'$WFOIL'F7$B]%PH4?]]'./I79UYO_P +%U_.
M?^$%U#/KF3_XW2_\+&\0?]"+J'YR?_&Z/;P_I,/[*Q-]E_X%'_,]'HKSC_A8
MWB#_ *$74/SD_P#C=+_PL;Q!_P!"+J'YR?\ QNCV\/Z3#^RL5V7_ (%'_,]&
MHKSG_A8WB#_H1=0_.3_XW1_PL;Q!_P!"+J'YR?\ QNG[>'])A_96*[+_ ,"C
M_F>C5D>*+*XU+POJEE:H'N)[62.-2V,L5('-<A_PL?Q!_P!"+J'YR?\ QND_
MX6-X@_Z$74/SD_\ C=+V\/Z3#^RL2NB_\"C_ )E[Q!!XD>'3=,M=+FN-+^S@
M7K6UW'%*[  >6"Q&%]2.O3O5C4XKZXT:VL7\'176GO$ ]C]IC5H6!XSD[2/H
M:R?^%C>(/^A%U#\Y/_C='_"QO$'_ $(NH?G)_P#&Z'7A_28?V5BK[+_P*/\
MF6TT?Q#HIL+N"T34[C[ ;*=!.$*'=N5MS=0.A[TZ71;[3_#=AH,F@1:[9) J
MR 3K&5D!SDAR!CTQS5+_ (6-X@_Z$74/SD_^-T?\+&\0?]"+J'YR?_&Z'7@_
M^&8?V5BNR_\  H_YG:Z!9W>GZ%9VM]-YUS%&%=\YR?J>M:5><?\ "QO$'_0B
MZA^<G_QNE_X6-X@_Z$74/SD_^-T_;P_I,%E.)[+_ ,"C_F>C45YS_P +&\0?
M]"+J'YR?_&Z/^%C>(/\ H1=0_.3_ .-T>WA_28?V5BNR_P# H_YGHU%><_\
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M&9(OL,H&"^TGU(;Y<_=I_P#PL;Q!_P!"+J'YR?\ QND_X6-X@_Z$;4/SD_\
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M7Z*EQ'$%9%  7T'''3TIBU-; ]!1@>@I:* $P/048'H*6B@!,#T%&!Z"EHH
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M )^X?^^J=]@L_P#GUA_[X%'V"S_Y]8?^^!0 W^T['_G[A_[ZH_M.Q_Y^X?\
MOJG?8+/_ )]8?^^!1]@L_P#GUA_[X% #?[3L?^?N'_OJC^T['_G[A_[ZIWV"
MS_Y]8?\ O@4?8+/_ )]8?^^!0 W^T['_ )^X?^^JP_$WC[P[X3MH+C5+MA'.
MY1/)0R'(&><5O?8+/_GUA_[X%<KXX^'&E^.+*TM;F:6S6VD,@:V506)&,'(H
M UM"\7Z+XBTB/4["[!MI&95,@*-D'!X-:7]IV/\ S]P_]]5C>$O!FG>$_#L&
MCP9NHXF=A+.B[CN8GG ]ZV_L%G_SZP_]\"@!O]IV/_/W#_WU1_:=C_S]P_\
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M_BJ/^%8^$?\ H%M_X$R__%47K=D'+EW\T_N7^9J_\)=X=_Z#FG?^!2?XT?\
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M?[1'N /;.:D_X2[P[_T'-._\"D_QK+_X5CX1_P"@6W_@3+_\51_PK'PC_P!
MMO\ P)E_^*HO6[(.7+OYI_<O\S5_X2[P[_T'-._\"D_QH_X2[P[_ -!S3O\
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M_P#GZ\.?^ T__P 71Y?CO_GZ\.?^ T__ ,77444 <OY?CO\ Y^O#G_@-/_\
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M8=#T6TTNW=WAMHQ&K28W$>^*OT <OY?CO_GZ\.?^ T__ ,71Y?CO_GZ\.?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M??)M"*3@M[GVK70[E!]:K:C8Q:C:-;3%@C$$[3@\'-65&U0/2DNH/<=1113
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH 2@T44 >67\-K>>.=?6^T/6M6$30B(V5PRI$#&"1CS$Y/7O6OKFM7N@0:
M=;V(72K'[,&66^MY+GY^T3;&)4@<[B2*U[KP='<:M=ZC;ZUJ]A+=E3,EK,BH
MQ4;0<,AYQ3[OPDEXL.[6M8BD2+R9)(KA09U_VQMQGKR .M"V0WO<XWQ'J>J0
MZYJ=[]JMI;0:'%-]E&\H29,<.K#OSN&.,"MK6?$'B&WN-7ET_P"P"TTM8V,<
MR,6FW*"5W _+UZX/TK4OO VDWVU=US;Q"S%D8H) JM$#E0<@\@]*OS^';*Y3
M4D<S :@%$V'Z;0 ,>G2CIH!AV^NZW;W]_8WTFG/,+%;V!^8HX@S%=CDDYQC[
MW&?2N5U?Q5JNIZ!KFGPZM;2S6J03?:X+26# :3:4VLV3R,[@<$&O0-1\*:;J
M<MP]R)6^T6:V;KOXV*Q8$<?>R>M4#X#L)8[U;O4=3NY+N!;=Y9YE+*JMN7;A
M0 0>1Q0K7NPT1AZAX[O['79;))(I/L+Q0S6RV,KO=,P!9D=<J@&X'!STKT=3
ME0?6N>E\(6LMZER-0U) 0GGQ1SA4N67@-( ,EN!G!&<5T0Z4=!==!:*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $I*=24
M <LMW;Z!XCU*34I4M[>]*2PW$AVH2J!2A8\ _*" >N3CH:Y[Q&8M134-9\II
M--=K2!3L.)PLVYF4?Q+\V 1UYQFO2L ]128%9N%U8ZZ>*5.2G;73J</=/INN
M:K<2VDYDL!I<L%W-: O]XC:HV@[F WG')&>G-5&N[F^@NK*QO-/U:9=-E$%Y
M:1!9(&P %8AF +>VWE3QZ>AX'H*, =A1[,I8M*VFW]=CSW36AO+K24CUNP>2
MT4[+:TL761%V;2CG>VP=,[@.0.]/@C73_ VAZS%'\VGA9GVCDQMQ)^C%OJ*[
M_ ]!2^U+V8/&7:TTO_GIMYGG09]-33)[J>TL;F\$]W)>7BEDC=]I\L#<HW8.
M 2>BG'4U!IMU#!I.GO-.1'!KLGF23*(RH(DP6& %SN4]!]X5Z9@>E)M'H*/9
M>9?UY6=X_P!:^7F<"?ETT7$O-E!KLTMUE<@('?!(] VTGTQGM5;6FM=3N=3N
MK/9/ITHLHI)$YCED$W.#T;"E03^':O2,#T%)@>@H]F2L;9WL<%XB,=IK5^P@
MC9&LK4/YF?+0><PWN 1E5')'H,=*SVNUFNO$C'48[TS:,Q6:&/9&^W?D)R<@
M9&3D\D\]AZ;BC ]!0Z>NXXXU*-G'I_EY%;3_ /D&6W_7)?Y5Q,ES;Z?>-96M
M]9W\4FH;GTNX@/VA&9\L5YR0I.\$H>.=V,&O0.U)@9Z53C=(PIU^63;6YYX+
MRWMXT>25%%GX@EDN26_U*L9 K-Z [AR:C>ZM[K6;C4=WFZ9#JL<DT@&5VBW
M5_\ =#;3GIT/09KT? ]!0 /05/LGW-_KJWY?Q_X!YAJ%S87FN:O<Z:R21/\
M8"\L?*NPGP2#T;L,CTQVJ[?.UGK>M+J&J:=91W04(+ZV,GFP[ ,*=Z@@'=\N
M"<GW%>A8'H*,9ZT>S\P>-V26GX]/+R. D\C1EM95\0P079T](F_M*V94N%7.
MT@,RL&Y.1DXR,CI77Z%)YFA6+_8Q9[H5/V=5VB/CIC Q^5:! ]*4=*J,;&%6
MO[2-FM?Z\D+10**LYPHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
AHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>sava-20230630x10qg002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sava-20230630x10qg002.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_X0!:17AI9@  34T *@    @  8=I  0
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /LN@ H
MRM5UB'1_L_GAV^UW,5JFP*<22[MI;++A!M.XC<W3"FMZ=*5;GY;+DA*;O?:-
MKVLGKKILO,SG-4^6]_>DHJW=_H:M8&@4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 95YK$-E>VNGR!S+?^=Y94+L'D()'WDL",@X7:K9/7 YK>-*4X3JJUJ?+
M?>_O.RMI]]VC-S491@[WE>W;17=S5K T"@ H * "@ H * "@ H * "@ H *
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M6_/3C/:UN:^F[O:V^GH8TY^TYM+<LG'UMU-VN4V"@ H X7QS_P PO_L,6?\
M[4KU,'_R_P#^P>I^AQU_^7?_ %]A^IW5>6=@4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 %  >1QQ0!PS^-H=*O3INM+]DEZQSC)MYD.=K@_>C/9E;<JL"/,( )]-825
M6'ML,^==8_;B^J[/R:LVNAQ^W4)>SJ^Z^C^RUW\OZU(M:E2?7]#DB971AJ!5
ME(92/LR\@C((^E523CA\2FK->RT>C7OL4VG5HM;>_P#^DG?5Y1VA0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M& ,DECQW))]Z\^4Y3DZDG>3=V_/\CI45%**V2LO0X_\ X5IX=_Y]/_(]S_\
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M>:9V>['_ &\R_P"-'UZKVA_X!$/JT.\O_ F'_"O=/'26\'_;U)1]>J?RT_\
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M#?\ E6?^0>SJ_P#/W_R2(?V!XB_Z#7_E/MO_ (JCVV&_Z!O_ "K/_(/9U?\
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M3+7J4/\ =L3_ -PO_2V<=3^+2_[?_P#23NJ\L[ H * "@ H * "@ H * "@
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M\BN9(Z<$,,CD'D$5!0M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MP==P!VL.C#/1AV(Y':J3<;V;5U9VZKMZ":3W]22I&% !0 4 % !0 4 % !0
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MWZNUK_<5%./IT6]CMZS+"@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0!%<3I:Q/-*=J1*SL?15!)/X 4>0'SUI=YXB^*-U/<6E[)H^FP/L3R2P;
M/4*?+>-I'VX9RT@5<@*,'%=;4:22:NSG7-/9V1T/AJ/Q7X;UH:9?M+JNFRJ#
M]J;)$8.[#^8YW!@RXDB+N=I#*#E2T2Y)1NM'V*7-%V>J[E3Q?XIU?6M<7PKX
M=D^S,G^OG!P<[=[?/@E$C7 )3YV<[0>@+C%1CSS^2%)MOEB9VNZ)XJ\"VW]L
M6^K2ZC'!M,\4_F, &(4D)+)*'3) 8J8W .X 8)%)PF^5QMVL)J4=4[G>R_$2
M"/PR/$80%V4((<G'VC<4*9Z[0P+YZF,9')%9<GO<G]6-.;W>8X31/#WBOQI;
M#5[K5IM.2X!>&*$R*"O\)*120JBG^$Y=RN"1DUHY0@^51O8A*4M;V.G\"3>*
M+#4)])UQ)+JUC!\N\;IN&"-LC;6E213W#,CC:<88")\C2E'1]BH\R=I;=SS#
M5?'6H^'/%MQ(T\\UE#<LKVS2NT7E' 8+&6**5!W)@## =B:W4%*"T5[;F3DX
MR\NQW'Q3UZX@ET:73+J6*"[>1B8)7C65"UJ4+;&7<,.<!LX#'U-94XKWDUM_
MP2YO:S_K0G\?ZK>V7B?1K:VN)H89Y8!+''*Z)(#=*I#HK!7!7Y2&!R.#Q1!+
MEDVN_P"0Y-J22_K4U_&/A#5+Z:XU2TUBZL8DBWBVB\T(/*BYP5N8U&\J22(^
M">_>8R2M%Q3\_P"D.47NFUY?TSS+P'HVN>-K::Y_MR^M/(E$>WS)Y=V5#9S]
MICQUQC!^M;3<8.W*G]W^1G%.6O,_Z^9UVEZA?P^/)-+ENIYK:&WC'EM+)Y3,
M+* E_*+E0S.2YZG<Q))))K-I>SYK*]_U92;Y[7_JQ1U#Q!K?CS7)M&T&X-A9
M69823H2K-L;8S[EP_P S\1QJR@J-S'J0U&-.*E)7;Z VY.T=$BOKB>)_AF8]
M1_M!]6L6D$<JW&\D$\X*R/*R!@I"R1R##8##!PS7+4TM9^0GS0UO=&M\5/$L
M[:)I^I:5<36RW<@?=#(\3%6B+;6*,I.T\$'HPJ:<?>:DMAS>B:+_ (/\:/XA
M\,W8ED8:CI]K,KON(D;$3F*<'.X-QAFSGS%+9&X4I0Y9+LW_ $AQE>+[I&C\
M'M1NM3T1IKV:6YD%U(N^:1Y&VA(B%W.2< DD#..3ZTJJ2E9::#@[K7N3?%N_
MN=-T(SV<LMM+Y\0WQ.T;X.[(W(0<'N,X-*DDY6?8<W9:',_!OQ#>7QNM.U*>
M6XF58KF)II'E;RY% 8!G)(49C.T' 9FZ'.;JQ2LXJW0BFWJF>8:MXQU:]UHW
M5O>745G/>M'#&D\J)Y4;HH^17" ,I!( P6+9R<D[**4;-*]NQFY.]TW:Y]"?
M$SQ _AW0YIH',=Q.5@A93M96DSN92.0RQAV5AR& ((/-<M./-)+IN;S?*CS#
MX?:YJNCZ]'I>MW$]PNH6L<D7GS22!'DC$R8\QFP<;XF QE\#L!6TTG&\4E9]
M#.+:=GU1W7Q@U&ZTS1%FLII;:0W4:[X9'C;:4E)7<A!P2 2,X.!Z5G22<K/L
M7-V6G<X_XDZU?V&@Z//:W-Q!+-$AD>.:1'D)MXV)=E8%CDD_,3R2>M:4TG*2
M:7],F;:2LSH?#OC1_$/A*]E,C)J-A97"R,K$2;E@<Q3AAA@S;<[@<B16(QQ4
M2ARS79M?GL-2O%]TAO@);_Q1X4DA>]N(KJ6:15NR\DDL85XVX8R*^, K@2+@
M,?H2=H3V5NP1O*.^O<\X\6Z?KGA;4;33?[:OKC[=M_>>;/'LW2"/[OVE]V,Y
M^\OI[UM%QDF^5*WI_D9R3BTKO4[O6?#NK^#]$U&]EUB[OG,,:Q[FF1HF\^/+
MHQN)2"5)4[=IP2,XXK)24I)<J7_#>AHTXIN[,GPOX-USQ)ID&I_V_?0?:%8^
M7NG?;M=D^]]K3.=N?NCKCWJI2C%N/*M/3_(E1;5^9_U\SO4T2_\ "OA_4_M&
MHW&H3_9KF6*:0R+)$5MVVA&::5@0PW JRX/(&>:RNI2C9):K\S2SBGK<\X^$
M?CRYEO&TC5IY)_M7S6\L\C.PD4<Q;G8G:ZC*#. ZX )>M:L$ES15K;V,X2UL
MSI?">JWMQXVU2SFN)I+:**8QPO*[1(1-;@%(RQ12 S $ 8!([FIDDH1:6O\
MPY46^9HL?%O7KRT6RT?2I9(;R^F'S0NZ2!00B*&0A@))'[==A%*E%:REL@FV
MK);LB^%&NWKW%_H.K32W%U9REE:9VD<JK>5( SDMM5@C*,D?O#CW*B5E*.B8
M0;UB]T8OQIUO4-)NK(6%S<6H>.4L(99(PQ#)C<$8!L=L@^E522:=TA5&U:QN
MWWC-]?\ !5QJEK(UO>0I''*8G*/',)8@Q4J0RK(IW+@_=;;DX-2H<LU%[#YK
MQNMR?2_%\F@^"H-8NF>ZN2C*AE=F:25II%3>Y)8A0,GG.Q< CBAQO-Q6B_X
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M:5F6% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M4G=R_KH)JW*=I\7]2EU76;31;6&2\^RKYTD$09GD9_F9 %5VXA3.0IVAV)!
MK.DK1<GI?^OS+F[M)'.^.O$&IZE<6>L/I-UI,FGLH$L@E*-AP\2Y:WA"[6#8
M&3NW$8XYJ$4DX\R=_P"NY,FW9V:L>C?%K4(]6\*VU]!_J[B>WD7G. \4IP<=
MUS@^A!!YK*FK3:[)FDW>-SE_BI_R+NB?]<H__2:*KI_%+^NI,_AB5OB%ID_@
M74Y[^Q7%CK5O<02(.%62:-E=<#IAF6>/@?Q(. :<'SI)[Q:?]?D*2Y'=;,]'
M^"W_ "+P_P"OB;_V6L:OQ?(TI_"<A\6?^1CTCZQ_^E(K2G\,OZZ$3^)'I7Q0
M_P"19OO]R/\ ]'15C3^)?UT-9_"SR_P;\)=)\0Z/;:E<RW:2W"N66-X0@VR.
M@VAH'8<*,Y8\Y^E;2J.+:5M/Z[F48)I/4]'G\+VOA'POJ5A9-+)$;6\ES,R,
MVYK9@1E$C&,*,?+GKS67,Y33?=?F:6Y8M+LSPZQ\+R:CX2CUJQRM[IEQ,^Y?
MO-"I5SC'>)OWB^@W]R*Z7*T^5[-&*7NW6Z-_X2ZH^M>*;R_E 62XLI'<#IN,
MUKN(] 2"0.P.*BHN6"2Z/_,<'>3?E_D4=7\07.H>,GU*TLIM5CTIC%'#!O./
M+#H'+1QRX7SV>13MP3M&2.2U%*%F[7_K\@;O*Z5[%8^([K3O%D&OWEA/I$5V
MZQRQS*X#J56*5U9XH<[04D8!>& ))W4^5.#@FG85[2YFK'7_ !<&=<T8'_GH
M/_1\59TOAE_70N>Z.&\;Z;<> [N]L+<'^S-9C!C7HJE)%D  _O0L"@_Z92 ]
M3QK!\Z3>Z(DN2Z6S.FU6SENOAS9M$-PMY!*^.R":="?P+C/H,GM4)VJ/^NQ3
M^!'K7@/7;*]\/VDB2QJ+2VBAFW.H\IH46-M^2-H.W<"< J0036$TU)^;T-8M
M60SPCX\A\7W5U;VL$B16C$"<L&CD4N50]%*LZJ7"D' !RV:)0Y$FWOT",N:]
MNAX9X%\"V/C2\U/[>\\?V69-GD-&N?->XW;M\<F<>6N,8ZG.>,=,YN"5K:_\
M PC%2;N>W^$_AMIO@Z[>^L9+F222)H2)GB9=K.CD@)#&=V8Q@Y(P3QT(YI5'
M-6=C:,%'5'=75P+2&2<JSB)&<J@!9MJEMJ@D L<8 ) )QR*S6NAIL> VWA;P
MO\3C->Z4T^G70<^9$1&,DC=YGD!W&UB3RCH-P;*YY/3S3I:2U7]=3GY8SU6@
M?#[4[_1/$4GAA[O^TK-4?:X)98V5!("A)8H!DQO&&90Y]1FG-)QY[681;4N6
M]T>@?%G_ )%>]_[=_P#TJ@K&G\:^?Y,TG\+_ *ZD_P +_P#D6;'_ ')/_1TM
M%3XG_70</A1YQ\,)X]/\2ZO9W#+'-)*X16(!<I/)N"YQN.&! &25Y' -;5-8
MQ:_K0RAI)H?XTN([SQQI,4#"1X# ) ISL(GD<AL="%^8CJ!U%*&E.7S_ "'+
MXT3>,_\ D?M)_P"N,'_H^ZHA_#E\_P D$OC7]=SK/B[J=O9>'KBVD=1-=&)(
MHR1N;$J.S!>N%5&.[& <#J16=)7DGV+F[*QK?#:R>S\-V4$X(9HG<AO[LTLD
MJY![%'''I2J.\G8<-(H\:\.>&K%/'D]D(\V]FTD\49Y56 1D'NL;/E0?[JYS
MSGHE)^S3ZLQ27/;L?3]<1TA0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M'25!1G:OJD6B6<U_.&:*V0R.$ +$+U"AF4$_5@/>FE=V0F[*X:/JD6M6<-_
M&6*Y02(' # -T#!68 _1B/>AKE=GT!.ZN:-(84 % !0 4 % !0!@7?B!(;EK
M&U@N+ZXB4/*L B A#8V>9)<2P1!G'*QJ[2;06*!<$THZ7;27G_P+DWZ+4N:5
MJT&L1&6#>IC<QRQR*4DBE4*6BD4]&4,.061@0R,RD,1KET&G?8TZD84 % &7
M+J\,5_'I9#^=/#).K #8%B9%8$[MVXF08 4C&<D<9JVE_D*^MB[=7"V<,EPX
M)6%&=@,9(12QQD@9P.,D#/<4EKH/8CT^]34K6&\B#+'<11RJ&P&"R*'4, 2
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M7-*]GS/6UPWLK75MKV.P\+:]J_AO0W*63ZJ(KXP00V]U'=/# 8B^QI;9;CB
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M8?\ "]M"_P">%_\ ]^X/_DFCZA5[P^^7_P B'UF':7W+_,/^%[:%_P \+_\
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M+_(/^%M>%_\ G]_\E[K_ .,4?5ZG:/\ X'#_ .2#VL//_P !E_D'_"VO"_\
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MT_PYX3TIUELQ:PND4D(9;ELF.7=O#DS'S"=Q :3<ZKM56"HH#>,I/>M3_P#
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M*T+POH<WVBP%M!)Y)@)%P2&B9MS*ZM*5D).,LX9\!1NPH 'BZ3T=6GW^./\
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M G_D&NV/A'Q*ZRZG)9321C"N+I8WV_W6:*5&91U56)"DDJ!N.18NE'X:M/\
M\#C_ )@\)6>]&I_X!+_(=<VWA.ZM8+"26Q%M9.)((TNEC5'&?F_=RJ6)+,6W
M%MS$LV6)-'UNDFW[6G=_WX_YA]4K;>QJ:?W)?Y$\3>%X;JXOUGLC/?)Y=PS7
M2.LJ8"[6C>5H\%0 0$&1USDT?6J5DO:T[+;WX_YA]5K+7V537^Y+_(SM&TWP
M;X>N#>:?)8PSD%=YNQ(5#==GF3.$R."4"G:2N<$BF\73EHZL+?XX_P"8EA*L
M=51J?^ 2_P BM?:'X'U&YDO;EM/:>?<9&%X%#%AAFV).J!SDL7"A]Y\S=O\
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M  +@_P#CE'L:O_/N?_@,O\@]I#^:/WH/^$QT+_H(V'_@7!_\<H]C5_Y]S_\
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MWH/^$QT+_H(V'_@7!_\ '*/8U?\ GW/_ ,!E_D'M(?S1^]!_PF.A?]!&P_\
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M .@:A7KTO]TJ?XU_[8<$_P"/'_#_ /)'L&ZO-.L-U !NH -U !NH -U !NH
M-U !NH -U !NH -U !NH -U !NH -U !NH -U !NH -U !NH -U !NH -U !
MNH -U !NH -U !NH -U !NH -U !NH ^>?CR<G3?^WO_ -MJ];"?!6_PK\I'
M#7^*'J_S1\^UD4% %NTL+F^)%K%+.5Y81HSD ]"=H.,^])M+?0=NPEU8W%@P
M2ZBD@9AD"1&0D=,@, 2,]Z$T]@M8JTQ!0!]%? 'KJ?\ VY_^W58U_@A_BG^4
M#:E\4O2/YR/HNO/.H\>^-O\ R!8/^OZ/_P!$7%>+F7\&/^-?^DR/=RO^-+_K
MV_\ TJ)\P+7R1]B3+2&3K2&3+2&3+2&3+2&3+2&3K2&3+2&3+2&3**0R912&
M3**0R912&3**0R512&3**!DRBJ1!*HJT9LF JT0R515H@E JT0R515D$H%42
M2 55B!X%585QX%58FX[;3L2+MHL ;:=@$VTK (5I6'<85I6*N,(J;#&$5)1&
M14EHB(J2T1$5#+1$14,M$+"H+1$14%HA85#+1"PJ2B%A3$1,*8B%A3$0L*8B
M%A3$0M3$0M3$0M3$0M3$0-3$0M5$D+4Q$+4Q$+4Q$#4Q'3>"O^0O:_\ 7S:?
M^EEO6]'^-1_Z^0_,YZ_\"M_UZG^1]KU^@'YR<UXL_P"/)/\ K^TW_P!.-I71
M1^)_X*G_ *;D95/A_P"WH_\ I2-G=4##=0 ;J #=0 ;J #=0 ;J #=0 ;J #
M=0 ;J #=0 ;J #=0 ;J #=0 ;J #=0 ;J #=0 ;J #=0!B^'_P#CZU3_ *_T
M_P#3=I]74VI_X'_Z7,4-Y?XO_;8G35SFH4 >(>(N/B'IG_7@_P#Z#?U[%+_=
M*G^-?^V'!/\ C1_P_P#R1ZWNKSK'2&ZBP!NHL ;J+ &ZBP!NHL ;J+ &ZBP!
MNHL ;J+ &ZBP!NHL ;J+ &ZBP!NHL ;J+ &ZBP!NHL ;J+ &ZBP!NHL ;J+
M&ZBP!NHL ;J+ &ZBP!NHL ;J+ &ZBP!NHL ;J+ &ZBP!NHL!\^_'8Y.F_P#;
MW_[;5ZN$^"M_A7Y2.*M\4/7]4> 5B6% 'J?@V1;S3)--AOKG3KK[5Y_^B6]S
M.\D7E*F'^S ':K<KEL [LJ<J1A+1WLFK6U:7YFL=K7L[]+_H<OXM3R;E8C?S
MZFZ*0YN(IXGB.?\ 5[;AF?D?-Q@<]*N.VR7I;]"9>MSE*T("@#Z*^ /74_\
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MJ>S]OR_N[VO==[;7OOY&*KT_:?5^;]Y:_+9]K[VMMYD5CI5UJ;%;6,R%>3R
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M75ON^\T6UKV90\7ZA%>/;0K<?VA-:V_E3W>''G/YLCA09 '=8D98UE8 N!G
M4+3BK7TM=Z(4GMUMU.0K0@* /5OAAXZL?!7VS[?'/)]J\C9Y"QMCRO.W;M\D
M>,^8N,9Z'..,Q4BYQBET<OQ4?\BX246[]4OPO_F=EJWQRVWD4NE0N]H$(GAN
M52-BV[(:*2)Y-IV\98,O^P3S7.J.GO;]+&KJ:Z;#OB!XMMO%WAN&ZM8YH=M]
M$&66-E&?(N<[)!F.09!^ZVX#!=$R ?G<UBX4HI_SK_TF1]%E,N:M)K_GV_\
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MM2="M%*</Y;VT=GNWW(/#UJ+J^B1AE5)<_\  06'Z@"L\)#VE:">R=W\E?\
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M W4 &Z@ W4 &Z@ W4 &Z@ W4 &Z@ W4 &Z@ W4 &Z@ W4 &Z@ W4 &Z@#/\
M#?\ Q\:G_P!?Z?\ INL*=7:G_@?_ *7,=/[7^+_VV)U-<IN% 'AOB;CX@Z9_
MUX/_ .@W]>S1_P!UJ?X__D#SZG\:/^'_ .2/4=U<1J&Z@ W4 &Z@ W4 &Z@
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M/;(4C1SF,9;<2R='/L^Y<?PYYKB4G%66AT.*>K//_C2BQ:';H@"JM[$ H
M$%Q@ #@ =@*\+,_X,?\ &O\ TF1[^5_QI?\ 7M_^E1/F1:^2/L29:0R=:0R9
M:0SU'P'XCLK2WN=%U8E+.^SB09^1V4(VXC. 0%(;&%*Y;@Y'KX.O"$9X:OI"
M?7LVK._X:]+:GBXW#U)RAB</K4I].Z3NK?C==4]-3=MO"7A?36:YO=3BO(0"
M5AC= V,'&[RI'D=AD$;0F2.01D5T1PV$I-SJUE..MHIJ_P ^5MM^B1SRQ6,J
MI0I4)0EI>33M\N9))>K>A%X5US3/(O\ 1)':SMKUI#;RRD-M#+LQ(> " JL,
MG!^92^<%L\-6H\M7"MN$)M\DI:VNK6?W)]MU>^^F*H5N:CBHI5)TTN>,=+V=
M[Q7S:[[.UKVMZ?/9>"M,NT%W!>WE\NQ$MG\Q% #JK,PZ8\PLP.,X"KGDU4)4
M\#1J+VD:E2HK)0=TK)I-OYW=_1=R9QJ8^M2?LYTZ=-W;FN5N[3:2_P"W;*WJ
M[;$&MW]M+X6L;:.6)YXY4+Q*ZF10$G!+(#N49(Y('4>HK*O4A+!4J<91<E)7
MBFKK2>ZW6Z-</3G''5JDHR4'%VDTU%ZPV>SV?W$WB*_MI_#EA;Q2Q/-&8]\:
MNK.N(I =R@EEP2 <@<D"GB:D)82C",HN2<;I--KW7NMT&%ISCC*\Y1DHM2M)
MII/WH[.UF;?B>XL]5GLM3@N[8K"8@T9D E^:9"3LZJ%!8ONQM"]\\=.+E3K2
MI8B%6%HN-X\RYM9+IT25V[VM8Y<'&I0A6PTZ52\E.TN5\ND'UZMNR5KWN:S:
MM9'Q(MP+B#R19;/,\U-F[S"=N[=MW8YQG.*W=:E]=53GAR^RMS<RM?F>E[VO
MY',J%7ZBZ?LY\_MK\O++FMRK6UKV\SG/"U];V^OW<\LL<<3_ &C:[.JHVZ92
M,,2 <CD8/(Y%>=@ZD(8RK.4HJ+]I9MI)WFFK-NVJV/3QM*<\'2IPA)R7L[Q4
M6VK0:=TE=6>C+VA:C:21ZEI\TT<'VJ28QR.P"$/N7(;(4XX/49!XSS6F&JTY
M+$X><XP]I*;C)M<KYKK?;31[ZIZ&6)HU8RPN)A"4_9Q@I12?,N6SVWUU6VC6
MI8LA9Z3HMW9_:[>:>0.Q$<@QED"A4S@OPN20.IQCBJI^RP^$K4?:TY3:D[1D
MK7:22C>SEMT76Q-3VN(QE&O[&I"$7%7E%WLFVW*UU'?9OI<U%U*V-M:FPO(;
M*WB ,\1P)6 P2 N"Y8D,#C&[=N!;@'I]M3]G1^KUH4J<=:D=.=I6=DOB;NFG
MWO>[Z\WL*BJ5OK-"=6I+2G/7D3=U=OX4K--7VM:RZ4]4U*V37K:\66-X1&%9
MT=7"D^8IW;2=N-P//8Y[&L*]:FL;2K*<7!12;332^):V>FZW.BA0J/ UJ#A)
M3YFU&47%OX7I=*^SV+$3VUOKGVTW-NT4XD(*R+\F$0#><X!8YVC)R!^ TBZ<
M,9[?VM-QFI;27NVC%>\]DV[VUZ&4E4G@OJ_LJBG!QW@_>O*3]U;M)6OIU*VG
M:K;>??V,\@2*[EF*2C!7YBPSNZ8((*G[O!R>165&O3Y\10J22C4G/EGTU;6^
MVJLT]O,UK8>IR8;$4XMSI0AS0V>B3VWT=TUOY;C[![;PW;3GSXKF:<!46%MP
M&-P!8CI][+9QC&!DU5)T\#3J/VD:DYJT5!W6E[-]M[O[E<FJJF/J4U[.=.$'
M>3FK/6UTEUVLO6[L1:C<POHMM"CHTB.I9 P+ ;9>2H.1U'4=QZU%:<7A*4%)
M.2DKI-76DMUOU+HPG'&59N,E%Q=I--)ZPV>SV)=5N89-)M8D=&D0IN4,"RX1
M@<J#D<\<BKKSC+#4H1DG)6NDU=>Z]UNB,/"<<56G*,E%\UFTTG[RV>S*?AB4
M0W\>>C!E_$J<?F1C\:PP4N6O&_6Z^]?TCHQT>:A*W2S^YJ_X:FA$(K75)A/(
M\'SN5="!C<=P#95@00>>P/7CD=,>6GB9JI*4/>=I1:ZNZO=/1I^ARRYJF&@Z
M<8S]V-XR3Z*SM9K5->IT']H+'!(M[-!<KC""/!=O]Y1P">.@P.N:]'VJC"2K
MSIU%;11W?JEHOT[GF^Q<IQ>'IU*;OJY745Z/=K\^QD)/%_8YAWKYF[[FX;O]
M8#]W.>G/3I7&I1^J\EUS7VNK_%VW.UPE];4^5\MM[.WPM;[%O6;B*6>V9'1@
MA&XJP('S+UP>/QK;$3C*=)QDFD];-.VJW[&.&A*%.JI1:;6B::OH]B2ZN(FU
M2*570HJ@%@PVC[_4YP.H_.JJ3B\3":DN5+>ZM]KJ13A-8:<'%J3>BL[_ &>F
MY);WT,6I3,SKLD4 /G*Y 7N./7GU&*J%6$<1-MKEDE9WTNDNNW<F=*<L/!*+
MYHMW5M;-OIOV%TJ*WTUI T\3%QQAAC SU/3<<]!Z=^SH1A0<KU(N^UFMEY]]
M=A8B52NH6IS5M[I[OLNVFY1T^:./3IXV95=BV%+ $_*HX&<G\*YZ,HQH5(MI
M-WLKJ[T6R.FM&3Q%.23:5KM)V6KW8T31C2##N7S-WW-PW?ZP'[N<].>G2ES1
M^JN%US7VNK_%VW'RR^MJ=GRVWL[?#WV+5]=6S261=D=(PV\ AMORIC<!G'([
M^AK:K.FY4')IQ5[V:=M(VO;S_(QI4ZBC744XRE;ENFKZRO9OR_,T8[U$NB[W
M41@88CC#+P< DL1P,8.,GG..#@'I51*HY2JPY&K1BFM/5]-G:[Z]-CD=)NDH
MQHS4T[RDT]=>BZ[J]ETZ[F+#<0I9WL9D0,\DI4;ERP(&"O/(/8CK7#&<52KQ
M<HW<IV5UKHMN_P CT)0FZV'DHRLHPN^5Z6;O?32WF4_M$0T0P[T\S=]S<-W^
ML!^[G/3GITYK#GC]3<.9<U_ANK_$NFYOR2^NJIROEM\5G;X&M]B/5[F*32K:
M)'1G0IN4,"PPC#D Y'/'(J<1.,L-2A&2<E:Z35U[KW6Z+P\)QQ56<HR46I6;
M32?O+9[,XMA7AL]]'6O=0_V (-Z>;OSY>Y=_^M)^[G/3GITYKV'.'U%4^:/-
M?X;J_P ;>V^QXBIS^ONIRRY.7XK/E^!+?;<32+JUO]-?2KJ46S!MR.Q 7&X,
M.I )#9RI(R#P>N##SI5L/+"5IJFT[J3M;>_6RWW5UIMY&)IU:&(CC*,'435I
M15[[6Z)O5;.SUW\UUC6+;3UL[2S?SULW21W4@@[>, C@E@S9P<#(&>N#$8BG
M15"C0ESJE)2;3WMT[:W=^P8;#5*SKUZ\>1U8RC%-6M?6]M[*RMW-4OI+7PUS
M[4@(3)BR-Q;9LSMSOSMXV!>6 .>QZ[X5UOK_ +5?#?DNKWY>7:_-MI:VYQ6Q
M2H/+O8RMS6Y[.UN;FM>W+OKS-[=#RO5;PZA=2W/3S79@#U"Y^4?@N!7R5>I[
M:I.K_-)M>2Z+Y(^RP]/V%*%'^6*3]>K^;N=3=7D!\,PVPDC,RR$F/>N\#S93
MDIG<!@@].A![U[$JD/[/A24H\ZD[QNN9>_)[;['BPIS68SJN,N1Q5I<KY?@@
MM[6WTW&^)+VWGT2QABEC>2,1[T5U++B(@[E!)7!X.0.>*K%U(2PE"$91<DHW
M2:;7N=4M5KW)P=*<,9B)RA)1;E9N+2?OWT;5GIV-C7M>M+;4]/NTE2:.%9!(
M8F5]H=0A)"D] Q..IP<5VXG$TX5\/5C*,HQ4E+E:E;F5NE^]_D<&&PM6>'Q%
M&491E)Q<>9.-^5\VE[=K7\QMMIUE)KZZE%>02K,Y:.&-MTID9&!# <*BC+[B
M0>-I7N7"E2>+6(A5A)2=XQB[RYG%WNELEO=^EA3JU8X-X:=&<7%)2E)6CRJ2
MLTWNWM9>MSSSQK_R&+K_ 'U_] 6O$QW^\U/5?DCW<!_NU+T?_I3.J\)265QH
M-UIUU=0VCSSO@R.@8*4APP1G0D94CJ!D'GBO4P;IRPM2A4J1IN4W\32=K0UL
MVK['E8U5(8NG7ITIU%""^%.U^:>ETG9ZE_P]8:3X2E>];58;@;"/+C9!GODH
MDLK.>/E  P?6NC#TZ&"DZKQ$9*WPQ:_)2DV^QS8FIB,=%45AI0=_BDGI\W&*
M2[F1I>LVDFB:MODCADNIKB2.%Y$60B1%*A5)!;GCY0<D$"L*5:#P^(O*,7.4
MVHMI/5*UEU[:'16HU(XG#6C*480A&4DFU[K=[NUEWU+BP:;K_AVSTZ;4+:RD
MA*R-O>-F! E7:4,L94G?G)/;ISD;)4L1A:5&5:$'&S=W%O3F5K.2MN8.5;#8
MNK7A1G44KQ5E)+7E=TU%WV*OV[2? NEW$&GW27]]>#;OC*D#Y2JL=C.JK&'9
M@"Q9F..GW9YZ. HSA1J*I4GI=6[63T;22NWO=O\ "N2OF%:$ZU-TZ4-;2O?>
M[6J3;=DMDDOQS/"$@L_"^K7$A 20/",_WFB" ?B95%9X5\F$KS>SO'YN-O\
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M_P"ZU/\ '_\ ('G5?XT?\/\ \D>F;JY+&@;J+ &ZBP!NHL ;J+ &ZBP!NHL
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M_P#XBOF/J];_ )]S_P# )?Y'U?UBC_S]I_\ @<?\R9?"FM#_ )<+W_P&F_\
MB*7U>M_S[G_X!+_(?UBC_P _:?\ X''_ #)E\*ZS_P ^%[_X#3?_ !%+ZO6_
MY]U/_ )?Y#^LT/\ G[3_ / X_P"9*OA;6!_RX7G_ (#3?_$4OJ];_GU4_P#
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M53_P"7^1'UJA_P _J?\ X''_ #)5T:_'_+M<?]^9/_B:M8:O_P ^JG_@$O\
M(AXFA_S]I_\ @<?\R9='OO\ GVG_ ._4G_Q-6L/6_P"?53_P"7^1F\30_P"?
MM/\ \#C_ )DRZ1??\^\__?I__B:T6'K?\^Y_^ 2_R(>)H_\ /VG_ .!Q_P R
M9=)O1_R[S_\ ?I__ (FK5"M_S[G_ . 2_P C-XBC_P _:?\ X''_ #)5TJ\_
MYX3?]^G_ /B:M4*O_/N?_@,O\B'B*/\ S\A_X''_ #)ETN\_YX3?]^W_ ,*M
M4*O_ #[G_P" R_R(=>E_S\A_X''_ #)ETR['_+&;_OV_^%6J-7_GW/\ \!?^
M1#KTO^?D/_ H_P"9*NFW7_/&7_OV_P#A5JC4_DG_ . O_(S]O2_Y^0_\"C_F
M2C3KK_GC+_W[;_"K]C4_DE_X"_\ (AUJ7\\/_ E_F2C3[G_GE+_WPW^%5[&I
M_)+_ ,!?^1'MJ?\ /#_P)?YD@T^X_P">4G_?#?X5?LJG\DO_  %_Y$^VI_SQ
M_P# E_F/%A<?\\I/^^&_PI^RG_)+_P !?^1/M:?\\?\ P)?YB_8+C_GE)_WP
MW^%/V4_Y)?\ @+_R#VM/^>/_ ($O\QIL+C_GE)_WPW^%+V53^27_ ("_\A^V
MI_SQ_P# E_F1G3[G_GE)_P!\-_A4^RJ?R2_\!?\ D4JU/^>/_@2_S(SIUS_S
MQE_[X;_"H]C4_DE_X"_\BU6I_P \/_ E_F1-IUU_SQE_[]O_ (5/L:G\D_\
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M?U]T? '+>,?^0</^OS3O_3C:UTT/C_[=G_Z1(QJ_#\X_^E(CW5N<P;J #=0
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MW.BV5W8C2IH]UFJ1QB/>X^2(J8QO#!_E*+SNR<<DY.3S UMU( W4 &Z@ W4
M&Z@!/"O^MU+_ *_U_P#3?85E7^Q_@_\ ;YF]+:7^+_VV)UU<AT!0!X1XMX\?
M:;_UX-_*_KVZ'^[3_P ?_P @>;6_BQ_P_P#R1Z%NKG&&Z@ W4 &Z@ W4 &Z@
M W4 &Z@#'UO6DT2 3-').\CB***)2SO(RLRJ .@(4Y8]/0G )8#%\%:S>ZS!
M=2Z@ DT5[+"(P !$J)%^[R/O;6+98DDGOC !8#+M;W6/$[W%UIUTEC:P2O#
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M[.+#3[,[@WF6T,D<G&?EW-,XVG/(V^G-4HVUNWZB;OI9(]B^ /74_P#MS_\
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M^&+QMJYE%X7) ^8J'"YXYP ,9Z=J974B%O$/!& JC,'F=!]_S<[O][WZ]NE
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MNL>'K*1[ZUCCAE>,&5F@DD1EWX5"DC.@?)WX&&VKD\"A2C)Z/\P<7%:H]9^
M/74_^W/_ -NJFO\ !#_%/\H%TOBEZ1_.1]%UYYU&5J/^OL_^OEO_ $DNJY*W
MQT/^OC_],U3LH_!7_P"O2_\ 3U$U:ZSC"@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * ,K5ONP_]?,/_H8%
M<E?:'_7R'_I1V8?>?_7JI_Z2:M=9QG*^-/\ D&_]OFG?^G"UKJP_\3_MV?\
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MM=MV23GD9YSD@]BWX @:T?4H7<RLE_("[?><X^\W^TW5O<F@&>B[J+"#=18
MW46 L^$/OZE_U_K_ .F^PKGQ'V/\'_M\SJH[2_Q?^VQ.RKB.D* /!?&/'CS3
MO^O!OY7U>YA_]VG_ (__ ) \RO\ Q8_X?_DCN-U9V(#=18 W46 -U%@#=18
MW46 -U%@#=18 W46 R]+TN'2?/\ )+M]JN)+E]Y!P\NW<%PJX0;1@')]6-*P
M[F/?>$;6\GDN$EN;4W(Q.MO+Y:2]B77:V21P2",Y.>222P7-8Z+9FP_LKRQ]
MDV;-F3TSG.>N[=\V[.=W/6BP7,FP\(VME/'</+<W36PQ MQ+YBQ<8^10JXP,
M 9SC [@&BP7.LW4[",*PT"WTZP?3(FD,,HE!9BI?]]G=@A0O&X[<J??-*P[]
M1G_"/6W]E_V+ND^S[/+W97S,;MV<[-N<_P"QC':BP7ZG+^)1I]I<6L-\+BTC
M@@Q#J$#L&1E.TPOLC8#*@-N(()8@*!DT#7D5O"%I#+J\^HV)GEM!;"'[3.6+
MW$K2+(SY<*2 JA>%4  <<\@WL=_J^FQ:U:26,Y=8Y@ Q0@,,,&X+*PZ@=0>*
M+$WL<_%X)L8VCWR7,T$#!H[:28M;HPZ$1[0<#L"Q')&,$BBP7.AFL/.NXKSS
MIT\E67R4DQ!)N##,D>/F*[LJ<C!"GM18+E&'0(;9+M899XS?R-*[HX5T9A@^
M4P4;<=L[B/6BP7"\\/6VH6<=C=-++Y.TI,S_ +]77I)YF!\_J<8/<46"YFV_
M@RT@NXM0>:[N+F Y#S2AR1@J%;Y!\HR2 NTY.2318+]#?MM/^S7,MUYUQ)Y^
M/W4DFZ*/'_/),#9GOR<T6"YI;J=A!NHL ;J+ &ZBP!NHL ;J+ &ZBP!NHL!X
MG\83DV'_ &\_^V]=E'X*O^'])&<OBCZ_JCQBN$Z@H [[P[>H^ERZ=#?+I-V;
ME9C*YEC2>+R]@B:6!'<>4VYU1EV,7R/F&1E):WM=6^[[S1;6O9E#Q?J$5X]M
M"MQ_:$UK;^5/=X<><_FR.%!D =UB1EC65@"X&<!0M.*M?2UWHA2>W6W4P[75
MKBTM9[%"&M[L)YB,,@-&P9)$Y!5UY7(X*LRL",8JVJ?5$WMH9E4(^BO@#UU/
M_MS_ /;JL:_P0_Q3_*!M2^*7I'\Y'T77GG4<AXQU^U\,PVVH7HE:..YVA851
MF+/;W"@'?)& H!))RQR -O)9?/Q52-%4ZL[VC.]DDVVZ<X]6K;WOKM:VMUZ.
M$IRK.I1IVO*G:\FTDE4IROHG?X;6TWO?2SXX?&O1?^>%[_W[@_\ DBN3^TJ/
M\L_NC_\ )'9_9=;^:G]\O_D1P^-.BG_EC>_]^X/_ )(H_M.C_+/[H_\ R0?V
M56_FI_?+_P"0'CXS:-_SQO?^_</_ ,D4?VG1_EJ?='_Y(?\ 95;^:G]\O_D!
MP^,>C_\ /&\_[]P__)%+^TZ/\M3[H_\ R0?V57_FI_?+_P"0'#XPZ.?^6-Y_
MW[A_^/T?VI1_EJ?='_Y(?]E5_P":G]\O_D!X^+VD?\\;S_OW#_\ 'Z/[4H_R
MU/NC_P#)!_9-?^:G]\O_ ) </BYI/_/&[_[XA_\ C]+^U*/\M3[H_P#R0_[)
MK_S4_OE_\@.'Q9TG_GE=_P#?$/\ \?H_M2C_ "U/NC_\D']DU_YJ?WR_^0'C
MXKZ5_P \KO\ [XB_^/TO[5H_RU/NC_\ )A_9%?\ FI_?+_Y </BII7_/*Z_[
MXB_^/4?VK0_EJ?='_P"3'_9%?^:G]\O_ ) </BEI?_/*Z_[XB_\ CU']JT/Y
M:GW1_P#DP_LBO_-3^^7_ ,@.'Q/TS_GE=?\ ?$7_ ,>I?VK0_EJ?='_Y,/[(
MK_S4_OE_\@/'Q-TS_GE=?]\1?_'J/[6H?RU/NC_\F/\ L>O_ #4_OE_\@.'Q
M*TW_ )Y7/_?$7_QZE_:U#^6I]T?_ ),/['K_ ,U/[Y?_ " X?$C3?^>=S_WQ
M'_\ ':/[6H?RU/NC_P#)C_L?$?S4_OE_\@.'Q%T[_GG<_P#?$?\ \=H_M:A_
M+4^Z/_R8?V/B/YJ?WR_^0'#XAZ?_ ,\[C_OB/_X[1_:]#^6I]T?_ ),/[&Q'
M\U+[Y?\ R X?$'3_ /GG<?\ ?,?_ ,=H_M:A_+4^Z/\ \F+^QZ_\U/[Y?_(#
MAX^L/^>=Q_WS'_\ ':?]JT/Y:GW1_P#DQ?V17_FI_?+_ .0'#QY8?\\Y_P#O
MF/\ ^.T_[5H_RU/NC_\ )B_LFO\ S4_OE_\ (#AXZL?^><__ 'S'_P#'*K^U
M*/\ +4^Z/_R0O[)K_P U/[Y?_(#AXXL?[D__ 'S'_P#'*?\ :='^6I]T?_DA
M?V56_FI_?+_Y </&UE_<G_[Y3_XY3_M*C_+/[H__ "0O[+K?S4_OE_\ (B_\
M)I9?W)_^^4_^.4_[2H_RS^Z/_P D+^S*W\U/[Y?_ "([_A,[/^Y-_P!\I_\
M'*/[1I?RS^Z/_P D+^S*W\U/[Y?_ "(O_"8V?]R;_OE/_CE/^T:7\L_NC_\
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M;V0_@G_[Y3_XY2_M.C_+/[H__)#_ ++K?S4_OE_\@-/CFQ'_ "SG_P"^8_\
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M_P"U:'\M3[H__)A_9%?^:G]\O_D!I^*NE#_EE=_]\1?_ !^C^U:'\M3[H_\
MR8O[(K_S4_OE_P#(#3\6-*'_ "RN_P#OB+_X_3_M2C_+4^Z/_P F']DU_P":
MG]\O_D!A^+6DC_EE=_\ ?$/_ ,?H_M2C_+4^Z/\ \D']DU_YJ?WR_P#D!I^+
MND#_ )8WG_?$/_Q^C^U*/\M3[H__ "0O[)K_ ,U/[Y?_ " T_&#2!_RQO/\
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MLW?X'WBOS/7:]\^=.4\:_P#(,_[>]/\ _3A:UU8?^(O\,_\ TB1A6^!^L?\
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MX[T[_KP;_P!OJ]S#?[M/_'_\@>97_B+_  _YG9[JDR#=0 ;J #=0 ;J #=0
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M "';'_KYB_\ 0UK>C_%I?]?*?_I:.>O_  :O_7JI_P"D,^UZ_0#\Y.3\;?\
M(,_[>]/_ /3A:UU8?^(O\,__ $B1A6^!^L?_ $I&'NKT#S@W4 &Z@ W4 &Z@
M W4 &Z@ W4 &Z@ W4 &Z@#EY_!NCW$IGDME+LVYL-(JENN3&KA#SSRM*Q5V=
M,@6-0B *J@  #  '   X  X '2@0[=3$&Z@ W4 &Z@ W4 &Z@ W4 &Z@ W4
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MW_Y!9_Z^]/\ _3A:UUX?^(O2?_I$CGK? _E_Z4CGMU>B>:&Z@ W4 &Z@ W4
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M_P '5W%AL+'%T)XJO*3JOFM+F?N\JTLMO^!9*QFZM91:1XBM?LH$:RO"Q4<
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MS\Q_SK>E_%I_]?*?_I<3"M_"J_\ 7NI_Z1(^V*_03\X.2\;_ /(+/_7WI_\
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M##?\_/\ R6?_ ,B2CX9^(A_RZ?\ D>V_^/4?4,3_ "?^30_^2'_:&&_Y^?\
MDL__ )$E'PU\0C_ET_\ (]O_ /'J7U#$_P#/O_R:'_R0_P"T,-_S\_\ )9__
M ")(/AOX@'_+I_Y&M_\ X[2^H8G_ )]_^30_^2#^T<+_ ,_/_)9__(DH^'.O
MC_EU_P#(UO\ _':7]GXG_GW_ .30_P#DA_VCA?\ GY_Y+/\ ^1)1\.]>'_+K
M_P"1K?\ ^.TO[/Q/_/O_ ,FA_P#)#_M'"_\ /S_R6?\ \B2K\/M>'_+K_P"1
MK?\ ^.TO[/Q/_/O_ ,FA_P#)#_M'"_\ /S_R2?\ \B2CX?ZZ/^7;_P C0?\
MQVC^S\3_ ,^__)H?_)#_ +1PO_/S_P DG_\ (DH\!:X/^7;_ ,C0?_':7]GX
MG_GW_P"30_\ DA_VEA?^?G_DD_\ Y$D'@36Q_P NW_D6#_X[2_L[%?\ /O\
M\FA_\D']I87_ )^?^23_ /D24>!M:'_+O_Y%@_\ CE+^SL5_S[_\FA_\D/\
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M#?\ /S_R6?\ \B1'PCJO_/#_ ,B1?_%U']GXG_GW_P"30_\ DBUF.%_Y^?\
MDL__ )$B/@_5O^>'_D2+_P".5/\ 9^)_Y]_^30_^2*6987_GY_Y)/_Y$B/@W
M5_\ GA_Y%A_^.5']G8K_ )]_^30_^2+6983_ )^?^23_ /D2(^"]8_Y]_P#R
M+#_\<I?V=BO^??\ Y-#_ .2'_:>$_P"?G_DD_P#Y$C/@G6/^??\ \BP__'*?
M]G8K_GW_ .30_P#DA?VEA/\ GY_Y)/\ ^1(3X'UG_GW_ /(L/_QRG_9V*_Y]
M_P#DT/\ Y(/[2PG_ #\_\DG_ /(D9\"ZT?\ EV_\BP?_ !RC^SL5_P ^_P#R
M:'_R0O[2PO\ S\_\DG_\B1'P'K?_ #[?^18/_CM/^S\3_P ^_P#R:'_R0O[2
MPO\ S\_\DG_\B1'P#KG_ #[?^1H/_CM/^S\3_P ^_P#R:'_R0O[2PO\ S\_\
MDG_\B1'X?Z[_ ,^W_D:#_P".T_[/Q/\ S[_\FA_\D+^T<+_S\_\ ))__ ")$
M?AYKW_/K_P"1K?\ ^.T_[/Q/_/O_ ,FA_P#)"_M'"_\ /S_R6?\ \B1GX=:_
M_P ^O_D:W_\ CM/^S\3_ ,^__)H?_)!_:.%_Y^?^2S_^1(C\./$'_/K_ .1K
M?_X[1]0Q/_/O_P FA_\ )"_M'"_\_/\ R6?_ ,B1'X;>(?\ GT_\CV__ ,>I
M_4,3_P ^_P#R:'_R0O[0PO\ S\_\EG_\B1-\-/$7_/I_Y'MO_CU/ZAB?^??_
M )-#_P"2%_:&&_Y^?^2S_P#D2(_#+Q'_ ,^G_D>V_P#CU/ZAB/Y/_)H?_)"_
MM##?\_/_ "6?_P B1'X8>)/^?/\ \CVW_P >I_4,1_)_Y-#_ .2%_:&&_P"?
MG_DL_P#Y$C/PN\2_\^?_ )'MO_CU'U'$?R?^30_^2#^T,-_S\_\ )9__ ")I
M:#\/]=T;4;:]O+7RH(9XR[^= V 7"CY4E9CR0. ?RJEA*U*4:DX6BIPN^:+^
MW'L[DO&4*L9TZ<[R<*EERR7V)=XI'U77VA\,<YXLM)[W3S':QF>59[241JR*
MS+#=P3.%,CQIG8C$;G4$C&<FNBC)1FG)V5I*^O6+2V3>[[&51.46HZNZ_!IG
M-[]1_P"@9>?]_=/_ /DZNSFA_P _(_=/_P"0.3DG_*_OC_F&_4?^@9>?]_=/
M_P#DZCFA_P _(_=/_P"0#DG_ "O[X_YAOU'_ *!EY_W]T_\ ^3J.:'_/R/W3
M_P#D Y)_RO[X_P"8;]1_Z!EY_P!_=/\ _DZCFA_S\C]T_P#Y .2?\K^^/^8;
M]1_Z!EY_W]T__P"3J.:'_/R/W3_^0#DG_*_OC_F&_4?^@9>?]_=/_P#DZCFA
M_P _(_=/_P"0#DG_ "O[X_YAOU'_ *!EY_W]T_\ ^3J.:'_/R/W3_P#D Y)_
MRO[X_P"8;]1_Z!EY_P!_=/\ _DZCFA_S\C]T_P#Y .2?\K^^/^8;]1_Z!EY_
MW]T__P"3J.:'_/R/W3_^0#DG_*_OC_F&_4?^@9>?]_=/_P#DZCFA_P _(_=/
M_P"0#DG_ "O[X_YAOU'_ *!EY_W]T_\ ^3J.:'_/R/W3_P#D Y)_RO[X_P"8
M;]1_Z!EY_P!_=/\ _DZCFA_S\C]T_P#Y .2?\K^^/^8;]1_Z!EY_W]T__P"3
MJ.:'_/R/W3_^0#DG_*_OC_F&_4?^@9>?]_=/_P#DZCFA_P _(_=/_P"0#DG_
M "O[X_YAOU'_ *!EY_W]T_\ ^3J.:'_/R/W3_P#D Y)_RO[X_P"8;]1_Z!EY
M_P!_=/\ _DZCFA_S\C]T_P#Y .2?\K^^/^8;]1_Z!EY_W]T__P"3J.:'_/R/
MW3_^0#DG_*_OC_F&_4?^@9>?]_=/_P#DZCFA_P _(_=/_P"0#DG_ "O[X_YA
MOU'_ *!EY_W]T_\ ^3J.:'_/R/W3_P#D Y)_RO[X_P"8;]1_Z!EY_P!_=/\
M_DZCFA_S\C]T_P#Y .2?\K^^/^8;]1_Z!EY_W]T__P"3J.:'_/R/W3_^0#DG
M_*_OC_F&_4?^@9>?]_=/_P#DZCFA_P _(_=/_P"0#DG_ "O[X_YFWX3M+FW%
MY+=PO:FYNQ*D<C1,^P6EK#N/DR2H,O$^!OS@ D#-<M>49.*@[VC9M76O-)]4
MGLUT.FE%Q3YE:[OT[)=+]CK*Y3<* "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@#*U'_7V?_7RW_I)=5R5OCH?]?'_ .F:IV4?@K_]>E_Z>HFK76<8
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0!E:U_P >I]I(?_1T=<F)_AO_ !0_]+B=F%_BK_#4_P#3<C5K
MK.,* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H RM1_U]G_ -?+?^DE
MU7)6^.A_U\?_ *9JG91^"O\ ]>E_Z>HFK76<84 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % 'C7B#QKXBBU^;0M"M;6Z,,22@2[E?:4C9B6:YA3AG
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MI--:-6!.^Q3@\1:7<SBUAO+62X)*B))XFD++G< @<MD8.1C(P<]*?*UK9V]
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M@ H * "@ H * "@ H * ,K6O^/1O]Z+_ -&I7)B?X3]8_P#I<3LPO\5>D_\
MTB1JUUG&% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 96H_P"OL_\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 96H_P"OL_\ KY;_ -)+JN2M\=#_ *^/_P!,U3LH
M_!7_ .O2_P#3U$U:ZSC"@ H * "@ H * "@ H * "@ H * "@ H * "@ H Q
M8_#UA%J+ZRD6+Z6,1/+ODY0!1C87\L<(O(0'CKR<US.W+T%97OU-6>%+F-H9
M1N2161ADC*L"",C!&0>H(/I4[#,K3?#MAH]DVF6<7E6K[P8]\C9\P8?YG=GY
MSV;CMBJ<FW=[B225EL9;> ]$>P323;?Z'%-YZ1>;/Q+AANW^;YAX=OE+%>>G
M Q7/*_-?7;H3RJUK:&I=>'K"\OX=6FBW7EJI2*3?(-BG=D; XC;[[<LI//L,
M3S-+E6S*LKWZD,/A72X)[JZ6!3+J(*W)9G=95/4%'9D /<*HI\ST5]MA<JU?
M<P8_A=X:B1HULE =E8GS;@N"F[;MD,I=!\QW!&4/A=X;:N*]I+O^1/)'L=(O
MAVP346UE8L7SIY9EWR<I@#&S?Y?11R$SQUJ.9VY>A=E>_4\Z\<>'=5\9ZA;:
M>;1(--M9Q(UZ9XV,B%%+JL(Q*ASN3!#!G"L65!D[0DH)N^KZ6,Y)R:5M.YZ\
MJA %4  #  X  Z #L!7.:G+Z[X*T?Q-,MQJ=OY\L:>6K>;,F%R6QB.1 >6)R
M03SUQ5J<HZ19+BGN4=,^''A_1[F.]L[7RIX3N1_.N&VG!&=KRLIX)Z@TW.35
MF]/1"4$M4C6L/"FF:9%<P6L/EQWY8W \R5O,+AE;EG)3(9A\A7&>,<4G)NS?
M38:BEMU$C\):5%IIT46ZFP.[]RS.^"S%B0[,9 VXDJP<,I^Z1@4<SOS7U#E5
MN7H9=C\.?#^FRQ7%K:+'+;/YD;B6<L&XY),IW@8&%?<J\X W'+<Y/1O\A<B6
MR.+T[X=+J.M:K<:]:+)9W,HDMG,@#'YW)*F&02H"I&0VT-QD$@8T<[1BHO5;
MD*-V^9:=#U6ST*PL+,:9!!&MF%*^25#(P/7>'W;RW5B^XL>6)-8MMN]]36R2
MMT,71_ 6A:!<?;+"T2*< A79Y9"N>I3S7<(Q'&Y &VDKG!(-.<I*S9*BHZI&
MD/#6G+>SZF(L7=Y%Y,\F^3YX]J+MV[]B_+&@RBJW&<Y)S/,[*/1;#LKWZE:'
MP=I-OIKZ+'!ML)3N>+S)CDEE;.\R&0?,JGAQT]":?,[\U]0Y4ER] O\ P=I&
MIV4.F75N)+6T"B%"\@*!5V@"17$F-O!RYW8!;) P*33NGJPY4U;H;=A8PZ9;
MQV=JOEPP($C7<S;548 W,68X'J2:EN^K&E;1%ND,* "@ H * "@ H * "@ H
M * "@ H * "@ H * "@#*UO_ (\I/HO_ *&M<F)_A2^7YH[,+_&A\_\ TEFK
M76<84 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * .'\2^%1K%
MY;W"<#=LN.V8QE@WUX*9Y/S)V4UX.,P/UFK3JQT5^6I_A6J?KO'YKHCZ' X_
MZI1JTI;VYJ?^)Z->FTNVDNK.W50@"J,*H  '0 < "O=225EHEHCY]MMMO5O5
MBTQ!0 4 % !0 4 <3XKL;I+JPUJSB:Z;37F$D"8WO#<1A)&CR0&D3:K*F1NY
M&>QTBU9Q>E^OFB&MFNGZD<FNZAK5Q;VVE6]U:1K*LEW<7=N85$"YW0QK,N7D
MD) #(I"8SNP3AV44W)I]DGU"[>BNN]S+M]/N5T+78##*);B?6&B38V^42^9Y
M9C7&7$F1L*@[\C;FG=<T?)1%;27S,R:34EG2VO/[5@LXK.U%NNG0\R2&("<3
MR[&:-U<!55FB4#YL@Y)K3=<M[N]_T%KL[VLMC/T#2;Z&'2DGM[B-X-6NY)@Z
M.QC5EFVN[D$,A+#$VXHY.0Q)IR:]ZS7PH23TTZLT/%6@7VJWVI?9HI&W6E@\
M605CF>WN&E:$.1M)*C[N>&*$\=5%I)7[OY70--MV[(FU+5SKVM:3"MM=6BYO
M@7N86A(=[&8;$5B#)MY+,OR?= 8YX27+&6J>VWJ-N[6C6_Y'-Z=H$%IIZ:5>
MZ5J-WJ"'R61;B]CLI1O($OGK,;:.,IABNS(;CR\<U;>O,I)+T5_NW)2LK-._
MSL>O>);9GT.]MH$9W:QN(XXT#.S$P.JHHY9F)P ,%F/N:PC\2;[K\S5[->1S
M^AV4\.LQS212)&-$M(2[(P42K-*6CW$8$B@@LF=P!!(JF_=_[>?Y$K?Y(N^$
MXI=/M]0>>.5,ZEJ$RKY;;WC:9F5HUQEPXY0J"'XVYS2EK:W9#CI?U9QVB^#M
M5U>RN+F[O);!M9>66YM#;0N560LBQLTR&52L6T  J4/3#9)T<E%I)7Y=G<A1
M;6KM?I8IQ2:C:V>DB^M;R671KZ6&;RK>61GBCADCBF0*OSQLK(H<$JS G=FG
MI>5FM5W#5)73T9T.J7-QXUFM+*WL[RVMH+J*ZN9KN%K<;(#N6*-7^=WD; )
MPHYSUQ"7)=MJ]K)+7<;]ZR2>]]="EI/A[5M;FOM8>ZFTLZA*T0@>UA=C:P@Q
M0[Q<1ETW#<2H"ALACDD&FY*-HVO;K?J_0$F[N]K^70BT1M:\.Z>^E?9&OH=-
MNS$X>)M]S8299'MBS+%))&20\>7 7"<'%-\LGS7M=?<_,2O%6ML_P\AD-A!?
MZM9W6A:;=:5)%,'NYY(#9Q-;[3OB,?"RO(<8VKP<L6[T7LFI-/LKWU"VJ<4U
MWZ&[>>$-:U&VNK2_U;[7#<P21I$;*&$+(<&-S)&Q<JC ;ACY@3WQ4J44TU&U
MO,KE;NF_P)(/%-[:6*VKZ;?'4XHA$$6 M;M*J[0XN0?)$)8;BQ?(4]">JY5>
M]U;UU^X+M*UG?^NI0ABU+P]J4.J:FD^H&?3DMKB2UA\TQ3I*TO$,2AO*8/M#
M(GWEW,!NXK22<8Z:W5^PM8N[UTZ&//H^H7,LGB(6LJ#^U;>\6SP!.]O! ;=I
M#'GB=LF18R=WW@>6&'=+W+_9:OTNW?[A6?Q6ZWL;-IK1O_$YN1;744<.CS[5
MEB,<TN+F!B$A?#_[*[@NYL@<#)5K1M=?$OR8[^]MT_4] T?5(]:LXKZ%9(TG
M4L$E 61<$J0RAF .0> QK%KE=C1.ZN>5://;Z5-J,6HZ5>7+S:G>RHZZ<\R/
M%))\A60I@JV"1@[<'.<&MWK:TDM%UL9+2]T]WT*]G;:QI&G6\21WEE97-]=R
MR1VD8GN[2U?YK:!5Q(4!;.\JC,@('!)!;Y6WLVDM]$WU8:I=4KO;=(BM=/G-
MSJDLUA?ZA:SVEL$CO6=9KA4E;S,/C$<B$EXX1Y<F%5@J%@:+Z1LTG=[=/Z[B
MMOHVK=2U9:7>W;7&G:6=233KBPNH9%U-758II$V0BW,JB4@%B7P60+T8G&$V
ME9NUTUM^-QV>RO:SW(--T>UDAM+*72=1>\5H4G$UQ>QVD1C(W3B4RO Z*5WQ
MQQJQ/"@"FVU=J2MTT5_3N"6RL[_.QI?V9=_\\)O^1H^T?ZM_]1_SVZ?ZK_II
M]SWI77?[%OF.W_I1KV-A<)IFN1M%(KW%UJ+1*48-*KQ (T8QEPYX0KD,>!FI
M;5X^B&EI+U9RJ:#]ANH;S4[2]N+:XTVSC!M#="6">",*T<T5M(DF&!R&96"L
M-N%^8U=[IJ+2=WO;5/U)M;5I[+:_Z'HO@VRCL[-S%9R::L\\DOE33233/D*H
MFE,C,T;R*@S%N;;C)))-92>N]]/0N.BVL4O%]G/<WND/#&\BPWX>0HC,(T\M
MQN<@$*N3C<V!GO3B[*7H$MUZF=97,_A.\U&.:TN[I+VZ:\MY;:%I@_F1HIA=
ME_U3(R8'F;5VG=NQU;7,E9I65G?07PMZ/5WT.A\$Z9<:1H]O:W:B.<>;(Z Y
M"&::2;9D<$H) IQQD''%1-WDVMO\D5%65F>9V^G:EI.GC5;:VG>]L-5O76#R
MGWRV]T3&Y6/;N=23'("N1A"W09&UTWRMZ.*^]&5FE=+5-_B6+GPA=B:WTY%D
MRVB7<$D^#Y8NIVWN'D V#S)7<E<Y*$XSUHYEJ_[R=O)#Y>GD_O-"\FO-?TNU
MT&.QNH+E6M%GDGA*00+;/&\DB3'Y)-WE[8Q&69E8@A3Q4JT6Y75M;6WU\AZM
M*-GT-:QL+A-,UR-HI%>XNM1:)2C!I5>(!&C&,N'/"%<ACP,TFU>/HAI:2]65
M](AN-.U/3I9H+CRY-&@M"ZPNRQ3*Z.4F('[G ZE]HSD=10[-.S7Q-_+R!:->
MEC/33+L>"+>R\B87*_9,P^6_FC;?1.V8\;QM4%FR.%!8\#-5=>T;OIK^0K>Y
M;T_,[KQEI$NO:-=6%N0)IH_W>3@%T99%7)X&XJ%R>!G)K*#Y9)LN2NFD<4D
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % %#5-,AUBUDLKD$Q3+AMK%6&"&5E8
M<AE8!E/8@<$<4T^5W0FKZ&/I_A6*RNDOI[BZOIX5=(6NI$<1!P ^Q8XXUW,
M SL&<CC=5.5U9))>0E&VNIT]04% !0 4 % !0 4 % !0 4 % !0 4 9.LZ-#
MK< @F:2,QR++')"^R2.1/NNC8(R 2/F5@02"*I/EV$U?0I:9X9@TZ:2ZDEN+
MRYFC$+37$@9Q$"6\M/+2)$7<2QV*"6P2<TW*^FB7D)*QMVEI%80I;6ZB.*%0
MB*.BJHP!SR>.Y))ZDDU+UU96VB+%( H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
@@ H * "@ H * "@ H * "@ H * "@ H * "@ H __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>sava-20230630x10qg003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sava-20230630x10qg003.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_X0!:17AI9@  34T *@    @  8=I  0
M   !    &@       9*&  <    F    +     !53DE#3T1%  !, $4 00!$
M %0 3P!/ $P 4P @ '8 ,@ P "X ,/_; $, !04%" 4(# <'# P)"0D,#0P,
M# P-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-
M#?_; $,!!0@("@<*# <'# T,"@P-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-
M#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#?_  !$( ?D#)@,!$0 "$0$#$0'_
MQ  ?   !!0$! 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#
M!04$!    7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*"
M"0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS
M='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$
MQ<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$!
M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /LN@ H
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MX8=B.A'8T /H XC5?'UAIEVVG1Q75_<Q#,J6</G&(8S\YW*!@8SC.W.#@Y%
M'4:7J,6KVL=[;[O*F7<H=2K#D@AE/0@@@CU'>@"_0 4 % './XGMK:.[N+V.
MXLH+!]CRSPL$D!;:)(-F]I8R<88*.H.* +$^N1Q?96AAN+J._90DD$1=(U<*
M5DG)*F*,A@=Q!( .1Q0!MT % !0!P^K^/K'2;M[!8;N\FMU#S_9(?-6!3@@R
MG<N.""<;@,X/S<4 =C:7*7L,=Q%DQS(LB$C!VNH9<@\@X(X[4 3T % !0 4
M% &9K.K0Z'9RZA<!VBMUWL$ +$9 PH8J,Y/=@/>@#"T#QBGB&14BLM1MXY(_
M-2>XMQ' RX!7;()&!W@@IC(8<@T -T+QUIWB&_FTVU$HE@#L'=56.54D\MFB
M(=F9=W3*KQVR"  5M4^(5AIEW+9+#=WDEJ ;AK6#S4@S_P ]6W+C ZD @<C.
MX$  [:"=+F-)HSE)%5U.,95@"#@\C@]#0!+0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!XW\0)%TWQ!
MH^IWGRV,3NC.1E8Y"<@D=NJMGKA"1]V@#0\>>(-.U?0-0@L+B*Y>**%W\I@Z
MJK3Q@9=<IDD'Y=VX=P* //\ Q5I>JVWA^PN+O4?M5J[V?EVWV6*+R]T1*?OD
M)=]BY7D?-G<>: .D\17-YKGB1XK&R.JP:5;- \8GC@59;M"LC;Y 5+>7E-H&
M<H3GY<4 <TM[,/!&I:/=J4N=)GBA="02JO=Q,HW*2&PPD4$94JH*DB@#8TF"
MYL/$&E+KUPU['+:9TYPJPQQ2-&H:-HT&&8+M4-NRQ,1;)X4 Z/\ YG[_ +AO
M_LU 'JES<Q6<;3W#I#$@RSR,$11ZLS$ #W)H \C^&VI6CZEK,:31,]QJ,TD*
MB1"TL>^5M\8!RZ;>=RY&.<XH [_7?[=W1_V']@VX;S?MGGYSD;=GD\8QG=NY
MSC'>@#)\?>9_PC-YYVWS?LZ[]F=N[<F[;GG;G.,\XQGF@#SCQ'KNG7OA"ST>
MWECNM0FM[".."(B21)4$6\,%R48!7C(;#9;;CK0!C>+;>YO=:&FW\MG'';6,
M'E#4)[B&#=Y:"1XW@9=TOF;\%SA@N,-@"@"69BUKH>GZS>+/I,LET)KB*241
M2>6Y6)'D<1/L1AL#$* I9E9E56 !OW<6FV][H46C2FXM$U"Y"DN9%4XB)1'8
M9:-<_*<L/]HT <SK+%='\0$$@C7&((['SNHH Z<Z4OA#Q1%:Z09?]*TZ>1U>
M1I#+,BS,KL&/S,SQJ2.!DG: #B@#SO08)KIK;5/MVGP7K7:[WDN+O^T'8RX,
M<D($D91^Q6,*5(#N/F  /=OBK_R+-Y_V[_\ I5#0!QLF@VWB3Q1]COO,: :/
M#(R)(R!V5XU7>5()"[RP&?O!2<@$$ Z7X27$DVB&.1F<6]S-$FXDD(-C 9/8
M%C@=!VH Y[P3JUGX<U76+76)H[6YDNS*KS,$$D9:1@5=L Y#!@N02'&T'G
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M6\_3I#,-[1O(J[W59&4AB'"H7Y#-U)!YH [#X7@VC:KIB,QM['4)8H%9BQ1
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M"X1)8G&&1U#(P]&5@01[$4 5YM+L[B%+::"&2"+;Y<31HT:;!A-B%2J[!PN
M-HX&!0!)>6-OJ,9@NXH[B(D$I*BR(2.AVL",CL<<4 4Y- TV647$EI;/,N,2
M-!$7&!@88KN&!P,'@4 :U !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M: ,C3-:;5"KQ6MS';R M'<2B!(W7^%A'YYN5$@^9-\"'!!8+0!N4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MZ;^ZG_?;?_&Z #=-_=3_ +[;_P"-T &Z;^ZG_?;?_&Z #=-_=3_OMO\ XW0
M;IO[J?\ ?;?_ !N@ W3?W4_[[;_XW0 ;IO[J?]]M_P#&Z #=-_=3_OMO_C=
M!NF_NI_WVW_QN@ W3?W4_P"^V_\ C= !NF_NI_WVW_QN@ W3?W4_[[;_ .-T
M &Z;^ZG_ 'VW_P ;H -TW]U/^^V_^-T &Z;^ZG_?;?\ QN@ W3?W4_[[;_XW
M0 ;IO[J?]]M_\;H -TW]U/\ OMO_ (W0 ;IO[J?]]M_\;H -TW]U/^^V_P#C
M= !NF_NI_P!]M_\ &Z #=-_=3_OMO_C= !NF_NI_WVW_ ,;H -TW]U/^^V_^
M-T &Z;^ZG_?;?_&Z #=-_=3_ +[;_P"-T &Z;^ZG_?;?_&Z #=-_=3_OMO\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '&>//^
M0=#_ -A71/\ T]6% '9T % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 <9X\_P"0=#_V%=$_]/5A0!V= !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MZ)!IVBW4\LD.FV,D$=W;:1J\PE61U5H6.C:DEU$PCB0S)/*+6XWHT<;/$WE
M'N?A;SAIENLZ)"438BQV[VB"%25@(M9))9+8&$(?(DD,L6=DBQN&C0 WZ "@
M H * "@ H * .,\>?\@Z'_L*Z)_Z>K"@#LZ "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * .,\>?\@Z'_L*Z)_Z>K"@#LZ "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * .,\>?\@Z'_ +"NB?\
MIZL* .SH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MA[3V'M%SWM;6U^W-;EO?2U]]-SO^IU_9^V]F^2U[Z7MWY;\UNM[;:[&M7><
M4 9UIK%CJ$LEO:7$$\T!(ECBEC=XR"5(=58LA# @A@.01UH L3WMO:O'%-+'
M%).Q6)7=5:1@,E8P2"[ <D*"<<T 6: "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MVR+!O;C< @<D<-D4 >HJP<!E(((R".00>A![@T +0 4 % !0 4 % !0 4 %
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /.OB'\3
M=-^&L$%SJD=S,MU(T:"V2)V!5=Q+"66$ 8Z8).>U '@=[^TAX<N-=L=62VU$
M0V=I?V\BF*VWEKJ2Q>,H!=E2JBVDWDLI!9,!LG: >Z_#OXJ:7\2UN6TN*ZA%
MD8A)]I2)"?-#E=GE339QY9W;MO48SS@ ],H * "@ H * "@ H * /.=;UB_C
M;4[JVG,*:,(2L CB*3GR4N91,SH\N'1Q&ODO"4P6.XT >B1N)%#CHP!&?<9H
M \;\4W=U-?3VLLS/;)/;311;4 B>W,%Q$P8*'8K<1K+AV93PI4ID'XS&XVO1
MKSI4I\L8VLK1>\4^J?<^[PF$PU7#492HKGM+GGS3O-\\K:<W*DHVC[J6S;;N
M:NE>,Y;*U6*\#WDZER924CR"[% 0B!<JA520HSC..:NGF[A!*I!SGK=W44]=
M-D^GD8XG*X5JKJ8?EHTFHV@N:=FHI2:<I-^]).5FW:]NA%=_$R*U^^+>#'_/
M68#'Y[*O^U:L_P"%0_&4OR2.;^RJ4/XE;\(Q_-LY>[^-5C!PU[IR8[+*KL/P
M$C']*/KF/G\%&W_<.7YR=@^IX"'Q5K_]Q(_E%7.8N_C_ *;%P=17Z16[M^HA
M(_\ 'J+YI/9<J_[AK\]0MEE/=\S_ .XC_+0YB[_:'T]>D]]+_P!<D"?^A21T
M?5LQG\57E_[?:_\ 24'UG+Z?PTN;_MQ/_P!*9G?\+\T6;_7_ -JG_ME _P#Z
M%?+1_9F(G_%K_C.7YV#^T\/#^%0_"$?RN2)\;O"0_P!8FKGZ6MH/YZ@U4LFC
M]JJWZ1M^<F2\X?V*27K*_P"4478_CEX(7[T&MM_VRL@/TNL_K73'**"^*4W\
MXK_VW]3F>;UW\,8+Y2?_ +=^A=C^/G@-.MCJ[_[R6_\ [+?"NF.686.\&_64
MOT:.=YGB7M-+TC']4R['^T5X%B^[INH_\"@M6_\ 0KXUT1P.&CM2C\U?\[G,
M\;B9;U9?)V_*Q=C_ &FO!D7W-/U!?]VULA_*\KIC0I0^&G!>D8K]#G=>K+XJ
MDWZRD_U+8_:I\**,"TU4#V@M/_DVMTK:(PO?<7_AJOPK_P ^NJ_]^;3_ .3:
M8@_X:K\*_P#/KJO_ 'YM/_DV@ _X:K\*_P#/KJO_ 'YM/_DV@ _X:K\*_P#/
MKJO_ 'YM/_DV@ _X:K\*_P#/KJO_ 'YM/_DV@ _X:K\*_P#/KJO_ 'YM/_DV
M@ _X:K\*_P#/KJO_ 'YM/_DV@ _X:K\*_P#/KJO_ 'YM/_DV@ _X:K\*_P#/
MKJO_ 'YM/_DV@ _X:K\*_P#/KJO_ 'YM/_DV@ _X:K\*_P#/KJO_ 'YM/_DV
M@ _X:K\*_P#/KJO_ 'YM/_DV@ _X:K\*_P#/KJO_ 'YM/_DV@ _X:K\*_P#/
MKJO_ 'YM/_DV@ _X:K\*_P#/KJO_ 'YM/_DV@ _X:K\*_P#/KJO_ 'YM/_DV
M@"M=?M/^#[U/+N++4Y%]&@M#CW!^VY!]Q@UC4I0K+DJQ4EYK\NJ^1M3JSHOG
MI2<7Y/\ /H_F<=/\=O"RRK)IR:K;'(_UD5OA/??'=L^!Z;&)KYRKE3@_:X*;
MC);)MK[I+7[_ +SZ*EFBFO9XR"E%[M)/[XO3[ON/;/"WQ2M]7B$D4L=]",9>
M,A94]G0X(/LZHW<DUE#,,1A&J>.IMKO:TOD_AE\K>;-9Y?0Q2]I@II>6\?FO
MBC\[^2*6O_'S2O#+[=0T[5XTSA95@M&B;Z2+>E<G^Z<-ZJ*^BH8JEB5>C)-_
MR[27R>OS6GF?/5L-5PSM5BTNC6L7\UI\M_(YK_AJOPK_ ,^NJ_\ ?FT_^3:[
M#C#_ (:K\*_\^NJ_]^;3_P"3: #_ (:K\*_\^NJ_]^;3_P"3: #_ (:K\*_\
M^NJ_]^;3_P"3: #_ (:K\*_\^NJ_]^;3_P"3: #_ (:K\*_\^NJ_]^;3_P"3
M: #_ (:K\*_\^NJ_]^;3_P"3: #_ (:K\*_\^NJ_]^;3_P"3: #_ (:K\*_\
M^NJ_]^;3_P"3: #_ (:K\*_\^NJ_]^;3_P"3: #_ (:K\*_\^NJ_]^;3_P"3
M: #_ (:K\*_\^NJ_]^;3_P"3: #_ (:K\*_\^NJ_]^;3_P"3: #_ (:K\*_\
M^NJ_]^;3_P"3: #_ (:K\*_\^NJ_]^;3_P"3: #_ (:K\*_\^NJ_]^;3_P"3
M: #_ (:K\*_\^NJ_]^;3_P"3: #_ (:K\*_\^NJ_]^;3_P"3: #_ (:K\*_\
M^NJ_]^;3_P"3: #_ (:K\*_\^NJ_]^;3_P"3: #_ (:K\*_\^NJ_]^;3_P"3
M: #_ (:K\*_\^NJ_]^;3_P"3: #_ (:K\*_\^NJ_]^;3_P"3: #_ (:K\*_\
M^NJ_]^;3_P"3: #_ (:K\*_\^NJ_]^;3_P"3: #_ (:K\*_\^NJ_]^;3_P"3
M: #_ (:K\*_\^NJ_]^;3_P"3: #_ (:K\*_\^NJ_]^;3_P"3: #_ (:K\*_\
M^NJ_]^;3_P"3: #_ (:K\*_\^NJ_]^;3_P"3: #_ (:K\*_\^NJ_]^;3_P"3
M: #_ (:K\*_\^NJ_]^;3_P"3: #_ (:K\*_\^NJ_]^;3_P"3: #_ (:K\*_\
M^NJ_]^;3_P"3: #_ (:K\*_\^NJ_]^;3_P"3: #_ (:K\*_\^NJ_]^;3_P"3
M: #_ (:K\*_\^NJ_]^;3_P"3: #_ (:K\*_\^NJ_]^;3_P"3: #_ (:K\*_\
M^NJ_]^;3_P"3: #_ (:K\*_\^NJ_]^;3_P"3: #_ (:K\*_\^NJ_]^;3_P"3
M: #_ (:K\*_\^NJ_]^;3_P"3: #_ (:K\*_\^NJ_]^;3_P"3: #_ (:K\*_\
M^NJ_]^;3_P"3: #_ (:K\*_\^NJ_]^;3_P"3: /6_ 'Q(TCXCVTEUI)E0V[!
M989U19H]^[RV98Y)4VR;'V$.2=IR!0!WU !0 4 % !0 4 % !0 4 >=^.O F
MF^-HXX=5@^TI Q>,>9-'M9A@G,4D9.1QALCVH \'O_@EX?@URPL$L\0W-M?R
M2)Y]T=S0-9",[C/N&T3/PI .[Y@<+@ ]R\"?#_2_ XE&DP?9A<E#+^\FDW&/
M=L_ULDF,;V^[C.><X& #TJ@ H * "@ H * "@ H YG4/"UOJ$TLK2SQQW8B%
MS!&T8BN/*^[YFZ-I5RN$?R9(MZ *V<4 =-0!Y)\1_#(-M]OTZ>2PO+K4=-AF
ME4"4.ES=6^GL!%-OB0JDRR!D56+1*"<,V?.JX*A7DZE6%Y/=\TELK='8]FGF
M>)I4Z=",H^SI74$X0O9R<FG+EYI+FDWJW:^ECC]>^'.O>&K@ZKX9NYKG:=QA
M=\S 9SC#?NKA!_=90W0!&/->7/ U,,_:81WMTTO_ )27X^3/TK!9_EN94E@,
M[P].E=652,;4_6Z]^E+S3:[RBM#6\+_&:"9Q8^(XS87*G:90K"+<.,2(<O"V
M>O#(.22@KIHX]-\F(7)+:_3YK=?EZ'GYEPC4A'ZUDTUB*+]Y4[ISM_<DO=J+
M[I=$I,]P@GCN466%EDC<95T(96![A@2"/<&O;335XNZZ-;'YA.$J4G3J1<91
M=G&2::?9IV:?J2TS,* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H \\U'X>6^H^+++QDT\B3Z=;-;+ %7RW5ENEW,WW@1]J;@<?*/4T >AT
M % !0 4 13V\=RACF570]58 C]?YUG.$:BY*B4HOHU=&D)RIOGIMQDNJ=F<7
MJ'@Q"?-T]S XY"DG;G_98?,O_CWX5\[7RJ+?/A).$EJDV[?)[K\3Z&CFLDO9
MXJ*G'9M)7^:V?X%"/7M3T)A%J,9ECZ!CU_X#(,JWKAOF]2*Y8XS%8%J&+@Y1
MZ2>_RFM'Z/7S1U2P>%QJY\)-0EUBMOG!V:]5IY,[#3=>L]4P(7P__/-_E?\
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MAU]J"]^*_OT]7IUE'FCU;CL>J5ZA\&% !0 4 % !0 4 % !0 4 % !0 4 %
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M'7P%;#7;CS0_FCJOFMU\U;S-^O5/+"@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * ."UKCQ5H_H;35A_Z0'^E '>T % !0 4
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MW1^48S 8G+:GL,;3E3ETO\,DNL9+W9+S3?GJ;-;'FA0 4 % !0 4 % !0 4
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M "@ H * "@ H * "@ H * "@ H * "@ H * ."UPX\3Z+_UQU3_T"UH [V@
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M7R8^J)"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MRR(>A4@C]._MU%?10G&HN>G)2B^J=T?/3A*D^2I%QDNC5F2UH9A0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % '!:^/^*ET0_[.I#\X(C_ $H [V@ H *
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M-?9TTJ^M+]H@"XMKB&<H&R 6$3L5!((!.,X.* -N@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * ,V_TBUU,8N(PQ[,.''T8<_@<CU%<=;#4
ML2K58IOH]I+T:U^6WD=E'$U<,[TI-+MO%^J>GSW\SC)_"]]I+&?2I68?W<A7
MQZ$?<?\ $#V4U\[/+Z^%?M,#4;_NWM+_ .1E\[>A]##,*&*7L\;32\[7C_\
M)1^5_4GLO&+P-Y&IQ-&XX+*I!'^\AY_%3]%K2EFDJ;]EC8.,ENTFOOB_S7W&
M57*XS7M,%-2B]DVG]TE^3^\[6UO(;U/,MW61?53T]B.H/L0#7TE.K"LN>E)2
M7D_S6Z^9\[4I3HODJQ<7YK\NC^19K8Q"@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@#@O$/'B/0S_V$1^=LI_I0!WM !0 4 % &1X@NY=/TR[NH.)8+6>6,D9
M=(F9>#U^8#COTH X&X\6ZO90-%=):+<SVT$]M)"SNBB:Y@M3YRL%RRFX5P4.
MQMK  @4 =AX8O[J\CN(+YDEGL;J2V:5$\M9 J1RJ^S<VPE90&4,0&!Q0!TM
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MRF/(E*M%EF4@@':3:KIOB;Q)HDOAF:"\&GK=->2V;H\5O92VS)%!,T>50RW
MB,-NQ#@Q.X0!&8 'L] !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0!2O=.M]079<HL@[$]1]&'(_ US5:%/$+EK14E^*]'NODSHI5ZF
M'?-1DX_D_5;/YG%77A&XL7\_2I6##HA;:WT#C"L/9@!CJ37SE3+*E&7M<#4:
M?\K=GZ*6S]';S;/HZ>94ZR]EC8)K^9*Z]7'=>JOY)"6OBVYL'\C58F!'\8&U
MOJ5X5A[J0/0&BGF56@_98ZF[_P R5GZVV?JK?,*F6TJZ]K@9JW\K=UZ7W7H[
M_([:RU*WU%=]LZN.X'##ZJ>1^(KZ.C7I8A<U&2EW75>JW1\[5H5,.^6K%Q[/
MH_1K1EVNDY@H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * ."\19'B+0L="VH _^ F?Z
M4 =[0 4 % !0!3U&YALK6:XN1N@ABDDD& V41"SC:>#E0>#P>AH \1;1(;2$
M:E?Z)!#IIP[^7>2FXBB?^-T#*C*@(?RE(\L_,F&7- 'LVCZ-;:%!]FLU94+M
M(Q=V=W=OO.[N2S,< 9)Z "@#4H * "@ H XSQY_R#H?^PKHG_IZL* .SH *
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M<:?9^7J6ISS:1$8UDA%M%YIBWJH66=2':,942%4#% 2>,T >HT % !0 4 %
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M, >A4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % '!>)3CQ!H/O/??^D$QH [V@ H * "@#E?$>GWSS6VI
MZ6L<MS9>:OD2L46:*<()%#\A'!C1D8@KP0>." <]J+Z[XHB;29K!=-MY\+<3
MR74,[+"3\PCCAYWN%959L*.?J #TN@ H * "@ H XSQY_P @Z'_L*Z)_Z>K"
M@#LZ "@ H * "@ H * "@ H * "@ H * "@ H * "@#AO%?P\TGQ:I>YC\FZ
MQ\MQ%A9/;?QMD'LX)QPK+UKAK86GB-9*TOYEH_GW^9]3EF?8W*&HT9\]'K1J
M7<//EZP?G%VONF>+O9>+/A.QDMV_M#2E.6&&>(+QDNF2]NW^TI\O.,L_2O&Y
M<1@-8^_2^]?-;Q]5IZGZ4JV3<6I0K+ZOCFK+51J-]%&5N6LO[K7/;91W/6O"
M7Q/TGQ5MAW?8[QN/(E(^8^D4G"R>PPK_ .QCFO6H8RG7]WX9_P K_1]?S\C\
M_P TX<QN4WJ<OML.O^7M-/1?]/(:N'KK'^\>CUZ)\8% !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ->-9%*.
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M=NX@A%O(963;R-ZY+*.,Y !V- '&>//^0=#_ -A71/\ T]6% '9T % !0 4
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M0 4 % !0 4 % !0 4 % !0 4 <%XH'_$]T ]Q>7GZZ9=_P"% '>T % !0 4
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M_GFG_?*_X4 'V2'_ )YI_P!\K_A0 ?9(?^>:?]\K_A0 ?9(?^>:?]\K_ (4
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M\T_[Y7_"@ ^R0_\ /-/^^5_PH /LD/\ SS3_ +Y7_"@ ^R0_\\T_[Y7_  H
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MA# ]P01^8K7T//:<7:2:?9JPZF2% !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % &1J.AV>IC,Z /\ WU^5_P QU^C CVK@KX.C
MB?XD?>_F6DOOZ_.Z.^ABZV&TIR]W^5ZQ^[I\K,XZ3P_J6AL9=-D,B=2HX)_W
MD.5?TR/F] *^>E@L5@G[3!S<H]8K?YQ>DOEKV2/H(XW#8U*GC(*,NCZ?*2UC
M\]/-E[3_ !FN[R=1C,+C@LH.,_[2'YE_#=]!751S57]GBXN$EHVD[?..Z_$Y
MJV5.WM,))3CNDVK_ "EL_P #M(+B*Z020LLB'H5((_3O[=17T4)QJKGIR4H]
MT[GSLX2I/DJ1<9+HU8FK0S"@ H * "@ H * "@ H * "@ H * "@ H * "@
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MEY=/5;KYGSE2E.@^2K%Q?FOR>S^19K8Q"@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * ."\7<:KX?/;^U)A^>DZGB@#O: "@ H * .1\5^$
M(/%2PF61X9+5F:([8Y(R7VY\V&162487@'&,GGDB@#F4M-=T"^BO9K:'4+>W
MMI;8?8 () LDL,F\V[G86!C^Y$^#NSQCD ]4H * "@ H * .,\>?\@Z'_L*Z
M)_Z>K"@#LZ "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@!KQK(-K@,/0@$?D:5KZ,I2<
M7>+:?=.S,BX\-Z5=?Z^SM9<_W[>)OYH:R=*G+XH1?K%?Y'H4\PQE'^%B:\/\
M-6I'\I(P[CX<^'+G[]A;C_<!C_\ 1;+6#PE![TX_+3\K'J4\_P TI?#BZK_Q
M-3_]+4C#N/@YX9F^Y;R0_P"Y/*?_ $-GK!X"@]HM>DG^K9ZE/BS-H?%6A/\
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M,4++*X>6#.X*A8T =/?RW:1!M/CAN)"PR)IW@3803N#QV]R2<[0%V $$G>,
M, 9WAK69M<M6NIH4@VSRQ)Y<K3)(L3F,R([0P-M9U<+F,9"A@2&& #H* "@
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M X+QB<:EH'_87?\ ]-6IT =[0 4 % !0 4 % !0 4 % !0 4 <9X\_Y!T/\
MV%=$_P#3U84 =G0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MB5^ZDF_Y7I)?+]5=>9\]6PM7#/\ >Q:7\RUB_G^CL_(TZ[3C"@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H X+QF/].T _\ 49_]Q6J4 =[0 4 % !0
M4 % !0 4 % !0 4 <9X\_P"0=#_V%=$_]/5A0!V= !0 4 % !0 4 % !0 4
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M<3I3E:7\LM)?+H_DV>!7P=;#:SC>/\T=8_\  ^:1LUZ)YX4 % !0 4 % !0
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MI^51+;RFO=?7E;2/4J]0^$"@ H * "@ H * "@ H * "@ H * "@!KHLBE'
M93P00"#]0>*EI27+))I[IZK[BDW%\T6TULUHT<?J7@VVN,O:$V\G7 Y3/TZK
M^!P/[M>!7RJE4]Z@_9R[;Q^[=?+3R/>H9I4I^[77M(]]I??L_FK^9CC4=7\.
M';=+]H@' 8DL,>T@Y7V#@^RUYZKXS+M*\?:4UU>J^4]UY*2^1Z#H8/,-:$O9
MU.RT?SAL_6+^9U6F^)K/4L*&\J0_P28!S_LG[K>V#GV%>YA\?0Q%HI\D_P"6
M6GW/9_GY'B5\!6PVK7-#^:.OWK=?EYG05ZIY04 % !0 4 % !0 4 % !0 4
M% !0 4 <%XVS]KT(CMK2?KI^H#^M '>T % !0 4 % !0 4 % !0 4 % '&>/
M/^0=#_V%=$_]/5A0!V= !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % 'CWCOX4V^OLVHZ25L]1'S87Y8IF'(+;?\
M5R9Z2+U/WP2=X\?$X*-7]Y2]VIOV3?Z/S^_N?HV2\35,O2P>8)UL(_=N_>G3
MB]+*_P </[CV7PNWNOF?"?Q1N]#G_L3Q>DD4L9"K<N/G7T\_'WU/\,Z9R.6W
M EQS4,9*D_88M--:<SW7^+NO[R_'<]K-.&Z..I_VGP[*,H23DZ,7[K[^RO\
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MYY%>T>*% !0 4 % !0 4 % !0 4 % !0!P7C?(N=$([:S%^ME?#^M '>T %
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * *E]86^I0/:W<:S0R#:R. 5(_H1U!&"#@@@C-1**FG&:33W3.BC7J86I&
MOAYRIU(N\91=FG_EW3T:T>A\Y:_X#U;X>W)UKPK)));#)EA^\Z(#N*R)_P M
MX??&].IY'F5\[5PU3"2]MA6W'JMVEV:^U'\5^)^R8'.L%Q#2669]"$:STA4^
M&,I/12A+_EU5\K\LMEOR'I_@;XE6/C!1 ^+6_4?- QX? Y:%C]X=RA^=1U#*
M-Y]/#8N&(]U^[/MW\UW]-U^)\/G/#V(R9NK&]7"MZ5$M8=E42^%_WOAEY-\J
M])KTCXL* "@ H * "@ H * "@ H * "@ H * "@ H 9)&LRF-P&5@001D$'J
M"*F45).,DFFK-/9HJ,G!J46TT[IK1IF?8Z-9Z:QDMHPC,,$Y9CCT!8G ]0,9
MKDHX6CAVY48*+?6[;MV5V[?(ZZN*K8A*-:;:72R2^=DK_,TZ[3B.(3P?(DP3
M[0O]G+?'45M_(_>B8N9MGG^:4\D7),P06XD'">;M'(!J26&L"W\F&^A\TO,6
MFELM[!'<F%8TCN845H$.S<ZRB0@,RCY@P!IZ3ID6C6D5A;[C%;H$4N=SMCJS
MG R['+,0 "Q)  XH T* "@ H * "@ H X+QR<2Z-G_H,V_ZV]T* .]H * "@
M H * "@ H * "@#,FUJSM[N/3GE7[5/G9$ 6;Y4:3Y]H(CRB.4\PKYFQ@FXJ
M0 #3H XSQY_R#H?^PKHG_IZL* .SH * "@ H * "@ H * "@ H * "@ H *
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MBW&2::=FGHTUNFNC0ZF2% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M_GH_Y1__ !% !Y+?\]'_ "C_ /B* #R6_P">C_E'_P#$4 'DM_ST?\H__B*
M#R6_YZ/^4?\ \10 >2W_ #T?\H__ (B@ \EO^>C_ )1__$4 'DM_ST?\H_\
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M4 =[0 4 % !0 4 % !0 4 % !0 4 <9X\_Y!T/\ V%=$_P#3U84 =G0 4 %
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MHU%]B7_DLNCO=+T*O0/D H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * ."\>#C2CZ:S8_SD'\C0!WM !0 4 % !0 4 % !0 4 % !0
M!QGCS_D'0_\ 85T3_P!/5A0!V= !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * .%\9^ -/\ &4/[X>1=J,1W* ;QZ*XX
M\R/_ &2<C^!E).>'$8:&(6NDNDEO\^Z_I'U.49YB<EG^Z?/0;]^C)^Z^[B]>
M2?FM']I/0\9TKQ-K?PHNETG7$:YTPG$3KEL+_>MY#C('5H'P5[;,Y;QH5JN
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M<0365RCF3!RUJY N801T9U56C8@@.@'RAV- 'J=O!':Q)!"HCBB541%&%55
M55 [    =@* ): "@ H * "@ H * "@ H * .,\>?\@Z'_L*Z)_Z>K"@#LZ
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M27]G';SO>:7]FE6-;:ZE^W;%F=F,?FO;1!I$9HK=X\E #W"@ H * "@ H *
M"@ H XSQY_R#H?\ L*Z)_P"GJPH [.@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M27^Z7E6!3B)2X21 #UR@ H * "@ H * "@ H XSQY_R#H?\ L*Z)_P"GJPH
M[.@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MY! (Q7T491FE*#33V:/QJM0JX6I*AB(2IU(NTHR5FO\ @/HUHUJFT6ZLYPH
M* "@##BU^";4VTA8YQ*D+3>8\92)@CHC*A<J[D&1#O1&A()592Z.B@#=7UX:
M3-;VJV\]W/>&01I!Y /[I0[EFGG@0#:>/F)/I0!M02-+&KNC1,RAC&Y4LA(!
M*,49T+*>"4=UR#M9A@D DH * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@#C/'G_ "#H?^PKHG_IZL* .SH * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '&>//^0=#_V%=$_]/5A0!V=
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MNF_NI_WVW_QN@ W3?W4_[[;_ .-T &Z;^ZG_ 'VW_P ;H -TW]U/^^V_^-T
M&Z;^ZG_?;?\ QN@ W3?W4_[[;_XW0 ;IO[J?]]M_\;H -TW]U/\ OMO_ (W0
M ;IO[J?]]M_\;H -TW]U/^^V_P#C= !NF_NI_P!]M_\ &Z #=-_=3_OMO_C=
M !NF_NI_WVW_ ,;H -TW]U/^^V_^-T &Z;^ZG_?;?_&Z #=-_=3_ +[;_P"-
MT &Z;^ZG_?;?_&Z #=-_=3_OMO\ XW0 ;IO[J?\ ?;?_ !N@ W3?W4_[[;_X
MW0 ;IO[J?]]M_P#&Z #=-_=3_OMO_C= !NF_NI_WVW_QN@ W3?W4_P"^V_\
MC= !NF_NI_WVW_QN@ W3?W4_[[;_ .-T &Z;^ZG_ 'VW_P ;H -TW]U/^^V_
M^-T >'?&+PE9RZ;+KHB2&\@:/<\;']Z'D2/$B[ &8;LA\AN,$D8 \/'T(.FZ
MZ5IJVJZW:6OW[[GZEPEFN)CBZ>52ESX>HIVC+5TW&$I^X^B?+9Q^'6Z2=[^3
M_"ZX$OB33(P,>4+@'W+17#9'X%1]0:\O"2YJU&*^RI+YOG?Y-(^[XAH.EEN8
MUI-/VTJ#2_EC%T(6?GS*3]&C[0K[ _G(* "@ H * "@ H * "@ H * "@ H
M* "@ H * "@!KHLBE' 96!!!&00>""#P01U% &/#X:TFW#K#96D8E4I(%MXE
M#H2"4?"#<I(!*G(R <<"@"U+I%C-<+>R6\#W*8VS-$AE7'3$A7>,=L'CM0!H
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M<1W$,\-N;9O(\TR7 4PA76=K?#AL@M.H&"IPV%( VZ\6PV3,LUO<J($CDNF
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M[=7MK?+"C6<D2J(2[#;+"LN&=]I<C=C<(XP?[@H Z6@ H * "@ H * "@ H
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M<W$$PO"C2)';/$0T<:Q)L9KJ;"[5RP*L2QR&4<4 =/0 4 % !0 4 % !0 4
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M/<W<OG3.J&-"P1(T6.,O(41(XT4 R.Q(+%N0  ;% !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
=% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>sava-20230630x10qg004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sava-20230630x10qg004.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_X0!:17AI9@  34T *@    @  8=I  0
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /LN@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M#MG/0' &2!G)% $ ^)=B[PB*UOY8KR4PV\R0H8IF5MC%,S!RJD'/R @ G'%
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MRI$GSXXV@OMQD%<%MP!WFEQ7LMGY6LK;-.VY9%MPY@*'("XF^8Y3A@>#R.E
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M"H!/'(H YS_A#];U;4;.\UF6PVZ?*LHEM8Y%N)BA!592RJH4E1D*=H&<+WH
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MFDW*WGLDORI)A2N(P$PQVA><@'IU !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MAF9EP-P!93QC+<BTBM;7?=7<MS!)%),(U@FM>)@T@C?>@(8JZIN*[3Y>XE%
M*5[XHU&>*U>RACAE.I-97,<DWREX]XV(_P!FD)BDV[C*$CD3"@1MN8J 5/[5
MO-(U+6+N.V2=8([2:X_?[-JI:[G6+]RQE? 8J&6%2%'S!FV@ ZGQ-K4FGZ++
MJ-GD2,D7E$J"5,[I&K;3D%D\S<%.02,'(H @\/3007+V+)?P78A24K?7)N/,
MCW,AD3;=7,"'>,.J>41N7";", '84 % !0 4 % !0 4 % !0 4 % !0 4 %
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M[N9(UB\V<QY6)26"*L,4* %B68["S'EF.!0!N4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0!1N8[MI8S;RPQQ CS5DA>1W&1D(ZSQ+&=N0"T<H
M!(."!M(!RGAQX8=4OT@@FMX9C"8LVEQ!$?+CQ+M9X4C!WDGJ"Y)9=PR: .YH
M Y?1K^XU&]U2"1RJ6%]';PA508C;3M/NCN)4ECYMS(<Y^[M&.* .A\E_^>C_
M )1__$4 'DO_ ,]'_*/_ .(H /)?_GH_Y1__ !% !Y+_ //1_P H_P#XB@ \
ME_\ GH_Y1_\ Q% !Y+_\]'_*/_XB@ \E_P#GH_Y1_P#Q% !Y+_\ /1_RC_\
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MC_\ B* #R7_YZ/\ E'_\10 >2_\ ST?\H_\ XB@ \E_^>C_E'_\ $4 'DO\
M\]'_ "C_ /B* #R7_P">C_E'_P#$4 'DO_ST?\H__B* #R7_ .>C_E'_ /$4
M 'DO_P ]'_*/_P"(H /)?_GH_P"4?_Q% !Y+_P#/1_RC_P#B* #R7_YZ/^4?
M_P 10 >2_P#ST?\ */\ ^(H /)?_ )Z/^4?_ ,10 >2__/1_RC_^(H /)?\
MYZ/^4?\ \10 >2__ #T?\H__ (B@!R1LAR79O8A,?HH/ZT 2T % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0!QGA?\ Y".N_P#85B_],ND4 =G0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0!QGA?_ )".N_\ 85B_],ND4 =G0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!XMKN
MH-X7UW5]607MZFFZ)!J*V8O[@0&5YM129A#+.;9$\JWC+ 1/Y8C9X(7G.V0
MGO/B;J5DMT9-) :RTU-88&^3 LF\_<LA6W8K> V[[((EFMVP2UY'\H< M:C\
M2;RVEU$6FF-/;:-;6][/+)=QQ-);3122LT$2QS%I52)BD4C1"3:X:2)O+$H
MJ_$N8G4K@V&RPTB9(#(]THN+B2>*![40P+$T0%P]Q$N9KJ+RD='<!_-AB #5
M?B!JFC+>076FVXO=.@BOF1;^1K:2P=G22XCN?L D$EM)&WGP/:IB("5)7R$(
M!H>*_$LFG1$W6G0:A8&\TVW#"X5P);F>'$LL4UNJA;9WADA:%IWDD:$A8=LL
MD(!1A^(]W+=21MIC0VEOJZ:1)-)=1>89)C$L4L4,22AQNE4S*\T7EQM&T;3N
M98H0"2W\?7]YJ-K:06$/V.^OKRQ69[UUN(S8&;[0\MHMDX3<()# OV@[PT/F
MM 90  >HT % !0 4 <9X7_Y".N_]A6+_ -,ND4 =G0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M^PK%_P"F72* .SH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H Y&Q\'P:>ZM%<7.VW2=+2-C"4LQ/
M]XP_N-SE!\L?VEK@(GR@$$@@#[[PA!J$SRRSW(2X6 742M$([DVYS&TO[DR(
M3P'^SR0!U 5@5&* .KH * "@ H * "@ H X+6?B1H^A:_9>%[MW%]J0S&5"&
M*,L6$2S,7#*T[J4B"H^YBN[:&!(!WM !0 4 % !0 4 % '&>%_\ D(Z[_P!A
M6+_TRZ10!V= !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M/#TI*<*<5);/5V\U=O7SW.*>,Q%6+A.I)Q>ZT5_+1+3RV-:N\X H * "@ H
M* "@ H * "@#A]<'_%1:,?1=1'YPQ?X4 =Q0 4 % ',ZQXDM[-7M[2:WEO\
M?#"L)D#-&\\T4"/+&C>8(T:57<?*6'RAE9E- $NBZC=7$]U97OE-+9O&!)"K
M1I(DL8D4^6\DK(RG*L/,8' (QG% &9X;UVZU"8P:@R0SE9&6U-G<VT@5)-@=
M9IY6CG7;M+>4@P77)'0@':4 <1X:F6/4M=!#?\A6'HC-_P P;2.Z@C\* .P^
MTIZ/_P!^Y/\ XF@ ^TIZ/_W[D_\ B: #[2GH_P#W[D_^)H /M*>C_P#?N3_X
MF@ ^TIZ/_P!^Y/\ XF@ ^TIZ/_W[D_\ B: #[2GH_P#W[D_^)H /M*>C_P#?
MN3_XF@ ^TIZ/_P!^Y/\ XF@ ^TIZ/_W[D_\ B: #[2GH_P#W[D_^)H /M*>C
M_P#?N3_XF@ ^TIZ/_P!^Y/\ XF@ ^TIZ/_W[D_\ B: #[2GH_P#W[D_^)H /
MM*>C_P#?N3_XF@ ^TIZ/_P!^Y/\ XF@ ^TIZ/_W[D_\ B: #[2GH_P#W[D_^
M)H /M*>C_P#?N3_XF@ ^TIZ/_P!^Y/\ XF@ ^TIZ/_W[D_\ B: #[2GH_P#W
M[D_^)H /M*>C_P#?N3_XF@ ^TIZ/_P!^Y/\ XF@ ^TIZ/_W[D_\ B: #[2GH
M_P#W[D_^)H /M*>C_P#?N3_XF@ ^TIZ/_P!^Y/\ XF@ ^TIZ/_W[D_\ B: #
M[2GH_P#W[D_^)H /M*>C_P#?N3_XF@ ^TIZ/_P!^Y/\ XF@ ^TIZ/_W[D_\
MB: #[2GH_P#W[D_^)H /M*>C_P#?N3_XF@ ^TIZ/_P!^Y/\ XF@ ^TIZ/_W[
MD_\ B: #[2GH_P#W[D_^)H /M*>C_P#?N3_XF@ ^TIZ/_P!^Y/\ XF@ ^TIZ
M/_W[D_\ B: #[2GH_P#W[D_^)H /M*>C_P#?N3_XF@ ^TIZ/_P!^Y/\ XF@
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ML?\ :69OT(Q^E=<<NPT/^7=_5M_A>WX')+,<3/\ Y>6]$E^E_P 35A@L[?\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M/1 ,C\D_]FH]CF%3XZT(+M%:_A'_ -N#VV7T_@I3F^[>GXR_]M#_ (1.:?\
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MT:%*G\%.$?2*7Y(X95JL_CG.7K)O]2W708!0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!P_B$XU[1/>6^'_DFY_H*
M .XH * "@ H * "@ H XSPO_ ,A'7?\ L*Q?^F72* .SH * "@ H * "@ H
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MJ_%I916"'^.8_.OX.P/_ )!/]*.:K+:*CZ_U^A'UG-L3_!H0HQ?6>Z^4G?\
M\D$/@?7-4.=5U5PIZQP!@I]N#$O_ )#-'LIR^.?R7](7]EXW$:XS&2MUC3O;
M_P!L7_DK-6Q^&&B6?S2I)=-US-(>O^['L!_$&J5&"WU]3LI9'@Z6LXRJ/O.3
M_*/*OON=E8Z/9:8,6<$,'O'&JD_4@9/XDUNHJ/PI(]REAZ.'TH4X0_PQ2?WI
M7?S-&J.H* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * .'\18&NZ)ZF>] _\  &8_TH [B@ H * "
M@ H * "@#C/"_P#R$==_["L7_IETB@#LZ "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * *U
MU>P6*[[F2.%/[TCJ@_-B!2;2W=C*=2%)<U648+O)J*_&QR%_\1M"L,C[1Y[#
M^&%6?/T; C_\?K%UH1ZW]#Q*N<8*C_R\YWV@G+\=(_\ DQSY^(]YJ/&C:9<7
M /21P0OXA%9?SE%9^V;^"+?]?UU/-_MFK7TP.$J3724KI?/E37_DZ%,/C75_
MO/;:8A[#:6Q]0)VS_P "7^E'[V7:/]?,?+G&)WE2P\>RLW^'M'^*%3X9R7IW
M:QJ-U=]]H)"@^F9&DX^BK^%'L;_')O\ KY@LDE5UQV)JU?)-I??)R_!(Z2Q^
M'^AV&"EJDC#^*8M+GW*N2GY*!6JI0CT^_4]6EE."HVY:*D^\VY_A)N/W(ZV&
M".V41PHL:#HJ*% ^@  K5*VB/9C"--<L$HI=$DE]R):984 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % '#^(\#6]#/?[3> ?CI]P?Z4 =Q0 4 % !0 4 % !0!QGA?_
M )".N_\ 85B_],ND4 =G0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0!6O+R'3X'NKEUBAA4N[MP%51DD_A^)Z#F@"GI>M6NK^8+5GWP,
M%DCEAFMY4+*&4M%/''(%=3E'V;&PP4DJP  6FMV5_=36-M*))[4*9E4-A=S.
M@&_&QB'C=&56)1T97"L,4 :M !0 4 % !0 4 % !0!D7VOZ=IG%W<PPD?PM(
MN[_OC.X_@*ARC'=I'%5Q>'P^E:K"+[.2O]U[_@<;>_%/1[<[+;SKQST$49 S
M]9-A_)36+KQ6UWZ'AU<]PD'RTN>J^G+&R_\ )K/[DRB/%WB/5N-+TLPJ>CW)
M(&/4;O)7\BU3[2I+X(6]?Z1S_P!H9AB?]TPG*OYJK:^>OLU^8@\/>+=5.;[4
M4LT/\-N#N'_?M8__ $:?\3DJR^*5O3^E^8OJ>:8G_>,3&E'M3W7_ ("H_P#I
M;+5M\*].W>9?S7%[(>I=]H/Y9?\ \B&FJ$=Y-LVAD.'OS8B=2K+JY2LG]WO?
M^3'7Z?X5TG2\&UM848=&*AW'_ WW/^M;*$8[)'M4<!A</_"HP375KFE_X%*[
M_$W^E:'I!0 4 % !0 4 % !0!6O+V#3XFN+N2.WA3&Z25U1%R0HRS$*,L0!D
M\D@#DU,I*"YIM)+JW9?>S>E1J8B:HX>$JE25[0A%RD[)MVC%-NR3;LM$FRE8
M:_INJR&&QN[:ZD52Y2&>*1@H(!8JC,0H+ $XQD@=Q41JTYNT)QD][*2;M\F=
M-? XK"153%8>M2@WRJ52E.$7)INR<HI7LF[;V3?0UJU//"@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M#_IFBI^>T#/XULHJ.R2]#W:="E05J-.$%_=BH_DB[5'0% !0 4 % !0 4 %
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MFN\9+1K\5U2>ANUN>4% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0!P_B8?\ $YT$]A?77ZZ7??X4 =Q0
M 4 % !0 4 % !0!QGA?_ )".N_\ 85B_],ND4 =G0 4 % !0 4 % !0 4 %
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M (6B*?\ M;PK,=+OUR=BDB"3/50!GR]W=<-$>AC')KR*N#L_:X5^SGV7PO\
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M\*C"+77E3E_X$[O\3;Z5H>@% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M'&^*/'FD^$U(O)=]Q_#;Q8>8\9&5R @/9G*@]LUQUL33P_QOWOY5J_NZ?,^D
MRW),9FSOAH<M+K5G>--=[.WO-=HIM=;'FY;Q;\1\%/\ B0Z2_?+>?*A'MMD<
M$>T,3 ]7Q7G?[3C-OW5)_P#@37X-_@O4^SMDW#6DO^%#'1\E[*G)>O-"+3_Z
M^336T;GHWA?P!I/A,!K2+S+C'S7$OSRD]]IQMC!](PN1][<>:]"CAJ>'U@KR
M_F>K_P"!\CX[,L\QN;-QQ$^6E?2E3]VFNUUO-^<V[/:VQVE=I\R<1XMUBYM;
M2:*.&XMH]]M$;T/;K'Y<]S;PRF,K.UQ&ZQ2R$2- @0H7##"D@$WAO?;:AJ-@
MLLLUM;26QB$TLD[QM+ KR1^;,[RL/N2!7=MOF?+A2  "OH\3-K$LEE/<7%G'
M%*ER\T\DT4EV\RLJ6ZL?*C-LBRI,+=4B4R)"5\V-Q& =#K?A^P\1VYM=1A6>
M/G;D89">-R.,,C>ZD9Z'(XK&I2A67)42:_%>CZ'I8/'8C+:BKX*I*G/K;X9+
MM*+TDO)I]U9GCDOA_P 1?#1VN-!=M5TD$L]G)S)&.I*A>2?]N$#)Y>%@,UX[
MI5\%[U!^TI=8/=?UW7S1^C1QV6<3)4<UBL)CK)1Q$-(3?1-O2W]VH]-HU$W8
M]$\)>/\ 3/%R[+=O)NP#OMI<"08ZE>TBCU7D#[RJ>*]&AB:>(TB[2ZQ>_P N
M_P OG8^/S3(\7D[YJT>>@_AK0NX.^REU@WVEH_LN6YV]=I\N% !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!P_BE
ML:MH ]=2N!_Y1]3/]* .XH * "@ H * ,6R\16%_/]FMY"TA$A3,<J)*(F"R
M&&5T6.<(Q&XPNX (/0YH GUC5$T:U:\D2254*#9$%+G>ZH"-[(N 6W,2PPH)
MY/%<]:M'#TW6G?EC:]M]6EY=SMPN&>,JQP\91@VI/FG=17+%RUY8R=W:RLG=
MM+S.)\)ZO&^J:DI1T74+D7L;G9L5(['3K(QR'=D2F2!W4 ,ACP=^[*CAP^/I
M8J3A!2BTK^]9*UTNDGW._$994PM+V\ITY>^H<D>?GU4GS6<$N5<MG[UTVM-3
MOGU"UC^_-$OUD4?S-=SKTH_%4@O645^IY:H59?#3F_2,G^A4?7M/3K<1?@P/
M\LU@\9AX[U8?*2?Y7-E@\0]J4_G%K\[%5_%6F)_RV!^B2'^2XK!YCA8_\O/N
MC)_^VFZR[%/_ )=V]917_MQ4?QGIR=#(WT3_ !(K!YKAELY/TC_G8W658E[J
M*]9?Y7*Y\:VS<10SO_P%1_)C67]K4GI"G4?R7Z-FO]DU5\=2G'YO_)!_PE<[
M_P"IL9W]/O#^4;4?VE4E_#PU1_?^D6']G4X_Q,33C]WZR0?V[JLG^KL&7_>+
M?U"T?7,7+X,*UZM_JHA]3PD?BQ*?HE^CD'V[Q!)]VVA0>Y']9?Z4>VS&6U&F
MO5K_ .6?H'L<NCO6J/T3_P#E?ZAL\12_Q01?]\G^CT6S*76G#[O\I!?+H]*D
MOO\ \XA_9FNR??NXU_W1_A$M'U?,)?%7@O1?Y00>WP$?AH2?J_\ .;#_ (1W
M49/]9J$@_P!T-_21:/J.)E\>*FO3F_\ DD'U[#1^#"P^?+_\BP_X1%G_ -==
MSO\ B?ZLU']F.7\3$5)?UYMA_::C_#H4X_UY)#E\$66<N\S'W9?_ (C/ZTUE
M%#>4JC^<?_D1/-J^T8TU\I?_ "193P?IJ=49OJ[?^RD5LLKPRWC)^LG^EC%Y
MGB7M)+TBOUN6T\,Z;'T@7\2[?S8UNLOPL=J2^;D_S;,'C\3+>H_DHK\DBTFB
MV$?W;>'\8U/\P:W6$P\=J5/_ ,!3_-&+Q=>6]6?RDU^3+:6<$?W(XU^B*/Y"
MMU2IQ^&$5Z12_0P=6I+XIR?K)O\ 4L  <#BMMMC$* "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@#GO$'BO3/"\7FZE.L1(^6,?-*_^
MY&N6/IN("@_>85SU:U.@KU)6[+J_1?TCV,#EF+S2?L\%2<[?%+:$?\4WHN]M
M9/HF>4-XD\3_ !"8Q:!$=)TUN#>39$CJ>#L;UZX$()! S,N:\KVM?%Z8=>SI
M_P [W?I_P/O1]\LORGAU*IFU18O&+58>G9PB]US+[M:EDT]*<CL/"WPPTOPX
MPN9@;^^SN-Q. V'ZEHT.X(<\[B6?_;KLHX.G1]Y^_/\ FEW\ET_%^9\YF7$>
M,S)>PIOZOAME2I.UX[6G)6<E;HE&/]T](KT3XP* "@".>".YC:&95DBD4HZ.
M RNK AE92"&5@2"""""01B@"A;Z+I]I&D$%M;Q10R>;&B0QJB2X(\Q%50%DP
M2-Z@-@D9YH AL_#NEZ?-]JM+.UMY^?WL5O%')\WWOG5 WS=^>>] &S0 4 ><
M^+?AKI_B5C>0$V&H@[EN8?E+..AE4$;C_M@K(./F(&*\ZOA(5O?C[E3=27?S
M[^N_F?997Q#B<L2P]6V(PC5G1J:I1ZJ#=^5?W6G#^[=W./M/&VM^!)5L/%T+
M7%J3MBU"$;LCMOP 'P.H8), "2LG!KDCB*N%?L\6KQZ5%K]_?\)>I]%5R? 9
M]!XOAZHJ5=*\\)4?+;OR[\OE9RI[).![/INJ6NL0+=V,J7$+]'0Y&>X/=6'=
M6 8'@@5[$)QJ+GIM-/JC\VQ&&K8*H\/BJ<J=2.\9*S\FNC3Z-73Z,OUH<@4
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MSXO'X/.,NO+%1G[-?\O(*,J=N[E!>[_V\HOR-N;X#6,_W]:\0X]!?0J/R6T
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MY^M5_P"_UI_\A4 '_#*GA7_GZU7_ +_6G_R%0 ?\,J>%?^?K5?\ O]:?_(5
M!_PRIX5_Y^M5_P"_UI_\A4 '_#*GA7_GZU7_ +_6G_R%0 ?\,J>%?^?K5?\
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M)P?4'!'0BO5C.,US0::[IW/@J^&K82?LL53G2FOLSBXOU5TKKS6CZ%ZK.4*
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M.W_+*YQ$V?0,28V/H%<M["NREC*-712Y7VEI^.S^3/F\=PYF.77E.DZM-?\
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ML"01[@U[*:DKQ=T]FMC\WG"5*3IU8N,XNSC).,D^S3LT_)DM,S"@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@#A_& S>Z'CMJ_\ [C-2
M% '<4 % 'F=O=ZMX-@^PFR6]M(I"MO<I<PP9660^5',LQ7:X9Q'O!*L2H'S'
MY@#I/#.GWEL+F]U((EW?SB9XXVW+$JQI#''NP [*D8W.  2?;) .HH * "@#
MC/"__(1UW_L*Q?\ IETB@#LZ "@ H * "@ H XW7_ &B>),M>6R+,W_+:+]U
M+GU++@.?^N@<>U<=7"TJVLXJ_=:/\-_G<^DP.>8_++1PU:3IK_EW/WX6[)2U
MC_VXXOS//_\ A!/$WA+YO#&H&YMUZ6EUC&/[J[LQ9/&2OD'WXKS_ *M7P^N&
MJ<T?Y)?IT_\ 23Z[^VLJS?W<\P:I57_R_H7O?N[6G\G[7T)[7XM3:3(+7Q5I
M\^GRDX\V-6:)O4A6.=OO&\W\ZI8UTWRXJFX/NEI_7HV95.%Z>+BZ^0XNGB8;
M^SG)1J+R;6E_*<:9ZGH_B#3M?C\W3;B*Y4<D(PW+_OH<.GT90:]2G5A55Z<D
M_3?YK=?,^#Q6!Q67RY,91G2?3F7NO_#)7C+_ +=;-BMCS@H * "@ H * "@
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MA17+3BDOQ?J]V?GN,Q^)S*I[;&U95)=$](Q\HQ5HQ7HE?K=FU6QY@4 % !0
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MR3?;9_<]3XK&Y3C<L?\ ME"<(_SI<U-^DXWCKV;3[HZ6ND\0* "@ H * "@
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M[L+=.9_%/_MYVOM%'=UW'R@4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0!%/!'<QM#,BR1N,,CJ&5@>H92""/8BDTI*S
M5T^CV-(3E2DJE*3C.+NI1;C)/NFK-/S1XUJWPSN]#N#JO@R<V<_5[1F_<RC.
M=JELJ!Z1R90'E7CP*\:>$E2?M<'+EEUCT?EK^3T\T?I&%XBHXZFL!Q)25:EM
M&O%?O(.UN9J-G?O.%I=XSNR_X;^*4-Q-_9?B*(Z5J*$*?,!6&1LX^4MS'GJ-
MY*$?=D;(%:4L8F_98A>SJ+OHG_E\].S.3,.&ITZ?U[)YK%X1ZKD:E4@O-1^.
MW7E2DOM05FSUL$$9'(->L?GVVC"@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * .'\9G$^CG_J+P_K:W@_D: .XH * /%-=L=.\.Q7.E6&J06'VR.1)
M;6X1)5Q,K*3YB 3Q':Y*F1I!WVD&@#TGPQ=W5W9K]KCBCV!4CD@G6>&= H E
MC8!2 >F&&>] '14 % !0!QGA?_D(Z[_V%8O_ $RZ10!V= !0 4 % !0 4 %
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M3%P]QNT:D=:<_271_P!V24O*VIU5=1X(4 % !0 4 % !0 4 % !0 4 % !0
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % 'E?B?X76NIR_VEHSG2M20[UDBRL;-ZNJ8*L>[ICJ2R
MOFO+K8.,W[2B_9U%K=:)OS2V]5\TS[S+N)*V%A]2S**Q>#:Y7"I9SC'M&4KJ
M272,O+EE$Q-,^(NH>&)UTOQI T+'Y8[Z-<QR#^\X3Y3[M$-PX#Q*<FL(8J=!
MJEC(V[36S\W;]/FCU,1D&&S2G+'<-55-;RPTW:<'_+'FU7DINSUY:C5D>SVE
MW#?1+<6SI-#(-R.C!E8>H(R#7LQDI)2BTT]FMC\UJTJF'G*C6C*%2+M*,DXR
M3[-/5%BJ,0H * "@ H * "@ H * "@ H * "@ H * .'\:XWZ23VU>V_6*X'
M]: .XH * /'=2\<:C>0W1M7M=(DM(99/*N=SWDAB5VPD+K%&H8J #^^QG.#T
MH ]$\.Z>]C;!I;BXO)+@+*[SN&P64?+&JJJQH.RJ,=^30!O4 % !0!QGA?\
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MG56M4Q$W6KSE4J2WE.3E)^K=V6:HP"@ H * "@ H * "@ H * "@ H * "@
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MS?\ ./\ ^+H /.?_ )YO^<?_ ,70 ><__/-_SC_^+H /.?\ YYO^<?\ \70
M><__ #S?\X__ (N@ \Y_^>;_ )Q__%T 'G/_ ,\W_./_ .+H /.?_GF_YQ__
M != !YS_ //-_P X_P#XN@ \Y_\ GF_YQ_\ Q= !YS_\\W_./_XN@ \Y_P#G
MF_YQ_P#Q= !YS_\ /-_SC_\ BZ #SG_YYO\ G'_\70 ><_\ SS?\X_\ XN@
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M_P"<?_Q= !YS_P#/-_SC_P#BZ #SG_YYO^<?_P 70 ><_P#SS?\ ./\ ^+H
M/.?_ )YO^<?_ ,70 ><__/-_SC_^+H /.?\ YYO^<?\ \70 ><__ #S?\X__
M (N@ \Y_^>;_ )Q__%T 'G/_ ,\W_./_ .+H /.?_GF_YQ__ != !YS_ //-
M_P X_P#XN@ \Y_\ GF_YQ_\ Q= !YS_\\W_./_XN@ \Y_P#GF_YQ_P#Q= !Y
MS_\ /-_SC_\ BZ #SG_YYO\ G'_\70 ><_\ SS?\X_\ XN@ \Y_^>;_G'_\
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MDC,<%&7W)3'Z,3^E $M !0 4 % !0 4 % !0 4 % '#^-QG^S/;5[/\ ]J4
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M -1?3OUN5']: .XH * "@ H * "@ H XSPO_ ,A'7?\ L*Q?^F72* .SH *
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M% !0 4 % !0 4 % '&>%_P#D(Z[_ -A6+_TRZ10!V= !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!P_CP?
MZ-9'IC5]*_\ 2Z$?UH [B@ H * "@ H * "@#C/"_P#R$==_["L7_IETB@#L
MZ "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@#A_'PS:6?MJ^D'_ ,J-N/ZT =Q0 4 % !0 4 % !0!QGA?_
M )".N_\ 85B_],ND4 =G0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 <-X_'^A6GMK&C?^G.UH [F@ H *
M "@ H * "@#C/"__ "$==_["L7_IETB@#LZ "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#RSXD^)M*L8(+
M2XO;2&YCU31Y'ADN(4E2-=2M)7=HV<,J+$&D9B %C!<D*,T >AZ;JUEK,/VG
M3KB"\AW%?,MY4E3<,97?&S+N&1D9R,C- &A0 4 % !0!CZ;K46ISW%O&DT;6
MA0,94\O=O#$,BL?,V_*>71,\,H9&5B ;% '&>%_^0CKO_85B_P#3+I% '9T
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M_GFG_?*_X4 'V6'_ )YI_P!\K_A0 ?98?^>:?]\K_A0 ?98?^>:?]\K_ (4
M'V6'_GFG_?*_X4 'V6'_ )YI_P!\K_A0 ?98?^>:?]\K_A0 ?98?^>:?]\K_
M (4 'V6'_GFG_?*_X4 'V6'_ )YI_P!\K_A0 ?98?^>:?]\K_A0 ?98?^>:?
M]\K_ (4 'V6'_GFG_?*_X4 'V6'_ )YI_P!\K_A0 ?98?^>:?]\K_A0 ?98?
M^>:?]\K_ (4 'V6'_GFG_?*_X4 'V6'_ )YI_P!\K_A0 ?98?^>:?]\K_A0
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H X!OB=H4:RR.UZD=JYCN)'TO5$B@8!6(GE:R$<.U75F,C*%1E8D*0:
M.YMKF*\B2XMW2:&9%DCDC8.CHX#(Z.I*LK*0RLI(((()!H FH YC1_%,.O12
M36,%RZP7LEE('1(71HFVR3%)I(W$*YSC'GD=(">* .GH KVL[W"EI(I+<AW4
M+(8R2%8JL@\J21=D@ = 6$@5@)$1]R  L4 % !0 4 % '&>%_P#D(Z[_ -A6
M+_TRZ10!V= !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MF72* .SH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * .:U?P[)J5RE[;7][ITR1-"?LWV5T="P<;
MH[RUNHU8,/OQ+&[ [9&<*@4 V=/LETZ!;=6>3;DM)(07D=F+R2/M54W2.S.P
M1$0%B$1% 4 %R@ H * .,\+_ /(1UW_L*Q?^F72* .SH * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H XSPO_ ,A'7?\ L*Q?^F72* .SH * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H XSPO_P A'7?^PK%_Z9=(H [.@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@#C/"__(1UW_L*Q?\ IETB@#LZ "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * .,\+_ /(1UW_L*Q?^F72* .SH * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M?_&Z #=-_=3_ +[;_P"-T &Z;^ZG_?;?_&Z #=-_=3_OMO\ XW0 ;IO[J?\
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MZ;^ZG_?;?_&Z #=-_=3_ +[;_P"-T &Z;^ZG_?;?_&Z #=-_=3_OMO\ XW0
M;IO[J?\ ?;?_ !N@ W3?W4_[[;_XW0 ;IO[J?]]M_P#&Z #=-_=3_OMO_C=
M!NF_NI_WVW_QN@ W3?W4_P"^V_\ C= !NF_NI_WVW_QN@ W3?W4_[[;_ .-T
M &Z;^ZG_ 'VW_P ;H -TW]U/^^V_^-T &Z;^ZG_?;?\ QN@ W3?W4_[[;_XW
M0 ;IO[J?]]M_\;H <ADS\ZJ![,2?R*+_ #H EH * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M#@T 9WAT2Q7NI6\LTUPL,\.TS-N(WVT4C!0 J(I9B=L:*H["@#K: "@ H *
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MWR7%U9)>^=]MFN$=789/D.D4-J2S@HENACV@H&P@R >B4 % !0 4 % !0 4
M% !0 4 % !0!3OM.M=3C$-[#%<QA@P2:-9%# $!@K@C(!(!QG!([T 59= TV
M:..&2TMGBM\^2C01%8MQ!;RU*X3) )V@9(!- $PTBR%PMX+> 7*#:LWE)YJK
MM*863;O VDK@'&TD=.* (H=!TVV=I(;6VC=RK,R0QJS,KB168A025D59%)Y#
MJ&'S &@"XME;QG<L4:D>8 0B@CSG$DW('_+60!Y/[[@,V2,T 4Y]"TZZ\L3V
MMM+Y"A(M\,;>6HQA8]RG8HP,!< 8&* -6@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@"I'I]M"8S'#$A@#+$511Y:OC>L>!\@? W!<!L#.<"@"M
M)H6G2^5YEK;-]FXAW0QGR@""/+ROR<@'Y<<@&@"XUG Q8M'&3(Z2/E%.YX]I
MC=N.7C*)L8\KL7:1M& "#^RK(/)+]GA\R<HTK>4FZ1HR&C9SMRY1@&0L25(!
M7!% %M(4B+,BJK2-N<@ %V"J@9B/O-L15R<G:JKT   ,^RT/3]-D,UG:V]O*
MP*L\4,<;E202"R*"02 2"<$@'J!0!J4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0!"]M%*ZR.B,Z!E5BH+*KXWA21D!MJ[@.&P,YP* (4TVUC5$2&
M)5B1HHP(T 2-]N^- !A4;:NY1A6VKD' H BMM'L;*,PVUM!#$760I'%&BF1"
MK(Y55 WJR*RMC<I52""!0 ZXTJSNT>*X@AECE<2.CQ(RNX 4.RLI#.%50&()
MPH&< 4 3M9P-DM'&2\BRME%.Z1 @20\<N@C0*Y^90B $;1@ @OM*LM3V&]@A
MN?*)*>=$DFPG&2N]3M)P,XQG ]!0!?H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@!" PP>0>"#0!533[6/:4AB7RXO(3$:C;#Q^Z7 XB^5?W8PORC
MC@4 0/HMA(\4CVUNSVH58&,,9:$)R@B)7,84\J$P%[8H LFRMSG]U'S()C\B
M\RC $AX_U@  #_>&!SP* (4TJSC=Y%@A5Y9%E=A$@9Y$.4D8A<LZDDJYRRDY
M!% %N*".#=Y:JF]B[;0!N8X!9L 98@ $GDX'/% %6RTNSTW>;."&V\T@OY4:
M1[R,X+;%&XC)P3GJ?6@"]0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>sava-20230630x10qg005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sava-20230630x10qg005.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %9 \8# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% &3XNU:70/"FM:I B23V5E-
M<QK)G:62-F ..V17YZ_#G]N?XY0>"_A5X_\ $\'@3Q-X9\=:VNC#P_HD=Q!K
M=N3,\9D5"[*ZJ(RW0_>4$C.:_0+Q]9SZCX%\1VEK$T]S/IMS%%$@RSNT3 */
M<DBOQ_\  _[/OB.\^#/@7PWX,^ WC?PE\?M-U-)I/B%/ ^G6ELHN';>\K288
M")E7&P?=[]& /TH^)7[;OP=^$OC*^\,>)?$\]KJ>GM$FH-;Z7=7$%B9 "@FF
MCC9$)#*<$]"*T?B9^U]\*_A-J6FZ?KOB.2:^U"P758;?2+"XU!Q9-TN7$"/L
MB/9FP#VKXP_:P_X7?X\\0?&7P/?Z3\0YM,FLXT\+Z?X.T:W;1]4B$0,TU]<L
MI<L2H^0,&S\JCH*C^+WA/Q1X/T?X::SX%\+?%3P[\;].\"Z/I=KJ?A[2A<Z3
MJ(6)-]E?!B1&8F!W;P.W#8& #[3^*7[7WPI^#M]I]EXD\2LE]?6(U..UT^PN
M+V6.S/\ R\2)#&QCC_VGQW]*\^^-G[0VI0_%#]F@> O$=O<^#O'>L7$=Y-;Q
MI*E];")&0!F&5Y8],'/7IBOG'XH?#GXB^#_VC/$'C;QG:?$NUTKQIX7TNWNK
MSX3VD-]Y5Y';1QW-I/&Z.1&761E*X'S#D\X[*'X&7OAD_L;V/@_PGXPA\-^'
M==U&[O(O$<*O?:;',=^;ORQLCRQ8@=A@=: /:_!?[2=EX1L_C5XC^('Q&TG6
MO#'A/Q'_ &>HTO1[B&31T+A%MYLIF9]SJ-Z;AP3NYP.O^%_[8_P?^,OC^[\&
M>#_&5MK'B""-IE@2"5([A%^^T$CH$E YR4)X!(R 37QCX^^#'CV^^ O[8VFV
M_@[6IM0\0>.$O-)MH[-S)?P"YB8RPC'SKM!.1V%>U^(OA;K=K^UU^S'J^F>%
MKJ#0M#\,7]CJ%Y:VFV"Q)M=L<4C 83YF("GN3CO0!ZOJ'[;GP8TSX@/X.N/&
M4:ZI'?C2I;E;*X:QBO#Q]G:[$?DK)GC!?@\'!KW2OR)\(_L^ZSH/A;5_@_\
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M)9[#RX&2:&$RON69V8^:YDWMOXX8#'&:^I:IJSL2G=7"BBBD,**** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**X'XV?%"]^$/@=_$%AX,U_QW<+<1P?V3X<@$USALYDVDCY1CDC/45\^_P##
M?'BC_HV3XM?^"I?\: /</V@/V>/#'[1?A>QTKQ!+J&FWFEW:ZAI6LZ1/Y%[I
M]ROW98GP<'V(P<#N 1POP]_8G\->%=<\0^(?$WBOQ1\1O%&M:1+H,FL^);U9
M);>QD4AX80JJ$SD\\GD],G/$_P##?'BC_HV3XM?^"I?\:/\ AOCQ1_T;)\6O
M_!4O^- &^G[!>@?\*7\/?#Z7QSXJE'A?5X]8\-ZYYT*7NCR(,)'$5C"L@^8X
M8$Y;KP*T]%_84\!V=O\ $F+6M4\0>+7^(5C;6>O7&M7BR2S/!N*3HRHNQ]Q#
M #Y5VJ  !BN-_P"&^/%'_1LGQ:_\%2_XT?\ #?'BC_HV3XM?^"I?\: .K\%?
ML7Z/\/?&WA;Q_?>,O&?COQ/X0LKBTTW^V+V*0-;M"T:VX0(J\ G#9!9CEB<#
M'#?LC_ ?5W_:6^+7QT\0>![KP"GB)DM=&T75)(WNT#!&NKAPC,J&1XU.,]V[
M<F]_PWQXH_Z-D^+7_@J7_&C_ (;X\4?]&R?%K_P5+_C0!]@45\?_ /#?'BC_
M *-D^+7_ (*E_P :0_M]>* P'_#,GQ:Y_P"H4/\ &@#[!HKX_P#^&^/%'_1L
MGQ:_\%2_XT?\-\>*/^C9/BU_X*E_QH ^P**^/E_;Z\4-G_C&3XM<''_(*'^-
M+_PWQXH_Z-D^+7_@J7_&@#[ HKX__P"&^/%'_1LGQ:_\%2_XT?\ #?'BC_HV
M3XM?^"I?\: /L"BOC_\ X;X\4?\ 1LGQ:_\ !4O^-'_#?'BC_HV3XM?^"I?\
M: /L"BOC_P#X;X\4?]&R?%K_ ,%2_P"-'_#?'BC_ *-D^+7_ (*E_P : /L"
MO-]8^!6AZU\>- ^+$UU?+X@T72)M&@MD=1;-#(Q9F9=N2P+'&#CVKP?_ (;X
M\4?]&R?%K_P5+_C1_P -\>*/^C9/BU_X*E_QH ]T\(_ 'P[X.^*GQ"\>6\UY
M=:GXW2UCU*UNG5K=5@C,:A%VY&5)SDG->??#O]B?1?AGXHT>XTGQ[XU_X1#0
M[V34-)\%MJ@73;.9R6(^51))&"S$1NQ4;CUR<\9_PWQXH_Z-D^+7_@J7_&C_
M (;X\4?]&R?%K_P5+_C0#UW+NI_\$Y?!NI0ZWIH\;>,K3PK?ZS_PD-OX;MKZ
M-;.SORX=I5!C+/R.%<D#/K@CM-2_8[T&_P#B%\2O$T?B?Q!96OQ"TIM-U[1(
M)8OLD[F P+<+E"RR*A..<9)X[5Y]_P -\>*/^C9/BU_X*E_QH_X;X\4?]&R?
M%K_P5+_C2MI8.MST_2/V1?".C:C\&[V&_P!5:7X6VDUGHX>5,3I+"(F,_P G
MS':.-NWFL"Z_83\#3^$]?T>'5M>L;S4?%DOC6TUJUND2\TO4WQ^\MW"8"C&-
MK YSSVKC_P#AOCQ1_P!&R?%K_P %2_XT?\-\>*/^C9/BU_X*E_QI@=OJ'[%N
MB>)/A#XO\"^*?&_C#Q6WBJZ@N]3UK5+]7N=T3J\:PIL\N)!M VJ@SW[8[#7?
MV:_#'B+XJ:7X[O;G4'U'3_#<_A=;595$$EK+G>6&W=OY/(('M7C'_#?'BC_H
MV3XM?^"I?\:/^&^/%'_1LGQ:_P#!4O\ C1_7Z#N>V?LY? .V_9Q\ _\ "'Z=
MXFUGQ%HT$[/81ZPT3&QB)SY,91%RN23SDY)^E>J5\?\ _#?'BC_HV3XM?^"I
M?\:/^&^/%'_1LGQ:_P#!4O\ C0(^P**^/_\ AOCQ1_T;)\6O_!4O^-'_  WQ
MXH_Z-D^+7_@J7_&@#[ HKX__ .&^/%'_ $;)\6O_  5+_C1_PWQXH_Z-D^+7
M_@J7_&@#[ HKX_\ ^&^/%'_1LGQ:_P#!4O\ C1_PWQXH_P"C9/BU_P""I?\
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MWCCQHOQ!\#>'_A3XW\/S>(M?%Y:+:>)X9?!RL9U9]1>,[9%=HPW[H@A2>!D
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M-;SXC:-%HFJ1I*@2&%(3"&A^7*MM;N2,]J\C_P"&^/%'_1LGQ:_\%2_XT?\
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M%2_XTB_M]>*&7/\ PS)\6O\ P5#_ !I=+!YGV#17Q_\ \-\>*/\ HV3XM?\
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M_1LGQ:_\%2_XT?\ #?'BC_HV3XM?^"I?\: /L"BOC_\ X;X\4?\ 1LGQ:_\
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M0!]@45\?_P##?'BC_HV3XM?^"I?\:/\ AOCQ1_T;)\6O_!4O^- 'V!17Q_\
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MP-XLU[P-J&E:9+HTNI6;0W,U]:RRM-)YWG(RF7SF>02@ JTCXX.*]WHH P?
M?@G2OAOX-T;POH<#6^D:3:I:6T;L7;8HQEF/WF/4GN236]110 4444 %%%%
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M_8ZW:VR32Z-;Y;RYO*B0;KJ)7DX&4WQ8.0<_5N@ZU;>)-"T[5[)M]G?VT=U
MQ&,QNH93^1% %^BBB@ HHHH **** "BBB@#Q>S_Y/(U7_L0[3_TX7%>T5\\>
M*/&4/@G]KJ]NY]+UC5EF\$6L0BT73I;V1,7]P=S+&"57W/&:[C_A?EA_T)OC
MO_PE[O\ ^(K"5>E!\LI:GJT,JQV)IJK1I-Q?4L_$KP'K>I>*O#?C'PM+8_\
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MX6^$_"_A6V^('AJ]T#0[>"R42>&Y5N)8(P%P7%U@,5'7;C/.*][HHH ****
M"BBB@ HHHH **** "BBB@ HHHH X+XN?"X_%*W\)1C4?[-_L'Q'8Z_GR?,\[
M[.Q;RNHQNS][G'H:F^-7PW_X6]\+M?\ !XO_ .R_[5A6+[7Y7F>7B17SMR,_
M=QU[UV]%/R ^4?'/[$5]XKUKQ?-:^,--L[7Q#K*ZXUY=>'8KK5HI%DBD%J+Q
MI PM@8@ JJ&53M!QG/=1_L]^)=(\0:I;^'_B)<Z#X(U;73XAO=)MK%?MJS/*
M)9X(;O>-D,L@)8;"P#NH8 \>Z44@/G+P%^R/)\/?%.E'3/$&EP^$M*U*74;6
MTC\.6W]J.KN[K:RWS9+1*SD@A!(0J@OQDQ>!/V2]9T/3/"/AOQ+X\_X27P3X
M9OI=4M-)72EMY9;AC*46682-NBC\YBJA020NYB% KZ2HH\@/G_P;^S'K&AWG
M@C3=;\=2:]X*\#7(NM TC^SEAN-Z1O%;_:K@.?-$*.P7:J;C@MDBOH"BBF 4
M444@"BBB@ HHHH **** "BBB@ HHHH **** "L7QKI>K:YX0UG3M"U8:#K-W
M:2P6>J& 3?9)64A9=A(#%2<X)[5M44 ?-7PK_90UGPQX/NO GC3Q#X?\9?#Z
M]@<:AI4>@/:W.HW+.KFYN+G[0S22,R[F8\DXY  %:7@7]B/X:>!?'_C#7K;0
M;.?3-?TZWTX:1<+)+%#&A8S;M[L'$A\L\CCRQCJ:^@Z* /&]=^ ^IZ#?Z3=_
M"GQ+!\.XK.SGL)-&_LX76ERQRR"3S1;AT"SJ^2) >0Q5@17-:7^RCJ/P[LO#
MK_#GQS+X>UBPT>70[^^U/3DOEOXI)WN3-Y89 DRS2S.N#M D*E2,5]$T4 <Q
M\,?A_IWPJ^'^@^$=):633](M4M8Y9SF24C[TCD?Q,Q+''<FNGHHH **** "B
MBB@ HHHH *\T^)'P[\9ZWXGM-?\ !?CZ3PK=+9/I]U87UC]OL)D+;EF6$NFR
M=#G#Y((.U@1BO2Z* /.OA=\*;GX2:-X:\.:/K7G^%]+L)H;B"\M@UW>7<DOF
M&Y,P8!<LTI*!<$N,$8Q5OPE\,SX7^)OC_P 7?VA]H_X2HV!%IY6W[-]F@,7W
ML_-NSGH,>]=U10!POP3^&/\ PJ'X<V'AI[_^UKJ*:YNKK4/*\HW,\\\DTDA7
M)P2TA[GI7=444 %%%% !1110!\_1_!/2]:^(WQ0\)>,/#IUWP1XPN;/Q1;-(
M'\@74<<4$T3NI!5U:""5>>0YQ]TTOPY_9'T;X*^(/B+KWP]FM?#^K^)(H8=.
MDFMY+F/352)5965I?WH:1=_)!&<9Q7T!10!P-Y\+Y-3^,GA_QW>ZGYXT;0[G
M2[?3Q#A1//+$TEP&SP2L(3;CH>M<!\0/V9-4\3:QXWCT+QJ_AWPOX\$?_"2Z
M7_9Z7$KL(E@D>UF+#R6EA14;<K@8W+@U[[10!QW@VR\0Z7XG\16-VEO'X0M8
M[*#08XXPLB*L)$X8[B6&X)@D+W&#C)\\^(W[/?B?QY=^*-)7XD7EKX!\52(V
MJZ)<68N+B&/:J30V=PS_ +F.55^92C;2SE<%N/=** /-?&'PU\3^)-(U*PT[
MQK+X96"ZL[KP_-I=IM:Q\A5W17 +XN8I""&0[?E;'4 UQ\W[-NLZQX1^)ZZU
MXS%WXU\>V"Z9=:U;:>(+>RM4C>..&"#>3@"24DLY):0G(  KWJB@#ROXW:/J
M-C\"=2\(^$]/DN=1U.Q7PYI\<,9V6XF3R/.<C[L<499R3V3'4BO0/"OA^#PG
MX7T?0[5F:UTRSALHF;J4C0(I/OA16I10 4444 %%%% !1110 4444 >+V?\
MR>1JO_8AVG_IPN*]HKQ>S_Y/(U7_ +$.T_\ 3A<5[10 4444 %%%% !1110
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M+>^$_AGQ>UH-/GU2T$D]JK;EAF5BDJ ]P'5@#W %=Q0 4444 %%%% !1110
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M=7N8M1O[B7 \L1K"47'[QB=V D;,2,4 ?1E%0V;3M:0&Y5$N2BF58R64-CD
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MUI3<I13;]I4W:_Q'TN88ZKA\75I4U%1BVE[D-O\ P$X+_A!?%/\ T/%S_P"
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MV+A.\_\ P94_^2#^U,1_=_\  (?_ ")S_P#P@OBG_H>+G_P$7_&C_A!?%/\
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M0\/>+-%BL9H=!MKN*].I+>3>1:BWF7:I+3@Q,& VD9Y'-']BX3O/_P &5/\
MY(/[4Q']W_P"'_R)WG_""^*?^AXN?_ 1?\:/^$%\4_\ 0\7/_@(O^-8/@_\
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M#KA@: /?Z*\+\&_M*ZGX@\1>%++6_A[J?A33O&4=PWAR]OKR)I+AXXFF$=S
MHW6S/$C. =V,$-M;BO2/AC\0K7XF>$X]8@M9-.N8YYK*^TZ=@TME=PR&.:%R
M."5=3@CJ,'H: .LHHHH **** "BBB@ HHHH \7L_^3R-5_[$.T_].%Q7M%?-
MOQ ^*GA/X-_M1:OXB\::[:^'=$'@JQMOMEV3L\Q]0N=J\ G)VG\C7K?PJ^-G
M@;XX:3>:IX$\26?B:PLY_LUQ/9EL1R;0VTY YP0?QH [>BBB@ HHHH ****
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M>FDHT>DV2,"&6! 0>N=HKC=<^ _P\\2>-(O%NJ>#])OO$4;QR"_FMP79X_\
M5NXZ.R\;68$C P17>T= ZA7!?%__ )!>B?\ 86M__9J[VN"^+_\ R"]$_P"P
MM;_^S5X6>?\ (NK>GZH];*O]]I^OZ'>T445[IY(5B^-==O/#'A'6=7T_1[KQ
M!?V-I+<6^DV1 FO)%4E8D)X!8X&3TS6U10!\K?LPWWB#Q)\0KWQ+\0_ ?C2S
M^(&J6!CFU?6;"&#2=*M@P8:=9!9G8+D@EV&Z5EW,1A5'=^#_  /XJC\<_'*:
MUN)O"\NN:K8RZ3K4ELERI5+"WC:18V.& 9'7#8Y%>W44 ?*/QXUKXKZ':^'_
M  $MIXP\7:+?0RW'B+QEX/TJWBOGB+D)8VZ>:JP.RYW3<E5QM&YLKR^O?"/2
M(?%WASQE/\#=:\0^!KGP9'X=M?!S6\#76C7$$\C1B6V>79ATD($P9BA!)(WD
MU]K44 >=_L\^%?$7@?X)>#M!\67+7/B"QT](KIFG,YC.25B,A^^44JF[^+9G
MO7HE%% !1110 4444 %%%% !7@OQ'C\1?#?X^1_$/3O"&K>--(U+PR-!FM="
M$3W-M<Q7+SPLRR.O[MQ*ZE@3M*C(P<U[U10!XY^SMH.L_"WX=^"_ >N:-='4
M_P"SKB_OK^U"R6-K/)<&5K8R;LEP9B!A2"(V.>E3?#7PKJVE?'SXRZO>Z=+;
MZ3JYT?[!=2 >7<B*S*2;>?X6X.:]=HH \E^%/AC5]'^,WQHU2_L)K;3]7U33
MIM/N9,;;E(].@C=EYZ!U9>>XKUJBB@ HHHH *YGXGZ/?>(OAKXMTG3&*:E?:
M1=VMJP.,2O"ZH<_[Q%=-10!X-\*=-\1^./@K\*K_ ,'^-O\ A$].M=#M+>\L
M/[(ANS+)$B1R1EI"#&4:-T('<'TKH/%GA?5KS]I3X=ZY;Z?-+HMAHFLV]U>*
M!Y<,LKVAC5N<Y;RWQQ_":](T3P[IOAN&YBTNRAL8KFYDO)8X5VJTTC;I'QZL
MQ)/J23WK1H \>^)?CCQ'=>'E:U^'.K:[X;;4;K2=?TT,(=2>SV,BW5FJR 2(
MS[>-RN4)(&1BO#? 'PX\:_"__A"O&D7@K6)/#/A_7-;33O!L#Q3ZKIFBWT47
ME<&3#NL\3.8][,J38RQ4BOM.B@#P'X,ZEJ/PVMU?Q1H%_INJ?$CQAJ&H6]@G
MERMIBR1%XDN2K85C%; G9N 9L=LUZ?\ &#2;O7?A-XUTZPMFN]0N]$OK>V@C
MQNDD>W=549[DD#\:ZJ2UAFFBFDAC>6')CD9063(P<'MD<<5+0!YOX N=2\*?
M#OX;>&[G0-0DOI]%@L[F58U,&GRQ6:DBY.[*@LNP;0WS?G7SIX5^'6HQ>*/A
ML^@?!"7X8ZQX*O+N_P!?U+3$@%M>V_D3*UG:3*^^[%Q(\;#S -FT%L,!7VG1
M0!\D? /Q!XI\<?%^V\5?$OX;^.+#Q9/'<6VFO>V,,>B>&[4@L8HF$Q=Y90BA
MYRF6)"@*@P?2/V88GO+KXLZ[!_R!=9\;7L^G$?<E2**"VEE7U5IH)>1UQGO7
MMDT2SQ/&XRCJ589QP:IZ#H.G>%]&L])TFSAT_3;.)8;>UMT"I&@&  * +],D
MC$T;HV=K J<'!YI]% '&_P#"JM'_ .?C4?\ P,>C_A5>C_\ /QJ/_@8U=E10
M!QO_  JO1_\ GXU'_P #&H_X57H__/QJ/_@8U=E10!QO_"J]'_Y^-1_\#&H_
MX57H_P#S\:C_ .!C5V5% 'PQ^UM^S/?_ +2'B[4/A+H>M6^B)#HMAXA2^U&-
MIV+BZN870L#NV[=I Z @GO76_L4_L+7'[,?@77]#\0^)5UVYU+4A>QRZ7YEN
MB*(E3:03R<@G->I6?_)Y&J_]B':?^G"XKVB@#C?^%5Z/_P _&H_^!C4?\*KT
M?_GXU'_P,:NRHH XW_A5>C_\_&H_^!C4?\*KT?\ Y^-1_P# QJ[*B@#C?^%5
MZ/\ \_&H_P#@8U'_  JG1S_R\:E_X&-7944 0V=JEE:PV\98I$@12[%FP!CD
MGJ:FHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH \^@^#\-FICM/$&L6D&XL(H9PJC/L!4G_  JI_P#H:=<_\"?_
M *U=[17@K(LNBK*E;YR_S/6>;8QZN?X+_(X+_A53_P#0TZY_X$__ %J/^%5/
M_P!#3KG_ ($__6KK/$6N6WA?P_J>LWF_['IUK+=S>6N6V1H7; [G ->.>'_V
MM]#U2'PQ?:IX/\7^%]"\22VT&FZYK&GQK9R27 !MU=HY7,?F%E"EE RP!(S3
M_L/+_P#GW_Y-+_,/[5QG\_X+_([?_A53_P#0TZY_X$__ %J/^%5/_P!#3KG_
M ($__6K@KK]K.*T\;)X2;X7>/V\0R6<FH16:6%L3):QR+$TP/VC&W>RCDY^8
M<5Z9X-^)VD^./$GBW0[&*ZBO_#%U!9WZW$85?,EMTG4(03NPL@!]P:/[#R__
M )]_^32_S#^U<9_/^"_R*'_"JG_Z&G7/_ G_ .M1_P *J?\ Z&G7/_ G_P"M
M3?B%\<O!_P ,?$WA3PYK6I@:_P")]0BT_3=-MP))W:1MHD90<K$#U<\9X&3Q
M7.>.OVI/"O@'Q'K6EW&F>(-4M?#ZQ-K^KZ5IQGLM'$BAU^T/D'A"'8(KE5(+
M8H_L/+_^??\ Y-+_ ##^U<9_/^"_R.E_X54__0TZY_X$_P#UJ/\ A53_ /0T
MZY_X$_\ UJYKQ-^TOIVB^.KSPMI/@SQ?XQNK&.UEO+SP[IR7%K;BX7?&'<R+
MR4PW /!![UZ/XT\9Z1\/?"6J^)=>NQ8:/IENUS<SLI8J@'0 <DDX  Y)( ZT
M?V'E_P#S[_\ )I?YA_:N,_G_  7^1SO_  JI_P#H:=<_\"?_ *U'_"JG_P"A
MIUS_ ,"?_K5#\,_C9I7Q*U;4='&D:YX8UZQ@BO)-(\167V6Y:VE+".= &8,A
M*,IP<JRD, :G^%_QK\+?&*Z\5Q>%[J2_B\-ZHVD7=ULQ#).J*S>4V?G4;L;N
MA(.,CFC^P\O_ .??_DTO\P_M7&?S_@O\A/\ A53_ /0TZY_X$_\ UJ/^%5/_
M -#3KG_@3_\ 6KO:*/[#R_\ Y]_^32_S#^U<9_/^"_R."_X54_\ T-.N?^!/
M_P!:C_A53_\ 0TZY_P"!/_UJ[VBC^P\O_P"??_DTO\P_M7&?S_@O\C@O^%5/
M_P!#3KG_ ($__6H_X54__0TZY_X$_P#UJ[VL#Q[XXTCX:^#M6\3Z]<-:Z1ID
M!GN)$0NV!P%51RS,2% '4D"C^P\O_P"??_DTO\P_M3&?S_@O\C!_X54__0TZ
MY_X$_P#UJ/\ A53_ /0TZY_X$_\ UJPO#7[0<>J>)+?0=<\$>*/!^J7UG/>Z
M9%J]M"5OTA4-(B/%*ZK*%(/ER%3CIG!QWVG>,M.NM%TO4+R0:*VH1Q-'9ZG(
MD4Z/(N5B9=Q&_M@$\@XS1_8>7_\ /O\ &7^8O[5QG\_X+_(Y[_A53_\ 0TZY
M_P"!/_UJ/^%5/_T-.N?^!/\ ]:NO@US3KI[Q(=0M97LVV7*QS*Q@;T?!^4^Q
MK%^)'Q(T'X4^"]9\4>(+HP:9I-L;JX$0WRE>@"IU9F/ '<FC^P\O_P"??XR_
MS'_:F,_G_!?Y&5_PJI_^AIUS_P "?_K4?\*J?_H:=<_\"?\ ZU9-C^T%I<C>
M'H]2\.^(-!FU[4[?2K*/4;:(%II;>2<$E)&&T+$P)SP2!SUKT.V\0:7>:E<Z
M?;ZE9SW]L,SVL<Z-+$/5E!ROXBC^P\O_ .??_DTO\P_M7&?S_@O\CDO^%5/_
M -#3KG_@3_\ 6H_X54__ $-.N?\ @3_]:NID\4:-$UVKZO8HUI&)K@-<H##&
M>COS\JGU/%<U\5?C7X.^#'@*Y\8>*=9@L]%CCWQ-&PDDNSC*I @.9&8= O;D
MX )H_L/+_P#GW_Y-+_,/[4QG\_X+_(C_ .%5/_T-.N?^!/\ ]:C_ (54_P#T
M-.N?^!/_ -:J7CKX\Z-X);P_;1Z1KGB36=<M7OK31=!LA<W?V9 IDF=2RJJ+
MO1>6R68*H)K'U3]J7PC%I/AN\T*RUSQG-K]A)JMKI_AVP,]REG&P62:5&*^6
M%<A"I.XOE0"011_8>7_\^_\ R:7^8?VKC/Y_P7^1TO\ PJI_^AIUS_P)_P#K
M4?\ "JG_ .AIUS_P)_\ K5L:#\2/#/B3PCI?B>RUJS_L/4X([FUNYY1$KI)]
MW.[&"3Q@\Y!'6MJ#5K&ZO[BQAO;>6]MPIFMHY5:2(-RI90<C/;-']AY?_P ^
M_P 9?YA_:N,_G_!?Y'&_\*J?_H:=<_\  G_ZU'_"JG_Z&G7/_ G_ .M77V.N
M:;J<LT5GJ%K=R0R&*1()E<HXZJP!X(]#S7$?%7XV6/PKUCPQI#Z!KGB36/$4
MEPEC8Z';QRR-Y$8DD9M[H  I]:/[#R__ )]_C+_,/[4QG\_X+_(L?\*J?_H:
M=<_\"?\ ZU'_  JI_P#H:=<_\"?_ *U<MI?[5'A6^N_[.OM*U[0M>CUFPT2X
MT75+$174$M[N^S2L Y4POL?YU8_=(ZC%>KQ:_ID^K2Z7'J5I)J<2[Y+-9U,R
M+ZE,Y Y':C^P\O\ ^??_ )-+_,/[5QG\_P""_P CD?\ A53_ /0TZY_X$_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!R7Q<ADN?A/XTAAB:>631+U$BC4LSL8' 4 <DD^E>&?!/\ 9ONO$GPJ
M^%,WC7QMXFUS3=+T_2M3A\+WD=O;6T5S##&\2RB.)9'$3@$([=4!;.*^H**
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M%F9CR2Q- &W1110 4444 <]KWA6ZUF^$\.O:AIJ! ODVS )]>G6LW_A +_\
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M]ZGHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFN3##G;YLLC2RMSW9W9C[F@#RS_A3/Q)_P"B[:__ ."/3/\ XQ1_PIGXD_\
M1=M?_P#!'IG_ ,8KVBB@#Q?_ (4S\2?^B[:__P""/3/_ (Q1_P *9^)/_1=]
M?_\ !'IG_P 8KVBB@#S#]F7QAK/CWX$^$==\07HU'6;NW?[3=B)8O-9973=M
M4!02%' XKT^LKPOX7TKP7H-IHNAV,6FZ5:*5@M8<[(P6+$#/N2?QK5H ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=\DLK,[G:JJ-S' 4 <"NIH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.K?+O %NHB*[#P0!7TU113$%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
$0!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>sava-20230630x10qg006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sava-20230630x10qg006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" #_!7(# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/[F?JK17Y5?\/\?B%_T)?@S\[G_XY1_P_P ?B%_T)?@S\[G_ ..4?\0ZSO\
MD7_@2#_6K+OYG]S/U5HK\JO^'^/Q"_Z$OP9^=S_\<H_X?X_$+_H2_!GYW/\
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M*/\ A_C\0O\ H2_!GYW/_P <H_XAUG?\B_\  D'^M67?S/[F?JK17Y5?\/\
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MYSF=L]O2A^'&=)?#'_P)!_K9E_=_<?K!17Y5?\/\?B%_T)?@S\[G_P".4?\
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M/SN?_CE'_$.L[_D7_@2#_6K+OYG]S/U5HK\JO^'^/Q"_Z$OP9^=S_P#'*/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_0W7XMXK_P ;#>DOS1^@\%?PZOJOU"BBBOR0^W"BBB@ HHHH **** "BBB@
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M4U[U^CVM<^S/VGM?@E_X)]?LZ:CK\CWEFFLZ7+?M-F0RPK;S;]V?O?(#5_\
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M)494R>3M YKG?C+\?O&/[0>OQ:GXQUZ\UR[MT,<)E"I' IY(2- J)GC.U1G
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M9_X6EXF_Z&+7?_ ^7_XJC_A:7B;_ *&+7?\ P/E_^*H_XA14_P"@E?\ @/\
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M_P#BJ/\ B%%3_H)7_@/_ -L'^NL/^?3^_P#X!_1-17\[/_"TO$W_ $,6N_\
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M_MC+_76'_/I_?_P#^B:BOYV?^%I>)O\ H8M=_P# ^7_XJC_A:7B;_H8M=_\
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M%KO_ ('R_P#Q5']B\1?]#'_RE$/[0RK_ *!?_)V?H;_Q#[V?_15;G_PG5_\
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M_P#@?+_\51_8O$7_ $,?_*40_M#*O^@7_P G9^AO_$/O9_\ 15;G_P )U?\
MY)JY%_P;^Z&-"FC?XEZJVIF9&BN%T>,0)$ VY6B\TLS$[2&$@  (VG.1^<W_
M  M+Q-_T,6N_^!\O_P 57L_A'XAZ^_[ ?C:Y.N:P;F/QII$:2F\DWJIM+XE0
MV<@$@<>PKEQ66<0THQ;S"]Y17\./5I&U'&97-M+"]&_B?1'U-_Q#[V?_ $56
MY_\ "=7_ .2:/^(?>S_Z*K<_^$ZO_P DU^>7_"TO$W_0Q:[_ .!\O_Q5'_"T
MO$W_ $,6N_\ @?+_ /%5U?V+Q%_T,?\ RE$Q_M#*O^@7_P G9^AO_$/O9_\
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M  M+Q-_T,6N_^!\O_P 51_8O$7_0Q_\ *40_M#*O^@7_ ,G9^AO_ !#[V?\
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M;G_PG5_^2:/^(?>S_P"BJW/_ (3J_P#R37YY?\+2\3?]#%KO_@?+_P#%4?\
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MS6RJG4PF,]G#WK1Y(NWO.^K[O4^ SS&8"GC91KT.:6FO,UT70_0W_B'WL_\
MHJMS_P"$ZO\ \DT?\0^]G_T56Y_\)U?_ ))K\\O^%I>)O^ABUW_P/E_^*H_X
M6EXF_P"ABUW_ ,#Y?_BJ^E_L7B+_ *&/_E*)Y/\ :&5?] O_ ).S]#?^(?>S
M_P"BJW/_ (3J_P#R31_Q#[V?_15;G_PG5_\ DFOSR_X6EXF_Z&+7?_ ^7_XJ
MC_A:7B;_ *&+7?\ P/E_^*H_L7B+_H8_^4HA_:&5?] O_D[/T-_XA][/_HJM
MS_X3J_\ R31_Q#[V?_15;G_PG5_^2:_/+_A:7B;_ *&+7?\ P/E_^*H_X6EX
MF_Z&+7?_  /E_P#BJ/[%XB_Z&/\ Y2B']H95_P! O_D[/T-_XA][/_HJMS_X
M3J__ "31_P 0^]G_ -%5N?\ PG5_^2:_/+_A:7B;_H8M=_\  ^7_ .*H_P"%
MI>)O^ABUW_P/E_\ BJ/[%XB_Z&/_ )2B']H95_T"_P#D[/T-_P"(?>S_ .BJ
MW/\ X3J__)-'_$/O9_\ 15;G_P )U?\ Y)K\\O\ A:7B;_H8M=_\#Y?_ (JC
M_A:7B;_H8M=_\#Y?_BJ/[%XB_P"AC_Y2B']H95_T"_\ D[/T-_XA][/_ **K
M<_\ A.K_ /)-'_$/O9_]%5N?_"=7_P"2:_/+_A:7B;_H8M=_\#Y?_BJ/^%I>
M)O\ H8M=_P# ^7_XJC^Q>(O^AC_Y2B']H95_T"_^3L_0W_B'WL_^BJW/_A.K
M_P#)-'_$/O9_]%5N?_"=7_Y)K\\O^%I>)O\ H8M=_P# ^7_XJC_A:7B;_H8M
M=_\  ^7_ .*H_L7B+_H8_P#E*(?VAE7_ $"_^3L_0W_B'WL_^BJW/_A.K_\
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M=_\  ^7_ .*H_L7B+_H8_P#E*(?VAE7_ $"_^3L_0W_B'WL_^BJW/_A.K_\
M)-'_ !#[V?\ T56Y_P#"=7_Y)K\\O^%I>)O^ABUW_P #Y?\ XJC_ (6EXF_Z
M&+7?_ ^7_P"*H_L7B+_H8_\ E*(?VAE7_0+_ .3L_2'P3_P0;M/!OC/2-7'Q
M/N;@Z5>PW@B.@*OF^6ZOMS]H.,XQG%?H+7\__P %/B9XDN/C)X21_$&MNCZU
M9JRM?2D,#.F01NK^@"OS3C[!YAAZE%8_$>U;4K>ZHVVOMO<^NX9KX6K"H\-2
MY-KZMWW[A1117Y\?3A1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P#3A<U^(U?MS_P2;_Y1]?#S_KG??^G"YK\T\4O^173_ .OB_P#29'UW!O\
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MWBO_ !L-Z2_-'Z#P5_#J^J_4****_)#[<**** "BBB@ HHHH **** "BBB@
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MY?\ 5[!Y>SR\?>;=G/&,5RWC/X=:W\/$T@ZUIT^G?V]IL6KV EQFYM)2PCF
M!R%;8Q&<$C!Z$$XE9X7*L%!QJT5=IW3<I2V3CNV]$I226RN]+E5L;B))PF[7
MZ62W:>R2ZI:[GT!H7[>$_ASXY_"+QM;>&8C+\*_#%KX:^R27Y9=46)+A&EW"
M,>466X.%P^TJ.6SBO(/BIX@\/^*?'=[?>%O#LOA30Y]GV?2I-2;4#:X10W[Y
ME5FW,&;D<;L<XKGJ*Z,/EV'H3]I25G:V[VNWM>V[=GNKOH9U<55J1Y)NZO?9
M;V2_)+[@KVW]KO\ Y)[\#?\ L0(O_3C?UXE7MO[7?_)/?@;_ -B!%_Z<;^LL
M9_O-#UE_Z2RZ'\&KZ+_TI'B5=7\$OC1K_P"SW\4-)\7>&;I;36-(E+Q%TWQR
MJ05>-U[HRDJ1P<'@@X(Y2BN^K2A5@Z=17B]&GU3.:$Y0DIQ=FCZMU;]O7X2>
M*O%"^)-9_9I\+7GB<DRS7$/B">WL;B5LEG>S$1B?)))W[CSR21FLCP#_ ,%+
M?$.C_ME#XP^(]$MM>NHK"33+?2K6Y^PV]I 4*I'&VR0A5R3R"26/(S7S317C
MKAW *,H.#:<7'64W:+W2O)\J?]VQW/-<2Y*2E9IWT45JNKLM?G<]<\*?M4?\
M(Q^QIXG^$?\ 87G_ /"1ZY%K/]K?;=OV?8(1Y?D^6=V?)^]O'WNG'-;6_P!I
M;^V?V/M&^%']B^7_ &1XCDU_^U/MF?-WQ/'Y7D[.,;\[MYZ=*\LHKM_LS#*7
M-RZ\W/N_BM:^_;IMY'/];K6M?IR]-KWM_6I[!XN_:UN?$/[,OPS^'UGI+Z9=
M_#;4+O4(-82]W-<R3W#SKB+RQY90N!G>V=N>.E>I>(/^"D_A;Q7X_L?B!J/P
M2\/77Q1M$MV;7FUF?[))/$JJMQ]BV;/, 4;&9F*E4^]M%?)M%<U3(L#4^*'6
M3TE)?&[R3LU=-ZM/3R-H9EB([2[=$_A5ENMTNNY]0:!_P4B_L/\ ;(\<_%K_
M (0SS?\ A--'?2?[*_M?;]CW16\?F>=Y)W_\>^=NQ?O]>.?-_AW^U!_P@/[*
M/Q"^&']A_:_^$\NK&Y_M+[9Y?V'[--'+M\KRSOW>7C.]<9SSC%>3T5<,DP4$
MHQAHN3J_^7?P=>GX];DRS#$2=W+^;HOM_%TZ_AT/IO3_ /@I;JOAOXB_"#Q%
MI'AJWM9_A;X9B\,2PSWIFCUJ%8A$[G$:F$L!D ;MI Y8 @Z_PT_X*)^ /@3\
M2(?%'@3X"Z+H&J23EKR:;Q%/>OY+;M\5MOB"6V[=C*HV%RN,8Q\FT5SSX;R^
M<>5P=FK-*4DFKMV=I:ZMVO>U]#6.;8J+YE+6]]D[.R6FFFRV/<[C]L])/@S\
M8_!\?ADI'\6-=BUE;IM2W'21'=K<B(KY0\[.W;NRGKM[5S^B?M+?V-^Q]K/P
MH_L7S/[7\1QZ_P#VI]LQY6R)(_*\G9SG9G=O'7I7EE%=D<JPL591^TI[OXDD
MD]^R6FQ@\;6;NWT<>FSNVOQ9ZYXK_:H_X2?]C3PQ\(_["\C_ (1S7)=9_M;[
M;N^T;Q,/+\GRQMQYWWMY^[TYX\CHHKIP^%I4%)4E;F;D_5N[9C5K3J-.;O9)
M?);&]\+/^2G>'/\ L*6W_HU:[']MK_D\7XI_]C9J?_I5)7'?"S_DIWAS_L*6
MW_HU:[']MK_D\7XI_P#8V:G_ .E4E<DO^1A'_!+_ -*B;K_=7_B7Y,\PHHHK
MTSC"OJ>3]O?X=>-/@WX#\)^//@A_PF+^ -,_LZRO/^$QNM/W A [>7#$/O>6
MO#,V,<'K7RQ17#C<NH8OE=9.\7=-2E%IVMO%I[:'3A\54HW]G;7>Z37?9IGN
M/B?]J?P=X7\:>%O$OPD^& ^&'B'PU?&\:[;Q+=:RMZNW'E,DR@*N-P.#\P8B
MN^A_X*)^!+'XB/X_M/@)X<M_B2S&Z&K?V[<&P2](YN18[-F[=\WW\YYW;OFK
MY0HKDJ9#@ZB2FI.R:OSSNT];-\UY+R;:-HYEB(OW6EU^&-K]TK63\UJ>U^ O
MVT-1\-?#CXS:/J^F'7=4^,8MWN]2-V+?[%+%+/(S^4(R'#&;A04"A>..!F?
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MGZH?*'_!:/\ Y,4U?_L*6/\ Z-K\:J_97_@M'_R8IJ__ &%+'_T;7XU5^_\
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M:=IUI>*(]+UJ5$DFLK9^ 'P%9=I 3#@;0,#YV^!O[//Q@L_A'XELKB[_ .$
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M9Y=2P\+TVVT[===-_A2^YRWW/(*]M\'_ /*/;QS_ -COHW_I)?UXE7MO@_\
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MZ5_0W7XMXK_QL-Z2_-'Z#P5_#J^J_4****_)#[<**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH \#_X*A?\ )A7Q'_Z\8?\ TIAK\-Z_<C_@
MJ%_R85\1_P#KQA_]*8:_#>OW?PL_Y%M7_&__ $F)^;\9_P"]P_P_JPHHHK]-
M/CPHHHH ^T/^"BOA+1/'G_!2[1M'\1ZC>Z5H>I66DP7ES96DEU<JAA'RQ1(K
MLTC'"KA6^9@=IQBO1O"W[!/AGXMQ^*],F^ >N?#728-,NY]"\57OB2Y>\EEB
M&83+93,/OCYF78-N"N<D&O&O&W_!0'PY=_\ !1+PY\8]+T/5[O1-'MH+66QO
MEBAN7 M7MY'4*[IE=Y=<MR5&=N<CH/A+^VG\%/@G\8-2\6647QI\5:EKUA=:
M9<7WB&XLYIM-@E5FQ$BR?OB9 @)>1 %+$ G@_FM7"YK3P5"E0C-2A2CLW\75
M64HJZ27Q<R>RC>]_KH5L%/$5)U'%J4WO;;ING^%GW9A:7X&^$?P?_82^&WQ#
M\2?#J3QGXD\4ZAJ.GW$9UZ[T^&1(KB0"4^63AT6-44*%!\QBP8@5%X\\%?!_
M]D'1/ ^@>-/A[J'CWQ-XGT6V\0:U?IKT]@ND17.=EO:QQ';(\:J23)D$XYPV
M$\W^)?[1>B>,OV+/AK\.;6UU1-;\':CJ%Y>SRQ1BUE2XE=T$;!RY(##.Y%]B
M:]^UOP?8_'CP%\*M3^)_PM^,&I>)K7P_:6>FWOA%+>\TWQ/IZDFV%Q)O8V\N
MUB'_ (QN)('RA?0K*K0?/BI3Y95*ETIM.R<N3E]Y6BENH^5]%IRTW"HN6BHW
M48:\J:O9<U]'K?OYVU9N7W_!.?P/XG_;6\3Z5H>@ZM<>!?!OA2SUS^QK&]?[
M9K5S-&#% ))7)3S2&+'< N,#;G(S/B5^PO8WGP'\3^,+KX)7WPIU+P&T.J_8
MIO$LVHV7B2R5_P#2(&=G:2&0("0RXSGMU%G]K+]K;1O@O^WWX\TO4],;7?!?
MB'PU:^%O$VF6,X1X_P#1T),$G3S(2Q49(&2X.",CP3QK\5?@GX)^#/B'P_\
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M)%%(K*DFW<QP>/*)P#7%?'ZP\?\ Q%^'/P7\"_$#P[\,OA;X9\9>++=[30]
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M&'![5YRS3%RA]=56U25*CTC:\JCBW9KY[]?2W4\'0C+ZNX7BIU.]](IK6_\
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M'_!_]G?P1XKC^$.C_$2]\5>+])FT&75?%<UK%'I=G-CS?)BMB0\C;5P7(VD
M@\%6K67[2/PN^-7P0\&>&/BSIOCFVU;X?P/I^FZKX7%H[7MD2"L,R3LH4I@
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M9<U^62AO>_NRE?6Z5K:.6#]A->[=J6RMK=VM=.7IJE;2USZ%^+_[)-A^TO\
M\%+?CAJFL:9J7B'3/!.FZ9=C0]/N!;W&M7,NFVXA@\PXV(=C[F!!&!SUKSG]
MH']A2&Y_9B\5>,T^$>I_!O7/!4D-S]D?76U:SUVTD<(^&D=GCEB^]Z$'&"3\
MN'XK_P""B/A7Q+^UA\5-<NO#^NZC\,?BSIEII>J:?)Y5OJ<(@M(HDGCPSQB1
M'20J"V"'!.",5YQ\1/BG\&/"GP3UCPQ\.?"WB35=:\17,,EQXA\7VUG]KTN&
M([A%:+"7"%^0SY4D'OA=O/@,%FM-T(-RBHQHI*SLDHQYU+WU&]^:]XR>W*[[
M:XFO@IJI)6=W/M>[;Y;>ZWVV:6]SPBO;O^"</_)[7@#_ *_9?_2>6O$:]N_X
M)P_\GM> /^OV7_TGEK[+.?\ D7U_\$O_ $EG@9?_ +U3_P 2_,\1HHHKTSC"
MBBB@ KZ1_P""1?\ RD,^'W_<1_\ 3;=U\W5ZU^PO\>M(_9C_ &I_"WCC7K;4
MKO2=$^U^?%81I)</YMI/ NU7=%/S2*3EAP#U/%>7G=&=;+L12IJ\I0FDN[<6
MD=F75(PQ=*<W9*46_O1]"_L0?"[X*?#G]IOPSJV@?'6;Q'XC@E=-(TN7PU=Z
M'#J%VZ,D<,ETYE54<MM(VY8L ,DX-3]GW]B>]^+GC'XR^,_&W@?4/%.K^&-<
MFLXO"&F7WV%+_4996>4--E2D$896!4_,K9&< -QGPW^(/[+?P@\>Z1XITZP^
M.6NZEX?NH[^SLM2_LR"UEGC.Z,R-$^_:'"GCKCG(R#7\'?MX:=XXU/XIZ5\5
M-*U?4_!_Q5OUU2X31YD6]T2YC;,+V_F81PJK&A#GD1+[AODZ^&S&<ZE7#<[O
M&"<II*5E.[45'D^RVWL^BE?;W*=7"QC"%7ET<G:+;6L=&^;FZV[KNCJ_VO?V
M(8?"O[,/_"QK?X<7_P )=4T;5$T_4M"N-8;4[>]MY<".YAD=F<,'(4H3C&3V
MY]1_:BO_ (+>-?\ @I3>> ?$WPXU'5]5\4ZE8Z9?>(_[>N+>2TN;BWACA\BW
MC_=E%#0@F3))+G& ,_*OQJ^*OPHM?@Q:^"_AIX6UAYI=1.HZCXF\36UI_:T@
M"!5MHC#N\N'(#'#C)'3DUK?%O]JWP]X]_P""B]K\7;.SUJ/PW!XCTK5VMIH8
MA?&*U^S>8H02%-Y\EMHWX.1DCG&E/+<;5M*LYZ1K<KO*+5W3Y4_?E)ZJ32E)
M^:T(EB\/"Z@HZN%U9-:<UW\*757LO0ZKX _LP>$U\7_%#3I_"7B7XM>*/"&M
MOHND^&K+[59VTD*3NCWEU>0IMC&$(5"Z9(;@Y!7M?VB?V5O ?P0\/_"3Q]XE
M^&\G@BPU7Q VD>*_"<FO7&H1BWY(G2=9/-1Q&K/L#]2H/0[N3\(_MN^!-4\'
M_$WPMXC'Q(T'2/&/C>Y\76.I^%Y;>/4"DN5%K<H\BJ4"[6P'8;C_ +()YC]H
MC]J#X>^-OV2?#'PQ\$Z+XJTR/PGK\E_!/JTD,QOH)(GWR2/&PV2F61OW:H5"
M@'?GBE[',ZF,BY\ZBVE+5VY7"S:M)17O?W')/7F#VF#AAWR\K=M-%OS>E]O[
MUK=#KO#W[%_AKX<?M<?%R+QAITNI_#CX6:9=:[Y"7,D2ZA%,@;3[?S5=7W.)
M%P0W+1$$\FJ?PT_8S\-?&OPY^S18VRMH5_\ $IO$,GB#48YI)&EAL;F1EV([
M%$801,@(4#)!8-69\;_V];'XK?L:Z!X'@T[4;?QI)#8Z=XGU65$,6J66GF<V
M:"3>9&;,B.Q91\RG!(-9_@G]N6'X3^&?@!+H&G75QKOPC?63J,=XJI:WT=]<
MLWEQ.K,W,#NI9D&UB,!@*U]CG$J//=JI=Q6NGNTII2:V]ZHT_P#P&^Q'M, I
M\MER:/;76<6UWT@K??W.Q^#OAWX#_M=?%N;X8^'?AUJO@J[UB&YC\/>)QX@N
M;NX::&-Y4-S;29B"R+&VX)RN< \[UCA^'/PI^!O[#_P[\=>+/AM/XM\5^(=4
MU/2[RWDUV[TZ,B&YD7S&\LG#QK&J*JA0=[%@Q JEX)_::^!7[/'CR_\ B!\.
M?#'Q"E\:>3<#1M.UN6U71]#FG5D9U:-FEE$:.X56 R#R<X9?._B=^T=HWC;]
MB_X;?#NWMM677?!^I:C>WUQ-&@M9EN)7=/+8.7+ ,,[E7GH336%Q=2M"-/VL
M:/-&_-.7-\-3FUYN;EOR=;7V!UJ$*<G+D=2SM:*MO&VEK7^+I>VYYE\._&/_
M  @'Q&T+Q +.&\_L34K?4!:N<1S^5*LGEDG/!VX[]>]?6OQ5T#X4_MJ_&6[\
M?^&?C?+X$\7ZJZ7L>D^++26V%A<)@(L=^C>6B@@;0NYEZCT'R?\ "KXD:C\'
MOB5H7BG2?*_M+P_?17]N)5W1L\;!@K#NIQ@^Q-?0OCGXM?LP_&/QK<>+]=\,
M_%_0=<U>8WVJ:5HUU8S:;-<NQ>4I+*1*JLQ;. .#P%KTLXHU/K$*U.,TU%KF
MARRW:]V49+9VO=>ET<F J1]DZ<W&UT[2NOFFNOD;MM^S;XF^)W[7WCZ__:#D
MNKL> O#DGB779]+BAA.NV]O&B0)$\2HN)% ^?:&Q&RDJW*^:^.O$WP-^*_PA
MU2?1O#$WPI\9Z7?6PL+9-3O=8M-:MI'VS;VD5O*>%?GR-NX<*"3@=9!_P4;B
MU?\ :?U7Q1K'A42> ]<\-GP5<^'H;H^9#HY4 *DO&9@07W''WF4%<@C+M_CW
M\%/@EX7>/X>>#_$GB;7KO5K&^?4O&EM8[M.@MIUF,-L(M^TR[=CO\IVL>.!7
MGT:6.A*'MJ<E)*GRJF^6"M\2:OR^MT]+*#OJ=52>&:E[.2:O*[DKR?9IVO\
M<UK\1]$?#3]B#P)XN^(>F>']/^ GBK5? ER(K=O'VK:]>:3>3;HQFY6RE\L8
M\S(">7\PY&017GNG_#=O!O\ P3R^._A"P:2^?2OB9!H]LS85K@QSPPJ3T +8
M'MS4FN?MV_!K5/VF]-^+<]E\8]9UVUOXKQ-%O[NT&EZ82%20P$.SL$7<R)A
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M/_Y+5X0_[#=E_P"CTK^ANOQ;Q7_C8;TE^:/T'@K^'5]5^H4445^2'VX4444
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M'4/P*_Z%S7?_  >R_P"%'_$1\K_EG]R_^2#_ %2QO>/WO_(_)&BOUN_X=0_
MK_H7-=_\'LO^%'_#J'X%?]"YKO\ X/9?\*/^(CY7_+/[E_\ )!_JEC>\?O?^
M1^2-=?X0_:"\>_#[0/[)T'QOXOT32\L?L>GZQ<6UO\Q)/[M'"\DG/'>OT_\
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M35&BVB)IPS$2E-B;2^=NQ<8P*S(/'6MVW@^;P]'K&J1Z!<W(O)M,6[D%G+.
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M%'_#J'X%?]"YKO\ X/9?\*:\1,H4G)0G=[^['7_R83X4QS23E&R\W_D?E?\
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M2:'3XSC*0HQ(C4[5X4 ?*/2OU7_X=0_ K_H7-=_\'LO^%'_#J'X%?]"YKO\
MX/9?\*E^(N4MIN$[K^['_P"2&N%,<E92C][_ ,C\IYO'NNW'@N+PW)K6K/X>
M@NOML6EM=R&RCGP5\Y8<[!)AF&X#.&//-/\ !'Q$\0?#/5SJ'AS7-8\/WY3R
MS<Z;>R6DQ7(.W?&0<9 XSVK]5?\ AU#\"O\ H7-=_P#![+_A1_PZA^!7_0N:
M[_X/9?\ "I?B%D[BXNG.SW]V.O\ Y,5_JKC[WYHW7F_\C\K/'/Q*\1_$_4TO
M?$NOZUXAO(T\M+C4[Z6[E5<YVAI&) SVK7_X:)^(!\(_\(__ ,)UXQ_L'R?L
M_P#9O]M7/V3RL8V>5OV;<<8QC%?IY_PZA^!7_0N:[_X/9?\ "C_AU#\"O^A<
MUW_P>R_X5+X_R5Q472E9;>['3T]X?^J^8)MJ:N_-_P"1^6&L?%7Q1XB\0Z=J
M^H>)->OM6T>..&PO;C4)9;BR2,EHUBD9BR*A)*A2 "3BM+5OVA_'^OW&HRWW
MCGQA>RZQ9C3K]Y]9N9&OK8;L02DN=\8WO\C97YVXY-?I[_PZA^!7_0N:[_X/
M9?\ "C_AU#\"O^A<UW_P>R_X4?Z_9*[7I2T_NQ_^2#_5C,/YU][_ ,C\H],\
M9:QHGA[4](L]5U*TTG6_*_M&RAN7CM[_ ,IB\7G1@[9-C$LNX':3D8-2VGQ
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M .2#_5+&]X_>_P#(_)&BOUN_X=0_ K_H7-=_\'LO^%'_  ZA^!7_ $+FN_\
M@]E_PH_XB/E?\L_N7_R0?ZI8WO'[W_D?DC17ZW?\.H?@5_T+FN_^#V7_  H_
MX=0_ K_H7-=_\'LO^%'_ !$?*_Y9_<O_ )(/]4L;WC][_P C\D:*_6[_ (=0
M_ K_ *%S7?\ P>R_X4?\.H?@5_T+FN_^#V7_  H_XB/E?\L_N7_R0?ZI8WO'
M[W_D?DC17ZW?\.H?@5_T+FN_^#V7_"C_ (=0_ K_ *%S7?\ P>R_X4?\1'RO
M^6?W+_Y(/]4L;WC][_R/R1HK];O^'4/P*_Z%S7?_  >R_P"%'_#J'X%?]"YK
MO_@]E_PH_P"(CY7_ "S^Y?\ R0?ZI8WO'[W_ )'Y(T5^MW_#J'X%?]"YKO\
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MN7_R0?ZI8WO'[W_D?DC17ZW?\.H?@5_T+FN_^#V7_"C_ (=0_ K_ *%S7?\
MP>R_X4?\1'RO^6?W+_Y(/]4L;WC][_R/RZ^!_P#R6KPA_P!ANR_]'I7]#=?'
M'A;_ ()<_!+P[XGT[4+3P]K:75C=17$+-K<K!71PRDC'/('%?8]?G/'?$.&S
M6I1EADURIWNDM[=FSZOAS*JV"A-5FM;;?\,%%%%? GTH4444 %%%% !1110
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M;PJN,C[Q%=UX _:/^)$?QY\%>"O&F@^'M(N?$-C=7E[';!GDB\L7!CV.L[H
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M2K/2K/4K:34?#<D4<B/=V\<TD;!RS$.V%/S*%&8I..@'9?\ "^M8_P"&Q_\
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MAG_@K9IQOW6V7Q)\+CI^FO(<"ZN(-4>:2%?5A&X?'H#71:.C2Z&%Y:IOJ/\
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M ,$V?@/XHTC0]+LO$K:CX8U9]62V07TES<(DLTC38WL6=B3DGH/08]:_9Q\
M>'?B_P#MJ?M"7'CK1]+U_P 2Z5J5GIMC;ZM9QS_9-(-OF'RHW! 23)+$#YC@
MDG-5[*-N8CVDKV/J3PIXZT3QW!=R:'K&EZS'I]RUE=/8W<=PMM.H5FB<H3M<
M!E)4\@,..16K7RE_P2:T;0?#O@3XP6'A9XW\.67Q2U>#33$^^,6ZP680(W=0
M  #W ')ZU]6UG./+*R-82YHW"BBBH*'VO_'S'_O#^=3ZY_R&;O\ Z[/_ #-0
M6O\ Q\Q_[P_G4^N?\AF[_P"NS_S-3]H?0JT4450@KQW]MCX[^)/@1\-M!E\'
M6FC7OBKQ7XET_P -Z7%JJ2/:&6Y<C+B-T; 56.=PQC)Z5[%7@?[:_P /OA?\
M6O%'PP\-_$C6-9L)+_7G?0[.SFDMX=4NEB(,4TJ(2@*MM&'C9B^%)YQ=.W-J
M3._+H;?P;A^/R>.(C\0;CX/R>&_*?S5\/6VHI?>9CY-IG<IMSUR,XZ5YP?CU
M^T9XL^'NM^/-(\%^!?#GA[36NI[3P]XEAOX=>O;6W9@6=LHD#R!&**R$8*G.
M"&//VOPOT#]E'_@H[\+O#7PQ\S1=(\;Z3JTGBOP_;7,DMK'';P;[6[:)F;RV
M>7*;AC.PCJS9VOBW\2_$G[=_BC5_AI\,[F72OA[93MIWC+QN@^6Y&,3:=IYQ
MB1R#M>7[JAO0@OM97OT,;Z6ZGOO[/OQELOVA?@KX:\:Z=;S6=IXCL4O%MYCE
M[=CPR$]#M8,,]\9[UQ?[.G[06O?$CXZ?%_P3XDM-*M+OX?ZM;KIYLXI$-QIU
MU$9;=Y-[MNDPIW%=JY_A%>F?#OP!I7PJ\!Z1X;T.U6STC0[2.RM(1SLCC4*,
MGN>,DGDDDGDU\<_M\_$B3]C_ /:0U?QS9Q.A^)'PYO\ 0K<Q-AFUBUD1K:3N
M2VR<* !SLXZ&LX14FXKY%SDXI2?S.W_8W_;UU[]HO]HKQ3X:UC2M'L/#5S;7
M6J>"[VV21)M4L;:_ELI'E+2,KN613\@7 #=>WH'P(_:0U7XL_&_XQ6%U'HUG
MX*^'6HV^D65X$=)YKA8/,O#-(S^6%C; &%& >3Q7A/Q:^&\'["/@W]F?Q@ZB
MW@^'<J^%_$;Q@$O!J%N1,[$?*56Y4L.<!I!UR37F/Q4\/:YX=_X);>!+NZ>.
M"X^+OQ M==\6R7]Q)!:26^H3S3C[1(BF18"%M [ ,V,D \"MO9QEK'9Z&7M)
M1TETU/T#\ _'+P5\5K^XM?"_C#PMXDN;12T\.E:K!>20 $#++&[%1D@<^HI/
M'?QU\$?"[4K>R\3>,?"OAV\NP#!!JFK6]I),"<#:LC@GGTKXV\>_"OQAX!^/
M?P/OM3LO@+\-[U/%%O:6$GA634OMVM69&+FQ")9A&C:(_>E*HK;<LN\YY_\
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M%^,$FC:3\"/[:\)K>Q0)XC_X36QMM\#;=\_V5D\P;,M\F<G;QUKP%_B=X_\
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MBY;_ / O_0C7#5W/@_\ Y%RW_P"!?^A&N?$?"7#<TZ***XS4YOXA_P"HM?\
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M?1;U9% ^X")F8#H0<?\ +/CNOBI\ =/_ &C?^"@VOZ'JE[>6=A;>'8KZ46V
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MN?!__(N6_P#P+_T(UPU=SX/_ .1<M_\ @7_H1KGQ'PEPW-.BBBN,U.;^(?\
MJ+7_ 'F_I7+UU'Q#_P!1:_[S?TKEZ[J'P&,MPHHHK8D**** "O!/C9\'X?B+
MXZ\07NK?"R7Q!]MT7_A']4OK;Q'):OJVBF<SK;6T:R(!.)6=G#^6"J[1*PD
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M  H_X6IX@_Z"4G_?"?X5?U2IY?U\B?:Q.XHKA_\ A:GB#_H)2?\ ?"?X4?\
M"U/$'_02D_[X3_"CZI4\OZ^0>UB=Q17#_P#"U/$'_02D_P"^$_PH_P"%J>(/
M^@E)_P!\)_A1]4J>7]?(/:Q.XHKA_P#A:GB#_H)2?]\)_A1_PM3Q!_T$I/\
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M*,D_5-=8I,[*BOD#_@H7XIL_BG\0=!^'W]NZ=I%G9:?=:Y=W-U=)% \_D/\
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M"UKHWP%^(_Q)TCXB?%#XF?#G4;OQ+>:Q8G2Y%CLM?MIV#)/&3;2EYNS+OR.
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MJFD_VMKVFQ)?Z3>O:S/;S,<[9$(.&4@^G2H_'7[&?B7PCX7O-5\#_%WXM?\
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M7..]'[47_!/[PS\/_#-KXY^&'@_1(_$?@Z3[?+I,]O\ :[36[9>9(C%+N7S
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MBQ-JOQ4^(J?\*NUW6- T-[+53;32BS!E6:Z=1NN&;>JX<XVICOD?3&B_ O\
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M_P"3$7_Q5'_"E?$O_0-_\F(O_BJ][HK?^U*O9?U\R/J\3P3_ (4KXE_Z!O\
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M4KXE_P"@;_Y,1?\ Q5'_  I7Q+_T#?\ R8B_^*KWNBC^U*O9?U\P^KQ/!/\
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M_%4?\*5\2_\ 0-_\F(O_ (JO>Z*/[4J]E_7S#ZO$\$_X4KXE_P"@;_Y,1?\
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M_%5[W16O]J5>R_KYD_5XG@G_  I7Q+_T#?\ R8B_^*H_X4KXE_Z!O_DQ%_\
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M^*KWNBC^U*O9?U\P^KQ/!/\ A2OB7_H&_P#DQ%_\51_PI7Q+_P! W_R8B_\
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,#2$%'8****YRS__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>sava-20230630xex10_3g001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sava-20230630xex10_3g001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $8 [ # 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\>?]#QXC_P#!I-_\57IQRFHU[TD<CQL>B/Z!Z*_GX_X6UX\_Z'CQ'_X-)O\
MXJC_ (6UX\_Z'CQ'_P"#2;_XJJ_LF7\_X"^NK^4_H'HK\,O!/[8GQE^'FFO8
M:+XYO/L['<?[01;ML^S29-?3'P8_X*E>+&U[P_H7C3PU9:K9S.+6?4K!F2ZD
MD8X1]A^0#)&<=JYZF65H*\;,TCC*<M'H?IK145K<"ZM89U!59$5P#U&1FI:\
M@[@HHHH ***^=?V[OC<?@M\!=5DLY8TUS6@VG6,;.R/\XQ(Z,O(9%.X>X%:4
MZ;J34([LF4E"+D^A]%45_/O'\5_'D<:K_P )SXD.T8R=4FY_\>I?^%M>//\
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M_A+-=_Z#FH_^!3_XU] LEG;6:^XX?KB['W_17SS^S+H^M:I<W?B+4M1OYK-
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MOFRBC^S*/=_A_D'^J^"_FE]Z_P CZ3_X7%X0_P"@J?\ ORU'_"XO"'_05/\
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ML]4O$*_;+%VA,;8P&5 =@(^E;0S:#^.-C*6"E]EGQ'_P2=_Y+UXK_P"Q?_\
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M@DX]*^HJ_&O_ ()[_&Q?A'\>K/3]0N6AT'Q(OV"?=*L<,4W6.:0MQ@8*_P#
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MKG_A<WC=.W]A1M_Y,+7ZFU\QF7^\/Y'KX3^$@HHHKS#L"BBB@ HHHH ****
M"OBK_@J)\74\)?!^R\&V=QMU3Q%< 2>1<;)88(\,6*@Y*,1M]#R*^U:_#_\
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M3USQ7@-?T&?$'X=^'_BEX5O_  [XFTR'5-*O(S')%*N2,]U/52/45^=/Q?\
M^"4NOZ.UU>_#C7X]9M%1/)TK5F"7+/SN_?<)CICBO4PN80E%0JNS[]SCK864
M7>&J/@=XUD7:ZAAZ,,U']CM_^>$?_?(KW/QY^Q7\:/AS;6T^J>"KB]2X;:HT
M>07K _[03I^-<7_PH7XG?]$Z\4?^"R3_  KUHUJ<E=27WG$X26Z. ^QV_P#S
MPC_[Y%'V.W_YX1_]\BN__P"%"_$[_HG7BC_P62?X4V3X%_$N&-Y)/AYXF2-
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MQAL';"/ND=P3SD>PKMQN(^K47/KLO4QHT_:32Z'L=C9Q:=9PVL"+'#"@1%4
M  "IZ**_/]]3W ILD@BC9VX502?PIU?,_P#P4%^+R_"S]GG5[>VN(TUC7B-,
MMHA,8Y@CC$DL>#G*#!X]:NG3=6:@NI$Y*$7)]#\Q?VLOBZ/C;\>O$WB*"?[3
MI<4QL=-D,>QOLT9(4$>N[=7D#-M4G&<"A00H!)8]V/4^]>C_ +.OPJD^-/QH
M\+>%-EP;*YNTDOI;7&^"W4Y:3GC ( _&ONERT:=NB1\[K4EYL_4+_@G3\&8/
MAC\ ;#69DA?6?%!&HSW$:LK>2?\ 4QL#W4$]/6OJBJEO;V^BZ6D,2+#:VL6
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MOY/+*?Z5'A90!Z9[U^%%?;W_  2V^,S>%?B5JW@*_N(X].UZ,7%J9Y#D7*#
MCC&<#<"Q/J0*ZLQH^UH\RWB8X6IR5+/9GZI4445\B>X%%%% !1110 5ROQ$\
M2CP_H3I&P^UW(,<:G/0]3[<5U$DBPQL[L$11EF/0#UKY^\8>(7\2:Y/<EF\A
M#LA0G.U1Z?4\URXBI[.-ENSW,IP?UJOS2^&.K_1&)^.3ZGO1117C'Z.%%%%
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MQW+:A=KYT,K[%:!/FE&>WR!J_>_2-*M=!TFRTVQB$%E9P);P1 Y"1HH55_
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M.D[P=B)0C-6DKGY2>./^"5'Q(T"UMG\-:_I7BN=SB6*7_0O+'J"Q.:X#6/\
M@G/\==%M&N)/#NGW2J,E+/44E?\ ("OV:HKT8YG76]F<CP=-['X5/^R3\8XY
M_*/P]UHMG&X6Y*_G7;Z+_P $[_CIKL EB\-6=HI&=M[?K"WY$5^SU%:/-:O2
M*)6#AU;/R8\#_P#!+/XJ:]?31>)=0TGPM:JF4N(IA>%V]-JXQ]:^C/A+_P $
MM_!/@^XTC5/%&NZAX@UNQN!<$6[""TD*G*@QD$_K7VW17-4S#$5-+V]#:.%I
M1Z7&11K#&D:+M1 %51V Z"ORK^-7["_[0?Q>^*_B;Q?>Z/H/F:E=LT?EZJBK
MY*_+'\I'!V!<^]?JO16&'Q$\.W*"5V:5*4:J2D?CG_P[0^/'_0'T7_P;Q_X5
M^@'[#7[.>J?LZ?"633?$7V8^(]2NFO+M;<AQ!D!1$)!]X +GTYKZ,HK:MCJN
M(AR2M8SIX>%.7,@HHHKSSJ"BBB@ HHHH \[_ &@?A+9_&[X2>(?"5U!!++>6
M[&T:XSLAN5!,4G']UL&ORW_X=G?'A,K_ &3HK[3C?_:R#=COC'>OV,HKNP^,
MJX=.,-CGJ4(57>1^.3?\$S_CP1QH^B9!!'_$VCZCD'IZU^I7P L_&FE_"7P_
MI_Q B1?%=E;BWO)H[A9Q.5X$FY0!R.WM7H=%&(QE3$)*:6@4Z$:3O$\H_:"_
M9I\&?M)Z#9:;XK@N%EL93+:7UE)Y<\&<!PIP1A@ #QVKY!\9_P#!(^&XUMW\
M)^/&T[2-@VV^J6QN)@_<EP0,?A7Z*T5%+%5J*M"6@YT:=1WDC\?M6_X)C_&Z
MSU*XAL;/1=0M$8B.Z.I)$9%]=I&1]*YO7_\ @GS\<O#L+RS>%X+Q5&<6%XLQ
M/T %?M+17:LTK]4C#ZG3[L_"F']DKXQ3S)$/AYK:ECC<]L0H^IKO=)_X)R_'
M76+831^'M/ME/.V[U%(F_(BOV9HJI9K5>R1*P<.K9^5/@+_@E/\ $/7K:67Q
M3X@TSPM*DBA+> ?;/-3N=RD!37V+\%OV!?A5\&=0CU2'39?$6M0R)-!?:RXE
M:W< @F-0  #G/.>U?2-%<=7&UZRLY67D;PP].&J04445PG2?*?QD_P""<OPT
M^+?BW6/% FU/0M9U+,LHL9P('G/65D()))QGFOF/Q5_P2;\:Z3H\USH?C+3=
M>U!3\EC);FV#C_?+$"OU(HKOIXZO35E+0YI8>E+5H_')O^":7QX52W]C:,<#
M.%U:,G^5<9XB_8F^-7AF0)<>![R\).,Z?^_'YBOW HKJ6:5NJ1B\'3Z-GX=:
M#^Q?\:/$5UY$'@74+1O[U\ODK^9KN8?^":/QWDV$Z/HT:MC.[5DRH^F*_8RB
MAYI6Z) L'3ZMGYU?#O\ X)*P1WBS>./&DEY9- ";/1XO(DCF/;S#D%1R.G-?
M:WPB^!/@CX&Z.VG^#M"M]*$JH+FX49FN&4 ;G8]2<9XP,]J[^BN"KBJU;2<M
M#IA1A3^%!7-_$:;7H/ VM'PO8+J7B!K9TLK=KE;<&1A@-YC @;<[OPKI**YD
M[.YJ]4?CS>?\$W?V@M4O;F]OM.T>ZOKJ1IIYWU>/=)(QRS'CJ35>7_@FA\>O
M+;9H^B;\<?\ $WCZ_E7['45ZW]J5^R^XXOJ=/NSSWX ?"^W^#?P?\,>$H(?(
M:QM$^T1[]X$[#=+@]QO+8KT*BBO*E)R;D]V=J2BK(****D84444 %?-7[=G[
M-6H?M%?"^U@\.Q12>*])NEN+%)I5ACE#?*ZNY'0*20/45]*T5I3J2I34X[HB
M45.+BS\<_P#AVA\>/^@/HO\ X-T_PK6\)_\ !/G]HCP/XJTCQ%I6DZ&-1TNZ
MCNX VL*%9D8$*V,$J<<CO7Z[45Z;S.NU9I?U\SD^IT^[*>CM>R:38MJ*1QZ@
MT"&Y2(Y19=HWA3Z9SBKE%%>0=P4444 <E\4?!2>/?!M]I>,W!7S+<@A?WB\J
M,GH"<9KYH7]FOQYM&;.QSCG_ $M:^Q**]+#8^MA8N$+6\SGJ48U'=GS#\.?V
M<_$%CXRL+KQ%;6Z:7;L9CY-PKEG'W5(QR">M?3H 4  8%+16.)Q53%24JG0N
MG3C35HA1117&:A7S[^VMX'^)'Q0^$K^$/AS90R7.J3*M_=SWZ6RQVZ\M&0P.
M\/TXZ8KZ"HK2G-TY*:6Q,H\T7%GXYC_@F?\ '=0 -'T0 ?\ 47C_ ,*Z7X:?
M\$T_BM'\1/#4GB_2-+7PM'?QOJ9MM41I/)!R=H Y.0*_6>BO2>9UVK:'&L'3
M3OJ1P0K;PQQ)]R-0H^@&*DHHKR3N"BBB@ HHHH *^!?VZOV'?%_QD^)VG^+_
M (?6=G<W%U:^1J<=Y=I;HA3_ %;(,<ELG)]A7WU16]&M/#SYX;F52G&K'ED?
MCG_P[0^/'_0'T7_P;I_A7M_['7[)/QV_9\^-6GZY?Z7HR>';R,V>J[=3$C)"
M?FWH@ZOD 9]":_1VBNV>8UJD7"25F81PL(M2384445Y9V!1110!\H?M!?#Q?
M"/B)=5LXUCTW4F)V+_!+U88]^N?>O**^YO'?A"W\<>&;S2;@[/-7*2#JKCE3
M^>*^)-6TNYT/4[G3[R-HKFW<HZN,'CH<>_7\:ZZ<N96/VSAG-/KV%]C4?OPT
M]5T?Z/\ X)4HHHK4^Q"BBB@ HHHH *S]>U9='T]I>#*WRQJ>Y]?PK1KSOQ-K
M!U:_(0G[/"2J ^O<U45=G9A:/MIZ[+<R&8LQ9CEF.2:I:QIB:O826[X!895L
M?=;L:NT5M.$:D7"2NF?2IVU1X_-"]O,\4BE70[2&&#3*Z_QUHXC*ZC$N QVR
M\]^QKD*_,,7AY86LZ4OEZ'J0ESJX4445QEA1110 4444 !.!FO7_ (8>%UTO
M2QJ4RC[7=+E#G.V/L/QK@? _AEO$VM(CAA:0_/,X''LN?4U[HJA5 48 & !7
MWW#.7<TGC:BT6D?7J_E_6Q^/<>YU[."RNA+66L_3HOGN_*W<*OV$^X&,]1R/
MI5"G1N8W##J*_2HRY7<_!<115:FX]>ALT4R*02QAAWI]=9\FTXNS"BBB@044
M44 %%%(S!5)/0<T =+\._!<_C[Q99Z3$'$+'?<2JNX1QCJ3Z9Z?C7W-ING6^
MDZ?;V5K&(K>!%C15&, # KR_]GKX<KX0\+)JEU&O]JZD@D9@V=L1Y51^A(]:
M]9KX?,\5]8J\D?AB>QAZ?)&[W84445XYUA1110 4444 %%%% !1110 4QYDC
M.&=5/^T<4^ORO_X*M:AJ%I\=/":VEUJ$$9T DK:2RJI/GMR=IQFNK#4/K%3V
M=[&-:I[*/-8_4U9HW;"R*Q] 0:?7XX_\$Y]2U.X_:V\,QW-YJ<T)L;[*7,LS
M(?W)QD,<5^QU5BL/]6GR7N*C5]M'FM8****XS<**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "OGK]I;X>!-GBNRC50,17
MJKU;)PK^YZ"OH6JFJZ;!K.FW-C<KN@N(VB<#K@C!Q[U49<KN>ME>/GEN*CB(
M[=5W77^NY\"45T'COP?<^!?$UUI,ZML0[H)&'^LC/0CU]/J*Y^NW<_H.E5A6
MIQJTW>+5T%%%%,T"BBF33);PO+(<(@W$T#,7Q;K T^Q-M&09YQC'HOK7 U<U
M;4GU6^DN&S@\(I_A7L*J5TQ5D?38>C[&FEUZA1115'2175NEY;R0R#*2#::\
MKU33WTN_EMGS\I^5B,;E[&O6:YOQIHHO;,WD8'GP#+'U6O S?!_6*/M(KWH_
MEU.BC/E=GU. HHHKX ] **** "@ LP4#+,<#\:*[GX7^&#J6I?VI.K"WM6_=
M\<.__P!:NW!X6>-KQH4]W^"ZOY'EYGF%+*\)/%UMHK;N^B^;.]\$^&E\,Z*D
M3*OVN;YYV'.3V'T%;]+25^Y4*,,-2C1IJT8Z'\F8O%5<=7GB:[O*3N_Z_(**
M**W.0MV,^UO+/1NE:%8O3FM6WF\Z,'OT-;TY=#P<?1Y7[6/7<EHHHK8\<***
M* "O2?@3\.CX\\7+-<HXTK3R)I7VY5W!^6//8]_H*\Y@MY+JXB@A&Z:9Q&@]
M6)P/U-?;_P *_ ,'P\\)V]@J+]LD DNI%.=\A'//<#H/I7DYEBOJ]&T?BEL=
M6'I^TEKLCL%4*H"@ #@ 4M%%?"GLA1145U=165M+<3R+%!"ADDD<X"J!DD^P
M% #;R^M]-M9+FZGCM[>-2[R2L%50!DDD^P->5W7[6OP<LXI'?XC>'VV=5CO%
M9OH *_+7]LC]JSQ%\?/B%?:=#=OI_@[1[J2"PL[*X.RX*DJ;AV&-VX9QV .*
M\U\#_LW_ !)^)&GVNI>&_ FK:GI=T2(M1CMOW#8.#\Q]Z]ZGEL5!2K2L>;+%
MOFM3C<_8S3_VP?@SJ499/B'HD./X9[D1G]:[?P3\6/!OQ(BN)/"_B;3-=2W8
M)*;&Y6383T!P:_%_6?V+?C/H^S?\.-6O-W_/G ),?6LOPC\/?&?PM^-'@+3_
M !%H&M>%[FZUBSE6WGCDB\V/SU!8A3@CMS5/+Z,D^2IK\B5BJB?O1/W@I"0H
M))P!3+BXCM8))IG6*&-2[NQP%4#))/IBORB_;*_;W\0?$3Q->>%OA[J=WH/A
M*Q:2UN;R [)M2;E'&>T74 =3US7E8?#3Q,N6)W5:L:2NS])_&'QT^'OP_P!2
MCT_Q'XRT;1KV1/,6WN[M$<KZXSTK"_X:N^#O_12?#G_@<G^-?AYX<\)Z_P#$
M/7+?2=$TO4/$FKRJWE6T*M/*P49(!.>@YZUW7_#)/QD_Z)3XD_\  $?XUZ_]
MFT8Z3J:_(X/K=27PQ/VU\#_%;P=\3%N3X4\2:;X@%MCSOL%PLOEYZ9QTK*^(
M7Q6^&O@35K>R\9^(="TG49H?-AAU21%D:/.-PW=LYKXJ_P""8?PA\;?##XC^
M.F\5^$]4\-0W6EP" ZA!Y:R,)3G;SR:\Y_X*S1H_QX\)%D5C_P (^>HS_P M
MVKCCA(2Q/L5+3N=#KR5'VC6I^A_@GXS?"?QAXC@TKPMXG\.ZEK<J.T5MI\L;
M3,JC+$ <X ZUZ97XR?\ !-Z%%_:\\,%453]@O^0/^F-?L-XJ\26/@WPWJ>NZ
MF[1Z?IUM)=3LHR0B*6; [G Z5AB\.L/44(NYI0J^TAS/0TY)$A7<[*B^K' K
MRZX_:F^$-G<S6\WQ&\.QS0NT<B-?)E6!P0>>Q%?DW^TY^V#XM_:,\43O'?76
MB>#X6VV&CVTQ0%0>)92N"7/Z X[5YOX+^!OCWXE:;+J?A7P1J_B.P24Q27=C
M:[T\P<D$GJ>17H4\L2CS5I6.66,=[4U<_;;0_P!I+X6^)M6MM+TKQ]H-_J%R
MVR&VAO4+NWH!FO1U=9%#*P93T(.17\_GC3X/^-_A5'9W7BKPEJWA5+IREM<7
MD!AWL!DA6!Z@5]'?L4_MH>)?A?XXT+PGXJUR74/ EVRV2K?/N_LXDG:ZN>0@
M).[.:BMEMH<]&5RH8N\N6:L?KMTY->5S?M5?""WFDAD^(_AU)8W,;HU\F0P.
M"#SUSQ7J"S)<6HEB8/'(FY67D$$9!%?SP^*+>(^*-=_=IG^T;DYVCKYS5S8+
M"QQ3ES.UC;$5G1M9;G]#T=S%+;I.DBM"ZAUDS\I4\@YKSC6/VF/A5X?U6ZTW
M4?B!H%G?VK^7/;RWJ!HV]",]:_)#X@?M<?$3XG?#OPC\/K>^OK:PTRS6TNOL
MLC-<:I+G :0KSM P O&,5S$G[*OQBDB:ZD^&'B21"OF--)9EB1C.XDG)XKKA
MEL8_QIV,)8MOX(W/VQ\#_&+P/\2I[J'PKXJTK7IK4*9H[&Y61DW=,@'O78U_
M.[HNK:IX/UB*^TF[NM%U2SFWI+;LT3QR*>X]0?6OV,_8/_:,E^/GPA1-9NQ/
MXMT1_LNH;Y TLR_P3L,<;^?^^:Y\7@'AX\\7=&M#$^U?*U9GTM3)9HX%W2.L
M:_WF.!7)_%CXIZ!\&? NI>*_$MV+33;),_[4LA!VQH.[,1@"OQG_ &AOVM/'
M7[0WB"XFO]3N=)\.K)FST2SE:..-03M=R#DN0>3FL,+@YXEW6B[FE:O&CYL_
M7>^_:@^$FF7L]I=?$3P_!<P.8Y(GOD#*PZ@\U7/[6'P<')^)/AS_ ,#T_P :
M_%#P5\'O&OQ06ZG\*^$-5\2K;D>?+96QD"D],D]<X-=/_P ,D_&3_HE/B3_P
M!'^->F\MH1=I5-?D<?UJH]5$_<WPYXETKQ?H]OJVB:A;ZIIMPNZ*ZM9 \;CV
M(K3KY8_X)N^%=<\%_LX_V1XATN\T?4X-;O=]G?(5DC&5QP>@KY__ &__ -MC
MQ%I_C&\^&O@+49-&ATUMFK:M:OB>27&&MU_NJ,_-ZY%>7'"RJ5W2IO;J=CK*
M--3EU/NKQ?\ 'GX=> =6&E^(_&FC:-J/EB7[-=W:H^T]#C/3BL3_ (:P^#@Y
M/Q)\.?\ @>G^-?B)X6\#^)OBCKCZ=X?T;4O%6L",S-!;JUQ*$!Y8DG@9/K72
M:_\ LT_%'PKHUWJ^L_#?7M-TNSC,MQ=W%EB.)!U9CZ5ZO]FT8Z2J:_(X_K=1
MZJ.A^\6C:WI_B+3;?4-,O(+^QN(UEBN+=PZ.I&001V(J[7X)_!S]H7QU\"=<
MAU+PKKEU%;>:DMSI<LA>VNU7C8ZGH,$XQC!Q7[:?!7XK:9\:OAKHGB[2GB\F
M_A#2PQ2>9]GFP-\3'^\IX->;BL'+"V=[IG71Q"K:;,[=F"*68A5'4DX%>;:[
M^TI\+/#.K76F:KX^T&QU"U8I-;37J!XV'8C/6OAC_@I%^UAKDGBB\^$WAF\%
MAH\,2/JU]9S?O;EF&?L^1R@7'S#J>*^*O!/PB\:_%5KN7PKX4U7Q2;=E6YFL
MX#-Y;-TW,375A\N4Z?M*LK)F-3%<LN6"N?L_:?MD?!B\N&A7XA:-&5.-TL^U
M3]":ZGPG\?/AQXZU8:7X?\:Z+J^H%"XMK6\1WVCJ<9K\=[_]B/XT6-C]I;X>
MZC<# /E01!Y/^^:X7QM\%/B+\+M(.I^(/!FO>&+:0F&.[FMVBW.0<*"ISFMO
M[/H2TA4U^1G]:JQ^*)^_ZL&4$'(/0BEKSK]G-G;X"?#UI"[2'0[/<9"2Q/E+
MUSSGZUZ+7@27+)H].+NDPHHHJ1A1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!Y)^T)\._^$J\.C5[-$&HZ:K.QQ\TD74KGVY-
M?*@.X U^@I 8$$9![5\=?&CX>R>!/%4KQ1O_ &7?,TMO(QS\QY9,^N<GZ5T4
MY?99^I\)9IS1> JO5:Q_5?JOF>?T445T'Z4%<GXVUA=JZ?$P)SNE]O05T>I7
MZ:9927$G(4<#/4]A7F-Q.]U/)-(Q:20[B3UK2"ZGIX*CS2]H]E^8RBBBMSW0
MHHHH *0@$$$9%+10!YEXET<Z/J)50WD2?-&Q_45DUZ=XDT8:SI[( //C^:-C
M_*O,2"I((P0<&OSG-,']5K^ZO=EJOU1Z5*?-$****\<V+&GV,NJ7T%G ,RS.
M$7/2O?\ 0]'AT'2H+&$#$8^9@,;F[FN)^%/A@V\+:S<*RR2 I K=-O=OQKT2
MOU/AO+OJ]'ZU47O3V\E_P?\ (_GSCC._KN*6 HO]W3W\Y?\  V];A1117V9^
M8!1110 5/9S>3*,_=;@U!133L[F=2"J1<);,VZ*K64_F1[3]Y?Y59KK3NKGR
M52FZ<W"70***U/"WAVY\7>(K#1[3 GNI-FYC@*O4G/TS1*2BG)[(S6NB/8?V
M9?AS_:NI2>*;Z-A;VC>79JR_+(Y&&<'N!R/K7T]65X7\.6?A/0K32K"-8K>W
M0*-HQN/=C[D\_C6K7Y[C,0\56<^G3T/<I4_9QL%%%%<1L%<_\0;"XU7P#XEL
MK2-IKJYTRYABC7JSM$P4#ZDBN@HIIV=Q'\Z%_I-UI,UWI5[&UM?6KO;3Q-]Z
M.13M93[@U^L'[-__  4"^%5U\-=!T77KD^$-6TNQBM9K>X3]PQ10@9''!W ;
ML8XS7G_[67_!.#6?&7C?4O&/PUGL5;4I?.N]%N#Y*H^W+R(_.YF;MQR:^.[K
M]C[XV0SO$?A=X@FV'&^.V#*?<'-?5SEA\=37-*QXL55PTG9'ZP6W[;GP4N9T
MB'CW38RQQND<JH^IKT/P7\0O _Q9MY+_ ,-:SI/B6*UD\IIK5TE\M\ X]1ZU
M^('BK]F_XH>!]!N=:\1?#S6]'TBU ,]Y=6N(XP2 "<$]R*R?A7\4=:^#'C73
M/%.A75Q;RV,RRRV\$I1;F,'YXSV^89&<=ZYI993E%NE.[-EC)IVG$_9;]M3Q
M]?\ PU_9H\;:UIL<<EU]E^R8D&1MF81,?KM<XK\/(X9-B0P(TTQPD:#EF;H!
M[DU^Q'[=6N'Q3^PWKNL"W:$ZC8V%YY(^<Q^8\3[<CKC/7VK\A-'U7^P=8T_4
M_+\T65Q'<>7_ 'MK X_2MLKC:C)VUN9XQWFO0_<?]E_X)^&_@O\ "/P]I^C:
M:L%W<6D=W>W4J SS3R(&8NW7(SM^@%>O5B>"=477/!NA:B@55NK""?:IR!NC
M4X_#-;=?-5).4FY;GKQ2C%)!7Y3?\%8_^2\>$O\ L7S_ .CVK]6:_*;_ (*Q
M_P#)>/"7_8OG_P!'M7H9;_O"]&<N+_A,X#_@G!_R=UX8_P"O"_\ _1-?=7_!
M3#Q%%H_[+^JV7VE[>\U&[MXH1&Q!?#AG&?3;7PK_ ,$X/^3NO#'_ %X7_P#Z
M)K[*_P""I_AJXU3X!V&K1'$&DZBKS#U$F$'ZUWXE)XZG?R_4YJ-_JTK'Y;^!
MM*TO7/&WA_3=;O1IFB7=]#!>WI;:+>$MAWSVP*_9_P &_M%? +P#X9T_0-#\
M?>&+#3+&)8H88;I5  '4^YZDU^+7A/PS>^-O%6C^'=-$9U'5KJ.RMA,VU/,<
MX7<>PS7TY_PZW^-7_/+PU_X'G_XBNS&TZ-5I59\IAAYSA=PC<^WOV@OC=\#?
MBU\(/$_AVX\<^%-2N;BQE-DES=*P2Y"$Q.O<,&QC%?C>T1B'ELXD:,X+J>&*
MGJ/8XKZS_P"'7'QJ_P">7AK_ ,#S_P#$4YO^"7OQNVD;?#O_ (,3_P#$5&&E
MAL,G&-2Z8ZJJUFFX'Z7_ +-OCJ?XF? 'P5XFN8%MI]0TQ'>).BE<IQ_WS7X7
M>)O^1IUS_L(W/_HUJ_<_]FOX>ZM\*/@'X.\(Z[Y']KZ38?9[G[,^^/=N8_*<
M<C!%?AAXF_Y&G7/^PC<_^C6K#+;>TJ\NW_#FN*OR0ON?IE_P2O\  'AN\^#^
MH>*9]$LYO$:ZQ<V@U*2(-,(0$(0$] ,G\Z^[:^,?^"4W_)N&I?\ 8P77_H,=
M?9U>/C&WB)W[G=A_X43\;O\ @H]X&TKP/^TW?-I2/'_;5C'JETK$%?.9F4[1
MV&%''UKVO_@D.!_:WQ...=EE_P"U*\T_X*F?\G,6/_8!@_\ 1CUZ9_P2'_Y"
MGQ._W++_ -J5[=5MY?=]E^9YT-,5IW.F_P""MWBS4M/\&>!O#L,JKI6JWLTU
MU$1R[0JK1G/L6-?#O[,_PC_X7C\;O#/A.:&6?2YYQ-J8ADV.MJO,A5NQZ?G7
MV5_P5Z/^C_"\=_M%]_Z!'7SQ_P $\?&ECX+_ &IO#QOA(1J\$NDP>6N?WTN-
MN?;Y:K#-PP/-#>S%6M+$6EMH?L/X5\):/X'T*ST;0M.M]+TRSB6&&WMT"JJJ
M, >_XUKT45\LVWJSVBEK$WV/1[^97\HQP2/OZ8(4G-?SU^)M<U#Q%XAUC5M4
MNI=1U.[NYIKBZF.7F?>?F)]< 5_05XOL?[2\*ZQ:;_+\ZTE3?Z90\U_//=,(
M[B[)Y"S2_HYKZ'*;>^_0\O'?9/U(_8<\<?!'X%_!G3_MOCOPY!XJUA1>:G+-
M*L=PA896!\\_N\D5]#7'[67P3NX)(9_B-X;FAD4J\<EVK*P/4$'J*_,3P/\
M\$Z_BS\1O"&D>)](C\/MIFK6R7=N9[W;)L89&X;3@^U;G_#K?XU?\\O#7_@>
M?_B*57#X:<W*=77Y!"K6C%*,-#R7]J/0O".@_'#Q#_P@NLV.M^&+YQ?6TFF_
MZBV\PDF!?]W'ZU]S?\$EO&&H:I\.?&7AR8I_9NC:A'):JJX8&96:3)[\@5\[
M+_P2\^-JC"IX< ]M0/\ \17V+_P3_P#V8_&O[-^G^-8?&(T\/JUQ;RVW]GW!
ME&U$8-NX&.2*UQE:C+#<BG=JQ%"%15>9QLC\Y?VO/#>I>%_VF/B'!JENUM+=
MZI)?P*YY:"0Y1Q[$"OJ#]@/]LOP!\(_AR? GBY9=%NTO))X=46/?%<*Y)/F,
M/N%> ,YS7O/[;'[$/_#1,D'B?PQ<VNF>,;. Q%9EPFH*,;$D?^':,X..]?GM
MXF_8F^-OAK5Y].;X>ZIJ_E''VK2XQ- _NK9&16D*E#&4%3J2LU\MB91J4*CE
M%7/U+_X;B^">0/\ A.M/_,UV?@_XY?#3XKWSZ7X?\6:+XBNXX_/:TAF61PN<
M;MI]SC\:_&>X_9)^,UK!)--\+?$4<,:EW=K0850,D]?2O,=/O;O1+Z.[TZXF
MTV_@?<DT),;HX.1TQT(Z&L?[-HS7[N>OR+^MU(_%$_HHCC2&-4151%& JC
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MIQ\X>Y7=TKY.\4?\$K?BGI^NW-OH&KZ)J^DICR+R\F:WEDXYW1A2%Y]ZRO\
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M\,8?$+_GMH__ ($-_P#$U]UT5K]8F?1?Z^9O_<_\!_X)\*?\,8?$+_GMH_\
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M_P#B:/\ AD[QS_SUTO\ [_M_\37V3179_:F(\ON/%]M(^-O^&3O'/_/72_\
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F1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>14
<FILENAME>sava-20230630.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created by Certent Disclosure Management 23.3.2.2 -->
<!--Based on XBRL 2.1-->
<!--Created on: 8/3/2023 3:28:41 PM-->
<!--Modified on: 8/3/2023 3:28:41 PM-->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" targetNamespace="http://www.cassavasciences.com/20230630" elementFormDefault="qualified" attributeFormDefault="unqualified" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:sava="http://www.cassavasciences.com/20230630" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-types="http://fasb.org/us-types/2023">
  <annotation>
    <appinfo><link:roleType roleURI="http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets" id="StatementCondensedConsolidatedBalanceSheets"><link:definition>00100 - Statement - Condensed Consolidated Balance Sheets</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations" id="StatementCondensedConsolidatedStatementsOfOperations"><link:definition>00200 - Statement - Condensed Consolidated Statements Of Operations</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" id="StatementCondensedConsolidatedStatementsOfCashFlows"><link:definition>00500 - Statement - Condensed Consolidated Statements Of Cash Flows</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" id="DisclosurePrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails"><link:definition>40301 - Disclosure - Prepaid Expenses And Other Current Assets (Schedule Of Prepaid Expenses And Other Current Assets) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureRealPropertyComponentsOfOtherIncomeNetDetails" id="DisclosureRealPropertyComponentsOfOtherIncomeNetDetails"><link:definition>40403 - Disclosure - Real Property (Components Of Other Income, Net) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails" id="DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails"><link:definition>40502 - Disclosure - Property And Equipment (Components Of Property And Equipment, Net) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureIntangibleAssetsComponentsOfIntangibleAssetsNetDetails" id="DisclosureIntangibleAssetsComponentsOfIntangibleAssetsNetDetails"><link:definition>40602 - Disclosure - Intangible Assets (Components Of Intangible Assets, Net) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureIntangibleAssetsAmortizationExpenseForFiniteLivedIntangibleAssetsDetails" id="DisclosureIntangibleAssetsAmortizationExpenseForFiniteLivedIntangibleAssetsDetails"><link:definition>40603 - Disclosure - Intangible Assets (Amortization Expense For Finite-Lived Intangible Assets) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation"><link:definition>00090 - Document - Document And Entity Information</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" id="StatementCondensedConsolidatedBalanceSheetsParenthetical"><link:definition>00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" id="StatementCondensedConsolidatedStatementsOfStockholdersEquity"><link:definition>00400 - Statement - Condensed Consolidated Statements Of Stockholders&apos; Equity</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureGeneralAndLiquidity" id="DisclosureGeneralAndLiquidity"><link:definition>10101 - Disclosure - General And Liquidity</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureSignificantAccountingPolicies" id="DisclosureSignificantAccountingPolicies"><link:definition>10201 - Disclosure - Significant Accounting Policies</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssets" id="DisclosurePrepaidExpensesAndOtherCurrentAssets"><link:definition>10301 - Disclosure - Prepaid Expenses And Other Current Assets</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureRealProperty" id="DisclosureRealProperty"><link:definition>10401 - Disclosure - Real Property</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosurePropertyAndEquipment" id="DisclosurePropertyAndEquipment"><link:definition>10501 - Disclosure - Property And Equipment</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureIntangibleAssets" id="DisclosureIntangibleAssets"><link:definition>10601 - Disclosure - Intangible Assets</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpense" id="DisclosureStockholdersEquityAndStockBasedCompensationExpense"><link:definition>10701 - Disclosure - Stockholders&apos; Equity And Stock-Based Compensation Expense</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureIncomeTaxes" id="DisclosureIncomeTaxes"><link:definition>10801 - Disclosure - Income Taxes</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureCommitments" id="DisclosureCommitments"><link:definition>10901 - Disclosure - Commitments</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlan" id="Disclosure2020CashIncentiveBonusPlan"><link:definition>11001 - Disclosure - 2020 Cash Incentive Bonus Plan</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureContingencies" id="DisclosureContingencies"><link:definition>11101 - Disclosure - Contingencies</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesPolicy" id="DisclosureSignificantAccountingPoliciesPolicy"><link:definition>20202 - Disclosure - Significant Accounting Policies (Policy)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesTables" id="DisclosureSignificantAccountingPoliciesTables"><link:definition>30203 - Disclosure - Significant Accounting Policies (Tables)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables" id="DisclosurePrepaidExpensesAndOtherCurrentAssetsTables"><link:definition>30303 - Disclosure - Prepaid Expenses And Other Current Assets (Tables)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureRealPropertyTables" id="DisclosureRealPropertyTables"><link:definition>30403 - Disclosure - Real Property (Tables)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentTables" id="DisclosurePropertyAndEquipmentTables"><link:definition>30503 - Disclosure - Property And Equipment (Tables)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureIntangibleAssetsTables" id="DisclosureIntangibleAssetsTables"><link:definition>30603 - Disclosure - Intangible Assets (Tables)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseTables" id="DisclosureStockholdersEquityAndStockBasedCompensationExpenseTables"><link:definition>30703 - Disclosure - Stockholders&apos; Equity And Stock-Based Compensation Expense (Tables)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureGeneralAndLiquidityNarrativeDetails" id="DisclosureGeneralAndLiquidityNarrativeDetails"><link:definition>40101 - Disclosure - General And Liquidity (Narrative) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails" id="DisclosureSignificantAccountingPoliciesNarrativeDetails"><link:definition>40201 - Disclosure - Significant Accounting Policies (Narrative) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetails" id="DisclosureSignificantAccountingPoliciesNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetails"><link:definition>40202 - Disclosure - Significant Accounting Policies (Numerators And Denominators In The Calculation Of Basic And Diluted Net Loss Per Share) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureRealPropertyNarrativeDetails" id="DisclosureRealPropertyNarrativeDetails"><link:definition>40401 - Disclosure - Real Property (Narrative) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentNarrativeDetails" id="DisclosurePropertyAndEquipmentNarrativeDetails"><link:definition>40501 - Disclosure - Property And Equipment (Narrative) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureIntangibleAssetsNarrativeDetails" id="DisclosureIntangibleAssetsNarrativeDetails"><link:definition>40601 - Disclosure - Intangible Assets (Narrative) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails" id="DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails"><link:definition>40701 - Disclosure - Stockholders&apos; Equity And Stock-Based Compensation Expense (Narrative) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockOptionsAndUnvestedPerformanceAwardOutstandingActivityDetails" id="DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockOptionsAndUnvestedPerformanceAwardOutstandingActivityDetails"><link:definition>40703 - Disclosure - Stockholders&apos; Equity And Stock-Based Compensation Expense (Stock Options And Unvested Performance Award Outstanding Activity) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockBasedCompensationExpensesDetails" id="DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockBasedCompensationExpensesDetails"><link:definition>40706 - Disclosure - Stockholders&apos; Equity And Stock-Based Compensation Expense (Stock-Based Compensation Expenses) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureIncomeTaxesNarrativeDetails" id="DisclosureIncomeTaxesNarrativeDetails"><link:definition>40801 - Disclosure - Income Taxes (Narrative) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureCommitmentsNarrativeDetails" id="DisclosureCommitmentsNarrativeDetails"><link:definition>40901 - Disclosure - Commitments (Narrative) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails" id="Disclosure2020CashIncentiveBonusPlanNarrativeDetails"><link:definition>41001 - Disclosure - 2020 Cash Incentive Bonus Plan (Narrative) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:roleType roleURI="http://www.cassavasciences.com/role/DisclosureContingenciesNarrativeDetails" id="DisclosureContingenciesNarrativeDetails"><link:definition>41101 - Disclosure - Contingencies (Narrative) (Details)</link:definition><link:usedOn>link:presentationLink</link:usedOn><link:usedOn>link:calculationLink</link:usedOn><link:usedOn>link:definitionLink</link:usedOn></link:roleType><link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:href="sava-20230630_cal.xml" xlink:title="Calculation Links, all"></link:linkbaseRef><link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:href="sava-20230630_def.xml" xlink:title="Definition Links, all"></link:linkbaseRef><link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:href="sava-20230630_lab.xml" xlink:title="Label Links, all"></link:linkbaseRef><link:linkbaseRef xlink:type="simple" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:href="sava-20230630_pre.xml" xlink:title="Presentation Links, all"></link:linkbaseRef></appinfo></annotation>
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"></import>
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"></import>
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"></import>
  <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"></import>
  <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"></import>
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"></import>
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"></import>
  <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"></import>
  <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"></import>
  <import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"></import>
  <element name="AustinMember" id="sava_AustinMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item"></element>
  <element id="sava_StockOptionAndPerformanceAwardActivity" name="StockOptionAndPerformanceAwardActivity" nillable="true" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_AtMarketEquityProgramMember" name="AtMarketEquityProgramMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_ReductionToResearchAndDevelopmentExpense" name="ReductionToResearchAndDevelopmentExpense" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit"></element>
  <element id="sava_TwoThousandEighteenEquityIncentivePlanMember" name="TwoThousandEighteenEquityIncentivePlanMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_SignificantAccountingPoliciesTable" name="SignificantAccountingPoliciesTable" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" abstract="true" xbrli:periodType="duration"></element>
  <element id="sava_SignificantAccountingPoliciesLineItems" name="SignificantAccountingPoliciesLineItems" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration"></element>
  <element id="sava_ResearchAndDevelopmentExpenseNetOfGrantReimbursement" name="ResearchAndDevelopmentExpenseNetOfGrantReimbursement" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit"></element>
  <element id="sava_ProceedsFromGrantsPolicyPolicyTextBlock" name="ProceedsFromGrantsPolicyPolicyTextBlock" nillable="true" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_ResearchContractCostsAndAccrualsPolicyPolicyTextBlock" name="ResearchContractCostsAndAccrualsPolicyPolicyTextBlock" nillable="true" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_PercentageOfCommissionAtmOffering" name="PercentageOfCommissionAtmOffering" nillable="true" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant"></element>
  <element id="sava_CashIncentiveBonusPlanTextBlock" name="CashIncentiveBonusPlanTextBlock" nillable="true" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_CashIncentiveBonusPlanAbstract" name="CashIncentiveBonusPlanAbstract" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration"></element>
  <element id="sava_PerformancePlanValuationAmount" name="PerformancePlanValuationAmount" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit"></element>
  <element id="sava_CashIncentiveBonusAward" name="CashIncentiveBonusAward" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit"></element>
  <element id="sava_CashIncentiveBonusPlanTable" name="CashIncentiveBonusPlanTable" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" abstract="true" xbrli:periodType="duration"></element>
  <element id="sava_CashIncentiveBonusPlanLineItems" name="CashIncentiveBonusPlanLineItems" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration"></element>
  <element id="sava_CashIncentiveBonusPlanMember" name="CashIncentiveBonusPlanMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_StockOptionAndPerformanceAwardActivity2020PlanMember" name="StockOptionAndPerformanceAwardActivity2020PlanMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_Exceeds5BillionMarketCapitalizationMember" name="Exceeds5BillionMarketCapitalizationMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_PercentageValuationMilestoneCashBonusAwardSubjectToApprovalAndAdjustment" name="PercentageValuationMilestoneCashBonusAwardSubjectToApprovalAndAdjustment" nillable="true" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_FirstValuationMilestoneMember" name="FirstValuationMilestoneMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_PaymentsForCashIncentiveBonus" name="PaymentsForCashIncentiveBonus" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit"></element>
  <element id="sava_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet" name="IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit"></element>
  <element id="sava_SecondThroughEighthValuationMilestonesMember" name="SecondThroughEighthValuationMilestonesMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_StockOptionsExercisedNetSettledSatisfactionOfExercisePrice" name="StockOptionsExercisedNetSettledSatisfactionOfExercisePrice" nillable="true" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_ProceedsFromStockOptionsExercisedNetSettledSatisfactionOfExercisePrice" name="ProceedsFromStockOptionsExercisedNetSettledSatisfactionOfExercisePrice" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit"></element>
  <element id="sava_OperatingLeasesMember" name="OperatingLeasesMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_PrepaidAndOtherAssetsDisclosureTextBlock" name="PrepaidAndOtherAssetsDisclosureTextBlock" nillable="true" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_LeasingCommissionsAndOtherMember" name="LeasingCommissionsAndOtherMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_PercentageOfCurrentlyLeased" name="PercentageOfCurrentlyLeased" nillable="true" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_PercentageOfOccupancy" name="PercentageOfOccupancy" nillable="true" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_ExceedingPerformanceMilestonesMinimum20ConsecutiveDaysMember" name="ExceedingPerformanceMilestonesMinimum20ConsecutiveDaysMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_NumberOfValuationMilestonesAchieved" name="NumberOfValuationMilestonesAchieved" nillable="true" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_MinimumNumberOfValuationMilestonesToRecognizeCompensationExpense" name="MinimumNumberOfValuationMilestonesToRecognizeCompensationExpense" nillable="true" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_MinimumNumberOfDaysValuationMilestoneMustBeAchievedAndMaintained" name="MinimumNumberOfDaysValuationMilestoneMustBeAchievedAndMaintained" nillable="true" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_ViolationsOfFederalSecuritiesLawsMember" name="ViolationsOfFederalSecuritiesLawsMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_ShareholderDerivativeActionsMember" name="ShareholderDerivativeActionsMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_TwoBuildingOfficeComplexAssetMember" name="TwoBuildingOfficeComplexAssetMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_RegisteredDirectOffering2022Member" name="RegisteredDirectOffering2022Member" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_IndependentDirectorsMember" name="IndependentDirectorsMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_IncreaseDecreaseInDevelopmentExpense" name="IncreaseDecreaseInDevelopmentExpense" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit"></element>
  <element id="sava_ShareholderDerivativeActionsU.s.DistrictCourtMember" name="ShareholderDerivativeActionsU.s.DistrictCourtMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_ShareholderDerivativeActionsTexasCourtMember" name="ShareholderDerivativeActionsTexasCourtMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element>
  <element id="sava_ShareholderDerivativeActionsDelwareCourtMember" name="ShareholderDerivativeActionsDelwareCourtMember" nillable="true" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration"></element></schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>15
<FILENAME>sava-20230630_cal.xml
<DESCRIPTION>EX-101.CAL
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created by Certent Disclosure Management 23.3.2.2 -->
<!--Based on XBRL 2.1-->
<!--Created on: 8/3/2023 3:28:41 PM-->
<!--Modified on: 8/3/2023 3:28:41 PM-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#StatementCondensedConsolidatedBalanceSheets" roleURI="http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#StatementCondensedConsolidatedStatementsOfOperations" roleURI="http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#StatementCondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosurePrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" roleURI="http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureRealPropertyComponentsOfOtherIncomeNetDetails" roleURI="http://www.cassavasciences.com/role/DisclosureRealPropertyComponentsOfOtherIncomeNetDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails" roleURI="http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureIntangibleAssetsComponentsOfIntangibleAssetsNetDetails" roleURI="http://www.cassavasciences.com/role/DisclosureIntangibleAssetsComponentsOfIntangibleAssetsNetDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureIntangibleAssetsAmortizationExpenseForFiniteLivedIntangibleAssetsDetails" roleURI="http://www.cassavasciences.com/role/DisclosureIntangibleAssetsAmortizationExpenseForFiniteLivedIntangibleAssetsDetails"></roleRef>
  <calculationLink xlink:role="http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets" xlink:type="extended" xlink:title="00100 - Statement - Condensed Consolidated Balance Sheets">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent_638266733182837627"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent_638266733182837627" order="1" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_638266733182837627"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_638266733182837627" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_638266733182837627" order="1" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_638266733182837627"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_638266733182837627" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_638266733182837627" order="2" use="optional" weight="1" priority="3"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_638266733182837627"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_638266733182837627" order="2" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_638266733182837627"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_638266733182837627" order="3" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_638266733182837627"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_638266733182837627" order="4" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities_638266733182837627"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities_638266733182837627" order="1" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent_638266733182837627"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_638266733182837627" xlink:to="us-gaap_LiabilitiesCurrent_638266733182837627" order="1" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent_638266733182837627"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_638266733182837627" xlink:to="us-gaap_AccountsPayableCurrent_638266733182837627" order="1" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent_638266733182837627"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_638266733182837627" xlink:to="us-gaap_AccruedLiabilitiesCurrent_638266733182837627" order="2" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_638266733182837627"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_638266733182837627" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_638266733182837627" order="3" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent_638266733182837627"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_638266733182837627" xlink:to="us-gaap_OtherLiabilitiesCurrent_638266733182837627" order="4" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_638266733182837627"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_638266733182837627" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_638266733182837627" order="5" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_638266733182837627"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_638266733182837627" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_638266733182837627" order="2" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_638266733182837627"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_638266733182837627" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_638266733182837627" order="3" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_638266733182837627"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity_638266733182837627" order="2" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue_638266733182837627"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_638266733182837627" xlink:to="us-gaap_PreferredStockValue_638266733182837627" order="1" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue_638266733182837627"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_638266733182837627" xlink:to="us-gaap_CommonStockValue_638266733182837627" order="2" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital_638266733182837627"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_638266733182837627" xlink:to="us-gaap_AdditionalPaidInCapital_638266733182837627" order="3" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_638266733182837627"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_638266733182837627" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_638266733182837627" order="4" use="optional" weight="1" priority="2"></calculationArc></calculationLink>
  <calculationLink xlink:role="http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations" xlink:type="extended" xlink:title="00200 - Statement - Condensed Consolidated Statements Of Operations">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_638266733182847600"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_638266733182847600" order="1" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndOtherIncome" xlink:label="us-gaap_InterestAndOtherIncome_638266733182847600"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_InterestAndOtherIncome_638266733182847600" order="2" use="optional" weight="1" priority="9"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_638266733182847600"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_638266733182847600" order="3" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses_638266733182847600"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss_638266733182847600" xlink:to="us-gaap_OperatingExpenses_638266733182847600" order="1" use="optional" weight="-1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense_638266733182847600"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses_638266733182847600" xlink:to="us-gaap_GeneralAndAdministrativeExpense_638266733182847600" order="1" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ResearchAndDevelopmentExpenseNetOfGrantReimbursement" xlink:label="sava_ResearchAndDevelopmentExpenseNetOfGrantReimbursement_638266733182847600"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses_638266733182847600" xlink:to="sava_ResearchAndDevelopmentExpenseNetOfGrantReimbursement_638266733182847600" order="2" use="optional" weight="1" priority="2"></calculationArc></calculationLink>
  <calculationLink xlink:role="http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" xlink:type="extended" xlink:title="00500 - Statement - Condensed Consolidated Statements Of Cash Flows">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_638266733182847600"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_638266733182847600" order="1" use="optional" weight="1" priority="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_IncreaseDecreaseInDevelopmentExpense" xlink:label="sava_IncreaseDecreaseInDevelopmentExpense_638266733182847600"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638266733182847600" xlink:to="sava_IncreaseDecreaseInDevelopmentExpense_638266733182847600" order="1" use="optional" weight="1" priority="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_638266733182847600"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638266733182847600" xlink:to="us-gaap_NetIncomeLoss_638266733182847600" order="2" use="optional" weight="1" priority="3"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation_638266733182847600"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638266733182847600" xlink:to="us-gaap_ShareBasedCompensation_638266733182847600" order="3" use="optional" weight="1" priority="3"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets_638266733182847600"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638266733182847600" xlink:to="us-gaap_AmortizationOfIntangibleAssets_638266733182847600" order="4" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation_638266733182847600"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638266733182847600" xlink:to="us-gaap_Depreciation_638266733182847600" order="5" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_638266733182847600"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638266733182847600" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_638266733182847600" order="6" use="optional" weight="1" priority="3"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_638266733182847600"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638266733182847600" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_638266733182847600" order="7" use="optional" weight="1" priority="3"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_638266733182847600"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638266733182847600" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_638266733182847600" order="8" use="optional" weight="-1" priority="3"></calculationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet" xlink:label="sava_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet_638266733182847600"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638266733182847600" xlink:to="sava_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet_638266733182847600" order="9" use="optional" weight="-1" priority="3"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_638266733182847600"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_638266733182847600" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_638266733182847600" order="10" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_638266733182847600"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_638266733182847600" order="2" use="optional" weight="1" priority="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_638266733182847600"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_638266733182847600" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_638266733182847600" order="1" use="optional" weight="-1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_638266733182847600"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_638266733182847600" order="3" use="optional" weight="1" priority="1"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_638266733182847600"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638266733182847600" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_638266733182847600" order="1" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_638266733182847600"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_638266733182847600" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_638266733182847600" order="2" use="optional" weight="1" priority="2"></calculationArc></calculationLink>
  <calculationLink xlink:role="http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" xlink:type="extended" xlink:title="40301 - Disclosure - Prepaid Expenses And Other Current Assets (Schedule Of Prepaid Expenses And Other Current Assets) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestReceivableCurrent" xlink:label="us-gaap_InterestReceivableCurrent_638266733182857574"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_InterestReceivableCurrent_638266733182857574" order="1" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_638266733182857574"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent_638266733182857574" order="2" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance_638266733182857574"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidInsurance_638266733182857574" order="3" use="optional" weight="1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositContractsAssets" xlink:label="us-gaap_DepositContractsAssets_638266733182857574"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_DepositContractsAssets_638266733182857574" order="4" use="optional" weight="1" priority="2"></calculationArc></calculationLink>
  <calculationLink xlink:role="http://www.cassavasciences.com/role/DisclosureRealPropertyComponentsOfOtherIncomeNetDetails" xlink:type="extended" xlink:title="40403 - Disclosure - Real Property (Components Of Other Income, Net) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="us-gaap_OtherNonoperatingExpense_638266733182877518"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingExpense_638266733182877518" order="1" use="optional" weight="-1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="us-gaap_OtherNonoperatingIncome_638266733182877518"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncome_638266733182877518" order="2" use="optional" weight="1" priority="2"></calculationArc></calculationLink>
  <calculationLink xlink:role="http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails" xlink:type="extended" xlink:title="40502 - Disclosure - Property And Equipment (Components Of Property And Equipment, Net) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_638266733182877518"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_638266733182877518" order="1" use="optional" weight="-1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_638266733182877518"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_638266733182877518" order="2" use="optional" weight="1" priority="2"></calculationArc></calculationLink>
  <calculationLink xlink:role="http://www.cassavasciences.com/role/DisclosureIntangibleAssetsComponentsOfIntangibleAssetsNetDetails" xlink:type="extended" xlink:title="40602 - Disclosure - Intangible Assets (Components Of Intangible Assets, Net) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_638266733182887493"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_638266733182887493" order="1" use="optional" weight="-1" priority="2"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_638266733182887493"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_638266733182887493" order="2" use="optional" weight="1" priority="2"></calculationArc></calculationLink>
  <calculationLink xlink:role="http://www.cassavasciences.com/role/DisclosureIntangibleAssetsAmortizationExpenseForFiniteLivedIntangibleAssetsDetails" xlink:type="extended" xlink:title="40603 - Disclosure - Intangible Assets (Amortization Expense For Finite-Lived Intangible Assets) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_638266733182887493"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_638266733182887493" order="1" use="optional" weight="1" priority="3"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_638266733182887493"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_638266733182887493" order="2" use="optional" weight="1" priority="3"></calculationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_638266733182887493"></loc>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_638266733182887493" order="3" use="optional" weight="1" priority="3"></calculationArc></calculationLink></linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>16
<FILENAME>sava-20230630_def.xml
<DESCRIPTION>EX-101.DEF
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created by Certent Disclosure Management 23.3.2.2 -->
<!--Based on XBRL 2.1-->
<!--Created on: 8/3/2023 3:28:41 PM-->
<!--Modified on: 8/3/2023 3:28:41 PM-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#StatementCondensedConsolidatedStatementsOfStockholdersEquity" roleURI="http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureSignificantAccountingPoliciesNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetails" roleURI="http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureRealPropertyNarrativeDetails" roleURI="http://www.cassavasciences.com/role/DisclosureRealPropertyNarrativeDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureRealPropertyComponentsOfOtherIncomeNetDetails" roleURI="http://www.cassavasciences.com/role/DisclosureRealPropertyComponentsOfOtherIncomeNetDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails" roleURI="http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureIntangibleAssetsComponentsOfIntangibleAssetsNetDetails" roleURI="http://www.cassavasciences.com/role/DisclosureIntangibleAssetsComponentsOfIntangibleAssetsNetDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails" roleURI="http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockOptionsAndUnvestedPerformanceAwardOutstandingActivityDetails" roleURI="http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockOptionsAndUnvestedPerformanceAwardOutstandingActivityDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockBasedCompensationExpensesDetails" roleURI="http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockBasedCompensationExpensesDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureCommitmentsNarrativeDetails" roleURI="http://www.cassavasciences.com/role/DisclosureCommitmentsNarrativeDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#Disclosure2020CashIncentiveBonusPlanNarrativeDetails" roleURI="http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureContingenciesNarrativeDetails" roleURI="http://www.cassavasciences.com/role/DisclosureContingenciesNarrativeDetails"></roleRef>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"></arcroleRef>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"></arcroleRef>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"></arcroleRef>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"></arcroleRef>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"></arcroleRef>
  <definitionLink xlink:role="http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" xlink:type="extended" xlink:title="00400 - Statement - Condensed Consolidated Statements Of Stockholders&apos; Equity">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_638266733182887493"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_638266733182887493" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesIssued" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="1" use="optional"></definitionArc></definitionLink>
  <definitionLink xlink:role="http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" xlink:title="40201 - Disclosure - Significant Accounting Policies (Narrative) (Details)">
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_SignificantAccountingPoliciesTable" xlink:label="sava_SignificantAccountingPoliciesTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="sava_SignificantAccountingPoliciesTable" xlink:to="us-gaap_AwardTypeAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638266733182897469"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638266733182897469" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="sava_SignificantAccountingPoliciesTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_638266733182907442"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_638266733182907442" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_BuildingMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="us-gaap_BuildingAndBuildingImprovementsMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_BuildingAndBuildingImprovementsMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="sava_SignificantAccountingPoliciesTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638266733182907442"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638266733182907442" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAcquiredInPlaceMember" xlink:label="us-gaap_LeasesAcquiredInPlaceMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_LeasesAcquiredInPlaceMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_SignificantAccountingPoliciesLineItems" xlink:label="sava_SignificantAccountingPoliciesLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="sava_SignificantAccountingPoliciesLineItems" xlink:to="sava_SignificantAccountingPoliciesTable" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ReductionToResearchAndDevelopmentExpense" xlink:label="sava_ReductionToResearchAndDevelopmentExpense"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="sava_SignificantAccountingPoliciesLineItems" xlink:to="sava_ReductionToResearchAndDevelopmentExpense" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="sava_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="sava_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="sava_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="sava_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="sava_SignificantAccountingPoliciesLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="1" use="optional"></definitionArc></definitionLink>
  <definitionLink xlink:role="http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetails" xlink:type="extended" xlink:title="40202 - Disclosure - Significant Accounting Policies (Numerators And Denominators In The Calculation Of Basic And Diluted Net Loss Per Share) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_638266733182917412"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_638266733182917412" priority="2" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="us-gaap_NetIncomeLossAbstract"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_NetIncomeLossAbstract" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLoss" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_EarningsPerShareBasic" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="1" use="optional"></definitionArc></definitionLink>
  <definitionLink xlink:role="http://www.cassavasciences.com/role/DisclosureRealPropertyNarrativeDetails" xlink:type="extended" xlink:title="40401 - Disclosure - Real Property (Narrative) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTable" xlink:label="us-gaap_AssetAcquisitionTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="srt_StatementGeographicalAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_638266733182927385"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_638266733182927385" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_AustinMember" xlink:label="sava_AustinMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_SegmentGeographicalDomain" xlink:to="sava_AustinMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="us-gaap_AssetAcquisitionAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="us-gaap_AssetAcquisitionAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="us-gaap_AssetAcquisitionDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="us-gaap_AssetAcquisitionDomain_638266733182927385"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionDomain_638266733182927385" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_TwoBuildingOfficeComplexAssetMember" xlink:label="sava_TwoBuildingOfficeComplexAssetMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_AssetAcquisitionDomain" xlink:to="sava_TwoBuildingOfficeComplexAssetMember" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionLineItems" xlink:label="us-gaap_AssetAcquisitionLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_AssetAcquisitionLineItems" xlink:to="us-gaap_AssetAcquisitionTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_PercentageOfOccupancy" xlink:label="sava_PercentageOfOccupancy"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_AssetAcquisitionLineItems" xlink:to="sava_PercentageOfOccupancy" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_PercentageOfCurrentlyLeased" xlink:label="sava_PercentageOfCurrentlyLeased"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_AssetAcquisitionLineItems" xlink:to="sava_PercentageOfCurrentlyLeased" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetRentableArea" xlink:label="us-gaap_NetRentableArea"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_AssetAcquisitionLineItems" xlink:to="us-gaap_NetRentableArea" priority="1" use="optional"></definitionArc></definitionLink>
  <definitionLink xlink:role="http://www.cassavasciences.com/role/DisclosureRealPropertyComponentsOfOtherIncomeNetDetails" xlink:type="extended" xlink:title="40403 - Disclosure - Real Property (Components Of Other Income, Net) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="srt_StatementGeographicalAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_AustinMember" xlink:label="sava_AustinMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_SegmentGeographicalDomain" xlink:to="sava_AustinMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_BuildingMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="us-gaap_OtherNonoperatingIncome"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_OtherNonoperatingIncome" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="us-gaap_OtherNonoperatingExpense"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_OtherNonoperatingExpense" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" priority="1" use="optional"></definitionArc></definitionLink>
  <definitionLink xlink:role="http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails" xlink:type="extended" xlink:title="40502 - Disclosure - Property And Equipment (Components Of Property And Equipment, Net) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember" xlink:label="us-gaap_LandMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LandMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_BuildingMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="us-gaap_BuildingAndBuildingImprovementsMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_BuildingAndBuildingImprovementsMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="1" use="optional"></definitionArc></definitionLink>
  <definitionLink xlink:role="http://www.cassavasciences.com/role/DisclosureIntangibleAssetsComponentsOfIntangibleAssetsNetDetails" xlink:type="extended" xlink:title="40602 - Disclosure - Intangible Assets (Components Of Intangible Assets, Net) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAcquiredInPlaceMember" xlink:label="us-gaap_LeasesAcquiredInPlaceMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_LeasesAcquiredInPlaceMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_LeasingCommissionsAndOtherMember" xlink:label="sava_LeasingCommissionsAndOtherMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="sava_LeasingCommissionsAndOtherMember" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" priority="1" use="optional"></definitionArc></definitionLink>
  <definitionLink xlink:role="http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails" xlink:type="extended" xlink:title="40701 - Disclosure - Stockholders&apos; Equity And Stock-Based Compensation Expense (Narrative) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_StatementClassOfStockAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638266733182957305"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_638266733182957305" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_AwardTypeAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_PerformanceSharesMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_PlanNameAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_638266733182957305"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_638266733182957305" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_RegisteredDirectOffering2022Member" xlink:label="sava_RegisteredDirectOffering2022Member"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_PlanNameDomain" xlink:to="sava_RegisteredDirectOffering2022Member" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_AtMarketEquityProgramMember" xlink:label="sava_AtMarketEquityProgramMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_PlanNameDomain" xlink:to="sava_AtMarketEquityProgramMember" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_StockOptionAndPerformanceAwardActivity2020PlanMember" xlink:label="sava_StockOptionAndPerformanceAwardActivity2020PlanMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_PlanNameDomain" xlink:to="sava_StockOptionAndPerformanceAwardActivity2020PlanMember" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_TwoThousandEighteenEquityIncentivePlanMember" xlink:label="sava_TwoThousandEighteenEquityIncentivePlanMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_PlanNameDomain" xlink:to="sava_TwoThousandEighteenEquityIncentivePlanMember" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="srt_RangeAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="srt_RangeMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="srt_RangeMember_638266733182967278"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_638266733182967278" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_PercentageOfCommissionAtmOffering" xlink:label="sava_PercentageOfCommissionAtmOffering"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="sava_PercentageOfCommissionAtmOffering" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_StockOptionsExercisedNetSettledSatisfactionOfExercisePrice" xlink:label="sava_StockOptionsExercisedNetSettledSatisfactionOfExercisePrice"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="sava_StockOptionsExercisedNetSettledSatisfactionOfExercisePrice" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ProceedsFromStockOptionsExercisedNetSettledSatisfactionOfExercisePrice" xlink:label="sava_ProceedsFromStockOptionsExercisedNetSettledSatisfactionOfExercisePrice"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="sava_ProceedsFromStockOptionsExercisedNetSettledSatisfactionOfExercisePrice" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="16" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="1" use="optional"></definitionArc></definitionLink>
  <definitionLink xlink:role="http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockOptionsAndUnvestedPerformanceAwardOutstandingActivityDetails" xlink:type="extended" xlink:title="40703 - Disclosure - Stockholders&apos; Equity And Stock-Based Compensation Expense (Stock Options And Unvested Performance Award Outstanding Activity) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_PerformanceSharesMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" priority="1" use="optional"></definitionArc></definitionLink>
  <definitionLink xlink:role="http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockBasedCompensationExpensesDetails" xlink:type="extended" xlink:title="40706 - Disclosure - Stockholders&apos; Equity And Stock-Based Compensation Expense (Stock-Based Compensation Expenses) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_638266733182997198"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_638266733182997198" priority="2" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="1" use="optional"></definitionArc></definitionLink>
  <definitionLink xlink:role="http://www.cassavasciences.com/role/DisclosureCommitmentsNarrativeDetails" xlink:type="extended" xlink:title="40901 - Disclosure - Commitments (Narrative) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:label="us-gaap_ScheduleOfOperatingLeasedAssetsTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="srt_StatementGeographicalAxis" priority="2" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" priority="2" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_AustinMember" xlink:label="sava_AustinMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_SegmentGeographicalDomain" xlink:to="sava_AustinMember" priority="2" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_BuildingMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="us-gaap_LeaseContractualTermAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain_638266733183007172"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain_638266733183007172" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_OperatingLeasesMember" xlink:label="sava_OperatingLeasesMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="sava_OperatingLeasesMember" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:label="us-gaap_OperatingLeasedAssetsLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_ScheduleOfOperatingLeasedAssetsTable" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetRentableArea" xlink:label="us-gaap_NetRentableArea"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_NetRentableArea" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_LeaseExpirationDate1" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeaseCost" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasePayments" priority="1" use="optional"></definitionArc></definitionLink>
  <definitionLink xlink:role="http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails" xlink:type="extended" xlink:title="41001 - Disclosure - 2020 Cash Incentive Bonus Plan (Narrative) (Details)">
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_CashIncentiveBonusPlanTable" xlink:label="sava_CashIncentiveBonusPlanTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="sava_CashIncentiveBonusPlanTable" xlink:to="us-gaap_PlanNameAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_CashIncentiveBonusPlanMember" xlink:label="sava_CashIncentiveBonusPlanMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_PlanNameDomain" xlink:to="sava_CashIncentiveBonusPlanMember" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="sava_CashIncentiveBonusPlanTable" xlink:to="srt_RangeAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="srt_RangeMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="sava_CashIncentiveBonusPlanTable" xlink:to="srt_StatementScenarioAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_638266733183027121"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_638266733183027121" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ExceedingPerformanceMilestonesMinimum20ConsecutiveDaysMember" xlink:label="sava_ExceedingPerformanceMilestonesMinimum20ConsecutiveDaysMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="sava_ExceedingPerformanceMilestonesMinimum20ConsecutiveDaysMember" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_Exceeds5BillionMarketCapitalizationMember" xlink:label="sava_Exceeds5BillionMarketCapitalizationMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="sava_Exceeds5BillionMarketCapitalizationMember" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_FirstValuationMilestoneMember" xlink:label="sava_FirstValuationMilestoneMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="sava_FirstValuationMilestoneMember" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_SecondThroughEighthValuationMilestonesMember" xlink:label="sava_SecondThroughEighthValuationMilestonesMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="sava_SecondThroughEighthValuationMilestonesMember" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="sava_CashIncentiveBonusPlanTable" xlink:to="srt_TitleOfIndividualAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_638266733183027121"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_638266733183027121" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_IndependentDirectorsMember" xlink:label="sava_IndependentDirectorsMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="sava_IndependentDirectorsMember" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_CashIncentiveBonusPlanLineItems" xlink:label="sava_CashIncentiveBonusPlanLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="sava_CashIncentiveBonusPlanLineItems" xlink:to="sava_CashIncentiveBonusPlanTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_MinimumNumberOfDaysValuationMilestoneMustBeAchievedAndMaintained" xlink:label="sava_MinimumNumberOfDaysValuationMilestoneMustBeAchievedAndMaintained"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="sava_CashIncentiveBonusPlanLineItems" xlink:to="sava_MinimumNumberOfDaysValuationMilestoneMustBeAchievedAndMaintained" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_MinimumNumberOfValuationMilestonesToRecognizeCompensationExpense" xlink:label="sava_MinimumNumberOfValuationMilestonesToRecognizeCompensationExpense"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="sava_CashIncentiveBonusPlanLineItems" xlink:to="sava_MinimumNumberOfValuationMilestonesToRecognizeCompensationExpense" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_NumberOfValuationMilestonesAchieved" xlink:label="sava_NumberOfValuationMilestonesAchieved"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="sava_CashIncentiveBonusPlanLineItems" xlink:to="sava_NumberOfValuationMilestonesAchieved" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_PerformancePlanValuationAmount" xlink:label="sava_PerformancePlanValuationAmount"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="sava_CashIncentiveBonusPlanLineItems" xlink:to="sava_PerformancePlanValuationAmount" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_PercentageValuationMilestoneCashBonusAwardSubjectToApprovalAndAdjustment" xlink:label="sava_PercentageValuationMilestoneCashBonusAwardSubjectToApprovalAndAdjustment"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="sava_CashIncentiveBonusPlanLineItems" xlink:to="sava_PercentageValuationMilestoneCashBonusAwardSubjectToApprovalAndAdjustment" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_CashIncentiveBonusAward" xlink:label="sava_CashIncentiveBonusAward"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="sava_CashIncentiveBonusPlanLineItems" xlink:to="sava_CashIncentiveBonusAward" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:label="us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="sava_CashIncentiveBonusPlanLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_PaymentsForCashIncentiveBonus" xlink:label="sava_PaymentsForCashIncentiveBonus"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="sava_CashIncentiveBonusPlanLineItems" xlink:to="sava_PaymentsForCashIncentiveBonus" priority="1" use="optional"></definitionArc></definitionLink>
  <definitionLink xlink:role="http://www.cassavasciences.com/role/DisclosureContingenciesNarrativeDetails" xlink:type="extended" xlink:title="41101 - Disclosure - Contingencies (Narrative) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseAxis" xlink:label="srt_LitigationCaseAxis"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_LossContingenciesTable" xlink:to="srt_LitigationCaseAxis" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseTypeDomain" xlink:label="srt_LitigationCaseTypeDomain"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="srt_LitigationCaseAxis" xlink:to="srt_LitigationCaseTypeDomain" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseTypeDomain" xlink:label="srt_LitigationCaseTypeDomain_638266733183057040"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="srt_LitigationCaseAxis" xlink:to="srt_LitigationCaseTypeDomain_638266733183057040" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ViolationsOfFederalSecuritiesLawsMember" xlink:label="sava_ViolationsOfFederalSecuritiesLawsMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="srt_LitigationCaseTypeDomain" xlink:to="sava_ViolationsOfFederalSecuritiesLawsMember" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ShareholderDerivativeActionsMember" xlink:label="sava_ShareholderDerivativeActionsMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="srt_LitigationCaseTypeDomain" xlink:to="sava_ShareholderDerivativeActionsMember" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ShareholderDerivativeActionsU.s.DistrictCourtMember" xlink:label="sava_ShareholderDerivativeActionsU.s.DistrictCourtMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="srt_LitigationCaseTypeDomain" xlink:to="sava_ShareholderDerivativeActionsU.s.DistrictCourtMember" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ShareholderDerivativeActionsTexasCourtMember" xlink:label="sava_ShareholderDerivativeActionsTexasCourtMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="srt_LitigationCaseTypeDomain" xlink:to="sava_ShareholderDerivativeActionsTexasCourtMember" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ShareholderDerivativeActionsDelwareCourtMember" xlink:label="sava_ShareholderDerivativeActionsDelwareCourtMember"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="srt_LitigationCaseTypeDomain" xlink:to="sava_ShareholderDerivativeActionsDelwareCourtMember" priority="1" use="optional"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true"></definitionArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyNewClaimsFiledNumber" xlink:label="us-gaap_LossContingencyNewClaimsFiledNumber"></loc>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingencyNewClaimsFiledNumber" priority="1" use="optional"></definitionArc></definitionLink></linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>17
<FILENAME>sava-20230630_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created by Certent Disclosure Management 23.3.2.2 -->
<!--Based on XBRL 2.1-->
<!--Created on: 8/3/2023 3:28:41 PM-->
<!--Modified on: 8/3/2023 3:28:41 PM-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"></roleRef>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"></roleRef>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"></roleRef>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Document And Entity Information [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Condensed Consolidated Balance Sheets [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Assets Current [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash And Cash Equivalents At Carrying Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid Expense and Other Assets, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Total prepaid expenses and other current assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Assets Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating Lease, Right-of-Use Asset</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating lease right-of-use assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property, Plant and Equipment, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Liabilities Current [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts Payable Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable and accrued expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued Development Expense Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued development expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Employee Related Liabilities Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued compensation and benefits</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating Lease, Liability, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease liabilities, current</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other current liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Liabilities Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating Lease, Liability, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liabilities, non-current</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Other Liabilities, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Other non-current liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments And Contingencies</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies (Notes 10, 11 and 12)</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders Equity [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&apos; equity:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred Stock Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, $0.001 par value; 10,000,000 shares authorized, none issued and outstanding</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common Stock Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $0.001 par value; 120,000,000 shares authorized; 41,919,527 and 41,735,557 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional Paid In Capital</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Retained Earnings Accumulated Deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Stockholders Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders&apos; equity</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Liabilities And Stockholders Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and stockholders&apos; equity</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred Stock, Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred Stock, Shares Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred Stock, Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Par value per share</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common Stock, Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common Stock, Shares, Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Condensed Consolidated Statements Of Operations [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating Expenses [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses:</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ResearchAndDevelopmentExpenseNetOfGrantReimbursement" xlink:label="sava_ResearchAndDevelopmentExpenseNetOfGrantReimbursement"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_ResearchAndDevelopmentExpenseNetOfGrantReimbursement" xlink:to="sava_ResearchAndDevelopmentExpenseNetOfGrantReimbursement_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_ResearchAndDevelopmentExpenseNetOfGrantReimbursement_lbl" xml:lang="en-US">Research and Development Expense, Net Of Grant Reimbursement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_ResearchAndDevelopmentExpenseNetOfGrantReimbursement_lbl" xml:lang="en-US">Research and Development Expense, Net Of Grant Reimbursement</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_ResearchAndDevelopmentExpenseNetOfGrantReimbursement_lbl" xml:lang="en-US">Research and development, net of grant reimbursement</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General And Administrative Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Operating Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating Income Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating loss</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndOtherIncome" xlink:label="us-gaap_InterestAndOtherIncome"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xml:lang="en-US">Interest And Other Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xml:lang="en-US">Interest income</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other Nonoperating Income (Expense)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other income, net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other income, net</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Earnings Per Share [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Net income (loss) per share</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Earnings Per Share, Basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Net loss per share, Basic</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Earnings Per Share, Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Net loss per share, Diluted</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="us-gaap_EarningsPerShareBasicAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAbstract" xlink:to="us-gaap_EarningsPerShareBasicAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAbstract_lbl" xml:lang="en-US">Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasicAbstract_lbl" xml:lang="en-US">Weighted-average shares used in computing net income (loss) per share</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Shares used in computing net loss per share, basic</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Shares used in computing net loss per share, diluted</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Condensed Consolidated Statements Of Stockholders&apos; Equity [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US">Equity Component [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US">Equity Component [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid In Capital [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-In Capital [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated Deficit [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Shares Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Balance, Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Balance, Shares</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan_lbl" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Ownership Plan</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan_lbl" xml:lang="en-US">Stock options for employees</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Adjustments to Additional Paid in Capital, Share-based Compensation, Stock Options, Requisite Service Period Recognition</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Stock options for non-employees</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Issuance of common stock pursuant to exercise of stock options</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Options exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Issuance of common stock pursuant to exercise of stock options, shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Stock options exercised</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Condensed Consolidated Statements Of Cash Flows [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Net Cash Provided By Used In Operating Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Share Based Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of Intangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization expense for intangible assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Increase Decrease In Operating Capital [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid and other current assets</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet" xlink:label="sava_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet" xlink:to="sava_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet_lbl" xml:lang="en-US">Increase Decrease In Operating Lease Right Of Use Assets and Liabilities, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet_lbl" xml:lang="en-US">Increase Decrease In Operating Lease Right Of Use Assets and Liabilities, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="sava_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet_lbl" xml:lang="en-US">Operating lease right-of-use assets and liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_IncreaseDecreaseInDevelopmentExpense" xlink:label="sava_IncreaseDecreaseInDevelopmentExpense"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_IncreaseDecreaseInDevelopmentExpense" xlink:to="sava_IncreaseDecreaseInDevelopmentExpense_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_IncreaseDecreaseInDevelopmentExpense_lbl" xml:lang="en-US">Increase (Decrease) in development expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_IncreaseDecreaseInDevelopmentExpense_lbl" xml:lang="en-US">Increase (Decrease) in development expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_IncreaseDecreaseInDevelopmentExpense_lbl" xml:lang="en-US">Accrued development expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl" xml:lang="en-US">Increase Decrease In Employee Related Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl" xml:lang="en-US">Accrued compensation and benefits</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xml:lang="en-US">Increase Decrease In Other Accrued Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xml:lang="en-US">Other liabilities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net Cash Provided By Used In Operating Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_lbl" xml:lang="en-US">Net Cash Provided By Used In Investing Activities Continuing Operations [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net Cash Provided By Used In Investing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Net Cash Provided By Used In Financing Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from Stock Options Exercised</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from issuance of common stock upon exercise of stock options</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds From Issuance Of Common Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from common stock offering, net of issuance costs</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net Cash Provided By Used In Financing Activities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">Net decrease in cash and cash equivalents</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents at beginning of period</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">General And Liquidity [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">General And Liquidity</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Significant Accounting Policies [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Significant Accounting Policies</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_lbl" xml:lang="en-US">Prepaid Expenses And Other Current Assets [Abstract]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_PrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="sava_PrepaidAndOtherAssetsDisclosureTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_PrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="sava_PrepaidAndOtherAssetsDisclosureTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_PrepaidAndOtherAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Prepaid And Other Assets Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_PrepaidAndOtherAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Prepaid And Other Assets Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_PrepaidAndOtherAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Prepaid Expenses and Other Current Assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="us-gaap_BusinessCombinationsAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationsAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationsAbstract_lbl" xml:lang="en-US">Real Property [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US">Business Combination Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US">Real Property</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property And Equipment [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Property And Equipment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Intangible Assets [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Intangible Assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Stockholders&#8217; Equity And Stock-Based Compensation Expense [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Shareholders&apos; Equity and Share-based Payments [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Stockholders&apos; Equity And Stock-Based Compensation Expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Taxes [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsDisclosureTextBlock" xlink:label="us-gaap_CommitmentsDisclosureTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsDisclosureTextBlock" xlink:to="us-gaap_CommitmentsDisclosureTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsDisclosureTextBlock_lbl" xml:lang="en-US">Commitments Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsDisclosureTextBlock_lbl" xml:lang="en-US">Commitments</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_CashIncentiveBonusPlanAbstract" xlink:label="sava_CashIncentiveBonusPlanAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_CashIncentiveBonusPlanAbstract" xlink:to="sava_CashIncentiveBonusPlanAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_CashIncentiveBonusPlanAbstract_lbl" xml:lang="en-US">2020 Cash Incentive Bonus Plan [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_CashIncentiveBonusPlanAbstract_lbl" xml:lang="en-US">2020 Cash Incentive Bonus Plan [Abstract]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_CashIncentiveBonusPlanTextBlock" xlink:label="sava_CashIncentiveBonusPlanTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_CashIncentiveBonusPlanTextBlock" xlink:to="sava_CashIncentiveBonusPlanTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_CashIncentiveBonusPlanTextBlock_lbl" xml:lang="en-US">Cash Incentive Bonus Plan [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_CashIncentiveBonusPlanTextBlock_lbl" xml:lang="en-US">Cash Incentive Bonus Plan [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_CashIncentiveBonusPlanTextBlock_lbl" xml:lang="en-US">2020 Cash Incentive Bonus Plan</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyAbstract" xlink:label="us-gaap_LossContingencyAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyAbstract" xlink:to="us-gaap_LossContingencyAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyAbstract_lbl" xml:lang="en-US">Contingencies [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDisclosures" xlink:label="us-gaap_LossContingencyDisclosures"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDisclosures" xlink:to="us-gaap_LossContingencyDisclosures_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyDisclosures_lbl" xml:lang="en-US">Contingencies Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LossContingencyDisclosures_lbl" xml:lang="en-US">Contingencies</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use Of Estimates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use Of Estimates</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash And Cash Equivalents Policy [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash And Cash Equivalents And Concentration Of Credit Risk</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Business Segments</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ProceedsFromGrantsPolicyPolicyTextBlock" xlink:label="sava_ProceedsFromGrantsPolicyPolicyTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_ProceedsFromGrantsPolicyPolicyTextBlock" xlink:to="sava_ProceedsFromGrantsPolicyPolicyTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_ProceedsFromGrantsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Proceeds From Grants Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_ProceedsFromGrantsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Proceeds From Grants Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_ProceedsFromGrantsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Proceeds From Grants</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xml:lang="en-US">Compensation Related Costs Policy [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xml:lang="en-US">Stock-Based Compensation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings Per Share Policy [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Net Loss Per Share</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value Of Financial Instruments</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ResearchContractCostsAndAccrualsPolicyPolicyTextBlock" xlink:label="sava_ResearchContractCostsAndAccrualsPolicyPolicyTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_ResearchContractCostsAndAccrualsPolicyPolicyTextBlock" xlink:to="sava_ResearchContractCostsAndAccrualsPolicyPolicyTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_ResearchContractCostsAndAccrualsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Research Contract Costs And Accruals Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_ResearchContractCostsAndAccrualsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Research Contract Costs And Accruals Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_ResearchContractCostsAndAccrualsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Research Contract Costs And Accruals</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Incentive Bonus Plan</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Lessee, Leases [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Leases</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property And Equipment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xml:lang="en-US">Intangible Assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Tax Policy [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Numerators And Denominators In The Calculation Of Basic And Diluted Net Loss Per Share</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule Of Prepaid Expenses And Other Current Assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_lbl" xml:lang="en-US">Schedule of Other Nonoperating Income (Expense) [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_lbl" xml:lang="en-US">Components Of Other Income, Net</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Components Of Property And Equipment, Net</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Components Of Intangible Assets, Net</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US">Amortization Expense For Finite-Lived Intangible Assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_StockOptionAndPerformanceAwardActivity" xlink:label="sava_StockOptionAndPerformanceAwardActivity"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_StockOptionAndPerformanceAwardActivity" xlink:to="sava_StockOptionAndPerformanceAwardActivity_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_StockOptionAndPerformanceAwardActivity_lbl" xml:lang="en-US">Tabular disclosure of the change in stock options and perfromance award activity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_StockOptionAndPerformanceAwardActivity_lbl" xml:lang="en-US">Stock Option And Performance Award Activity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_StockOptionAndPerformanceAwardActivity_lbl" xml:lang="en-US">Stock Options And Unvested Performance Award Outstanding Activity</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xml:lang="en-US">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xml:lang="en-US">Stock-Based Compensation Expense</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_SignificantAccountingPoliciesTable" xlink:label="sava_SignificantAccountingPoliciesTable"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_SignificantAccountingPoliciesTable" xlink:to="sava_SignificantAccountingPoliciesTable_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_SignificantAccountingPoliciesTable_lbl" xml:lang="en-US">Significant Accounting Policies [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_SignificantAccountingPoliciesTable_lbl" xml:lang="en-US">Significant Accounting Policies [Table]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_SignificantAccountingPoliciesLineItems" xlink:label="sava_SignificantAccountingPoliciesLineItems"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_SignificantAccountingPoliciesLineItems" xlink:to="sava_SignificantAccountingPoliciesLineItems_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_SignificantAccountingPoliciesLineItems_lbl" xml:lang="en-US">Significant Accounting Policies [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_SignificantAccountingPoliciesLineItems_lbl" xml:lang="en-US">Significant Accounting Policies [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_SignificantAccountingPoliciesLineItems_lbl" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ReductionToResearchAndDevelopmentExpense" xlink:label="sava_ReductionToResearchAndDevelopmentExpense"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_ReductionToResearchAndDevelopmentExpense" xlink:to="sava_ReductionToResearchAndDevelopmentExpense_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_ReductionToResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Reduction To Research And Development Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_ReductionToResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Reduction To Research And Development Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="sava_ReductionToResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Reimbursement from National Institutes of Health research grants</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xml:lang="en-US">Number of Operating Segments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xml:lang="en-US">Number of business segments</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period 1</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Vesting period of stock options</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Property, Plant and Equipment, Useful Life</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Property and equipment, Estimated useful lives</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Intangible assets, Estimated useful lives</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Dilutive common stock options excluded from net loss per share, diluted</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US">Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xml:lang="en-US">Antidilutive Securities Name [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xml:lang="en-US">Antidilutive Securities, Name [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Employee Stock Option [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Stock Option [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="us-gaap_NetIncomeLossAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLossAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAbstract_lbl" xml:lang="en-US">Net Income Loss [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLossAbstract_lbl" xml:lang="en-US">Numerator:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_lbl" xml:lang="en-US">Weighted Average Number Of Shares Outstanding Basic [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_lbl" xml:lang="en-US">Denominator:</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidInsurance" xlink:to="us-gaap_PrepaidInsurance_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidInsurance_lbl" xml:lang="en-US">Prepaid Insurance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidInsurance_lbl" xml:lang="en-US">Prepaid insurance</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositContractsAssets" xlink:label="us-gaap_DepositContractsAssets"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositContractsAssets" xlink:to="us-gaap_DepositContractsAssets_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositContractsAssets_lbl" xml:lang="en-US">Deposit Contracts, Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepositContractsAssets_lbl" xml:lang="en-US">Contract research organization and other deposits</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestReceivableCurrent" xlink:label="us-gaap_InterestReceivableCurrent"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestReceivableCurrent" xlink:to="us-gaap_InterestReceivableCurrent_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestReceivableCurrent_lbl" xml:lang="en-US">Interest Receivable Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InterestReceivableCurrent_lbl" xml:lang="en-US">Interest receivable</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="us-gaap_OtherPrepaidExpenseCurrent"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPrepaidExpenseCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_lbl" xml:lang="en-US">Other Prepaid Expense, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_lbl" xml:lang="en-US">Other</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTable" xlink:label="us-gaap_AssetAcquisitionTable"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionTable" xlink:to="us-gaap_AssetAcquisitionTable_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionTable_lbl" xml:lang="en-US">Asset Acquisition [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionLineItems" xlink:label="us-gaap_AssetAcquisitionLineItems"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionLineItems" xlink:to="us-gaap_AssetAcquisitionLineItems_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionLineItems_lbl" xml:lang="en-US">Asset Acquisition [Line Items]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_PercentageOfOccupancy" xlink:label="sava_PercentageOfOccupancy"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_PercentageOfOccupancy" xlink:to="sava_PercentageOfOccupancy_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_PercentageOfOccupancy_lbl" xml:lang="en-US">Percentage Of Occupancy</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_PercentageOfOccupancy_lbl" xml:lang="en-US">Percentage Of Occupancy</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_PercentageOfCurrentlyLeased" xlink:label="sava_PercentageOfCurrentlyLeased"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_PercentageOfCurrentlyLeased" xlink:to="sava_PercentageOfCurrentlyLeased_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_PercentageOfCurrentlyLeased_lbl" xml:lang="en-US">Percentage Of Currently Leased</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_PercentageOfCurrentlyLeased_lbl" xml:lang="en-US">Percentage Of Currently Leased</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetRentableArea" xlink:label="us-gaap_NetRentableArea"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetRentableArea" xlink:to="us-gaap_NetRentableArea_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetRentableArea_lbl" xml:lang="en-US">Net Rentable Area</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetRentableArea_lbl" xml:lang="en-US">Office space</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US">Property Plant And Equipment Type [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingMember" xlink:to="us-gaap_BuildingMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BuildingMember_lbl" xml:lang="en-US">Building [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BuildingMember_lbl" xml:lang="en-US">Buildings [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US">Business Acquisition [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="us-gaap_OtherNonoperatingIncome"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncome" xlink:to="us-gaap_OtherNonoperatingIncome_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncome_lbl" xml:lang="en-US">Other Nonoperating Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherNonoperatingIncome_lbl" xml:lang="en-US">Lease revenue</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="us-gaap_OtherNonoperatingExpense"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="us-gaap_OtherNonoperatingExpense_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingExpense_lbl" xml:lang="en-US">Other Nonoperating Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_OtherNonoperatingExpense_lbl" xml:lang="en-US">Property operating expenses</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property, Plant and Equipment, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Gross property and equipment</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Accumulated depreciation</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Gross intangible assets</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated amortization</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Total amortization</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl" xml:lang="en-US">2023</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">2024</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">2025</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xml:lang="en-US">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US">Class Of Stock [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US">Class of Stock [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US">Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US">Equity Award [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PerformanceSharesMember" xlink:to="us-gaap_PerformanceSharesMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PerformanceSharesMember_lbl" xml:lang="en-US">Performance Shares [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PerformanceSharesMember_lbl" xml:lang="en-US">Performance Award [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameDomain_lbl" xml:lang="en-US">Plan Name [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PlanNameDomain_lbl" xml:lang="en-US">Plan Name [Domain]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_AtMarketEquityProgramMember" xlink:label="sava_AtMarketEquityProgramMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_AtMarketEquityProgramMember" xlink:to="sava_AtMarketEquityProgramMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_AtMarketEquityProgramMember_lbl" xml:lang="en-US">At-The-Market Equity Program [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_AtMarketEquityProgramMember_lbl" xml:lang="en-US">At Market Equity Program [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_AtMarketEquityProgramMember_lbl" xml:lang="en-US">ATM [Member]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_StockOptionAndPerformanceAwardActivity2020PlanMember" xlink:label="sava_StockOptionAndPerformanceAwardActivity2020PlanMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_StockOptionAndPerformanceAwardActivity2020PlanMember" xlink:to="sava_StockOptionAndPerformanceAwardActivity2020PlanMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_StockOptionAndPerformanceAwardActivity2020PlanMember_lbl" xml:lang="en-US">Stock Option And Performance Award Activity 2020 Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_StockOptionAndPerformanceAwardActivity2020PlanMember_lbl" xml:lang="en-US">Stock Option And Performance Award Activity2020 Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_StockOptionAndPerformanceAwardActivity2020PlanMember_lbl" xml:lang="en-US">Stock Option And Performance Award [Member]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_TwoThousandEighteenEquityIncentivePlanMember" xlink:label="sava_TwoThousandEighteenEquityIncentivePlanMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_TwoThousandEighteenEquityIncentivePlanMember" xlink:to="sava_TwoThousandEighteenEquityIncentivePlanMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_TwoThousandEighteenEquityIncentivePlanMember_lbl" xml:lang="en-US">Two Thousand Eighteen Equity Incentive Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_TwoThousandEighteenEquityIncentivePlanMember_lbl" xml:lang="en-US">Two Thousand Eighteen Equity Incentive Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_TwoThousandEighteenEquityIncentivePlanMember_lbl" xml:lang="en-US">2018 Equity Incentive Plan [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Range [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="srt_RangeMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeMember_lbl" xml:lang="en-US">Range [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_RangeMember_lbl" xml:lang="en-US">Range [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xml:lang="en-US">Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xml:lang="en-US">Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl" xml:lang="en-US">Sale of Stock, Consideration Received Per Transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_lbl" xml:lang="en-US">Aggregate offering price</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_PercentageOfCommissionAtmOffering" xlink:label="sava_PercentageOfCommissionAtmOffering"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_PercentageOfCommissionAtmOffering" xlink:to="sava_PercentageOfCommissionAtmOffering_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_PercentageOfCommissionAtmOffering_lbl" xml:lang="en-US">Percentage Of Commission ATM Offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_PercentageOfCommissionAtmOffering_lbl" xml:lang="en-US">Percentage Of Commission ATM Offering</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_PercentageOfCommissionAtmOffering_lbl" xml:lang="en-US">Percentage of commission in ATM offering</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Number of shares issued</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Sale of Stock, Price Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Price per share</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_StockOptionsExercisedNetSettledSatisfactionOfExercisePrice" xlink:label="sava_StockOptionsExercisedNetSettledSatisfactionOfExercisePrice"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_StockOptionsExercisedNetSettledSatisfactionOfExercisePrice" xlink:to="sava_StockOptionsExercisedNetSettledSatisfactionOfExercisePrice_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_StockOptionsExercisedNetSettledSatisfactionOfExercisePrice_lbl" xml:lang="en-US">Stock Options Exercised Net Settled Satisfaction Of Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_StockOptionsExercisedNetSettledSatisfactionOfExercisePrice_lbl" xml:lang="en-US">Stock Options Exercised Net Settled Satisfaction Of Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_StockOptionsExercisedNetSettledSatisfactionOfExercisePrice_lbl" xml:lang="en-US">Stock options exercised, net settled in satisfaction of the exercise price</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ProceedsFromStockOptionsExercisedNetSettledSatisfactionOfExercisePrice" xlink:label="sava_ProceedsFromStockOptionsExercisedNetSettledSatisfactionOfExercisePrice"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_ProceedsFromStockOptionsExercisedNetSettledSatisfactionOfExercisePrice" xlink:to="sava_ProceedsFromStockOptionsExercisedNetSettledSatisfactionOfExercisePrice_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_ProceedsFromStockOptionsExercisedNetSettledSatisfactionOfExercisePrice_lbl" xml:lang="en-US">Proceeds From Stock Options Exercised Net Settled Satisfaction Of Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_ProceedsFromStockOptionsExercisedNetSettledSatisfactionOfExercisePrice_lbl" xml:lang="en-US">Proceeds From Stock Options Exercised Net Settled Satisfaction Of Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_ProceedsFromStockOptionsExercisedNetSettledSatisfactionOfExercisePrice_lbl" xml:lang="en-US">Proceeds from stock options exercised net settled in satisfaction of the exercise price</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price or options</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Allocated Share Based Compensation Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Stock-based compensation expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Total stock-based compensation expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US">Expiration period</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xml:lang="en-US">Shares issued</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Outstanding as of, Ending</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Outstanding as of, Beginning</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Options granted</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Options forfeited/canceled</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US">Outstanding as of, Ending</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US">Outstanding as of, Beginning</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US">Options granted</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US">Vested</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US">Options forfeited/cancelled</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US">Income Statement Location [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US">Income Statement Location [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US">Research And Development Expense [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US">Research and development [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General And Administrative Expense [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General and administrative [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="us-gaap_OperatingLossCarryforwardsTable"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsTable_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsTable_lbl" xml:lang="en-US">Operating Loss Carryforwards [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for income taxes</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:label="us-gaap_ScheduleOfOperatingLeasedAssetsTable"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="us-gaap_ScheduleOfOperatingLeasedAssetsTable_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOperatingLeasedAssetsTable_lbl" xml:lang="en-US">Schedule Of Operating Leased Assets [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfOperatingLeasedAssetsTable_lbl" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_SegmentGeographicalDomain_lbl" xml:lang="en-US">Segment Geographical [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_SegmentGeographicalDomain_lbl" xml:lang="en-US">Geographical [Domain]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_AustinMember" xlink:label="sava_AustinMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_AustinMember" xlink:to="sava_AustinMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_AustinMember_lbl" xml:lang="en-US">Austin [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_AustinMember_lbl" xml:lang="en-US">Austin [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_AustinMember_lbl" xml:lang="en-US">Austin, Texas [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:label="us-gaap_OperatingLeasedAssetsLineItems"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasedAssetsLineItems" xlink:to="us-gaap_OperatingLeasedAssetsLineItems_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasedAssetsLineItems_lbl" xml:lang="en-US">Operating Leased Assets [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasedAssetsLineItems_lbl" xml:lang="en-US">Operating Leased Assets [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xml:lang="en-US">Lease Expiration Date</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xml:lang="en-US">Lease expiration date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Operating Lease, Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Rent expense</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Operating Lease, Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Cash paid for operating lease liabilities</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_CashIncentiveBonusPlanTable" xlink:label="sava_CashIncentiveBonusPlanTable"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_CashIncentiveBonusPlanTable" xlink:to="sava_CashIncentiveBonusPlanTable_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_CashIncentiveBonusPlanTable_lbl" xml:lang="en-US">Cash Incentive Bonus Plan [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_CashIncentiveBonusPlanTable_lbl" xml:lang="en-US">Cash Incentive Bonus Plan [Table]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_CashIncentiveBonusPlanLineItems" xlink:label="sava_CashIncentiveBonusPlanLineItems"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_CashIncentiveBonusPlanLineItems" xlink:to="sava_CashIncentiveBonusPlanLineItems_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_CashIncentiveBonusPlanLineItems_lbl" xml:lang="en-US">Cash Incentive Bonus Plan [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_CashIncentiveBonusPlanLineItems_lbl" xml:lang="en-US">Cash Incentive Bonus Plan [Line Items]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_MinimumNumberOfDaysValuationMilestoneMustBeAchievedAndMaintained" xlink:label="sava_MinimumNumberOfDaysValuationMilestoneMustBeAchievedAndMaintained"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_MinimumNumberOfDaysValuationMilestoneMustBeAchievedAndMaintained" xlink:to="sava_MinimumNumberOfDaysValuationMilestoneMustBeAchievedAndMaintained_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_MinimumNumberOfDaysValuationMilestoneMustBeAchievedAndMaintained_lbl" xml:lang="en-US">Minimum Number of Days Valuation Milestone must be achieved and maintained</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_MinimumNumberOfDaysValuationMilestoneMustBeAchievedAndMaintained_lbl" xml:lang="en-US">Minimum Number of Days Valuation Milestone must be achieved and maintained</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_MinimumNumberOfValuationMilestonesToRecognizeCompensationExpense" xlink:label="sava_MinimumNumberOfValuationMilestonesToRecognizeCompensationExpense"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_MinimumNumberOfValuationMilestonesToRecognizeCompensationExpense" xlink:to="sava_MinimumNumberOfValuationMilestonesToRecognizeCompensationExpense_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_MinimumNumberOfValuationMilestonesToRecognizeCompensationExpense_lbl" xml:lang="en-US">Minimum number of valuation milestones to recognize compensation expense.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_MinimumNumberOfValuationMilestonesToRecognizeCompensationExpense_lbl" xml:lang="en-US">Minimum number of valuation milestones to recognize compensation expense</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_NumberOfValuationMilestonesAchieved" xlink:label="sava_NumberOfValuationMilestonesAchieved"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_NumberOfValuationMilestonesAchieved" xlink:to="sava_NumberOfValuationMilestonesAchieved_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_NumberOfValuationMilestonesAchieved_lbl" xml:lang="en-US">Number of Valuation Milestones Achieved</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_NumberOfValuationMilestonesAchieved_lbl" xml:lang="en-US">Number of Valuation Milestones Achieved</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_PerformancePlanValuationAmount" xlink:label="sava_PerformancePlanValuationAmount"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_PerformancePlanValuationAmount" xlink:to="sava_PerformancePlanValuationAmount_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_PerformancePlanValuationAmount_lbl" xml:lang="en-US">Performance Plan Valuation Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_PerformancePlanValuationAmount_lbl" xml:lang="en-US">Performance Plan Valuation Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_PerformancePlanValuationAmount_lbl" xml:lang="en-US">Valuation milestone amount in market capitalization</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_PercentageValuationMilestoneCashBonusAwardSubjectToApprovalAndAdjustment" xlink:label="sava_PercentageValuationMilestoneCashBonusAwardSubjectToApprovalAndAdjustment"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_PercentageValuationMilestoneCashBonusAwardSubjectToApprovalAndAdjustment" xlink:to="sava_PercentageValuationMilestoneCashBonusAwardSubjectToApprovalAndAdjustment_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_PercentageValuationMilestoneCashBonusAwardSubjectToApprovalAndAdjustment_lbl" xml:lang="en-US">Percentage Valuation Milestone Cash Bonus Award Subject To Approval And Adjustment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_PercentageValuationMilestoneCashBonusAwardSubjectToApprovalAndAdjustment_lbl" xml:lang="en-US">Percentage Valuation Milestone Cash Bonus Award Subject To Approval And Adjustment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_PercentageValuationMilestoneCashBonusAwardSubjectToApprovalAndAdjustment_lbl" xml:lang="en-US">Percentage of each cash bonus award associated with Valuation Milestone subject to adjustment and approval</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_CashIncentiveBonusAward" xlink:label="sava_CashIncentiveBonusAward"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_CashIncentiveBonusAward" xlink:to="sava_CashIncentiveBonusAward_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_CashIncentiveBonusAward_lbl" xml:lang="en-US">Cash Incentive Bonus Award</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_CashIncentiveBonusAward_lbl" xml:lang="en-US">Cash Incentive Bonus Award</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_CashIncentiveBonusAward_lbl" xml:lang="en-US">Cash bonus award</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:label="us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_lbl" xml:lang="en-US">Share-based Payment Arrangement, Expense, after Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_lbl" xml:lang="en-US">Compensation expense</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_PaymentsForCashIncentiveBonus" xlink:label="sava_PaymentsForCashIncentiveBonus"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_PaymentsForCashIncentiveBonus" xlink:to="sava_PaymentsForCashIncentiveBonus_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_PaymentsForCashIncentiveBonus_lbl" xml:lang="en-US">Payments For Cash Incentive Bonus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_PaymentsForCashIncentiveBonus_lbl" xml:lang="en-US">Payments For Cash Incentive Bonus</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_PaymentsForCashIncentiveBonus_lbl" xml:lang="en-US">Payments authorized or made to participants under the Plan</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesTable_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingenciesTable_lbl" xml:lang="en-US">Loss Contingencies [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesLineItems_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xml:lang="en-US">Loss Contingencies [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyNewClaimsFiledNumber" xlink:label="us-gaap_LossContingencyNewClaimsFiledNumber"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyNewClaimsFiledNumber" xlink:to="us-gaap_LossContingencyNewClaimsFiledNumber_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyNewClaimsFiledNumber_lbl" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LossContingencyNewClaimsFiledNumber_lbl" xml:lang="en-US">Putative class action lawsuits</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems" xlink:label="ecd_InsiderTradingArrLineItems"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingArrLineItems" xlink:to="ecd_InsiderTradingArrLineItems_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingArrLineItems_lbl" xml:lang="en-US">Insider Trading Arrangements [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US">Restricted Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US">Restricted Stock [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="us-gaap_BuildingAndBuildingImprovementsMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="us-gaap_BuildingAndBuildingImprovementsMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BuildingAndBuildingImprovementsMember_lbl" xml:lang="en-US">Building And Building Improvements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BuildingAndBuildingImprovementsMember_lbl" xml:lang="en-US">Site Improvements [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Tenant Improvements [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US">Finite Lived Intangible Assets Major Class Name [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAcquiredInPlaceMember" xlink:label="us-gaap_LeasesAcquiredInPlaceMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAcquiredInPlaceMember" xlink:to="us-gaap_LeasesAcquiredInPlaceMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesAcquiredInPlaceMember_lbl" xml:lang="en-US">Leases Acquired In Place [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeasesAcquiredInPlaceMember_lbl" xml:lang="en-US">Lease-In-Place Agreements [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="us-gaap_AssetAcquisitionAxis"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionAxis" xlink:to="us-gaap_AssetAcquisitionAxis_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionAxis_lbl" xml:lang="en-US">Asset Acquisition [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="us-gaap_AssetAcquisitionDomain"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionDomain" xlink:to="us-gaap_AssetAcquisitionDomain_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionDomain_lbl" xml:lang="en-US">Asset Acquisition [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetAcquisitionDomain_lbl" xml:lang="en-US">Asset Acquisition [Domain]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_TwoBuildingOfficeComplexAssetMember" xlink:label="sava_TwoBuildingOfficeComplexAssetMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_TwoBuildingOfficeComplexAssetMember" xlink:to="sava_TwoBuildingOfficeComplexAssetMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_TwoBuildingOfficeComplexAssetMember_lbl" xml:lang="en-US">Two-building office complex</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_TwoBuildingOfficeComplexAssetMember_lbl" xml:lang="en-US">Two Building Office Complex Asset [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_TwoBuildingOfficeComplexAssetMember_lbl" xml:lang="en-US">Two-building office complex [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember" xlink:label="us-gaap_LandMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LandMember" xlink:to="us-gaap_LandMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LandMember_lbl" xml:lang="en-US">Land [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LandMember_lbl" xml:lang="en-US">Land [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture And Fixtures [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture And Equipment [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressMember" xlink:to="us-gaap_ConstructionInProgressMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xml:lang="en-US">Construction In Progress [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xml:lang="en-US">Construction In Progress [Member]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_LeasingCommissionsAndOtherMember" xlink:label="sava_LeasingCommissionsAndOtherMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_LeasingCommissionsAndOtherMember" xlink:to="sava_LeasingCommissionsAndOtherMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_LeasingCommissionsAndOtherMember_lbl" xml:lang="en-US">Leasing Commissions And Other [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_LeasingCommissionsAndOtherMember_lbl" xml:lang="en-US">Leasing Commissions And Other [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_LeasingCommissionsAndOtherMember_lbl" xml:lang="en-US">Leasing Commissions And Other [Member]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_RegisteredDirectOffering2022Member" xlink:label="sava_RegisteredDirectOffering2022Member"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_RegisteredDirectOffering2022Member" xlink:to="sava_RegisteredDirectOffering2022Member_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_RegisteredDirectOffering2022Member_lbl" xml:lang="en-US">Registered Direct Offering 2022 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_RegisteredDirectOffering2022Member_lbl" xml:lang="en-US">Registered Direct Offering2022 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_RegisteredDirectOffering2022Member_lbl" xml:lang="en-US">Registered Direct Offering 2022 [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermAxis_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseContractualTermAxis_lbl" xml:lang="en-US">Lease Contractual Term [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="us-gaap_LeaseContractualTermDomain_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseContractualTermDomain_lbl" xml:lang="en-US">Lease Contractual Term [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseContractualTermDomain_lbl" xml:lang="en-US">Lease Contractual Term [Domain]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_OperatingLeasesMember" xlink:label="sava_OperatingLeasesMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_OperatingLeasesMember" xlink:to="sava_OperatingLeasesMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_OperatingLeasesMember_lbl" xml:lang="en-US">Operating Leases [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_OperatingLeasesMember_lbl" xml:lang="en-US">Operating Leases [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_OperatingLeasesMember_lbl" xml:lang="en-US">Operating Leases [Member]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_CashIncentiveBonusPlanMember" xlink:label="sava_CashIncentiveBonusPlanMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_CashIncentiveBonusPlanMember" xlink:to="sava_CashIncentiveBonusPlanMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_CashIncentiveBonusPlanMember_lbl" xml:lang="en-US">Cash Incentive Bonus Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_CashIncentiveBonusPlanMember_lbl" xml:lang="en-US">Cash Incentive Bonus Plan [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_CashIncentiveBonusPlanMember_lbl" xml:lang="en-US">Cash Incentive Bonus Plan [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US">Scenario Unspecified [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US">Scenario, Unspecified [Domain]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ExceedingPerformanceMilestonesMinimum20ConsecutiveDaysMember" xlink:label="sava_ExceedingPerformanceMilestonesMinimum20ConsecutiveDaysMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_ExceedingPerformanceMilestonesMinimum20ConsecutiveDaysMember" xlink:to="sava_ExceedingPerformanceMilestonesMinimum20ConsecutiveDaysMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_ExceedingPerformanceMilestonesMinimum20ConsecutiveDaysMember_lbl" xml:lang="en-US">Exceeding Performance Milestones Minimum 20 Consecutive Days</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_ExceedingPerformanceMilestonesMinimum20ConsecutiveDaysMember_lbl" xml:lang="en-US">Exceeding Performance Milestones Minimum20 Consecutive Days [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_ExceedingPerformanceMilestonesMinimum20ConsecutiveDaysMember_lbl" xml:lang="en-US">Exceeding Performance Milestones Minimum 20 Consecutive Days [Member]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_Exceeds5BillionMarketCapitalizationMember" xlink:label="sava_Exceeds5BillionMarketCapitalizationMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_Exceeds5BillionMarketCapitalizationMember" xlink:to="sava_Exceeds5BillionMarketCapitalizationMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_Exceeds5BillionMarketCapitalizationMember_lbl" xml:lang="en-US">Exceeds 5 Billion Market Capitalization [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_Exceeds5BillionMarketCapitalizationMember_lbl" xml:lang="en-US">Exceeds5 Billion Market Capitalization [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_Exceeds5BillionMarketCapitalizationMember_lbl" xml:lang="en-US">Exceeds $5 Billion Market Capitalization For No Less Than 20 Consecutive Trading Days [Member]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_FirstValuationMilestoneMember" xlink:label="sava_FirstValuationMilestoneMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_FirstValuationMilestoneMember" xlink:to="sava_FirstValuationMilestoneMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_FirstValuationMilestoneMember_lbl" xml:lang="en-US">First Valuation Milestone [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_FirstValuationMilestoneMember_lbl" xml:lang="en-US">First Valuation Milestone [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_FirstValuationMilestoneMember_lbl" xml:lang="en-US">First Valuation Milestone [Member]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_SecondThroughEighthValuationMilestonesMember" xlink:label="sava_SecondThroughEighthValuationMilestonesMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_SecondThroughEighthValuationMilestonesMember" xlink:to="sava_SecondThroughEighthValuationMilestonesMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_SecondThroughEighthValuationMilestonesMember_lbl" xml:lang="en-US">Second Through Eighth Valuation Milestones [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_SecondThroughEighthValuationMilestonesMember_lbl" xml:lang="en-US">Second Through Eighth Valuation Milestones [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_SecondThroughEighthValuationMilestonesMember_lbl" xml:lang="en-US">Second Through Eighth Valuation Milestones [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US">Title Of Individual With Relationship To Entity [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US">Title of Individual [Domain]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_IndependentDirectorsMember" xlink:label="sava_IndependentDirectorsMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_IndependentDirectorsMember" xlink:to="sava_IndependentDirectorsMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_IndependentDirectorsMember_lbl" xml:lang="en-US">Independent Directors</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_IndependentDirectorsMember_lbl" xml:lang="en-US">Independent Directors [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_IndependentDirectorsMember_lbl" xml:lang="en-US">Independent Directors [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseAxis" xlink:label="srt_LitigationCaseAxis"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_LitigationCaseAxis" xlink:to="srt_LitigationCaseAxis_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_LitigationCaseAxis_lbl" xml:lang="en-US">Litigation Case [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseTypeDomain" xlink:label="srt_LitigationCaseTypeDomain"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_LitigationCaseTypeDomain" xlink:to="srt_LitigationCaseTypeDomain_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_LitigationCaseTypeDomain_lbl" xml:lang="en-US">Litigation Case Type [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_LitigationCaseTypeDomain_lbl" xml:lang="en-US">Litigation Case [Domain]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ViolationsOfFederalSecuritiesLawsMember" xlink:label="sava_ViolationsOfFederalSecuritiesLawsMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_ViolationsOfFederalSecuritiesLawsMember" xlink:to="sava_ViolationsOfFederalSecuritiesLawsMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_ViolationsOfFederalSecuritiesLawsMember_lbl" xml:lang="en-US">violations of the federal securities laws</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_ViolationsOfFederalSecuritiesLawsMember_lbl" xml:lang="en-US">Violations Of Federal Securities Laws [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_ViolationsOfFederalSecuritiesLawsMember_lbl" xml:lang="en-US">Violations of the federal securities laws [Member]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ShareholderDerivativeActionsMember" xlink:label="sava_ShareholderDerivativeActionsMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_ShareholderDerivativeActionsMember" xlink:to="sava_ShareholderDerivativeActionsMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_ShareholderDerivativeActionsMember_lbl" xml:lang="en-US">Shareholder derivative actions</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_ShareholderDerivativeActionsMember_lbl" xml:lang="en-US">Shareholder Derivative Actions [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_ShareholderDerivativeActionsMember_lbl" xml:lang="en-US">Shareholder derivative actions [Member]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ShareholderDerivativeActionsU.s.DistrictCourtMember" xlink:label="sava_ShareholderDerivativeActionsU.s.DistrictCourtMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_ShareholderDerivativeActionsU.s.DistrictCourtMember" xlink:to="sava_ShareholderDerivativeActionsU.s.DistrictCourtMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_ShareholderDerivativeActionsU.s.DistrictCourtMember_lbl" xml:lang="en-US">Shareholder derivative actions U.S. District Court</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_ShareholderDerivativeActionsU.s.DistrictCourtMember_lbl" xml:lang="en-US">Shareholder Derivative Actions U.s. District Court [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_ShareholderDerivativeActionsU.s.DistrictCourtMember_lbl" xml:lang="en-US">Shareholder derivative actions U.S. District Court [Member]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ShareholderDerivativeActionsTexasCourtMember" xlink:label="sava_ShareholderDerivativeActionsTexasCourtMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_ShareholderDerivativeActionsTexasCourtMember" xlink:to="sava_ShareholderDerivativeActionsTexasCourtMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_ShareholderDerivativeActionsTexasCourtMember_lbl" xml:lang="en-US">Shareholder derivative actions Texas Court</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_ShareholderDerivativeActionsTexasCourtMember_lbl" xml:lang="en-US">Shareholder Derivative Actions Texas Court [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_ShareholderDerivativeActionsTexasCourtMember_lbl" xml:lang="en-US">Shareholder derivative actions Texas Court [Member]</label>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ShareholderDerivativeActionsDelwareCourtMember" xlink:label="sava_ShareholderDerivativeActionsDelwareCourtMember"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="sava_ShareholderDerivativeActionsDelwareCourtMember" xlink:to="sava_ShareholderDerivativeActionsDelwareCourtMember_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="sava_ShareholderDerivativeActionsDelwareCourtMember_lbl" xml:lang="en-US">Shareholder derivative actions Delaware Court</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="sava_ShareholderDerivativeActionsDelwareCourtMember_lbl" xml:lang="en-US">Shareholder Derivative Actions Delware Court [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="sava_ShareholderDerivativeActionsDelwareCourtMember_lbl" xml:lang="en-US">Shareholder derivative actions Delware Court [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscLineItems" xlink:label="ecd_AwardsCloseToMnpiDiscLineItems"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscLineItems" xlink:to="ecd_AwardsCloseToMnpiDiscLineItems_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscLineItems_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="ecd_AwardsCloseToMnpiDiscTable"></loc>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTable" xlink:to="ecd_AwardsCloseToMnpiDiscTable_lbl"></labelArc>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTable_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ecd_AwardsCloseToMnpiDiscTable_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</label></labelLink></linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>18
<FILENAME>sava-20230630_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created by Certent Disclosure Management 23.3.2.2 -->
<!--Based on XBRL 2.1-->
<!--Created on: 8/3/2023 3:28:41 PM-->
<!--Modified on: 8/3/2023 3:28:41 PM-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#StatementCondensedConsolidatedBalanceSheets" roleURI="http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#StatementCondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#StatementCondensedConsolidatedStatementsOfOperations" roleURI="http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#StatementCondensedConsolidatedStatementsOfStockholdersEquity" roleURI="http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#StatementCondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureGeneralAndLiquidity" roleURI="http://www.cassavasciences.com/role/DisclosureGeneralAndLiquidity"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureSignificantAccountingPolicies" roleURI="http://www.cassavasciences.com/role/DisclosureSignificantAccountingPolicies"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosurePrepaidExpensesAndOtherCurrentAssets" roleURI="http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssets"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureRealProperty" roleURI="http://www.cassavasciences.com/role/DisclosureRealProperty"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosurePropertyAndEquipment" roleURI="http://www.cassavasciences.com/role/DisclosurePropertyAndEquipment"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureIntangibleAssets" roleURI="http://www.cassavasciences.com/role/DisclosureIntangibleAssets"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureStockholdersEquityAndStockBasedCompensationExpense" roleURI="http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpense"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureIncomeTaxes" roleURI="http://www.cassavasciences.com/role/DisclosureIncomeTaxes"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureCommitments" roleURI="http://www.cassavasciences.com/role/DisclosureCommitments"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#Disclosure2020CashIncentiveBonusPlan" roleURI="http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlan"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureContingencies" roleURI="http://www.cassavasciences.com/role/DisclosureContingencies"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureSignificantAccountingPoliciesPolicy" roleURI="http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesPolicy"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureSignificantAccountingPoliciesTables" roleURI="http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesTables"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosurePrepaidExpensesAndOtherCurrentAssetsTables" roleURI="http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureRealPropertyTables" roleURI="http://www.cassavasciences.com/role/DisclosureRealPropertyTables"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosurePropertyAndEquipmentTables" roleURI="http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentTables"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureIntangibleAssetsTables" roleURI="http://www.cassavasciences.com/role/DisclosureIntangibleAssetsTables"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureStockholdersEquityAndStockBasedCompensationExpenseTables" roleURI="http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseTables"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureGeneralAndLiquidityNarrativeDetails" roleURI="http://www.cassavasciences.com/role/DisclosureGeneralAndLiquidityNarrativeDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureSignificantAccountingPoliciesNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetails" roleURI="http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosurePrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" roleURI="http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureRealPropertyNarrativeDetails" roleURI="http://www.cassavasciences.com/role/DisclosureRealPropertyNarrativeDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureRealPropertyComponentsOfOtherIncomeNetDetails" roleURI="http://www.cassavasciences.com/role/DisclosureRealPropertyComponentsOfOtherIncomeNetDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosurePropertyAndEquipmentNarrativeDetails" roleURI="http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentNarrativeDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails" roleURI="http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureIntangibleAssetsNarrativeDetails" roleURI="http://www.cassavasciences.com/role/DisclosureIntangibleAssetsNarrativeDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureIntangibleAssetsComponentsOfIntangibleAssetsNetDetails" roleURI="http://www.cassavasciences.com/role/DisclosureIntangibleAssetsComponentsOfIntangibleAssetsNetDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureIntangibleAssetsAmortizationExpenseForFiniteLivedIntangibleAssetsDetails" roleURI="http://www.cassavasciences.com/role/DisclosureIntangibleAssetsAmortizationExpenseForFiniteLivedIntangibleAssetsDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails" roleURI="http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockOptionsAndUnvestedPerformanceAwardOutstandingActivityDetails" roleURI="http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockOptionsAndUnvestedPerformanceAwardOutstandingActivityDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockBasedCompensationExpensesDetails" roleURI="http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockBasedCompensationExpensesDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureIncomeTaxesNarrativeDetails" roleURI="http://www.cassavasciences.com/role/DisclosureIncomeTaxesNarrativeDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureCommitmentsNarrativeDetails" roleURI="http://www.cassavasciences.com/role/DisclosureCommitmentsNarrativeDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#Disclosure2020CashIncentiveBonusPlanNarrativeDetails" roleURI="http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="sava-20230630.xsd#DisclosureContingenciesNarrativeDetails" roleURI="http://www.cassavasciences.com/role/DisclosureContingenciesNarrativeDetails"></roleRef>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingArrangements" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"></roleRef>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document And Entity Information">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638266733183076989"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType_638266733183076989" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638266733183076989"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag_638266733183076989" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport_638266733183076989"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentQuarterlyReport_638266733183076989" order="3" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus_638266733183076989"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus_638266733183076989" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate_638266733183076989"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate_638266733183076989" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus_638266733183076989"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus_638266733183076989" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_638266733183076989"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate_638266733183076989" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport_638266733183076989"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentTransitionReport_638266733183076989" order="8" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_638266733183076989"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber_638266733183076989" order="9" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638266733183076989"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName_638266733183076989" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_638266733183086961"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_638266733183086961" order="11" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_638266733183086961"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber_638266733183086961" order="12" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_638266733183086961"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1_638266733183086961" order="13" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2_638266733183086961"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2_638266733183086961" order="14" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_638266733183086961"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown_638266733183086961" order="15" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_638266733183086961"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince_638266733183086961" order="16" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_638266733183086961"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode_638266733183086961" order="17" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_638266733183086961"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode_638266733183086961" order="18" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_638266733183086961"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber_638266733183086961" order="19" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_638266733183086961"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle_638266733183086961" order="20" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_638266733183086961"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol_638266733183086961" order="21" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_638266733183086961"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName_638266733183086961" order="22" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus_638266733183086961"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus_638266733183086961" order="23" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent_638266733183086961"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent_638266733183086961" order="24" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory_638266733183086961"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory_638266733183086961" order="25" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness_638266733183086961"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness_638266733183086961" order="26" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_638266733183086961"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany_638266733183086961" order="27" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany_638266733183086961"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityShellCompany_638266733183086961" order="28" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding_638266733183086961"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding_638266733183086961" order="29" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638266733183096933"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey_638266733183096933" order="30" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets" xlink:type="extended" xlink:title="00100 - Statement - Condensed Consolidated Balance Sheets">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract_638266733183096933"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_638266733183096933" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_638266733183096933"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638266733183096933" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_638266733183096933" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_638266733183096933"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638266733183096933" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_638266733183096933" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent_638266733183096933"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_638266733183096933" xlink:to="us-gaap_AssetsCurrent_638266733183096933" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_638266733183096933"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_638266733183096933" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_638266733183096933"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_638266733183096933" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_638266733183096933"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_638266733183096933" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets_638266733183096933"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Assets_638266733183096933" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract_638266733183096933"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_638266733183096933" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent_638266733183096933"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638266733183096933" xlink:to="us-gaap_AccountsPayableCurrent_638266733183096933" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent_638266733183096933"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638266733183096933" xlink:to="us-gaap_AccruedLiabilitiesCurrent_638266733183096933" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_638266733183096933"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638266733183096933" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_638266733183096933" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_638266733183096933"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638266733183096933" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_638266733183096933" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent_638266733183096933"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638266733183096933" xlink:to="us-gaap_OtherLiabilitiesCurrent_638266733183096933" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent_638266733183096933"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638266733183096933" xlink:to="us-gaap_LiabilitiesCurrent_638266733183096933" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_638266733183096933"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638266733183096933" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_638266733183096933" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_638266733183096933"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_638266733183096933" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_638266733183096933" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities_638266733183096933"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Liabilities_638266733183096933" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies_638266733183096933"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommitmentsAndContingencies_638266733183096933" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract_638266733183096933"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_638266733183096933" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue_638266733183096933"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_638266733183096933" xlink:to="us-gaap_PreferredStockValue_638266733183096933" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="8"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue_638266733183096933"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_638266733183096933" xlink:to="us-gaap_CommonStockValue_638266733183096933" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="9"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital_638266733183106906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_638266733183096933" xlink:to="us-gaap_AdditionalPaidInCapital_638266733183106906" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_638266733183106906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_638266733183096933" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_638266733183106906" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="9"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_638266733183106906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_638266733183096933" xlink:to="us-gaap_StockholdersEquity_638266733183106906" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_638266733183106906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_638266733183106906" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended" xlink:title="00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_638266733183106906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_638266733183106906" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized_638266733183106906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized_638266733183106906" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued_638266733183106906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesIssued_638266733183106906" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding_638266733183106906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding_638266733183106906" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_638266733183106906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_638266733183106906" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized_638266733183106906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized_638266733183106906" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued_638266733183106906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued_638266733183106906" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_638266733183106906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding_638266733183106906" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations" xlink:type="extended" xlink:title="00200 - Statement - Condensed Consolidated Statements Of Operations">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract_638266733183106906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_638266733183106906" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ResearchAndDevelopmentExpenseNetOfGrantReimbursement" xlink:label="sava_ResearchAndDevelopmentExpenseNetOfGrantReimbursement_638266733183106906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_638266733183106906" xlink:to="sava_ResearchAndDevelopmentExpenseNetOfGrantReimbursement_638266733183106906" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense_638266733183106906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_638266733183106906" xlink:to="us-gaap_GeneralAndAdministrativeExpense_638266733183106906" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses_638266733183106906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract_638266733183106906" xlink:to="us-gaap_OperatingExpenses_638266733183106906" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_638266733183106906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss_638266733183106906" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndOtherIncome" xlink:label="us-gaap_InterestAndOtherIncome_638266733183106906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_InterestAndOtherIncome_638266733183106906" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_638266733183106906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_638266733183106906" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_638266733183106906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss_638266733183106906" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract_638266733183106906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_638266733183106906" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic_638266733183106906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract_638266733183106906" xlink:to="us-gaap_EarningsPerShareBasic_638266733183106906" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="5"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted_638266733183106906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract_638266733183106906" xlink:to="us-gaap_EarningsPerShareDiluted_638266733183106906" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="5"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicAbstract" xlink:label="us-gaap_EarningsPerShareBasicAbstract_638266733183106906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasicAbstract_638266733183106906" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638266733183106906"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicAbstract_638266733183106906" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638266733183106906" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/netLabel" priority="5"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_638266733183116880"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicAbstract_638266733183106906" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_638266733183116880" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/netLabel" priority="5"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" xlink:type="extended" xlink:title="00400 - Statement - Condensed Consolidated Statements Of Stockholders&apos; Equity">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_638266733183116880"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable_638266733183116880" order="1" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis_638266733183116880"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638266733183116880" xlink:to="us-gaap_StatementEquityComponentsAxis_638266733183116880" order="1" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember_638266733183116880"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638266733183116880" xlink:to="us-gaap_CommonStockMember_638266733183116880" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember_638266733183116880"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638266733183116880" xlink:to="us-gaap_AdditionalPaidInCapitalMember_638266733183116880" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember_638266733183116880"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638266733183116880" xlink:to="us-gaap_RetainedEarningsMember_638266733183116880" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_638266733183116880"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_638266733183116880" xlink:to="us-gaap_EquityComponentDomain_638266733183116880" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_638266733183116880"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_638266733183116880" xlink:to="us-gaap_StatementLineItems_638266733183116880" order="2" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_638266733183116880"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638266733183116880" xlink:to="us-gaap_StockholdersEquity_638266733183116880" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="5"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued_638266733183116880"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638266733183116880" xlink:to="us-gaap_SharesIssued_638266733183116880" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="5"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan_638266733183116880"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638266733183116880" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan_638266733183116880" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="6"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_638266733183116880"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638266733183116880" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_638266733183116880" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="6"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_638266733183116880"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638266733183116880" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_638266733183116880" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_638266733183116880"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638266733183116880" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_638266733183116880" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_638266733183116880"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638266733183116880" xlink:to="us-gaap_NetIncomeLoss_638266733183116880" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="8"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_6382667331831168801"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638266733183116880" xlink:to="us-gaap_StockholdersEquity_6382667331831168801" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="5"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued_6382667331831168801"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_638266733183116880" xlink:to="us-gaap_SharesIssued_6382667331831168801" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="5"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" xlink:type="extended" xlink:title="00500 - Statement - Condensed Consolidated Statements Of Cash Flows">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638266733183116880"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638266733183116880" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_638266733183116880"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638266733183116880" xlink:to="us-gaap_NetIncomeLoss_638266733183116880" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="9"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638266733183116880"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638266733183116880" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638266733183116880" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation_638266733183116880"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638266733183116880" xlink:to="us-gaap_ShareBasedCompensation_638266733183116880" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation_638266733183116880"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638266733183116880" xlink:to="us-gaap_Depreciation_638266733183116880" order="2" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets_638266733183116880"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_638266733183116880" xlink:to="us-gaap_AmortizationOfIntangibleAssets_638266733183116880" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638266733183116880"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638266733183116880" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638266733183116880" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_638266733183116880"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638266733183116880" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_638266733183116880" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet" xlink:label="sava_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet_638266733183116880"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638266733183116880" xlink:to="sava_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet_638266733183116880" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_638266733183126852"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638266733183116880" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_638266733183126852" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_IncreaseDecreaseInDevelopmentExpense" xlink:label="sava_IncreaseDecreaseInDevelopmentExpense_638266733183126852"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638266733183116880" xlink:to="sava_IncreaseDecreaseInDevelopmentExpense_638266733183126852" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_638266733183126852"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638266733183116880" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_638266733183126852" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_638266733183126852"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_638266733183116880" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_638266733183126852" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_638266733183126852"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_638266733183116880" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_638266733183126852" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_638266733183126852"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_638266733183126852" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_638266733183126852"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_638266733183126852" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_638266733183126852" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="8"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_638266733183126852"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_638266733183126852" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_638266733183126852" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638266733183126852"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638266733183126852" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_638266733183126852"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638266733183126852" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_638266733183126852" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_638266733183126852"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638266733183126852" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_638266733183126852" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_638266733183126852"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_638266733183126852" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_638266733183126852" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_638266733183126852"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_638266733183126852" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_638266733183126852"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_638266733183126852" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6382667331831268521"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6382667331831268521" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureGeneralAndLiquidity" xlink:type="extended" xlink:title="10101 - Disclosure - General And Liquidity">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_638266733183126852"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_638266733183126852" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureSignificantAccountingPolicies" xlink:type="extended" xlink:title="10201 - Disclosure - Significant Accounting Policies">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_638266733183126852"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_638266733183126852" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssets" xlink:type="extended" xlink:title="10301 - Disclosure - Prepaid Expenses And Other Current Assets">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"></loc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_PrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="sava_PrepaidAndOtherAssetsDisclosureTextBlock_638266733183136833"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="sava_PrepaidAndOtherAssetsDisclosureTextBlock_638266733183136833" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureRealProperty" xlink:type="extended" xlink:title="10401 - Disclosure - Real Property">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="us-gaap_BusinessCombinationsAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_638266733183136833"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_638266733183136833" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosurePropertyAndEquipment" xlink:type="extended" xlink:title="10501 - Disclosure - Property And Equipment">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_638266733183136833"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_638266733183136833" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureIntangibleAssets" xlink:type="extended" xlink:title="10601 - Disclosure - Intangible Assets">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_638266733183136833"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_638266733183136833" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpense" xlink:type="extended" xlink:title="10701 - Disclosure - Stockholders&apos; Equity And Stock-Based Compensation Expense">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_638266733183136833"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_638266733183136833" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureIncomeTaxes" xlink:type="extended" xlink:title="10801 - Disclosure - Income Taxes">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_638266733183136833"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_638266733183136833" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureCommitments" xlink:type="extended" xlink:title="10901 - Disclosure - Commitments">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsDisclosureTextBlock" xlink:label="us-gaap_CommitmentsDisclosureTextBlock_638266733183136833"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsDisclosureTextBlock_638266733183136833" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlan" xlink:type="extended" xlink:title="11001 - Disclosure - 2020 Cash Incentive Bonus Plan">
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_CashIncentiveBonusPlanAbstract" xlink:label="sava_CashIncentiveBonusPlanAbstract"></loc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_CashIncentiveBonusPlanTextBlock" xlink:label="sava_CashIncentiveBonusPlanTextBlock_638266733183136833"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sava_CashIncentiveBonusPlanAbstract" xlink:to="sava_CashIncentiveBonusPlanTextBlock_638266733183136833" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureContingencies" xlink:type="extended" xlink:title="11101 - Disclosure - Contingencies">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyAbstract" xlink:label="us-gaap_LossContingencyAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDisclosures" xlink:label="us-gaap_LossContingencyDisclosures_638266733183136833"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingencyAbstract" xlink:to="us-gaap_LossContingencyDisclosures_638266733183136833" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesPolicy" xlink:type="extended" xlink:title="20202 - Disclosure - Significant Accounting Policies (Policy)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates_638266733183136833"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates_638266733183136833" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_638266733183136833"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_638266733183136833" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_638266733183136833"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_638266733183136833" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_638266733183136833"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_638266733183136833" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ProceedsFromGrantsPolicyPolicyTextBlock" xlink:label="sava_ProceedsFromGrantsPolicyPolicyTextBlock_638266733183136833"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="sava_ProceedsFromGrantsPolicyPolicyTextBlock_638266733183136833" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_638266733183136833"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_638266733183136833" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_638266733183136833"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_638266733183136833" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_638266733183136833"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_638266733183136833" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ResearchContractCostsAndAccrualsPolicyPolicyTextBlock" xlink:label="sava_ResearchContractCostsAndAccrualsPolicyPolicyTextBlock_638266733183136833"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="sava_ResearchContractCostsAndAccrualsPolicyPolicyTextBlock_638266733183136833" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_638266733183146800"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_638266733183146800" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_638266733183146800"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_638266733183146800" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_638266733183146800"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_638266733183146800" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_638266733183146800"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_638266733183146800" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_638266733183146800"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_638266733183146800" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesTables" xlink:type="extended" xlink:title="30203 - Disclosure - Significant Accounting Policies (Tables)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_638266733183146800"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_638266733183146800" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables" xlink:type="extended" xlink:title="30303 - Disclosure - Prepaid Expenses And Other Current Assets (Tables)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_637390404728571071"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_638266733183146800"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_637390404728571071" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_638266733183146800" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureRealPropertyTables" xlink:type="extended" xlink:title="30403 - Disclosure - Real Property (Tables)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="us-gaap_BusinessCombinationsAbstract_637709203959354913"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_638266733183146800"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationsAbstract_637709203959354913" xlink:to="us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_638266733183146800" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentTables" xlink:type="extended" xlink:title="30503 - Disclosure - Property And Equipment (Tables)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_637708885067040668"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_638266733183146800"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract_637708885067040668" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_638266733183146800" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureIntangibleAssetsTables" xlink:type="extended" xlink:title="30603 - Disclosure - Intangible Assets (Tables)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_637709277228814078"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_638266733183146800"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_637709277228814078" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_638266733183146800" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_638266733183146800"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_637709277228814078" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_638266733183146800" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseTables" xlink:type="extended" xlink:title="30703 - Disclosure - Stockholders&apos; Equity And Stock-Based Compensation Expense (Tables)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"></loc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_StockOptionAndPerformanceAwardActivity" xlink:label="sava_StockOptionAndPerformanceAwardActivity_638266733183146800"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="sava_StockOptionAndPerformanceAwardActivity_638266733183146800" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_638266733183146800"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_638266733183146800" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureGeneralAndLiquidityNarrativeDetails" xlink:type="extended" xlink:title="40101 - Disclosure - General And Liquidity (Narrative) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_638266733183146800"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_638266733183146800" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" xlink:title="40201 - Disclosure - Significant Accounting Policies (Narrative) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"></loc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_SignificantAccountingPoliciesTable" xlink:label="sava_SignificantAccountingPoliciesTable_638266733183156773"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="sava_SignificantAccountingPoliciesTable_638266733183156773" order="1" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_638266733183156773"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sava_SignificantAccountingPoliciesTable_638266733183156773" xlink:to="us-gaap_AwardTypeAxis_638266733183156773" order="1" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638266733183156773"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_638266733183156773" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638266733183156773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember_638266733183156773"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638266733183156773" xlink:to="us-gaap_EmployeeStockOptionMember_638266733183156773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember_638266733183156773"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638266733183156773" xlink:to="us-gaap_RestrictedStockMember_638266733183156773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_638266733183156773"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sava_SignificantAccountingPoliciesTable_638266733183156773" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_638266733183156773" order="2" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_638266733183156773"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis_638266733183156773" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_638266733183156773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember_638266733183156773"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_638266733183156773" xlink:to="us-gaap_BuildingMember_638266733183156773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="us-gaap_BuildingAndBuildingImprovementsMember_638266733183156773"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_638266733183156773" xlink:to="us-gaap_BuildingAndBuildingImprovementsMember_638266733183156773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember_638266733183156773"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_638266733183156773" xlink:to="us-gaap_LeaseholdImprovementsMember_638266733183156773" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638266733183156773"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sava_SignificantAccountingPoliciesTable_638266733183156773" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638266733183156773" order="3" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638266733183156773"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638266733183156773" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638266733183156773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAcquiredInPlaceMember" xlink:label="us-gaap_LeasesAcquiredInPlaceMember_638266733183156773"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638266733183156773" xlink:to="us-gaap_LeasesAcquiredInPlaceMember_638266733183156773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_SignificantAccountingPoliciesLineItems" xlink:label="sava_SignificantAccountingPoliciesLineItems_638266733183156773"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sava_SignificantAccountingPoliciesTable_638266733183156773" xlink:to="sava_SignificantAccountingPoliciesLineItems_638266733183156773" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ReductionToResearchAndDevelopmentExpense" xlink:label="sava_ReductionToResearchAndDevelopmentExpense_638266733183156773"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sava_SignificantAccountingPoliciesLineItems_638266733183156773" xlink:to="sava_ReductionToResearchAndDevelopmentExpense_638266733183156773" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments_638266733183156773"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sava_SignificantAccountingPoliciesLineItems_638266733183156773" xlink:to="us-gaap_NumberOfOperatingSegments_638266733183156773" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_638266733183156773"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sava_SignificantAccountingPoliciesLineItems_638266733183156773" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_638266733183156773" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_638266733183156773"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sava_SignificantAccountingPoliciesLineItems_638266733183156773" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_638266733183156773" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_638266733183156773"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sava_SignificantAccountingPoliciesLineItems_638266733183156773" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_638266733183156773" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_638266733183156773"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sava_SignificantAccountingPoliciesLineItems_638266733183156773" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_638266733183156773" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetails" xlink:type="extended" xlink:title="40202 - Disclosure - Significant Accounting Policies (Numerators And Denominators In The Calculation Of Basic And Diluted Net Loss Per Share) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract_635240128367044116"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_638266733183156773"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_635240128367044116" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_638266733183156773" order="1" use="optional" priority="3"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_638266733183156773"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_638266733183156773" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_638266733183156773" order="1" use="optional" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_638266733183166747"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_638266733183156773" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_638266733183166747" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember_638266733183166747"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain_638266733183166747" xlink:to="us-gaap_EmployeeStockOptionMember_638266733183166747" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_638266733183166747"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_638266733183156773" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_638266733183166747" order="2" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="us-gaap_NetIncomeLossAbstract_638266733183166747"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_638266733183166747" xlink:to="us-gaap_NetIncomeLossAbstract_638266733183166747" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_638266733183166747"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAbstract_638266733183166747" xlink:to="us-gaap_NetIncomeLoss_638266733183166747" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="8"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_638266733183166747"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_638266733183166747" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_638266733183166747" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638266733183166747"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_638266733183166747" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638266733183166747" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/netLabel" priority="5"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_638266733183166747"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_638266733183166747" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_638266733183166747" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/netLabel" priority="5"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic_638266733183166747"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_638266733183166747" xlink:to="us-gaap_EarningsPerShareBasic_638266733183166747" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted_638266733183166747"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_638266733183166747" xlink:to="us-gaap_EarningsPerShareDiluted_638266733183166747" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_638266733183166747"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_638266733183166747" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_638266733183166747" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" xlink:type="extended" xlink:title="40301 - Disclosure - Prepaid Expenses And Other Current Assets (Schedule Of Prepaid Expenses And Other Current Assets) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_637390406778822622"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance_638266733183166747"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_637390406778822622" xlink:to="us-gaap_PrepaidInsurance_638266733183166747" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositContractsAssets" xlink:label="us-gaap_DepositContractsAssets_638266733183166747"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_637390406778822622" xlink:to="us-gaap_DepositContractsAssets_638266733183166747" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestReceivableCurrent" xlink:label="us-gaap_InterestReceivableCurrent_638266733183166747"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_637390406778822622" xlink:to="us-gaap_InterestReceivableCurrent_638266733183166747" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_638266733183166747"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_637390406778822622" xlink:to="us-gaap_OtherPrepaidExpenseCurrent_638266733183166747" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_638266733183166747"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_637390406778822622" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_638266733183166747" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureRealPropertyNarrativeDetails" xlink:type="extended" xlink:title="40401 - Disclosure - Real Property (Narrative) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="us-gaap_BusinessCombinationsAbstract_637709232385376924"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionTable" xlink:label="us-gaap_AssetAcquisitionTable_638266733183166747"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationsAbstract_637709232385376924" xlink:to="us-gaap_AssetAcquisitionTable_638266733183166747" order="1" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis_638266733183166747"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionTable_638266733183166747" xlink:to="srt_StatementGeographicalAxis_638266733183166747" order="1" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_638266733183166747"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis_638266733183166747" xlink:to="srt_SegmentGeographicalDomain_638266733183166747" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_AustinMember" xlink:label="sava_AustinMember_638266733183166747"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain_638266733183166747" xlink:to="sava_AustinMember_638266733183166747" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionAxis" xlink:label="us-gaap_AssetAcquisitionAxis_638266733183166747"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionTable_638266733183166747" xlink:to="us-gaap_AssetAcquisitionAxis_638266733183166747" order="2" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionDomain" xlink:label="us-gaap_AssetAcquisitionDomain_638266733183166747"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionAxis_638266733183166747" xlink:to="us-gaap_AssetAcquisitionDomain_638266733183166747" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_TwoBuildingOfficeComplexAssetMember" xlink:label="sava_TwoBuildingOfficeComplexAssetMember_638266733183176720"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionDomain_638266733183166747" xlink:to="sava_TwoBuildingOfficeComplexAssetMember_638266733183176720" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionLineItems" xlink:label="us-gaap_AssetAcquisitionLineItems_638266733183176720"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionTable_638266733183166747" xlink:to="us-gaap_AssetAcquisitionLineItems_638266733183176720" order="3" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_PercentageOfOccupancy" xlink:label="sava_PercentageOfOccupancy_638266733183176720"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionLineItems_638266733183176720" xlink:to="sava_PercentageOfOccupancy_638266733183176720" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_PercentageOfCurrentlyLeased" xlink:label="sava_PercentageOfCurrentlyLeased_638266733183176720"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionLineItems_638266733183176720" xlink:to="sava_PercentageOfCurrentlyLeased_638266733183176720" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetRentableArea" xlink:label="us-gaap_NetRentableArea_638266733183176720"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionLineItems_638266733183176720" xlink:to="us-gaap_NetRentableArea_638266733183176720" order="3" use="optional" priority="2"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureRealPropertyComponentsOfOtherIncomeNetDetails" xlink:type="extended" xlink:title="40403 - Disclosure - Real Property (Components Of Other Income, Net) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="us-gaap_BusinessCombinationsAbstract_637709261558608168"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_638266733183176720"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationsAbstract_637709261558608168" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_638266733183176720" order="1" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_638266733183176720"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_638266733183176720" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_638266733183176720" order="1" use="optional" priority="3"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_638266733183176720"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis_638266733183176720" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_638266733183176720" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember_638266733183176720"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_638266733183176720" xlink:to="us-gaap_BuildingMember_638266733183176720" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis_638266733183176720"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_638266733183176720" xlink:to="srt_StatementGeographicalAxis_638266733183176720" order="2" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_638266733183176720"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis_638266733183176720" xlink:to="srt_SegmentGeographicalDomain_638266733183176720" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_AustinMember" xlink:label="sava_AustinMember_638266733183176720"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain_638266733183176720" xlink:to="sava_AustinMember_638266733183176720" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems_638266733183176720"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_638266733183176720" xlink:to="us-gaap_BusinessAcquisitionLineItems_638266733183176720" order="3" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="us-gaap_OtherNonoperatingIncome_638266733183176720"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_638266733183176720" xlink:to="us-gaap_OtherNonoperatingIncome_638266733183176720" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="us-gaap_OtherNonoperatingExpense_638266733183176720"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_638266733183176720" xlink:to="us-gaap_OtherNonoperatingExpense_638266733183176720" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="8"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_638266733183176720"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_638266733183176720" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_638266733183176720" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentNarrativeDetails" xlink:type="extended" xlink:title="40501 - Disclosure - Property And Equipment (Narrative) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation_638266733183176720"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_Depreciation_638266733183176720" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails" xlink:type="extended" xlink:title="40502 - Disclosure - Property And Equipment (Components Of Property And Equipment, Net) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_637708886452535935"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_638266733183176720"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract_637708886452535935" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_638266733183176720" order="1" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_638266733183176720"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_638266733183176720" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_638266733183176720" order="1" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_638266733183176720"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis_638266733183176720" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_638266733183176720" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandMember" xlink:label="us-gaap_LandMember_638266733183176720"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_638266733183176720" xlink:to="us-gaap_LandMember_638266733183176720" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember_638266733183176720"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_638266733183176720" xlink:to="us-gaap_BuildingMember_638266733183176720" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="us-gaap_BuildingAndBuildingImprovementsMember_638266733183176720"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_638266733183176720" xlink:to="us-gaap_BuildingAndBuildingImprovementsMember_638266733183176720" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember_638266733183186694"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_638266733183176720" xlink:to="us-gaap_LeaseholdImprovementsMember_638266733183186694" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember_638266733183186694"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_638266733183176720" xlink:to="us-gaap_FurnitureAndFixturesMember_638266733183186694" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember_638266733183186694"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_638266733183176720" xlink:to="us-gaap_ConstructionInProgressMember_638266733183186694" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_638266733183186694"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_638266733183176720" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_638266733183186694" order="2" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_638266733183186694"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638266733183186694" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_638266733183186694" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_638266733183186694"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638266733183186694" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_638266733183186694" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_638266733183186694"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems_638266733183186694" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_638266733183186694" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="4"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureIntangibleAssetsNarrativeDetails" xlink:type="extended" xlink:title="40601 - Disclosure - Intangible Assets (Narrative) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets_638266733183186694"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets_638266733183186694" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureIntangibleAssetsComponentsOfIntangibleAssetsNetDetails" xlink:type="extended" xlink:title="40602 - Disclosure - Intangible Assets (Components Of Intangible Assets, Net) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_637709278730154570"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_638266733183186694"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_637709278730154570" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_638266733183186694" order="1" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638266733183186694"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_638266733183186694" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638266733183186694" order="1" use="optional" priority="3"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638266733183186694"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_638266733183186694" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638266733183186694" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAcquiredInPlaceMember" xlink:label="us-gaap_LeasesAcquiredInPlaceMember_638266733183186694"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638266733183186694" xlink:to="us-gaap_LeasesAcquiredInPlaceMember_638266733183186694" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_LeasingCommissionsAndOtherMember" xlink:label="sava_LeasingCommissionsAndOtherMember_638266733183186694"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_638266733183186694" xlink:to="sava_LeasingCommissionsAndOtherMember_638266733183186694" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_638266733183186694"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_638266733183186694" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_638266733183186694" order="2" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_638266733183186694"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems_638266733183186694" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_638266733183186694" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_638266733183186694"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems_638266733183186694" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_638266733183186694" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="3"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_638266733183186694"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems_638266733183186694" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_638266733183186694" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="3"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureIntangibleAssetsAmortizationExpenseForFiniteLivedIntangibleAssetsDetails" xlink:type="extended" xlink:title="40603 - Disclosure - Intangible Assets (Amortization Expense For Finite-Lived Intangible Assets) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_637720627070870562"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_638266733183186694"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_637720627070870562" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_638266733183186694" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_638266733183186694"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_637720627070870562" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_638266733183186694" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_638266733183186694"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_637720627070870562" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_638266733183186694" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_638266733183186694"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_637720627070870562" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_638266733183186694" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails" xlink:type="extended" xlink:title="40701 - Disclosure - Stockholders&apos; Equity And Stock-Based Compensation Expense (Narrative) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_638266733183196667"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_638266733183196667" order="1" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_638266733183196667"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_638266733183196667" xlink:to="us-gaap_StatementClassOfStockAxis_638266733183196667" order="1" use="optional" priority="3"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_638266733183196667"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_638266733183196667" xlink:to="us-gaap_ClassOfStockDomain_638266733183196667" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember_638266733183196667"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_638266733183196667" xlink:to="us-gaap_CommonStockMember_638266733183196667" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_638266733183196667"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_638266733183196667" xlink:to="us-gaap_AwardTypeAxis_638266733183196667" order="2" use="optional" priority="3"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638266733183196667"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_638266733183196667" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638266733183196667" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember_638266733183196667"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638266733183196667" xlink:to="us-gaap_EmployeeStockOptionMember_638266733183196667" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember_638266733183196667"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638266733183196667" xlink:to="us-gaap_PerformanceSharesMember_638266733183196667" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis_638266733183196667"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_638266733183196667" xlink:to="us-gaap_PlanNameAxis_638266733183196667" order="3" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_638266733183196667"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis_638266733183196667" xlink:to="us-gaap_PlanNameDomain_638266733183196667" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_RegisteredDirectOffering2022Member" xlink:label="sava_RegisteredDirectOffering2022Member_638266733183196667"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain_638266733183196667" xlink:to="sava_RegisteredDirectOffering2022Member_638266733183196667" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_AtMarketEquityProgramMember" xlink:label="sava_AtMarketEquityProgramMember_638266733183196667"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain_638266733183196667" xlink:to="sava_AtMarketEquityProgramMember_638266733183196667" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_StockOptionAndPerformanceAwardActivity2020PlanMember" xlink:label="sava_StockOptionAndPerformanceAwardActivity2020PlanMember_638266733183196667"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain_638266733183196667" xlink:to="sava_StockOptionAndPerformanceAwardActivity2020PlanMember_638266733183196667" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_TwoThousandEighteenEquityIncentivePlanMember" xlink:label="sava_TwoThousandEighteenEquityIncentivePlanMember_638266733183196667"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain_638266733183196667" xlink:to="sava_TwoThousandEighteenEquityIncentivePlanMember_638266733183196667" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_638266733183196667"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_638266733183196667" xlink:to="srt_RangeAxis_638266733183196667" order="4" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="srt_RangeMember_638266733183196667"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_638266733183196667" xlink:to="srt_RangeMember_638266733183196667" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_638266733183196667"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638266733183196667" xlink:to="srt_MaximumMember_638266733183196667" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638266733183196667"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_638266733183196667" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638266733183196667" order="5" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_638266733183196667"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638266733183196667" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_638266733183196667" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_638266733183196667"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638266733183196667" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_638266733183196667" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_638266733183196667"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638266733183196667" xlink:to="us-gaap_SaleOfStockConsiderationReceivedPerTransaction_638266733183196667" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_PercentageOfCommissionAtmOffering" xlink:label="sava_PercentageOfCommissionAtmOffering_638266733183196667"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638266733183196667" xlink:to="sava_PercentageOfCommissionAtmOffering_638266733183196667" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_638266733183196667"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638266733183196667" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_638266733183196667" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare_638266733183196667"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638266733183196667" xlink:to="us-gaap_SaleOfStockPricePerShare_638266733183196667" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="7"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_638266733183196667"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638266733183196667" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_638266733183196667" order="7" use="optional" preferredLabel="http://www.xbrl.org/2009/role/netLabel" priority="7"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_StockOptionsExercisedNetSettledSatisfactionOfExercisePrice" xlink:label="sava_StockOptionsExercisedNetSettledSatisfactionOfExercisePrice_638266733183206640"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638266733183196667" xlink:to="sava_StockOptionsExercisedNetSettledSatisfactionOfExercisePrice_638266733183206640" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ProceedsFromStockOptionsExercisedNetSettledSatisfactionOfExercisePrice" xlink:label="sava_ProceedsFromStockOptionsExercisedNetSettledSatisfactionOfExercisePrice_638266733183206640"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638266733183196667" xlink:to="sava_ProceedsFromStockOptionsExercisedNetSettledSatisfactionOfExercisePrice_638266733183206640" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_638266733183206640"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638266733183196667" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_638266733183206640" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_638266733183206640"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638266733183196667" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_638266733183206640" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_638266733183226587"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638266733183196667" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_638266733183226587" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_638266733183226587"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638266733183196667" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_638266733183226587" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_638266733183226587"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638266733183196667" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_638266733183226587" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_638266733183226587"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638266733183196667" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_638266733183226587" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockOptionsAndUnvestedPerformanceAwardOutstandingActivityDetails" xlink:type="extended" xlink:title="40703 - Disclosure - Stockholders&apos; Equity And Stock-Based Compensation Expense (Stock Options And Unvested Performance Award Outstanding Activity) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638266733183226587"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638266733183226587" order="1" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_638266733183226587"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638266733183226587" xlink:to="us-gaap_AwardTypeAxis_638266733183226587" order="1" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638266733183226587"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_638266733183226587" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638266733183226587" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember_638266733183226587"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638266733183226587" xlink:to="us-gaap_EmployeeStockOptionMember_638266733183226587" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember_638266733183226587"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_638266733183226587" xlink:to="us-gaap_PerformanceSharesMember_638266733183226587" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638266733183226587"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_638266733183226587" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638266733183226587" order="2" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_638266733183226587"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638266733183226587" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_638266733183226587" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="6"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638266733183226587"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638266733183226587" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_638266733183226587" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_638266733183226587"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638266733183226587" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_638266733183226587" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="7"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_638266733183226587"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638266733183226587" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_638266733183226587" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="7"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6382667331832265871"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638266733183226587" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6382667331832265871" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="6"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_638266733183226587"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638266733183226587" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_638266733183226587" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="6"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_638266733183226587"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638266733183226587" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_638266733183226587" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_638266733183236560"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638266733183226587" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_638266733183236560" order="8" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_638266733183236560"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638266733183226587" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_638266733183236560" order="9" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="7"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_638266733183236560"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_638266733183226587" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_638266733183236560" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="6"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockBasedCompensationExpensesDetails" xlink:type="extended" xlink:title="40706 - Disclosure - Stockholders&apos; Equity And Stock-Based Compensation Expense (Stock-Based Compensation Expenses) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_638266733183236560"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_638266733183236560" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis_638266733183236560"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_638266733183236560" xlink:to="us-gaap_IncomeStatementLocationAxis_638266733183236560" order="1" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_638266733183236560"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis_638266733183236560" xlink:to="us-gaap_IncomeStatementLocationDomain_638266733183236560" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_638266733183236560"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_638266733183236560" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_638266733183236560" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_638266733183236560"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_638266733183236560" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_638266733183236560" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638266733183236560"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_638266733183236560" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638266733183236560" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_638266733183236560"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_638266733183236560" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_638266733183236560" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureIncomeTaxesNarrativeDetails" xlink:type="extended" xlink:title="40801 - Disclosure - Income Taxes (Narrative) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit_638266733183236560"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit_638266733183236560" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureCommitmentsNarrativeDetails" xlink:type="extended" xlink:title="40901 - Disclosure - Commitments (Narrative) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:label="us-gaap_ScheduleOfOperatingLeasedAssetsTable_638266733183236560"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfOperatingLeasedAssetsTable_638266733183236560" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis_638266733183236560"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable_638266733183236560" xlink:to="srt_StatementGeographicalAxis_638266733183236560" order="1" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_638266733183236560"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis_638266733183236560" xlink:to="srt_SegmentGeographicalDomain_638266733183236560" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_AustinMember" xlink:label="sava_AustinMember_638266733183236560"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain_638266733183236560" xlink:to="sava_AustinMember_638266733183236560" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_638266733183236560"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable_638266733183236560" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_638266733183236560" order="2" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_638266733183236560"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis_638266733183236560" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_638266733183236560" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BuildingMember" xlink:label="us-gaap_BuildingMember_638266733183236560"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain_638266733183236560" xlink:to="us-gaap_BuildingMember_638266733183236560" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis_638266733183236560"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable_638266733183236560" xlink:to="us-gaap_LeaseContractualTermAxis_638266733183236560" order="3" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain_638266733183236560"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermAxis_638266733183236560" xlink:to="us-gaap_LeaseContractualTermDomain_638266733183236560" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_OperatingLeasesMember" xlink:label="sava_OperatingLeasesMember_638266733183236560"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermDomain_638266733183236560" xlink:to="sava_OperatingLeasesMember_638266733183236560" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasedAssetsLineItems" xlink:label="us-gaap_OperatingLeasedAssetsLineItems_638266733183236560"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfOperatingLeasedAssetsTable_638266733183236560" xlink:to="us-gaap_OperatingLeasedAssetsLineItems_638266733183236560" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetRentableArea" xlink:label="us-gaap_NetRentableArea_638266733183246532"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems_638266733183236560" xlink:to="us-gaap_NetRentableArea_638266733183246532" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1_638266733183246532"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems_638266733183236560" xlink:to="us-gaap_LeaseExpirationDate1_638266733183246532" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost_638266733183246532"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems_638266733183236560" xlink:to="us-gaap_OperatingLeaseCost_638266733183246532" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments_638266733183246532"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeasedAssetsLineItems_638266733183236560" xlink:to="us-gaap_OperatingLeasePayments_638266733183246532" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails" xlink:type="extended" xlink:title="41001 - Disclosure - 2020 Cash Incentive Bonus Plan (Narrative) (Details)">
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_CashIncentiveBonusPlanAbstract" xlink:label="sava_CashIncentiveBonusPlanAbstract_637399223356820786"></loc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_CashIncentiveBonusPlanTable" xlink:label="sava_CashIncentiveBonusPlanTable_638266733183246532"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sava_CashIncentiveBonusPlanAbstract_637399223356820786" xlink:to="sava_CashIncentiveBonusPlanTable_638266733183246532" order="1" use="optional" priority="3"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis_638266733183246532"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sava_CashIncentiveBonusPlanTable_638266733183246532" xlink:to="srt_RangeAxis_638266733183246532" order="1" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember" xlink:label="srt_RangeMember_638266733183246532"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis_638266733183246532" xlink:to="srt_RangeMember_638266733183246532" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember_638266733183246532"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638266733183246532" xlink:to="srt_MinimumMember_638266733183246532" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember_638266733183246532"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember_638266733183246532" xlink:to="srt_MaximumMember_638266733183246532" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis_638266733183246532"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sava_CashIncentiveBonusPlanTable_638266733183246532" xlink:to="us-gaap_PlanNameAxis_638266733183246532" order="2" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_638266733183246532"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis_638266733183246532" xlink:to="us-gaap_PlanNameDomain_638266733183246532" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_CashIncentiveBonusPlanMember" xlink:label="sava_CashIncentiveBonusPlanMember_638266733183246532"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain_638266733183246532" xlink:to="sava_CashIncentiveBonusPlanMember_638266733183246532" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis_638266733183246532"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sava_CashIncentiveBonusPlanTable_638266733183246532" xlink:to="srt_StatementScenarioAxis_638266733183246532" order="3" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_638266733183246532"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis_638266733183246532" xlink:to="srt_ScenarioUnspecifiedDomain_638266733183246532" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ExceedingPerformanceMilestonesMinimum20ConsecutiveDaysMember" xlink:label="sava_ExceedingPerformanceMilestonesMinimum20ConsecutiveDaysMember_638266733183246532"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_638266733183246532" xlink:to="sava_ExceedingPerformanceMilestonesMinimum20ConsecutiveDaysMember_638266733183246532" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_Exceeds5BillionMarketCapitalizationMember" xlink:label="sava_Exceeds5BillionMarketCapitalizationMember_638266733183246532"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_638266733183246532" xlink:to="sava_Exceeds5BillionMarketCapitalizationMember_638266733183246532" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_FirstValuationMilestoneMember" xlink:label="sava_FirstValuationMilestoneMember_638266733183246532"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_638266733183246532" xlink:to="sava_FirstValuationMilestoneMember_638266733183246532" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_SecondThroughEighthValuationMilestonesMember" xlink:label="sava_SecondThroughEighthValuationMilestonesMember_638266733183246532"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain_638266733183246532" xlink:to="sava_SecondThroughEighthValuationMilestonesMember_638266733183246532" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis_638266733183246532"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sava_CashIncentiveBonusPlanTable_638266733183246532" xlink:to="srt_TitleOfIndividualAxis_638266733183246532" order="4" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_638266733183246532"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis_638266733183246532" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_638266733183246532" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_IndependentDirectorsMember" xlink:label="sava_IndependentDirectorsMember_638266733183246532"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain_638266733183246532" xlink:to="sava_IndependentDirectorsMember_638266733183246532" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_CashIncentiveBonusPlanLineItems" xlink:label="sava_CashIncentiveBonusPlanLineItems_638266733183246532"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sava_CashIncentiveBonusPlanTable_638266733183246532" xlink:to="sava_CashIncentiveBonusPlanLineItems_638266733183246532" order="5" use="optional"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_MinimumNumberOfDaysValuationMilestoneMustBeAchievedAndMaintained" xlink:label="sava_MinimumNumberOfDaysValuationMilestoneMustBeAchievedAndMaintained_638266733183256506"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sava_CashIncentiveBonusPlanLineItems_638266733183246532" xlink:to="sava_MinimumNumberOfDaysValuationMilestoneMustBeAchievedAndMaintained_638266733183256506" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_MinimumNumberOfValuationMilestonesToRecognizeCompensationExpense" xlink:label="sava_MinimumNumberOfValuationMilestonesToRecognizeCompensationExpense_638266733183256506"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sava_CashIncentiveBonusPlanLineItems_638266733183246532" xlink:to="sava_MinimumNumberOfValuationMilestonesToRecognizeCompensationExpense_638266733183256506" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_NumberOfValuationMilestonesAchieved" xlink:label="sava_NumberOfValuationMilestonesAchieved_638266733183256506"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sava_CashIncentiveBonusPlanLineItems_638266733183246532" xlink:to="sava_NumberOfValuationMilestonesAchieved_638266733183256506" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_PerformancePlanValuationAmount" xlink:label="sava_PerformancePlanValuationAmount_638266733183256506"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sava_CashIncentiveBonusPlanLineItems_638266733183246532" xlink:to="sava_PerformancePlanValuationAmount_638266733183256506" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_PercentageValuationMilestoneCashBonusAwardSubjectToApprovalAndAdjustment" xlink:label="sava_PercentageValuationMilestoneCashBonusAwardSubjectToApprovalAndAdjustment_638266733183256506"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sava_CashIncentiveBonusPlanLineItems_638266733183246532" xlink:to="sava_PercentageValuationMilestoneCashBonusAwardSubjectToApprovalAndAdjustment_638266733183256506" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_CashIncentiveBonusAward" xlink:label="sava_CashIncentiveBonusAward_638266733183256506"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sava_CashIncentiveBonusPlanLineItems_638266733183246532" xlink:to="sava_CashIncentiveBonusAward_638266733183256506" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:label="us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_638266733183256506"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sava_CashIncentiveBonusPlanLineItems_638266733183246532" xlink:to="us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_638266733183256506" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_PaymentsForCashIncentiveBonus" xlink:label="sava_PaymentsForCashIncentiveBonus_638266733183256506"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="sava_CashIncentiveBonusPlanLineItems_638266733183246532" xlink:to="sava_PaymentsForCashIncentiveBonus_638266733183256506" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://www.cassavasciences.com/role/DisclosureContingenciesNarrativeDetails" xlink:type="extended" xlink:title="41101 - Disclosure - Contingencies (Narrative) (Details)">
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyAbstract" xlink:label="us-gaap_LossContingencyAbstract"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable_638266733183256506"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingencyAbstract" xlink:to="us-gaap_LossContingenciesTable_638266733183256506" order="1" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseAxis" xlink:label="srt_LitigationCaseAxis_638266733183256506"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable_638266733183256506" xlink:to="srt_LitigationCaseAxis_638266733183256506" order="1" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_LitigationCaseTypeDomain" xlink:label="srt_LitigationCaseTypeDomain_638266733183256506"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_LitigationCaseAxis_638266733183256506" xlink:to="srt_LitigationCaseTypeDomain_638266733183256506" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ViolationsOfFederalSecuritiesLawsMember" xlink:label="sava_ViolationsOfFederalSecuritiesLawsMember_638266733183256506"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_LitigationCaseTypeDomain_638266733183256506" xlink:to="sava_ViolationsOfFederalSecuritiesLawsMember_638266733183256506" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ShareholderDerivativeActionsMember" xlink:label="sava_ShareholderDerivativeActionsMember_638266733183256506"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_LitigationCaseTypeDomain_638266733183256506" xlink:to="sava_ShareholderDerivativeActionsMember_638266733183256506" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ShareholderDerivativeActionsU.s.DistrictCourtMember" xlink:label="sava_ShareholderDerivativeActionsU.s.DistrictCourtMember_638266733183256506"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_LitigationCaseTypeDomain_638266733183256506" xlink:to="sava_ShareholderDerivativeActionsU.s.DistrictCourtMember_638266733183256506" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ShareholderDerivativeActionsTexasCourtMember" xlink:label="sava_ShareholderDerivativeActionsTexasCourtMember_638266733183256506"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_LitigationCaseTypeDomain_638266733183256506" xlink:to="sava_ShareholderDerivativeActionsTexasCourtMember_638266733183256506" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="sava-20230630.xsd#sava_ShareholderDerivativeActionsDelwareCourtMember" xlink:label="sava_ShareholderDerivativeActionsDelwareCourtMember_638266733183256506"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_LitigationCaseTypeDomain_638266733183256506" xlink:to="sava_ShareholderDerivativeActionsDelwareCourtMember_638266733183256506" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems_638266733183256506"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable_638266733183256506" xlink:to="us-gaap_LossContingenciesLineItems_638266733183256506" order="2" use="optional" priority="2"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyNewClaimsFiledNumber" xlink:label="us-gaap_LossContingencyNewClaimsFiledNumber_638266733183256506"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems_638266733183256506" xlink:to="us-gaap_LossContingencyNewClaimsFiledNumber_638266733183256506" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3"></presentationArc></presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended" xlink:title="995445 - Disclosure - Insider Trading Arrangements">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems" xlink:label="InsiderTradingArrLineItems"></loc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag_638266733183266479"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InsiderTradingArrLineItems" xlink:to="ecd_Rule10b51ArrAdoptedFlag_638266733183266479" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="9"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_638266733183266479"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InsiderTradingArrLineItems" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_638266733183266479" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="9"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag_638266733183266479"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InsiderTradingArrLineItems" xlink:to="ecd_Rule10b51ArrTrmntdFlag_638266733183266479" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="9"></presentationArc>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_638266733183266479"></loc>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InsiderTradingArrLineItems" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_638266733183266479" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="9"></presentationArc></presentationLink></linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687335731072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Aug. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Document And Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-29959<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cassava Sciences, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">91-1911336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6801 N. Capital of Texas Highway<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Building 1; Suite 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Austin<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">78731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">501-2444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SAVA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,969,994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001069530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687333130432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 168,438<span></span>
</td>
<td class="nump">$ 201,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">6,095<span></span>
</td>
<td class="nump">10,211<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">174,533<span></span>
</td>
<td class="nump">211,226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">22,328<span></span>
</td>
<td class="nump">22,864<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">387<span></span>
</td>
<td class="nump">622<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">197,248<span></span>
</td>
<td class="nump">234,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">10,338<span></span>
</td>
<td class="nump">4,017<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued development expense</a></td>
<td class="nump">7,044<span></span>
</td>
<td class="nump">2,280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">220<span></span>
</td>
<td class="nump">170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">293<span></span>
</td>
<td class="nump">492<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">17,895<span></span>
</td>
<td class="nump">7,063<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">197<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">17,895<span></span>
</td>
<td class="nump">7,295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Notes 10, 11 and 12)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value; 10,000,000 shares authorized, none issued and outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; 120,000,000 shares authorized; 41,919,527 and 41,735,557 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">513,510<span></span>
</td>
<td class="nump">511,049<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(334,199)<span></span>
</td>
<td class="num">(283,552)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">179,353<span></span>
</td>
<td class="nump">227,539<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 197,248<span></span>
</td>
<td class="nump">$ 234,834<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687341117824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Condensed Consolidated Balance Sheets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">120,000,000<span></span>
</td>
<td class="nump">120,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">41,919,527<span></span>
</td>
<td class="nump">41,735,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">41,919,527<span></span>
</td>
<td class="nump">41,735,557<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687340944624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements Of Operations - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_ResearchAndDevelopmentExpenseNetOfGrantReimbursement', window );">Research and development, net of grant reimbursement</a></td>
<td class="nump">$ 24,969<span></span>
</td>
<td class="nump">$ 16,948<span></span>
</td>
<td class="nump">$ 47,089<span></span>
</td>
<td class="nump">$ 31,854<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">3,808<span></span>
</td>
<td class="nump">2,969<span></span>
</td>
<td class="nump">8,200<span></span>
</td>
<td class="nump">5,884<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">28,777<span></span>
</td>
<td class="nump">19,917<span></span>
</td>
<td class="nump">55,289<span></span>
</td>
<td class="nump">37,738<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(28,777)<span></span>
</td>
<td class="num">(19,917)<span></span>
</td>
<td class="num">(55,289)<span></span>
</td>
<td class="num">(37,738)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Interest income</a></td>
<td class="nump">2,198<span></span>
</td>
<td class="nump">314<span></span>
</td>
<td class="nump">4,249<span></span>
</td>
<td class="nump">345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">203<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="nump">393<span></span>
</td>
<td class="nump">538<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (26,376)<span></span>
</td>
<td class="num">$ (19,328)<span></span>
</td>
<td class="num">$ (50,647)<span></span>
</td>
<td class="num">$ (36,855)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income (loss) per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, Basic</a></td>
<td class="num">$ (0.63)<span></span>
</td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="num">$ (1.21)<span></span>
</td>
<td class="num">$ (0.92)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, Diluted</a></td>
<td class="num">$ (0.63)<span></span>
</td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="num">$ (1.21)<span></span>
</td>
<td class="num">$ (0.92)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Weighted-average shares used in computing net income (loss) per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used in computing net loss per share, basic</a></td>
<td class="nump">41,793<span></span>
</td>
<td class="nump">40,015<span></span>
</td>
<td class="nump">41,766<span></span>
</td>
<td class="nump">39,989<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in computing net loss per share, diluted</a></td>
<td class="nump">41,793<span></span>
</td>
<td class="nump">40,015<span></span>
</td>
<td class="nump">41,766<span></span>
</td>
<td class="nump">39,989<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sava_ResearchAndDevelopmentExpenseNetOfGrantReimbursement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and Development Expense, Net Of Grant Reimbursement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sava_ResearchAndDevelopmentExpenseNetOfGrantReimbursement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sava_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687335884224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements Of Stockholders' Equity - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-In Capital [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="nump">$ 461,181,000<span></span>
</td>
<td class="num">$ (207,306,000)<span></span>
</td>
<td class="nump">$ 253,915,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, Shares at Dec. 31, 2021</a></td>
<td class="nump">40,016,792<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan', window );">Stock options for employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">471,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">471,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock options for non-employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock pursuant to exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock pursuant to exercise of stock options, shares</a></td>
<td class="nump">14,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,527,000)<span></span>
</td>
<td class="num">(17,527,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2022</a></td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="nump">461,887,000<span></span>
</td>
<td class="num">(224,833,000)<span></span>
</td>
<td class="nump">237,094,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, Shares at Mar. 31, 2022</a></td>
<td class="nump">40,031,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="nump">461,181,000<span></span>
</td>
<td class="num">(207,306,000)<span></span>
</td>
<td class="nump">253,915,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, Shares at Dec. 31, 2021</a></td>
<td class="nump">40,016,792<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,855,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2022</a></td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="nump">462,491,000<span></span>
</td>
<td class="num">(244,161,000)<span></span>
</td>
<td class="nump">218,370,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, Shares at Jun. 30, 2022</a></td>
<td class="nump">40,097,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2022</a></td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="nump">461,887,000<span></span>
</td>
<td class="num">(224,833,000)<span></span>
</td>
<td class="nump">237,094,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, Shares at Mar. 31, 2022</a></td>
<td class="nump">40,031,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan', window );">Stock options for employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">462,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">462,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock options for non-employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock pursuant to exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock pursuant to exercise of stock options, shares</a></td>
<td class="nump">66,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,328,000)<span></span>
</td>
<td class="num">(19,328,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2022</a></td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="nump">462,491,000<span></span>
</td>
<td class="num">(244,161,000)<span></span>
</td>
<td class="nump">218,370,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, Shares at Jun. 30, 2022</a></td>
<td class="nump">40,097,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 42,000<span></span>
</td>
<td class="nump">511,049,000<span></span>
</td>
<td class="num">(283,552,000)<span></span>
</td>
<td class="nump">227,539,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, Shares at Dec. 31, 2022</a></td>
<td class="nump">41,735,557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan', window );">Stock options for employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock options for non-employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock pursuant to exercise of stock options</a></td>
<td class="nump">$ 13,878<span></span>
</td>
<td class="nump">64,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,271,000)<span></span>
</td>
<td class="num">(24,271,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2023</a></td>
<td class="nump">$ 42,000<span></span>
</td>
<td class="nump">511,786,000<span></span>
</td>
<td class="num">(307,823,000)<span></span>
</td>
<td class="nump">204,005,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, Shares at Mar. 31, 2023</a></td>
<td class="nump">41,749,435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 42,000<span></span>
</td>
<td class="nump">511,049,000<span></span>
</td>
<td class="num">(283,552,000)<span></span>
</td>
<td class="nump">227,539,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, Shares at Dec. 31, 2022</a></td>
<td class="nump">41,735,557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50,647,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2023</a></td>
<td class="nump">$ 42,000<span></span>
</td>
<td class="nump">513,510,000<span></span>
</td>
<td class="num">(334,199,000)<span></span>
</td>
<td class="nump">179,353,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, Shares at Jun. 30, 2023</a></td>
<td class="nump">41,919,527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2023</a></td>
<td class="nump">$ 42,000<span></span>
</td>
<td class="nump">511,786,000<span></span>
</td>
<td class="num">(307,823,000)<span></span>
</td>
<td class="nump">204,005,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, Shares at Mar. 31, 2023</a></td>
<td class="nump">41,749,435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan', window );">Stock options for employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">812,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">812,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock options for non-employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock pursuant to exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">889,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">889,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock pursuant to exercise of stock options, shares</a></td>
<td class="nump">170,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,376,000)<span></span>
</td>
<td class="num">(26,376,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2023</a></td>
<td class="nump">$ 42,000<span></span>
</td>
<td class="nump">$ 513,510,000<span></span>
</td>
<td class="num">$ (334,199,000)<span></span>
</td>
<td class="nump">$ 179,353,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, Shares at Jun. 30, 2023</a></td>
<td class="nump">41,919,527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock issued during the period as a result of employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 25<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480637/718-40-25-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687339513504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements Of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (26,376,000)<span></span>
</td>
<td class="num">$ (19,328,000)<span></span>
</td>
<td class="num">$ (50,647,000)<span></span>
</td>
<td class="num">$ (36,855,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,508,000<span></span>
</td>
<td class="nump">980,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">272,000<span></span>
</td>
<td class="nump">174,000<span></span>
</td>
<td class="nump">544,000<span></span>
</td>
<td class="nump">352,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">119,000<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
<td class="nump">238,000<span></span>
</td>
<td class="nump">260,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,116,000<span></span>
</td>
<td class="nump">4,431,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet', window );">Operating lease right-of-use assets and liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,000)<span></span>
</td>
<td class="num">(4,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,661,000<span></span>
</td>
<td class="num">(2,368,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_IncreaseDecreaseInDevelopmentExpense', window );">Accrued development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,764,000<span></span>
</td>
<td class="nump">515,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation and benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="num">(1,701,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(396,000)<span></span>
</td>
<td class="num">(254,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33,179,000)<span></span>
</td>
<td class="num">(34,644,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(351,000)<span></span>
</td>
<td class="num">(1,891,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(351,000)<span></span>
</td>
<td class="num">(1,891,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from issuance of common stock upon exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">953,000<span></span>
</td>
<td class="nump">330,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">953,000<span></span>
</td>
<td class="nump">330,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net decrease in cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32,577,000)<span></span>
</td>
<td class="num">(36,205,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">201,015,000<span></span>
</td>
<td class="nump">233,437,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 168,438,000<span></span>
</td>
<td class="nump">$ 197,232,000<span></span>
</td>
<td class="nump">$ 168,438,000<span></span>
</td>
<td class="nump">$ 197,232,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sava_IncreaseDecreaseInDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in development expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sava_IncreaseDecreaseInDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sava_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sava_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase Decrease In Operating Lease Right Of Use Assets and Liabilities, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sava_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sava_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687337009856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General And Liquidity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>General And Liquidity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">General And Liquidity</a></td>
<td class="text"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Note 1.  General and Liquidity</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Cassava Sciences, Inc. and its wholly-owned subsidiary (collectively referred to as the &#8220;Company&#8221;) discover and develop proprietary pharmaceutical product candidates that may offer significant improvements to patients and healthcare professionals. The Company generally focuses its discovery and product development efforts on disorders of the nervous system. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) for interim financial information and pursuant to the instructions to the Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">All intercompany transactions and balances have been eliminated in consolidation.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> Accordingly, the condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete consolidated financial statements. In the opinion of management of the Company, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation have been included. Operating results for the three and six months ended June 30, 2023 are not necessarily indicative of the results that may be expected for any other interim period or for the year 2023</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">For further information, refer to the consolidated financial statements and footnotes thereto included in the Company&#8217;s Annual Report on Form&#160;10-K for the year ended December 31, 2022.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Liquidity</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company has incurred significant net losses and negative cash flows since inception, and as a result has an accumulated deficit of $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">334.2</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million at June 30, 2023. The Company expects its cash requirements to be significant in the future. The amount and timing of the Company&#8217;s future cash requirements will depend on regulatory and market acceptance of its product candidates and the resources it devotes to researching and developing, formulating, manufacturing, commercializing and supporting its products. The Company may seek additional funding through public or private financing in the future, if such funding is available and on terms acceptable to the Company. There are no assurances that additional financing will be available on favorable terms, or at all. However, management believes that the current working capital position will be sufficient to meet the Company&#8217;s working capital needs for at least the next 12 months.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687337811264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Note 2.&#160;&#160;Significant Accounting Policies</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Use of Estimates</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company makes estimates and assumptions in preparing its condensed consolidated financial statements in conformity with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amount of revenue earned and expenses incurred during the reporting period. The Company evaluates&#160;its estimates on an ongoing basis, including those estimates related to manufacturing agreements and research collaborations. Actual results could differ from these estimates</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> and assumptions.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Cash and Cash Equivalents and Concentration of Credit Risk</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company invests in cash and cash equivalents. The Company considers highly liquid financial instruments with original maturities of three months or less to be cash equivalents. Highly liquid investments that are considered cash equivalents include money market accounts and funds, certificates of deposit, and U.S. Treasury securities.&#160;The Company maintains&#160;its cash and cash equivalents at one financial institution. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Fair Value Measurements </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company recognizes financial instruments in accordance with the authoritative guidance on fair value measurements and disclosures for financial assets and liabilities. This guidance defines fair value, establishes a framework for measuring fair value in accordance with GAAP, and expands disclosures about fair value measurements. The guidance also establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Level 1 includes quoted prices in active markets.</span></p><p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Level 2 includes significant observable inputs, such as quoted prices for identical or similar securities, or other inputs that are observable and can be corroborated by observable market data for similar securities. The Company uses market pricing and other observable market inputs obtained from third-party providers. It uses the bid price to establish fair value where a bid price is available. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company does not have any financial instruments where the fair value is based on Level 2 inputs.</span></p><p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Level 3 includes unobservable inputs that are supported by little or no market activity. The Company does not have any financial instruments where the fair value is based on Level 3 inputs.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">If a financial instrument uses inputs that fall in different levels of the hierarchy, the instrument will be categorized based upon the lowest level of input that is significant to the fair value calculation. The fair value of cash and cash equivalents was based on Level 1 inputs at </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023 and December 31, 2022.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">&#65279;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Business Segments</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company reports segment information based on how it internally evaluates the operating performance of its business units, or segments. The Company&#8217;s operations are confined to </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">one</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> business segment: the development of novel drugs and diagnostics.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Proceeds from Grants</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">&#65279;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During the three and six months ended </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023,&#160;there were </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">no</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> reimbursements received pursuant to National Institutes of Health (&#8220;NIH&#8221;) research grants. </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During the </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">three and six months ended </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2022</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, the Company received reimbursements totaling $</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0.4</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million and $</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0.5</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million, respectively, pursuant to NIH research grants. </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company records the proceeds from these grants as reductions to its research and development expenses.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Stock-based Compensation</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#65279;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The&#160;Company recognizes non-cash expense for the fair value of all stock options and other share-based awards. The Company uses the Black-Scholes option valuation model (&#8220;Black-Scholes&#8221;) to calculate the fair value of stock options, using the single-option award approach and straight-line attribution method. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">This model requires the input of subjective assumptions including expected stock price volatility, expected life and estimated forfeitures of each </span><span id="_cp_text_1_372" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">award. These assumptions consist of estimates of future market conditions, which are inherently uncertain, and therefore, are subject to management's judgment. </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">For all options granted, it recognizes the resulting fair value as expense on a straight-line basis over the vesting period of each respective stock option, generally </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">four years</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.25in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#65279;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company has granted share-based awards that vest upon achievement of certain performance criteria (&#8220;Performance Awards&#8221;). The Company multiplies the number of Performance Awards by the fair value of its common stock on the date of grant to calculate the fair value of each award. It estimates an implicit service period for achieving performance criteria for each award. The Company recognizes the resulting fair value as expense over the implicit service period when it concludes that achieving the performance criteria is probable. It periodically reviews and updates as appropriate its estimates of implicit service periods and conclusions on achieving the performance criteria. Performance Awards vest and common stock is issued upon achievement of the performance criteria.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">&#65279;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Net Loss per Share </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">&#65279;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company computes basic net loss per share on the basis of the weighted-average number of common shares outstanding for the reporting period. Diluted net loss per share is computed on the basis of the weighted-average number of common shares outstanding plus potential dilutive common shares outstanding using the treasury-stock </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">method. Potential dilutive common shares consist of outstanding common stock options.&#160;&#160;There is no difference between the Company&#8217;s net loss and comprehensive loss. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The numerators and denominators in the calculation of basic and diluted net loss per share were as follows (in thousands, except net loss per share data):</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.20in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.31in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Three months ended</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Six months ended</span></p></td></tr><tr style="height: 0.20in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p></td></tr><tr style="height: 0.16in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Numerator:</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.17in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net loss</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">26,376</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">19,328</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">50,647</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">36,855</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Denominator:</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.17in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Shares used in computing net loss per share, basic and diluted</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">41,793</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">40,015</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">41,766</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">39,989</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net loss per share, basic and diluted</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0.63</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0.48</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1.21</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0.92</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr style="height: 0.08in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> Dilutive common stock options excluded from net loss per share, diluted</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2,001</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,937</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2,018</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2,095</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr style="height: 0.07in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company excluded common stock options outstanding from the calculation of net loss per share, diluted, because the effect of including outstanding options would have been anti</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">-</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">dilutive. The Company also excluded </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">57,143</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> restricted stock awards from the calculation of net loss per share, diluted, until their expiration in June 2022 because the effect of including restricted stock awards would have been anti</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">-</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">dilutive.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Fair Value of Financial Instruments</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160; &#160; </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 6pt;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Financial instruments include accounts payable and accrued liabilities. The estimated fair value of certain financial instruments may be determined using available market information or other appropriate valuation methodologies. However, considerable judgment is required in interpreting market data to develop estimates of fair value; therefore, the estimates are not necessarily indicative of the amounts that could be realized or would be paid in a current market exchange. The effect of using different market assumptions and/or estimation methodologies may be material to the estimated fair value amounts. The carrying amounts of accounts payable and accrued liabilities are at cost, which approximates fair value due to the short maturity of those instruments. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Research Contract Costs and Accruals </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company has entered into various research and development contracts with research institutions and other third-party vendors. These agreements are generally cancelable. Related payments are recorded as research and development expenses as incurred. The Company records prepaids and accruals for estimated ongoing research costs. When evaluating the adequacy of prepaid expenses and accrued liabilities, the Company analyzes progress of the studies including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made in determining the prepaid and accrued balances at the end of any reporting period. Actual results could differ from the Company&#8217;s estimates. The Company&#8217;s historical prepaid and accrual estimates have not been materially different from actual costs.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Incentive Bonus Plan</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In 2020, the Company established the 2020 Cash Incentive Bonus Plan (the &#8220;Plan&#8221;) to incentivize Plan participants. Awards under the Plan are accounted for as liability awards under Accounting Standards Codification (ASC) 718 &#8220;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Stock-based Compensation</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#8221;.&#160;The fair value of each&#160;potential Plan&#160;award&#160;will be&#160;determined&#160;once&#160;a&#160;grant date occurs and&#160;will be&#160;remeasured each reporting period.&#160;Compensation expense associated with the Plan&#160;will be&#160;recognized over the expected achievement period for each&#160;Plan award, when&#160;a Performance Condition&#160;(as defined below) is considered probable of being met. See Note 10 for further discussion of the Plan.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 1.00in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Leases</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company recognizes&#160;assets and liabilities that arise from leases.&#160;For operating leases, the Company is required to recognize a right-of-use asset and a lease liability, initially measured at the present value of the lease payments during the lease term, in the&#160;condensed consolidated balance sheets.&#160;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company elected the short-term lease recognition exemption for all leases that qualify. This means, for those leases that qualify, the Company does not recognize right-of-use assets or lease liabilities. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">As the Company`s leases do not provide an implicit rate, it uses its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. Lease expense for lease payments is recognized on a straight-line basis over the lease term.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Property and equipment</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Property and equipment is recorded at cost, net of accumulated depreciation. Depreciation is recorded using the straight-line method over the estimated useful lives of the assets. Owned buildings and related improvements have estimated useful lives of </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">39</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years and approximately </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">10</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years, respectively. Tenant improvements are amortized using the straight-line method over the useful lives of the improvements or the remaining term of the corresponding leases, whichever is shorter. The remaining term of the corresponding leases is approximately </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0.9</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Property and equipment are reviewed for impairment when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. If property and equipment are considered to be impaired, an impairment loss is recognized.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Intangible assets</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Acquired intangible assets are recorded at fair value at the date of acquisition and primarily consist of lease-in-place agreements and leasing commissions. Intangible assets are amortized over the estimated life of the lease-in-place agreements, which is approximately </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0.8</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years at </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Intangible assets are reviewed for impairment on an annual basis, and when there is reason to believe that their values have been diminished or impaired. If intangible assets are considered</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> to be impaired, an impairment loss is recognized.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Income Taxes</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company accounts for income taxes under the asset and liability method. &#160;Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.&#160;Deferred tax balances are adjusted to reflect tax rates based on currently enacted tax laws, which will be in effect in the years in which the temporary differences are expected to reverse.&#160;The Company has accumulated significant deferred tax assets that reflect the tax effects of net operating loss and tax credit carryovers and temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Realization of certain deferred tax assets is dependent upon future earnings. The Company is uncertain about the timing and amount of any future earnings. Accordingly, the Company offsets these deferred tax assets with a valuation allowance.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company accounts for uncertain tax positions in accordance with ASC 740, &#8220;Income Taxes&#8221;, which clarifies the accounting for uncertainty in tax positions. These provisions require recognition of the impact of a tax position in the Company&#8217;s </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">condensed</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> consolidated financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Any interest and penalties related to uncertain tax positions will be reflected as a component of income tax expense.</span></p><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687337009728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses And Other Current Assets<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Prepaid Expenses And Other Current Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_PrepaidAndOtherAssetsDisclosureTextBlock', window );">Prepaid Expenses and Other Current Assets</a></td>
<td class="text"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;letter-spacing: 0;margin: 0;padding: 0;">Note 3.  Prepaid Expenses and </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Other Current Assets</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Prepaid expenses and other current assets at </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023 and December 31, 2022 consisted of the following (in thousands):</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.17in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.21in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.31in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br/>&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">December 31,</span><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br/>&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Prepaid insurance</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">5</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">874</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr style="height: 0.17in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Contract research organization and other deposits</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">4,527</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">9,177</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Interest receivable</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,328</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td></tr><tr style="height: 0.17in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Other</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">235</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">160</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr style="height: 0.21in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">  Total prepaid expenses and other current assets</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">6,095</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">10,211</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;"> </span></p><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Contract research organization and other deposits represent cash payments made to vendors in excess of expenses incurred.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sava_PrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid And Other Assets Disclosure [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sava_PrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sava_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687338592800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Property<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Real Property [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Real Property</a></td>
<td class="text"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;letter-spacing: 0;margin: 0;padding: 0;">Note 4. Real Property</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company owns a two-building office complex in Austin, Texas, a portion of which serves as its corporate headquarters. This property is intended to accommodate the Company&#8217;s anticipated growth and expansion of its operations in the coming years. Maintenance, physical facilities, leasing, property management and other key responsibilities related to property ownership are being outsourced to professional real-estate managers. The office complex measures approximately </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">90,000</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> rentable square feet. At </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023, the property was over </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">60</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">% leased. The Company also occupies approximately </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">25</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">% of the property.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company records the net income from building operations and leases as other income, net, as leasing is not core to the Company&#8217;s operations. Building depreciation and amortization for space not occupied by the Company is included in general and administrative expense. Building depreciation and amortization for space occupied by the Company is allocated between general and administrative expense and research and development expense. Components of other income, net, for the periods presented were as follows (in thousands):</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.05in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.21in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #FF0000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Three months ended</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Six months ended</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.18in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #FF0000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.16in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #FF0000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.25in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Lease revenue</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #FF0000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">559</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">586</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,116</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,160</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.17in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.25in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Property operating expenses</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #FF0000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">356</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">311</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">723</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">622</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.25in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">  Other income, net</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #FF0000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">203</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">275</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">393</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">538</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.06in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #FF0000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//805/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687336975664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property And Equipment<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property And Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property And Equipment</a></td>
<td class="text"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;letter-spacing: 0;margin: 0;padding: 0;">Note 5.  Property and equipment</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The components of property and equipment, net, as of </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023&#160;and&#160;December 31, 2022&#160;were as follows (in thousands):</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">December 31,</span><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br/>&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Land</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">3,734</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">3,734</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Buildings</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">15,980</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">15,980</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Site improvements</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">470</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">470</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Tenant improvements</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">3,018</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">3,016</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Furniture and equipment</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">868</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">851</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Construction in progress</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">13</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">  Gross property and equipment</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">24,072</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">24,064</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Accumulated depreciation</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,744</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,200</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">  Property and equipment, net</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">22,328</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">22,864</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Depreciation expense for property and equipment was&#160;$</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">272,000</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;and&#160;$</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">174,000</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;for the three months ended&#160;June 30, 2023&#160;and 2022, respectively. </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Depreciation expense for property and equipment was $</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">544,000</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> and $</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">352,000</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> for the six months ended June 30, 2023 and 2022, respectively.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687339509664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
<td class="text"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;letter-spacing: 0;margin: 0;padding: 0;">Note 6.  Intangible assets</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The components of intangible assets, net, as of </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023&#160;and&#160;December 31, 2022&#160;were as follows (in thousands):</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">December 31,</span><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br/>&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Lease-in-place agreements</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,053</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,053</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Leasing commissions and other</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">293</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">290</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">  Gross intangible assets</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,346</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,343</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Accumulated amortization</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">959</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">721</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">  Intangible assets, net</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">387</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">622</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Amortization expense for intangible assets was&#160;$</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">119,000</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> and $</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">125,000</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> for the three months ended&#160;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023 and 2022, respectively. Amortization expense for intangible assets was&#160;$</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">238,000</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> and $</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">260,000</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> for the six months ended&#160;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023 and 2022, respectively.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Amortization expense for finite-lived intangible assets as of </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023 is expected to be as follows (in thousands):</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;text-decoration: underline;">For the year ending December 31,</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2023</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">216</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2024</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">167</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2025</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">4</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total amortization</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">387</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350-30/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687338429584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity And Stock-Based Compensation Expense<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Stockholders&#8217; Equity And Stock-Based Compensation Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">Stockholders' Equity And Stock-Based Compensation Expense</a></td>
<td class="text"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;letter-spacing: 0;margin: 0;padding: 0;">Note 7.  Stockholders&#8217; Equity and Stock-Based Compensation Expense</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">2022 Registered Direct Offering</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On November&#160;22, 2022, the Company completed a common stock offering pursuant to which certain investors purchased </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,666,667</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> shares of common stock at a price of $</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">30.00</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> per share. Net proceeds of the offering were approximately $</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">47.3</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million after deducting offering expenses.</span></p><div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">At-the-Market Common Stock Offering </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On May 1, 2023, the Company established a new at-the-market offering program (&#8220;ATM&#8221;) to sell, from time to time, shares of Company common stock having an aggregate offering price of up to $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">200</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million in common stock pursuant to a shelf registration statement that was filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on May 1, 2023 and became effective immediately upon filing. The Company is obligated to pay a commission of up to </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">3</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">% of the gross proceeds from the sale of shares of common stock in the offering. The Company is not obligated to sell any shares in the offering.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">There were </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">no</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> common stock sales under the ATM during the three and six months ended </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In March 2020, the Company established an at-the-market offering program (&#8220;2020 Program&#8221;) to sell, from time to time, shares of Company common stock having an aggregate offering price of up to $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">100</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">in transactions pursuant to a shelf registration statement that was declared effective by the </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">SEC</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> on May 5, 2020</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">. The Company gave notice of termination for the 2020 Program on April 26, 2023, which was effective May 1, 2023. There were </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">no</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> common stock sales under the 2020 Program through its termination. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Stock Option and Performance Award Activity in 2023</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During the six months ended </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023, stock options and unvested Performance Awards outstanding under the Company&#8217;s stock option plans changed as follows:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Stock Options</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Performance Awards</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Outstanding as of December 31, 2022</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2,529,448</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">7,142</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Options granted</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">122,000</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-a5e09c6a-9923-4b88-9aac-2bab00d80bb7;">&#8212;</span></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Options exercised</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">281,175</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-a4ac9c2f-0510-422d-88c4-81f94dcb8f78;">&#8212;</span></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Options forfeited/canceled</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">7,142</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-cf26586d-83aa-4eed-9015-9e654cf00456;">&#8212;</span></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Outstanding as of June 30, 2023</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2,363,131</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">7,142</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The weighted average exercise price of options outstanding at </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023 was $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">12.67</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">. As outstanding options vest over the current remaining vesting period of </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2.4</span><span style="white-space:pre-wrap; color: #FF0000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">years, the Company expects to recognize stock-based compensation expense of $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">8.8</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million. If and when outstanding Performance Awards vest, the Company will recognize stock-based compensation expense of $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0.1</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million over the implicit service period.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During the three months ended </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023, there were </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">262,158</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> stock options exercised. </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Of the stock options exercised, </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">92,066</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> stock options were net settled in satisfaction of the exercise price, with </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">no</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> cash proceeds received. Cash proceeds</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> to the Company </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">for options not net settled</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> totaled $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">889,000</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> during the three months ended </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During the six months ended </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023, there were </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">281,175</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> stock options exercised. Of the stock options exercised, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">97,205</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> stock options were net settled in satisfaction of the exercise price, with </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">no</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> cash proceeds received. Cash proceeds to the Company for options not net settled totaled $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">953,000</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> during the six months ended </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Stock-based Compensation Expense in 2023</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.21in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During the three and six months ended </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023 and 2022, the Company&#8217;s stock-based compensation expense was as follows (in thousands):</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Three months ended</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Six months ended</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Research and development</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">392</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">413</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">781</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">835</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">General and administrative</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">443</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">72</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">727</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">145</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total stock-based compensation expense</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">835</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">485</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,508</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">980</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0.03in;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">2018 Equity Incentive Plan </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company&#8217;s Board of Directors (the &#8220;Board&#8221;) or a designated committee of the Board is responsible for administration of the Company&#8217;s 2018 Omnibus Incentive Plan, as amended (the &#8220;2018 Plan&#8221;) and determines the terms and conditions of each option granted, consistent with the terms of the 2018 Plan. The Company&#8217;s employees, directors, and consultants are eligible to receive awards under the 2018 Plan, including grants of stock options and Performance Awards. Share-based awards generally expire </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">10</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years from the date of grant. The 2018 Plan, as amended on May 5, 2022, provides for issuance of up to </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">5,000,000</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> shares of common stock, par value $</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0.001</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> per share, subject to adjustment as provided in the 2018 Plan. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#65279; </span></p><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">When stock options or Performance Awards are exercised net of the exercise price and taxes, the number of shares of stock issued is reduced by the number of shares equal to the amount of taxes owed by the award recipient and that number of shares are cancelled. The Company then uses&#160;its cash to pay tax authorities the amount of statutory taxes owed by and on behalf of the award recipient.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687332605280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Note 8.  Income Taxes</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"> </span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company did </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">no</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">t provide for income taxes during the three and six months ended </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, because it has projected a net loss for the full year 2023 </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">for which any benefit will be offset by an increase in the valuation allowance</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">. There was also </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">no</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> provision for income taxes for the three and six months ended </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">,</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> 2022.</span></p><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687338344432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsDisclosureTextBlock', window );">Commitments</a></td>
<td class="text"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Note 9.  </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Commitments</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 1.00in;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Right-of-use Asset and Liability</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 1.00in;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company had an operating lease for approximately </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">6,000</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> square feet of office space in Austin, Texas with an expiration of </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">April 30, 2024</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">. The Company and the landlord consented to early terminate this lease on February 22, 2023 with no continuing obligations.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">There was </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">no</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> rent expense for the three months ended June 30, 2023. Rent expense for the </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">three months ended&#160;</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2022&#160;totaled $</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">41,000</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Rent expense for the six months ended&#160;June&#160;30, 2023&#160;and 2022&#160;totaled $</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">24,000</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> and $</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">82,000</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, respectively.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">There was </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">no</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> cash paid for operating lease liabilities during the three months ended June 30, 2023. Cash paid for operating lease liabilities during the three months ended </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2022 totaled $</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">41,000</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Cash paid for operating lease liabilities during the six months ended June&#160;30, 2023 and 2022 totaled $</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">24,000</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> and $</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">82,000</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, respectively.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Other Commitments</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company conducts its product research and development programs through a combination of internal and collaborative programs that include, among others, arrangements with universities, contract research organizations and clinical research sites. The Company has contractual arrangements with these organizations that are cancelable. The Company&#8217;s obligations under these contracts are largely based on services performed.</span></p><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687339372080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2020 Cash Incentive Bonus Plan<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_CashIncentiveBonusPlanAbstract', window );"><strong>2020 Cash Incentive Bonus Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_CashIncentiveBonusPlanTextBlock', window );">2020 Cash Incentive Bonus Plan</a></td>
<td class="text"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Note&#160;10.&#160; 2020 Cash Incentive Bonus Plan</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In August 2020, the Board approved the Plan. The Plan was established to promote the long-term success of the Company by creating an &#8220;at-risk&#8221; cash bonus program that rewards&#160;Plan&#160;participants with additional cash compensation in lockstep with significant increases in the Company&#8217;s market capitalization. The Plan is considered &#8220;at-risk&#8221; because Plan participants&#160;will&#160;not receive a cash bonus&#160;unless&#160;the Company&#8217;s market capitalization increases&#160;significantly and&#160;certain&#160;other&#160;conditions specified in the Plan&#160;are met.&#160;Specifically, Plan participants&#160;will&#160;not&#160;be paid&#160;any cash bonuses unless (1) the Company completes a&#160;merger or acquisition transaction that constitutes a sale of ownership of the Company or its assets (a Merger Transaction) or (2) the Compensation Committee of the Board&#160;(the Compensation Committee) determines the Company has sufficient cash on hand, as </span></p><div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">defined in the Plan. Because&#160;of the inherent discretion and uncertainty regarding&#160;these&#160;requirements, the Company has concluded that&#160;a&#160;Plan&#160;grant date has not occurred&#160;as of </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Plan participants will be paid all earned cash bonuses in the event of a Merger Transaction.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">As of December 31, 2022, the Company&#8217;s independent directors were participants in the Plan. However, effective March 16, 2023, the Board of Directors amended the Plan to remove all independent directors as participants in the Plan and the independent directors consented to such removal. The independent directors&#8217; share of potential benefits under the Plan were completely forfeited to the Company and will not be allocated to any other participant under the Plan. The Company&#8217;s independent directors have </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">no</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">t received, and as a result of such amendment will never receive, any payments under the Plan.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company&#8217;s market capitalization for purposes of the Plan&#160;is&#160;determined based on either (1) the closing price&#160;of one share&#160;of the Company&#8217;s common stock on the Nasdaq Capital&#160;Market&#160;multiplied by the total issued and outstanding shares and options to purchase shares of the Company, or (2) the aggregate consideration payable to security holders of the Company in a&#160;Merger Transaction.&#160;This constitutes a market condition under applicable accounting guidance.&#160; &#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Plan&#160;triggers a potential cash bonus each time&#160;the&#160;Company&#8217;s market capitalization increases significantly, up to a maximum&#160;$</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">5</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;billion in market capitalization. The Plan specifies 14&#160;incremental&#160;amounts&#160;between&#160;$</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">200</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million and&#160;$</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">5</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;billion&#160;(each increment,&#160;a &#8220;Valuation Milestone&#8221;). Each&#160;Valuation Milestone&#160;triggers&#160;a potential cash bonus award in a pre-set amount defined in the Plan. Each&#160;Valuation&#160;Milestone&#160;must be achieved and maintained for no less than </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">20</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> consecutive trading days for&#160;Plan&#160;participants to be eligible for a potential cash bonus award.&#160;Approximately </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">67</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">% of each&#160;cash bonus award&#160;associated with a Valuation Milestone&#160;is subject to&#160;adjustment and&#160;approval&#160;by the Compensation Committee.&#160;Any amounts&#160;not awarded by the Compensation Committee&#160;are&#160;no longer available for distribution.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">If the Company were to exceed a $</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">5</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;billion market capitalization&#160;for no less than 20 consecutive trading days, all&#160;Valuation&#160;Milestones would be deemed achieved, in which case cash bonus awards would&#160;range from&#160;a minimum of&#160;$</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">111.4</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million&#160;up to&#160;a hypothetical maximum of&#160;$</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">289.7</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million.&#160;Payment of cash bonuses is deferred until such time as&#160;(1)&#160;the Company completes a Merger Transaction, or&#160;(2)&#160;the&#160;Compensation Committee determines the&#160;Company has sufficient cash&#160;on hand&#160;to render payment&#160;(each, a &#8220;Performance Condition&#8221;),&#160;neither&#160;of which may ever occur. Accordingly, there can be no assurance that&#160;Plan&#160;participants will&#160;ever&#160;be&#160;paid a cash bonus that is awarded under the Plan, even if the Company&#8217;s market capitalization increases&#160;significantly.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Plan is accounted for as a liability award.&#160;The fair value of each&#160;Valuation&#160;Milestone&#160;award&#160;will be&#160;determined&#160;once&#160;a&#160;grant date occurs and&#160;will be&#160;remeasured each reporting period.&#160;Compensation expense associated with the Plan&#160;will be&#160;recognized over the expected achievement period for each&#160;of the </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">14</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;Valuation&#160;Milestones, when&#160;a Performance Condition&#160;is considered probable of being met. &#160;&#160;</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In October 2020, the Company&#160;achieved&#160;the first&#160;Valuation&#160;Milestone.&#160;Subsequently, the Compensation Committee&#160;approved&#160;a potential cash bonus&#160;award&#160;of&#160;$</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">6.5</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million&#160;in total&#160;for&#160;all Plan participants (after the March 2023 Plan amendment), subject to future satisfaction of a Performance Condition.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During the year ended December&#160;31, 2021, the Company achieved </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">11</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> additional Valuation Milestones triggering potential Company obligations to all Plan participants from a minimum of $</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">74.9</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million up to a hypothetical maximum of $</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">202.3</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million (after the March 2023 Plan amendment), to be determined by the Compensation Committee and contingent upon future satisfaction of a Performance Condition. However,&#160;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">no</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;compensation expense was recorded&#160;since no&#160;grant date has occurred and no&#160;Performance Conditions are considered probable of being met.&#160;There is no continuing service requirement for Plan participants once&#160;the Compensation Committee approves a cash&#160;bonus award.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">No Valuation Milestones were achieved during 2022 or the six months ended </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">No</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> actual cash payments were authorized or made to participants under the Plan through the date of filing of </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">this Form 10-Q</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span></p></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sava_CashIncentiveBonusPlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>2020 Cash Incentive Bonus Plan [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sava_CashIncentiveBonusPlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sava_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sava_CashIncentiveBonusPlanTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Incentive Bonus Plan [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sava_CashIncentiveBonusPlanTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sava_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687338345824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAbstract', window );"><strong>Contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDisclosures', window );">Contingencies</a></td>
<td class="text"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Note 11. Contingencies</span><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 120.0%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">From time to time, the Company may become involved in litigation or other legal proceedings and claims, including U.S. government inquiries, investigations</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">and Citizen Petitions submitted to FDA, and may receive inquiries from government authorities relating to matters arising from the ordinary course of business</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">. The outcome of these proceedings is inherently uncertain. Regardless of outcome, legal proceedings can have an adverse impact on the Company because of defense and settlement costs, diversion of management resources, and other factors. At this time, no assessment can be made as to their likely outcome or whether the outcome will be material to the Company. No information is available to indicate that it is probable that a loss has been incurred or can be reasonably estimated as of the date of the condensed consolidated financial statements and, as such, no accrual for these matters has been recorded within the condensed consolidated financial statements.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Government Investigations</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On November 15, 2021, the Company disclosed that certain government agencies had asked the Company to provide corporate information and documents. These were confidential requests. The Company has been voluntarily cooperating and intends to continue to cooperate with these inquiries. No government agency has informed the Company that it has found evidence of research misconduct or wrongdoing by the Company or its officers, employees or directors. No government agency has filed any claims or charges relating to these inquiries. We cannot predict the outcome or impact of these ongoing matters, including whether a government agency may pursue an enforcement action against the Company or others.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Securities Class Actions and Shareholder Derivative Actions</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Between August 27, 2021 and October 26, 2021, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">four</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> putative class action lawsuits were filed alleging violations of the federal securities laws by the Company and certain named officers. The complaints rely on allegations contained in Citizen Petitions submitted to FDA and allege that various statements made by the defendants regarding simufilam were rendered materially false and misleading. The Citizen Petitions were all subsequently denied by FDA. These actions were filed in the U.S. District Court for </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">the Western District of Texas. The complaints seek unspecified compensatory damages and other relief on behalf of a purported class of purchasers.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On June 30, 2022, a federal judge consolidated the four class action lawsuits into one case and appointed a lead plaintiff and a lead counsel. Lead plaintiff filed a consolidated amended complaint on August 18, 2022 on behalf of a putative class of purchasers of the Company&#8217;s securities between September 14, 2020 and July 26, 2022. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On May 11, 2023, the court dismissed with prejudice plaintiffs&#8217; claims against (deceased) defendant Nadav Friedmann, PhD, MD, but otherwise denied defendants&#8217; motion to dismiss. Defendants filed an answer to the consolidated amended complaint on July 3, 2023.   The Company believes the claims are without merit and intends to defend against these lawsuits vigorously. The Company is unable to estimate the possible loss or range of loss, if any, associated with these lawsuits.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On November 4, 2021, a related shareholder derivative action was filed, purportedly on behalf of the Company, in the U.S. District Court for the Western District of Texas, asserting claims under the U.S. securities laws and state fiduciary duty laws against certain named officers and the members of the Company&#8217;s board of directors. This complaint relies on the allegations made in Citizen Petitions that were submitted to </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">(and subsequently denied by) </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">FDA. The complaint alleges, among other things, that the individual defendants exposed the Company to unspecified damages and securities law liability by causing it to make materially false and misleading statements, in violation of the U.S. securities laws and in breach of their fiduciary duties to the Company. The derivative case seeks, among other things, to recover unspecified compensatory damages on behalf of the Company arising out of the individual defendant&#8217;s alleged wrongful conduct. Although the plaintiff in this derivative case does not seek relief against the Company, the Company has certain indemnification obligations to the individual defendants. Since November 4, 2021, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">four</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> additional shareholder derivative actions were filed alleging substantially similar claims, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">two</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> in the U.S. District Court for the Western District of Texas, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">one</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> in Texas state court (Travis County District Court) and </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">one</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> in the Delaware Court of Chancery. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On July 5, 2022, the three federal court actions were consolidated into a single action.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">On August 19, 2022, a shareholder derivative action was filed, purportedly on behalf of the Company, in the Delaware Court of Chancery, asserting claims under state fiduciary duty laws against certain named officers and members of the Company&#8217;s board of directors. The complaint alleges, among other things, that the individual defendants breached their fiduciary duties by approving the 2020 Cash Incentive Bonus Plan in August 2020. The complaints seek unspecified compensatory damages and other relief. On </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">January 6, 2023, the plaintiffs filed an amended complaint. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Defendants filed a partial answer to the amended complaint on March 10, 2023, and moved to partially dismiss the amended complaint on March 14, 2023. Defendants&#8217; motion to dismiss remains pending. </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Although the plaintiffs in this derivative case do</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> not seek relief against the Company, the Company has certain indemnification obligations to the individual defendants. </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company is unable to estimate the possible loss or range of loss, if any, associated with these lawsuits.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480102/450-20-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480102/450-20-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450-20/tableOfContent<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450-30/tableOfContent<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483049/450-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687340933424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policy)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use Of Estimates</a></td>
<td class="text"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Use of Estimates</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company makes estimates and assumptions in preparing its condensed consolidated financial statements in conformity with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amount of revenue earned and expenses incurred during the reporting period. The Company evaluates&#160;its estimates on an ongoing basis, including those estimates related to manufacturing agreements and research collaborations. Actual results could differ from these estimates</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> and assumptions.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash And Cash Equivalents And Concentration Of Credit Risk</a></td>
<td class="text"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Cash and Cash Equivalents and Concentration of Credit Risk</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company invests in cash and cash equivalents. The Company considers highly liquid financial instruments with original maturities of three months or less to be cash equivalents. Highly liquid investments that are considered cash equivalents include money market accounts and funds, certificates of deposit, and U.S. Treasury securities.&#160;The Company maintains&#160;its cash and cash equivalents at one financial institution. </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Fair Value Measurements </span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company recognizes financial instruments in accordance with the authoritative guidance on fair value measurements and disclosures for financial assets and liabilities. This guidance defines fair value, establishes a framework for measuring fair value in accordance with GAAP, and expands disclosures about fair value measurements. The guidance also establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include:</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Level 1 includes quoted prices in active markets.</span></p><p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Level 2 includes significant observable inputs, such as quoted prices for identical or similar securities, or other inputs that are observable and can be corroborated by observable market data for similar securities. The Company uses market pricing and other observable market inputs obtained from third-party providers. It uses the bid price to establish fair value where a bid price is available. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company does not have any financial instruments where the fair value is based on Level 2 inputs.</span></p><p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"><span style="white-space:pre-wrap; color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;">&#61623;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Level 3 includes unobservable inputs that are supported by little or no market activity. The Company does not have any financial instruments where the fair value is based on Level 3 inputs.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">If a financial instrument uses inputs that fall in different levels of the hierarchy, the instrument will be categorized based upon the lowest level of input that is significant to the fair value calculation. The fair value of cash and cash equivalents was based on Level 1 inputs at </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023 and December 31, 2022.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Business Segments</a></td>
<td class="text"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Business Segments</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company reports segment information based on how it internally evaluates the operating performance of its business units, or segments. The Company&#8217;s operations are confined to </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">one</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> business segment: the development of novel drugs and diagnostics.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_ProceedsFromGrantsPolicyPolicyTextBlock', window );">Proceeds From Grants</a></td>
<td class="text"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Proceeds from Grants</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">&#65279;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During the three and six months ended </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023,&#160;there were </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">no</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> reimbursements received pursuant to National Institutes of Health (&#8220;NIH&#8221;) research grants. </span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">During the </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">three and six months ended </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2022</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, the Company received reimbursements totaling $</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0.4</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> million and $</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0.5</span><span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;million, respectively, pursuant to NIH research grants. </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company records the proceeds from these grants as reductions to its research and development expenses.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Stock-based Compensation</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#65279;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The&#160;Company recognizes non-cash expense for the fair value of all stock options and other share-based awards. The Company uses the Black-Scholes option valuation model (&#8220;Black-Scholes&#8221;) to calculate the fair value of stock options, using the single-option award approach and straight-line attribution method. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">This model requires the input of subjective assumptions including expected stock price volatility, expected life and estimated forfeitures of each </span><span id="_cp_text_1_372" style="text-decoration: none;"></span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">award. These assumptions consist of estimates of future market conditions, which are inherently uncertain, and therefore, are subject to management's judgment. </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">For all options granted, it recognizes the resulting fair value as expense on a straight-line basis over the vesting period of each respective stock option, generally </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">four years</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.25in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#65279;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company has granted share-based awards that vest upon achievement of certain performance criteria (&#8220;Performance Awards&#8221;). The Company multiplies the number of Performance Awards by the fair value of its common stock on the date of grant to calculate the fair value of each award. It estimates an implicit service period for achieving performance criteria for each award. The Company recognizes the resulting fair value as expense over the implicit service period when it concludes that achieving the performance criteria is probable. It periodically reviews and updates as appropriate its estimates of implicit service periods and conclusions on achieving the performance criteria. Performance Awards vest and common stock is issued upon achievement of the performance criteria.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Net Loss per Share </span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">&#65279;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company computes basic net loss per share on the basis of the weighted-average number of common shares outstanding for the reporting period. Diluted net loss per share is computed on the basis of the weighted-average number of common shares outstanding plus potential dilutive common shares outstanding using the treasury-stock </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">method. Potential dilutive common shares consist of outstanding common stock options.&#160;&#160;There is no difference between the Company&#8217;s net loss and comprehensive loss. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The numerators and denominators in the calculation of basic and diluted net loss per share were as follows (in thousands, except net loss per share data):</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.20in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.31in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Three months ended</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Six months ended</span></p></td></tr><tr style="height: 0.20in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p></td></tr><tr style="height: 0.16in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Numerator:</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.17in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net loss</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">26,376</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">19,328</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">50,647</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">36,855</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Denominator:</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.17in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Shares used in computing net loss per share, basic and diluted</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">41,793</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">40,015</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">41,766</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">39,989</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net loss per share, basic and diluted</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0.63</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0.48</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1.21</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0.92</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr style="height: 0.08in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> Dilutive common stock options excluded from net loss per share, diluted</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2,001</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,937</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2,018</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2,095</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr style="height: 0.07in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company excluded common stock options outstanding from the calculation of net loss per share, diluted, because the effect of including outstanding options would have been anti</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">-</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">dilutive. The Company also excluded </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">57,143</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> restricted stock awards from the calculation of net loss per share, diluted, until their expiration in June 2022 because the effect of including restricted stock awards would have been anti</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">-</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">dilutive.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value Of Financial Instruments</a></td>
<td class="text"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Fair Value of Financial Instruments</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160; &#160; </span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 6pt;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Financial instruments include accounts payable and accrued liabilities. The estimated fair value of certain financial instruments may be determined using available market information or other appropriate valuation methodologies. However, considerable judgment is required in interpreting market data to develop estimates of fair value; therefore, the estimates are not necessarily indicative of the amounts that could be realized or would be paid in a current market exchange. The effect of using different market assumptions and/or estimation methodologies may be material to the estimated fair value amounts. The carrying amounts of accounts payable and accrued liabilities are at cost, which approximates fair value due to the short maturity of those instruments. </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_ResearchContractCostsAndAccrualsPolicyPolicyTextBlock', window );">Research Contract Costs And Accruals</a></td>
<td class="text"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Research Contract Costs and Accruals </span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company has entered into various research and development contracts with research institutions and other third-party vendors. These agreements are generally cancelable. Related payments are recorded as research and development expenses as incurred. The Company records prepaids and accruals for estimated ongoing research costs. When evaluating the adequacy of prepaid expenses and accrued liabilities, the Company analyzes progress of the studies including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made in determining the prepaid and accrued balances at the end of any reporting period. Actual results could differ from the Company&#8217;s estimates. The Company&#8217;s historical prepaid and accrual estimates have not been materially different from actual costs.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Incentive Bonus Plan</a></td>
<td class="text"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Incentive Bonus Plan</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In 2020, the Company established the 2020 Cash Incentive Bonus Plan (the &#8220;Plan&#8221;) to incentivize Plan participants. Awards under the Plan are accounted for as liability awards under Accounting Standards Codification (ASC) 718 &#8220;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Stock-based Compensation</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#8221;.&#160;The fair value of each&#160;potential Plan&#160;award&#160;will be&#160;determined&#160;once&#160;a&#160;grant date occurs and&#160;will be&#160;remeasured each reporting period.&#160;Compensation expense associated with the Plan&#160;will be&#160;recognized over the expected achievement period for each&#160;Plan award, when&#160;a Performance Condition&#160;(as defined below) is considered probable of being met. See Note 10 for further discussion of the Plan.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Leases</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company recognizes&#160;assets and liabilities that arise from leases.&#160;For operating leases, the Company is required to recognize a right-of-use asset and a lease liability, initially measured at the present value of the lease payments during the lease term, in the&#160;condensed consolidated balance sheets.&#160;</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company elected the short-term lease recognition exemption for all leases that qualify. This means, for those leases that qualify, the Company does not recognize right-of-use assets or lease liabilities. </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">As the Company`s leases do not provide an implicit rate, it uses its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. Lease expense for lease payments is recognized on a straight-line basis over the lease term.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property And Equipment</a></td>
<td class="text"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Property and equipment</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Property and equipment is recorded at cost, net of accumulated depreciation. Depreciation is recorded using the straight-line method over the estimated useful lives of the assets. Owned buildings and related improvements have estimated useful lives of </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">39</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years and approximately </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">10</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years, respectively. Tenant improvements are amortized using the straight-line method over the useful lives of the improvements or the remaining term of the corresponding leases, whichever is shorter. The remaining term of the corresponding leases is approximately </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0.9</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Property and equipment are reviewed for impairment when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. If property and equipment are considered to be impaired, an impairment loss is recognized.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible Assets</a></td>
<td class="text"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Intangible assets</span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Acquired intangible assets are recorded at fair value at the date of acquisition and primarily consist of lease-in-place agreements and leasing commissions. Intangible assets are amortized over the estimated life of the lease-in-place agreements, which is approximately </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0.8</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> years at </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">June 30</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">, 2023.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Intangible assets are reviewed for impairment on an annual basis, and when there is reason to believe that their values have been diminished or impaired. If intangible assets are considered</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> to be impaired, an impairment loss is recognized.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Income Taxes</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">&#160;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company accounts for income taxes under the asset and liability method. &#160;Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.&#160;Deferred tax balances are adjusted to reflect tax rates based on currently enacted tax laws, which will be in effect in the years in which the temporary differences are expected to reverse.&#160;The Company has accumulated significant deferred tax assets that reflect the tax effects of net operating loss and tax credit carryovers and temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Realization of certain deferred tax assets is dependent upon future earnings. The Company is uncertain about the timing and amount of any future earnings. Accordingly, the Company offsets these deferred tax assets with a valuation allowance.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The Company accounts for uncertain tax positions in accordance with ASC 740, &#8220;Income Taxes&#8221;, which clarifies the accounting for uncertainty in tax positions. These provisions require recognition of the impact of a tax position in the Company&#8217;s </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">condensed</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> consolidated financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Any interest and penalties related to uncertain tax positions will be reflected as a component of income tax expense.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sava_ProceedsFromGrantsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Grants Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sava_ProceedsFromGrantsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sava_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sava_ResearchContractCostsAndAccrualsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research Contract Costs And Accruals Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sava_ResearchContractCostsAndAccrualsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sava_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 60<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482053/820-10-60-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483256/920-350-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483256/920-350-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483256/920-350-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687337797840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Numerators And Denominators In The Calculation Of Basic And Diluted Net Loss Per Share</a></td>
<td class="text"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.20in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.31in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Three months ended</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Six months ended</span></p></td></tr><tr style="height: 0.20in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p></td></tr><tr style="height: 0.16in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Numerator:</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.17in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net loss</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">26,376</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">19,328</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">50,647</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">36,855</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Denominator:</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.17in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Shares used in computing net loss per share, basic and diluted</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">41,793</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">40,015</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">41,766</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">39,989</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Net loss per share, basic and diluted</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0.63</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0.48</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1.21</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">0.92</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr style="height: 0.08in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> Dilutive common stock options excluded from net loss per share, diluted</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2,001</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,937</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2,018</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2,095</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr style="height: 0.07in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687337797840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses And Other Current Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Prepaid Expenses And Other Current Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule Of Prepaid Expenses And Other Current Assets</a></td>
<td class="text"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.17in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.21in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.31in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br/>&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">December 31,</span><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br/>&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Prepaid insurance</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">5</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">874</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr style="height: 0.17in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Contract research organization and other deposits</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">4,527</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">9,177</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Interest receivable</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,328</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> &#8212;</span></p></td></tr><tr style="height: 0.17in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Other</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">235</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">160</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr style="height: 0.21in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">  Total prepaid expenses and other current assets</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">6,095</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">10,211</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687337823776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Property (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Real Property [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Components Of Other Income, Net</a></td>
<td class="text"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr style="height: 0.01in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.05in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.21in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #FF0000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Three months ended</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Six months ended</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.18in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #FF0000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.16in;"><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #FF0000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.25in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Lease revenue</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #FF0000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">559</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">586</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,116</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,160</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.17in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.25in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Property operating expenses</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #FF0000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">356</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">311</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">723</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">622</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.17in;"><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.25in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">  Other income, net</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #FF0000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">203</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">275</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">393</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">538</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr style="height: 0.06in;"><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #FF0000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687339176672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property And Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property And Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Components Of Property And Equipment, Net</a></td>
<td class="text"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">December 31,</span><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br/>&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Land</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">3,734</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">3,734</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Buildings</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">15,980</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">15,980</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Site improvements</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">470</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">470</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Tenant improvements</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">3,018</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">3,016</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Furniture and equipment</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">868</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">851</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Construction in progress</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">13</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">  Gross property and equipment</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">24,072</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">24,064</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Accumulated depreciation</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,744</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,200</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">  Property and equipment, net</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">22,328</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">22,864</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687337085552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Components Of Intangible Assets, Net</a></td>
<td class="text"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">December 31,</span><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"><br/>&#8206;</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Lease-in-place agreements</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,053</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,053</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Leasing commissions and other</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">293</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">290</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">  Gross intangible assets</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,346</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,343</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Accumulated amortization</span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">959</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">721</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">  Intangible assets, net</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">387</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">622</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Amortization Expense For Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;text-decoration: underline;">For the year ending December 31,</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2023</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">216</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2024</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">167</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2025</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">4</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total amortization</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">387</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"><p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687337009856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity And Stock-Based Compensation Expense (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Stockholders&#8217; Equity And Stock-Based Compensation Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_StockOptionAndPerformanceAwardActivity', window );">Stock Options And Unvested Performance Award Outstanding Activity</a></td>
<td class="text"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Stock Options</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Performance Awards</span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Outstanding as of December 31, 2022</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2,529,448</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">7,142</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Options granted</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">122,000</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-a5e09c6a-9923-4b88-9aac-2bab00d80bb7;">&#8212;</span></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Options exercised</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">281,175</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-a4ac9c2f-0510-422d-88c4-81f94dcb8f78;">&#8212;</span></span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Options forfeited/canceled</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">7,142</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">)</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"><span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-cf26586d-83aa-4eed-9015-9e654cf00456;">&#8212;</span></span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Outstanding as of June 30, 2023</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">2,363,131</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">7,142</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Stock-Based Compensation Expense</a></td>
<td class="text"><div style="text-align:left"><table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Three months ended</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">Six months ended</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">June 30,</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2023</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">2022</span></p></td><td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Research and development</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">392</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">413</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">781</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">835</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">General and administrative</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">443</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">72</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">727</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">145</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">Total stock-based compensation expense</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">835</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">485</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">1,508</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">$</span></p></td><td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">980</span><span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">&#160;</span></p></td><td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr><tr><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"><p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td><td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"><p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"><span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sava_StockOptionAndPerformanceAwardActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in stock options and perfromance award activity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sava_StockOptionAndPerformanceAwardActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sava_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687337897120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>General And Liquidity (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>General And Liquidity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">$ 334,199<span></span>
</td>
<td class="nump">$ 283,552<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687339531584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>segment </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_SignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_ReductionToResearchAndDevelopmentExpense', window );">Reimbursement from National Institutes of Health research grants | $</a></td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of business segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LeasesAcquiredInPlaceMember', window );">Lease-In-Place Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_SignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, Estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_SignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, Estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">39 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Site Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_SignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, Estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Tenant Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_SignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, Estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_SignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Dilutive common stock options excluded from net loss per share, diluted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sava_ReductionToResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reduction To Research And Development Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sava_ReductionToResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sava_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sava_SignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sava_SignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sava_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LeasesAcquiredInPlaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LeasesAcquiredInPlaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687339536848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Numerators And Denominators In The Calculation Of Basic And Diluted Net Loss Per Share) (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (26,376)<span></span>
</td>
<td class="num">$ (24,271)<span></span>
</td>
<td class="num">$ (19,328)<span></span>
</td>
<td class="num">$ (17,527)<span></span>
</td>
<td class="num">$ (50,647)<span></span>
</td>
<td class="num">$ (36,855)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used in computing net loss per share, basic</a></td>
<td class="nump">41,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,766<span></span>
</td>
<td class="nump">39,989<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in computing net loss per share, diluted</a></td>
<td class="nump">41,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,766<span></span>
</td>
<td class="nump">39,989<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, Basic</a></td>
<td class="num">$ (0.63)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.21)<span></span>
</td>
<td class="num">$ (0.92)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, Diluted</a></td>
<td class="num">$ (0.63)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.21)<span></span>
</td>
<td class="num">$ (0.92)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Dilutive common stock options excluded from net loss per share, diluted</a></td>
<td class="nump">2,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,937<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,018<span></span>
</td>
<td class="nump">2,095<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687333449552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaid Expenses And Other Current Assets (Schedule Of Prepaid Expenses And Other Current Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Prepaid Expenses And Other Current Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepaid insurance</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 874<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositContractsAssets', window );">Contract research organization and other deposits</a></td>
<td class="nump">4,527<span></span>
</td>
<td class="nump">9,177<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivableCurrent', window );">Interest receivable</a></td>
<td class="nump">1,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Other</a></td>
<td class="nump">235<span></span>
</td>
<td class="nump">160<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepaid expenses and other current assets</a></td>
<td class="nump">$ 6,095<span></span>
</td>
<td class="nump">$ 10,211<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositContractsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of assets as of the balance sheet date pertaining to amounts paid by the insured (including a ceding company) under insurance or reinsurance contracts for which insurance risk is not transferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483081/340-30-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483054/340-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositContractsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482955/340-10-05-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687333134544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Property (Narrative) (Details) - Austin, Texas [Member] - Two-building office complex [Member] - ft&#178;<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Aug. 04, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionLineItems', window );"><strong>Asset Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_PercentageOfOccupancy', window );">Percentage Of Occupancy</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_PercentageOfCurrentlyLeased', window );">Percentage Of Currently Leased</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetRentableArea', window );">Net Rentable Area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sava_PercentageOfCurrentlyLeased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Currently Leased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sava_PercentageOfCurrentlyLeased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sava_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sava_PercentageOfOccupancy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Occupancy</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sava_PercentageOfOccupancy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sava_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetRentableArea">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net rentable area for properties owned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetRentableArea</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=sava_AustinMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=sava_AustinMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=sava_TwoBuildingOfficeComplexAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=sava_TwoBuildingOfficeComplexAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687335902960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Property (Components Of Other Income, Net) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">$ 203<span></span>
</td>
<td class="nump">$ 275<span></span>
</td>
<td class="nump">$ 393<span></span>
</td>
<td class="nump">$ 538<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings [Member] | Austin, Texas [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncome', window );">Lease revenue</a></td>
<td class="nump">559<span></span>
</td>
<td class="nump">586<span></span>
</td>
<td class="nump">1,116<span></span>
</td>
<td class="nump">1,160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingExpense', window );">Property operating expenses</a></td>
<td class="num">(356)<span></span>
</td>
<td class="num">(311)<span></span>
</td>
<td class="num">(723)<span></span>
</td>
<td class="num">(622)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">$ 203<span></span>
</td>
<td class="nump">$ 275<span></span>
</td>
<td class="nump">$ 393<span></span>
</td>
<td class="nump">$ 538<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=sava_AustinMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=sava_AustinMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687333086464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property And Equipment (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property And Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 272,000<span></span>
</td>
<td class="nump">$ 174,000<span></span>
</td>
<td class="nump">$ 544,000<span></span>
</td>
<td class="nump">$ 352,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687333596416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property And Equipment (Components Of Property And Equipment, Net) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property and equipment</a></td>
<td class="nump">$ 24,072<span></span>
</td>
<td class="nump">$ 24,064<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(1,744)<span></span>
</td>
<td class="num">(1,200)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">22,328<span></span>
</td>
<td class="nump">22,864<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property and equipment</a></td>
<td class="nump">3,734<span></span>
</td>
<td class="nump">3,734<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property and equipment</a></td>
<td class="nump">15,980<span></span>
</td>
<td class="nump">15,980<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Site Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property and equipment</a></td>
<td class="nump">470<span></span>
</td>
<td class="nump">470<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Tenant Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property and equipment</a></td>
<td class="nump">3,018<span></span>
</td>
<td class="nump">3,016<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture And Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property and equipment</a></td>
<td class="nump">868<span></span>
</td>
<td class="nump">851<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction In Progress [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property and equipment</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687333550016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense for intangible assets</a></td>
<td class="nump">$ 119,000<span></span>
</td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="nump">$ 238,000<span></span>
</td>
<td class="nump">$ 260,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687339521136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets (Components Of Intangible Assets, Net) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross intangible assets</a></td>
<td class="nump">$ 1,346<span></span>
</td>
<td class="nump">$ 1,343<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(959)<span></span>
</td>
<td class="num">(721)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total amortization</a></td>
<td class="nump">387<span></span>
</td>
<td class="nump">622<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LeasesAcquiredInPlaceMember', window );">Lease-In-Place Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross intangible assets</a></td>
<td class="nump">1,053<span></span>
</td>
<td class="nump">1,053<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=sava_LeasingCommissionsAndOtherMember', window );">Leasing Commissions And Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross intangible assets</a></td>
<td class="nump">$ 293<span></span>
</td>
<td class="nump">$ 290<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483147/928-340-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LeasesAcquiredInPlaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LeasesAcquiredInPlaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=sava_LeasingCommissionsAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=sava_LeasingCommissionsAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687339576048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets (Amortization Expense For Finite-Lived Intangible Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2023</a></td>
<td class="nump">$ 216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total amortization</a></td>
<td class="nump">$ 387<span></span>
</td>
<td class="nump">$ 622<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687330854512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity And Stock-Based Compensation Expense (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 01, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Nov. 22, 2022</div></th>
<th class="th"><div>May 05, 2022</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from issuance of common stock upon exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 953,000<span></span>
</td>
<td class="nump">$ 330,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 835,000<span></span>
</td>
<td class="nump">$ 485,000<span></span>
</td>
<td class="nump">$ 1,508,000<span></span>
</td>
<td class="nump">$ 980,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Par value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sava_AtMarketEquityProgramMember', window );">ATM [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_PercentageOfCommissionAtmOffering', window );">Percentage of commission in ATM offering</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sava_AtMarketEquityProgramMember', window );">ATM [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Aggregate offering price</a></td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sava_TwoThousandEighteenEquityIncentivePlanMember', window );">2018 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Par value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sava_TwoThousandEighteenEquityIncentivePlanMember', window );">2018 Equity Incentive Plan [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">262,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">281,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from issuance of common stock upon exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 889,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 953,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_StockOptionsExercisedNetSettledSatisfactionOfExercisePrice', window );">Stock options exercised, net settled in satisfaction of the exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_ProceedsFromStockOptionsExercisedNetSettledSatisfactionOfExercisePrice', window );">Proceeds from stock options exercised net settled in satisfaction of the exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Option [Member] | Stock Option And Performance Award [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price or options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Award [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Registered Direct Offering 2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,666,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sava_PercentageOfCommissionAtmOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Commission ATM Offering</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sava_PercentageOfCommissionAtmOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sava_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sava_ProceedsFromStockOptionsExercisedNetSettledSatisfactionOfExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Stock Options Exercised Net Settled Satisfaction Of Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sava_ProceedsFromStockOptionsExercisedNetSettledSatisfactionOfExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sava_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sava_StockOptionsExercisedNetSettledSatisfactionOfExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Options Exercised Net Settled Satisfaction Of Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sava_StockOptionsExercisedNetSettledSatisfactionOfExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sava_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedPerTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sava_AtMarketEquityProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sava_AtMarketEquityProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sava_TwoThousandEighteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sava_TwoThousandEighteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sava_StockOptionAndPerformanceAwardActivity2020PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sava_StockOptionAndPerformanceAwardActivity2020PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sava_RegisteredDirectOffering2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sava_RegisteredDirectOffering2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687335938272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity And Stock-Based Compensation Expense (Stock Options And Unvested Performance Award Outstanding Activity) (Details) - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding as of, Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,529,448<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised</a></td>
<td class="num">(262,158)<span></span>
</td>
<td class="num">(281,175)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options forfeited/canceled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,142)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding as of, Ending</a></td>
<td class="nump">2,363,131<span></span>
</td>
<td class="nump">2,363,131<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Award [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding as of, Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Options forfeited/cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding as of, Ending</a></td>
<td class="nump">7,142<span></span>
</td>
<td class="nump">7,142<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687339642288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity And Stock-Based Compensation Expense (Stock-Based Compensation Expenses) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 835<span></span>
</td>
<td class="nump">$ 485<span></span>
</td>
<td class="nump">$ 1,508<span></span>
</td>
<td class="nump">$ 980<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">392<span></span>
</td>
<td class="nump">413<span></span>
</td>
<td class="nump">781<span></span>
</td>
<td class="nump">835<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 443<span></span>
</td>
<td class="nump">$ 72<span></span>
</td>
<td class="nump">$ 727<span></span>
</td>
<td class="nump">$ 145<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687341042144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687333502192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for operating lease liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 41,000<span></span>
</td>
<td class="nump">$ 24,000<span></span>
</td>
<td class="nump">$ 82,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Buildings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Rent expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 41,000<span></span>
</td>
<td class="nump">$ 24,000<span></span>
</td>
<td class="nump">$ 82,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=sava_AustinMember', window );">Austin, Texas [Member] | Operating Leases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetRentableArea', window );">Office space | ft&#178;</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 30,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetRentableArea">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net rentable area for properties owned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetRentableArea</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=sava_AustinMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=sava_AustinMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=sava_OperatingLeasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=sava_OperatingLeasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687332789312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>2020 Cash Incentive Bonus Plan (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 03, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>item</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>item</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_CashIncentiveBonusPlanLineItems', window );"><strong>Cash Incentive Bonus Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_MinimumNumberOfValuationMilestonesToRecognizeCompensationExpense', window );">Minimum number of valuation milestones to recognize compensation expense | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_NumberOfValuationMilestonesAchieved', window );">Number of Valuation Milestones Achieved | item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=sava_IndependentDirectorsMember', window );">Independent Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_CashIncentiveBonusPlanLineItems', window );"><strong>Cash Incentive Bonus Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_CashIncentiveBonusAward', window );">Cash bonus award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sava_CashIncentiveBonusPlanMember', window );">Cash Incentive Bonus Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_CashIncentiveBonusPlanLineItems', window );"><strong>Cash Incentive Bonus Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_MinimumNumberOfDaysValuationMilestoneMustBeAchievedAndMaintained', window );">Minimum Number of Days Valuation Milestone must be achieved and maintained</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_PercentageValuationMilestoneCashBonusAwardSubjectToApprovalAndAdjustment', window );">Percentage of each cash bonus award associated with Valuation Milestone subject to adjustment and approval</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_PaymentsForCashIncentiveBonus', window );">Payments authorized or made to participants under the Plan</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sava_CashIncentiveBonusPlanMember', window );">Cash Incentive Bonus Plan [Member] | Exceeding Performance Milestones Minimum 20 Consecutive Days [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_CashIncentiveBonusPlanLineItems', window );"><strong>Cash Incentive Bonus Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_PerformancePlanValuationAmount', window );">Valuation milestone amount in market capitalization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sava_CashIncentiveBonusPlanMember', window );">Cash Incentive Bonus Plan [Member] | First Valuation Milestone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_CashIncentiveBonusPlanLineItems', window );"><strong>Cash Incentive Bonus Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_CashIncentiveBonusAward', window );">Cash bonus award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sava_CashIncentiveBonusPlanMember', window );">Cash Incentive Bonus Plan [Member] | Second Through Eighth Valuation Milestones [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_CashIncentiveBonusPlanLineItems', window );"><strong>Cash Incentive Bonus Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Cash Incentive Bonus Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_CashIncentiveBonusPlanLineItems', window );"><strong>Cash Incentive Bonus Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_PerformancePlanValuationAmount', window );">Valuation milestone amount in market capitalization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Cash Incentive Bonus Plan [Member] | Exceeds $5 Billion Market Capitalization For No Less Than 20 Consecutive Trading Days [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_CashIncentiveBonusPlanLineItems', window );"><strong>Cash Incentive Bonus Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_CashIncentiveBonusAward', window );">Cash bonus award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Cash Incentive Bonus Plan [Member] | Second Through Eighth Valuation Milestones [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_CashIncentiveBonusPlanLineItems', window );"><strong>Cash Incentive Bonus Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_CashIncentiveBonusAward', window );">Cash bonus award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Cash Incentive Bonus Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_CashIncentiveBonusPlanLineItems', window );"><strong>Cash Incentive Bonus Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_PerformancePlanValuationAmount', window );">Valuation milestone amount in market capitalization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Cash Incentive Bonus Plan [Member] | Exceeds $5 Billion Market Capitalization For No Less Than 20 Consecutive Trading Days [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_CashIncentiveBonusPlanLineItems', window );"><strong>Cash Incentive Bonus Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_CashIncentiveBonusAward', window );">Cash bonus award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 289,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Cash Incentive Bonus Plan [Member] | Second Through Eighth Valuation Milestones [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_CashIncentiveBonusPlanLineItems', window );"><strong>Cash Incentive Bonus Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sava_CashIncentiveBonusAward', window );">Cash bonus award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 202,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sava_CashIncentiveBonusAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Incentive Bonus Award</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sava_CashIncentiveBonusAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sava_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sava_CashIncentiveBonusPlanLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Incentive Bonus Plan [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sava_CashIncentiveBonusPlanLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sava_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sava_MinimumNumberOfDaysValuationMilestoneMustBeAchievedAndMaintained">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum Number of Days Valuation Milestone must be achieved and maintained</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sava_MinimumNumberOfDaysValuationMilestoneMustBeAchievedAndMaintained</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sava_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sava_MinimumNumberOfValuationMilestonesToRecognizeCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum number of valuation milestones to recognize compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sava_MinimumNumberOfValuationMilestonesToRecognizeCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sava_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sava_NumberOfValuationMilestonesAchieved">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Valuation Milestones Achieved</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sava_NumberOfValuationMilestonesAchieved</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sava_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sava_PaymentsForCashIncentiveBonus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Cash Incentive Bonus</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sava_PaymentsForCashIncentiveBonus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sava_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sava_PercentageValuationMilestoneCashBonusAwardSubjectToApprovalAndAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Valuation Milestone Cash Bonus Award Subject To Approval And Adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sava_PercentageValuationMilestoneCashBonusAwardSubjectToApprovalAndAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sava_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sava_PerformancePlanValuationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Performance Plan Valuation Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sava_PerformancePlanValuationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sava_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=sava_IndependentDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=sava_IndependentDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sava_CashIncentiveBonusPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sava_CashIncentiveBonusPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=sava_ExceedingPerformanceMilestonesMinimum20ConsecutiveDaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=sava_ExceedingPerformanceMilestonesMinimum20ConsecutiveDaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=sava_FirstValuationMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=sava_FirstValuationMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=sava_SecondThroughEighthValuationMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=sava_SecondThroughEighthValuationMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=sava_Exceeds5BillionMarketCapitalizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=sava_Exceeds5BillionMarketCapitalizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687335855424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Narrative) (Details) - item<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 04, 2021</div></th>
<th class="th"><div>Oct. 26, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=sava_ViolationsOfFederalSecuritiesLawsMember', window );">Violations of the federal securities laws [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Putative class action lawsuits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=sava_ShareholderDerivativeActionsMember', window );">Shareholder derivative actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Putative class action lawsuits</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=sava_ShareholderDerivativeActionsU.s.DistrictCourtMember', window );">Shareholder derivative actions U.S. District Court [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Putative class action lawsuits</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=sava_ShareholderDerivativeActionsTexasCourtMember', window );">Shareholder derivative actions Texas Court [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Putative class action lawsuits</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=sava_ShareholderDerivativeActionsDelwareCourtMember', window );">Shareholder derivative actions Delware Court [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Putative class action lawsuits</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=sava_ViolationsOfFederalSecuritiesLawsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=sava_ViolationsOfFederalSecuritiesLawsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=sava_ShareholderDerivativeActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=sava_ShareholderDerivativeActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=sava_ShareholderDerivativeActionsU.s.DistrictCourtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=sava_ShareholderDerivativeActionsU.s.DistrictCourtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=sava_ShareholderDerivativeActionsTexasCourtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=sava_ShareholderDerivativeActionsTexasCourtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=sava_ShareholderDerivativeActionsDelwareCourtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=sava_ShareholderDerivativeActionsDelwareCourtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140687339636448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingArrLineItems', window );"><strong>Insider Trading Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingArrLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingArrLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>sava-20230630x10q_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:sava="http://www.cassavasciences.com/20230630"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="sava-20230630.xsd" xlink:type="simple"/>
    <context id="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="Duration_4_1_2023_To_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="Duration_4_1_2022_To_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="As_Of_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="As_Of_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_5_5_2022_To_5_5_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_sava_TwoThousandEighteenEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-05</startDate>
            <endDate>2022-05-05</endDate>
        </period>
    </context>
    <context id="As_Of_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_sava_StockOptionAndPerformanceAwardActivity2020PlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:StockOptionAndPerformanceAwardActivity2020PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_6_30_2023_us-gaap_PlanNameAxis_sava_TwoThousandEighteenEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="As_Of_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_11_22_2022_us-gaap_PlanNameAxis_sava_RegisteredDirectOffering2022Member_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:RegisteredDirectOffering2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-22</instant>
        </period>
    </context>
    <context id="Duration_4_30_2023_To_4_30_2023_us-gaap_PlanNameAxis_sava_AtMarketEquityProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:AtMarketEquityProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="Duration_5_1_2023_To_5_1_2023_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_sava_AtMarketEquityProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:AtMarketEquityProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-01</endDate>
        </period>
    </context>
    <context id="Duration_3_1_2020_To_3_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_sava_AtMarketEquityProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:AtMarketEquityProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="Duration_11_22_2022_To_11_22_2022_us-gaap_PlanNameAxis_sava_RegisteredDirectOffering2022Member_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:RegisteredDirectOffering2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-22</startDate>
            <endDate>2022-11-22</endDate>
        </period>
    </context>
    <context id="Duration_4_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">sava:AustinMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">sava:AustinMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="Duration_4_1_2022_To_6_30_2022_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">sava:AustinMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_6_30_2022_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">sava:AustinMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="Duration_4_1_2023_To_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="Duration_4_1_2022_To_6_30_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_6_30_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="As_Of_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_LeaseContractualTermAxis_sava_OperatingLeasesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">sava:AustinMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">sava:OperatingLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="As_Of_8_4_2021_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_AssetAcquisitionAxis_sava_TwoBuildingOfficeComplexAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">sava:AustinMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">sava:TwoBuildingOfficeComplexAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-04</instant>
        </period>
    </context>
    <context id="Duration_4_1_2023_To_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="Duration_4_1_2022_To_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="Duration_11_4_2021_To_11_4_2021_srt_LitigationCaseAxis_sava_ShareholderDerivativeActionsU.s.DistrictCourtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">sava:ShareholderDerivativeActionsU.s.DistrictCourtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-04</startDate>
            <endDate>2021-11-04</endDate>
        </period>
    </context>
    <context id="Duration_11_4_2021_To_11_4_2021_srt_LitigationCaseAxis_sava_ShareholderDerivativeActionsTexasCourtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">sava:ShareholderDerivativeActionsTexasCourtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-04</startDate>
            <endDate>2021-11-04</endDate>
        </period>
    </context>
    <context id="Duration_11_4_2021_To_11_4_2021_srt_LitigationCaseAxis_sava_ShareholderDerivativeActionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">sava:ShareholderDerivativeActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-04</startDate>
            <endDate>2021-11-04</endDate>
        </period>
    </context>
    <context id="Duration_11_4_2021_To_11_4_2021_srt_LitigationCaseAxis_sava_ShareholderDerivativeActionsDelwareCourtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">sava:ShareholderDerivativeActionsDelwareCourtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-04</startDate>
            <endDate>2021-11-04</endDate>
        </period>
    </context>
    <context id="Duration_8_28_2021_To_10_26_2021_srt_LitigationCaseAxis_sava_ViolationsOfFederalSecuritiesLawsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">sava:ViolationsOfFederalSecuritiesLawsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-28</startDate>
            <endDate>2021-10-26</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_LeaseContractualTermAxis_sava_OperatingLeasesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">sava:AustinMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">sava:OperatingLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="As_Of_6_30_2023_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LeasesAcquiredInPlaceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LeasesAcquiredInPlaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2023_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_sava_LeasingCommissionsAndOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">sava:LeasingCommissionsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LeasesAcquiredInPlaceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LeasesAcquiredInPlaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_sava_LeasingCommissionsAndOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">sava:LeasingCommissionsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="As_Of_5_5_2022_us-gaap_PlanNameAxis_sava_TwoThousandEighteenEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:TwoThousandEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-05</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="Duration_4_1_2023_To_6_30_2023_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_6_30_2023_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="Duration_4_1_2022_To_6_30_2022_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_6_30_2022_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_6_30_2023_srt_StatementScenarioAxis_sava_SecondThroughEighthValuationMilestonesMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">sava:SecondThroughEighthValuationMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:CashIncentiveBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="Duration_4_1_2023_To_6_30_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="Duration_4_1_2023_To_6_30_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_sava_StockOptionAndPerformanceAwardActivity2020PlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:StockOptionAndPerformanceAwardActivity2020PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_6_30_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_6_30_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="Duration_4_1_2022_To_6_30_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="Duration_4_1_2022_To_6_30_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_6_30_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_6_30_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="Duration_4_1_2023_To_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_3_31_2023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="Duration_4_1_2022_To_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="As_Of_6_30_2023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="Duration_4_1_2022_To_6_30_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_3_31_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="Duration_4_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_6_30_2023_srt_RangeAxis_srt_MinimumMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:CashIncentiveBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_6_30_2023_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:CashIncentiveBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_6_30_2023_srt_StatementScenarioAxis_sava_ExceedingPerformanceMilestonesMinimum20ConsecutiveDaysMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">sava:ExceedingPerformanceMilestonesMinimum20ConsecutiveDaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:CashIncentiveBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_AssetAcquisitionAxis_sava_TwoBuildingOfficeComplexAssetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">sava:AustinMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">sava:TwoBuildingOfficeComplexAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="As_Of_5_1_2023_us-gaap_PlanNameAxis_sava_AtMarketEquityProgramMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:AtMarketEquityProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-01</instant>
        </period>
    </context>
    <context id="Duration_8_3_2023_To_8_3_2023_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:CashIncentiveBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-03</startDate>
            <endDate>2023-08-03</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2021_To_12_31_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_6_30_2023_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:CashIncentiveBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="Duration_1_1_2022_To_6_30_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="As_Of_6_30_2023_srt_RangeAxis_srt_MinimumMember_srt_StatementScenarioAxis_sava_Exceeds5BillionMarketCapitalizationMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">sava:Exceeds5BillionMarketCapitalizationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:CashIncentiveBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2023_srt_RangeAxis_srt_MaximumMember_srt_StatementScenarioAxis_sava_Exceeds5BillionMarketCapitalizationMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">sava:Exceeds5BillionMarketCapitalizationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:CashIncentiveBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="As_Of_6_30_2023_srt_TitleOfIndividualAxis_sava_IndependentDirectorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">sava:IndependentDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_srt_StatementScenarioAxis_sava_SecondThroughEighthValuationMilestonesMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">sava:SecondThroughEighthValuationMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:CashIncentiveBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_srt_StatementScenarioAxis_sava_SecondThroughEighthValuationMilestonesMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">sava:SecondThroughEighthValuationMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:CashIncentiveBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="As_Of_10_31_2020_srt_StatementScenarioAxis_sava_FirstValuationMilestoneMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">sava:FirstValuationMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sava:CashIncentiveBonusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="Duration_4_1_2023_To_6_30_2023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="As_Of_8_1_2023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
        </entity>
        <period>
            <instant>2023-08-01</instant>
        </period>
    </context>
    <context id="Duration_1_1_2023_To_6_30_2023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001069530</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <unit id="Unit17">
        <measure>sava:segment</measure>
    </unit>
    <unit id="Unit16">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="Unit15">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit14">
        <measure>pure</measure>
    </unit>
    <unit id="Unit13">
        <measure>sava:item</measure>
    </unit>
    <unit id="Unit12">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Unit1">
        <measure>shares</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-12e78671-2cf4-4cfe-8e28-031279a864d7">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-a196a7f4-fea8-42f9-9d9a-d4d64ea3ef94">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-ac580dec-0f3e-4cb0-a1a8-f217867fb7fe">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-c5df03a3-289e-47bd-a31d-389becb4d206">2023</dei:DocumentFiscalYearFocus>
    <dei:EntityCentralIndexKey
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-0c28ee8c-fffe-4ac3-9349-90d40ee0132d">0001069530</dei:EntityCentralIndexKey>
    <dei:EntityCurrentReportingStatus
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-7611e968-3bc7-44e8-9f2b-7bb19dff574f">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-92eef08b-0ada-4e53-849a-20931e2e17e7">Yes</dei:EntityInteractiveDataCurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="As_Of_12_31_2022"
      id="ct-nonFraction-f054078c-0570-4d0c-9c55-32ed2826ad26"
      unitRef="Unit12"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="As_Of_6_30_2023"
      id="ct-nonFraction-f5fbd7c9-7e72-4ab7-8180-fb220e6f5c8d"
      unitRef="Unit12"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="As_Of_12_31_2022"
      id="ct-nonFraction-9456fc3f-d3a1-4567-ad49-a87cc8abe7e8"
      unitRef="Unit12"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="As_Of_6_30_2023"
      id="ct-nonFraction-6e7f225c-4650-4e5a-853e-ad6507fb9bc1"
      unitRef="Unit12"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      id="ct-nonFraction-cf26586d-83aa-4eed-9015-9e654cf00456"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      id="ct-nonFraction-a5e09c6a-9923-4b88-9aac-2bab00d80bb7"
      unitRef="Unit1"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      id="ct-nonFraction-a4ac9c2f-0510-422d-88c4-81f94dcb8f78"
      unitRef="Unit1"
      xsi:nil="true"/>
    <dei:DocumentType
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-60e9c6c4-ee9d-46c3-b219-f1ca95b0cd3c">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-ff02ca1b-02d5-4af4-84c0-74dc076fe405">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-e506cc62-bfbf-4a7e-abea-16a46f566fbe">2023-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-88196bf6-e358-47ec-8e09-0e95bb06d8ea">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-f04001e7-d490-4ad9-bd5e-11bcf2bfe402">000-29959</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-08244c28-662f-40b6-a429-f455b8c14917">Cassava Sciences, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-8a600e1b-ea79-427a-8a94-4147bae321cd">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-c7fbf5c5-a736-449d-b8e5-a4e850ee29ff">91-1911336</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-0d15256c-9fa8-4bed-963b-98ca032f7f93">6801 N. Capital of Texas Highway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-11ecd369-86d4-433b-ba07-d907dd8d17c6">Building 1; Suite 300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-8df5c0f0-b819-4ffd-81da-19b4fdd90c24">Austin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-935cc672-e61f-485c-b8ec-f83f7c2accfa">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-033abb89-716f-4f37-b3ea-afa3e5f155f3">78731</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-a702e3e8-c6aa-4ced-a32c-8983fdeeec9c">512</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-286e55ce-cfd2-4214-bc93-17fd9fdaa1dd">501-2444</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-3d867cd9-69ee-4795-9e9e-16200a8f4295">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-99b68c09-7500-459d-bb46-dccff4307996">SAVA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-3b6917a5-bef1-4e38-9aff-a79cef51f4a3">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityFilerCategory
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-90fef519-856f-4f6b-8b26-c4144f737954">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-f0997658-cc64-4a5f-98f9-bc1b70f8fc5b">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-ec2b4531-722c-42ec-a3df-aa114dcd035e">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-4d6df1e3-f722-44eb-ab65-366f37dbc4b7">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="As_Of_8_1_2023"
      decimals="INF"
      id="ct-nonFraction-b49d038f-c680-4d45-920a-d2281935cc1e"
      unitRef="Unit1">41969994</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-6a51b9e0-3ba9-473b-bfaa-5c763914b3ab"
      unitRef="Unit12">168438000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-abcab2fb-4720-48d1-b813-a449ac46899f"
      unitRef="Unit12">201015000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-e6293ab9-4de3-414f-b3e8-8a7f66743608"
      unitRef="Unit12">6095000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-d3225e70-c596-46ca-92d9-c4db7637fa93"
      unitRef="Unit12">10211000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-1a6d8594-c2c3-48eb-abd0-b25213bad235"
      unitRef="Unit12">174533000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-ea04b8ae-11fa-481d-9663-60436f07ecad"
      unitRef="Unit12">211226000</us-gaap:AssetsCurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-fb0b066b-747b-4011-931a-ac2cdac2231d"
      unitRef="Unit12">122000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-7362e236-cf04-45ed-a3b3-e2796aaad946"
      unitRef="Unit12">22328000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-f99dc0e7-eded-4565-b5cb-d7d6e19de09b"
      unitRef="Unit12">22864000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-008f949c-38bb-437c-96f0-cd093f5333a7"
      unitRef="Unit12">387000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-26a00772-49ef-47e2-83ff-85aebc431434"
      unitRef="Unit12">622000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Assets
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-b03498c9-15fe-42b1-96ad-16a0f56f1ca2"
      unitRef="Unit12">197248000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-80a8d4a6-2b32-48b1-b990-14d389f27449"
      unitRef="Unit12">234834000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-1b2ba653-2878-4bf7-a2a1-a4bcd704eec8"
      unitRef="Unit12">10338000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-03c23549-fdcc-4296-b1f7-75820c4324b0"
      unitRef="Unit12">4017000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-05191533-e517-4f2b-a4d9-778b724eb818"
      unitRef="Unit12">7044000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-6a1a5d3f-4d6e-491b-b920-7714930a8cd7"
      unitRef="Unit12">2280000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-ff09562a-7ec1-4b9f-a988-78df88b0184a"
      unitRef="Unit12">220000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-a45a400a-f109-448d-8cf5-a6cf32aa0371"
      unitRef="Unit12">170000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-f1ce2c5b-8fdf-418a-8d55-6dfb85126767"
      unitRef="Unit12">104000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-51bc3d17-0a7c-4531-96bb-478bf65e5266"
      unitRef="Unit12">293000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-0ada7fb5-f0ab-44f1-b24b-4369da6ead62"
      unitRef="Unit12">492000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-a87ecf75-9520-4142-852d-4572e7e2166a"
      unitRef="Unit12">17895000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-0349cebb-29ff-4916-9f85-fcea59cee309"
      unitRef="Unit12">7063000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-5f063d3d-1ec2-4c12-817f-a08c804aed8c"
      unitRef="Unit12">35000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-16c80de4-d802-476d-8d33-ccfe6cbd7385"
      unitRef="Unit12">197000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-6e71c3bc-215a-4022-af61-5c5ec837f1b6"
      unitRef="Unit12">17895000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-2e8c51fa-cb32-4e5a-b76b-e6c685e40c03"
      unitRef="Unit12">7295000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2022"
      decimals="INF"
      id="ct-nonFraction-e726e997-c49b-434c-b08b-faad05646928"
      unitRef="Unit15">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="As_Of_6_30_2023"
      decimals="INF"
      id="ct-nonFraction-410f0a6b-acab-441b-91f5-180af86cb9ef"
      unitRef="Unit15">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="As_Of_12_31_2022"
      decimals="INF"
      id="ct-nonFraction-c07259f5-c127-40d1-bfb0-0622d64229e6"
      unitRef="Unit1">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="As_Of_6_30_2023"
      decimals="INF"
      id="ct-nonFraction-cdea114c-3c1a-4139-b94f-f4824fe4e909"
      unitRef="Unit1">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="As_Of_12_31_2022"
      decimals="INF"
      id="ct-nonFraction-3ffa8e19-1ba7-4bd9-b37d-b9337962a0e8"
      unitRef="Unit1">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="As_Of_6_30_2023"
      decimals="INF"
      id="ct-nonFraction-0a4ed798-9d52-4b52-a418-73c5a1057766"
      unitRef="Unit1">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="As_Of_12_31_2022"
      decimals="INF"
      id="ct-nonFraction-59e2ed6d-2bc9-436c-96a9-25e42299d6d0"
      unitRef="Unit1">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="As_Of_6_30_2023"
      decimals="INF"
      id="ct-nonFraction-824b4b10-d1ae-4ead-9228-97de721c6257"
      unitRef="Unit1">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_12_31_2022"
      decimals="INF"
      id="ct-nonFraction-b74d93e6-5e7d-4e07-8f0f-d24dc1723e6b"
      unitRef="Unit15">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_6_30_2023"
      decimals="INF"
      id="ct-nonFraction-4169f8e9-5866-46e2-81e7-0507a7870ec2"
      unitRef="Unit15">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_12_31_2022"
      decimals="INF"
      id="ct-nonFraction-442c3716-6aa6-4b40-9668-c1174046c74a"
      unitRef="Unit1">120000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="As_Of_6_30_2023"
      decimals="INF"
      id="ct-nonFraction-f7ac6b68-9d52-4297-b5ad-1888405f02d0"
      unitRef="Unit1">120000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_6_30_2023"
      decimals="INF"
      id="ct-nonFraction-9d6be6d1-226b-4972-b857-94804fac10d7"
      unitRef="Unit1">41919527</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_6_30_2023"
      decimals="INF"
      id="ct-nonFraction-35a58ac2-a8de-46e4-93dd-06b327cfd50f"
      unitRef="Unit1">41919527</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="As_Of_12_31_2022"
      decimals="INF"
      id="ct-nonFraction-1f25f47f-f525-454d-bdec-04061b6b063e"
      unitRef="Unit1">41735557</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="As_Of_12_31_2022"
      decimals="INF"
      id="ct-nonFraction-5d1c073a-4de1-4b9b-81ab-ca6a60789cd6"
      unitRef="Unit1">41735557</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-d347c7e2-8000-4114-94ed-f8e614900689"
      unitRef="Unit12">42000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-a16418cb-bdb5-4509-b491-c5ede2348f09"
      unitRef="Unit12">42000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-4c0e743e-817e-43ca-96b6-118144a473a0"
      unitRef="Unit12">513510000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-a63b8005-a15f-48d4-a4ab-a5e8a0a7167e"
      unitRef="Unit12">511049000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-dcae85da-cdc3-47ed-abd0-47caaf12bcac"
      unitRef="Unit12">-334199000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-ed417891-2746-428a-babd-81d79e9bfc41"
      unitRef="Unit12">-283552000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-2adf73a3-7bf0-4596-8479-c8c12c4d55cf"
      unitRef="Unit12">179353000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-3bcda201-312f-4c4f-885b-f7436fa74111"
      unitRef="Unit12">227539000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-edaa00b4-06df-4081-a117-eeda008e63c0"
      unitRef="Unit12">197248000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-1a20eec0-3806-4759-b431-a7d98221a948"
      unitRef="Unit12">234834000</us-gaap:LiabilitiesAndStockholdersEquity>
    <sava:ResearchAndDevelopmentExpenseNetOfGrantReimbursement
      contextRef="Duration_4_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-44c3deff-fd61-4da9-938f-3af7d896b11e"
      unitRef="Unit12">24969000</sava:ResearchAndDevelopmentExpenseNetOfGrantReimbursement>
    <sava:ResearchAndDevelopmentExpenseNetOfGrantReimbursement
      contextRef="Duration_4_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-49d63b5b-9e0c-4e10-86dc-6570d78f6fa5"
      unitRef="Unit12">16948000</sava:ResearchAndDevelopmentExpenseNetOfGrantReimbursement>
    <sava:ResearchAndDevelopmentExpenseNetOfGrantReimbursement
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-fd9736d0-164c-4132-9a6e-a7dd043d435c"
      unitRef="Unit12">47089000</sava:ResearchAndDevelopmentExpenseNetOfGrantReimbursement>
    <sava:ResearchAndDevelopmentExpenseNetOfGrantReimbursement
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-1ebecc14-7972-46ee-a0b8-58a28e8af70f"
      unitRef="Unit12">31854000</sava:ResearchAndDevelopmentExpenseNetOfGrantReimbursement>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="Duration_4_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-f0147ef6-adc1-41e0-a7f4-b82706826fbf"
      unitRef="Unit12">3808000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="Duration_4_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-c16637b0-cd75-4ee2-94db-e2012f47d815"
      unitRef="Unit12">2969000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-385473f5-5bd4-44ed-adc7-c8645e2267a0"
      unitRef="Unit12">8200000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-d25f93b9-50ec-4e01-8e34-9a3d1a7ff78c"
      unitRef="Unit12">5884000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="Duration_4_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-823ed6cc-3e63-43c3-a3b0-13b64fa3780c"
      unitRef="Unit12">28777000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="Duration_4_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-3312b4bb-c484-457e-ab77-475fab129909"
      unitRef="Unit12">19917000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-352039b4-21d3-4ae4-a335-08ee2d48bb8f"
      unitRef="Unit12">55289000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-e424766f-5311-4dec-9963-55092697a29f"
      unitRef="Unit12">37738000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_4_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-d8ac2121-69b7-4cdc-b1dd-230494f6d8ce"
      unitRef="Unit12">-28777000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_4_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-f90edea2-184f-4efa-bc34-1ca4366c50de"
      unitRef="Unit12">-19917000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-98cc70e1-483e-48a7-8503-94d781be4906"
      unitRef="Unit12">-55289000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-25804fc3-06b7-45dc-a829-29009cae9951"
      unitRef="Unit12">-37738000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestAndOtherIncome
      contextRef="Duration_4_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-de4d2112-6962-48aa-b407-259da13bb59b"
      unitRef="Unit12">2198000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="Duration_4_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-c646d659-2f85-45cb-a87b-68493ea495b0"
      unitRef="Unit12">314000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-494d52eb-5d1f-4dbc-9552-2fb38f3a6348"
      unitRef="Unit12">4249000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-59bf2ffa-f4f7-4662-be9f-6e0b175edbb4"
      unitRef="Unit12">345000</us-gaap:InterestAndOtherIncome>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="Duration_4_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-cac95c31-35c5-4845-9bfd-e55b22d64f3f"
      unitRef="Unit12">203000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="Duration_4_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-3c542561-21bc-410c-aab4-16cb08a8c527"
      unitRef="Unit12">275000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-d2ff81b4-7968-423e-a310-b3d2493a4d7a"
      unitRef="Unit12">393000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-a058eb3f-44a3-41f0-a335-46817ac6523d"
      unitRef="Unit12">538000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_4_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-fe5c3910-137c-45f0-87b3-0f247c5f032f"
      unitRef="Unit12">-26376000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_4_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-3de1e787-2ea4-4ae9-a01f-eaaeae04ffa5"
      unitRef="Unit12">-19328000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-f9db00d6-bc3e-4686-8a47-df53dbff9899"
      unitRef="Unit12">-50647000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-a0e85607-c898-4963-a819-7e6b549d0d50"
      unitRef="Unit12">-36855000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_4_1_2023_To_6_30_2023"
      decimals="2"
      id="ct-nonFraction-6dc65c81-482c-4125-9562-7c1818b67ba2"
      unitRef="Unit15">-0.63</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_4_1_2022_To_6_30_2022"
      decimals="2"
      id="ct-nonFraction-cba19182-100f-4941-accf-7c22b96c9b6c"
      unitRef="Unit15">-0.48</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="2"
      id="ct-nonFraction-202434b2-44cc-4f34-9e78-7abe4f67f24d"
      unitRef="Unit15">-1.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="2"
      id="ct-nonFraction-b5ccd96a-71b2-46af-8d67-88bd55fab4e9"
      unitRef="Unit15">-0.92</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_4_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-5cd14108-6393-4eea-b411-efc30d1ba297"
      unitRef="Unit1">41793000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_4_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-12ac4a9d-72c7-4952-986c-d51e4cd5cb20"
      unitRef="Unit1">40015000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-acd0e00c-ed32-4416-8177-aae658cf737d"
      unitRef="Unit1">41766000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-3c74575c-5a45-4436-ab57-b8e4e8e9cce9"
      unitRef="Unit1">39989000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesIssued
      contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="ct-nonFraction-cc7fb1f1-fecf-4ebb-a6a9-d7dd02e47195"
      unitRef="Unit1">40016792</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-3"
      id="ct-nonFraction-502ff467-59aa-463b-a81d-30952deb6fdd"
      unitRef="Unit12">40000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="ct-nonFraction-b07bb722-78e0-4240-a424-28dde2f784e8"
      unitRef="Unit12">461181000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="ct-nonFraction-2d0a59fb-dcea-4491-944b-628f7b215ee3"
      unitRef="Unit12">-207306000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2021"
      decimals="-3"
      id="ct-nonFraction-261f0ae3-9141-4a13-a8fc-adf1f79a1a6f"
      unitRef="Unit12">253915000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="ct-nonFraction-dabd6634-063c-4889-adf6-2255e68230e3"
      unitRef="Unit12">471000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
      contextRef="Duration_1_1_2022_To_3_31_2022"
      decimals="-3"
      id="ct-nonFraction-74e5be70-0d07-424c-bd64-d82effbca3c7"
      unitRef="Unit12">471000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="ct-nonFraction-917d57f1-154d-4714-9667-08d8c04b3906"
      unitRef="Unit12">24000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="Duration_1_1_2022_To_3_31_2022"
      decimals="-3"
      id="ct-nonFraction-9671812d-72a4-4b3d-bd52-42cebf4586c5"
      unitRef="Unit12">24000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="ct-nonFraction-869676e3-d2cf-4e60-ab5f-3a4b08d6dca9"
      unitRef="Unit1">14488</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="ct-nonFraction-273c0eb5-5bbf-4864-a7e6-3e1948ed78e6"
      unitRef="Unit12">211000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2022_To_3_31_2022"
      decimals="-3"
      id="ct-nonFraction-18efcbc3-aa0b-496f-b81b-10be4de7d184"
      unitRef="Unit12">211000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="ct-nonFraction-1c48af99-494b-4296-8a2e-381620300ecd"
      unitRef="Unit12">-17527000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_3_31_2022"
      decimals="-3"
      id="ct-nonFraction-15ad3755-890c-4b2e-aa71-18cfcaac16c8"
      unitRef="Unit12">-17527000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="As_Of_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="ct-nonFraction-eb40ad74-3ed0-4eff-9366-38abb415b5b5"
      unitRef="Unit1">40031280</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-3"
      id="ct-nonFraction-aa72228d-aa35-41af-aaf4-0dfdc5ddba8f"
      unitRef="Unit12">40000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="ct-nonFraction-eaf534f8-8ee4-4b8c-b8e6-77ec7f7119ce"
      unitRef="Unit12">461887000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="ct-nonFraction-ef88d86b-19d1-4714-969b-6f1d77071360"
      unitRef="Unit12">-224833000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2022"
      decimals="-3"
      id="ct-nonFraction-7a7d0713-ab55-4861-a3ce-d77c346c5a32"
      unitRef="Unit12">237094000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
      contextRef="Duration_4_1_2022_To_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="ct-nonFraction-29924d63-b539-4eb2-be1c-207ce249a55f"
      unitRef="Unit12">462000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
      contextRef="Duration_4_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-4898dff4-05a9-49e9-9e45-62bec4d30fcf"
      unitRef="Unit12">462000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="Duration_4_1_2022_To_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="ct-nonFraction-e4f27b11-8ecc-430d-9231-c85d851e860d"
      unitRef="Unit12">23000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="Duration_4_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-7331dba7-40a3-4124-b4e8-9e9fa146c8e0"
      unitRef="Unit12">23000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_4_1_2022_To_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="ct-nonFraction-1bf251bb-dec0-4fc9-81a5-8100a18d8386"
      unitRef="Unit1">66637</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_4_1_2022_To_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="ct-nonFraction-af543458-faf4-4abd-b272-003e8cd0a5a9"
      unitRef="Unit12">119000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_4_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-0409b108-925c-4084-a500-9d33a15aac10"
      unitRef="Unit12">119000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_4_1_2022_To_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="ct-nonFraction-c04e1a8b-63ac-4a69-a90b-456403034caf"
      unitRef="Unit12">-19328000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_4_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-3170b43d-56b6-422a-9b35-9b8fb2df3609"
      unitRef="Unit12">-19328000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="As_Of_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="ct-nonFraction-3c7b6293-2a41-4988-94f4-09b8425d9cbc"
      unitRef="Unit1">40097917</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-3"
      id="ct-nonFraction-9c4769ad-96d4-4938-9583-6fd2ad0b38b7"
      unitRef="Unit12">40000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="ct-nonFraction-89c4ffa3-e52f-49f2-b6b0-a6359c4f95ab"
      unitRef="Unit12">462491000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_6_30_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="ct-nonFraction-c318f9c2-209e-4948-b52c-614254bfd464"
      unitRef="Unit12">-244161000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-c9dd330e-14c7-4ebc-ae45-cafa60eb70a9"
      unitRef="Unit12">218370000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="ct-nonFraction-65646f5f-c16f-4ce9-bbcb-740c4dbdb69c"
      unitRef="Unit1">41735557</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-3"
      id="ct-nonFraction-50466e3c-9d13-4f04-ac33-88ee820381ac"
      unitRef="Unit12">42000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="ct-nonFraction-e146bb76-2049-451d-8e8c-812c898ae18d"
      unitRef="Unit12">511049000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="ct-nonFraction-e659b2a3-2d72-40c3-9de2-a3dc0068eba5"
      unitRef="Unit12">-283552000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-2f4593a8-d5b8-4e86-b6c0-bf42554a795e"
      unitRef="Unit12">227539000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="ct-nonFraction-c4b30589-ee4a-4550-af7c-964eb271d233"
      unitRef="Unit12">650000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
      contextRef="Duration_1_1_2023_To_3_31_2023"
      decimals="-3"
      id="ct-nonFraction-a69cf9ee-3e50-441c-945a-baf9bb36724d"
      unitRef="Unit12">650000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="ct-nonFraction-20e8d28e-9eba-44b3-9d22-883e13691dca"
      unitRef="Unit12">23000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="Duration_1_1_2023_To_3_31_2023"
      decimals="-3"
      id="ct-nonFraction-a90c8793-c1e1-4448-8ffb-e0ba26b4e7d0"
      unitRef="Unit12">23000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="ct-nonFraction-265442f8-ec94-4f86-a806-bb315219b2e4"
      unitRef="Unit12">13878</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="ct-nonFraction-7cfa7bcf-74ba-4c1a-84a0-f2ba6dadcd1d"
      unitRef="Unit12">64000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_1_1_2023_To_3_31_2023"
      decimals="-3"
      id="ct-nonFraction-11a94b40-fd1a-4b1d-b919-a733e4ea911f"
      unitRef="Unit12">64000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2023_To_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="ct-nonFraction-914325b7-60b6-48b9-9901-ce54f5ccaaa2"
      unitRef="Unit12">-24271000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2023_To_3_31_2023"
      decimals="-3"
      id="ct-nonFraction-85213c16-5e1e-4cdd-bde3-80505df487a5"
      unitRef="Unit12">-24271000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="As_Of_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="ct-nonFraction-505d3608-5991-401f-aa8c-986d500fa197"
      unitRef="Unit1">41749435</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-3"
      id="ct-nonFraction-a8604059-1fe3-4e54-9cc0-440817f77ad9"
      unitRef="Unit12">42000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="ct-nonFraction-662c8364-5b1b-4fb3-b87b-35a4a2be6b3b"
      unitRef="Unit12">511786000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="ct-nonFraction-e62c8fa3-d8c6-4287-8172-7f9e1c1764c2"
      unitRef="Unit12">-307823000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_3_31_2023"
      decimals="-3"
      id="ct-nonFraction-aaca66b4-f574-4c05-bce0-70d5fd7dd4a4"
      unitRef="Unit12">204005000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
      contextRef="Duration_4_1_2023_To_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="ct-nonFraction-2afa030f-240a-4710-92dc-2360acd1a4a3"
      unitRef="Unit12">812000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
      contextRef="Duration_4_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-97d55499-25c6-42ac-96b9-8425ee0c4680"
      unitRef="Unit12">812000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="Duration_4_1_2023_To_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="ct-nonFraction-44a931e2-f4f1-47b2-bd35-937fe8ddff1c"
      unitRef="Unit12">23000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="Duration_4_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-f5f661f7-04c6-4780-a1a5-b9f3931ea55e"
      unitRef="Unit12">23000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_4_1_2023_To_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="ct-nonFraction-5f608138-a807-497b-847d-5385363b1639"
      unitRef="Unit1">170092</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_4_1_2023_To_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="ct-nonFraction-f385e204-783a-4a44-af00-64a5c268932f"
      unitRef="Unit12">889000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="Duration_4_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-4b752bf7-3640-4b77-bac5-e58e77779478"
      unitRef="Unit12">889000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_4_1_2023_To_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="ct-nonFraction-d9c283d1-c087-45a6-89b8-70d3b5a864a7"
      unitRef="Unit12">-26376000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_4_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-e2ac072f-3f2e-4ba7-b95e-a5d5d383dc4d"
      unitRef="Unit12">-26376000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="As_Of_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="ct-nonFraction-e41210c9-4f3b-4190-a819-9931d19d1828"
      unitRef="Unit1">41919527</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember"
      decimals="-3"
      id="ct-nonFraction-092855f0-77c5-44ab-93a4-a72aa91dd11e"
      unitRef="Unit12">42000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="ct-nonFraction-a14a9e1c-897f-4c05-9a5a-d17ba503b569"
      unitRef="Unit12">513510000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_6_30_2023_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember"
      decimals="-3"
      id="ct-nonFraction-491a3bbd-3797-4c31-a0ee-8b66cdb291d8"
      unitRef="Unit12">-334199000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-9978e5ea-e1e4-4641-831e-16cef375add1"
      unitRef="Unit12">179353000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-e437c07f-3c48-476b-baaf-7eed9db9667f"
      unitRef="Unit12">-50647000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-8adda230-0567-46ff-98d8-0681276b1107"
      unitRef="Unit12">-36855000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-7cdbcdc3-fcda-4dac-8b21-1b33faf064f8"
      unitRef="Unit12">1508000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-845b6f44-31ef-48fd-8c81-7059b6fbc46d"
      unitRef="Unit12">980000</us-gaap:ShareBasedCompensation>
    <us-gaap:Depreciation
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-6db29935-b30b-4734-ae4b-ef73607bf0b9"
      unitRef="Unit12">544000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-751bdc96-e127-4fd1-ae5f-30a2b3fd3841"
      unitRef="Unit12">352000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-183674fe-397b-4e1b-b9ad-eb928d7be56f"
      unitRef="Unit12">238000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-cbc4a23c-fa1e-45f9-b5a2-7b77e7e94200"
      unitRef="Unit12">260000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-493583f7-3c42-48fc-988c-467b518e8ab6"
      unitRef="Unit12">-4116000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-db49ffb6-92b9-4fb0-8684-cc68ad6d355a"
      unitRef="Unit12">-4431000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <sava:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-2d65349c-a047-451c-a61d-b9e88a75ef31"
      unitRef="Unit12">17000</sava:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet>
    <sava:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-580b0b2b-ffd4-4c6e-bf9e-d902240b5c61"
      unitRef="Unit12">4000</sava:IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-f081a72e-e603-4cc2-87db-5899612d6e0a"
      unitRef="Unit12">6661000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-95a39044-b6bc-4b52-8d7f-61a8d717c86b"
      unitRef="Unit12">-2368000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <sava:IncreaseDecreaseInDevelopmentExpense
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-024a03cd-06c9-4c75-a6d0-4f719c6838e3"
      unitRef="Unit12">4764000</sava:IncreaseDecreaseInDevelopmentExpense>
    <sava:IncreaseDecreaseInDevelopmentExpense
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-52e4c40e-7621-46f0-a118-120166cb6942"
      unitRef="Unit12">515000</sava:IncreaseDecreaseInDevelopmentExpense>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-a7df4c05-1d54-42c1-8d27-5ea0df04e8cc"
      unitRef="Unit12">50000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-8a098a6f-fafc-4dba-bc4d-b5b0f9ffd7df"
      unitRef="Unit12">-1701000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-ed3b64c6-ac19-4ea4-a818-e21e189b9a54"
      unitRef="Unit12">-396000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-d2098c4a-3b7f-41b5-9bff-034eabba97e5"
      unitRef="Unit12">-254000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-e9424130-f026-4506-bffa-a37ddb20a618"
      unitRef="Unit12">-33179000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-2dcaeadc-0193-40f2-b5f9-393b6fa8c78a"
      unitRef="Unit12">-34644000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-b73eb3c0-4dc7-4f31-a71d-7d0b0189d740"
      unitRef="Unit12">351000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-c6c84310-70c0-44d1-88ee-2b65e92be6ac"
      unitRef="Unit12">1891000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-0e3931e3-a7e2-4f32-904f-14bc34b6110a"
      unitRef="Unit12">-351000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-d6a87795-f5a4-4713-b9ec-adcb19a54bde"
      unitRef="Unit12">-1891000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-54b05005-7888-4936-bc3a-b1fa5e19a1db"
      unitRef="Unit12">953000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-a812279d-081d-4652-a59f-6dfe092153fe"
      unitRef="Unit12">330000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-d464ba86-8944-4cf3-aa94-39e9aec54323"
      unitRef="Unit12">953000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-c39e44ab-73a0-433f-a975-cfabb35df8f6"
      unitRef="Unit12">330000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-d16a3605-ff87-40af-b93a-7cbc312f1816"
      unitRef="Unit12">-32577000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-1ef090d4-5d1e-44cd-bc78-c713f4bcef01"
      unitRef="Unit12">-36205000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-42d5b9a2-60ef-4fe6-9707-0ea93025137c"
      unitRef="Unit12">201015000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_12_31_2021"
      decimals="-3"
      id="ct-nonFraction-b77b32a9-eac1-489e-8483-5776cec4ed85"
      unitRef="Unit12">233437000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-c88e0fcd-6634-43de-a434-b7f0c4ec8ffb"
      unitRef="Unit12">168438000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="As_Of_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-21586ef4-f845-4d16-a54b-261ad210bc37"
      unitRef="Unit12">197232000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-06fe4a74-b07b-44f3-83b3-3feef1ad567b">&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;Note 1.  General and Liquidity&lt;/span&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Cassava Sciences, Inc. and its wholly-owned subsidiary (collectively referred to as the &#x201c;Company&#x201d;) discover and develop proprietary pharmaceutical product candidates that may offer significant improvements to patients and healthcare professionals. The Company generally focuses its discovery and product development efforts on disorders of the nervous system. &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) for interim financial information and pursuant to the instructions to the Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; Accordingly, the condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete consolidated financial statements. In the opinion of management of the Company, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation have been included. Operating results for the three and six months ended June 30, 2023 are not necessarily indicative of the results that may be expected for any other interim period or for the year 2023&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;. &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;For further information, refer to the consolidated financial statements and footnotes thereto included in the Company&#x2019;s Annual Report on Form&#160;10-K for the year ended December 31, 2022.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Liquidity&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company has incurred significant net losses and negative cash flows since inception, and as a result has an accumulated deficit of $&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;334.2&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; million at June 30, 2023. The Company expects its cash requirements to be significant in the future. The amount and timing of the Company&#x2019;s future cash requirements will depend on regulatory and market acceptance of its product candidates and the resources it devotes to researching and developing, formulating, manufacturing, commercializing and supporting its products. The Company may seek additional funding through public or private financing in the future, if such funding is available and on terms acceptable to the Company. There are no assurances that additional financing will be available on favorable terms, or at all. However, management believes that the current working capital position will be sufficient to meet the Company&#x2019;s working capital needs for at least the next 12 months.&lt;/span&gt;&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="As_Of_6_30_2023"
      decimals="-5"
      id="ct-nonFraction-517afb0d-d01e-4ac5-afd4-1fa685560441"
      unitRef="Unit12">-334200000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-b9c44816-6c71-4750-ad99-e7da8f52a206">&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;Note 2.&#160;&#160;Significant Accounting Policies&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Use of Estimates&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company makes estimates and assumptions in preparing its condensed consolidated financial statements in conformity with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amount of revenue earned and expenses incurred during the reporting period. The Company evaluates&#160;its estimates on an ongoing basis, including those estimates related to manufacturing agreements and research collaborations. Actual results could differ from these estimates&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; and assumptions.&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Cash and Cash Equivalents and Concentration of Credit Risk&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company invests in cash and cash equivalents. The Company considers highly liquid financial instruments with original maturities of three months or less to be cash equivalents. Highly liquid investments that are considered cash equivalents include money market accounts and funds, certificates of deposit, and U.S. Treasury securities.&#160;The Company maintains&#160;its cash and cash equivalents at one financial institution. &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Fair Value Measurements &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company recognizes financial instruments in accordance with the authoritative guidance on fair value measurements and disclosures for financial assets and liabilities. This guidance defines fair value, establishes a framework for measuring fair value in accordance with GAAP, and expands disclosures about fair value measurements. The guidance also establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include:&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;"&gt;&#xf0b7;&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Level 1 includes quoted prices in active markets.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;"&gt;&#xf0b7;&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Level 2 includes significant observable inputs, such as quoted prices for identical or similar securities, or other inputs that are observable and can be corroborated by observable market data for similar securities. The Company uses market pricing and other observable market inputs obtained from third-party providers. It uses the bid price to establish fair value where a bid price is available. &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company does not have any financial instruments where the fair value is based on Level 2 inputs.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;"&gt;&#xf0b7;&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Level 3 includes unobservable inputs that are supported by little or no market activity. The Company does not have any financial instruments where the fair value is based on Level 3 inputs.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;If a financial instrument uses inputs that fall in different levels of the hierarchy, the instrument will be categorized based upon the lowest level of input that is significant to the fair value calculation. The fair value of cash and cash equivalents was based on Level 1 inputs at &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2023 and December 31, 2022.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;&#xfeff;&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Business Segments&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company reports segment information based on how it internally evaluates the operating performance of its business units, or segments. The Company&#x2019;s operations are confined to &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;one&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; business segment: the development of novel drugs and diagnostics.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Proceeds from Grants&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"&gt;&#xfeff;&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;During the three and six months ended &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2023,&#160;there were &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;no&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; reimbursements received pursuant to National Institutes of Health (&#x201c;NIH&#x201d;) research grants. &lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;During the &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;three and six months ended &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2022&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, the Company received reimbursements totaling $&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;0.4&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; million and $&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;0.5&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;million, respectively, pursuant to NIH research grants. &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company records the proceeds from these grants as reductions to its research and development expenses.&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Stock-based Compensation&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#xfeff;&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The&#160;Company recognizes non-cash expense for the fair value of all stock options and other share-based awards. The Company uses the Black-Scholes option valuation model (&#x201c;Black-Scholes&#x201d;) to calculate the fair value of stock options, using the single-option award approach and straight-line attribution method. &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;This model requires the input of subjective assumptions including expected stock price volatility, expected life and estimated forfeitures of each &lt;/span&gt;&lt;span id="_cp_text_1_372" style="text-decoration: none;"&gt;&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;award. These assumptions consist of estimates of future market conditions, which are inherently uncertain, and therefore, are subject to management's judgment. &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;For all options granted, it recognizes the resulting fair value as expense on a straight-line basis over the vesting period of each respective stock option, generally &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;four years&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;.&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.25in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#xfeff;&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company has granted share-based awards that vest upon achievement of certain performance criteria (&#x201c;Performance Awards&#x201d;). The Company multiplies the number of Performance Awards by the fair value of its common stock on the date of grant to calculate the fair value of each award. It estimates an implicit service period for achieving performance criteria for each award. The Company recognizes the resulting fair value as expense over the implicit service period when it concludes that achieving the performance criteria is probable. It periodically reviews and updates as appropriate its estimates of implicit service periods and conclusions on achieving the performance criteria. Performance Awards vest and common stock is issued upon achievement of the performance criteria.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;&#xfeff;&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Net Loss per Share &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;&#xfeff;&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company computes basic net loss per share on the basis of the weighted-average number of common shares outstanding for the reporting period. Diluted net loss per share is computed on the basis of the weighted-average number of common shares outstanding plus potential dilutive common shares outstanding using the treasury-stock &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;method. Potential dilutive common shares consist of outstanding common stock options.&#160;&#160;There is no difference between the Company&#x2019;s net loss and comprehensive loss. &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The numerators and denominators in the calculation of basic and diluted net loss per share were as follows (in thousands, except net loss per share data):&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="text-align:left"&gt;&lt;table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"&gt;&lt;tr style="height: 0.01in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.20in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.31in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;Three months ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;Six months ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.20in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.16in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Numerator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;26,376&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;19,328&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;50,647&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;36,855&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Denominator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Shares used in computing net loss per share, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;41,793&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;40,015&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;41,766&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;39,989&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;0.63&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;0.48&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1.21&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;0.92&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.08in;"&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; Dilutive common stock options excluded from net loss per share, diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;2,001&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1,937&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;2,018&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;2,095&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.07in;"&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company excluded common stock options outstanding from the calculation of net loss per share, diluted, because the effect of including outstanding options would have been anti&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;-&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;dilutive. The Company also excluded &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;57,143&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; restricted stock awards from the calculation of net loss per share, diluted, until their expiration in June 2022 because the effect of including restricted stock awards would have been anti&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;-&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;dilutive.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 6pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160; &#160; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 6pt;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Financial instruments include accounts payable and accrued liabilities. The estimated fair value of certain financial instruments may be determined using available market information or other appropriate valuation methodologies. However, considerable judgment is required in interpreting market data to develop estimates of fair value; therefore, the estimates are not necessarily indicative of the amounts that could be realized or would be paid in a current market exchange. The effect of using different market assumptions and/or estimation methodologies may be material to the estimated fair value amounts. The carrying amounts of accounts payable and accrued liabilities are at cost, which approximates fair value due to the short maturity of those instruments. &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Research Contract Costs and Accruals &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company has entered into various research and development contracts with research institutions and other third-party vendors. These agreements are generally cancelable. Related payments are recorded as research and development expenses as incurred. The Company records prepaids and accruals for estimated ongoing research costs. When evaluating the adequacy of prepaid expenses and accrued liabilities, the Company analyzes progress of the studies including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made in determining the prepaid and accrued balances at the end of any reporting period. Actual results could differ from the Company&#x2019;s estimates. The Company&#x2019;s historical prepaid and accrual estimates have not been materially different from actual costs.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Incentive Bonus Plan&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;In 2020, the Company established the 2020 Cash Incentive Bonus Plan (the &#x201c;Plan&#x201d;) to incentivize Plan participants. Awards under the Plan are accounted for as liability awards under Accounting Standards Codification (ASC) 718 &#x201c;&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"&gt;Stock-based Compensation&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#x201d;.&#160;The fair value of each&#160;potential Plan&#160;award&#160;will be&#160;determined&#160;once&#160;a&#160;grant date occurs and&#160;will be&#160;remeasured each reporting period.&#160;Compensation expense associated with the Plan&#160;will be&#160;recognized over the expected achievement period for each&#160;Plan award, when&#160;a Performance Condition&#160;(as defined below) is considered probable of being met. See Note 10 for further discussion of the Plan.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 1.00in;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company recognizes&#160;assets and liabilities that arise from leases.&#160;For operating leases, the Company is required to recognize a right-of-use asset and a lease liability, initially measured at the present value of the lease payments during the lease term, in the&#160;condensed consolidated balance sheets.&#160;&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company elected the short-term lease recognition exemption for all leases that qualify. This means, for those leases that qualify, the Company does not recognize right-of-use assets or lease liabilities. &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;As the Company`s leases do not provide an implicit rate, it uses its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. Lease expense for lease payments is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Property and equipment&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Property and equipment is recorded at cost, net of accumulated depreciation. Depreciation is recorded using the straight-line method over the estimated useful lives of the assets. Owned buildings and related improvements have estimated useful lives of &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;39&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; years and approximately &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;10&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; years, respectively. Tenant improvements are amortized using the straight-line method over the useful lives of the improvements or the remaining term of the corresponding leases, whichever is shorter. The remaining term of the corresponding leases is approximately &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;0.9&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; years.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Property and equipment are reviewed for impairment when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. If property and equipment are considered to be impaired, an impairment loss is recognized.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Intangible assets&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Acquired intangible assets are recorded at fair value at the date of acquisition and primarily consist of lease-in-place agreements and leasing commissions. Intangible assets are amortized over the estimated life of the lease-in-place agreements, which is approximately &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;0.8&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; years at &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Intangible assets are reviewed for impairment on an annual basis, and when there is reason to believe that their values have been diminished or impaired. If intangible assets are considered&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; to be impaired, an impairment loss is recognized.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Income Taxes&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company accounts for income taxes under the asset and liability method. &#160;Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.&#160;Deferred tax balances are adjusted to reflect tax rates based on currently enacted tax laws, which will be in effect in the years in which the temporary differences are expected to reverse.&#160;The Company has accumulated significant deferred tax assets that reflect the tax effects of net operating loss and tax credit carryovers and temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Realization of certain deferred tax assets is dependent upon future earnings. The Company is uncertain about the timing and amount of any future earnings. Accordingly, the Company offsets these deferred tax assets with a valuation allowance.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company accounts for uncertain tax positions in accordance with ASC 740, &#x201c;Income Taxes&#x201d;, which clarifies the accounting for uncertainty in tax positions. These provisions require recognition of the impact of a tax position in the Company&#x2019;s &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;condensed&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; consolidated financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Any interest and penalties related to uncertain tax positions will be reflected as a component of income tax expense.&lt;/span&gt;&lt;/p&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-4731bdcf-8ce3-4ca6-a0c4-e141221efb28">&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Use of Estimates&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company makes estimates and assumptions in preparing its condensed consolidated financial statements in conformity with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amount of revenue earned and expenses incurred during the reporting period. The Company evaluates&#160;its estimates on an ongoing basis, including those estimates related to manufacturing agreements and research collaborations. Actual results could differ from these estimates&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; and assumptions.&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-27bed824-293c-461c-accb-1a8e8aff90ba">&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Cash and Cash Equivalents and Concentration of Credit Risk&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company invests in cash and cash equivalents. The Company considers highly liquid financial instruments with original maturities of three months or less to be cash equivalents. Highly liquid investments that are considered cash equivalents include money market accounts and funds, certificates of deposit, and U.S. Treasury securities.&#160;The Company maintains&#160;its cash and cash equivalents at one financial institution. &lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-a6b441e0-ce6e-4495-b317-1f130bc4b25e">&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Fair Value Measurements &lt;/span&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company recognizes financial instruments in accordance with the authoritative guidance on fair value measurements and disclosures for financial assets and liabilities. This guidance defines fair value, establishes a framework for measuring fair value in accordance with GAAP, and expands disclosures about fair value measurements. The guidance also establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include:&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;"&gt;&#xf0b7;&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Level 1 includes quoted prices in active markets.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;"&gt;&#xf0b7;&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Level 2 includes significant observable inputs, such as quoted prices for identical or similar securities, or other inputs that are observable and can be corroborated by observable market data for similar securities. The Company uses market pricing and other observable market inputs obtained from third-party providers. It uses the bid price to establish fair value where a bid price is available. &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company does not have any financial instruments where the fair value is based on Level 2 inputs.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: Symbol;font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.50in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: -0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;display: inline-block;font-family: Symbol;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;text-indent: 0;width: 0.250in;"&gt;&#xf0b7;&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Level 3 includes unobservable inputs that are supported by little or no market activity. The Company does not have any financial instruments where the fair value is based on Level 3 inputs.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;If a financial instrument uses inputs that fall in different levels of the hierarchy, the instrument will be categorized based upon the lowest level of input that is significant to the fair value calculation. The fair value of cash and cash equivalents was based on Level 1 inputs at &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2023 and December 31, 2022.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-c58ad7df-730f-43a5-833b-2fcdd0ff93ae">&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Business Segments&lt;/span&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company reports segment information based on how it internally evaluates the operating performance of its business units, or segments. The Company&#x2019;s operations are confined to &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;one&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; business segment: the development of novel drugs and diagnostics.&lt;/span&gt;&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="INF"
      id="ct-nonFraction-a6b423f2-1d29-447c-9714-74b6951334cd"
      unitRef="Unit17">1</us-gaap:NumberOfOperatingSegments>
    <sava:ProceedsFromGrantsPolicyPolicyTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-60246e56-f1ec-4360-b24a-8926515fce87">&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Proceeds from Grants&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"&gt;&#xfeff;&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;During the three and six months ended &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2023,&#160;there were &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;no&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; reimbursements received pursuant to National Institutes of Health (&#x201c;NIH&#x201d;) research grants. &lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;During the &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;three and six months ended &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2022&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, the Company received reimbursements totaling $&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;0.4&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; million and $&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;0.5&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;million, respectively, pursuant to NIH research grants. &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company records the proceeds from these grants as reductions to its research and development expenses.&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;</sava:ProceedsFromGrantsPolicyPolicyTextBlock>
    <sava:ReductionToResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-6"
      id="ct-nonFraction-69861e31-f6a7-448d-83db-cd34362094cd"
      unitRef="Unit12">0</sava:ReductionToResearchAndDevelopmentExpense>
    <sava:ReductionToResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2022_To_3_31_2022"
      decimals="-5"
      id="ct-nonFraction-2c520583-023a-4c49-ad2f-03046f24f02e"
      unitRef="Unit12">400000</sava:ReductionToResearchAndDevelopmentExpense>
    <sava:ReductionToResearchAndDevelopmentExpense
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-5"
      id="ct-nonFraction-f6afe69b-5bfe-479f-b36a-4886995653a2"
      unitRef="Unit12">500000</sava:ReductionToResearchAndDevelopmentExpense>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-04d4ea4a-090a-4526-8386-0bdba1ab4dbe">&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Stock-based Compensation&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#xfeff;&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The&#160;Company recognizes non-cash expense for the fair value of all stock options and other share-based awards. The Company uses the Black-Scholes option valuation model (&#x201c;Black-Scholes&#x201d;) to calculate the fair value of stock options, using the single-option award approach and straight-line attribution method. &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;This model requires the input of subjective assumptions including expected stock price volatility, expected life and estimated forfeitures of each &lt;/span&gt;&lt;span id="_cp_text_1_372" style="text-decoration: none;"&gt;&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;award. These assumptions consist of estimates of future market conditions, which are inherently uncertain, and therefore, are subject to management's judgment. &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;For all options granted, it recognizes the resulting fair value as expense on a straight-line basis over the vesting period of each respective stock option, generally &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;four years&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;.&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0.25in;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#xfeff;&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company has granted share-based awards that vest upon achievement of certain performance criteria (&#x201c;Performance Awards&#x201d;). The Company multiplies the number of Performance Awards by the fair value of its common stock on the date of grant to calculate the fair value of each award. It estimates an implicit service period for achieving performance criteria for each award. The Company recognizes the resulting fair value as expense over the implicit service period when it concludes that achieving the performance criteria is probable. It periodically reviews and updates as appropriate its estimates of implicit service periods and conclusions on achieving the performance criteria. Performance Awards vest and common stock is issued upon achievement of the performance criteria.&lt;/span&gt;&lt;/p&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-6b59cda7-718b-4cb2-bb76-14eb4a395ed6">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-b0368df7-2366-430e-8ed3-a6d2ebc0e5f7">&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Net Loss per Share &lt;/span&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Tahoma', 'sans-serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;&#xfeff;&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company computes basic net loss per share on the basis of the weighted-average number of common shares outstanding for the reporting period. Diluted net loss per share is computed on the basis of the weighted-average number of common shares outstanding plus potential dilutive common shares outstanding using the treasury-stock &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;method. Potential dilutive common shares consist of outstanding common stock options.&#160;&#160;There is no difference between the Company&#x2019;s net loss and comprehensive loss. &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The numerators and denominators in the calculation of basic and diluted net loss per share were as follows (in thousands, except net loss per share data):&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="text-align:left"&gt;&lt;table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"&gt;&lt;tr style="height: 0.01in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.20in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.31in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;Three months ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;Six months ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.20in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.16in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Numerator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;26,376&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;19,328&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;50,647&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;36,855&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Denominator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Shares used in computing net loss per share, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;41,793&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;40,015&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;41,766&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;39,989&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;0.63&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;0.48&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1.21&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;0.92&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.08in;"&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; Dilutive common stock options excluded from net loss per share, diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;2,001&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1,937&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;2,018&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;2,095&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.07in;"&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company excluded common stock options outstanding from the calculation of net loss per share, diluted, because the effect of including outstanding options would have been anti&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;-&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;dilutive. The Company also excluded &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;57,143&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; restricted stock awards from the calculation of net loss per share, diluted, until their expiration in June 2022 because the effect of including restricted stock awards would have been anti&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;-&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;dilutive.&lt;/span&gt;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-df189d84-7ccf-40ff-89f2-3fe4057fcee2">&lt;div style="text-align:left"&gt;&lt;table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"&gt;&lt;tr style="height: 0.01in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.20in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.31in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;Three months ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;Six months ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.20in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.16in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Numerator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;26,376&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;19,328&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;50,647&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;36,855&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Denominator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Shares used in computing net loss per share, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;41,793&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;40,015&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;41,766&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;39,989&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;0.63&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;0.48&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1.21&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;0.92&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.08in;"&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; Dilutive common stock options excluded from net loss per share, diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;2,001&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1,937&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;2,018&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;2,095&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.07in;"&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_4_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-be72c532-e074-48c2-9b68-8289bcc3a17d"
      unitRef="Unit12">-26376000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_4_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-4a022d74-f953-4869-a9f0-c1951411884d"
      unitRef="Unit12">-19328000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-c08662cc-0ba3-4ab1-ac7d-9ed3b45ff024"
      unitRef="Unit12">-50647000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-f1df0159-42ec-4882-8d4a-a22bfdcd83d1"
      unitRef="Unit12">-36855000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_4_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-5ff515d1-490e-4575-b334-4226ee0416f8"
      unitRef="Unit1">41793000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_4_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-3b0f51a6-7864-4d29-bb5d-9d68d3c11ad5"
      unitRef="Unit1">41793000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_4_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-595430dc-b51b-4a4c-8c56-b2bd98a8da9a"
      unitRef="Unit1">40015000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_4_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-ff753831-e1ea-4f16-902d-f51bec8f2d0b"
      unitRef="Unit1">40015000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-dda77587-5062-4fc2-ac49-a95c847d9513"
      unitRef="Unit1">41766000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-5921ed80-29b4-45a4-b1ca-54c81dcd153c"
      unitRef="Unit1">41766000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-aa92a356-2219-4ddb-ae5d-fa2304ef86d4"
      unitRef="Unit1">39989000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-64ca593e-e850-42f3-a49e-4c2333c0c910"
      unitRef="Unit1">39989000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_4_1_2023_To_6_30_2023"
      decimals="2"
      id="ct-nonFraction-ac4c3fef-c11f-4566-82cb-2452a2491baa"
      unitRef="Unit15">-0.63</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_4_1_2023_To_6_30_2023"
      decimals="2"
      id="ct-nonFraction-b19c8459-4287-430a-afbf-d0e1a1c59259"
      unitRef="Unit15">-0.63</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_4_1_2022_To_6_30_2022"
      decimals="2"
      id="ct-nonFraction-257b83d1-0792-4995-a061-1b3a3b86731c"
      unitRef="Unit15">-0.48</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_4_1_2022_To_6_30_2022"
      decimals="2"
      id="ct-nonFraction-89598112-7bcf-4129-ad35-20396a3c2ba5"
      unitRef="Unit15">-0.48</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="2"
      id="ct-nonFraction-5e052eb4-bafe-44fb-a707-0c616ffc2ac9"
      unitRef="Unit15">-1.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="2"
      id="ct-nonFraction-fcc1589c-5dec-4412-918b-7c8a40a0ebce"
      unitRef="Unit15">-1.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="2"
      id="ct-nonFraction-bc4b5931-1459-48be-831d-59025bd1e478"
      unitRef="Unit15">-0.92</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="2"
      id="ct-nonFraction-195f340f-070f-400c-ad6e-bf6e20cee21e"
      unitRef="Unit15">-0.92</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Duration_4_1_2023_To_6_30_2023_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-3"
      id="ct-nonFraction-2802c998-21a0-40fd-8d04-e45001a21226"
      unitRef="Unit1">2001000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Duration_4_1_2022_To_6_30_2022_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-3"
      id="ct-nonFraction-4a3c00de-927f-4651-8d41-6bed8e24313a"
      unitRef="Unit1">1937000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-3"
      id="ct-nonFraction-5450853b-bd89-4ea4-b6ea-ee61ae8a1db1"
      unitRef="Unit1">2018000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Duration_1_1_2022_To_6_30_2022_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember"
      decimals="-3"
      id="ct-nonFraction-dcfa3dad-cefe-48bd-a0d7-2434e4905310"
      unitRef="Unit1">2095000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="ct-nonFraction-dece492a-d2ff-4f82-92e7-296ec05cc72f"
      unitRef="Unit1">57143</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-2b78b96d-67fb-42d0-9005-fa949686e2ed">&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160; &#160; &lt;/span&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 6pt;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Financial instruments include accounts payable and accrued liabilities. The estimated fair value of certain financial instruments may be determined using available market information or other appropriate valuation methodologies. However, considerable judgment is required in interpreting market data to develop estimates of fair value; therefore, the estimates are not necessarily indicative of the amounts that could be realized or would be paid in a current market exchange. The effect of using different market assumptions and/or estimation methodologies may be material to the estimated fair value amounts. The carrying amounts of accounts payable and accrued liabilities are at cost, which approximates fair value due to the short maturity of those instruments. &lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <sava:ResearchContractCostsAndAccrualsPolicyPolicyTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-cf8dbfbd-1fe4-4f8e-a909-80188e65e001">&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Research Contract Costs and Accruals &lt;/span&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company has entered into various research and development contracts with research institutions and other third-party vendors. These agreements are generally cancelable. Related payments are recorded as research and development expenses as incurred. The Company records prepaids and accruals for estimated ongoing research costs. When evaluating the adequacy of prepaid expenses and accrued liabilities, the Company analyzes progress of the studies including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made in determining the prepaid and accrued balances at the end of any reporting period. Actual results could differ from the Company&#x2019;s estimates. The Company&#x2019;s historical prepaid and accrual estimates have not been materially different from actual costs.&lt;/span&gt;&lt;/p&gt;</sava:ResearchContractCostsAndAccrualsPolicyPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-e40ee3fb-1a00-48e1-a83d-9322c611086c">&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Incentive Bonus Plan&lt;/span&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;In 2020, the Company established the 2020 Cash Incentive Bonus Plan (the &#x201c;Plan&#x201d;) to incentivize Plan participants. Awards under the Plan are accounted for as liability awards under Accounting Standards Codification (ASC) 718 &#x201c;&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"&gt;Stock-based Compensation&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#x201d;.&#160;The fair value of each&#160;potential Plan&#160;award&#160;will be&#160;determined&#160;once&#160;a&#160;grant date occurs and&#160;will be&#160;remeasured each reporting period.&#160;Compensation expense associated with the Plan&#160;will be&#160;recognized over the expected achievement period for each&#160;Plan award, when&#160;a Performance Condition&#160;(as defined below) is considered probable of being met. See Note 10 for further discussion of the Plan.&lt;/span&gt;&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-f71531e7-2332-40ef-a6e4-aee8f817908f">&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Leases&lt;/span&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company recognizes&#160;assets and liabilities that arise from leases.&#160;For operating leases, the Company is required to recognize a right-of-use asset and a lease liability, initially measured at the present value of the lease payments during the lease term, in the&#160;condensed consolidated balance sheets.&#160;&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company elected the short-term lease recognition exemption for all leases that qualify. This means, for those leases that qualify, the Company does not recognize right-of-use assets or lease liabilities. &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;As the Company`s leases do not provide an implicit rate, it uses its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. Lease expense for lease payments is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-98e8dfad-4451-4387-9f95-a9c8b946ddb8">&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Property and equipment&lt;/span&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Property and equipment is recorded at cost, net of accumulated depreciation. Depreciation is recorded using the straight-line method over the estimated useful lives of the assets. Owned buildings and related improvements have estimated useful lives of &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;39&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; years and approximately &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;10&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; years, respectively. Tenant improvements are amortized using the straight-line method over the useful lives of the improvements or the remaining term of the corresponding leases, whichever is shorter. The remaining term of the corresponding leases is approximately &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;0.9&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; years.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Property and equipment are reviewed for impairment when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. If property and equipment are considered to be impaired, an impairment loss is recognized.&lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"
      id="ct-nonNumeric-b869ba84-c8b6-4a5b-9ed3-7303540baf9e">P39Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember"
      id="ct-nonNumeric-66408b36-2321-42ba-b62d-5d88650d1f46">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember"
      id="ct-nonNumeric-81e89339-39d1-4805-8c56-d729264a993d">P0Y10M24D</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-f6b6655a-6b3e-4ded-9086-f4cb692297c6">&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Intangible assets&lt;/span&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Acquired intangible assets are recorded at fair value at the date of acquisition and primarily consist of lease-in-place agreements and leasing commissions. Intangible assets are amortized over the estimated life of the lease-in-place agreements, which is approximately &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;0.8&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; years at &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Intangible assets are reviewed for impairment on an annual basis, and when there is reason to believe that their values have been diminished or impaired. If intangible assets are considered&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; to be impaired, an impairment loss is recognized.&lt;/span&gt;&lt;/p&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="As_Of_6_30_2023_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LeasesAcquiredInPlaceMember"
      id="ct-nonNumeric-20a9fc5f-95ea-4af5-b513-660f0d5cc33a">P0Y9M18D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-98d79a4d-93ce-402b-ba74-d2a9f88ab40a">&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;Income Taxes&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company accounts for income taxes under the asset and liability method. &#160;Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.&#160;Deferred tax balances are adjusted to reflect tax rates based on currently enacted tax laws, which will be in effect in the years in which the temporary differences are expected to reverse.&#160;The Company has accumulated significant deferred tax assets that reflect the tax effects of net operating loss and tax credit carryovers and temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Realization of certain deferred tax assets is dependent upon future earnings. The Company is uncertain about the timing and amount of any future earnings. Accordingly, the Company offsets these deferred tax assets with a valuation allowance.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company accounts for uncertain tax positions in accordance with ASC 740, &#x201c;Income Taxes&#x201d;, which clarifies the accounting for uncertainty in tax positions. These provisions require recognition of the impact of a tax position in the Company&#x2019;s &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;condensed&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; consolidated financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Any interest and penalties related to uncertain tax positions will be reflected as a component of income tax expense.&lt;/span&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <sava:PrepaidAndOtherAssetsDisclosureTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-bd33eec4-8f1e-45e3-945c-296b26be5f54">&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;letter-spacing: 0;margin: 0;padding: 0;"&gt;Note 3.  Prepaid Expenses and &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;Other Current Assets&lt;/span&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Prepaid expenses and other current assets at &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2023 and December 31, 2022 consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="text-align:left"&gt;&lt;table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"&gt;&lt;tr style="height: 0.01in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.21in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.31in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;June 30,&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;&lt;br/&gt;&#x200e;&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;December 31,&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;&lt;br/&gt;&#x200e;&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Prepaid insurance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;5&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;874&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Contract research organization and other deposits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;4,527&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;9,177&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Interest receivable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1,328&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;235&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;160&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.21in;"&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;  Total prepaid expenses and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;6,095&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;10,211&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Contract research organization and other deposits represent cash payments made to vendors in excess of expenses incurred.&lt;/span&gt;</sava:PrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-1aef33c9-f0d7-49cf-8f5e-cda08eb881c7">&lt;div style="text-align:left"&gt;&lt;table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"&gt;&lt;tr style="height: 0.01in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.21in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.31in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;June 30,&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;&lt;br/&gt;&#x200e;&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;December 31,&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;&lt;br/&gt;&#x200e;&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Prepaid insurance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;5&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;874&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Contract research organization and other deposits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;4,527&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;9,177&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Interest receivable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1,328&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;235&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;160&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.21in;"&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;  Total prepaid expenses and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;6,095&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;10,211&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:PrepaidInsurance
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-7b145ab6-f045-43a1-99a4-9e476d4fca80"
      unitRef="Unit12">5000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-ed0e10d0-bba8-4de7-9369-c099a230bc25"
      unitRef="Unit12">874000</us-gaap:PrepaidInsurance>
    <us-gaap:DepositContractsAssets
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-a51ff561-62f4-4be1-aa41-84a80fc779a1"
      unitRef="Unit12">4527000</us-gaap:DepositContractsAssets>
    <us-gaap:DepositContractsAssets
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-11066c2a-9835-45d0-bd35-0672c8588ff8"
      unitRef="Unit12">9177000</us-gaap:DepositContractsAssets>
    <us-gaap:InterestReceivableCurrent
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-b8a9052f-1110-4db4-9972-dd36eae9c579"
      unitRef="Unit12">1328000</us-gaap:InterestReceivableCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-b792fda3-4be6-45fa-b754-a6ac8c78785d"
      unitRef="Unit12">235000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-572681b0-203e-4b57-ba76-dedceb3cf4a0"
      unitRef="Unit12">160000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-7e8ca0f6-cb8a-4baa-b11f-b68c6dfe7e6e"
      unitRef="Unit12">6095000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-9cfe0acd-b53c-444b-b35c-a727658bc0db"
      unitRef="Unit12">10211000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-3e816cce-1dd2-4462-b0d1-0d786252799a">&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;letter-spacing: 0;margin: 0;padding: 0;"&gt;Note 4. Real Property&lt;/span&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company owns a two-building office complex in Austin, Texas, a portion of which serves as its corporate headquarters. This property is intended to accommodate the Company&#x2019;s anticipated growth and expansion of its operations in the coming years. Maintenance, physical facilities, leasing, property management and other key responsibilities related to property ownership are being outsourced to professional real-estate managers. The office complex measures approximately &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;90,000&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; rentable square feet. At &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2023, the property was over &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;60&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;% leased. The Company also occupies approximately &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;25&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;% of the property.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company records the net income from building operations and leases as other income, net, as leasing is not core to the Company&#x2019;s operations. Building depreciation and amortization for space not occupied by the Company is included in general and administrative expense. Building depreciation and amortization for space occupied by the Company is allocated between general and administrative expense and research and development expense. Components of other income, net, for the periods presented were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="text-align:left"&gt;&lt;table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"&gt;&lt;tr style="height: 0.01in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.05in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.21in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #FF0000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;Three months ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;Six months ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.18in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #FF0000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.16in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #FF0000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.25in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Lease revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #FF0000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;559&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;586&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1,116&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1,160&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.25in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Property operating expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #FF0000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;356&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;311&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;723&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;622&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.25in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;  Other income, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #FF0000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;203&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;275&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;393&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;538&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.06in;"&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #FF0000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:NetRentableArea
      contextRef="As_Of_8_4_2021_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_AssetAcquisitionAxis_sava_TwoBuildingOfficeComplexAssetMember"
      decimals="0"
      id="ct-nonFraction-8ef94d06-0f1c-4f35-b7e5-47a01f4a19bd"
      unitRef="Unit16">90000</us-gaap:NetRentableArea>
    <sava:PercentageOfCurrentlyLeased
      contextRef="Duration_1_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_AssetAcquisitionAxis_sava_TwoBuildingOfficeComplexAssetMember"
      decimals="2"
      id="ct-nonFraction-2c47e26d-4a50-4963-8046-709d1ae795f0"
      unitRef="Unit14">0.60</sava:PercentageOfCurrentlyLeased>
    <sava:PercentageOfOccupancy
      contextRef="Duration_1_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_AssetAcquisitionAxis_sava_TwoBuildingOfficeComplexAssetMember"
      decimals="2"
      id="ct-nonFraction-07d074c2-2c33-426a-84de-286859c99b77"
      unitRef="Unit14">0.25</sava:PercentageOfOccupancy>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-a97ab4c9-686f-41bd-9a9a-3dc9ca3000c3">&lt;div style="text-align:left"&gt;&lt;table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"&gt;&lt;tr style="height: 0.01in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.05in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.21in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #FF0000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;Three months ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;Six months ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.18in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #FF0000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.16in;"&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #FF0000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.25in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Lease revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #FF0000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;559&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;586&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1,116&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1,160&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.25in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Property operating expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #FF0000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;356&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;311&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;723&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;622&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.17in;"&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.25in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;  Other income, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #FF0000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;203&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;275&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;393&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;538&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height: 0.06in;"&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #FF0000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
    <us-gaap:OtherNonoperatingIncome
      contextRef="Duration_4_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"
      decimals="-3"
      id="ct-nonFraction-ba660392-94b0-4b81-ada1-074f79c43763"
      unitRef="Unit12">559000</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome
      contextRef="Duration_4_1_2022_To_6_30_2022_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"
      decimals="-3"
      id="ct-nonFraction-a6ed5354-4c86-415b-849c-4cd38fc91fef"
      unitRef="Unit12">586000</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome
      contextRef="Duration_1_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"
      decimals="-3"
      id="ct-nonFraction-843bb95d-ad34-455b-87ea-b81dc7ebd676"
      unitRef="Unit12">1116000</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome
      contextRef="Duration_1_1_2022_To_6_30_2022_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"
      decimals="-3"
      id="ct-nonFraction-45cba965-23e8-475c-84f6-e1341adfadef"
      unitRef="Unit12">1160000</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingExpense
      contextRef="Duration_4_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"
      decimals="-3"
      id="ct-nonFraction-0828c4f4-3faf-4b22-8561-704b1ab5ac22"
      unitRef="Unit12">356000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense
      contextRef="Duration_4_1_2022_To_6_30_2022_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"
      decimals="-3"
      id="ct-nonFraction-4251c9f6-0be4-4e0d-a722-e51a742e400e"
      unitRef="Unit12">311000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense
      contextRef="Duration_1_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"
      decimals="-3"
      id="ct-nonFraction-3ceb9b9e-22bc-4a23-8212-ff539c1a1fb7"
      unitRef="Unit12">723000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense
      contextRef="Duration_1_1_2022_To_6_30_2022_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"
      decimals="-3"
      id="ct-nonFraction-fd45c941-a043-477c-b936-627944081fbe"
      unitRef="Unit12">622000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="Duration_4_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"
      decimals="-3"
      id="ct-nonFraction-67edf1cf-962b-4c44-b928-a8fc4d63d96b"
      unitRef="Unit12">203000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="Duration_4_1_2022_To_6_30_2022_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"
      decimals="-3"
      id="ct-nonFraction-b28db0fb-6e7a-4cf0-a43b-1bc9a4aae456"
      unitRef="Unit12">275000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="Duration_1_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"
      decimals="-3"
      id="ct-nonFraction-757be9ff-cb34-4018-86b2-119d4473afb8"
      unitRef="Unit12">393000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="Duration_1_1_2022_To_6_30_2022_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"
      decimals="-3"
      id="ct-nonFraction-2c82ebef-bb65-4eae-b6be-d44f2de89518"
      unitRef="Unit12">538000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-4ef8b207-a6ad-4bb2-b763-9ea683c16c8c">&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;letter-spacing: 0;margin: 0;padding: 0;"&gt;Note 5.  Property and equipment&lt;/span&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The components of property and equipment, net, as of &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2023&#160;and&#160;December 31, 2022&#160;were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="text-align:left"&gt;&lt;table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;December 31,&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;&lt;br/&gt;&#x200e;&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Land&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;3,734&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;3,734&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Buildings&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;15,980&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;15,980&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Site improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;470&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;470&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Tenant improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;3,018&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;3,016&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Furniture and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;868&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;851&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Construction in progress&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;13&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;  Gross property and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;24,072&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;24,064&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Accumulated depreciation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1,744&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1,200&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;  Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;22,328&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;22,864&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Depreciation expense for property and equipment was&#160;$&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;272,000&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;and&#160;$&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;174,000&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;for the three months ended&#160;June 30, 2023&#160;and 2022, respectively. &lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Depreciation expense for property and equipment was $&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;544,000&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; and $&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;352,000&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; for the six months ended June 30, 2023 and 2022, respectively.&lt;/span&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-2e63c3fa-9330-4516-8596-e38861f2dde3">&lt;div style="text-align:left"&gt;&lt;table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;December 31,&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;&lt;br/&gt;&#x200e;&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Land&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;3,734&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;3,734&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Buildings&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;15,980&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;15,980&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Site improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;470&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;470&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Tenant improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;3,018&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;3,016&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Furniture and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;868&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;851&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Construction in progress&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;13&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;  Gross property and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;24,072&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;24,064&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Accumulated depreciation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1,744&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1,200&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;  Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;22,328&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;22,864&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandMember"
      decimals="-3"
      id="ct-nonFraction-086e3294-4e34-4c96-ac8f-f5ce226bb34d"
      unitRef="Unit12">3734000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LandMember"
      decimals="-3"
      id="ct-nonFraction-c42fc924-812e-42da-8362-0678a59c6695"
      unitRef="Unit12">3734000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"
      decimals="-3"
      id="ct-nonFraction-b4d39502-d0fc-4c57-a65b-269389a7a3f7"
      unitRef="Unit12">15980000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"
      decimals="-3"
      id="ct-nonFraction-15e5ef62-d58e-4f37-9acb-ddba6db1ff0d"
      unitRef="Unit12">15980000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember"
      decimals="-3"
      id="ct-nonFraction-be4a9adb-1252-43d1-a028-d83db6e40be1"
      unitRef="Unit12">470000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember"
      decimals="-3"
      id="ct-nonFraction-1ade08bb-5497-4918-8e1c-75821c17bedd"
      unitRef="Unit12">470000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember"
      decimals="-3"
      id="ct-nonFraction-c82b5093-2a36-4257-9c8c-a0f47551bfca"
      unitRef="Unit12">3018000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_LeaseholdImprovementsMember"
      decimals="-3"
      id="ct-nonFraction-b5e83336-8da4-45c9-8194-e35f7a7048f5"
      unitRef="Unit12">3016000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember"
      decimals="-3"
      id="ct-nonFraction-a22f685d-97fa-4bed-afce-969ce1908ec0"
      unitRef="Unit12">868000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_FurnitureAndFixturesMember"
      decimals="-3"
      id="ct-nonFraction-b3658073-1037-410f-b3a4-7ec77697fdd5"
      unitRef="Unit12">851000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember"
      decimals="-3"
      id="ct-nonFraction-9b0d8d3c-c416-4b3b-ae2b-c2ef12b960ef"
      unitRef="Unit12">2000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember"
      decimals="-3"
      id="ct-nonFraction-b8a6e4b2-6c6d-4f5a-aca7-2c6686fdfd9e"
      unitRef="Unit12">13000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-844a0884-de5a-4aa1-beb0-65cf9050027b"
      unitRef="Unit12">24072000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-5dc2aeae-1886-4c07-9c1d-5dc6b195b058"
      unitRef="Unit12">24064000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-97d08f78-7afd-41ea-a25d-1cac47d1aa3a"
      unitRef="Unit12">1744000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-5ce04f41-43c2-4089-aa4b-ae7ebb936807"
      unitRef="Unit12">1200000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-d11483d1-f22c-4aa9-b823-d3c0397f8a8d"
      unitRef="Unit12">22328000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-f338ccdc-de1f-4df9-87c9-aca4c1ee9a3d"
      unitRef="Unit12">22864000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="Duration_4_1_2023_To_6_30_2023"
      decimals="0"
      id="ct-nonFraction-451dd3d3-bb39-4f72-afbf-e9b3ec9b51f2"
      unitRef="Unit12">272000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="Duration_4_1_2022_To_6_30_2022"
      decimals="0"
      id="ct-nonFraction-314d86a1-b2e2-473e-b1a9-19c626c959b7"
      unitRef="Unit12">174000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="0"
      id="ct-nonFraction-03c5e503-a6c3-46fd-8c0a-b0ad9b471d70"
      unitRef="Unit12">544000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="0"
      id="ct-nonFraction-641469d8-3950-4251-831e-0338682af4d9"
      unitRef="Unit12">352000</us-gaap:Depreciation>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-cfddc871-100e-499f-87b1-d80de20c8c86">&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;letter-spacing: 0;margin: 0;padding: 0;"&gt;Note 6.  Intangible assets&lt;/span&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;letter-spacing: 0;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The components of intangible assets, net, as of &lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2023&#160;and&#160;December 31, 2022&#160;were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="text-align:left"&gt;&lt;table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;December 31,&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;&lt;br/&gt;&#x200e;&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Lease-in-place agreements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1,053&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1,053&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Leasing commissions and other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;293&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;290&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;  Gross intangible assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1,346&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1,343&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Accumulated amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;959&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;721&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;  Intangible assets, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;387&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;622&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Amortization expense for intangible assets was&#160;$&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;119,000&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; and $&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;125,000&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; for the three months ended&#160;&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2023 and 2022, respectively. Amortization expense for intangible assets was&#160;$&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;238,000&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; and $&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;260,000&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; for the six months ended&#160;&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2023 and 2022, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Amortization expense for finite-lived intangible assets as of &lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2023 is expected to be as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="text-align:left"&gt;&lt;table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;text-decoration: underline;"&gt;For the year ending December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;216&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;167&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;4&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Total amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;387&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-81c3597a-7a88-4f4c-96b8-96b615c47526">&lt;div style="text-align:left"&gt;&lt;table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;December 31,&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;&lt;br/&gt;&#x200e;&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Lease-in-place agreements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1,053&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1,053&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Leasing commissions and other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;293&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;290&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;  Gross intangible assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1,346&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1,343&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Accumulated amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;959&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;721&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;  Intangible assets, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;387&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 11pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 11pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;622&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 52.1%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 3.3%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 19.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="As_Of_6_30_2023_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LeasesAcquiredInPlaceMember"
      decimals="-3"
      id="ct-nonFraction-eef188b7-6dc3-4186-8515-bebdf86742f2"
      unitRef="Unit12">1053000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LeasesAcquiredInPlaceMember"
      decimals="-3"
      id="ct-nonFraction-9037892e-5011-4a10-8cf7-443d3b086087"
      unitRef="Unit12">1053000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="As_Of_6_30_2023_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_sava_LeasingCommissionsAndOtherMember"
      decimals="-3"
      id="ct-nonFraction-aa21e7c2-562e-4c76-82cc-d021970a0f8f"
      unitRef="Unit12">293000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="As_Of_12_31_2022_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_sava_LeasingCommissionsAndOtherMember"
      decimals="-3"
      id="ct-nonFraction-40271ac9-0ccf-4c12-a257-3c36aec1537e"
      unitRef="Unit12">290000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-14304140-cae6-4f77-8e7f-fde598865f9d"
      unitRef="Unit12">1346000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-3ed16889-7cac-49ef-9feb-b28570a71c53"
      unitRef="Unit12">1343000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-219eabfd-9ad5-4145-984e-255742e41cc0"
      unitRef="Unit12">959000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-ee7a8b5d-1732-4939-adad-ece58b22c549"
      unitRef="Unit12">721000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-9642b871-0929-4c05-ba38-6d65a5af46e3"
      unitRef="Unit12">387000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="As_Of_12_31_2022"
      decimals="-3"
      id="ct-nonFraction-4d1e020b-5ac4-4772-869f-a759c96cd9c8"
      unitRef="Unit12">622000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="Duration_4_1_2023_To_6_30_2023"
      decimals="0"
      id="ct-nonFraction-00da773d-a69c-465a-bdc5-8e8170f08a6a"
      unitRef="Unit12">119000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="Duration_4_1_2022_To_6_30_2022"
      decimals="0"
      id="ct-nonFraction-0a6c331b-640b-4822-8fc1-d44fd318ebdf"
      unitRef="Unit12">125000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="0"
      id="ct-nonFraction-9356df7b-af4a-4ef1-bee2-e0319746a92b"
      unitRef="Unit12">238000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="0"
      id="ct-nonFraction-91fb453e-a541-4555-847c-47af76e45fcd"
      unitRef="Unit12">260000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-96750b72-d4dd-4b58-92df-53b2098ca38b">&lt;div style="text-align:left"&gt;&lt;table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;text-decoration: underline;"&gt;For the year ending December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;216&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;167&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;4&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.33in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Total amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;387&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 85.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.5%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: Calibri;font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-8e789382-8012-4dcf-99cd-90432c52c825"
      unitRef="Unit12">216000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-cef4c90b-51b0-493c-b1ef-1730a92d0df0"
      unitRef="Unit12">167000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-8cdc8d47-61bd-44a9-bee0-fc4b695fd641"
      unitRef="Unit12">4000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="As_Of_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-729e3eaa-7d64-482b-994f-05a4679d9f67"
      unitRef="Unit12">387000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-ae9f0d21-c45b-4482-8ffb-576f7211369a">&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;letter-spacing: 0;margin: 0;padding: 0;"&gt;Note 7.  Stockholders&#x2019; Equity and Stock-Based Compensation Expense&lt;/span&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;2022 Registered Direct Offering&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;On November&#160;22, 2022, the Company completed a common stock offering pursuant to which certain investors purchased &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1,666,667&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; shares of common stock at a price of $&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;30.00&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; per share. Net proceeds of the offering were approximately $&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;47.3&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;million after deducting offering expenses.&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"&gt;At-the-Market Common Stock Offering &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;On May 1, 2023, the Company established a new at-the-market offering program (&#x201c;ATM&#x201d;) to sell, from time to time, shares of Company common stock having an aggregate offering price of up to $&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;200&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; million in common stock pursuant to a shelf registration statement that was filed with the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) on May 1, 2023 and became effective immediately upon filing. The Company is obligated to pay a commission of up to &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;3&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;% of the gross proceeds from the sale of shares of common stock in the offering. The Company is not obligated to sell any shares in the offering.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;There were &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;no&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; common stock sales under the ATM during the three and six months ended &lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;In March 2020, the Company established an at-the-market offering program (&#x201c;2020 Program&#x201d;) to sell, from time to time, shares of Company common stock having an aggregate offering price of up to $&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;100&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; million &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;in transactions pursuant to a shelf registration statement that was declared effective by the &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;SEC&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; on May 5, 2020&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;. The Company gave notice of termination for the 2020 Program on April 26, 2023, which was effective May 1, 2023. There were &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;no&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; common stock sales under the 2020 Program through its termination. &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"&gt;Stock Option and Performance Award Activity in 2023&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;During the six months ended &lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2023, stock options and unvested Performance Awards outstanding under the Company&#x2019;s stock option plans changed as follows:&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="text-align:left"&gt;&lt;table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;Stock Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;Performance Awards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Outstanding as of December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;2,529,448&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;7,142&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Options granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;122,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&lt;span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-a5e09c6a-9923-4b88-9aac-2bab00d80bb7;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Options exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;281,175&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&lt;span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-a4ac9c2f-0510-422d-88c4-81f94dcb8f78;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Options forfeited/canceled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;7,142&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&lt;span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-cf26586d-83aa-4eed-9015-9e654cf00456;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Outstanding as of June 30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;2,363,131&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;7,142&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The weighted average exercise price of options outstanding at &lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2023 was $&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;12.67&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;. As outstanding options vest over the current remaining vesting period of &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;2.4&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #FF0000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;years, the Company expects to recognize stock-based compensation expense of $&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;8.8&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; million. If and when outstanding Performance Awards vest, the Company will recognize stock-based compensation expense of $&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;0.1&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; million over the implicit service period.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;During the three months ended &lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2023, there were &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;262,158&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; stock options exercised. &lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Of the stock options exercised, &lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;92,066&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; stock options were net settled in satisfaction of the exercise price, with &lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;no&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; cash proceeds received. Cash proceeds&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; to the Company &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;for options not net settled&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; totaled $&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;889,000&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; during the three months ended &lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;During the six months ended &lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2023, there were &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;281,175&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; stock options exercised. Of the stock options exercised, &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;97,205&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; stock options were net settled in satisfaction of the exercise price, with &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;no&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; cash proceeds received. Cash proceeds to the Company for options not net settled totaled $&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;953,000&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; during the six months ended &lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"&gt;Stock-based Compensation Expense in 2023&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.21in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;During the three and six months ended &lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2023 and 2022, the Company&#x2019;s stock-based compensation expense was as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="text-align:left"&gt;&lt;table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;Three months ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;Six months ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;392&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;413&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;781&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;835&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;443&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;72&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;727&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;145&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;835&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;485&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1,508&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;980&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0.03in;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt;2018 Equity Incentive Plan &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company&#x2019;s Board of Directors (the &#x201c;Board&#x201d;) or a designated committee of the Board is responsible for administration of the Company&#x2019;s 2018 Omnibus Incentive Plan, as amended (the &#x201c;2018 Plan&#x201d;) and determines the terms and conditions of each option granted, consistent with the terms of the 2018 Plan. The Company&#x2019;s employees, directors, and consultants are eligible to receive awards under the 2018 Plan, including grants of stock options and Performance Awards. Share-based awards generally expire &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;10&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; years from the date of grant. The 2018 Plan, as amended on May 5, 2022, provides for issuance of up to &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;5,000,000&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; shares of common stock, par value $&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;0.001&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; per share, subject to adjustment as provided in the 2018 Plan. &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#xfeff; &lt;/span&gt;&lt;/p&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;When stock options or Performance Awards are exercised net of the exercise price and taxes, the number of shares of stock issued is reduced by the number of shares equal to the amount of taxes owed by the award recipient and that number of shares are cancelled. The Company then uses&#160;its cash to pay tax authorities the amount of statutory taxes owed by and on behalf of the award recipient.&lt;/span&gt;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="Duration_11_22_2022_To_11_22_2022_us-gaap_PlanNameAxis_sava_RegisteredDirectOffering2022Member_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember"
      decimals="INF"
      id="ct-nonFraction-daed6580-6fef-4e77-8d54-effad77d31f4"
      unitRef="Unit1">1666667</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="As_Of_11_22_2022_us-gaap_PlanNameAxis_sava_RegisteredDirectOffering2022Member_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember"
      decimals="2"
      id="ct-nonFraction-c4d036e7-d46c-4448-9159-b963f56517d0"
      unitRef="Unit15">30.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="Duration_11_22_2022_To_11_22_2022_us-gaap_PlanNameAxis_sava_RegisteredDirectOffering2022Member_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember"
      decimals="-5"
      id="ct-nonFraction-0b9f19f7-fd44-4b5a-98c8-461eb5c1a6c0"
      unitRef="Unit12">47300000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="Duration_5_1_2023_To_5_1_2023_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_sava_AtMarketEquityProgramMember"
      decimals="-6"
      id="ct-nonFraction-69238766-1a4e-4aab-9f46-6de3587a1f42"
      unitRef="Unit12">200000000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <sava:PercentageOfCommissionAtmOffering
      contextRef="As_Of_5_1_2023_us-gaap_PlanNameAxis_sava_AtMarketEquityProgramMember"
      decimals="4"
      id="ct-nonFraction-2b7197fa-dc41-402b-b05f-126a777bf409"
      unitRef="Unit14">0.03</sava:PercentageOfCommissionAtmOffering>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="INF"
      id="ct-nonFraction-fe4f2380-b2ae-480e-be6d-532f2be4138e"
      unitRef="Unit1">0</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="Duration_3_1_2020_To_3_31_2020_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_sava_AtMarketEquityProgramMember"
      decimals="-6"
      id="ct-nonFraction-8a396c8a-8ac0-4ff2-bf47-e453c379fc8d"
      unitRef="Unit12">100000000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="Duration_4_30_2023_To_4_30_2023_us-gaap_PlanNameAxis_sava_AtMarketEquityProgramMember"
      decimals="INF"
      id="ct-nonFraction-75c376b1-edab-45bd-9546-98d7223b7030"
      unitRef="Unit1">0</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <sava:StockOptionAndPerformanceAwardActivity
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-d03da9ef-c6f2-46ea-9ef3-0307d5584d97">&lt;div style="text-align:left"&gt;&lt;table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;Stock Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;Performance Awards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Outstanding as of December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;2,529,448&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;7,142&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Options granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;122,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&lt;span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-a5e09c6a-9923-4b88-9aac-2bab00d80bb7;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Options exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;281,175&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&lt;span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-a4ac9c2f-0510-422d-88c4-81f94dcb8f78;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Options forfeited/canceled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; (&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;7,142&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&lt;span style="white-space:pre-wrap; -sec-ix-hidden:ct-nonFraction-cf26586d-83aa-4eed-9015-9e654cf00456;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Outstanding as of June 30, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;2,363,131&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;7,142&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 62.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.7%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 15.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sava:StockOptionAndPerformanceAwardActivity>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-04532607-c292-4ff0-9255-ea2103179de3"
      unitRef="Unit1">2529448</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="INF"
      id="ct-nonFraction-d44c06e6-fa49-4918-b53a-f9fdc79057fd"
      unitRef="Unit1">7142</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-7be1a46c-20d3-4a7c-b834-1157b5fd4805"
      unitRef="Unit1">122000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-ffefb78e-d984-4509-bfbc-877ae9df38e6"
      unitRef="Unit1">281175</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-6d017226-1b93-4225-ac6b-fd5c05847e69"
      unitRef="Unit1">7142</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="As_Of_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-761bfd61-3a46-4dc2-bb55-949bc83001c8"
      unitRef="Unit1">2363131</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="As_Of_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="INF"
      id="ct-nonFraction-dcd09ee0-5584-46be-8e5b-dc7c216e6b80"
      unitRef="Unit1">7142</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="As_Of_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_sava_StockOptionAndPerformanceAwardActivity2020PlanMember"
      decimals="2"
      id="ct-nonFraction-3e924ed3-f99e-492c-af70-bbc218fea621"
      unitRef="Unit15">12.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_sava_StockOptionAndPerformanceAwardActivity2020PlanMember"
      id="ct-nonNumeric-824473da-819e-40db-9ff9-e7b005d1aef0">P2Y4M24D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_us-gaap_PlanNameAxis_sava_StockOptionAndPerformanceAwardActivity2020PlanMember"
      decimals="-5"
      id="ct-nonFraction-a2b6bdd3-11b5-40d3-8c0a-e3ea09bd1d0a"
      unitRef="Unit12">8800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember"
      decimals="-5"
      id="ct-nonFraction-4171778e-a8f8-42ff-b67a-eea0682e4777"
      unitRef="Unit12">100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_4_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-053f7790-cb34-464b-b13e-a0c868df7e2a"
      unitRef="Unit1">262158</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <sava:StockOptionsExercisedNetSettledSatisfactionOfExercisePrice
      contextRef="Duration_4_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-90e9f9f0-f84f-4f96-af26-75e12b1a0bba"
      unitRef="Unit1">92066</sava:StockOptionsExercisedNetSettledSatisfactionOfExercisePrice>
    <sava:ProceedsFromStockOptionsExercisedNetSettledSatisfactionOfExercisePrice
      contextRef="Duration_4_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-3a288816-5de9-45ed-9809-3db8fa5940e5"
      unitRef="Unit12">0</sava:ProceedsFromStockOptionsExercisedNetSettledSatisfactionOfExercisePrice>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="Duration_4_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="0"
      id="ct-nonFraction-6e7cbf24-77e4-4fe7-b96e-d47704b7ac6c"
      unitRef="Unit12">889000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-3aa703da-a540-41af-a5f1-08e3e494664e"
      unitRef="Unit1">281175</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <sava:StockOptionsExercisedNetSettledSatisfactionOfExercisePrice
      contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-1c7213f3-f95f-49b2-aa69-81c3abbd356a"
      unitRef="Unit1">97205</sava:StockOptionsExercisedNetSettledSatisfactionOfExercisePrice>
    <sava:ProceedsFromStockOptionsExercisedNetSettledSatisfactionOfExercisePrice
      contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="ct-nonFraction-69a32b1a-ef31-4d64-9e95-25d2956a78d9"
      unitRef="Unit12">0</sava:ProceedsFromStockOptionsExercisedNetSettledSatisfactionOfExercisePrice>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember"
      decimals="0"
      id="ct-nonFraction-b7ff777c-c213-4bc2-bf38-b23ed8e258a9"
      unitRef="Unit12">953000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-e5c66e48-ac7b-4739-87bb-f38313ce473b">&lt;div style="text-align:left"&gt;&lt;table dir="ltr" style="border: none;border-collapse: collapse;margin-bottom: .001pt;margin-left: 0;margin-right: auto;width: 100%;"&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;Three months ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;Six months ended&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="5" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;June 30,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td colspan="2" style="background: white;border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 0.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 8pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: white;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;392&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;413&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;781&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;835&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;443&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;72&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: center;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;727&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 8pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 8pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom: solid #000000 1.0pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;145&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.17in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;835&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;485&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;1,508&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom: double #000000 2.5pt;border-left-style: none;border-right-style: none;border-top: solid #000000 1.0pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;980&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="background: #CCEEFF;border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 9pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 9pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 47.7%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.6%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 8.4%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 2.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0.08in;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 10.0%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top: double #000000 2.5pt;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 9.2%;"&gt;&lt;p dir="ltr" style="text-align:left; font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-bottom-style: none;border-left-style: none;border-right-style: none;border-top-style: none;padding-bottom: 0;padding-left: 0;padding-right: 0;padding-top: 0;vertical-align: bottom;width: 1.9%;"&gt;&lt;p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 1pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: right;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 1pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_4_1_2023_To_6_30_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="ct-nonFraction-de7dff0e-c92a-4b41-8fb7-a4722ed9f521"
      unitRef="Unit12">392000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_4_1_2022_To_6_30_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="ct-nonFraction-20e3c239-e8b4-4366-b39d-8a088bc34427"
      unitRef="Unit12">413000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="ct-nonFraction-09692604-833c-41cd-b085-b56e4f8fa98e"
      unitRef="Unit12">781000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2022_To_6_30_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="ct-nonFraction-b3034df3-acd5-4a85-b554-f422f4a5b8d2"
      unitRef="Unit12">835000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_4_1_2023_To_6_30_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="ct-nonFraction-3bd1c7a6-735b-4742-964c-3968b27ffa34"
      unitRef="Unit12">443000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_4_1_2022_To_6_30_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="ct-nonFraction-139611f3-b4c0-4df5-a62b-d9e984d3b29e"
      unitRef="Unit12">72000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="ct-nonFraction-3143c34a-0944-43f4-8941-d0b267a8c923"
      unitRef="Unit12">727000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2022_To_6_30_2022_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="ct-nonFraction-88325696-02c4-476a-81d8-52a35123ab54"
      unitRef="Unit12">145000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_4_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-7daadd49-7643-49e5-bdc1-fd85e5396674"
      unitRef="Unit12">835000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_4_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-7d006d34-6ec4-40b9-a807-2c90f5b9b465"
      unitRef="Unit12">485000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="-3"
      id="ct-nonFraction-61c4086f-6f49-437c-9f1f-060e746566bf"
      unitRef="Unit12">1508000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-92051db0-2a93-4d2d-91a7-d47ac2cffa3a"
      unitRef="Unit12">980000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_PlanNameAxis_sava_TwoThousandEighteenEquityIncentivePlanMember"
      id="ct-nonNumeric-726157a6-4eaa-4f2b-a4a0-31d4e1551c28">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="Duration_5_5_2022_To_5_5_2022_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_sava_TwoThousandEighteenEquityIncentivePlanMember"
      decimals="0"
      id="ct-nonFraction-92a56718-81f1-4417-a2c6-11a28064b5e5"
      unitRef="Unit1">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="As_Of_5_5_2022_us-gaap_PlanNameAxis_sava_TwoThousandEighteenEquityIncentivePlanMember"
      decimals="INF"
      id="ct-nonFraction-b156ec7f-1444-4ead-a54b-f2a849702291"
      unitRef="Unit15">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-9a2eceb0-91fb-436a-945e-8582067de29e">&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;Note 8.  Income Taxes&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company did &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;no&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;t provide for income taxes during the three and six months ended &lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2023&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, because it has projected a net loss for the full year 2023 &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;for which any benefit will be offset by an increase in the valuation allowance&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;. There was also &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;no&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; provision for income taxes for the three and six months ended &lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;,&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; 2022.&lt;/span&gt;&lt;/p&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="INF"
      id="ct-nonFraction-b0941293-7b5b-4189-9bc9-190e34541391"
      unitRef="Unit12">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_4_1_2023_To_6_30_2023"
      decimals="INF"
      id="ct-nonFraction-0a0bf506-714b-47f6-9697-d31288203960"
      unitRef="Unit12">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="INF"
      id="ct-nonFraction-4e06ddcb-9bbd-4dcc-bc16-50a0f270580c"
      unitRef="Unit12">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="Duration_4_1_2022_To_6_30_2022"
      decimals="INF"
      id="ct-nonFraction-5ccdc675-a9c4-43d0-b53d-d1e03b72d318"
      unitRef="Unit12">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:CommitmentsDisclosureTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-e0940d7c-06fa-4815-8b5f-ca1899610b0d">&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;Note 9.  &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;Commitments&lt;/span&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 1.00in;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"&gt;Right-of-use Asset and Liability&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 1.00in;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company had an operating lease for approximately &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;6,000&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; square feet of office space in Austin, Texas with an expiration of &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;April 30, 2024&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;. The Company and the landlord consented to early terminate this lease on February 22, 2023 with no continuing obligations.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;There was &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;no&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; rent expense for the three months ended June 30, 2023. Rent expense for the &lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;three months ended&#160;&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2022&#160;totaled $&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;41,000&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Rent expense for the six months ended&#160;June&#160;30, 2023&#160;and 2022&#160;totaled $&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;24,000&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; and $&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;82,000&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;There was &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;no&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; cash paid for operating lease liabilities during the three months ended June 30, 2023. Cash paid for operating lease liabilities during the three months ended &lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2022 totaled $&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;41,000&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Cash paid for operating lease liabilities during the six months ended June&#160;30, 2023 and 2022 totaled $&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;24,000&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; and $&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;82,000&lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"&gt;Other Commitments&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company conducts its product research and development programs through a combination of internal and collaborative programs that include, among others, arrangements with universities, contract research organizations and clinical research sites. The Company has contractual arrangements with these organizations that are cancelable. The Company&#x2019;s obligations under these contracts are largely based on services performed.&lt;/span&gt;&lt;/p&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;</us-gaap:CommitmentsDisclosureTextBlock>
    <us-gaap:NetRentableArea
      contextRef="As_Of_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_LeaseContractualTermAxis_sava_OperatingLeasesMember"
      decimals="0"
      id="ct-nonFraction-f85e91ce-39bb-4f84-ad89-3902619a786e"
      unitRef="Unit16">6000</us-gaap:NetRentableArea>
    <us-gaap:LeaseExpirationDate1
      contextRef="Duration_1_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_LeaseContractualTermAxis_sava_OperatingLeasesMember"
      id="ct-nonNumeric-95837df1-1e32-4858-98ab-ab2dd4f1ebef">2024-04-30</us-gaap:LeaseExpirationDate1>
    <us-gaap:OperatingLeaseCost
      contextRef="Duration_4_1_2023_To_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"
      decimals="INF"
      id="ct-nonFraction-57556222-df9c-4c13-8015-e336830da7e4"
      unitRef="Unit12">0</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="Duration_4_1_2022_To_6_30_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"
      decimals="0"
      id="ct-nonFraction-2692d9dc-46c0-4b12-a4a5-ea12dff266bc"
      unitRef="Unit12">41000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"
      decimals="0"
      id="ct-nonFraction-91865e15-f1f5-4a13-baa5-adc8445eb339"
      unitRef="Unit12">24000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="Duration_1_1_2022_To_6_30_2022_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember"
      decimals="0"
      id="ct-nonFraction-153eac7b-398f-414f-8919-abbd92f972f9"
      unitRef="Unit12">82000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="Duration_4_1_2023_To_6_30_2023"
      decimals="INF"
      id="ct-nonFraction-573b1a21-7220-4c6e-93e0-dfb154011663"
      unitRef="Unit12">0</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="Duration_4_1_2022_To_6_30_2022"
      decimals="-3"
      id="ct-nonFraction-92b23ec1-68da-40be-a2ba-c2ef06b37fba"
      unitRef="Unit12">41000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="0"
      id="ct-nonFraction-20a95a6b-dc23-4a68-bedd-26658364bc58"
      unitRef="Unit12">24000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="Duration_1_1_2022_To_6_30_2022"
      decimals="0"
      id="ct-nonFraction-c8a84857-cc1f-4c83-80ca-5ef45bdee289"
      unitRef="Unit12">82000</us-gaap:OperatingLeasePayments>
    <sava:CashIncentiveBonusPlanTextBlock
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-3743b548-35cc-4467-93f9-22790f412cc8">&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;Note&#160;10.&#160; 2020 Cash Incentive Bonus Plan&lt;/span&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;In August 2020, the Board approved the Plan. The Plan was established to promote the long-term success of the Company by creating an &#x201c;at-risk&#x201d; cash bonus program that rewards&#160;Plan&#160;participants with additional cash compensation in lockstep with significant increases in the Company&#x2019;s market capitalization. The Plan is considered &#x201c;at-risk&#x201d; because Plan participants&#160;will&#160;not receive a cash bonus&#160;unless&#160;the Company&#x2019;s market capitalization increases&#160;significantly and&#160;certain&#160;other&#160;conditions specified in the Plan&#160;are met.&#160;Specifically, Plan participants&#160;will&#160;not&#160;be paid&#160;any cash bonuses unless (1) the Company completes a&#160;merger or acquisition transaction that constitutes a sale of ownership of the Company or its assets (a Merger Transaction) or (2) the Compensation Committee of the Board&#160;(the Compensation Committee) determines the Company has sufficient cash on hand, as &lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;defined in the Plan. Because&#160;of the inherent discretion and uncertainty regarding&#160;these&#160;requirements, the Company has concluded that&#160;a&#160;Plan&#160;grant date has not occurred&#160;as of &lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Plan participants will be paid all earned cash bonuses in the event of a Merger Transaction.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;As of December 31, 2022, the Company&#x2019;s independent directors were participants in the Plan. However, effective March 16, 2023, the Board of Directors amended the Plan to remove all independent directors as participants in the Plan and the independent directors consented to such removal. The independent directors&#x2019; share of potential benefits under the Plan were completely forfeited to the Company and will not be allocated to any other participant under the Plan. The Company&#x2019;s independent directors have &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;no&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;t received, and as a result of such amendment will never receive, any payments under the Plan.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company&#x2019;s market capitalization for purposes of the Plan&#160;is&#160;determined based on either (1) the closing price&#160;of one share&#160;of the Company&#x2019;s common stock on the Nasdaq Capital&#160;Market&#160;multiplied by the total issued and outstanding shares and options to purchase shares of the Company, or (2) the aggregate consideration payable to security holders of the Company in a&#160;Merger Transaction.&#160;This constitutes a market condition under applicable accounting guidance.&#160; &#160;&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Plan&#160;triggers a potential cash bonus each time&#160;the&#160;Company&#x2019;s market capitalization increases significantly, up to a maximum&#160;$&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;5&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;billion in market capitalization. The Plan specifies 14&#160;incremental&#160;amounts&#160;between&#160;$&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;200&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;million and&#160;$&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;5&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;billion&#160;(each increment,&#160;a &#x201c;Valuation Milestone&#x201d;). Each&#160;Valuation Milestone&#160;triggers&#160;a potential cash bonus award in a pre-set amount defined in the Plan. Each&#160;Valuation&#160;Milestone&#160;must be achieved and maintained for no less than &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;20&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; consecutive trading days for&#160;Plan&#160;participants to be eligible for a potential cash bonus award.&#160;Approximately &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;67&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;% of each&#160;cash bonus award&#160;associated with a Valuation Milestone&#160;is subject to&#160;adjustment and&#160;approval&#160;by the Compensation Committee.&#160;Any amounts&#160;not awarded by the Compensation Committee&#160;are&#160;no longer available for distribution.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;If the Company were to exceed a $&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;5&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;billion market capitalization&#160;for no less than 20 consecutive trading days, all&#160;Valuation&#160;Milestones would be deemed achieved, in which case cash bonus awards would&#160;range from&#160;a minimum of&#160;$&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;111.4&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;million&#160;up to&#160;a hypothetical maximum of&#160;$&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;289.7&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;million.&#160;Payment of cash bonuses is deferred until such time as&#160;(1)&#160;the Company completes a Merger Transaction, or&#160;(2)&#160;the&#160;Compensation Committee determines the&#160;Company has sufficient cash&#160;on hand&#160;to render payment&#160;(each, a &#x201c;Performance Condition&#x201d;),&#160;neither&#160;of which may ever occur. Accordingly, there can be no assurance that&#160;Plan&#160;participants will&#160;ever&#160;be&#160;paid a cash bonus that is awarded under the Plan, even if the Company&#x2019;s market capitalization increases&#160;significantly.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Plan is accounted for as a liability award.&#160;The fair value of each&#160;Valuation&#160;Milestone&#160;award&#160;will be&#160;determined&#160;once&#160;a&#160;grant date occurs and&#160;will be&#160;remeasured each reporting period.&#160;Compensation expense associated with the Plan&#160;will be&#160;recognized over the expected achievement period for each&#160;of the &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;14&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;Valuation&#160;Milestones, when&#160;a Performance Condition&#160;is considered probable of being met. &#160;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;In October 2020, the Company&#160;achieved&#160;the first&#160;Valuation&#160;Milestone.&#160;Subsequently, the Compensation Committee&#160;approved&#160;a potential cash bonus&#160;award&#160;of&#160;$&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;6.5&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;million&#160;in total&#160;for&#160;all Plan participants (after the March 2023 Plan amendment), subject to future satisfaction of a Performance Condition.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;During the year ended December&#160;31, 2021, the Company achieved &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;11&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; additional Valuation Milestones triggering potential Company obligations to all Plan participants from a minimum of $&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;74.9&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;million up to a hypothetical maximum of $&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;202.3&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;million (after the March 2023 Plan amendment), to be determined by the Compensation Committee and contingent upon future satisfaction of a Performance Condition. However,&#160;&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;no&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;compensation expense was recorded&#160;since no&#160;grant date has occurred and no&#160;Performance Conditions are considered probable of being met.&#160;There is no continuing service requirement for Plan participants once&#160;the Compensation Committee approves a cash&#160;bonus award.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;No Valuation Milestones were achieved during 2022 or the six months ended &lt;/span&gt;&lt;span style="white-space:pre-wrap; background: #FFFFFF;color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;June 30&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;No&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; actual cash payments were authorized or made to participants under the Plan through the date of filing of &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;this Form 10-Q&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;&#160;&lt;/span&gt;</sava:CashIncentiveBonusPlanTextBlock>
    <sava:CashIncentiveBonusAward
      contextRef="As_Of_6_30_2023_srt_TitleOfIndividualAxis_sava_IndependentDirectorsMember"
      decimals="INF"
      id="ct-nonFraction-5bdb431d-85b6-4e4e-b129-296cfd6a5ffc"
      unitRef="Unit12">0</sava:CashIncentiveBonusAward>
    <sava:PerformancePlanValuationAmount
      contextRef="Duration_1_1_2023_To_6_30_2023_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember"
      decimals="-9"
      id="ct-nonFraction-559f096e-356d-4657-9e31-65e274fb57fc"
      unitRef="Unit12">5000000000</sava:PerformancePlanValuationAmount>
    <sava:PerformancePlanValuationAmount
      contextRef="Duration_1_1_2023_To_6_30_2023_srt_RangeAxis_srt_MinimumMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember"
      decimals="-6"
      id="ct-nonFraction-d475cd38-dd68-47fc-b04d-e0f5013a1c60"
      unitRef="Unit12">200000000</sava:PerformancePlanValuationAmount>
    <sava:PerformancePlanValuationAmount
      contextRef="Duration_1_1_2023_To_6_30_2023_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember"
      decimals="-9"
      id="ct-nonFraction-9f477fce-2a4b-4d73-8a25-0252ba7c2b2e"
      unitRef="Unit12">5000000000</sava:PerformancePlanValuationAmount>
    <sava:MinimumNumberOfDaysValuationMilestoneMustBeAchievedAndMaintained
      contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember"
      id="ct-nonNumeric-43b123d5-ee76-4640-b5cc-e6625b80b6c9">P20D</sava:MinimumNumberOfDaysValuationMilestoneMustBeAchievedAndMaintained>
    <sava:PercentageValuationMilestoneCashBonusAwardSubjectToApprovalAndAdjustment
      contextRef="Duration_1_1_2023_To_6_30_2023_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember"
      decimals="2"
      id="ct-nonFraction-0b6e9863-a848-4669-8e83-a44a30d2c374"
      unitRef="Unit14">0.67</sava:PercentageValuationMilestoneCashBonusAwardSubjectToApprovalAndAdjustment>
    <sava:PerformancePlanValuationAmount
      contextRef="Duration_1_1_2023_To_6_30_2023_srt_StatementScenarioAxis_sava_ExceedingPerformanceMilestonesMinimum20ConsecutiveDaysMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember"
      decimals="-9"
      id="ct-nonFraction-c5067883-7d95-41c3-a435-3b3aea67c58a"
      unitRef="Unit12">5000000000</sava:PerformancePlanValuationAmount>
    <sava:CashIncentiveBonusAward
      contextRef="As_Of_6_30_2023_srt_RangeAxis_srt_MinimumMember_srt_StatementScenarioAxis_sava_Exceeds5BillionMarketCapitalizationMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember"
      decimals="-5"
      id="ct-nonFraction-aeb6e182-dbed-4b1e-93de-20f07aaec3d5"
      unitRef="Unit12">111400000</sava:CashIncentiveBonusAward>
    <sava:CashIncentiveBonusAward
      contextRef="As_Of_6_30_2023_srt_RangeAxis_srt_MaximumMember_srt_StatementScenarioAxis_sava_Exceeds5BillionMarketCapitalizationMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember"
      decimals="-5"
      id="ct-nonFraction-e0e6401c-ad80-4c8a-aabc-212b90554250"
      unitRef="Unit12">289700000</sava:CashIncentiveBonusAward>
    <sava:MinimumNumberOfValuationMilestonesToRecognizeCompensationExpense
      contextRef="Duration_1_1_2023_To_6_30_2023"
      decimals="INF"
      id="ct-nonFraction-e0ed36b4-5f9f-49a6-9ad6-31c655c3489f"
      unitRef="Unit13">14</sava:MinimumNumberOfValuationMilestonesToRecognizeCompensationExpense>
    <sava:CashIncentiveBonusAward
      contextRef="As_Of_10_31_2020_srt_StatementScenarioAxis_sava_FirstValuationMilestoneMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember"
      decimals="-5"
      id="ct-nonFraction-cf30123a-a970-4ed5-a539-0d8625432b4c"
      unitRef="Unit12">6500000</sava:CashIncentiveBonusAward>
    <sava:NumberOfValuationMilestonesAchieved
      contextRef="Duration_1_1_2021_To_12_31_2021"
      decimals="INF"
      id="ct-nonFraction-bae15d55-397c-4b4c-a1a2-70d2119d49c5"
      unitRef="Unit13">11</sava:NumberOfValuationMilestonesAchieved>
    <sava:CashIncentiveBonusAward
      contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MinimumMember_srt_StatementScenarioAxis_sava_SecondThroughEighthValuationMilestonesMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember"
      decimals="-5"
      id="ct-nonFraction-59baea89-eb6e-4e07-9f07-8624efe9ddb5"
      unitRef="Unit12">74900000</sava:CashIncentiveBonusAward>
    <sava:CashIncentiveBonusAward
      contextRef="As_Of_12_31_2021_srt_RangeAxis_srt_MaximumMember_srt_StatementScenarioAxis_sava_SecondThroughEighthValuationMilestonesMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember"
      decimals="-5"
      id="ct-nonFraction-a146aed8-278b-4be6-97fa-f1b86689e7fc"
      unitRef="Unit12">202300000</sava:CashIncentiveBonusAward>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="Duration_1_1_2023_To_6_30_2023_srt_StatementScenarioAxis_sava_SecondThroughEighthValuationMilestonesMember_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember"
      decimals="-5"
      id="ct-nonFraction-f659cf2c-1c55-4c07-b82d-ff1843ad495a"
      unitRef="Unit12">0</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <sava:PaymentsForCashIncentiveBonus
      contextRef="Duration_8_3_2023_To_8_3_2023_us-gaap_PlanNameAxis_sava_CashIncentiveBonusPlanMember"
      decimals="-5"
      id="ct-nonFraction-0c1760a2-49a7-49bd-889e-dcafc4b43ce4"
      unitRef="Unit12">0</sava:PaymentsForCashIncentiveBonus>
    <us-gaap:LossContingencyDisclosures
      contextRef="Duration_1_1_2023_To_6_30_2023"
      id="ct-nonNumeric-4873d7f1-1f82-44db-bb62-3e1e457330b1">&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;"&gt;Note 11. Contingencies&lt;/span&gt;&lt;p dir="ltr" style="font-family: 'Arial', 'sans-serif';font-size: 10pt;line-height: 120.0%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;From time to time, the Company may become involved in litigation or other legal proceedings and claims, including U.S. government inquiries, investigations&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;and Citizen Petitions submitted to FDA, and may receive inquiries from government authorities relating to matters arising from the ordinary course of business&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;. The outcome of these proceedings is inherently uncertain. Regardless of outcome, legal proceedings can have an adverse impact on the Company because of defense and settlement costs, diversion of management resources, and other factors. At this time, no assessment can be made as to their likely outcome or whether the outcome will be material to the Company. No information is available to indicate that it is probable that a loss has been incurred or can be reasonably estimated as of the date of the condensed consolidated financial statements and, as such, no accrual for these matters has been recorded within the condensed consolidated financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"&gt;Government Investigations&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;On November 15, 2021, the Company disclosed that certain government agencies had asked the Company to provide corporate information and documents. These were confidential requests. The Company has been voluntarily cooperating and intends to continue to cooperate with these inquiries. No government agency has informed the Company that it has found evidence of research misconduct or wrongdoing by the Company or its officers, employees or directors. No government agency has filed any claims or charges relating to these inquiries. We cannot predict the outcome or impact of these ongoing matters, including whether a government agency may pursue an enforcement action against the Company or others.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;"&gt;Securities Class Actions and Shareholder Derivative Actions&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 120.0%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Between August 27, 2021 and October 26, 2021, &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;four&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; putative class action lawsuits were filed alleging violations of the federal securities laws by the Company and certain named officers. The complaints rely on allegations contained in Citizen Petitions submitted to FDA and allege that various statements made by the defendants regarding simufilam were rendered materially false and misleading. The Citizen Petitions were all subsequently denied by FDA. These actions were filed in the U.S. District Court for &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;the Western District of Texas. The complaints seek unspecified compensatory damages and other relief on behalf of a purported class of purchasers.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;On June 30, 2022, a federal judge consolidated the four class action lawsuits into one case and appointed a lead plaintiff and a lead counsel. Lead plaintiff filed a consolidated amended complaint on August 18, 2022 on behalf of a putative class of purchasers of the Company&#x2019;s securities between September 14, 2020 and July 26, 2022. &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;On May 11, 2023, the court dismissed with prejudice plaintiffs&#x2019; claims against (deceased) defendant Nadav Friedmann, PhD, MD, but otherwise denied defendants&#x2019; motion to dismiss. Defendants filed an answer to the consolidated amended complaint on July 3, 2023.   The Company believes the claims are without merit and intends to defend against these lawsuits vigorously. The Company is unable to estimate the possible loss or range of loss, if any, associated with these lawsuits.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;On November 4, 2021, a related shareholder derivative action was filed, purportedly on behalf of the Company, in the U.S. District Court for the Western District of Texas, asserting claims under the U.S. securities laws and state fiduciary duty laws against certain named officers and the members of the Company&#x2019;s board of directors. This complaint relies on the allegations made in Citizen Petitions that were submitted to &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;(and subsequently denied by) &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;FDA. The complaint alleges, among other things, that the individual defendants exposed the Company to unspecified damages and securities law liability by causing it to make materially false and misleading statements, in violation of the U.S. securities laws and in breach of their fiduciary duties to the Company. The derivative case seeks, among other things, to recover unspecified compensatory damages on behalf of the Company arising out of the individual defendant&#x2019;s alleged wrongful conduct. Although the plaintiff in this derivative case does not seek relief against the Company, the Company has certain indemnification obligations to the individual defendants. Since November 4, 2021, &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;four&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; additional shareholder derivative actions were filed alleging substantially similar claims, &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;two&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; in the U.S. District Court for the Western District of Texas, &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;one&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; in Texas state court (Travis County District Court) and &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;one&lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; in the Delaware Court of Chancery. &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;On July 5, 2022, the three federal court actions were consolidated into a single action.&lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"&gt;&lt;span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;On August 19, 2022, a shareholder derivative action was filed, purportedly on behalf of the Company, in the Delaware Court of Chancery, asserting claims under state fiduciary duty laws against certain named officers and members of the Company&#x2019;s board of directors. The complaint alleges, among other things, that the individual defendants breached their fiduciary duties by approving the 2020 Cash Incentive Bonus Plan in August 2020. The complaints seek unspecified compensatory damages and other relief. On &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;January 6, 2023, the plaintiffs filed an amended complaint. &lt;/span&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Defendants filed a partial answer to the amended complaint on March 10, 2023, and moved to partially dismiss the amended complaint on March 14, 2023. Defendants&#x2019; motion to dismiss remains pending. &lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;Although the plaintiffs in this derivative case do&lt;/span&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; not seek relief against the Company, the Company has certain indemnification obligations to the individual defendants. &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; color: #000000;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-align: justify;text-indent: 0.25in;"&gt;&lt;span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"&gt;The Company is unable to estimate the possible loss or range of loss, if any, associated with these lawsuits.&lt;/span&gt;&lt;/p&gt;</us-gaap:LossContingencyDisclosures>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="Duration_8_28_2021_To_10_26_2021_srt_LitigationCaseAxis_sava_ViolationsOfFederalSecuritiesLawsMember"
      decimals="INF"
      id="ct-nonFraction-d162c3fb-03e8-4062-9174-3088f58da73d"
      unitRef="Unit13">4</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="Duration_11_4_2021_To_11_4_2021_srt_LitigationCaseAxis_sava_ShareholderDerivativeActionsMember"
      decimals="INF"
      id="ct-nonFraction-3b448c9a-3848-4609-b30a-9ac8c9a3e4cb"
      unitRef="Unit13">4</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="Duration_11_4_2021_To_11_4_2021_srt_LitigationCaseAxis_sava_ShareholderDerivativeActionsU.s.DistrictCourtMember"
      decimals="INF"
      id="ct-nonFraction-4a259f7b-6971-4174-95ab-78c0079f9d58"
      unitRef="Unit13">2</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="Duration_11_4_2021_To_11_4_2021_srt_LitigationCaseAxis_sava_ShareholderDerivativeActionsU.s.DistrictCourtMember"
      decimals="INF"
      id="ct-nonFraction-d4196505-d0d4-4251-8e3d-1ef40124802c"
      unitRef="Unit13">2</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="Duration_11_4_2021_To_11_4_2021_srt_LitigationCaseAxis_sava_ShareholderDerivativeActionsTexasCourtMember"
      decimals="INF"
      id="ct-nonFraction-d4ebadf0-b552-4b33-9695-a25efb07beec"
      unitRef="Unit13">1</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="Duration_11_4_2021_To_11_4_2021_srt_LitigationCaseAxis_sava_ShareholderDerivativeActionsDelwareCourtMember"
      decimals="INF"
      id="ct-nonFraction-c3a23cb0-6350-4ec7-9251-ba1c18cccea6"
      unitRef="Unit13">1</us-gaap:LossContingencyNewClaimsFiledNumber>
    <ecd:Rule10b51ArrAdoptedFlag
      contextRef="Duration_4_1_2023_To_6_30_2023"
      id="ct-nonNumeric-28a28610-17f8-407c-8ca0-9ff0dc069bcd">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag
      contextRef="Duration_4_1_2023_To_6_30_2023"
      id="ct-nonNumeric-65374b8f-a867-40bc-8ddb-dcc17ae74bdf">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag
      contextRef="Duration_4_1_2023_To_6_30_2023"
      id="ct-nonNumeric-9dd4babb-e791-4f8e-a5a9-006c8cb95f08">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag
      contextRef="Duration_4_1_2023_To_6_30_2023"
      id="ct-nonNumeric-801dbf81-bfec-42ad-bab7-255cd68dc674">false</ecd:NonRule10b51ArrTrmntdFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>63
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M7@G5.ZZ=/F=<::&B-7D4"ZFTC0^WTBJSXJ&JFGCG)=[Y<7BW8>KSB#P(%<J
MW,)MZ]R%NWUF-CY44Y/OHN2[0$LTS)3:P?LJN#(3*X%)WSKJ<+=FD[*F2VV0
MJ+ F9+^$[']3(^:4>YL0]]JW2*"JFGS4J59;YSC"3?_$FO" 5;D<[ET/<8.Z
MK#O)@AZY,B@.L2]?%/=/.0?,]LZIN*XN)*L@&5JNS<)_&T:"W&?Q1"@K'&[B
M.$Z3]?O=OA40U=8%K%(.1=/#%O!1S$(39Z Y[WEL[Z^XT9"G*5]R,O)#D?@B
M/8.TY+>LQ*?(,[0*-!2/)&66\Z6"WIJGN3,RTC!,B51D*+-$JS7\#^S5<" O
MW5B13Y%W:!5X*)Y8-LAC_DSN ABRX33TBQ2+]&G<LD^;M$^IZ_:LO*>(0K3*
M0A1/,!M>+PC '7KBY@/Y ,^13XF]77'+WH5#R7V+#/DBU+!VR2D9BV>>DO>P
MD5SQM;463I&8:!69*)YRT%H8KZ2U%G#+ZRR,@C"9$?J6C+(01HSK.%;T4X0I
M6J4IB@>@U^A#<P6#>RQ7B14;M_-@HQ[:A$-<6)>S"E043T&O.<M9[$')90C3
ML!46]QS_904]1;!B5;!B>!IZ#?H@4S,*_PX7>R?J X[G%^?VA(SKZI)6L8KA
M22COJIX2?#\8;M"EUMT-KJJ+504IAF>@#S+?MLUE@@6I R9=AS99I].Q\ITB
M1[$J1S$\_HQ##1$15@7*?I[\0D;"SQ2TI!7R0)"2<0PK\TA+_^F,_.BT'%AY
M%K!36O+(OC''#>NB5X&*X9$'\G^^)HS6\41&5F+<8.1]\:Q<ITA-K$I-#(\X
MVS8D-\_^G"<SL3<:'S"Z]T;O/.MK,%Q8E[#*2>RHG+1]^5#LWO*FA'7$OBL_
MX/C5^BIYB*OJ<E9)B!V5A.X2+51QL&!VY7P+;N7$'?=QGB+VL"KVL*-BC]FM
MPD8&HL!,*OL4A/M\X IZN^?[ HS )B@LK<2G"$"L"D#LJ  TBGD4D>LLA:]3
M>[_%??:^?\!U-?G<*O>X1^6>FUBHF1F8OX*#GD,TB!<\L3;M <.]H+BN+F@5
M>UP\M6P;<BZ@(3&\FN^1<%U=O"K^N$>]1WJYMH_RHS?R*=,09A.SAEJ)OU.P
MV=1#X=;-W<PA\'+0H?U>O]^'5+6T,>X<F!WU*FD(,ZJ"K'>7!.*9_"[LS8A;
M.9!YG%Z_ZUHWE[CX6]NRO7.Z:H99?NB<$M^\!RH.6LN[Y<&VEQ_GMJO'BU/Q
MC]R,TI1$8@I2IW4.U:R*@^;B0LM%?E8[D5K+./\X%SP0RCP WT^EU-L+\P/E
M<?_@?U!+ P04    " !DA -7,*;J":P%  #=%P  &    'AL+W=O<FMS:&5E
M=',O<VAE970R+GAM;*U8;6_;-A#^*X17;"O@Q"(E65;J&&@3#&N!K4'3;I]I
MB8Z)2J)*4DFS7[\C_2);HABGS8?$HGUW>NYXO.>.\P<AOZHU8QI]+XM*78[6
M6M<7DXG*UJRDZES4K()?5D*65,-2WDU4+1G-K5)93$@03"<EY=5H,;??W<C%
M7#2ZX!6[D4@U94GEXSM6B(?+$1[MOOC$[];:?#%9S&MZQVZ9_E+?2%A-]E9R
M7K)*<5$AR5:7H[?XXHHD1L%*_,/9@SIX1L:5I1!?S>)]?CD*#")6L$P;$Q0^
M[MD5*PIC"7!\VQH=[=]I% ^?=];_L,Z#,TNJV)4H_N6Y7E^.9B.4LQ5M"OU)
M//S)M@[%QEXF"F7_HX>M;#!"6:.T*+?*@*#DU>:3?M\&XD !1P,*9*M 3E4(
MMPJA=72#S+IU335=S*5X0-)(@S7S8&-CM<$;7IEMO-42?N6@IQ=7HLIA4UB.
MX$F)@N=4P^(=+6B5,71K#"MTAK[<7J/?7[U&KQ"OT.>U:!2M<C6?:,!@+$VR
M[?O>;=Y'!M[WH:G.41B,$0E(Z%"_\JM?LPS4L54GQ^H3\'SO/MF[3ZR]<,C]
M1DI6:425 C\O7/YL#$1N ^:47:B:9NQR!,=(,7G/1HM??\'3X(W+NQ<R=N1K
MN/<U]%E?7%&U1K!K*#,/[%O#[VD!SCMW<6-J:DV94G"_P--9%,[FD_M#?_IB
M), !CO=B1TBC/=+(B_1&LIKR'+'OM<E-95$+O682CL3AAKF0;TS'!Y"F01IW
M</>%<$ P=L..][!C+^S/0M/B!(1Q_^5)%(=A!V-?#! 2,G6#G.Y!3KT@/]9,
M4LVK.U0P*'](FCIW)E9G#2R&,7N-/O<43/L!,*?9Y5:R=RMY(F6 V:1^M*EB
M<KL&KM%C5#'M<B?IQY:$I)O=+JG9-'(CG>V1SKQ(WU>:5G=\6>S"/0ARUGM]
M.$LZ$/LRTZ%0IGN Z0EI/)P*:7_WTH1$W>#UQ4@8S<*!Z.&@):S@I))=<+KD
M!=><N>OVULP+I>Q+63MV^H"EL7=/WF:9:*!4HYH^4ILZD.8TRV3#VC+IC )V
M5+JP5\<=8E& DX&]:MD5>PG-P+8(<W8/#:,]DCNT3K"DAR()HJB+M2\%QS(8
MP-JR(_;3XPYK)DH#D&ZZ3 CSDE5LQ=UG86OS&$O0!=P7PLD0WI8CL9\DNX7\
MX#R,=R3DA.PU^^QSX6+2H3/>$BGV,^G'(ZX_\,SID(,HTRZ9.H2B=*!0XI9+
ML9],CQG_*9P.VDMFO=;$(98$TW  :LN/V$^0WG2I1'7F2QFOZ6>G3)]6PX&&
M$;>DBOVLNLF8 S^>W VOO6?[U.=A(,4!IUHBQJ<P\5.../C8E59]L82D W$G
M+1L3+_'!_%B67)O"ONG2,U&9)&-5!G#1[W\+#1\8YCV,[>^8O'8.63] K\@Y
M8/V\H>-(M!1-L+<ON=4B^[H61<ZD^LVVH/K1/5!ZJ?[9$^4+63OV^F!^]C,\
MC&HK!@<N1\KX/T:O@O,@P-"G2 3C9</>F-T/ ON'U)I*,\XU>BTD_X_EMO0P
MQ)4RU&O'O$8K:)!S2")G\'Y@@G8GRL\;.@Y9VVB0)^9P.#+06@S'BW@"]@9%
M>)SB=!R3Q,8+EDD8C^,XV0F[@XFH1A\:B/7N\L4*7+.,E4NHG+L[E3$"$S6S
MEVO%HW,'^MU,1#K%QB]S'+>VX2'^AN=MGG/3E$%)-+<#9[Q"&:TYE$@GS'YC
M$N,PQMWFS"D'+4PZ +?M88B_AX%^LBF;PEZGY=! 9MS)K:3?F)R%8833M O4
M(4AF81P/!;;M8L@I78QRU"\G8%<;DX9QM^-RR!&2Q.%08-M.AO@[F1XKVDP^
M&7[2O]ERC:\..>?\.CFX>S47WW]1><<K!5W6"A2#\P0"(#=WR9N%%K6]CET*
MK45I']>, FPC +^O!'#F=F%N>/<W^HO_ 5!+ P04    " !DA -7PV1,:-<"
M  #Q"0  &    'AL+W=O<FMS:&5E=',O<VAE970S+GAM;*V676_3,!2&_XH5
M$ )I-%]-TXXVTM8) 1)2M0FX0%RXR6EC+;&#[;2#7\]QDH5FR_HQZ$5C.^=]
M_1SG)/9T*^2M2@$TN<LSKF96JG5Q;MLJ3B&G:B *X'AG)61.-7;EVE:%!)I4
MHCRS/<<9V3EEW(JFU=A"1E-1ZHQQ6$BBRCRG\M<E9&([LUSK?N":K5-M!NQH
M6M UW(#^4BPD]NS6)6$Y<,4$)Q)6,^O"/9^[CA%4$5\9;-5.FYA4ED+<FL['
M9&8YA@@RB+6QH'C9P!RRS#@AQ\_&U&KG-,+=]KW[^RIY3&9)%<Q%]HTE.IU9
M8XLDL*)EIJ_%]@,T"07&+Q:9JO[)MHX=A1:)2Z5%WHB1(&>\OM*[9B%V!.[P
M"8'7"+QC!7XC\*M$:[(JK2NJ:3258DNDB48WTZC6IE)C-HR;QWBC)=YEJ-/1
M7/ $'PHD!%M*9"RA&CN7-*,\!G)CC!5YO: 2N$Y!LYAF;\A;\I+81*4XJJ:V
M1@[C9L?-G)?UG-X3<WXJ^8#XSAGQ',_OD<_WRZ\@1KE;R;VNW,;LVR7PVB7P
M*C__GY;@^\52:8E5]Z,OX7J&8?\,YE4\5P6-86;ANZ9 ;L"*7KUP1\Z[OO3_
MDUEG,?QV,?Q][M$"WR*0$O/'THMOSTA!)=G0K(2^M&NOL/(R'XQ-Y P<QYW:
MF]U\#D5U0(<MZ/ TT+H:"2UU*B3[#4D?<.T9[*"X3OU[P'Q$8 <[:+&#9V$S
MI<I^Y. 1R4/6?1$=R%$+.7H6)&X#2E.>,+[N(QT=)-T7T2$-6])P+^E<Y#EN
M!L?4:GA4K1Z*ZE".6\KQ"91'%>KX<?UY_95Z3&2'>M)23TZG?KI.)X\XAN[$
MG01>^ "X+S#T@R (^WE=Y^]>YIQ.?*!H&\LCN'LC>\'MG?W8'(8^4[EF7)$,
M5BAU!B%ZR/I\47>T**HM>BDT;OA5,\4S&4@3@/=70NC[CMGUVU->] =02P,$
M%     @ 9(0#5X3R5)NZ!   _A0  !@   !X;"]W;W)K<VAE971S+W-H965T
M-"YX;6RM6&UOVS80_BN$5@PMD$2BWI79!NJ7;BW0-DC:]3-CT;902?1(RL[^
M_4A)D6WQK"6;OUBB_-Q#/G='\LC1GO&?8D.I1$]%7HJQM9%R>VO;8KFA!1$W
M;$M+]<^*\8)(U>1K6VPY)6EM5.2VZSBA79"LM":C^ML=GXQ8)?.LI'<<B:HH
M"/][2G.V'UO8>OYPGZTW4G^P)Z,M6=,'*K]O[[AJV1U+FA6T%!DK$:>KL?4>
MWRYPJ UJQ)\9W8NC=Z2E/#+V4S<^IF/+T2.B.5U*34'48T=G-,\UDQK'7RVI
MU?6I#8_?G]D_U.*5F$<BZ(SE/[)4;L96;*&4KDB5RWNV_X.V@@+-MV2YJ'_1
MOL4Z%EI60K*B-58C*+*R>9*GUA%'!HH'-G!; [=OX)\Q\%H#[Z4]^*V!_](>
M@M:@EFXWVFO'S8DDDQ%G>\0U6K'IE]K[M;7R5U;J1'F07/V;*3LYF;$R56&G
M*5)O@N592J1J/$CU4/D@!?JZ0E^WE!,=5X&NT?>'.7K[YAT2&\*I0%F)OFU8
M)4B9BBOTYJ0]LJ4:HN[(7K;#F3;#<<\,QT.?62DW BW4L%+ ?CYL'P[8V\HU
MG7_<9_],W4'"3U5Y@SSG"KF.ZP'CF;W<W(7D_+_>%_^Y]Q-G>%VR>#6?=X:O
MS8-RC>C35F>-N(5"W)#X,(E>^6[%EBSIV%)+FZ!\1ZW)K[_@T/D-\N\ER>:7
M)%M<B.PD$GX7"7^(?7*O& E?;I":9FI=W*D%?ZNGZQ4JU>;"5FC-22G52IX5
MCQ47]52&0M7T$M:]Z#UE-W'])$Q&]NXX!B8*AXD?GZ+F)LJ/G+C'M3!1'HX#
MOT.=N"/HW!$,NN-W6JK,S&MOD%0MDYF0.E-W%!+=< 7'0XB=GIJ9"7(-Q\Q-
M4*QVZ)YB$Q3$\1G!82<X'!3\C4DEEQGS$9(;FDKB*(IZ>DT43A+<0\U-5!"X
M1HQ-E!=%7@Q+CCK)T:#DP^*3,P$*C8QNKR&E  R2"L @K0!L0&S<B8T'Q7XL
M)56KAE3;Z9(58!;'9EAQTL]B$^1AOR?4Q/AJ$>C)!(C\ -:8=!J3X8#*#>6M
MP'K=@E0FIDK'ZXD$,%'0$VEBO*3'LS QP;DX8N=07SF#*K^H]?A<PK:FX4G&
MAEX4]@1".)QX;G\%AG"!$_J]U%Y ."^,@S,!Q4?%)!XL$+38)J#HK1;]#JE)
MVU2*H'Y\R4KAHFSSB[(M+L5V&A?W$!?W14EX",<5FA*1+<&H-%SQ<78X-V%_
MUL$PHRJ 8/C&Q?V4!-D2]TQ&'BI6/%B&@<KG65Y)\'0Q;=G^53L(,[4#,$@[
MR'96^Z%&Q/[@;/Q1GY)I>DUV:NM<T^<C6Z6/>^J<IN;IMJIWU/*5\W:P.'WU
MO+TDV_RB;(M+L9U&\%#6XN&Z]F$H8/VT?CP[H<T*U,=1?_N;03#'P?V=%&8+
MPWY2 U5VDAR53Z<N.12^>+CR?95+TH&9;A:IH%, &.04D,UT"E 9 TZQC^YS
M"LK7]46:4%JK4C:G]>YK=UGWOKZBZGV?XML9!K[/]>5>?7]TH&]N!C\3OLY*
M@7*Z4ETY-Y$:*V\NVYJ&9-OZ-NF12<F*^G5#24JY!JC_5XS)YX;NH+ORG/P#
M4$L#!!0    ( &2$ U= SN#_\P<  ,H^   8    >&PO=V]R:W-H965T<R]S
M:&5E=#4N>&ULM5MK;]LV%/TK@C?L =2U^-"K2PRT,8=U0+>@6;</PSXH-AT+
ME2Q7DI/VWX^27=,TKRBQ8/JAL>S+<\6C*_(<D;IZ*JN/]8;SQOM<Y-OZ>K)I
MFMVKV:Q>;GB1UB_+'=^*7]9E5:2-.*P>9O6NXNFJ:U3D,^S[X:Q(L^UD?M5]
M=UO-K\I]DV=;?EMY];XHTNK+&YZ73]<3-/GZQ?OL8=.T7\SF5[OT@=_QYL/N
MMA)'LQ/**BOXML[*K5?Q]?7D-7K%:-@VZ"+^SOA3??;9:[MR7Y8?VX.WJ^N)
MWYX1S_FR:2%2\>>1W_ \;Y'$>7PZ@DY..=N&YY^_HO_:=5YTYCZM^4V9_Y.M
MFLWU))YX*[Y.]WGSOGSZC1\[%+1XRS*ON_^]IT-L)#(N]W53%L?&XKC(MH>_
MZ><C$6<-,.YI@(\-\$4#$O8T(,<&Y#)#TM. 'AO0BP:(]C0(C@VZKL\.?>^(
M6Z1-.K^JRB>O:J,%6ONA8[]K+?C*MFVAW#65^#43[9KY3;E=B<O.5Y[X5)=Y
MMDH;<7#7B#^B'IK:^W,MCLKEQTV9KWA5_^BQ3_NL^>)-O0]W"^^G[W^^FC7B
M1%JXV?*8],TA*>Y-6A2B2#I8[]]WO+CGU7\ S(T9YO5JE;75EN;>;9JMIF^W
MWDVZRQIQ; !=#( NE_MBGW<L+/@Z6V:-"8V9T?XJQ=FHS6;B"ITN$SY=)MSA
MT!Z<-VF>;I?<2QMQ4LN7'D$O/.QC!'%_0 H[I':<>)Q37_R[FCV>4PM$A0C%
M2(M<Z)%3[$?$#[50IH?B@"0H.(]4^D]._2=C^O_"N]ND%:]'\7! #%0>4!@E
M^((*8^IVI'Y5[](EOYZ(H;CFU2.?S'_X#H7^+U!UN01CCL 4RNF)<FJD_'!W
MEKOV#JL],25YO-CEY1?.:XAM(YAEOV^H?NDBH#)=YF2#.146@Q.+@26+VW([
M-3)I!+1E,M!ZA:E.I,N4;"BEPF-XXC$T\OBVKO?="%BNO>5A^J@[:G?[JOVE
M\9K2XY]YM<SJ+J@^)QZBV9C/EN90[S,""M9E3C:84R$Z.A$=/2/1+[RZ&Z A
MPB/M?!&E<7PQ&!O/SG8P=@G&'($I5R4^7978>%7^$)8A+VN05V-+VT)V";:(
MM2L^15& (UTXC(E4B$M.Q"5CA=.[M#H)!@P1F8P23HD^3X0HCO5.+?3(*<8T
M)D3OOQZ*2>0G_>,F\J7 ]VVETR 31\@+[400CB_9,">W+1BG:,P5FDK\F;-"
MSC3[$6JH]HYA%\4'JG8@M%>V [$#NAU)XX)&.1<KY7Z$'"'=S<FMR\\E&G.%
MIA(O'1,R6R;3E&%N:CMG.$5;.$5C2'>!4Q+&@:&TI4%"9H=T=H/_OM^*DO8-
M(RH==X,#+B3$-(%N<#UTBBE%H1[+@%B,8A+Y_2Q(@X/,#@>XP8?9T#V"8".)
M$A1=$N+2FBR<HC%7:"KQTA$ALR6RD39'J,'RTSU%G[@!0GO5#1 [)&^D74%F
MO_)-\D:W(GWRQJD=<8K&7*&IQ$M'@LR6Q/+YD!G->LK1#8,8)X$J=9F5#6=5
MN90F!9E=RC<\)3(C6O,)&1" 3I=)V6!2]5&Y=#S8['C</RLR)[0E&^ON"J$$
M>/#NU T-9U7IECX'FWW.\STQPKHO"<.07&H$\_G9#M).T9@K-/7:G"T;F=V7
MR028FUH7M5,GAG4'.$4)$1.TON8T)E2E3WHH/&K9:92F/4(-KKL!RU(]"A\(
M[57X0.R PL?2Y^!1/L=*X6/ R, *WYS<NG"<K@FY0E.)E]8*C[)6E\],8,(#
MO?QT072#=><5(.13:/K10Z<X)D&@PS(@%N,H((;Y1?H</,KG]#U!@MD C R*
MQ+D'6OFY7)-9.$5CKM!4XJ6UPF9K9:GPS6C6\XGNT<) 'T\73K.RX:PJE](M
M85NW-*CPS8C6?.K>!5+X3I.RP:0JF](O8;-?>@:%KR_^(!)'EZN36+<L(;">
M;CY]:Q:'DJI;:J1/(F:?9!*'YJ:VQ><4;4%T)R-T$09VB+!1H2I]TO>0T>L[
MYT^<"$@GL+X#S,Y$-SQB=HYB?<UF 81.B1_%P$W-@%CLBPHR[,N2#H-8K^\,
MLP&L[Z"()I0$EX0X=15.T9@K-)7XLQUQH[W)H!PB@#>!RD\W$7WB$ CM%8=
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MQ:LV0/R^+LOFZT'[LO'I]?7Y_U!+ P04    " !DA -72S:>VE@&  !;)
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MT0=FE=\&<;8FI=PT'G<MWFM>W]C;VBYLH>M&71>%:^O&UK?JDZML84UX>=0
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MT@L#ZZ$PT B1)>PIV&;"S_PZO8$P4 S ,S8JF")R,]T*!K9N\$^,;*]8R6E
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MQHO;?SL4/ITPD,7Q-,IIKQ%)04O#W)B6P0B2I&S3I;I,+$DC)$?*K(<AT;Q
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M@:K;:CTQLG2M;"4--48WS.A+A,H"Z/U:TIEM)C9 ^VV;_@)02P,$%     @
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M3]3.@-9WBNIS4-P&XW.\^@902P,$%     @ 9(0#5Q\ZI5\U P  \P<  !D
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MQW!'A).?G]&_(!]6^_9X1VW4(EV(.4!CQP*5=#9*DB30)RF;!LE;D"_TT1V
M[$H-?:D="H6_O1%U2]M@Z'?B?OS_B63Y^1Z1K$@>$;'\[N?2V'#%'9X*TJL.
M<#J8=MP&B-('RFE8'\VVUSWS>V3&<_;Y\FW.^8S*TL)/)Y 69WXRA0G<:,?$
MXUSH@GRHV..]1BS1;,-S8RDW6^6ZGCRL#B_:JFOD7]6[Y_ M,UM.N2QP0Z;)
M^&P:@>F>F$YPN@EM?:T=/1)A6M.KC,8KT/Y&4\GW@C]@>.>7_P%02P,$%
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MP-0<GLO%0I>RS+0LA*OA AAX30_#3>AC=+T%"ZA7XN_7UW=CQ "0.GRJ7"S
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M .E@/E=W[0FT8H<^,)>L*23'E-^ZOV%Z>C Z;>0>9Z:!9#@8:B8%-9/@HHE
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MH'8.]/VHE+TH+L'PLUK_"U!+ P04    " !DA -7,K-E[J$"  #J!0  &0
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MO)*&9H-;9C2,45D#NE]+:78;ZZ ;[_$?4$L#!!0    ( &2$ U<%XUX>?0(
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M4"[ GN^D-$?'S47W#":_ 5!+ P04    " !DA -729@>N_<$  " '0  &0
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M4'LHRG9?>:/XJFB S;A2/"TNET@2%&: ?C_G7*UOC(*ZZ3KY%U!+ P04
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M;2T#Q 7C)*O!8@09SJM?^%I_B!9 \*@!3@UPNH#!$8!; ]Q3 8,:,#@5X-4
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M>63LJQ[<I'/+T09!#HG4"E@]=K"$/-="RHQOC:;5+JF)A^_/ZN\JWY4OCUC
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MKM&TNP]%'QB)MHE*I$I2=OOW)659%UMA*D!^L769.3YS>"B-9[KEXKM<$Z+
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M%*)JX]5$\=)VPAE7NJ_:8:YO/A F0._/.5?/$]-<F[LT^0=02P,$%     @
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MB]=7O7QK'^,LB\/RY8I[<YX4"^2_7\1Q]O9#T<%SG'PK-V?Z/U!+ P04
M" !DA -7!XP/L,,#  #.$   &0   'AL+W=O<FMS:&5E=',O<VAE970S-RYX
M;6S%6%UOVC 4_2M6)NU#6ILX@4 [B 2LTS:M&EJU[6':@TDN)&IB,]M ^^]G
M.VF $=RF0MI+L1W?XWN.[>M[.]@P?BM2 (GNBIR*H9-*N;QT71&G4!!QSI9
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M*1!5<.H)ZON<,?G0T0O4_\*(_@)02P,$%     @ 9(0#5PTS?!*U P  *1$
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M)"V[RT2GC=?FHDU8;!.66((=!>JR"=3E3RD3ES9#8Q,6VX0EEF!'H?&]QT[
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M*K"9;*Z#J';^F,KWX[*B59'4M0AQ-Z[SM01)BT!I&(IFRVR\ G]XJ(4(J$L
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MYY1=_^LF6M2NY^R%-AW,#2OSRP!I \Q^(80^3.P!PT\H_0-02P,$%     @
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MHAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%
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M(2I'02I'82I'@2I'H2I'P2I'X2I' 2M'(:M (:M (:M (:M (:M (:M (:M
M(:M (:M (:M (:M$(:M$(:M$(:M$(:M$(:M$(:M$(:M$(:M$(:M$(6N"0M8$
MA:P)"EF3_R3KN]:KO_ZIT:YQK<KFZ,^Z/T?S3U!+ 0(4 Q0    ( &2$ U<'
M04UB@0   +$    0              "  0    !D;V-0<F]P<R]A<' N>&UL
M4$L! A0#%     @ 9(0#5XGH^Z7O    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ 9(0#5YE<G",0!@  G"<
M !,              ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    " !DA -7>ZY_^_T%  #Z'P  &               @($."   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ 9(0#5S"FZ@FL!0  W1<
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M965T-BYX;6Q02P$"% ,4    " !DA -7;6;!.4 &  !M#@  &
M    @('7*@  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @
M9(0#5]N4>AVR$@  73<  !@              ("!33$  'AL+W=O<FMS:&5E
M=',O<VAE970X+GAM;%!+ 0(4 Q0    ( &2$ U?%[(H:Z0(  .<&   8
M          " @35$  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4
M    " !DA -7#3ED2FL$   /"@  &0              @(%41P  >&PO=V]R
M:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( &2$ U=9UKP=*P,  )H'
M   9              " @?9+  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL
M4$L! A0#%     @ 9(0#5Q\ZI5\U P  \P<  !D              ("!6$\
M 'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " !DA -7.F53
M4IT(   +&   &0              @('$4@  >&PO=V]R:W-H965T<R]S:&5E
M=#$S+GAM;%!+ 0(4 Q0    ( &2$ U?E'A""FP(  /@%   9
M  " @9A;  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @
M9(0#5TW%\8[D P  X D  !D              ("!:EX  'AL+W=O<FMS:&5E
M=',O<VAE970Q-2YX;6Q02P$"% ,4    " !DA -7JZA6-F()  !:&@  &0
M            @(&%8@  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4
M Q0    ( &2$ U<8<VC3M D  %(;   9              " @1YL  !X;"]W
M;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ 9(0#5_*R?U[$$P
MICX  !D              ("!"78  'AL+W=O<FMS:&5E=',O<VAE970Q."YX
M;6Q02P$"% ,4    " !DA -7V";'5/P"  "X!@  &0              @($$
MB@  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( &2$ U<R
MLV7NH0(  .H%   9              " @3>-  !X;"]W;W)K<VAE971S+W-H
M965T,C N>&UL4$L! A0#%     @ 9(0#5P7C7AY] @  BP4  !D
M     ("!#Y   'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( &2$ U=)F!Z[]P0  ( =   9              "
M@9Z>  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ 9(0#
M5QEG&_V:!   G1@  !D              ("!S*,  'AL+W=O<FMS:&5E=',O
M<VAE970R-RYX;6Q02P$"% ,4    " !DA -7N[0.G=@"   O"   &0
M        @(&=J   >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0
M   ( &2$ U>B8\2,Q0(  (D'   9              " @:RK  !X;"]W;W)K
M<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ 9(0#5ZP9*YEU P  R0T
M !D              ("!J*X  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q0
M2P$"% ,4    " !DA -7;SO?7HP"  #*!P  &0              @(%4L@
M>&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( &2$ U=CT>3D
M$00  *L6   9              " @1>U  !X;"]W;W)K<VAE971S+W-H965T
M,S(N>&UL4$L! A0#%     @ 9(0#5UOF7G^2 @  U@<  !D
M ("!7[D  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " !D
MA -7O^\]H" #  #7"P  &0              @($HO   >&PO=V]R:W-H965T
M<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( &2$ U>(-RQH?0(  %<'   9
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M970S.2YX;6Q02P$"% ,4    " !DA -7Y[<^;J4#   ,$@  &0
M    @(':UP  >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    (
M &2$ U<U4^?)@ <  &E#   9              " @;;;  !X;"]W;W)K<VAE
M971S+W-H965T-#$N>&UL4$L! A0#%     @ 9(0#5ZWZ6%9U P  31(  !D
M             ("!;>,  'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"
M% ,4    " !DA -7I<=&AD,"  "0!@  &0              @($9YP  >&PO
M=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( &2$ U<#U[=Q)P,
M &82   -              "  9/I  !X;"]S='EL97,N>&UL4$L! A0#%
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K  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     S #, W T  (#U      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>120</ContextCount>
  <ElementCount>184</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>38</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00100 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00200 - Statement - Condensed Consolidated Statements Of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>Condensed Consolidated Statements Of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00400 - Statement - Condensed Consolidated Statements Of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements Of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00500 - Statement - Condensed Consolidated Statements Of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Condensed Consolidated Statements Of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>10101 - Disclosure - General And Liquidity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureGeneralAndLiquidity</Role>
      <ShortName>General And Liquidity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>10201 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureSignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>10301 - Disclosure - Prepaid Expenses And Other Current Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssets</Role>
      <ShortName>Prepaid Expenses And Other Current Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>10401 - Disclosure - Real Property</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureRealProperty</Role>
      <ShortName>Real Property</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>10501 - Disclosure - Property And Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosurePropertyAndEquipment</Role>
      <ShortName>Property And Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>10601 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureIntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>10701 - Disclosure - Stockholders' Equity And Stock-Based Compensation Expense</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpense</Role>
      <ShortName>Stockholders' Equity And Stock-Based Compensation Expense</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>10801 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>10901 - Disclosure - Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureCommitments</Role>
      <ShortName>Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>11001 - Disclosure - 2020 Cash Incentive Bonus Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlan</Role>
      <ShortName>2020 Cash Incentive Bonus Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>11101 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureContingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>20202 - Disclosure - Significant Accounting Policies (Policy)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesPolicy</Role>
      <ShortName>Significant Accounting Policies (Policy)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.cassavasciences.com/role/DisclosureSignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>30203 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cassavasciences.com/role/DisclosureSignificantAccountingPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>30303 - Disclosure - Prepaid Expenses And Other Current Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables</Role>
      <ShortName>Prepaid Expenses And Other Current Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssets</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>30403 - Disclosure - Real Property (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureRealPropertyTables</Role>
      <ShortName>Real Property (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cassavasciences.com/role/DisclosureRealProperty</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>30503 - Disclosure - Property And Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentTables</Role>
      <ShortName>Property And Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cassavasciences.com/role/DisclosurePropertyAndEquipment</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>30603 - Disclosure - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureIntangibleAssetsTables</Role>
      <ShortName>Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cassavasciences.com/role/DisclosureIntangibleAssets</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>30703 - Disclosure - Stockholders' Equity And Stock-Based Compensation Expense (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseTables</Role>
      <ShortName>Stockholders' Equity And Stock-Based Compensation Expense (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpense</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>40101 - Disclosure - General And Liquidity (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureGeneralAndLiquidityNarrativeDetails</Role>
      <ShortName>General And Liquidity (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cassavasciences.com/role/DisclosureGeneralAndLiquidity</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>40201 - Disclosure - Significant Accounting Policies (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Significant Accounting Policies (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesTables</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>40202 - Disclosure - Significant Accounting Policies (Numerators And Denominators In The Calculation Of Basic And Diluted Net Loss Per Share) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetails</Role>
      <ShortName>Significant Accounting Policies (Numerators And Denominators In The Calculation Of Basic And Diluted Net Loss Per Share) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>40301 - Disclosure - Prepaid Expenses And Other Current Assets (Schedule Of Prepaid Expenses And Other Current Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails</Role>
      <ShortName>Prepaid Expenses And Other Current Assets (Schedule Of Prepaid Expenses And Other Current Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>40401 - Disclosure - Real Property (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureRealPropertyNarrativeDetails</Role>
      <ShortName>Real Property (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cassavasciences.com/role/DisclosureRealPropertyTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>40403 - Disclosure - Real Property (Components Of Other Income, Net) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureRealPropertyComponentsOfOtherIncomeNetDetails</Role>
      <ShortName>Real Property (Components Of Other Income, Net) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cassavasciences.com/role/DisclosureRealPropertyTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>40501 - Disclosure - Property And Equipment (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentNarrativeDetails</Role>
      <ShortName>Property And Equipment (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>40502 - Disclosure - Property And Equipment (Components Of Property And Equipment, Net) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails</Role>
      <ShortName>Property And Equipment (Components Of Property And Equipment, Net) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>40601 - Disclosure - Intangible Assets (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Intangible Assets (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cassavasciences.com/role/DisclosureIntangibleAssetsTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>40602 - Disclosure - Intangible Assets (Components Of Intangible Assets, Net) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureIntangibleAssetsComponentsOfIntangibleAssetsNetDetails</Role>
      <ShortName>Intangible Assets (Components Of Intangible Assets, Net) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cassavasciences.com/role/DisclosureIntangibleAssetsTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>40603 - Disclosure - Intangible Assets (Amortization Expense For Finite-Lived Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureIntangibleAssetsAmortizationExpenseForFiniteLivedIntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets (Amortization Expense For Finite-Lived Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cassavasciences.com/role/DisclosureIntangibleAssetsTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>40701 - Disclosure - Stockholders' Equity And Stock-Based Compensation Expense (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails</Role>
      <ShortName>Stockholders' Equity And Stock-Based Compensation Expense (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>40703 - Disclosure - Stockholders' Equity And Stock-Based Compensation Expense (Stock Options And Unvested Performance Award Outstanding Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockOptionsAndUnvestedPerformanceAwardOutstandingActivityDetails</Role>
      <ShortName>Stockholders' Equity And Stock-Based Compensation Expense (Stock Options And Unvested Performance Award Outstanding Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>40706 - Disclosure - Stockholders' Equity And Stock-Based Compensation Expense (Stock-Based Compensation Expenses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockBasedCompensationExpensesDetails</Role>
      <ShortName>Stockholders' Equity And Stock-Based Compensation Expense (Stock-Based Compensation Expenses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>40801 - Disclosure - Income Taxes (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureIncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cassavasciences.com/role/DisclosureIncomeTaxes</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>40901 - Disclosure - Commitments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureCommitmentsNarrativeDetails</Role>
      <ShortName>Commitments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cassavasciences.com/role/DisclosureCommitments</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>41001 - Disclosure - 2020 Cash Incentive Bonus Plan (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails</Role>
      <ShortName>2020 Cash Incentive Bonus Plan (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlan</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>41101 - Disclosure - Contingencies (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cassavasciences.com/role/DisclosureContingenciesNarrativeDetails</Role>
      <ShortName>Contingencies (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cassavasciences.com/role/DisclosureContingencies</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="sava-20230630x10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0712-Presentation-Base-Set-Order] Role '41101 - Disclosure - Contingencies (Narrative) (Details)', a level 4, Detail role, appears before '995445 - Disclosure - Insider Trading Arrangements', a level 1, Note role. https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd 108, sava-20230630.xsd 8</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="sava-20230630x10q.htm">sava-20230630x10q.htm</File>
    <File>sava-20230630.xsd</File>
    <File>sava-20230630_cal.xml</File>
    <File>sava-20230630_def.xml</File>
    <File>sava-20230630_lab.xml</File>
    <File>sava-20230630_pre.xml</File>
    <File>sava-20230630xex10_2.htm</File>
    <File>sava-20230630xex10_3.htm</File>
    <File>sava-20230630xex31_1.htm</File>
    <File>sava-20230630xex31_2.htm</File>
    <File>sava-20230630xex32_1.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>sava-20230630x10qg001.jpg</File>
    <File>sava-20230630x10qg002.jpg</File>
    <File>sava-20230630x10qg003.jpg</File>
    <File>sava-20230630x10qg004.jpg</File>
    <File>sava-20230630x10qg005.jpg</File>
    <File>sava-20230630x10qg006.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="371">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>69
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "sava-20230630x10q.htm": {
   "axisCustom": 0,
   "axisStandard": 15,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 371,
    "http://xbrl.sec.gov/dei/2023": 30,
    "http://xbrl.sec.gov/ecd/2023": 4
   },
   "contextCount": 120,
   "dts": {
    "calculationLink": {
     "local": [
      "sava-20230630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "sava-20230630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "sava-20230630x10q.htm"
     ]
    },
    "labelLink": {
     "local": [
      "sava-20230630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sava-20230630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "sava-20230630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"
     ]
    }
   },
   "elementCount": 304,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2023": 7,
    "http://xbrl.sec.gov/dei/2023": 7,
    "total": 14
   },
   "keyCustom": 21,
   "keyStandard": 163,
   "memberCustom": 19,
   "memberStandard": 17,
   "nsprefix": "sava",
   "nsuri": "http://www.cassavasciences.com/20230630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00090 - Document - Document And Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10401 - Disclosure - Real Property",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.cassavasciences.com/role/DisclosureRealProperty",
     "shortName": "Real Property",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10501 - Disclosure - Property And Equipment",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.cassavasciences.com/role/DisclosurePropertyAndEquipment",
     "shortName": "Property And Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10601 - Disclosure - Intangible Assets",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.cassavasciences.com/role/DisclosureIntangibleAssets",
     "shortName": "Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10701 - Disclosure - Stockholders' Equity And Stock-Based Compensation Expense",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpense",
     "shortName": "Stockholders' Equity And Stock-Based Compensation Expense",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10801 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.cassavasciences.com/role/DisclosureIncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10901 - Disclosure - Commitments",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.cassavasciences.com/role/DisclosureCommitments",
     "shortName": "Commitments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sava:CashIncentiveBonusPlanTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11001 - Disclosure - 2020 Cash Incentive Bonus Plan",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlan",
     "shortName": "2020 Cash Incentive Bonus Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sava:CashIncentiveBonusPlanTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "11101 - Disclosure - Contingencies",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.cassavasciences.com/role/DisclosureContingencies",
     "shortName": "Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "20202 - Disclosure - Significant Accounting Policies (Policy)",
     "menuCat": "Policies",
     "order": "18",
     "role": "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesPolicy",
     "shortName": "Significant Accounting Policies (Policy)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30203 - Disclosure - Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "19",
     "role": "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesTables",
     "shortName": "Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "As_Of_6_30_2023",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00100 - Statement - Condensed Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "As_Of_6_30_2023",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30303 - Disclosure - Prepaid Expenses And Other Current Assets (Tables)",
     "menuCat": "Tables",
     "order": "20",
     "role": "http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables",
     "shortName": "Prepaid Expenses And Other Current Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30403 - Disclosure - Real Property (Tables)",
     "menuCat": "Tables",
     "order": "21",
     "role": "http://www.cassavasciences.com/role/DisclosureRealPropertyTables",
     "shortName": "Real Property (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30503 - Disclosure - Property And Equipment (Tables)",
     "menuCat": "Tables",
     "order": "22",
     "role": "http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentTables",
     "shortName": "Property And Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30603 - Disclosure - Intangible Assets (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsTables",
     "shortName": "Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sava:StockOptionAndPerformanceAwardActivity",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "30703 - Disclosure - Stockholders' Equity And Stock-Based Compensation Expense (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseTables",
     "shortName": "Stockholders' Equity And Stock-Based Compensation Expense (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sava:StockOptionAndPerformanceAwardActivity",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "As_Of_6_30_2023",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "reportCount": 1,
      "unitRef": "Unit12",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40101 - Disclosure - General And Liquidity (Narrative) (Details)",
     "menuCat": "Details",
     "order": "25",
     "role": "http://www.cassavasciences.com/role/DisclosureGeneralAndLiquidityNarrativeDetails",
     "shortName": "General And Liquidity (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2022_To_3_31_2022",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "sava:ReductionToResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40201 - Disclosure - Significant Accounting Policies (Narrative) (Details)",
     "menuCat": "Details",
     "order": "26",
     "role": "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Significant Accounting Policies (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2022_To_3_31_2022",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "sava:ReductionToResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_4_1_2023_To_6_30_2023",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "Unit12",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40202 - Disclosure - Significant Accounting Policies (Numerators And Denominators In The Calculation Of Basic And Diluted Net Loss Per Share) (Details)",
     "menuCat": "Details",
     "order": "27",
     "role": "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetails",
     "shortName": "Significant Accounting Policies (Numerators And Denominators In The Calculation Of Basic And Diluted Net Loss Per Share) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_4_1_2023_To_6_30_2023_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "As_Of_6_30_2023",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PrepaidInsurance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40301 - Disclosure - Prepaid Expenses And Other Current Assets (Schedule Of Prepaid Expenses And Other Current Assets) (Details)",
     "menuCat": "Details",
     "order": "28",
     "role": "http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails",
     "shortName": "Prepaid Expenses And Other Current Assets (Schedule Of Prepaid Expenses And Other Current Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "As_Of_6_30_2023",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PrepaidInsurance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_AssetAcquisitionAxis_sava_TwoBuildingOfficeComplexAssetMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "sava:PercentageOfOccupancy",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit14",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40401 - Disclosure - Real Property (Narrative) (Details)",
     "menuCat": "Details",
     "order": "29",
     "role": "http://www.cassavasciences.com/role/DisclosureRealPropertyNarrativeDetails",
     "shortName": "Real Property (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_AssetAcquisitionAxis_sava_TwoBuildingOfficeComplexAssetMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "sava:PercentageOfOccupancy",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit14",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "As_Of_6_30_2023",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit15",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00105 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "As_Of_6_30_2023",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit15",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_4_1_2023_To_6_30_2023",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherNonoperatingIncomeExpense",
      "reportCount": 1,
      "unitRef": "Unit12",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40403 - Disclosure - Real Property (Components Of Other Income, Net) (Details)",
     "menuCat": "Details",
     "order": "30",
     "role": "http://www.cassavasciences.com/role/DisclosureRealPropertyComponentsOfOtherIncomeNetDetails",
     "shortName": "Real Property (Components Of Other Income, Net) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_4_1_2023_To_6_30_2023_srt_StatementGeographicalAxis_sava_AustinMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OtherNonoperatingIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_4_1_2023_To_6_30_2023",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unitRef": "Unit12",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40501 - Disclosure - Property And Equipment (Narrative) (Details)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentNarrativeDetails",
     "shortName": "Property And Equipment (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "As_Of_6_30_2023",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40502 - Disclosure - Property And Equipment (Components Of Property And Equipment, Net) (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails",
     "shortName": "Property And Equipment (Components Of Property And Equipment, Net) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "As_Of_6_30_2023",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_4_1_2023_To_6_30_2023",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unitRef": "Unit12",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40601 - Disclosure - Intangible Assets (Narrative) (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsNarrativeDetails",
     "shortName": "Intangible Assets (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "As_Of_6_30_2023",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40602 - Disclosure - Intangible Assets (Components Of Intangible Assets, Net) (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsComponentsOfIntangibleAssetsNetDetails",
     "shortName": "Intangible Assets (Components Of Intangible Assets, Net) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "As_Of_6_30_2023",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "As_Of_6_30_2023",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40603 - Disclosure - Intangible Assets (Amortization Expense For Finite-Lived Intangible Assets) (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsAmortizationExpenseForFiniteLivedIntangibleAssetsDetails",
     "shortName": "Intangible Assets (Amortization Expense For Finite-Lived Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "As_Of_6_30_2023",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromStockOptionsExercised",
      "reportCount": 1,
      "unitRef": "Unit12",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40701 - Disclosure - Stockholders' Equity And Stock-Based Compensation Expense (Narrative) (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails",
     "shortName": "Stockholders' Equity And Stock-Based Compensation Expense (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "sava:StockOptionAndPerformanceAwardActivity",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40703 - Disclosure - Stockholders' Equity And Stock-Based Compensation Expense (Stock Options And Unvested Performance Award Outstanding Activity) (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockOptionsAndUnvestedPerformanceAwardOutstandingActivityDetails",
     "shortName": "Stockholders' Equity And Stock-Based Compensation Expense (Stock Options And Unvested Performance Award Outstanding Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "sava:StockOptionAndPerformanceAwardActivity",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "As_Of_12_31_2022_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit1",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_4_1_2023_To_6_30_2023",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "Unit12",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40706 - Disclosure - Stockholders' Equity And Stock-Based Compensation Expense (Stock-Based Compensation Expenses) (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockBasedCompensationExpensesDetails",
     "shortName": "Stockholders' Equity And Stock-Based Compensation Expense (Stock-Based Compensation Expenses) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_4_1_2023_To_6_30_2023_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxExpenseBenefit",
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_4_1_2023_To_6_30_2023",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40801 - Disclosure - Income Taxes (Narrative) (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.cassavasciences.com/role/DisclosureIncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IncomeTaxExpenseBenefit",
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_4_1_2023_To_6_30_2023",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_4_1_2023_To_6_30_2023",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "sava:ResearchAndDevelopmentExpenseNetOfGrantReimbursement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00200 - Statement - Condensed Consolidated Statements Of Operations",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations",
     "shortName": "Condensed Consolidated Statements Of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_4_1_2023_To_6_30_2023",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "sava:ResearchAndDevelopmentExpenseNetOfGrantReimbursement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_4_1_2023_To_6_30_2023",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "40901 - Disclosure - Commitments (Narrative) (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.cassavasciences.com/role/DisclosureCommitmentsNarrativeDetails",
     "shortName": "Commitments (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_4_1_2023_To_6_30_2023",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "sava:MinimumNumberOfValuationMilestonesToRecognizeCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit13",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41001 - Disclosure - 2020 Cash Incentive Bonus Plan (Narrative) (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails",
     "shortName": "2020 Cash Incentive Bonus Plan (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "sava:MinimumNumberOfValuationMilestonesToRecognizeCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit13",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_8_28_2021_To_10_26_2021_srt_LitigationCaseAxis_sava_ViolationsOfFederalSecuritiesLawsMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:LossContingencyNewClaimsFiledNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit13",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "41101 - Disclosure - Contingencies (Narrative) (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.cassavasciences.com/role/DisclosureContingenciesNarrativeDetails",
     "shortName": "Contingencies (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_8_28_2021_To_10_26_2021_srt_LitigationCaseAxis_sava_ViolationsOfFederalSecuritiesLawsMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:LossContingencyNewClaimsFiledNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit13",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_4_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "menuCat": "Uncategorized",
     "order": "43",
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "shortName": "Insider Trading Arrangements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_4_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "As_Of_12_31_2021_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "Unit12",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00400 - Statement - Condensed Consolidated Statements Of Stockholders' Equity",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity",
     "shortName": "Condensed Consolidated Statements Of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2022_To_3_31_2022_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_4_1_2023_To_6_30_2023",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "Unit12",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00500 - Statement - Condensed Consolidated Statements Of Cash Flows",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
     "shortName": "Condensed Consolidated Statements Of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit12",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10101 - Disclosure - General And Liquidity",
     "menuCat": "Notes",
     "order": "7",
     "role": "http://www.cassavasciences.com/role/DisclosureGeneralAndLiquidity",
     "shortName": "General And Liquidity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10201 - Disclosure - Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sava:PrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "10301 - Disclosure - Prepaid Expenses And Other Current Assets",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssets",
     "shortName": "Prepaid Expenses And Other Current Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sava-20230630x10q.htm",
      "contextRef": "Duration_1_1_2023_To_6_30_2023",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sava:PrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 38,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Document And Entity Information [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "ecd_InsiderTradingArrLineItems": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "localname": "InsiderTradingArrLineItems",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "xbrltype": "stringItemType"
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "localname": "NonRule10b51ArrAdoptedFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "localname": "NonRule10b51ArrTrmntdFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "localname": "Rule10b51ArrAdoptedFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "booleanItemType"
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "localname": "Rule10b51ArrTrmntdFlag",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "xbrltype": "booleanItemType"
    },
    "sava_AtMarketEquityProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At-The-Market Equity Program [Member]",
        "label": "At Market Equity Program [Member]",
        "terseLabel": "ATM [Member]"
       }
      }
     },
     "localname": "AtMarketEquityProgramMember",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sava_AustinMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Austin [Member]",
        "label": "Austin [Member]",
        "terseLabel": "Austin, Texas [Member]"
       }
      }
     },
     "localname": "AustinMember",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureCommitmentsNarrativeDetails",
      "http://www.cassavasciences.com/role/DisclosureRealPropertyComponentsOfOtherIncomeNetDetails",
      "http://www.cassavasciences.com/role/DisclosureRealPropertyNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sava_CashIncentiveBonusAward": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Incentive Bonus Award",
        "label": "Cash Incentive Bonus Award",
        "terseLabel": "Cash bonus award"
       }
      }
     },
     "localname": "CashIncentiveBonusAward",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sava_CashIncentiveBonusPlanAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Cash Incentive Bonus Plan [Abstract]",
        "label": "2020 Cash Incentive Bonus Plan [Abstract]"
       }
      }
     },
     "localname": "CashIncentiveBonusPlanAbstract",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "xbrltype": "stringItemType"
    },
    "sava_CashIncentiveBonusPlanLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Incentive Bonus Plan [Line Items]",
        "label": "Cash Incentive Bonus Plan [Line Items]"
       }
      }
     },
     "localname": "CashIncentiveBonusPlanLineItems",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sava_CashIncentiveBonusPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Incentive Bonus Plan [Member]",
        "label": "Cash Incentive Bonus Plan [Member]",
        "terseLabel": "Cash Incentive Bonus Plan [Member]"
       }
      }
     },
     "localname": "CashIncentiveBonusPlanMember",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sava_CashIncentiveBonusPlanTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Incentive Bonus Plan [Table]",
        "label": "Cash Incentive Bonus Plan [Table]"
       }
      }
     },
     "localname": "CashIncentiveBonusPlanTable",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sava_CashIncentiveBonusPlanTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Incentive Bonus Plan [Text Block]",
        "label": "Cash Incentive Bonus Plan [Text Block]",
        "terseLabel": "2020 Cash Incentive Bonus Plan"
       }
      }
     },
     "localname": "CashIncentiveBonusPlanTextBlock",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sava_ExceedingPerformanceMilestonesMinimum20ConsecutiveDaysMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exceeding Performance Milestones Minimum 20 Consecutive Days",
        "label": "Exceeding Performance Milestones Minimum20 Consecutive Days [Member]",
        "terseLabel": "Exceeding Performance Milestones Minimum 20 Consecutive Days [Member]"
       }
      }
     },
     "localname": "ExceedingPerformanceMilestonesMinimum20ConsecutiveDaysMember",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sava_Exceeds5BillionMarketCapitalizationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exceeds 5 Billion Market Capitalization [Member]",
        "label": "Exceeds5 Billion Market Capitalization [Member]",
        "terseLabel": "Exceeds $5 Billion Market Capitalization For No Less Than 20 Consecutive Trading Days [Member]"
       }
      }
     },
     "localname": "Exceeds5BillionMarketCapitalizationMember",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sava_FirstValuationMilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Valuation Milestone [Member]",
        "label": "First Valuation Milestone [Member]",
        "terseLabel": "First Valuation Milestone [Member]"
       }
      }
     },
     "localname": "FirstValuationMilestoneMember",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sava_IncreaseDecreaseInDevelopmentExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in development expense",
        "label": "Increase (Decrease) in development expense",
        "terseLabel": "Accrued development expense"
       }
      }
     },
     "localname": "IncreaseDecreaseInDevelopmentExpense",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sava_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase Decrease In Operating Lease Right Of Use Assets and Liabilities, Net",
        "label": "Increase Decrease In Operating Lease Right Of Use Assets and Liabilities, Net",
        "negatedLabel": "Operating lease right-of-use assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilitiesNet",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sava_IndependentDirectorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Independent Directors",
        "label": "Independent Directors [Member]",
        "terseLabel": "Independent Directors [Member]"
       }
      }
     },
     "localname": "IndependentDirectorsMember",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sava_LeasingCommissionsAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leasing Commissions And Other [Member]",
        "label": "Leasing Commissions And Other [Member]",
        "terseLabel": "Leasing Commissions And Other [Member]"
       }
      }
     },
     "localname": "LeasingCommissionsAndOtherMember",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsComponentsOfIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sava_MinimumNumberOfDaysValuationMilestoneMustBeAchievedAndMaintained": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum Number of Days Valuation Milestone must be achieved and maintained",
        "label": "Minimum Number of Days Valuation Milestone must be achieved and maintained"
       }
      }
     },
     "localname": "MinimumNumberOfDaysValuationMilestoneMustBeAchievedAndMaintained",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sava_MinimumNumberOfValuationMilestonesToRecognizeCompensationExpense": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum number of valuation milestones to recognize compensation expense.",
        "label": "Minimum number of valuation milestones to recognize compensation expense"
       }
      }
     },
     "localname": "MinimumNumberOfValuationMilestonesToRecognizeCompensationExpense",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sava_NumberOfValuationMilestonesAchieved": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Valuation Milestones Achieved",
        "label": "Number of Valuation Milestones Achieved"
       }
      }
     },
     "localname": "NumberOfValuationMilestonesAchieved",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sava_OperatingLeasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Leases [Member]",
        "label": "Operating Leases [Member]",
        "terseLabel": "Operating Leases [Member]"
       }
      }
     },
     "localname": "OperatingLeasesMember",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureCommitmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sava_PaymentsForCashIncentiveBonus": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Cash Incentive Bonus",
        "label": "Payments For Cash Incentive Bonus",
        "terseLabel": "Payments authorized or made to participants under the Plan"
       }
      }
     },
     "localname": "PaymentsForCashIncentiveBonus",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sava_PercentageOfCommissionAtmOffering": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Of Commission ATM Offering",
        "label": "Percentage Of Commission ATM Offering",
        "terseLabel": "Percentage of commission in ATM offering"
       }
      }
     },
     "localname": "PercentageOfCommissionAtmOffering",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sava_PercentageOfCurrentlyLeased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Of Currently Leased",
        "label": "Percentage Of Currently Leased"
       }
      }
     },
     "localname": "PercentageOfCurrentlyLeased",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureRealPropertyNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sava_PercentageOfOccupancy": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Of Occupancy",
        "label": "Percentage Of Occupancy"
       }
      }
     },
     "localname": "PercentageOfOccupancy",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureRealPropertyNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sava_PercentageValuationMilestoneCashBonusAwardSubjectToApprovalAndAdjustment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Valuation Milestone Cash Bonus Award Subject To Approval And Adjustment",
        "label": "Percentage Valuation Milestone Cash Bonus Award Subject To Approval And Adjustment",
        "terseLabel": "Percentage of each cash bonus award associated with Valuation Milestone subject to adjustment and approval"
       }
      }
     },
     "localname": "PercentageValuationMilestoneCashBonusAwardSubjectToApprovalAndAdjustment",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "sava_PerformancePlanValuationAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Plan Valuation Amount",
        "label": "Performance Plan Valuation Amount",
        "terseLabel": "Valuation milestone amount in market capitalization"
       }
      }
     },
     "localname": "PerformancePlanValuationAmount",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sava_PrepaidAndOtherAssetsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid And Other Assets Disclosure [Text Block]",
        "label": "Prepaid And Other Assets Disclosure [Text Block]",
        "terseLabel": "Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "PrepaidAndOtherAssetsDisclosureTextBlock",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sava_ProceedsFromGrantsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Grants Policy [Policy Text Block]",
        "label": "Proceeds From Grants Policy [Policy Text Block]",
        "terseLabel": "Proceeds From Grants"
       }
      }
     },
     "localname": "ProceedsFromGrantsPolicyPolicyTextBlock",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sava_ProceedsFromStockOptionsExercisedNetSettledSatisfactionOfExercisePrice": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Stock Options Exercised Net Settled Satisfaction Of Exercise Price",
        "label": "Proceeds From Stock Options Exercised Net Settled Satisfaction Of Exercise Price",
        "terseLabel": "Proceeds from stock options exercised net settled in satisfaction of the exercise price"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercisedNetSettledSatisfactionOfExercisePrice",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sava_ReductionToResearchAndDevelopmentExpense": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reduction To Research And Development Expense",
        "label": "Reduction To Research And Development Expense",
        "verboseLabel": "Reimbursement from National Institutes of Health research grants"
       }
      }
     },
     "localname": "ReductionToResearchAndDevelopmentExpense",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sava_RegisteredDirectOffering2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Registered Direct Offering 2022 [Member]",
        "label": "Registered Direct Offering2022 [Member]",
        "terseLabel": "Registered Direct Offering 2022 [Member]"
       }
      }
     },
     "localname": "RegisteredDirectOffering2022Member",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sava_ResearchAndDevelopmentExpenseNetOfGrantReimbursement": {
     "auth_ref": [],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and Development Expense, Net Of Grant Reimbursement",
        "label": "Research and Development Expense, Net Of Grant Reimbursement",
        "terseLabel": "Research and development, net of grant reimbursement"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseNetOfGrantReimbursement",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sava_ResearchContractCostsAndAccrualsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research Contract Costs And Accruals Policy [Policy Text Block]",
        "label": "Research Contract Costs And Accruals Policy [Policy Text Block]",
        "terseLabel": "Research Contract Costs And Accruals"
       }
      }
     },
     "localname": "ResearchContractCostsAndAccrualsPolicyPolicyTextBlock",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sava_SecondThroughEighthValuationMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second Through Eighth Valuation Milestones [Member]",
        "label": "Second Through Eighth Valuation Milestones [Member]",
        "terseLabel": "Second Through Eighth Valuation Milestones [Member]"
       }
      }
     },
     "localname": "SecondThroughEighthValuationMilestonesMember",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sava_ShareholderDerivativeActionsDelwareCourtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shareholder derivative actions Delaware Court",
        "label": "Shareholder Derivative Actions Delware Court [Member]",
        "terseLabel": "Shareholder derivative actions Delware Court [Member]"
       }
      }
     },
     "localname": "ShareholderDerivativeActionsDelwareCourtMember",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sava_ShareholderDerivativeActionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shareholder derivative actions",
        "label": "Shareholder Derivative Actions [Member]",
        "terseLabel": "Shareholder derivative actions [Member]"
       }
      }
     },
     "localname": "ShareholderDerivativeActionsMember",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sava_ShareholderDerivativeActionsTexasCourtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shareholder derivative actions Texas Court",
        "label": "Shareholder Derivative Actions Texas Court [Member]",
        "terseLabel": "Shareholder derivative actions Texas Court [Member]"
       }
      }
     },
     "localname": "ShareholderDerivativeActionsTexasCourtMember",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sava_ShareholderDerivativeActionsU.s.DistrictCourtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shareholder derivative actions U.S. District Court",
        "label": "Shareholder Derivative Actions U.s. District Court [Member]",
        "terseLabel": "Shareholder derivative actions U.S. District Court [Member]"
       }
      }
     },
     "localname": "ShareholderDerivativeActionsU.s.DistrictCourtMember",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sava_SignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant Accounting Policies [Line Items]",
        "label": "Significant Accounting Policies [Line Items]",
        "terseLabel": "Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesLineItems",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sava_SignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant Accounting Policies [Table]",
        "label": "Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTable",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sava_StockOptionAndPerformanceAwardActivity": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in stock options and perfromance award activity",
        "label": "Stock Option And Performance Award Activity",
        "terseLabel": "Stock Options And Unvested Performance Award Outstanding Activity"
       }
      }
     },
     "localname": "StockOptionAndPerformanceAwardActivity",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sava_StockOptionAndPerformanceAwardActivity2020PlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Option And Performance Award Activity 2020 Plan [Member]",
        "label": "Stock Option And Performance Award Activity2020 Plan [Member]",
        "terseLabel": "Stock Option And Performance Award [Member]"
       }
      }
     },
     "localname": "StockOptionAndPerformanceAwardActivity2020PlanMember",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sava_StockOptionsExercisedNetSettledSatisfactionOfExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Options Exercised Net Settled Satisfaction Of Exercise Price",
        "label": "Stock Options Exercised Net Settled Satisfaction Of Exercise Price",
        "terseLabel": "Stock options exercised, net settled in satisfaction of the exercise price"
       }
      }
     },
     "localname": "StockOptionsExercisedNetSettledSatisfactionOfExercisePrice",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "sava_TwoBuildingOfficeComplexAssetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-building office complex",
        "label": "Two Building Office Complex Asset [Member]",
        "terseLabel": "Two-building office complex [Member]"
       }
      }
     },
     "localname": "TwoBuildingOfficeComplexAssetMember",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureRealPropertyNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sava_TwoThousandEighteenEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Eighteen Equity Incentive Plan [Member]",
        "label": "Two Thousand Eighteen Equity Incentive Plan [Member]",
        "terseLabel": "2018 Equity Incentive Plan [Member]"
       }
      }
     },
     "localname": "TwoThousandEighteenEquityIncentivePlanMember",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sava_ViolationsOfFederalSecuritiesLawsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "violations of the federal securities laws",
        "label": "Violations Of Federal Securities Laws [Member]",
        "terseLabel": "Violations of the federal securities laws [Member]"
       }
      }
     },
     "localname": "ViolationsOfFederalSecuritiesLawsMember",
     "nsuri": "http://www.cassavasciences.com/20230630",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case Type [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r162",
      "r164",
      "r165",
      "r166",
      "r186",
      "r276",
      "r297",
      "r328",
      "r329",
      "r380",
      "r382",
      "r384",
      "r385",
      "r387",
      "r404",
      "r405",
      "r414",
      "r416",
      "r418",
      "r423",
      "r467",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails",
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r162",
      "r164",
      "r165",
      "r166",
      "r186",
      "r276",
      "r297",
      "r328",
      "r329",
      "r380",
      "r382",
      "r384",
      "r385",
      "r387",
      "r404",
      "r405",
      "r414",
      "r416",
      "r418",
      "r423",
      "r467",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r162",
      "r164",
      "r165",
      "r166",
      "r185",
      "r186",
      "r216",
      "r217",
      "r218",
      "r275",
      "r276",
      "r297",
      "r328",
      "r329",
      "r380",
      "r382",
      "r384",
      "r385",
      "r387",
      "r404",
      "r405",
      "r414",
      "r416",
      "r418",
      "r423",
      "r426",
      "r462",
      "r467",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails",
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r162",
      "r164",
      "r165",
      "r166",
      "r185",
      "r186",
      "r216",
      "r217",
      "r218",
      "r275",
      "r276",
      "r297",
      "r328",
      "r329",
      "r380",
      "r382",
      "r384",
      "r385",
      "r387",
      "r404",
      "r405",
      "r414",
      "r416",
      "r418",
      "r423",
      "r426",
      "r462",
      "r467",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [Member]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails",
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r118",
      "r187",
      "r443",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario Unspecified [Domain]",
        "terseLabel": "Scenario, Unspecified [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r145",
      "r146",
      "r325",
      "r326",
      "r327",
      "r381",
      "r383",
      "r386",
      "r388",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r406",
      "r417",
      "r426",
      "r468",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureCommitmentsNarrativeDetails",
      "http://www.cassavasciences.com/role/DisclosureRealPropertyComponentsOfOtherIncomeNetDetails",
      "http://www.cassavasciences.com/role/DisclosureRealPropertyNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r145",
      "r146",
      "r325",
      "r326",
      "r327",
      "r381",
      "r383",
      "r386",
      "r388",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r406",
      "r417",
      "r426",
      "r468",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureCommitmentsNarrativeDetails",
      "http://www.cassavasciences.com/role/DisclosureRealPropertyComponentsOfOtherIncomeNetDetails",
      "http://www.cassavasciences.com/role/DisclosureRealPropertyNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r118",
      "r187",
      "r443",
      "r444",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r459",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title Of Individual With Relationship To Entity [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r9",
      "r422"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable Current",
        "verboseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Development Expense Current",
        "terseLabel": "Accrued development expense"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r30",
      "r85",
      "r292"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r41",
      "r422",
      "r510"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid In Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r221",
      "r222",
      "r223",
      "r313",
      "r452",
      "r453",
      "r454",
      "r497",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid In Capital [Member]",
        "terseLabel": "Additional Paid-In Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.",
        "label": "Adjustments to Additional Paid in Capital, Share-based Compensation, Stock Options, Requisite Service Period Recognition",
        "verboseLabel": "Stock options for non-employees"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r220",
      "r228"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Allocated Share Based Compensation Expense",
        "terseLabel": "Stock-based compensation expense",
        "verboseLabel": "Total stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails",
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, after Tax",
        "terseLabel": "Compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r3",
      "r24",
      "r28"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets",
        "verboseLabel": "Amortization expense for intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsNarrativeDetails",
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount",
        "verboseLabel": "Dilutive common stock options excluded from net loss per share, diluted"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails",
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionAxis": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by asset acquisition.",
        "label": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureRealPropertyNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionDomain": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition.",
        "label": "Asset Acquisition [Domain]",
        "terseLabel": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureRealPropertyNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetAcquisitionLineItems": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Asset Acquisition [Line Items]"
       }
      }
     },
     "localname": "AssetAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureRealPropertyNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionTable": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset acquisition.",
        "label": "Asset Acquisition [Table]"
       }
      }
     },
     "localname": "AssetAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureRealPropertyNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r66",
      "r87",
      "r103",
      "r132",
      "r141",
      "r143",
      "r147",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r248",
      "r250",
      "r261",
      "r285",
      "r350",
      "r422",
      "r433",
      "r465",
      "r466",
      "r500"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r81",
      "r91",
      "r103",
      "r147",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r248",
      "r250",
      "r261",
      "r422",
      "r465",
      "r466",
      "r500"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r191",
      "r192",
      "r193",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails",
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails",
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockOptionsAndUnvestedPerformanceAwardOutstandingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building And Building Improvements [Member]",
        "terseLabel": "Site Improvements [Member]"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails",
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Buildings [Member]"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureCommitmentsNarrativeDetails",
      "http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails",
      "http://www.cassavasciences.com/role/DisclosureRealPropertyComponentsOfOtherIncomeNetDetails",
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureRealPropertyComponentsOfOtherIncomeNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r64",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Real Property"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureRealProperty"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Real Property [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r16",
      "r83",
      "r407"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash And Cash Equivalents At Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash And Cash Equivalents Policy [Text Block]",
        "verboseLabel": "Cash And Cash Equivalents And Concentration Of Credit Risk"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r16",
      "r51",
      "r101"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r0",
      "r51"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Net decrease in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r78",
      "r88",
      "r89",
      "r90",
      "r103",
      "r121",
      "r122",
      "r124",
      "r126",
      "r130",
      "r131",
      "r147",
      "r170",
      "r172",
      "r173",
      "r174",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r261",
      "r307",
      "r308",
      "r309",
      "r310",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r338",
      "r359",
      "r377",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r442",
      "r450",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class Of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r14",
      "r37",
      "r286",
      "r337"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments And Contingencies",
        "terseLabel": "Commitments and contingencies (Notes 10, 11 and 12)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsDisclosureTextBlock": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.",
        "label": "Commitments Disclosure [Text Block]",
        "terseLabel": "Commitments"
       }
      }
     },
     "localname": "CommitmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureCommitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r424",
      "r425",
      "r426",
      "r428",
      "r429",
      "r430",
      "r431",
      "r452",
      "r453",
      "r497",
      "r509",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails",
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value",
        "verboseLabel": "Par value per share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails",
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r40",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r6",
      "r40",
      "r338",
      "r356",
      "r511",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r40",
      "r288",
      "r422"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock Value",
        "terseLabel": "Common stock, $0.001 par value; 120,000,000 shares authorized; 41,919,527 and 41,735,557 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.",
        "label": "Compensation Related Costs Policy [Text Block]",
        "verboseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction In Progress [Member]",
        "terseLabel": "Construction In Progress [Member]"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expenses And Other Current Assets [Abstract]"
       }
      }
     },
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DepositContractsAssets": {
     "auth_ref": [
      "r150",
      "r151"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of assets as of the balance sheet date pertaining to amounts paid by the insured (including a ceding company) under insurance or reinsurance contracts for which insurance risk is not transferred.",
        "label": "Deposit Contracts, Assets",
        "terseLabel": "Contract research organization and other deposits"
       }
      }
     },
     "localname": "DepositContractsAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r3",
      "r29"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentNarrativeDetails",
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders\u2019 Equity And Stock-Based Compensation Expense [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income (loss) per share"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r98",
      "r110",
      "r111",
      "r112",
      "r113",
      "r114",
      "r119",
      "r121",
      "r124",
      "r125",
      "r126",
      "r128",
      "r259",
      "r260",
      "r283",
      "r295",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Net loss per share, Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetails",
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]",
        "terseLabel": "Weighted-average shares used in computing net income (loss) per share"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r98",
      "r110",
      "r111",
      "r112",
      "r113",
      "r114",
      "r121",
      "r124",
      "r125",
      "r126",
      "r128",
      "r259",
      "r260",
      "r283",
      "r295",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "verboseLabel": "Net loss per share, Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetails",
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r18",
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share Policy [Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee Related Liabilities Current",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]",
        "terseLabel": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails",
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Stock Option [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails",
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetails",
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails",
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockOptionsAndUnvestedPerformanceAwardOutstandingActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r6",
      "r79",
      "r95",
      "r96",
      "r97",
      "r105",
      "r106",
      "r107",
      "r109",
      "r115",
      "r117",
      "r129",
      "r148",
      "r149",
      "r184",
      "r221",
      "r222",
      "r223",
      "r239",
      "r240",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r274",
      "r298",
      "r299",
      "r300",
      "r313",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r5",
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "verboseLabel": "Fair Value Of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "verboseLabel": "Intangible assets, Estimated useful lives"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r86",
      "r155"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsComponentsOfIntangibleAssetsNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsComponentsOfIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsAmortizationExpenseForFiniteLivedIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsAmortizationExpenseForFiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsAmortizationExpenseForFiniteLivedIntangibleAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsAmortizationExpenseForFiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsAmortizationExpenseForFiniteLivedIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsAmortizationExpenseForFiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r156",
      "r281",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsComponentsOfIntangibleAssetsNetDetails",
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r56",
      "r282"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsComponentsOfIntangibleAssetsNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsComponentsOfIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsComponentsOfIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r25",
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite Lived Intangible Assets Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsComponentsOfIntangibleAssetsNetDetails",
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r56",
      "r281"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsAmortizationExpenseForFiniteLivedIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsComponentsOfIntangibleAssetsNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Total amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsAmortizationExpenseForFiniteLivedIntangibleAssetsDetails",
      "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsComponentsOfIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture And Fixtures [Member]",
        "terseLabel": "Furniture And Equipment [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r48",
      "r361"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General And Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General And Administrative Expense [Member]",
        "terseLabel": "General and administrative [Member]"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Consolidated Statements Of Operations [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r157",
      "r158",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r158",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r104",
      "r229",
      "r233",
      "r234",
      "r237",
      "r241",
      "r243",
      "r244",
      "r245",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureIncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r69",
      "r77",
      "r116",
      "r117",
      "r133",
      "r232",
      "r242",
      "r296"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "verboseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureIncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r94",
      "r230",
      "r231",
      "r234",
      "r235",
      "r236",
      "r238",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax Policy [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r2"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r2"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase Decrease In Employee Related Liabilities",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase Decrease In Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "auth_ref": [
      "r449"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current liabilities classified as other.",
        "label": "Increase Decrease In Other Accrued Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r2"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "auth_ref": [
      "r27",
      "r277",
      "r278",
      "r279",
      "r281",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.",
        "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r23",
      "r26"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndOtherIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).",
        "label": "Interest And Other Income",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestAndOtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestReceivableCurrent": {
     "auth_ref": [
      "r446"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.",
        "label": "Interest Receivable Current",
        "verboseLabel": "Interest receivable"
       }
      }
     },
     "localname": "InterestReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land [Member]"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseContractualTermAxis": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Axis]"
       }
      }
     },
     "localname": "LeaseContractualTermAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureCommitmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseContractualTermDomain": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Domain]",
        "terseLabel": "Lease Contractual Term [Domain]"
       }
      }
     },
     "localname": "LeaseContractualTermDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureCommitmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseExpirationDate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format.",
        "label": "Lease Expiration Date",
        "terseLabel": "Lease expiration date"
       }
      }
     },
     "localname": "LeaseExpirationDate1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureCommitmentsNarrativeDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Tenant Improvements [Member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails",
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAcquiredInPlaceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of value allocated by a lessor (acquirer) to lease agreements which exist at acquisition of a leased property. Such amount may include the value assigned to tenant relationships and excludes the market adjustment component of the value assigned for above or below-market leases acquired.",
        "label": "Leases Acquired In Place [Member]",
        "terseLabel": "Lease-In-Place Agreements [Member]"
       }
      }
     },
     "localname": "LeasesAcquiredInPlaceMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsComponentsOfIntangibleAssetsNetDetails",
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "verboseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r10",
      "r103",
      "r147",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r249",
      "r250",
      "r251",
      "r261",
      "r336",
      "r411",
      "r433",
      "r465",
      "r500",
      "r501"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r45",
      "r67",
      "r290",
      "r422",
      "r451",
      "r460",
      "r498"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities And Stockholders Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r12",
      "r82",
      "r103",
      "r147",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r249",
      "r250",
      "r251",
      "r261",
      "r422",
      "r465",
      "r500",
      "r501"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [
      "r160",
      "r162",
      "r164",
      "r169",
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r160",
      "r162",
      "r164",
      "r169",
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingencies [Abstract]"
       }
      }
     },
     "localname": "LossContingencyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyDisclosures": {
     "auth_ref": [
      "r159",
      "r160",
      "r161",
      "r163",
      "r165",
      "r166",
      "r167",
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.",
        "label": "Contingencies Disclosure [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "LossContingencyDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "Putative class action lawsuits"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureContingenciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided By Used In Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided By Used In Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Investing Activities Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r51",
      "r52",
      "r53"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided By Used In Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided By Used In Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r46",
      "r53",
      "r68",
      "r80",
      "r92",
      "r93",
      "r97",
      "r103",
      "r108",
      "r110",
      "r111",
      "r112",
      "r113",
      "r116",
      "r117",
      "r123",
      "r132",
      "r140",
      "r142",
      "r144",
      "r147",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r260",
      "r261",
      "r294",
      "r358",
      "r375",
      "r376",
      "r412",
      "r432",
      "r465"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income Loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetails",
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows",
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations",
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income Loss [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetRentableArea": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net rentable area for properties owned.",
        "label": "Net Rentable Area",
        "terseLabel": "Office space"
       }
      }
     },
     "localname": "NetRentableArea",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureCommitmentsNarrativeDetails",
      "http://www.cassavasciences.com/role/DisclosureRealPropertyNarrativeDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of business segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r132",
      "r140",
      "r142",
      "r144",
      "r412"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income Loss",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r272",
      "r421"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Rent expense"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r269"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r269"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities, non-current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r270",
      "r273"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Cash paid for operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r268"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Leased Assets [Line Items]",
        "terseLabel": "Operating Leased Assets [Line Items]"
       }
      }
     },
     "localname": "OperatingLeasedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureCommitmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General And Liquidity [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r38",
      "r65",
      "r303",
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block]",
        "terseLabel": "General And Liquidity"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureGeneralAndLiquidity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r11",
      "r422"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingExpense": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/DisclosureRealPropertyComponentsOfOtherIncomeNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Expense",
        "negatedTerseLabel": "Property operating expenses"
       }
      }
     },
     "localname": "OtherNonoperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureRealPropertyComponentsOfOtherIncomeNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncome": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/DisclosureRealPropertyComponentsOfOtherIncomeNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income",
        "terseLabel": "Lease revenue"
       }
      }
     },
     "localname": "OtherNonoperatingIncome",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureRealPropertyComponentsOfOtherIncomeNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/DisclosureRealPropertyComponentsOfOtherIncomeNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income, net",
        "totalLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureRealPropertyComponentsOfOtherIncomeNetDetails",
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "auth_ref": [
      "r447",
      "r461"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Other Prepaid Expense, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherPrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Award [Member]"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails",
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockOptionsAndUnvestedPerformanceAwardOutstandingActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails",
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/Disclosure2020CashIncentiveBonusPlanNarrativeDetails",
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r39",
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r39",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r39",
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r39",
      "r338",
      "r356",
      "r511",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r39",
      "r287",
      "r422"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock Value",
        "verboseLabel": "Preferred stock, $0.001 par value; 10,000,000 shares authorized, none issued and outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r448"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Total prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails",
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidInsurance": {
     "auth_ref": [
      "r408",
      "r415",
      "r461"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Insurance",
        "terseLabel": "Prepaid insurance"
       }
      }
     },
     "localname": "PrepaidInsurance",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r1"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds From Issuance Of Common Stock",
        "netLabel": "Proceeds from offering",
        "verboseLabel": "Proceeds from common stock offering, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails",
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r1",
      "r7"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from issuance of common stock upon exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails",
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property And Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureCommitmentsNarrativeDetails",
      "http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails",
      "http://www.cassavasciences.com/role/DisclosureRealPropertyComponentsOfOtherIncomeNetDetails",
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r58",
      "r72",
      "r75",
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property And Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosurePropertyAndEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r59",
      "r84",
      "r293"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Gross property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r4",
      "r284",
      "r293",
      "r422"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails",
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r4",
      "r72",
      "r75",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property And Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Components Of Property And Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Property Plant And Equipment Type [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureCommitmentsNarrativeDetails",
      "http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails",
      "http://www.cassavasciences.com/role/DisclosureRealPropertyComponentsOfOtherIncomeNetDetails",
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "verboseLabel": "Property and equipment, Estimated useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research And Development Expense [Member]",
        "terseLabel": "Research and development [Member]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock [Member]"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r42",
      "r62",
      "r289",
      "r301",
      "r302",
      "r311",
      "r339",
      "r422"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated undistributed earnings (deficit).",
        "label": "Retained Earnings Accumulated Deficit",
        "negatedLabel": "Accumulated deficit",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureGeneralAndLiquidityNarrativeDetails",
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r79",
      "r105",
      "r106",
      "r107",
      "r109",
      "r115",
      "r117",
      "r148",
      "r149",
      "r221",
      "r222",
      "r223",
      "r239",
      "r240",
      "r252",
      "r254",
      "r255",
      "r257",
      "r258",
      "r298",
      "r300",
      "r313",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated undistributed earnings (deficit).",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedPerTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.",
        "label": "Sale of Stock, Consideration Received Per Transaction",
        "terseLabel": "Aggregate offering price"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedPerTransaction",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Number of shares issued"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "verboseLabel": "Price per share"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r35",
      "r36",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureRealPropertyComponentsOfOtherIncomeNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]",
        "terseLabel": "Numerators And Denominators In The Calculation Of Basic And Diluted Net Loss Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]",
        "terseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails",
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockBasedCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]",
        "terseLabel": "Stock-Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r25",
      "r27",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsComponentsOfIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r25",
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Components Of Intangible Assets, Net"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOperatingLeasedAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Schedule Of Operating Leased Assets [Table]",
        "terseLabel": "Schedule of Operating Leased Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfOperatingLeasedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureCommitmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other current assets.",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule Of Prepaid Expenses And Other Current Assets"
       }
      }
     },
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.",
        "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]",
        "terseLabel": "Components Of Other Income, Net"
       }
      }
     },
     "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureRealPropertyTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosurePropertyAndEquipmentComponentsOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockOptionsAndUnvestedPerformanceAwardOutstandingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Amortization Expense For Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r145",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Business Segments"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r2"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share Based Compensation",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period 1",
        "terseLabel": "Vesting period of stock options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails",
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Options forfeited/cancelled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockOptionsAndUnvestedPerformanceAwardOutstandingActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockOptionsAndUnvestedPerformanceAwardOutstandingActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r203",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding as of, Ending",
        "periodStartLabel": "Outstanding as of, Beginning"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockOptionsAndUnvestedPerformanceAwardOutstandingActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockOptionsAndUnvestedPerformanceAwardOutstandingActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockOptionsAndUnvestedPerformanceAwardOutstandingActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Options forfeited/canceled"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockOptionsAndUnvestedPerformanceAwardOutstandingActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockOptionsAndUnvestedPerformanceAwardOutstandingActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r195",
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding as of, Ending",
        "periodStartLabel": "Outstanding as of, Beginning"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockOptionsAndUnvestedPerformanceAwardOutstandingActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r195",
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "verboseLabel": "Weighted average exercise price or options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period",
        "terseLabel": "Shares issued"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r191",
      "r192",
      "r193",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails",
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails",
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockOptionsAndUnvestedPerformanceAwardOutstandingActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r188",
      "r194",
      "r213",
      "r214",
      "r215",
      "r216",
      "r219",
      "r224",
      "r225",
      "r226",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Incentive Bonus Plan"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r61",
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).",
        "label": "Shareholders' Equity and Share-based Payments [Text Block]",
        "terseLabel": "Stockholders' Equity And Stock-Based Compensation Expense"
       }
      }
     },
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpense"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares Issued",
        "periodEndLabel": "Balance, Shares",
        "periodStartLabel": "Balance, Shares"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r54",
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r78",
      "r88",
      "r89",
      "r90",
      "r103",
      "r121",
      "r122",
      "r124",
      "r126",
      "r130",
      "r131",
      "r147",
      "r170",
      "r172",
      "r173",
      "r174",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r261",
      "r307",
      "r308",
      "r309",
      "r310",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r338",
      "r359",
      "r377",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r442",
      "r450",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r6",
      "r15",
      "r79",
      "r95",
      "r96",
      "r97",
      "r105",
      "r106",
      "r107",
      "r109",
      "r115",
      "r117",
      "r129",
      "r148",
      "r149",
      "r184",
      "r221",
      "r222",
      "r223",
      "r239",
      "r240",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r274",
      "r298",
      "r299",
      "r300",
      "r313",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r129",
      "r280",
      "r305",
      "r324",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r338",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r357",
      "r360",
      "r361",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r377",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Consolidated Statements Of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Consolidated Balance Sheets [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Consolidated Statements Of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r129",
      "r280",
      "r305",
      "r324",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r338",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r357",
      "r360",
      "r361",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r377",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r6",
      "r39",
      "r40",
      "r62",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Options exercised",
        "terseLabel": "Issuance of common stock pursuant to exercise of stock options, shares",
        "verboseLabel": "Stock options exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseNarrativeDetails",
      "http://www.cassavasciences.com/role/DisclosureStockholdersEquityAndStockBasedCompensationExpenseStockOptionsAndUnvestedPerformanceAwardOutstandingActivityDetails",
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan": {
     "auth_ref": [
      "r6",
      "r34",
      "r39",
      "r40",
      "r62"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate value of stock issued during the period as a result of employee stock ownership plan (ESOP).",
        "label": "Stock Issued During Period, Value, Employee Stock Ownership Plan",
        "verboseLabel": "Stock options for employees"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r6",
      "r15",
      "r62"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of common stock pursuant to exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r40",
      "r43",
      "r44",
      "r55",
      "r340",
      "r356",
      "r378",
      "r379",
      "r422",
      "r433",
      "r451",
      "r460",
      "r498",
      "r511"
     ],
     "calculation": {
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.",
        "label": "Stockholders Equity",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets",
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders Equity [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r20",
      "r21",
      "r22",
      "r70",
      "r71",
      "r73",
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use Of Estimates",
        "terseLabel": "Use Of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r120",
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "netLabel": "Shares used in computing net loss per share, diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetails",
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r119",
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "netLabel": "Shares used in computing net loss per share, basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetails",
      "http://www.cassavasciences.com/role/StatementCondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number Of Shares Outstanding Basic [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.cassavasciences.com/role/DisclosureSignificantAccountingPoliciesNumeratorsAndDenominatorsInCalculationOfBasicAndDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "340",
   "URI": "https://asc.fasb.org//1943274/2147483081/340-30-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "340",
   "URI": "https://asc.fasb.org//1943274/2147483054/340-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org//350-30/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org//450-20/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "https://asc.fasb.org//450-30/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483049/450-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org//718/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org//740/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(iv)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(i)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(b)",
   "Topic": "920",
   "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(c)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f(1))",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(e)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(f)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(g)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(h)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)(2)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(2)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(e)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(f)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(14))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(15))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(17))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "40",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480637/718-40-25-10",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(19))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(8))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "220",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(9))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org//205/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(c)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "47",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r434": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r435": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r436": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r437": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r438": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r439": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Publisher": "SEC",
   "Section": "408",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Regulation S-K",
   "Number": "229",
   "Paragraph": "1",
   "Publisher": "SEC",
   "Section": "408",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r441": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147480123/805-50-15-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(18))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org//235/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org//360/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org//440/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org//505/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org//718/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org//805/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org//810/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>70
<FILENAME>0001069530-23-000039-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001069530-23-000039-xbrl.zip
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M>% 5Z+/C!=3_7L+5[<&*$<X^[.%)E(XR\:J0_(<:.UIGJ!@ \1%@+&BT<#0
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M$2-'EQ'*&8!RG(:B9Q>Q3TB$?#GZ1?3^#F<>B7#PP4LB:K#IVO</NP//.KG
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MLP[3D#MA\I:+%FD3,.CEUV QG%IX=:30KKI4U"Y9A'J]I2!UR!*TBQ29%:Q
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MJE-B=H2SSDRM9PN?A(2-<Q)O3PXI5L0^CH0^:]^/#U&6WGJO'EMJ10']2W+
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MNIM19.P_MF'VY(5L4^V.+K\3XF<X8!^LHZ#YAQJEJ'[7/N?^\.*'!];HE?[
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MD&95XE%#0A8R'@]<7?$LKPF0\CA&W'K,+TD6M8[&O804]3\,X%4OEWZ\4'5
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MJE55C=TN?37N]5CQ E<*LQ:N71',R A;^<L.GB* 9D>.[9I=XDKQZ_Q.WZ+
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M5S#P9+KRESH[L"V-$>XSR;"=+,N5D'J,P\#:I'0<T 6E]()TZDK)R8'+2VE
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M=.R_?YE\&W\9 5MW#-/>_/U+X*^_+K[\^[_]S__QM__U]>M_7CS>C0Q'#W;
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M.RY4!+A'?$_G$@7(N!^7CD&6,+56EEV+^?E\(KW A0E*Y%_PY_0AQ6?M_=9
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MR9 NCC(Y\M#7E(FX!W"[@)PGKHS>1(Y;6.1K28,' H.RINP^R2& ID/(A*O
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MU+N2Z'$#X*X==X<> UR^::X1O<J6/_$5J"FEWFDN.51-3BB\+J[6U[N]Y7P
M\ 3<5U,'Y0%<2PL/ X5RK1^![FQL[!/%+_)@.0@<0S7;G^+([85_RBR>):\U
MW6LN\JZ]@BO@:Z;%MTZ><+_>-/I+TL%?1W^)^NAZ+3R^Z53&E4<D#!L8\6GP
M4M>#78 GY!58F[I)(IE=44HEU-J[2]7X47L1/0]GMPTVJ"=IHVHJ*ACQMY6D
M4#4]!]N0S&5FV%.IJ<RLE<7UZ?SL;%@W/ZI12)NY\>/,T]XM6FS%/\,.EN\F
M*?])IHQ4PJPCGJ*&9M(Y#)$2;%NH].Q-N$Q=?!12^X:[N80!<*VS-/M>VX$K
M9P>7+:';.O6ZD@I@_- HV7QTQ!P%]]G);NW@?/@)=B_ )>"06%Y*,'4&C"(F
MA1BE(+ >DS>8,0>HH"HM>P14?E?#R:1NO"-RA&M<?# L*HZ:4@&M63NK(O4T
M!,EC?9%C46"G5&.*HZ94H*@K3I$X'BH'%%RG+@+(;CB]J M4MM"PL,&0:!$;
M;&(5A@'D7/SQ=K=WG==P5>="![7N)P&-, \4M%9PR@ 4H,"-($H-Q7$C2+F"
M^2LI\447'S^U?SKNI:5Y'L7&%6A!*C0U:^O6Y (-6?+8O!0B#R0RG8F"K4@%
MFJ;$+00@7JXH:!B%^6^6.M3P+F(,5/DZ8"]FY36&AB1NN1,6-GXNR(><*D>7
M=Z8-;GVPRZ]4 C6E@D@S*U1-ZEO(P9Q:TTY:2X%H!#IJ[]F)\_FAC ;@%5@.
M-A5SC\MFLQ[RU1T85NA2SN&E#@^:4B:93&0IS,QZ7Y7N Z1(5^M5?!<URG!.
M,I&)Y16%4"6Z6]B*-ZEHVC^NIY[=_ 8\+ D<HSHAX*S)+A2'9MNL:L%5(-56
MD.B#^=4#Z\"Z,]?YM56@IN+8J\B!IBPQTKK:OXHD[X68J.*IJCBLJK*@J?<U
MY,75$O+50-G,(&^>@![ <4'^7K_K5F   SU)@A:!( [XSB=$6^Z09$A!DTVT
MK3@R6^-1*X]\L*#;>PA]L$/FM.-Z>$MF.SN47 ?^>6M?:I:.KAI@-N;R^-T#
M'SW8&3-5-/Y>_*7*PSCQ):#T2$>W]NAY"T:I\8Y6ZQ$><5@X'/,(#GJ$1CV"
MPQ[A<2L1S ^Q?#H]&4^FBQG*=W(RF<Q[SC]1<XJ6W1IHIQ.I5&4U29=M1UKG
M$4],>_^>E9K47WR4-T"[]-!>CU)"M0.D-6X B#*9!^NR6J7,XU-6M2Q#X(>3
ML_Y1US4 >"%(9UL+QV)2.7%:NGXA->88$B\"1XAHU1%3<QZ33FB;;EY*/ YQ
MY:5R=!B!^G +&::*1?M(QHZMM*R48&I5KB4G>;R,:5<!]K]!R3""!T52HH=?
MG PHM D!DE-NT3L(_@',S=8'QA(.4=N ^)@;SRQO%?B>K]DH!CWTP-%53J6V
MI 15QRJI,<:U&WC0O\H28E03*)42G<W!I2846U&92?8?OP# 4UD!&/GX"UP2
M@R"IE2,(Q?E36Q-*#</2=ZY(GHZRLE)"JN-5EYLQ305 R1L%FF=%--,X$165
M/F)*B#5MQT#UCZJ!Q:I\3L2VQLA>8K$D>5GQX!_E*2T6OS(KYH]\X'^(,1X9
MBE'AKM9?H(K<+SC.S\X6B^ET/IWV]/82'NZM#0>'TIL3HY2SQ:34>BV(I#1<
MF<T*^2X0-C"+]HYG^I>.C9GEA5PD3HZRPI\8-/P,43 %QZT-!P,\_Q'HP'Q%
MIW71TD! #['\)P:0$$]:V6SVC2+,Q:PI1(<1N<(GQI$84UJX[=PWC+*T9[E*
MQQ-'S4\,K(K<:6J'YSN0JC[3_*=?IZZ8U?^DN"O+O5,M00[_EAZMGDUGB]/9
MV?Q\>M++/@@#%2<(@68:NNA/B> O+2OEU!?E?)EOAY?8'K/$>ZZ?DC'\ZR!?
M^,?OR4,E/X"S<;7]UM0UJR0&GEI62OGR"^<@6&$J)19LF#\A341IK#BUK%2"
M%1=.3K B5,KGI2"DKUD&*+] :2QVX7?YQ"DDDI0X>2B33X2-K\2TRTHE1:62
M?QT]+4KD,,*/\]30[_:4%AZ$A#GTM3B5\LUV@L)^?G/BQ,.K]=K4 3K_L\ [
M)I6LQSFJ9=ER-C^;2O!XGH $<_J](L7R :%QQ7#'NAM#*C\(A-19 *B4=I(Y
MES#K'X"KHR8W8+5>Z7JPUVR]])GITH*#D!N=][G)S4UF4]/9RL<W3#J0=.3<
MLSYPDM5\O!>KN-I2YR"VJ?.^YF7?Q.6@1]0YRKOD HU\/2A=2BE "-!867%W
M[-M&!HICPX8]J-20BS^\_00I%'5VSQC.[D-/*- HC"D*._L_*!&.<B[P^>3T
M=#$?+R;S1<_9;^+1IA#O77QP>L=%FY%RPHO*JV3.-\&'8;R\VN&#<)+ HQ'9
MEIVA5F+','(9=?A"G"0HJ2I. 6#0.:"@FZ#V"W&R8X,AT2(VV,0.!0;='^-*
M H:&EQ-A!O1X=-#]"6_/,A<73J437EEG?N,GO#*(4T@DW">\LHJPL?VS@+>?
M5D4J/+2\0Q#EPS >TL.^G7O'=N*'44(W#RVNNUA:2A@(RZLH<@%RV\TVU7^*
MT (KRI^M8A7_-$BAT-M<;HL-M&6,YU+$])^:BC!Y!'&3J?1IT,.DNK%'?0ZQ
M^U+<S0YWYNE-><6 _M.R:];1\0:Z)YVT+T5D/]$EP3C;8-?KXS3C"D!,Z"9&
M!&'@Z2)2SFINB>2NFE*IZF9#T=-$39].EDYDT6/*T^)+'Z0IG#VO+"_5\\EE
M:U,\/!-;+!;SD]/IZ>ST?';:\QDFV<'*=79)KSY,;5$F).K!I3@3C@>6LKLC
M*LBTTX-*B=%Q/*@\'E1RH^A.LPWJ(>6AP+ P(7Q 22=40=$?SZBKGU$KE/8F
M)AIR+OYXN]N[SBL^^O.XT$&M^TE (\R#%AZ;[AM+.'Y\ZU@&-X(H-;(\6\SG
MY_F<"X/&C2#E"N:XN0E<V_11#A?;N#'?T2<Z6,@5%,>*&.&-):N1!RJ7CNWY
M;J"CSF]MR-@-' T=++0JBL-%E/2F'F26"#!$9K)".-@5I01/5YX3*A>(UK&T
M:/CADA^$HE>2$@45Q28@?R+MJ@=U+'4]V*%7SX&1/KJ"GRV !V0;RYWC^N:?
M^'LB PE@:ZIYM6'9)I<:#C4I0'C>.X2)[+@'PB=JL(K:4!.E7,THDUO8C+TQ
MT85@G"*S8H3)O!AA<F@Y2=@O07#)#\<QWDS+@@+/D\Z=<E^LC5ZR2*9TY&J=
M'R1IA:)6DE(95))F9KT1IKF59S3EF/OIH)6"7A -6)D7 U9*-$(V5J50H.<P
ME<Z517RE^VQQ-AM/3D].S_*>]*[#5VY,V_3!'=39A>'S!;"P&AB^7BD3&C6<
MI0I+AA&R0*'LXN.G]D_'O;2@7J($M@BT("5R:DJYQ#-<CR'#N)-/(?) XKVV
MHX>]"+8B)7[JBEL(0+Q<43 V A_.A=<47,08N O4 ?L@L[S&T)#$+7?"H28_
M%^1##N'B+Z++M#?0'MV9GH?N1L9/1Y O [/J? )85.:#@G$V%,ZRSJ1XJDJ)
MIB[-G6HG4T.QCVD'5:QJ4D*CLB2%0-'3<974)G/J$"7MWQ('%Z&A3PPW 8ZT
M?=PD-03)!T[T2I\86KT<.Y6"J ?7<WHR13>];QR7PBU19W0AR6N),SH]B/@A
MZ1$<QB@<QU<\D&+%S^:?GH[GT[/QV7AQ-CZ=]_-:-$U#%Y'T"-!.!LXB9*5Z
MNF;]%]"($:CU6Y92A]46L^ Z68-7\OD,.L;K/=1CSV_ >@4_'=O?5M@5<#1Z
M1&EE-GTNWT4)D]#,?7YS&L%EU-81CJ+<4?!VT6?94'2,*\;.HO:%H[Z?/'[R
M'?T/=-$*(AE%\>%4*_C+"_3:"8HQ@7,IH^6K1;F=%:/<TGW_B[9WO'\=A4/
M^5;PKU_Q*$;I822["QE"X@[TK-;I03X"[.? SW4_;2&H7Q =#]H'OLC&V%;4
M;+3?H)?KW=YR/@!X NZKJ0,\S@*4EA8>!@X<>P2ZL['Q8^8 [JU#\OCB8QKL
M*SO)S^?P8_^ZKAETE0?2M,R[8<3<)$F<\<G=:HUU#B7"AEA>2OAT)^P2H(EP
M:AB!-FE*J+$TQ8)RPD-(1$41\Y&IH$<"'=8[-J:;<<DV5TY*&'"*L43^/.0I
M*/[EF^8:C!QCF3)2BKW/Q8')'9Z(A/X7! *GX*;$WH09*RX^#F4B\PS3?F"
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MZ"AJ=91IMOIT2 \^G FZ<9@ \(_?"]20M!VE8%V/+GN4CX$%)N.7TPGL=VE
MV #CQM(VN2%22F;1.)^?G)WW-PW9/$=S39":=N?6>:-:FBWP>\?FESFY\$#%
M+D90N^E?NY9\FO!G=V?[/#/]4'"@$N<GIMV,KCW/<ZK B64'*G,A>MH-&BP5
M>XGI!)D*_WF!&\U_^_]02P,$%     @ 9(0#5T.PKZ2^G@$ ?CDA !4   !S
M879A+3(P,C,P-C,P>#$P<2YH=&WLO6MWVSB6-?R]U^K_P,?53TUJ+<$!0/#F
M7)ZE.$Z79Q([;3L]T^\7+Q  8W;)I(JD$GM^_0M0%\NV+,NV+B!U4MV)+A2)
MR\;9^QP< &__W]5ES_FABC+-LW<[9!?O."H3N4RS[^]V!E6"PIW_]_ZO?WG[
M?Q ZS'IIIIS_^7#RV9&Y&%RJK')$H7BEI!-?._NJJ,Q'']-2]/)R4"CG"\_X
M=U5?J&]M_D-H=+?]T0_S;,_!X6OLOJ:8N@[%>S3:(Z[S]<OPTHM*%U 7,BO?
M[5Q457_O]>N?/W_N_G1W\^+[:Q)%T>LK<\W.\**]].K6=5=QT:NOI)BXK].Z
M"J8&X\OU^S\>^H$ND_DZYJ4:7WYU[_I;!3'?WA2DFGWCFT*\K@J>E4E>7/)*
MM[\IHX<P1=2?N@DJE;AU(_U^]WO^X]'[A,@EDW*7Z:Q2ZSJ2U__SY?.IN%"7
M'*596?%,W-16%UG>_'"Z:?S7PR_'ETIUY[IQ*?47=<^.+U1"SKY0?W'KPI+_
MX+?*+'AI/BM%JA&JREV17]8_P+Z+)S\J;AH]X65<%U=_>.O.@Q)]Y[Q__\+1
M%[<N3LN<41+,P<CHBLG=J^+!BZ/7^MOIUDWGW7?<&WH8.,[;"\5E_4J_KM*J
MI]Z;UD#C%K@B^,^WKX=?C*ZZ5!5WS.V1^G.0_GBWLY]G9H2BL^N^[F,Q?/=N
MIU)7U>OA&'K]_NWKR8/>QKF\-H7=ZW%C#E2&OIWNC.\NTQ].65WWU+L=F9;]
M'K_>R_),E_9M>K5G[J&*X<M42I75+_7W1]IL%*EP,GYI?JC2O:XV#]*8B$\]
M_GW'234\1(5N+D6$JB#T X*H2!AB(E$H5#1$V"4TB'CH,QF,:G-5G:CDW<['
M05$/A'.B_S,-='Z6G_OG+CX?]NQPI+S;T:-K+\[SGN)9PGMZE+^O_WG[^E99
M'R[Z_J H3,&UP>.]?RE>'&3RH[9JLVK!2>3S0%<@43Q$C"81BF3$D6329XJ[
M*HG8DVKQ'NF6T4-\X=)^'-GL87&_ZF]S^4E_5LXLKO!"+)5 .'&5;O08ZQKH
M@B<:Z;HSDCA(U-.*^P_ZS)*:AGVPG,*3"7:YBV@8Z7(&L43<)1*Y810K$3-)
ML?^T<IJ_%R[I0:9'W/6^+FO!>X>95%?_I:YGE1,+&BH5"I0D&K^,"Q=%+M,8
MP))AI30Y4?FT<F)MN[$?>2Y^:FF'J#U1_;RH-,^?5KR:W;B!3XB*?$TDL0@0
M8RI$44)C%,0QB622> %+GE;H?ZGRB:4]U#<ON*C2'TH/+3XJ_*S21E2I!(<Q
MPEQRQ)3GHI!%QD)&+E%4D4 ]S4[,*>VGNDAY-E6,\4<HP1[#@>YJ[ 48,8EU
MT83G(9<J24/J<VGX?5C/$>/L[>>7EVEE,%]V,VGLM.X837.I*F\7N5N>'R?G
MA)Z[=8GICC/(TN%7W_0+HC_07+^7I3UMUXN!,<>O;Q=YH2IX22P#$2'=9%2C
M-0Y02$*,DIA2K/S$$Z%\816FS/$J:A QST^$FR#I<H+TFP!QJ<<;#P,A0AZK
M0(5W:_"U4(G2\)*G52[^^"?O#=0F&M]704*I)Q#S/6QPS%'H:2/,I7ZO+6\4
M"_+,HJ^XT45"?2_T)0I=;D:@DMJ^:2D:*=_3O(VQ[H>[)3^]X(7ZH"6VALQE
M7V5E/2*[A5:T0\_AP_7-)5_YM?FH^Y,7\D!K&F,>2EW>&G7'U84JSBYX=MPW
MMR@_Y46B4NUC'&9#LGO*X#\?E>^\?I813-VKM)Q\JF]8BP@MS^K2E5_49:R*
MN\VZE%;EGL*1\#F*(NHB%H?:"G,N$(UYC+$,<1P'ZVO5O^M;5&73FU03<"1H
MHDTTT4.,4@W94#!MY+0*DR(.D^">=5A=D_Y3E;:C]/5M(5];F]H+>__6^+Q[
M9>U ZELZM0^\5^FBO-LIT\M^SWB3]6<7A7GB+:=E]ZJ4YG&W[S%\W/0SZK=E
M/BCJ=[7CM#=JI;I[9[:2.S+3-ZUDE$[=5<,N,?VH/19#6-.M9H@LSVI#.FJO
M\2-5K4C&[U)IWB>I*IRZZ&JFE[Y_^%^WM=K='X]O5ZKOIFC#MU(_[*K?2T5:
M#<O@R%1_.XS23! YKSH[[Z>)^59]WKZ>^8CWX[)-2O)Z5K7[-4HGI:YX41F?
MI];-"!/]O\E])M]-VD].7>K6SLOM;\;OQP]Y?:NOYW8]FSM H.M7WO5L\:[W
MT4US+*_KZ7374^CZ-74]7;SKZ=*[GDQU_=C@0]>OL>L7-?AT60;_CB?SQ+X^
M415/,R4/>)%I_[1L18?/KM0R>WT8BZYFF._Q-^ONR*Z4J;$ O/>5IUH\[_-^
M6O%>*_IS;MV:T:W/%=\P/I?0D=.&=E,=">.S&=VZZJ[8:"UO0K5@AM9LANAX
M=G+#/0EVR.I^?:Z[#@/TY1VY$AT/XW/3XW,E.A[&YP;&YRH$'XS/C8_/E72K
M73I^R;6<J#\"9FC-9HBL2,<_M2?!#EG=KS#CNH:Y%_O"M=!]5D3SGAT=@?YK
M=!0$NJ_13C)TGQ4^U+,U*?3?AK7G) W(T_^-TX FK\NB.C\QV;EUIYEW7_A5
M>CFX'-;B)DVVQ[,C?CFZC/_@YV<_\[.+?%#R3!ZDWR\JI;)Q%J\P=?RAS&_L
M['-=S[U)K7?>F[>WJOU@GRZ,INGVVJE7(>X]I<&6":J[V4B>_M_D/O.SD:8O
M77XVTNR$[(/+?B^_5JH>8L/L[T>Q.'5M-Y-3*=WU([IF991N'OUP;"\F)X[N
M=*O<V)T'FV4E6'U.@S;#BWLQ#%N/&ZNZ:X;7!OUEI9>VX"J<=@D)V^G^::M-
MEI-W_C0[^]#Z*TL[^H%1^T M6F9CH:\V'@4CNJ/H[;ZZ;U%/U/>TK%2AY,>T
M4*(Z3A+]F.R[^=D=+3WQ>O=[O"R/DYIVFNG S[#!CS?$R]7S@RVXD8@K090N
MD<O9Q(IK,F<+D'FW^L*+/]0HB/*UR+\7_+)QN)E3BU52-9LRZH]0-5ON$C%O
M2K--7C\_-M0@%&PD%+0A?'F+2\'I2Y> +W>(*3R]!!$#P%H%,&QF'!8#&%[U
M0D==8WT377/=-%4WJ_>7Z)MJ?;B^IVH_*UZJB[PG#R_[1?ZCYG++E>T"U;M1
M'W/JUPS_Y(7=JQWP-O7FI#K;T'F?!D665H-"Z>L^I5?F59N&YL/5VX;.W<_K
M_7[J[7,.LYJD5-FF[IU7P6WHX ^#M&=V26Y1E]ZNTC9UHKYL_+*E0FFAFC:C
MRV>$=$$2;U(2KWZI+VCB;>D]$,5M[EU0Q6WO89#%;>I%T,6-Z/.;]*2;&?2S
M'.;383Y]?KKTK1GU^>G2MRY=V6Z]9IILTD9_5V9FIW^1"MZ;FAT;E%5Z+VNZ
M-0QEIM >;('Q!-A4$RQAALT.+KR?+["IW81GYW@"- &:F\HZ?62C:X F0-.J
MC;@!F@#-EVP4OAJK^="BC=9 S68 6*CH  !;KIL  %NN3@  ;=< =Y-$GJM'
MZTEU<Z:E.1%MP'MGJKB\^<FQ+A WQUW6EUD:'E^_$'VHT48/F]EJS4A!"36C
MU/O%/!=/W;)455?H45G6.__=6C$\'H_'29(*939KZ:FK^A> K-'JQQG-=[,T
M^;'V6Q'&M'$+-<<M<3IG&4?:P0ZH+7)>X%2=C8)@XX=;ONB$0P!!BYP8V)=_
MHR!8^ZF'TRD>(^TYS/"8$J*?M1;Z7E^UKP7UU YB9B<(DQ&LBH_Z@3^XV:"E
M6^>HE=]VR]V/:5D5J:CV\T%AL<2\7[WQAEY/K]_*L$%,IL2-")R'C3N7VH>-
M,W7%RS:"XF[%  T+H*%E&(">7[CG/ZK>3_UM&RW!_:JU$Q'A.0UO$*'=!_]Q
M2/PSS7OUQ^5Q\DGIUN.]4R4&A;Y<E9_YSR9:A 7KM$(0X!#1<$$08$3]E4^#
M0DA\BT+B&Y^2?6C5[J<T2ROU65MF>9A5//N>QCU5QVS+#]=?^+_SHDZ9OK^2
MLZS#P(7YV=<>%\I.I$W6?RU>S3LK.F?7LQG3)2_K[MJ>F#;0X\)DQZ>E:=.R
MF\GCZD(5+>KPV@8\5M-F=/F,!4@PQ&T:XJM?< 9CW+8QON0^GQRT\?#J,MC_
M>H5GX$R?8+&T$ZBL.T=T):Q$[*KF\@_$F9\ZT-7%DFEO8)!ZX_\>7(G>0"KY
MJ<@OS53+H*KO=9R,YU6^JJ(.IGRXGGV#AA]:L+I&6?,1"'8F+RRZ:_Z)&D[7
M*-F A<0/[,,^LPZM<N07[6*P--MD:6Q-\0<8;@\,K<G1 1AN.0PWM^1Q@:F>
M4^VI<GWCJ3E@I>\ESRZ*?/#]HO9K+_[)>X/ZCE_2GI8T>3:>E)CC\^_S\F+B
M!W_(LT%IKX]_:P9HND7&<\=/:)*7SP[-B#3,:\Q6$_D#>E*W17ZI)EWV.1=\
MLGYBRH%0O! 775T8]4/U\GKET\%57[>WY<'C.=6[Y5P\5K]V>I,OA\;?56;F
M_'7+=>5EFIG$P#H=I#W@6*B&[83'<X(-<"(OG,AK$?G-AS"0W\;)SU9HP*&6
M6]'-H'&LT#@;]XX>B"\!06R6(#8:>GPY-,!RM!@>\R/38#DV;CDV'BT&RV&S
MY;!U_\3%UIUWI:QW:N&]KSR5A]D^[Z<5[]D-C 67G\^M6_M#;<_=E 0@T:HM
M2F9"PH(T2WM::!F;N,"@::TH?^Z6+@")-FSP<F>EG 6&<QV+P^RJYO(/9)II
M\BVHM.46T,(6VMR.3X\LY7C:M+:M?+"T>>C6N%70U5LXTV\R-$]X]GV4;:+?
M?4FS]')PV;JLRTDM=]Z;M[>J^6"/+XPQR*1\"L3XU59 ;+J: +$50VQ.GOG!
ME5#*;- ]E=@QE4P]M 04F[.4E:BS^C_RZ^W*.W])$P&TUP5MV/!_1B.T?,/_
MC0-TO/?&G3F7^_:P6WWAQ1]J%&&KSZ+GEW8":H[AF5.+97;K[6"7-]6I2X@"
MA>?NQ)1,7K>#R"RDC!!A=\$1.7WI\BACN,FF35N-W-V#<E&C=6=?DM4?Q0=C
MH>'L-#^GR+:A8,N19/-"/@LY4Z7W(>WU3,BL)LO1-%GZOWRA!4U-&F2KBQTM
MYI,MT-*-=L#6L0OH8R$H@/R:8ED ^75"_BRM>NHX.<QD^B.5@^F8@?Y,]36G
MZ&)^3 LEJKRP=*V6@<S,BHPZ[>&:-*/+;G3[2YEY2[?3V PY;\U&':O8-7(1
MY#^%H 'Y:^1H0/[+D8]'R,>/(?M36I35_>9M'93G 6YN&[0%8=B<OK+Z'7EM
M"XAL(OMI?*2V-2L&;HO+<+ES 3,#H!94>B.1PT&6#IOGFWY!@DDS7"I>#@HU
M'/VC$3R^Q?B[\7MSC]GW\^_=;U 5>^6?R3/NY4WN5?L\:OJJH\&E.;8G+^X^
M+BUS1DFP]^WTX[PGWON]^?"CRO++-)MUVU&GU%MAS+OOK5N\OEWZ1RO,[C7>
MJ$/URZ<WGSN[:U--,D^_&;UWLP4;>O;M'JCHX^VKWZ17>_JB?% (50[?7B@N
MZR&G6_K]7__BZ#]O]4M'F",@]/BMOS8G0)D3:PWWW[GP_=N^9L7BW4ZO*G:<
MLKKNZ5&?Z.M1PB_3WO6>\Q]GFC1+YTC]=$[R2Y[]1\?YCU(/L^0_WM37E>G_
MJCV'L'[UIJ>?@2Z4$87Z$QS^WS>7O/B>9BC.JRJ_W'-VM=G0UXT^[:E$7X=W
M*4FS\6?%\,=X_+[*^^:=&<6(]]+OV9YCB%D5;W1=RC[/QF7^>:%[%^E/A-KK
M%PK]+'C_C?/<F@S?FSOO.9E)B.D-/_HYJER<]^2HB*9X?2Y-0H!YN?/^V]'A
MV<%'Y_2L>W9P^O:U*:1N]KX%+=VB1CX]V/]V<GAV>'#J=(\^.@?_L_][]^CO
M!\[^\9<OAZ>GA\='*VAYW(:6QR]L^?_6ZEB_T1J\XWS<W=]U*/98M/S6CEK0
MV-$";3WZ[('6/I_U9UL:>UF-Z*S %OA6MM@S*O$26_!)7S]I7*U&LCRKU64J
MG(P;_T&J=.]C+@9&49LU&#NU#A(5NKD2^5A%PA<,*15)Q'SAHIB2""5$\,B+
ML9"NV'%&4OY$)0MX-W:VEG;Q_S%!XJW6:O]0MLYN&I$\*O94Q8;UTM6J>-Q3
M]_LCS@NMI\W#,_5F^ :)O-?C_5(7<_QJD=;F@RJ_T^#U1S]365V83L/_US1O
M58P?/>Y.O(N-7C;?R=O%&CWOIM%NRFB>.>OS^LFSOM!]?NOC4>-.JC1I[@EX
MQN\GZ!E_,(+/#U54)FEW#"']\;BRT2ZM*SMC $SUC7G0\P;NJD;$4YF,+)?)
M7E>R12 (HET,*-AV%!"R&P(*GHF"UU5A&.-!.-P'P@P(W.O\1[O]10;>5H7S
M;[.@)+G>M+<R;W1OK#OGF>I-]J>[2_%-*-%.V3K/07AE,MZ<XTS]9CT$YMEI
M&-)@JJUV1L%2-R0"_EA(Z1\#7NA+>]<GJI\7U:SH4I)@*CB)$:;20XPG#(5,
M8!0P*7#@)XIA[TG1):=>(%V]VTFOJKTXSWN*9U4Q4$\GE?_6?6CZL7QR?'X^
M+)]:CE__'.35FTEIAF]WWO_Z"_78FPG$9\>M-C=',;\-?OV%^/C-]-_C&EC)
M_/_XUCTY.SCY_"_GY.#K\<F9\_7;R>FW[M&9<W;LG![LGQT>'SG$=8Y/'.*]
MDBW2!P\/ EMY8PGH!#VP+3K/MNZTU76S?+)AGNT^_N2<_7[@3&4D3+(1NOMG
MCOZ:1"ZS'AE-].@L4OZU 7]=3QN-DJR6U)">Q0WIV3@U;R?RUFN3/N6%4UTH
M9^(@.5_KS%CG()-*+CQE/_S1P3#)=I9WI3SL"^%3%"=QHKVK0"$>*XZ(SYF?
M>+Z?Q.KYWI4TJP+T;R\DO[Y6O%"9K>W]GX-,.2[N.*82,,>_CB;/B^V8SF^)
M\E_9Q-LRE/\:IV3;HORA/]NEU[>N/R'BLG'W 0(NC9^!.2MX-MPC\^$IF# D
MD1\G/E*N%R(6*/V1PA'"*O+B&/LR5/S%4S )[Y5MG(,A?@AS,&MQ*,Y.ND>G
MA_5,R[9-PEA$)38%[T$BM+-?;>M.F)2Q8%*FS6UO\4(Z.QMLW<N5QO'Z&SD]
M#M@G17[I3*UATG;#>6!)DY6V#32(I?.*H2TK(4(;S9*E&4AK7NN_GU]>IJ79
M,,OYE/:4HUW.V,R7/#9_>%#O_&-^,OS%S,1,S'3KJ0!)%F'$N(Q0+#V%"(E%
M0F.3F$FM6/;[TD;$&",:15ZT^GG![4'MDU;_+M\\V+GZ_Z9L:[2GIUJQU,-R
MNGTHM2-,.31$)^I[6E9:6E5FI[]9Q@B'E#%!0^3[-$$,QS[BC$8H89X7AX*P
MB 1+-T8B[^7:F/Y"/K$H^/AFP59]D3WGI=D(RSD5J<J$*CO.829V5V^7U@V'
ME=BE%[>^L]+PYUT956^:+IXR[%\=7'%1U:/'R1.GF(P:AY=.V5?";.\GG333
M]RX=<5&G%OVV?./JVJSQW>5:U_;FK31O[3FEL ,![$!  ]B! %! O=T(4+#U
M*&"[+J"@;;.G\WC>UI"T'5,^5LXPS"-L^[MS?N1"N^=YT<^'H8;ZE(3]?)!5
MQ?5^+F<&,D+N8ZQ(C!0/(L1HP/5'$4.,L"#FRJ5$R&?G6J%2";,[>Z7Z1?[#
ME-7>%1D?58__Y&;S\#4F3;VTT T8;'-T4=,'VQF_.AR=8B#J(?'PY(4(DCCQ
MA(=XX/J(L4BB.%3Z+5.AAY6B49+8,'GQ4D!&!)&($-?U81PM=QS-49;VCZ.-
M:Q#0ENWL5^NZ<[G:LA7SLW?[_1D3#;627>ELR-+2U]>:LO[TIKQ9!0O-^))F
MK"X4M.0R6O+?@R(M92J,UH4&708T$_M9<KE.(;#DD"4/=T]V3W=M'T1.(T;1
MP66_EU^KPOZQ!(XA.(;0K]8/4W ,5V"ET^GI#MN)KQ&\!_[ADIKQ.\_2_ZUQ
M:?^Z;]#CJ\# [;DA&%9+:-+A!%L#!A2(\A>+\E6L881E.'8C;_Y\>U?*0I7E
MZ)_/NEADYMH<23SJ^0)%"0\1BY5$D>_&* H%QRY-@B1RFS+7/K_#_1 3YVC7
MV>=]8TO-(HPS=<5+YW?]ZY_\VKHY^/G5Z2RX3O0^#N@L'!"BA'3]"(6^9(BY
M&@(QQP&2$0ZD#"4)A-\.''P8I#WSSB%OG-.!+I;C8MSNSM_7+X^+L_QG-C.K
M32:>P E&<4@BQ))$HI!(CD@4LT1J  C*VM'U7;,L*6MW7]>SO\?%UR+_H1W^
MF6F,D>L)X0<4*9\DB(6>,/E5 B6AFP2"<B&2IVT99VW;G?U/PSK[:7W]-2\U
MD_U_:?^AA%7LNCR.PP@%Q-<]G;@!BEW%$4^XJ[R$>%[2$G8/PL EL#?XFE#Z
MZC&8&L;I%HH_!$P>8*I<%2+A<XZ8T+*3NU1S4:1MD%1*B<B*8^E?WE8>H0VS
M0;\]:H0^Y]J3_WJA'?^'DWAIZ"O/$PJ)1%+$*&$H%I&+2)#(*)&<$_FT7'EK
MV\O#!%'&V.JMS\IV%5JC]5G"2OH1^W4<+7!Z@UK+_V_:UUB2JG-[;?VOOX24
M!&]*IU_H:].^=OO4E1*#*OUA5N$GJ= %YIE<?BP NLIT5:5ZJF_LA)/5AF*Z
MR[BFA[K/5K#)P5I"5^--#NK/TLP$L/4EPU.2(9ZUWE9<M\T_U4:D2*M4/VMH
M;52AI-,?%.7 ;.E1Y8Z^HMYID-!7\6_&*ID="+NBVGM\@PK3B.O8GN)N-VW7
MWA3#.XWKZX:MWY[BZ05^V1C!SY]YLAHJI/5(@<T+%L*!M]2DLX4T"UZC6%R7
M,H%!LZST/+N'"YA-,)L:!VR.V00@O#@#N\Q[J71^P?4?,^AT*=:4T[.XHEY5
M0&6=]/BR6,J3S\])JUZ]<:3BXL(1/5Z6=B9V+6ST5Q60L!<#+]UXX7;6X>/=
M;HTI6+)2WG934'#S9D,QZ_:VZ^GUI?[Z56EIQNPJ#>N6]WQC#>L\+0TP>"H,
MCD9[<]<22UV)"YY]UQ]DCBZA_N0FT+^VA9&S@/:25/LE:_+UZ;&',A%&\S#7
MA,:U0IZ5B>#*T ^$C) ?*858$'DH4I%"Q*<8\S!A-/+:D8E@3I31<#VM<O%'
MQ_D;-EZNT^>%\X/W!O9MUM?(9:K@WZRPSY]*Q!NTJBOU<#9O6$=.QE 3STPB
MCF(_%#A"@8<Q8I[9I#%F/I)") ES<1!%+5DP<-K]9Q=L)]A.L)VKL9U+=F(V
M;SO'HO1@Y$(\="Z6&_L1";B'8I40Q)0;HH@G">)!)%3BD83QIV7GW]M.VC@Q
MF]])^I%ERKR4_,^F&=CQ*L(OO/A#56M<E=O6Z:VM2UE<"=>OL17]S3?AND?]
M82;-!A7*B:\=<:'$'XZ^\ _GYX4R.US6&9Y3Y[J](K\Y%[QTDK2GI,-[/?UE
M/R\JDS+ZYR U":-5[L1J=(&^YR1GU'7R0OL4K^0D<W0JX71,*R:;U'QMSEIW
MI/XV^UY?JAM)J.$*5^I<ZMI=E,XK?3]-#DXY$!=.>9&;P^6<OJH/P:XN>'6W
M[#_Y[5*:(@Y_/*K#;QV3-^^\HL,ZQIIB]/?QOW4-S/7UI?I'IA2C^USJ/B[K
M0M2%Y&7E1-B1_+K<=?ZERA=MJ?'?^CFFQN5R^_NIQ?CUST%>O9D49OAVH=L8
MMD;I%;I(I1X+>[=U0N 3HB(_U()!!(@QI75"0F,4Q#&)9))X 4MJ 4@]=B,
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MY&QP*?-J=,'.>T8ZD1]UHHB-IUK'E6CQZJ(-'(_5(LH&#6<#(&#) 8@XFX$
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M:33#3,(>1WFERO.S_'RR!]_YC=N_#;&/N@%TOSH/!$'F[DT(CEI;:73MCEH
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M 1- ,>"K68J2+6"3C?EJ/OAJS036Q%<[N+I(X[3:BD3(<5W!,VL];:[?,XO
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M.7]*.RZ%/1XL80 P_B -0!K8B@Z0!B -GAV B"(IL J0DEH5,,_W4.R)&,E
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M!ID/XIZ:<(,VVHTD&VL%2VL0^+>MPQ0(&! PSY_$XASCF"'L2RU@<$@0)R1
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MZQF+?U>9*GBOSA/B\C+-TK(RX^"'LB+!L2%2&,)LVX436,D#. $!; V)M5
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MB >[R+B%XL%U"8U9'"/!0H:8%RC$XR! +/ 2'A,:13AZH7A8R:X]42<B(![
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M-ALC<Q*<P9C -"P@!:0J  64*P#%<J"T>LX6@ +4 T !Z@&@V B45D_P E"
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M % !J"P8$ "H %06S,(!J !4@(  *D!  )6-I.( 5  J0$  %2 @@,IF\G$
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M$@ONBF#]'O@:O6;84P%R<):9@Z/[%RV4A]-XD$'.C4U.4^/A! X2)"*#,P3
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M5+4C1'4(9[/!E_5?-0>=_]9.PD=^H9^]".[,W)\OR]D/)G#)RU+SW^=3TS9
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M04L>H8*6/$(%+?G^8^5^2]Y#2QXM^;U8\A_>OW[S_O.;UPZ\^OSAMW>OS[_
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MS(1!3\Y1 6B+7NVJ;,]SIRK&F9H]$C!@T\&^  _=.L<.2O4;/UWV^0PQ.C5
MNJ:5+T(F0\(E30C3G!$>TYAHCVH:)R+A ?LQ7;,R_553TOZ8'I\%5_.3^PLE
M]V3VL'I/=_0AJL*.0Z>[SBV$3L>ATV6G%[*HXW=XDSK1GIO$DG'BBR@EC(J
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M;/*YAN$F3=A_>7(ZIUH>SFSKU[+>[LC@K4#8/_%Q\,C.-FH$(SN=C>QT@F@
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M-<4'[L6[W>_%3;76\;CX5CD_V7L5TXK;\X/T=ZF!**_YH2FT^O/SKH]<[XO
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M?/Q#/$W6O9\= _9\0T4Y'(3M.0-A>X#MUV?^=,QLZC/?*U2.Q:KVNHD),3-
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M%.S&:P4V&QAC^FX2[,>T*/'!=ZKQRN_P_#7/YJ-1)K3E&*OR7JE-1J#_-(M
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MO-5@T)]7WUWVKK:=J[]^?+^^I=>%[_OPOWU2:SN!%ZO0RXCE_1=V"R]A_TR
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M;_7,ZCP!P'B.__II)*2,!:[D)'00_K:,290D$5%!;-N>=+A*[.<XB'!P6+:
MA]F)+^4T?U \[[ "I)=L1CF6*-OF+//]^Q-JL"VT\&D&B @H+O0&Q>W$QP_
M,"9*E(559K!7178]AF?!T %R),8]!3,[WW?ZZG&AB<@0E!^GL1]+4'Z.$WNX
M^UT2"IL3Y2IN1[%TI,V7E=_5:)0)#BIKM6CZI9JA7LJ,155&VZJ,>.MTF56
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M5^4<,S=VJ"L]HE3@ Y=BV,I0"*)\GWIQ:,>^B'8KMK;E#EEV^,EI+OE#?RP
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M>%EL;CK;QHWTF-T%]NUUSF\O:A,O!098ET+ M#4@45CRBFA)D6DI%&/=K-)
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M6GS$% K#(8MBDTKAA_.X.NI\/>J,%:<>IQ+;*\?P3E].$83*%)^:LJ:RO(F
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M:W,YNRG-+4SL7'<<(UEQC9(#]5_<B 9MSYV@_L<.U/\ER,1I2VO/Y, X!G.
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MJVQ#[=;._*;FB#P J_<-S<VE&;2P-F.J]/4>FMXIMJ8_1-F[+A+==D?\7+[
MQE!(6=!H.&(T)8K*E"3XC)FN.$(U2!,]#7%QAE$>!F+K]/+]-ANTD80M;)40
M?;*#93.93]/EXN!MY>);1H@<D:Z7A+P$\<8P_F#/=4E6@IF4@.&G&,4O*B"$
M*=6W. $L_6[FE]Z16']A\'QK&"MSM#*# FN80<V6"B*6$>2@M T!P.R;C##'
MI=?EOZK".+L*?;432(12JXG%<7)E@"\,LBJ6@E3Z[Q42;'_;2LV)E4\@A1:$
MIC6X'R\J/412U?FR8H0R2W><@-&9?&,XZ$&RX'M^Z$*5JV)FOSBO&5!R8,*)
MFC=;34.-31FJ.08:'P\[!V;\MS+]H)A(\7(T^.V 3]FA@.E+U9?ZZ%UF%_0$
M37&=I0DBNUJ/ )O\W.4)HZLTIL\[F<Q[1SU,@T 70<0AU3GC#1V\*P*\%/.+
MH[E9%S@(\8Z60T6=#OFMQ3:R_T/GHQ%-G5,1N:.$9F7M#J+^8-"TM2#UD)M4
M?;'#^!V&\2E&E-M4&>AL UA4=#ADYPNJ1%D(RM"-0G/N>9@R$"_HL3 *G]&[
M80Q9&@Y ;72%>^LD61JK_GPJK2!2@.#?C'VSB9K0!A/H&J@^'_(R5(E <LKV
M)*Q8^JR>,*R3M=T+05I( H1!W@$9 **5Y0MP=NQ95"VVJ=4\2E"RHFC')C9Y
MY1.\I6\G28=,G^/%TS2G9&CL3K13-C$$.6O5*JNPP<+AZS 0 "I$A-,8JVAJ
M,,])KO#]M IA/.;22=/V"!-G8N,KH$0IU'4P(ZDJFRB.C1(KDZ0/2)""Z4AY
MY+Z/*>YP UD/%0R\UM0HO9GH<LS#2;<[I=O79+J#2X#J'!ZH-JVRH]:FKN-;
M6/D?R!@I+/P0[3&3\'Z7\ &!85%6.>9:J2,N\$P6L%KYPAN%IK=;4'P#]4&A
MM_)G3/ UC@%Z%HC> 5A1908OB ZTC;#M$-MHY!=?@W:2&*GFY6]9:BXE;]ML
M[0KID'9Q0TNB9+,D4JF%?TB&"S3&'XUGAYPYHG3F]/K"(IQ.8(CC%H"%GL2<
MFVCB1H,_,4L0%*0K;E>#F=U:UYP:"B'_L7N-BH-I FI8!4'3^B?055%F;%"B
M1N&>:I57P$FLIJ[C6TBL?\HX1W0*D%F["U[I::+9G9A9_<PXI0O#!QG$,EN.
MTX#X_*DX30BM FM-L+KCZ<@(6Q\^7)Z+WL%._V"[(\[M6>5 YP0NR:F8)2,(
M=1KPEAU#ELXYJ$E,#+B:.[+NR+;QR-X\'92 N"P%W[I=; , /'\9W.J5@JR:
MN(@1@235JD1_NG$TJ8O"+1D,*%S'Y;LS^0V%)A5815%'G)R=7.Z<)MC "G0)
MXXTWW:0G(95ZP@"VN"<F!B^VF6'TN!4V37(,"X3N>-!]4D[VRS,_F9"W1BY&
MNV"03V4T;\8;]A]'T'AY8ZW\1:.^Z%0!C#HV5."5G!H4,\N:&Z]@;C4=QBY*
MKE3*19/8Z[5HW8KR&F7H]MNO\%VD\^-CSM\M4*CWGK4#A_3:<J17*U)Z/2M4
M6)X8/T7+K/K><:<G5LQ9'C_*'_[>.SQ\!&4T8FF/._WMQ@N5[#%-!1JQK$"Q
M!XYB7V=I=SN[VU4IZ*KGVU0]WW/5\RY_Z:W4T08[+SC2L KM?C'GP.GV[=+M
MR=.[!EI]O]?9=SK2JPQZMW/@M/I7H%A@%HYB7V70!YV];2?\G/"[CTX^?K[H
M=9=*OUT\FTS[>\C^@+WT.\?5KYSKU%'8_13VR]GE.FA7O<Z1$U6OM;).N7J-
M9=US!/M**WO\*-GWUKXME]*S6>AW7PC@42MQ$LMHKL,R'V)9"L1&[,#;$*PS
MJC93Y5U,0"M@>L)8[!U^7\T7>\?P"5BU,!5C2>T*,&G)I*O!E3M[G4-K=>VB
MJF0R4;<6,F^V'Y5*YDAS,TD3D29*L D9B?YNC1Z],GLR4)CF"%0;80U#!@0I
M]@WQW4^U??1%,]&"(FJ)=B4DZEP&;2?2S[5D6AACQ4N%Q/5OE98 HL:=L-?_
M'K6:_;WOL6E+0+#8U!TBR+' P"*"[EBD$$)NF>JY/PYEEH:^T//)%.A'"XIX
MVV3@)*XT+7L%5:G?IJKFOM/WFZCO%VH^'(US6UY6E*RT*,%\#6HFBO4W]0*F
M8DCB%IF6-A)!$HL&>%Z!:SP(DPI^%7:NP61V@ND/TXF(^.[+_-\R!@ON5[@]
M#:\]\7E\QC50.'5L2Q .0ZRH2L.)7%9O:/OLH*!&<$9K$B)*99'E2DC'!<:3
MAO%@\YL "S=RS8KLS9*&HBK"%O1VQ'FU\K$HHC(]#0*JXO@ -^U\X)Z2E]3Z
MX/P:6PT;Y$G*(:_44A;]W[$^!!?$KT)125@I>-0[AAU;9/$7\0Q^Q+%LD42I
M/=="1A=04@8;^QV7M<+S?D%0*'K0F>)N7C# 2UJ;K5_.+K=Y&][G451:WI<J
M$UOO3RY1 YKFD9G4QY_ZO8-MV@E:3DR6SZB,K=Q_63G5-XM&VU0WL@;'^I92
MJ"H6>X$>=HE-7+GZN8K<GLVG!I>.*8Z/<YE\4F+I45&11T5$95T1HH71Q?W>
M3O_@G2A*BVY>@56+W0X<K"@P=8BVIBH?[)#.7@#FQ0E#F0?A<(A(,;XBG+=*
M(7)A#MQ?2W/#(EU)<<7;6Z0+3FFG^S_30$5.V/2R)SR<35_*\KQ[-VHBK4O*
M:V<P=K_3=<&M5TH<VG71V%>@V+XK8'FE01]VCERJF],LUD:S,-IZTY?S+NV"
MP1W:JEWT]S'BUO3U;R6O=N6QKU.?T'4%W:]7'MM[LVROS72V57"5"<2X[#!0
M<TC5,'OB!7>9P2ZNM+'0!-%<>-OQR44_PM2&K<>ASA+T\)I.!S8(+E BF\8!
M<3Y1(/:T**'_0FQ'^)Z;'/;0$:_9(T>NMZCZ8!G91^JJQQTG //@!@ &@.ST
M0OP?FI5!$\/YO35JT"HKL!^K5MT5(ON/< +$D/H__4W+F=Q!!+KNP6[WNM?]
M:P13ZOPY'16+9Q3<@\Y^O]O;/8:S(NR2]#N]WO[Q83^,_R9DE/WTM].Q3+,?
M_GY]\H[^=::TGX93;@^2PXI)VXO$0&;9WAU1<H4!GB%08NPKJJK>\!UM42S9
MU9>[]6GN^KR"P7H79[52[\>FV]447+;!U4(NEPJ":7=4$=2]'=(M%E2!>^3V
MHJAN^K)TFC[ _]#Y]/\BRDD^K0E)!U/3)IB:_HVM<S U3DPV)V7/+5>3,QPO
MN;_ F<SD1BROH\;V>:TN"TUR27L+S/1C%P U)@5R)D61/%+<,2/CK$I* %N*
M<0]*-J62Q@FU9RD2V7$RZ(V2 6JP2J@9=R?[.DZ5XHZAZ#K;41.5CJCW9.U"
ML?7U_.1<;XO$]_,TY5%@C9+IQ($Z,H%<6]?:C^+TTW]?G.WTCL56K__]MB?R
M-(PQU31+I8\N.FP)3FF.O>[W[+M"^2O]L1);Q]]O=\07A7W7X%7T:DI<&U F
M?\+-P^LOI'ZIJ?)5.&/(_0CTZ@RNA<5-&'H<%X2S+X&>8 UQYE@<D,3<., \
M"G5R'W8TC'-*Q#3)N>B1"5)Y)<DBX$YJV%,=:RBQ=>S'GWI[V+9]8=W@ZUW3
MO=P\'AN24E?Z4,:P]7#%X>.JLM;J!#HFUF21^G/1*==)U4TBR)9)U6H!0:5'
M=[VH@L(R/GPU2!,]I0;GPR@/ [%U>OE^&^.($<=YZ,+^?BE:3/>)&UW24.3(
M$8@1ZGI%W3!'"796RR<#= GEL9^AVZO: (9Z.H^PSS17D!V8+E;4&\.*X0YU
M&]<2A,3-VA!X#"6%8Y\;Z8/).@E]&KT<\!K@^TXQM?SW.$1A9++,<1O^)TF_
M=<0)2,^%=N;TCGM::7NB[*5=*!9JZ=)3VU.@BADJ'9C,7O3PJ?24)RT&[BEJ
M&*AK!M5,8'T%.<JX,_D_<WA&_]C#ID ])RO;RYH>&:I>"^8D/N]0GV$NIX@Q
M:IU<%>HL,849')B#'2Z1,"WO!ZC:AJAI9SO8-W=#JB1<\N)S2&V!J5=*BT"6
MC9,H&<T]I">9LT6"?_6.>AY&+4R9].[1]_1;[^A[#YGUE'L58BLDH)*QF/X0
M9>^Z'<RU>5S&BZ-)1Y-,DU147_8'P^Z5]!4V=D45(#9U]^0G08LYPO=@N5F(
M59'#W[:K!'O89X+=WV\(P3IDB34EV3 > D%.#,GJKU_./_2)]/[G/W_;V>M6
MB?)@GXER;^_[YY+A6P>3G!K[3$O@X)9\R\8Z?7X+)V%F7)] ^Y]*L_>2S%XD
M[,5F>F\%>K*2\.AF(YJTS-Q"1V79#QA=.8L-@3E,R"Z<(,'J=O+B9V&69XH[
M:8.EED=4^ [F&@C13*4P+W1%2(U:Q@A!&@BN8L;)F10!X0<G:8G$@&&%2G;Q
M,CR, A&@Z5+Q2SA***.YF#/.#H,JU<[NQ=1#1,M(*1K#NX#H(29<%,$;8*5!
MWPN2"8PO\&S^U Y&7DQ_YB)G^FO=^<:MYGF?X.;"E<0[.I%SW##0,',88H$V
M@AM12>T:A%+3<&29=5M0#;6"Q5]P_X=YQ(E;"+*2AWJ,N 572L4\=9@O*)R:
M1L/S$3.)""# /COBS" FP.,4&&"!YDC9,OR.N!QK@"1,BT9P'Z $5^86*4GN
MQJ*-/(W.OH;2SBV\"DZ&5L]DG-E4].KK@_*U0R7174EC7-9$&P'A!$6NU'7(
MA!Y51 6,B8;KPWUD>N(LBJ-C%N2BA)7SK+^QZ.:-=YASP<@9.@=U*YW;OL'U
M!9JF(0*B\%MY6!10A(LE[1K-;DB.7@F4E.& _\J!NV5S2V9+GSR@X_@'/722
MX_<9>7@KHQ0Z82K1V%88+.L %47$N,-^QNCP]'W"PTMNSH+6LCC^0X0ABT>Z
MG$ZN31P32Q/P!IX"OE:K#"L([$>B!P/20^02(L:-C.IC=?[2C1;?C54S_W7'
M/R^_WD>OX)Y>M69_]&Q"YC194<^3;>A8BYQQ\1[+A3-0$9*LX6,V*>.#N?B,
M6&6I%*=).DU2(_T:/GI2G3$)28/X]ZWBAD&_4E.S6IG8"CNJ@T7='R^V*]H/
M:W,5+2X#92C239\Z#!CTQ8SAMHR>A/#H24IAR6D-:[3A<^%2 [,_2PL$;[="
M6BSHFJ@KN/*#-I4?[+KR U=^X!3T(@S"F*E@4G^0:,?'E*]*/N"6Y(^L"=3!
M!>[ G)*?/'&EC)E/WDAQQR:)K=,/%F\6_F*72E5+JZ0T&V\H>=8ZXN+TUZ9[
M(\F2Z:_ D'D)[A2H(=6$DILRFT\K"?/6F8DIZ%&47.D?&X\]A4ICO_L.77D5
M<JI2$^G\'F(__4G.T=*?)04F,W';[2+=D1S)4I2PU.A$HPPI?CRCX<(R<:*E
M2<XGV\(^@?1R=);AXRO?LTO-%N<:G;B>RB_)BXHWPYK.MYN^^N0UW>VN.(C^
M%"K!/3Z)2^^TK]AGRC4FNO"CX[9QDY"23I;ML478-M>6E%?9X2N*VP1J@@$=
M<NH3A LYZ:T#UFZX?7#3V4?CBZ^)(?3>M5@':YE"8"5Z3810 G6&_0+H1"A,
M.B4\;QM_+(Q]&[/"F%.A/I@*K CX:-&58&G LE9Q9<\I,V"*B)4'UH EU&XH
MBZO4PN6@=F2LHP1)/H@P:0EVY$%1PGD=I.&&PP:='K#].P7&^1UAV,MZ65DI
MA8C5;/5^[%%#@/)M20G^P.'>:Y/2#YH7;$.,XRR*]@QJ>_'X"1"@&,M9+5O>
M!+/@=;U^41Y05MI5XG(+ K!L0F.B1/QVO@!4C-[^8?%JA*!7%HZJ[QP_&VV#
M-H[_/0!,IM^YT_@Y(ZZXL7NRT63]=G!C=T/(]1\.(=?M]X][AP6$W"\PUC%E
M*.0:NV?@_(8PD8U#E=ND$]!H"+#'<NT59(PV8%';3W1O+KG>$).C[I$J2G-U
M1&V0RAYB%N]U,*=Z*=3795IW1!BLV8=9'=S C%HR'1B'K7V.3"=EC]5>Q_96
MK<++><8S@K93]6J9$4[&!-Z0I\:K9OJ"T2M*$Z9V6[=SO/PE-->*,P>F.)0S
M6"B#K8$OY!K& [%UO/^].+WPBJ;B_4X/EZ?7Z;ZCM$I4SD),%36+S<7.E-"I
MM]DV^4I-IWHT.X)0%:[VM\6,Y69=5%-$V6/1+ UA_FA%&1Z +Z6/X(_2O<RF
MB#T#)0/AI$W/IJF:'&!MVP!6MP@CQ&8%S""*Y:M0&6N\L&*V4]O"K@Z2-,#8
M<YS$ZAU_V"',@*F&!;!_/416HFZYL''T%;X[M:^S=-#M='M,YEE0'XIY1TG'
MY;CP/<N^I[<M^P'37:M?VW4J#^_BRMG/!>79+PSIS51*VK,]PY,P"")E*]J.
M#CL865R>L5'9%'S;TRBT,8K,"Z?#9,%Z44*OM]<YO)T67HV7]E>5NK-:V>/.
MS@:=G8-C=W3<T7%'YPE'YW"OL^LT$$<*I('T.P>.%)Y*"O_(4K1;;J6)'X5.
MHA ]YV#>7>%RH@L#!E*AC_NN,=._^R):DULNN8^&]CM[E:O,Z^I?/M^N61.!
MO/+DF/=HXI]8$_]290]E1QM%>IMA2*T:$'T!;/JM/']KO<A;'\5/XK#>7-@=
MZTVR\59,<)\Y,N0.\ZL=YD-WF!]O=3J">PK!?2SP6LZ*P*HCOD?;N8[XGB1)
M5(I#O(OT-MP^AJ_?UCA>91+DRA-O+.3U*4,8A6W,UFW^*ML,'B=6&N1W6&N*
M*S+(W'E^#8!+3M1SQ[DY_H:UIK<BZ=2=9G>:&^1P>)'8YM-:4.PNP?/O8+5.
MDXHQ[J_9QIS4;N? T5YS_ UKS>NP?F"Q:&"YQ^$?E,9L$;!<>=#=F0SKLSYK
M#4'[6@MLV%133STC-8EV@,Y>( ^-":Y51N(4FQ:&$14H_2K321*'_Y869/RK
M\L<,&OY%_96'J9H0H@->^WD,%\-L<A(P_-VO.0Q;_([%7A>GOVY[V$(C],5Y
MK^N)TW$2<@\!A/]#7/)?".,&F.6I12;_2CBJ;U8 Y?AB<_ T7W')'&!IFP!+
M]QQ@Z2;PJ5,@X4$:WK,8^]U.]\9R]%I:[G WCL;N0W$T]CK=H_V]"H[&B1@A
MD@:U8K7]-2HES1:23F(CE8%B*Z5HKJ)]!*)_ N3&1 5A/FD(ZL:;ES*O7 /]
M?0H;9$&\6'\+8],XYO3#I8<E\G'9C9=J\7FON2]V[ZAS8)JB=GJDS&7U\GGL
MI5K6Z^MZ'\J.^%![O(W'U5]QW-FEY_1[G>/'OZ+%M-1TYMO:Y5IQ47R9;'R&
M6!#G!F/P/3I[@ ]^K@'R?5C>A>"L_5T('#FOLR1Y.E3,#R/0M_O=[IUH,7?A
M4B+>YTU4RR5W;)'\ZO<02P817.P[*@ O!TL 7D0R4Y6)2 3B)*3=1[P:'E=!
MX9Q,TV2V\+Y;WH'H,OWN_MWP,DLP90YP$;N=O4=BRO0KF#)O!WVYCJ;*FP+&
MM$I>&DI\ 1 9.HSV?+86.J;M9;F55-'CW;NR4%Q-[EJ79U?HH ?&W*&C@XVG
M@\.]3L_Q T<'A\>=OB.#C2>#7N_8X<>]+61'<XGC;MVQ2;3P$H&BU;&)=E/%
MW9JDHXK-I(J[]4I'%1M*%7=IF8XH-I,H[M8Y'54XH+C'%$>\O)+:N!3 UPH)
MW$UW%!?_O,25O\%U.:^J!J\EW;45)V[=UWGKXT]BK^O I59@R#AZ>WNDN'5?
M7CS.NP?N.+^^!>K(K0H5Y\[SZRRP0^"[IR+^I5T(CNH<"-_C)(MS/*P$BD^_
M(1;?^J^U ^1S_IV5(_(=O"V&U_HO\067.V!)B#O8SL'C#O:Z++%#Z+L#H<]Y
M>EX3G>^'O_<.NN]ZG9XC/N>06!WU426F ^IK4?7D6F&_.$"JU@)2[3M *L>G
M5@8B84[0\S D5@19M?<(R*KCW>[^P9V056E9,RYMZ??_UO"UCP@+\T=!5#DL
MJI9@42&D1:W6GZ&C&.X#R(9 +>RGE\>INN7UO9YY,_S1;P]RE6/+]ZF/FP%6
MA03;.RK@>\"<"2,"X# X&W0^[P/G<43< ")VX@5CBZ@@BTQ^0TTAF2J8NARH
MJ,*/B>#[AN ]<7CP,&@G0^IU="D5ITD4P6&!(V($&/%[$@QI"68#\@U4$X6@
M-0K> 2,LQ[/U\:>][K: 45DI =_LPL.KN%H=1HPK1EI_=@5SJAP'JDOP<YP(
MT'D4@F<76%QA?$.X$3!5R0>JR%2P^: R9;B@FB%R"M9P][ JX%YV4%NX.K@
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MK)V?;BVIL64'_^MM0B>)"Z%CN3B2\[\Y4>(S3$^F4IPFZ11D(%[NP068V*%
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M0\G@3UML6'07SY#0&$RW---AL4RB6L(E*K775W2TH9*H0G$$+$^YVH3>"P?
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M0VW[]\YE!Q3V)"!WS1DZTTZ"21B'.C.QKBU@@MOL[9OFH,%KX^@+M< W%"]
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MRBO%'0= ;%U^/F'P54*0:IE+B+3UIDO!A10M4.)AS<O]PAPV/R\U?6O>%/5
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M<UA41B >PD1^^/OUR3OZUYG2?AI.66/*81DE1?^B$@,Z,/Y@%83YA!$>"/2
M&'Z+=MJ=!,<]-B9'Z\OYUU\O/O[GSLEO_X\,H2_G[S^=_GZ)G]NTOHXF-S+R
MB6A%6$!7A-E:EF551@49A=Z&!)ON)L+ (T:5%PL'&S_N2B2[Z6-M?I#\A#SA
M!GQ@U\-3N(O^MHR@ 4U]J^AY^T>'9<X )5@.L >(BDV> 3;LNYG"P."%&>8M
M9/9V<P\%@VQU^F+F0VA[9GJ'V#6S:/B,O2GBHL_\S?X7M[R"$ ^65,TCN0_F
M8JYDJD!NXMP[XK.=9379<(#]/5*8,4]UH5,GMWTSV7.(Z^B)4QG+0'KB<ZY2
MN/]+Z"<>+#-B.T98!TP(ATD.X_K/)%6R\34'[9.*&ZQ);%[6=UFG6T/%\ 2:
MMXA'6JK('C=DT@Q0B!7U7&>D3+>AFPV<D'.D=,QM E6OVQ5@Q(?( ,<R]C%4
M40]&Z"BYJGP[4S4H,NQCHWSJ5$-\;K\/BH_ZAJT@"PBMHL%1 :O*6 5E*+TJ
M"6WI)O=C0MS%&)%+IWKNCT$G0;A3/9],@3PXL=H'EC<*\=V#/(5=7I!48?#3
MW_[U:_3M^.#PX/B@VRUHEN@"QF[:2>"^Q HIH^'\ZRNF?U5SY>I9=+=DSLT)
M7D$S[@)^SSAUU^$$Z"6:BZIT>FPF7:N2NS:)>[;.-W#W.IZI3(:1MM4-56=!
M'4'(<)D?UW/=WX8N3W\1O$);?WS<?J$EZ>QW01@_4Z3O/$:F \<"/@C3"6,:
M\B!*_&]U<_L/6!_JY_:BU%O70MX9;S@.O4MC_^'O![V#_8.G5DC?O3O/-*Q>
M3% 8^\.:6H^2&X[^-I7^"C.6J:?2872K]V-OFRKH%O79)"UZ@&57B)L?8(9<
MQW$\1W&/ISA"',3V<D!5O3YVBLO&C^N<X$AI4TGIZ[B. KZ()LVP>#;]O-=O
MX!1>HIOE*PZ/<RJM;\)FWL>!>";$_:LOZ?,2U5][22L.'EK3=^Q[IC*S3*)C
MIX("E"4(UXINXZ*?YAU=(QSG=)SS(5A,=X#PH^?S.;T/7OUP/Z\0X+4/]_(3
M_, #O+Q%Q4V_L/:QAR\WY2WJJWZ0$YBL9<V.%SA>\*":<NZ\7/*#0GNR 058
M4CV18A F$P3G38F$+<$B87[\?-' B1&OV&LTKZBS"#K['+G!]DW8T \.>='J
M3JN92@W:M*VOWTE51/;30(WE+$S25L4+7 1VTR*P%['XF,S49  L9PEB0CTW
MRK8*NC5:6R0P>B\4JL6K]MG)A4'/PP,;<'V=P&#/ZW9=:'#MCO6ZAP:+8^="
M@RXTZ/3RE80&GR<J7'#04>!+!P=O"0]ZK$!YU3#ASQ=GSAOA:.Z9X<%"&W>4
MY"CII:.##9R BPVZV& M-@BG3Q&6M7+A0<<Z77BPE>'!6P^QBQ Z=M!,=G!_
MA/#T\KUGPX34D&%"705<R-"%#!T6LL-"=EC(#@MY[2C.82&O%@O9T=Y+F3BK
MAD(6K<7R=33W4FKQRFCNXR*@P44\ RF:@-VR!4;']B/'_V)+.$C%/Z@G:_>@
MUI/5 2BW"4#YV $H;T+6S89;N0]IHW<>9\!23U,85QI*X++D"=(@N#^S'P@L
M&#DWC2$3/1T#!V:_PU>9BZWI#OQG>R5[XD 4*UUOL;FGFA4Y_1&V*275?HK;
M@KWF51AKX<,$X,,L#)3 ^4T539*Q?M-)D:)[4YTSB$(R&R=1,IIWQ!VXHP6\
M6HY>0;8Y#MZEMCL:?IO$T=P\VT,4H1V3SVN=6.IZ&B'*$,KWSSN9S'M'O<(3
M2128)=C9-8+M>DC"5(DB=Y*1/VVUD$6/5RQZ^TT?(6F/V7@%ZN,+#':A)1_(
MVJ%*R9\*!%\@P7\U<9KX=GOF3?%)'S_O'_[>.^@^(O@PD/ZW49KD<0 C?T__
MO&L$T.K6Z=>3L\=J^:L'2NQW^WVT<L'$!7HS7ON,^2HP7* RY&Y2['9%//K'
M;\+/07.D\*L>)U?P4Z_;_5[ /3HD!PU7.!P=P7=3Y8?#T,?O4/HN8=%!*$<Q
MV-:4-]#O$\H[F$P[AKMC]8)$P$S=]&4DUK+_%ISE\6-EE-.::+I2).."! 80
M)QD*M3DR%8D-7$\^?SK?0<1]K"C-<HT)E8QC>@WVP2@!S6L\H3PY*Z@E/$#G
M4;:V 1UG##3,&/@$>N$.=8P7Y]<9,B.@7G8@+X+VMK5Y2KLU_HM8?/*SQ)3;
M]9<T*%XHN8-_EWNJBCW5Q9[>@M\,LL04 =5A4RUOBK$X3F="^K[2NIXX3H\%
M/H<(R_C+[5JYN!HGC"NM<WK0,,>^) ;>F01FO22I"G[:JGHY5QJ[:4<5M8,[
MSAZ<*[!UE9_QN;*M>$24Q*,=4"$GU4K7+(G@UT$8H1(8R$S2&=O"HM?MFU6O
M%12W1:!A&%2J\-UQ(I(!K"]S"GR:+'#4^<-XKD'IA+7%4R_3 G_= )[?/K7V
MH)HW=8#GTA^7B4%A/%-P D;6AJ48&M4_XV5VT_QQDF#.T-5847K7LEU#@/W;
MM\UBX-^$ZB^$P4"-9+WBN]\J+KRV''?]5=-+.9-GUTY\K8H'8<?$1<X#RE^0
M^QEZDX,0Q) JL!MX=PAD'Y2^: [O!:.WZ.PQ3'Q*D 9>$X!>YU-F0"V[\<X4
M:4IZE@(,[2@RK@R\81 E2= 1[['71ZXQ?5I[ IX^9KZ)+'*J4IW$,7"[%)Z4
MQ)HTYFJ/CVD:HND-R_9(]W CO&,!^ON3Z8W& ![I]3$PZD@$:3ZJ;AFI!';#
M*I>Q$PDD1GEQ\SO9\#R0[LA;0H&&'1MHN#?"4.0SOYD4>TO&LHR"6R;W6K"B
M;V)XI&J41TSC&+J[,I%;<UHF\%%A%DU.;4!MUO^0'@M\4T9S:A$J9K P 9L(
M-K1';42L:FJ_I+1UG4^;SBVF20KJ[8R[FQ+#+!WN7LW3CM-,2)&>R324@XA;
M/>&')-<F4XTO,U(J*%3Q:3+%Q8=5X^95Y.! ?S 67.1D\>D<5/?JD@8)7<$F
M(<HE<VW]2G3O4[NJ-BG="Z?)U,>LJ2+>,(;TUD+9S],4!@U,IG B2B1X:N@V
M2(+YSH".CM$*D<_,=:;8APA'3*4(%H :#9#^B=AZ_]O'DVTX5$GZ#55(@DT!
M^S0-V-A5^I&])-]F?;#XUX":646XJI60^C($+JTU\:0,U%^%V3E-GQ>P+=Y(
M@?L$UD!'=3S:I"3G[ LS-;/[L%^M<A\\]FC:?EJ[NWM[!X?'!R_=3ZO]O+'I
MN=;/=EN\#V/L% >ZTB<PNV:ANMJ<I7;DV5+Y;776N<IJL0D9HQD-AD-N*]&M
M1TA+4)!+91<%O._GDYQ-[D"15HV<_SO@A9T^9NY%5/61B7_FL1*[7<]HMF"]
M:(R"4 $L/8R3(%"_3L%2":=DL]#;,0))1<NH97"+5G3VL")!ND&1>T@Z=L59
M(HLZ* \'#VJ]4<19Z2_\1D5U+;\+K^#EB.";=)K0NJ#6'FM<@"_WOZ\PM_B)
M6 1CS2GR6*6JWF=6H\9TI1!L5%<LKWPZC6C,6B? 7W"(-&-TZ-SPTV&+R8=/
MT@Y09XG_S2AH&)*%.;(MN/A.NE D4S)Y*B]0?^5D2UW)--!BE(+8-XBN$]!V
MYLJ,!ITTQ3<=@9Y'4[X&RA'OOB:;=1C!K @)5N<#Q&7/PI(8X(XPX1@U_R5U
MD4&#JUR):N"FU5?>K+0-B-]<0$]DX03'@ZFUE2VJ["O-&]UIR@!<W=BL5BD[
M:\OGUR-6L@F5ZP=P>0LKZUSM>HMKUUM*<ZYZ?2VJUUM*?:Y^O=7UZRVENC6K
M8'=D\CIDLHIZDL6A/L'VN03;$8;QND[^YR\IUI5B3::I"O[99E"(SRJE #)A
ME5&,AVJ(*<'0E!53+=2-?O2+1:3&%H<K'PZ([XD/<C+!I,9,R*CC":P:H_Q$
MA\VP2#8-LE/OPF;8[3IL!N?'<>OSUNO3OMA%+8FF2/3$T#.F(&"&C\2$>:DI
M/D!BE\1-4CJ>T8]M*]YB6 !&WI01U309'[5YP%]YF!(4IW$?%Y[K!=>P+Z<H
M;3E8$(19CG"^Z-4.8S\EB\/(QF&.O['7OUF]EYX*[[OQ1ZR1N,B7\\D@B5[T
M^#T(%+F_^U10Y)4QD8)O$$N(1PF>YX4J21/ZLAG7[QS!.8)[,L'!L_,A" QD
M_!%< N,B3WL1YD71XFC-T=K+,#<*;ILD@&HP>UEN]^TQ\7=UD!E'C(X8'TV,
M6JEOU6H%:J@[NSL7XYU3[AS)/;MFSJ-Z%\I0\T15_A(73"83E6+>)A8&.C)T
M9/CB9!AB&2OG!L*WIL(V9+2ZR)1!Z&H>H8AA3&$\3*7.TIQHU<E>1X'/*$/Q
MR7>%>!^XB:&/2:Q5:C0\CZ#*J*X:(4 I91:^4-=3@B8IJSJ031:7S1U[=,3Y
M+(LXI-"+A]GC"@B-$$]*FM-^,BVH#MEF%"E,#B:JG:HTFSOFZ.CO&>(9JPI,
M0KQ-C\^2MN%#1&K$)\)7BGK@&1M?AA/@XISHC[[-WSN7'3%"9(B85)(P1M$0
MHI(+-[B#Y [2DTEPC"I&5:FP52<;B;FQSE&NE:_CRFGYLW$"F"(X<15&D6 T
M?<0V0E7$HO2!K$B5K\*9NM6]Q>VU:\B7E$N5>;=6<5VPOE.M+%-#>!0)*:IT
M"N-E[UMX4\V_48"%WE;Y=%4-J1?%@'8-J/@**$_9,D#[*,0=(GGS#YQJ.,3G
M6".C_!T>:0+>(# C.> B>'@K/3<C+!-8QBG5<-G;A[9T+$WF,J(0.UU>O-]<
M&!0F#-4F%IYO>/NME8$FO(>@)FF2C\:<^CL(XV*="B.=/45VU+C5]F9Z70'_
MG*8R'ID< 8H:YC%<G&I3?^B#MBJI>+&V "U3-3!FFDI8W5K9(ZQ0Z5NC^KET
M)&-#=%IL-5UZG9Y]^*2W/7'ZY=,"]DU!0)@3K@V$9C7!!,%FEIRL)6?724(G
M"5LF"?]0#.JW4(F+ 'V&WF]EL%9@F70GF2J)]U"?&6XQ@^5H0V"&R17!HR#Z
M$KQG D.!X>NBW+IM''(P%]@&8H2"&=G%O2O4=.:X15N8Y!HFH+=_W/ SV&A>
MUKIE?-E5Q,1N\^K*B'&*,#!F,#>6&32Q !/$"9N'/^R0BC;5,"#[UU,6$?NS
M6(,>^[[@ZF2I?:_=HFZGV^.5RX)B3)4V/;2&=F#\^G*URB'C$)9]3V-9]@/L
M;.UKLZH5I<%^8V=G/Q<T8K\P1 *Z+N$)6D+A)]D5V#OL'-(2+"'UA<UZ&J-K
M3.;XR]+T/[)@W4FCUSEVE.$H8REE'#C*<)2QA#*..GN.,AQE.&GB*.,1E.%X
MAJ,,)TT<93AIXBCCN931[_0=93C*6,8S"'K2D88C#2=.'&4XRG"4\2S*.':*
MAJ,,QS->F#+^D:6WA&/W7#CV3MHY0>0^HA@9ZYW&@7BMKM^AXS".2AR5/"M,
MZZAD<ZCDZ4YV1R6;0R5.XC@J><U0KJ.2S:$2)W$<E3B)XZCD;<.]CDHVATJ>
M$?IU9+)!9.)$CJ,21R6.2MXT/.RH9'.HQ/&25PX;]UT5[PND'+Q23\-GT](+
M=/YS#,<1RI,)!5Z(7_[TM_V_K3/1W&$]-XE&GMJ3\?GX- \AKT$2!;<1U]=Q
MJI28P.5C+50<J,"Q)<>6'%MR;.E-V=)E>.V8DF-*KVF?]8Z<?>9(R=EG#^ Y
M3:*+EY1I#5.%?A0ZB<+ CA%V!!U6;:$?IQ.]LD[TSSQ68K?K.;ZT[G3E^)+C
M2XXO-9RN'%]R5IJSTII'2NM-*8[KO)(VU'\S;6CY YU:U'*UJ-_M[[X]<WH;
MXG)<RG$IQZ5:PJ7Z;\^EG KEF)-C3BT@)*=".17*<:E6$9+C4DZ%<LRIP<SI
MB;[OOY^>GI^_?[\&U/3:WN_C)],7-S%\)1?XXR?Q/,H[32;80)5:,#^07ZT/
MC;UR1N732>QU RS/IYJ'!EA>E53>2@5_U69SS:.957.D[S:7MNY HFH2*54U
M*+JD/<0E>M[A<?>'O_<.NN^:0&=.W#EQUVB6],K=\)I',T[<.7&W3N+N:._8
MB;O-8%U.W#V;9EZY75_S:,:)N]6I4B\;=''R;@GGVO4.NGM.WFT&[W+RSM%,
MTSG2!LN[.R GFT1*[19WAWN'3MQM!NMZ/7'WF&2#UM.-2RQ846)!G*72SY)4
M#!6\4,9 0_ET&H5*W\6K6D]?CB^]AAJ^!F2Q87D#CBQ<#*0)@DCT^][1\>[]
M6G+K:<E)'L=B7 C?D863/ V1/+T][ZC_@&RSUM.2DSR.Q;AHNB,+%PAOBNC9
MZWO'>STG>AR/V5 >X\C"D86+2;^%N^W0.S@\<)+'L9C7"4"O93*#"TJOA#E]
MRL8JA9%,)DD,_]'9G:'HM:0TQ[5>0S&ZCU3:C9;O8M>.9EQXH6G"3/2/'J!F
M.R'6(&IS#,F%P1W-M(=FG!!;@;O(U:<[AN08DHNH.YIQX?:V2K']/5=U[CB2
MXTB.9AS-N,A]2X78WNX#$L:<$&L0M360(;E:<D<X&Y]FYOC):Y/%CR)(\D&D
M"FVFW]E_GC;CX.170BF- F!:1XIR,8O7CUGL><<'#PA;.#G6-N[DY)B+KC>3
MZ3@YYN38B]>G'WC'>T=.CJT?=W)RS 78F\ET-DZ.N?#["B(7AU[WR!ED:\B>
MG"!SE-),IK-Q@LQ%X%\?S[WG'>T_()/,R;&V<:<W"+AW]US O4(X)VDH(R(7
M&>N=FS33ZSZ]1KY[]'HU\I71N9#[:W"45R0,1Q,W59>ERE!SP^R.;6P(B=P1
M;W ,I#G4X82*HXF&<(RGQ[P==:P_=3AYT@KJ</+$T41#.,;38\_.2-D0$KDK
MF.PX2'/(PTD51Q--81F..AQU/"6HZZBC.=3AY$D+:8(BL__())QJ^&\0SEXJ
M=^+UEK&://%GKK-P..?OPCA0,=D#A ?^H.5^Q?7=J'5\?FK*"RS_%Z653/TQ
M-?(.U$Q%R70"4Q'J>JIB#6,(8S_* X7PZOB-S,(D]N#3[7W A=3B2D41_E=&
M4>++3 4U>/:.N*N/N!BI6*5PY[QX>3&:(=S@P]XBFX/ES8/0W SKNO1[>A_=
M!O^;Y!&-GWZ!9<V',(0\A=40\$<X"S.XK2-NXLD7 X%?[)SP.<FP?IG.<2GA
M?=(/(WZ:H^]79\L;OZPK9QMG?&CP-&3C5"D^O^&U@*.0C;50,+&@V*,'RI25
MS^*?>:S$;O?APVS$VGNBW^WO>L!B@>P#N#@3P/M4.%/PWW RR%.MB(4/TV0B
M/E[\"E\;)C]*98S<]^$SK@$#O:=_WC5B%3:4 AN['T25?:)*0XV!^*[;V1,P
MCLB*7/ABO_CB-O+T\(NI0GFLHOECB+41"_%U#-.IGT14AU):%[3\ M*+X%.0
M^Z1$9(E(\K1<AMM4L4[3J7ESA;);QQ=<QY73[2<X?9GRQS'PC]%<C.%\#I0"
MED7V")Q7/TVT%KY*,QF2TH_G=9HF>(*%#^<U#,#& <%Z)C/IB6]Q<K4S3JX\
M,56I3N)815YIM< YSR/#YOC FV_HX"=D>TQDEL&M\$M$QA.P")1TM[((&)*,
MYR(!:7+KZ,!NT8EY(CS0HX<,\Y1>B$^O/]"CQ_!PEDWUA)D8CMPSUD]I[,%X
MI4 F'@Y#7P1I/BKOA<G-26N)04YH+5/8;'C0, *6S_85V&2P3M:B2DG<H;"_
M:_K96&8WQRF"'.<J> -I/TO+#=\%1J$:)?#PITD9D+ZO3+*10DJ@01AZO86(
M-]?0=,RWS<SW'$8-[,XJ\\RJV*\R!>*W7A;+/2O'GCD8WL2L L\YWZ3JE]W.
M$J^2/ J V8LQ#!78$+(L\A'-E >L9_ GJZ'L84HR>%I(?JE)J",E<1(=\7DL
M87Z^RLGWONPMF?RFD!_"-B$_!"57R DP-69<L,XX=,O</#MVX[Z:3%3JPUMA
MO3OB*T[6+D6&;GD85EIE:(M2 ;CL%3-@&:%XR'5.,T!R .X*5Z?PD#F\6IO'
MPUKR?&%.=NF&>9:G=\B?TGLF)%P'(_R&<I.<>K2(M#EC&8_4>C%:\O__?_]+
MP#__0:$ ^!?LD-0:.0503(J>3M :5/IB-9:K82<^[*M*'\8Y&L1/[.+[V:]P
M0%7ZGC;ALQRIO_W?W=Z-K?N/<6KOF,(U/Z=*?BOVQKRA=S3-! Y,^-D.7K4S
MP,M^A .8JW>B_&9'#N%=/\))NY)S#6/Y1XT>QC2@*CWP$&[04-/)Q$GEQTME
MMV:ON6:OP&4&213<MK*G:<C"_L3W48ZC\F+T&*4W9]571JG+O)Z-7\<%/7SW
MZ*%Z>&-]O%_'H8;-T7ZNM77IREA&<QWJ0E,,8QFCOHHAXB LHJW6QX&734'G
MQ!^T@/L&4H.JB ILGM(]Z.M$Q3<F- QR)Y0/U1E\03Y5#[4.4$7'$O1S<M?
M"DY!^PQ$"*_TT=<*-REQ%6;C.O9"2SS)OW<N.^*7DY//:Q >8-N"=ZCJ@-'J
M,7L.5/17'@(I@1F#%L4$#2ME&2_3H];Y9,K413XA.1Q:QQ*\'8PE-$S(^B)B
MA.N5<;U%H1R8J'UA62*U1XE&XX=L4N+U9/'<<E]66+'6(GL435=2)VHC+A(@
M\(6QRD2$#JTP]O,4*3XHHV%\"WZ"8Q8F >8SP,FJK!+,I7;HX%1G24KR#%^3
MA@J/#3DC8S&3\!!8;78$#BEEPZSL%9Z[*%1H'Y-Q*'428UJ4 /HS/D4_3/U\
M C.$1\+TC!/3<@(^P9B80;_ J$+.U8"-Q1G\F0<CWG@Y2')>6E^FZ1Q_G,DH
M5W=L(>\^#(PCI&"M@]DKI\@B;'"4)Z5A$7QR:;+CT0X0_91!".23\M5,KN5"
M\BSY"D,2!>DE:<G_[LT!>2GQMDNYI:\GX"K"["6R0'BX3G-X.<VA$:P>&#T<
MNE(LQ\BGP2XFG8!<0-J&/'VK1\M2CR[/5X6I+0;V'RO/773_)7).6J8_,9$8
MUIUH](UJH+@!:X@__/VHW^^^^P *[(BD+W[1.WRGQ5E=PSVI:+CO"Z%]6M-N
MOY0R[5.AW=(;>N]L[B"]%:G^)(Y1S'PA08TR]CT*P%YWYS])]B&]HS_6I+"<
M*5]-!B!H=GLVQP(3#,,(?D/5EJZ_/#^%!SWV5#26W-ZK09K+="[Z1ZVDO-;'
MXAKH UBC-5NQMVHI<R+^UP/N]+7(GKL$(?N!A>QY0[+G[IK6HZ7K6PS2:_;P
MB+G2YJ-DV9P3Z+C6RKE6F,&;_<>L;:TVY:P2;3YG9\CF++TCUY8FM]Q?7H4^
MP5!CZAI8O90*1WY&S?*:$C>J]UTEZ3=T-"5@A&36 EB>W.(9PP,'T_9MW_BC
MTMGOWHO7<N]YV7G,@0E"/8TDS"V,:<B#*/&_U>VIR_D$E(L7/3+U\VU+EW'<
M71KX#W\_Z!WT=QOO^JDG:6G/$9,CIB<3$[Z_)"ATD,8C1U&.HEZ /94UVQ2C
MYVJ#Q4KI0&'J*FLEE'3K:,_1WM-IKP(D4"EY*4IE=BP9WJA[:P2Y.>W5&7I/
M,?2H!/2[_GZG6R^)[1UTCHMO@L6JYEHUL_%X>G6OW=/K9=\J/AQJL7?X/9JG
MF#.BQ)745*A5VL!98G^ED'"<)E'$A08%I =5>\1D\^)R)3&5<6$U!CQQMZR2
M ,-XE,H)<QK8BYU(#E2)$1+"&H63?!A&>$V9?8,%(53Y5L**T-:B04Y"<V[&
M@>R,LLY,C1Y,(DDI@-=ZON4JLIJPCHWE97N'G5Z=E^WVEO.R&[@,Z\3)CC:
MDVWX$72LK*6L[ ^&#O.S>]$U*@=5X5$BQE0]$<B@^%@5IU7><T891FP1E8Q<
M]L5)]4Q2,=>ICT/,5X5EJ0 'E#AEJGIH/<-!S,T8 ZA-:PA6?.9LITT\I V.
MZ?["T'Z<6!=,X&CH+*5Z:Q?5=03;0 E2)5A9)]@;,=QD6/+MPEM:8*+42CA8
M-M1@+9,\TV& :E<R5)1^BD)#I;/0KP5S1:1&$N3".(=YHUSC\@5X%?S,>F4E
MG=H^H",^UX=6';66$6BK^(Q!$N?X'YCU,#1%%3I+_&\[7#)2==ZU#IKKY.9>
M+ V_&_1.JQ?CYK1LIJ@-G*+R@J! 5[$*'C[^QB8%P\X,@9(-QL<U*FDGR#]B
M3WQ5UU*W;(L>@>;6W"TY4VA6AJ4O7TZP^.S?_ 5Q-=XTFA)P+F(B@SRCHJS$
M]_,I FP-YF1P6HH-=2UG?G0O"^X\=B!WO+EDV .576$!R_WOMQ6N=UH8S?=G
M_*$8(XS*"BOR:C'=B).($309,<"F^0"40+:5XGE54.&S,Y9C)+,(ZMDK'UQ!
M-Z-#'1;UNEPHF$=%8')DXI':5E5BQ0/^]%'J0/[E5=\5QCI/I:UA9*EHWXG#
MFRFL=^2WTR-+]!I/7,IT(&.E=SY=1VI>'=<2^7V;0L" U$O$>.O-L2;Z41P&
M3YLP>/HWMLYA\#@,GA8PKT::GAR)V>T<+01B*E'FEX@I(WA#_]Y 1]/UFQH>
M==79>YN%:]=Y'51U@X2*SF7"V1;R2J9!K<J: 2.JL2-8L=W*BC5^ATVLB[7-
MXI"8J=O &O]J(7:E"^$[T;&YHN.HTZ^+COT7#>&CX-@]?CG!T5C^^EVOLI!K
MR2G!QF[\K$!>'3@)_Q@)W_0=E?5]1/N-8AOL8[D1TG""W GR=1+D90++ [S0
MZ.8F:7P%'+ \-C>R6&[(WUNYHWV&?@QS@0'6I,L-;RAU_*LX?ZVXT<K/4P9O
M(W<-.6:+&I0TG/%T(WFE\Q"#JZ-DIM(8G>SD]D7';CBR3EW#XRKN_0+AQSQ!
MR)$,8X0[![X2C& !\YC';UM] *&$LS#(901/&R=5R#MU#:,E,$$+):3'B.=#
M@R5$O<P" /D27H\5-/9]IS Y.9/BTB>LO?:[A1O(B5:*_-9=T1*^@J+Q^!R>
M"W1*PU$3%S$P"[5N&]'.AI<;O<HK%\O%$0CY"*!5^UU_T92N.L_N]L(V70MO
M<Z?,VWP3[D YMN78EOAN[X%L:_V;JS9BCQS3<DRKR:O\%GC2-1=@N(2)&>]$
MZ:ZH7I<2FO1RWZ#%R'<[[L[5AIVKTK6X>*)JQVAY(=S]!\[YM#;0N][@RK-/
ME+'+%.Y1"Y7-66Q'H&O#LM<@4)TJ[,UE6WW;OK&5>%!DT!)J)1NDMH4I]J5-
M,X-W,,C#")]+5=G)58Q!GV3QG%._!/O(4%/E"0Q 645P,3A4MB?KB!M,PS.N
MONZN!PO(]G+_<)\^--T>9EN^9>:P\Y@VQ_FP#LSGMA-=30TV7K#]XHNF$UM[
M3[9S*C;A7"\Y%$W?!SRT47)%PZ[("*I7OR=557/YIXS]N5C$FN2L6).^LLSZ
MK:>5M8P,K+O+MI>T9:\#-8+QTZI0:T4YG:;)-;5AB^:BO_^]K;J$K^$1V;SQ
MY $S"N.8<EBQ%>=)/@(#@&C_$777S=@S9W*]A2]R?9>UL:K9_37\!(^W@ +Q
M8*R A]3H>Z;Q;\YF8JJ&$4A)T[IO44@Z#^<&'KLW]7#>U<KKM_"O/ P0M09)
M^%1.\0'8F)+A@=J^[B[_O0GKN'*9<!DB] ;^BQIK>^CHH];"W#X=FYCG:<5E
M5\UK'X.0&XTM/@EGH6,.N>)\=Y0D"NUF[8FIG-L&\[X"81&8YMX@%R,Y2$S+
M>CD"$\/T(X^#,MX%(B4NVZG[4K-\H3^P8?U,1G330$;4![TC_E!T=VRP3TH
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M?!SS:2/SN4"]"P.-0,3=FU9'_%"3 V\7G_G+E=H>O7;9'F!5Q)H1S_23;(]
M^1&EJ9:*IFEOTO39M\@,V2>FWGC10ZKR"!,E0%<VQR)3Z22,Z]ETU<-9H1NX
MX@2.4R3Z!X77@4)%2&?E916[C*!^'ZJLU-YJ\S2PW5AEB*[G[";*S<;ZEXED
M3S&_Y2+&F!*2_\_8+$]\CF"\G]@:1=[]5LO=-$"#]A-PTU;T+53 LG("=$#D
MW3\G,@TX9H]Y<@4[O_UL;.$U^-<VX\'3ER1(*OHD.I) %4PR18^,DGBT@])
MZ-SWE2Y2!XJ2E;E Z(G,J(-&UP25- WUMQ)X%<9$+2T+K92TI501>"UG&>!P
M^"^J+/9#>'YFVC17NHK1LQ; <6&8_C>=J:EMZCR*PV'HH]Y60\985F9LU&:3
MBV>RW"L+%)KFE $E)RV?'SH6,6.0;JB.GN>#,,#\%R>S4VHC^NJ*9>%?\QC$
ML_G[P4,M9\@W5B8?40XR?VUR2_@#Y1>:[Y.8EU8+K$2#.SG+WM(*7X7.OHG*
M.OSIDB_T983MKQ\R:?YCH."ZT P(B:=< %)+</9BJ[==(S";2*.%--DH*AV!
M_@**D_3_RD--HZ]J[4Q;N&E9F.5T9^'@Q":<J1Z'TT4ZAL=1GU6M%?QG2XH/
M_)JOY7.W\:*M?CF\@@(QS!EFF5(\PD"Q_J3JU5UC.&HZQ[*)$.T%FCS</(8]
MHMKX0 W#N+[ZG9NKRZ#29BFQ2Z)->ZTMIGF&FN&;8*K+YO-F#I&F\7,G(=OG
M%>$$Z#/@I91[M]NSN7?+&"=."Q.P\3 $E%Z*R75D(M6.5NWD_9I<P?%)O9J=
MA7Z87F&+E7(8QU(\6$[8PVN?A4(U59,$F3X!PB\;#3" V\9BBJ'4+7<BI\/L
M*H[ Y#!">IF,6(HMO<DL#?MXJ&$V2'S0&&14]IPN[436%'"Y+#<&T0*FZU"%
M65F.:_D<CI:8%$J[@:IT<D4G"O):2F^OS';A51WQ*4]OF>S8V-)%A0"7BE$'
MU%3I/.)&VK@*M WDFN'1X&[:VSP:2%%NL/#^33S&CC&NI>GP]:%Z9*UA,!R7
M),_ +(CIL\E<IM(?;8 ZCHX[>POIP9EA4J9(R*I8K$;73)B.N*BK7\1<@#VH
M:XQ,PUG^;M_HC.;A2\?,EZ /+4:T(HWZED2P .:)?DY<&U1#FD4@YYJY147I
M!5:"[QL@<\8'&98@C,;KX5J4]@GZL3$U&U6[JR2/,*< ]#8UP6?X8VQ($>!"
MVH1NA,K,DLR:+6P"F8X==#\_&G0R['H!=I?1C056S$[R"2PA?_-=K]=;6&]C
M,Z"/W=XUGD^1MV:HFL.*7=<?T8<M.ZP]HLV,SC$UQ]2J3*U48+@D$?]*"F\@
M^35NF%(R:WQ(IM4X-\3Z@#5^=]#9K\N*+:XE01%0!#=WC;)KU;9M3W K)$K-
M8I@Z8K$38]0"&Q9UKOPH)X_!E0%A]#'!JLV\SJ8+Y9!4SH%2*(0"99781</<
M6P1S07,?%=4YO!C]!)I<*]*T0JJ*((6.-9F22HU@"SF^%5YCC?Q%[?BLS"]!
M\!N33V)M(5YH8Q#UEAM$=WN2 M"?!RC\\3B9[I&Z"D>; :<9D3]LR:[T>E5W
MW8+4[,!0HL@B'GG+[B?=O2)G?9*SYI658UYX;DJ7/R[:38<)2E=<+PIQ5T6K
M^.YPKW-<)TR.6=\J2C&3MK]0%^6QUU%= PTM;%_A"0IL"'BYW\AJ)>A&Q67@
M9,0<ZX4-[1C7%KER/JMTB,</2[)/+1VU698[HZ71*[IR\0'\^+]EE/,A^5!1
MN:E,T>C9U30[JB$VH70'9;<)275-.R..ZZP#UZEJ@87^QUPGS\9)"J\*D,]8
M1;"F9RSX2R5YJ!WS>3WFXS'+Y[0E7'<NWQ !IR,B3K46[^%!\,J=_VI]_N];
MYRRYXO0V%:?ON>+TU2;"M5\#6/OB]-\UR05,D6K[&KNDUB:LX^IU5&42AW)M
MT% 9<@^#=F4/#PK0[>Y6&DH.;S..%R#D.(1NJC@F#.!75(EBLYXHX1S [_:[
MG0-1>,!($49G(9:!:+AN@'D M7YQTO?9-0:*M1Q$[/."+T&P5'"_\=$'G</R
MR3>?0C=4$/<LOIZ]?:]S5+D=RS$J/>M@7HHSIPJ</3]/4PKY<>X7/Z)7ZT)
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MXCO);X(#?L_D2T!F>^_7SM'2J_ME'.5_,85KWH,B_5:\F^P)=A\@C -C3M+
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MZ>O1^H06;:C)+8NUQ>//Z/0\34_/.["63\]K#4-W!O\9)Q/_U_\'4$L#!!0
M   ( &2$ U=I&?3]Z;T  (CR   9    <V%V82TR,#(S,#8S,'@Q,'%G,# Q
M+FIP9^R[!5A<3;HNV@3W$-Q)@. 0W#VX!0CN+HV[!DD@P2U (,'=M7'7X&[=
M2&C<O7$X9/;>,__,G;//['WW.6??Y\[B>:&?ZEKO^KZJCZKOK:KU./_X"_!<
M7EI.&@ '!P<P?OH!/*X"=*6\;"P! "4E ",  $ !(,+# 1"?/L$]01X>_D]_
M?P.@^OQ?/O_^I8H#0/B7<JQNU1=_^?R['@ N-!, J(IYA  D 2A(2,A(B"C(
MR,BHJ"AH&'B8&.CH&,0O<+'QR$DH*<A)R,BH:%CIJ%XQ4Y.1T?,R,+]AY^+B
MHJ3C%^;C$&+EY.+X30*'BHJ*@8Y!A(E)Q/&2["7'?_AZ[ #@H#Q#1*B!AWL%
M>(8#!X\#]]@#H'RR%!'N3Q?@7R^X9_ (B$C(**AHZ$\50,\!S^#@X9\AP",B
M(CRY".?_]#T  0?QQ4MV<21<51/D5\YX'$%Q62C4$E6=^&H3QS2<IB[!J&@$
MA$3$)+2OZ>@9&+FX>7CY^ 4DWTI)R\C*R:N_U]#4TM;1-3.WL+2RMK%U=7/W
M\/3R]OGX*23T\Y>P\/B$KXE)R=]24K-S<O/R"PJ+BJMK:D%U]0V-35W=/;U]
M_3\'!B>GIF=FY^87P*O0M?6-S:WMG=V3T[/S"]CEU?7-;[_@ /!P_W;]7;]P
MGOQZAH  CX#\VR^X9YZ_*^ @(+YD1WHAKHILXHS[BB,(!4\B+JNJ$Y6:4^T8
MW]1E HV AFN5]N2W:W_R[!]S+/@_Y=F?'?N+7V  QE-@/L.!QP&( BYOZ+,#
MT?Z)?^*?^&\'DG5Z&AAQ.;7825\.E"&GJ7*"P(!"(;F>%]5-:+[NAZ/73R(R
M#YHY^Y<OM4-8@L;=N:%6*F%"!F:%5SP0W<D+AJ/@70&_V?U*;^_KA;!K]GY3
MUU0%IVV?T+0U<OCW2=<L($%7&$-+2L3/8GBW-;I\K[$R8$2SF1,,"J7F8(5%
M\BV6S,=-HQT?J+QM("&,LGLUF7_K"*M>RLXK^7 *V'6)BN3] %>&*;VB>H+4
MOH:>1C)Y\F$FJYN\I5KLQ#L2>[A8&X,B.SW(K"6C7Y,!NB0J7>]K<U!>MI&N
MT-.H5F6W[]R_RY1+.!MI\FSWA17Q)U3D(V3]BHI50]%\&YA 19007Y(N[4CK
M9QC7;+W%/I@+2PM1CPKC8JM5=+4OS=MUC:>V?:A_5=:\,FCL),DU]!'0]H9>
M(5.XW)<^+U-5#!'O'P<*,#(!BEC6WI-Q)7EH?U?OA1"K[_U#T$S0.9J/ K20
M#EHWI#X&+3>O9> J(+SH=\>,:@'[3T@ 4K"<2-N<@QF,5$O(CS[Z*?II9(MD
MVG\8UH1J"[7>MJV9\7?L&6#[G!U]?&>D=X6*E&//TCJUI'A*4_65G^7'K[G,
M&3F=^:]XJE(O0WY;\C(OEPMNT\<RN>1..MC XZP'W)>0/\19GF&5JX^"$J9=
M?DV)4&6*VB\.F9^;ZUDFO7*&$EU@FBK$5+<$&$\G*24CO1B(>[WHUQW7+,JK
M+IU68KN"E9TLWG3<5U6\XZQX4&"P\P9U[.NP-DU8[/LB&JNL?486=S\MJ"C<
M5?R>ZI15L. 8K=L]F31-*I>6VO"MM *O6GL7\FR@@# N]'5"V5Y)KA2P"*+
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M20<F"DQ#N18MWURBKS+V-I@=L13:S7Q/0L[X;AO>-!P1#Z J]7\':JK+'\4
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M"T3JZY-FV)^A*=M?#&,XMB&76F][A+>4Y^GN$.1\91#?DFUO/\/[V_YO)DP
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M6VV*A^EG[F?[?LTT'A%R$3XE+B9)#[>JF9<&8U4NZNMW%MQIU(@:\UL=/_+
M<$QQQO_$/0>YU*<KJ/JJ%V^\[B[C<[5W"S?/YXXLEL]V&]=,=2INW!IL;JB#
MB._G8T8FA$4TG9?\R(MOC1HG$WE<[\!6/N7=^GW!AP0$SI(L*D\;D>?T+8C<
ME-D,,JA?)3.'R-BO@G5U671HQR%BD/E'%GM2M>:S^0]# MJNDCH4.%0\A3S[
M]FA#Y <=A*IM".V#1!_I$K>O,NP"DU;GMUJ8%6Q$N#:5(=$CNK*U!12RO482
MZ&D2P[9OO,8AG8>7SNP:9;>>5JVE RIN4PH)\N!%YFWAPC'T3[215E]>/D,R
M9?#K73.KV7=NU-571"=\:A)/^+6N>WK4/KI'V'FEOEGH;=T11A+B[#R=+;PE
M^XD$'I<O[7.)']-/@]EZQHJW210+2[8%.Z]BV1[>G+?.'#U6+\/7>M@2MI:>
MQU38FQ"<Z>H*=E_T_ "$C]<<G2>[>I*)F4Q00Q+]I3S9*K5I:9<,FV_;RBK(
MPJ;"VK,6]=P%3>+OV$XFBGJCX0409;0^K!I_5&5.#ZTJJF](6TQCL;E'Q*L%
MJCE3U3<]HU+XA6UT#N<RE+@\7O> D=]A\_H29:S;@BZY1S0:\KNDGG'Z@C.Q
M"L^\<([]I3V7L'I5)PJ.%Q>$1#I@"79G^.'W +3(8)\MU'R?I5\,Q8>?+EWO
M?#U<[Q[D7ZHV,D]<MS;>/:Z,.\,S\0CIN0=\E.EH/44>;SW$%_L6>?G:2^@>
M("[R\P^2V@UC([K:_MW!)7VWUH1*W!E^Y)\L,__-LHH+0?[\[>*A0DJDBES4
M#@OE'3;ETY\_ $OQ'M"F?@]X(K:,?7AP"S@]N'FH=)BUQZ;4>-VZE$Q,D146
MJ:)]#_B+K;_V0VAHZ;TX?P] F8&+2)$&%Y38_LW-O_Z(T J(Z,'^/<#?:LTC
MY.W_9ES5YQO=,OP>T/M/SUS_L%_.%\X-UO?0ISA>W9MZ7!.4\-$J[' >U>"R
M+%!'7Y()A4("_YN>%]L8^]D/CHU.%Q-&>2$G['+DE*A=1&2I2ZV+RY5WCDOM
MEQQ.:<Y/ 8 GGP1J?T2DJ-L5/3O'A%K;0FX^=['A:08_^Y^B)XQ-44U2/$5*
MSP43S-8W$2SWS+ ;S"JL4G*M\I]OU!3'_9TKILZWWCBF771R4KU]7F\15T&M
M:)7</[K(LB$,*!WG7*!8-C+W>JQ.(IX*XY %5?Z(HM3>W20I(@J/-Z$?N+ "
M6QI"ZEZB7$=R$"1+RBT,ED]58#/L6"FEWMG9&1M#F#;4:K%1P)2[/ *-.!?]
M>%2QR$ LF=L-$=D<,Q172%S?\'--47RJ'O?4 Y11E>22OK4<1?CE?0V$9?D.
M/$M]0",+Y'*SC:40V=&7Z1)DC\.L@28,D.B5;;W)%ET_^R'1MEFXXLO+6"*T
M2&CAX7VJZ:H5%J-0(_.)UM1ZT14#KUP,6-5"-9:&[AY_AN%*^ A&W_YC'<4_
M.Z)>[8?RHUS\H=;P&_X$:ZNK'#!S-5._Z/Q 2MF>L2MJV$:>$H&%;0YO$<?4
M'H@A]KNQ7?L]H+$B?*ZY,DE03W!Z+JN^<9$$],5B9&?D#4,-. HE/$B->%-
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MZE$$7^]^&?KR(^LYQ+XN7MB53(/R\BUM8T5%C-R865-CHY9M=4W6"R))R(4
MBAT<"SATI*>VPT=B#6_0+.1-\C>))WT]YU#^!2_LV=Q3+,EAXI+SQB/ZJ&5O
MEC?Z[+=O5R3M'8UMJD1J=#]KS**1]D?%S,7T;22("REPZ"JH2=Z-R8/B8CD]
MO6R<G7N9111E*)HT1!@Z7?F2RL]=\G/Z\N!RC]/F@:8QW\7%!7KF:6@"=A%O
MQVP1)=P#\NB8]%>H%K31I)X?ISL+B9\ZV,D)].WJ"!JFV>(.E,QM795FW:9V
M[2Q@))+Z%Z/17E%\10WQELRL+G,+N9!-T@I]G;;1/8^2P"=M&J[B&8>:0/5
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M0>'.*"Z?/5V&&<,Z<$W",,@'?>'V8^D^*XU=F/0QV9"S&LT!9^$JI37?,#Y
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M9&2+O_%EIA#GLS<.B^#>$;0W]=S:..=R.Y-^/D^\<&H-W])TPJWC:<#T2=C
M\S'W*O[JA>*_($_D)'!B?--+0<\UX$[8:4*!EXECYHJJ0^6P\QBS&/8T5]=9
M8GFZCO6O^2WF%\$%+-%7F31D*7]@JZ!C^]?IT/5/QOC;%51U:HY7#8+HV=BP
M;11=#:A"/MPCW:3O6 (%_ZJK]*_-IO^6K&J_Q3GXQ$1NA#4(-^B<<QPXH?4
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MVN<)/?84B59<A4)0U7Z0/:+/J?QF%F4.)XF/QQ[UE,?8OL=*6:%H(?<)QS6
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MNG^<M<<>LT;M->>:WUQ3UMI[P?[ 5@$L>6DY:0#A&0)@ K\ V!J@)^5M\Q$
M%!4!)@  4 "$$!L "?X+ 7X3 W\; C@80(93.OC-\O</324Y2>7W4@#P 9 "
MQ('W@ :@#+\^ .H )> )< )O 3;@+6P!D 2>/W^.\AP%'1D9'1T5%17]%3J\
MO?I?:'^%(#Q'04%#1OLKY!4ZVO\2^W\(^05@HR"((V$@(F #S[ 1$+$18-T
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M,TX, MLZ90,,.^^)A#7!DIG"H8"3$R%FFYNE7#X>(FF,F\2C!2DO-ZV?W&@
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M%UH872CO&6Y_^3W.7RK26**>X;?.6/Y30U;-DO  >QKDRTMR_V^10CX%6)%
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M_LI'44=61ZF,=9 CPS\BKS/ B!O :M1\JS@*&;'1N]MZM3<B"!V#M<-DK&\
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M"L%'(V#NUD@S>W2_8Z'T <Y%+:[\%$Q:I +LPH ,SUAW($C?'&ML2*^&[Q\
M$_+56QKC2Y+%/S%5!G)WC4KC<97M< ^1ZI/YIH$H=^:GKP(I'U.6<MP=/'+?
M--OU.*NUWM;)&]$KL7JMJ^%3^L#VC(M)S=*_<EW5+\776'_*/?=L!SV]UK#]
MI"*E9.]WX5B%U[S =_M75-\=/L;%O.Y_5\9/5E/&?S]9=T@%,KZGTH@,(,/S
M[N2=D?SEXKT>]RIF[$?9SG6GX-Z^QWP@?*8#H\K3KN!V&N&U8(Z&AU>W0QLS
MJ1+2_<MJ+4R'(X-E7^*%.'UXE?K3A0N?B5B+AXH7_KEG$+F3@H(G^WM3UFQ*
MC^MU(.$8H,0%5?7)=KP8NB+M<2T=X-=K.:7;;R[H!Z%T/\+2[9?/;P!1'JH>
MJC#IP_5"#HY&CY!2Y]CH;OK,Z-U;>+/Q\R8!TM<C6-T@;CZ#=A2_6SW+&SE"
M7 MZ'2QF'SR^/*/3F;U2&0E]O@L^M,@XK!VIJ18ZO6MJ0$;X7UI]29"-_O0G
MD9_=:[U5NOG"'-V 2E6FR1-;WSC?&6B@_M?I;VIY<<&?<JN#H,_SC5L+7\,%
M$N@UJ$J'.*L]S>0$9IY.;Z98!W&9U;TOS9I]_6"(*BCGI73NYYV?3#J,)"'&
M=5WVW*52!@$6LSV8>W GH@#ZHC16/:N-JJ).ZI3'NPT,R&V@UZ_$<%C'T\1V
MO/F/CU%F;QAOD0Z65D/M"*BX[AF_];J[L+=I/G@E$=%.UG9(N3DJZL*K;;QJ
M'#*/]*N$69F%?/]R.5I\R\K"8C]*KYEA)-)')"'^@5W_WAT_Y3O614;J3PY#
M2D>H4 ,B>242I!K:.>MN_/2KJ>A/8YF5038&/Y* X;A/XUZP/-K.?S)6_XBK
MAIUB5)I^M(H>>B>DQBUPK+I=/)[;WG69A9^N9$;+X"KKV7#KV-[.;D$'1-;"
M<N^HB*BRTB0*W^.Q*CZ;1Z0G ^[J\Z=EVF3Q9H(^)JN!6C(A<BRI]8OUHO&F
MVC[%-/M?YP9'Q,+SRJR"*Z"MA4P5%/IXY?_RQ400+T:9NO/T&*N7Q2^,3\#Q
M:I@.Y6.I;6R6UW@=DK\2#K7YR)*3,Q,+_MVCL'VEA96R>*B?WL4-8!>1?_DT
MKCQ, 5N";:J/SZLK_:\E2[B\W9V'QUCAG;D$;[;JE%? % X4K@7L2&%_95+/
MLK=+D9EE65N>U>W?,@F>=P=C<YHDV<O\WL0+,(IMJM$$I^G_RLRM!IH:RPQ3
M]@35R!AULJD8R:TJ'!G30..NLU);OKVB?_H.<)H:ML61&3K6WP?@EK$? $Y%
M=_! '9VE5E2F M!B-]I/M[/$^;[@\128KKY\D"2L^" YAF]&L=F'\*> 9B6Y
M&MN3'O:[6SV,_B: W$J9"MLKO7]?^_\2 VPRG^#"I8W5N^IK>+4!X8'1#8
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MT-0,JPPQ^&*WI:*<K(J4W,!X58^N14>C%;!5SK,,<WCA WC#VX9467<</J4
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M#\Q#:J#<;U7 3<YQ9]'ZS,3K8'*_+,[/3<_P5ZY&;2(?=;*)9JE'JTJ$-(5
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M-*#"ONMA!4?.+LQ?9;9TOI$?^HS\B>@WE^E*<^E=(1S:^Z+[T^:#K4#$/NU
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MWC1Y8(N"<,PUQ6+] RQQJ=9E%)T&9"L;%1KVFI:[V:7"WLTPCC/_SH,GWRA
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M;W#M2<P;N#W4?9[Z?'DLK\C4J.GN&QWG^NG-VDUSFR_JJ>PLEC?T#,H;CKZ
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M(]#)M!<U_A4/9_?VL,P;&\/T"A*4QZ_ W;D8.=A%!7_#AQ!L>(-1_)(H.LS
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M<GZ3N_O-U^H?R[TY5;[V*_.M/M=B^S31'AV&]V.UWF^((XT9_)7Z=W9HL .
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M$JB/Z-HA!POL2P%&EBLXW^UWP#(-[;5I6E MU740<0932A=_7 ,7PPV7?R]
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M&! 0N?':Z=.G.#$RZ92B[E)HKY=]RT"J&X,+4V<\JIDP*F6@L(PG !%#!O!
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M)PE*5$J%8)[J'_C>#1K@@L7AJP **SL4"H8+;M#N/R?TI(1;W1A,4M7'+C2
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M]2#+D?O/(W[$!S!X,^3'QE#H;T1ZG/#C@I"*0#MWURVL4MC&[+3UKF^Q N^
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M:/24H?VQ>VIF'HAJ7N:4SE0>YG$'/EQ/]B>"QSD*B28S,B]NISVV6NVC>_*
M*@CQ!8+1O"(FA7M:Q:67:NN%KR,(L[^5=\537%]A'MFNA-W*5H4&&EP\)J0C
M_*D]@$TDO8]3GHXL SPU6SYYI;J6)<R>?;@[RG".Y54+O)#!*O1)7JP4)0-F
M_M^M&L!5.5Q+STET@:^"X,/B&D,UFPN?AKZ2KFNV_&R?ZQ4M1UEMHGQH!PS[
M3S9-"XV+LCBLT !;I2%'X>K>ZGN%')MY&L;=+T-W5O,HD,M"&W-WQ9<;R(([
MS0]2\3D^^"0V>]-N4"NYFCS_?-KW*9I1\4"ISA:>&%R5MB+(]$=IQ8.>-U=H
M@!A%]W&NL"[85M%W_;&7D)W/"GC ^V!]\-&%NHS7N?L>_:PU..Y"MX<ZXGUV
M+PT_06[6,RS:KU2:/SOEK.7P>1'6<SZ;%Q>O6^$#O!-;A7QPT^W0OV<8%AO4
M8XL]/!"HG_6TZ;%YM/^:"J,*";5L2%\>E2W]/,-WD X?+* 8(2<58#/^B#&7
M\X+\>A@BE($GIBO7<)A6;U-5%[0VHN-W/#M?]P;2?H> )% J\@>DMTV([M9S
MQ1=B?WYSZ!^O5T,@TN&+,]*@2210AB&</^U$0ZS>LK+>-9AU5?(G:3NA8MW9
M1"-#A2WRFGHHNX_GBX4J;VDEIT+E@)SOJ4!)T\&TPT7F\E55A3A5U*(T5LQ*
M\B.>]!8Z[^CV[RBI)G:YG_'"U61PO87UII5+&Q>J(Q(G,KV*KQK\VVO*(^4G
M<L1*2/G^2WQO_2-<)<R!4>0A@ :2-+VCK]R=+C7K]XY*Y]/0P-X$&CA)]%6!
MEU"T"_2$(QQ0S9V@2S<V=R0'X?UI<!<BKIH:[.Y$B JF)?'Y4.$K;!B8M.$$
M+D@V=SC3^W'=>,D'.DDB;J>ES=QRRJTCFC1O<1C.5.KCD^<QM$DU@#1O1EBV
M',]'<7/O#<AV':DS7E"ZH0'J"EG!1-SNZ*O8Y\CV%C2P4EG7G^\:,=D#&H-O
MM&J=HP&"$AIYI/H3-/#(SO?IVLU/PALXVV<(N3Y_B@:FB79<HS/.X@S*P)F6
MR>(/!KX>#@>B@38-*&J..?6F>:(&(><SSKVNJUU3-##\T=8\+ .13YL.38OF
M\,2VEE_^H0Y>D@-?OHRM=5@68SFX?KU65(M:/1* .^L65*P=#G*.R".'.#Q]
MN:./',>74"SJ]!<=CS9WZ'X%/A=KQ?(UJ3P117S1ST[Q22G=-@OZ.YB*F8TP
M=?HW'N&;B5@PO DZ7).;+=$VB[" K% 4@\_!NH[\P<YQG<BFR8YQ12ZG^X5!
MV56==]&@L!+AM@XEA<LT7NA8WB+T+&;-\(]BE ]:;!IWK]Y0_<J:8 5_,8!<
MV$[3;])'MIFJY$;X1]2)0Y^QFQZ/#B15H &*D@,FY8@?*_Z]!#RH$=ID,/Z"
MA+Z:LSK8,CP\,#$R>^\X:N=(J/ OB5%8L_]7,4K!;V(4L=':X_+ ?'&Y6"?(
MYGAHX<N_Z7K/'[>P-GR'AD:LN:)$>B/;1NU?ZDI@])TGM4T(=T<MH[3M@C+B
MWI4-&LU\WUVH[<2^&RD<VYU!R%1?>7@]%MRF$*<^86$N%#:_+A5NQ4+9GW#T
M<"A9PDCO5B\!-S/FYKU_\ #NWQO+>.@<;4R.F2%O?7-C]+<7;V][[B[6+ENM
MQ("KPA;Z'R61LH_XYLV0VJB@2-8(#WNZX%;M-8>^H:ZHJA\#T;#I91S4Y3W"
M'2UADIQ&0? B*S):,=WVLPJ*AO-^DH.=,JRV=^%CB--A=9L Z$,G'QIP6H]&
M R]B7YL<NM <&CZ=7!U2@1);C#51J4'/LQ3!EVH4H4Z'JFUQ/ATU(=<]H3=+
M.YS1"'Y):,ZXB08&-_*5PH]EO%5R0$>J\FA QO'YOO@M:SM4YOXVZ*Q="0UD
M9+L&]#V[3N[Y,(WZ=+)UU,0.)B.4-%Q"Q"#7>!ZC,!7LW;6WS97>M72##[*_
MH(%-OB2$;51I(1J S,)C-TOX<Y7?+S_7-%!72T)ALL@?4]Z IK;.AZ"CM<)#
M$9^"?5$4AC:8)\Q0M;UM\>:/XA1\(V"GT?0PU''2SL*4\<9Y[>OK;E"9.,,6
M&MBV]T:"1ZUHT8 <B6^%EZB+.(7A!AD:R,&9%-0D0LK1#*&6QJ-1R0Z'A'M#
MH<+@RQU#$.U))PX:&'&CS:$9I<9? <<;HB"TJDMZTH<[5Z"K4 W0I2>H';1D
MY?&C"P5RB<(!?Y_KNDPT1P8S7ZX_I:7F1";:GAJCBE=O]MU<.;Z7E_<-O+I-
MWMP8I13-HYN6E&*LNB=T@Q.]&V[^BV3N=?9$7,Y-+W0/G1@/W[!PO!/GX]N0
ME04O*A<TTQLLK$PD+NSL<62A >=>\/K11!]W+N(KXY;E9=8@%,N4[+",A!'%
M:4W8RR/ CN+S>._0='8?#33?!5VR]>BR_0B8Z_G0A2SQ=%["&Z'%LU9"\A'?
M]&P,OP\<)DY1>Y4T#+O:X@5?4MFPND9D(%(NOC7S>L8M-<PD=03%H0&\_"$T
M()O*OX<TSM0'YS>7FWCY9-*!#R MJ(0ZF)RN6@@*J[D?OFVN=6G8_L.$^&#7
M1O= N7K9KM7]=G<_-T/ =; &ZM5$KRR2'23E&9>CDICPF!D<Q@%*>1V6=?^O
MZSMWKI].JNCI29$CC-L(LPC !.F9-3O&^2;J!1T"PWN,FQ/-[ U1=8(I-98?
M5*Q==3LN<W.'P#SAT!]G=:K))_G:94B&(.\/M(M.NR\0V$UNGJ[>K(B:1Y%H
MP V1E OOVW!XN?GU\]MVF'FDOX%; _B"&0G;5C!?(:MVH%<+S7)J-5>Y@P8\
M"8]53W1&$JU9'*9-C588Z^6&-L@N8!">PH1.VQFC;SEDW^UWUA@O0*DBMO)3
MG'&_R77 TV+B67^2ZQ0+]Z7'QR<E*:G774"%5.(WQ>7*G'QMX5Z@6(LJKK_1
MA>EW%BX=SUZI&%]L":<S8S;^":/%'AD&TAVI_#"/78*,)V>*F$*X#>V]I\PT
M9*7(_)PBTCV?^ G%5TRZX&["+*I"WE975R5.^?C=8<!E*.UIF*V=TB)'K2H%
MU(N:QA"J_6TZT'_(/#HJ"K#U:_OI)[UJK7/)'?]%?WG&9[2<FT-4($<?#"NO
M3 (M5(<VISSJ&<GE#"/R+3-<_4!RC&=.NV1BVX;DLY&&0V[\"]7Y^XV#*=WH
M,XP;S_7Z^P3A78D#11 [B)4FYV9S\>8<+F\W'_&!KMEEVFK.A9:2F]8:;MA7
MK6@N&GAI641S*V"&_8,LJC@]1YQMX.N1QDT0[Y"#HJ;)/R?1WN*5%0KVZH[^
M=O[95^H^^&B[8ZVB3LYV';KY(?Y\DI::1:6M!QR<;;BD#&MIAR[B:0\T96Q*
M*R"6FM430*(:A&R&%ED&96C /UJ1RDFLT&B% UFI!\91-$PV1)&@@4]%S2MM
M&K-1T(;:D!NGRQD&S9N(/MQ&<1LF##1/-'ROOIHP]$6M/8)>JGP"_Z _(KQQ
MH*IYGC?()/<;^)I9XG)XEZOTW,80->]PX\,DKO/;!*.7C<6@URT1X)-^Z"*M
M]7E:[O7)\1BXW P-7+*%("\RS\_M86C #]3W%N'-].G<?'>AA(7V4G_E# ?)
M-"]2B@:BTS@',/.OJ%O10%=FG!4R[W*0@Y:4%0W,0JZI ZX(0VS1  YM]R5G
MD3(RE\#AQMFYV[@9'EWGV'49IFN!3P2A)&"KL>@N^2/;XS>@L5W&&XCF<^55
ML0W>X@G]ZG"$Z&F>G!J@O8+<N*U->6JK<L'K/+[-431 '^5-J _&)54T7 [\
M>B&45-(DM,5I^ZPB:EGD*^7%$ZN83O,9-VRN?L61J:&7T7+#Z[P7AD\@"6DE
M"; 1A)?>6F[KYZF);X6#$7G.73/"SI"4H$F>:#'>VEH'N]-]ITNRSD@'E3&[
M=VMA_=+.SGB*&D(O;T->2[&\6<7T=Y2A%XMT&NUG&70*>%L>KSJ\.V/8[_-0
M(-"1_!V[MX+0,M66<K[*L\%4O9^!V24)#'NNQ2FC^:?X/D+GQNW;*(XD!<AN
MVSNFRI% *80J?P^)3*8&_#&1#".79!]K2"+>_KV@2,#E##Z7+5%QOE034]J=
MXOZ1_[[BXM'L+XASQ>TI#*RT%> YMGMP97)EGT9="DG .WA[NEXQMTR94$1W
MU,^66>WQ'^M<,5\_/@X&A/_])GHVOX6X]-^M>1WC-J1\8NP/NL6:7GS/(ZA/
MAT5^R'7SS/"IB\H?:Q!U7+S[3684Q;+SX\$T")HCU]N6R6/GD.'D)UT.<(VE
M7/0FF\MQSBS:\$Y.VP\-RUI=4S?,BH>E6RI^1VA-/:W/<=U>/C4H0,GB5QZ9
M3Z2CI H?F(')*76W-8.,][,)BQ5$>TNHK]A<J-% ,JO\Q"Q(W>'SMGE%(<SV
M8THUO-KCTM!U<]^M2CBA*K-^+\UPS,7X5+4;*27&NL4\F?-);\P,ZCK^H7CX
MN#)/K:U)I\QI]Q(D56&^O27D__M2]J/0SIP,\)3^#8\8S_]S-NK?'4G\'RK'
MB %URIZ^^1VP:G\]-.#+X'!]5\%BZ:ZWLM+X4]?1#LTL),OX8Q1%+RA.6BC?
M6_RG*[-9X+1NRP@],X3<-.H5VYWY($W*)"$L?VXA[-J-H"S>20;UB2V&R911
MYYFVC=JHAXYY97P660P7+&I?EAC2+LR^P'H1;M:S%M'<X[Z8,^SU_ FNPG,P
MKO  BLA/*&+32(J[NRMNH#HOS[@^T[ZK?/G47+[B<X9)V*)/%66DK7"!X"5)
M&DYV(P22HE2@^B6+U34J:;]NY+"Y_08_W?L5B=/1O;,64_A^VOJ^B^ICBN-,
ML1R5@:CZRR+ECL' QF!V,?'1N0]G!K9'PN4<-&WK%<V5'A^4O6?JN$:(?=0X
M'2S%3];,9Y-@F3;"MR>*$0>[6^SFHZ<G@3U<L6?M6/(.K)*AE%V"'D1XGBGX
M$/L>X[!+DC%(O/[H='%T5X%J&H5<@E:-(L=(1)P"7YWU=O*HP>SVB,Z\[BQ?
M!<=*7ZFC.3:OU;CVNN"[WBC]K#O\I43!=(F/DU,N70.%U8LT--K>\1]ERXB1
MDC /Y;?TB W*[KP@^PN:)/Z8>:8_:I) 28X^G?CF?RH>HY^"K/^0I>/*]/IX
M)"Y\/ZT)]4=)DG5HPQZWQK]*DJ)\IC0')GJ_&%:T#G3*JZ6" Q,+-\"JFUL6
M8?+3*W0Y9%G6G)V<TO#JKSJTQ N;^X_'GW T8AIA7P;3TJ/(Q8NUNF@__0!9
M1@;8-@VM3M9SM@VD]&&$=,"L_5.4JG;6H8VTV]V[)]<FDZH4U8ZZ=314X!8E
MT*?N,UCFU["L4,,ZB,.% <20<US_MSHQN)IX:,#K8=(QNPD*G%4.Y]VI6/D]
M'&$!&JW 1 /*T.L.F_B_M\+>_W9#-10F2I][7C4U:YC;CP%?U[MKPE3'+_PA
MO[?:*>;.>K$D^2?XP ?QPE%DE5A_-6_[&JE/%;$.*"JU/G#2FN,ZNYAQ^  ,
MR%:B@0!W22$>GZQNI.D3GO1Z)9!EZKBB\DTHZUP[Y-3E2( VRC8GH0%;SM8+
M:+&@>8.E=/K#KY\EQ?6VYR;2)Y(LBIE_PX1@20^'CH<T+%5D'UQ26Y:&:R#\
MJ-W0N(!-*?6Z0B)#";D*UJ[TU%-]S0)40W0W#U[U@_CQRR9N*IA'C^W=DL,D
M0[XL7=[DGY,2JW^K8.=I?.8EGXL>$XM#2JJ3;8&;)46>!P>_N%W 9ZKW)!!-
M\7YQ\YOHW.@'2X,EO&[R9DL3LH^SGX2#2< /-JTLOH>M=KQ6%.&'**TWD9U3
M;!5OI^#>.27O'S[!^X BQ@L^;3-OE"EY'=ZQ^%OM",?-^1N679B[>7HB//_@
M;I2BARRSTH7&@J (WW;%J?"U@&'YV.$3G^_@(8$+W4-J2M0M!:\3K@HG8=6$
M'.3W$4..Z-7I1<W6B39;P7G0 +7I#5U?CRTW"/TKE2-P;J\HIP[@S.JHHH'X
M.1GPWWU1[G^_89V;>0G&G=7+[,/+*,SRZVU!T-TL=T^J/Q0ZD-O:3ZYD*6\;
MY,N3_9%-O<)<SWOU+3K-6_;P0.50O6=2E %.GG61#LC+A(\G60]!"0NJ]*4(
M!R)WCL<=*Y^/(,ZE=JNC]L!P^3ZP_M 4''EU-VT$U;=\IU511ZI0[GG<YGYS
MD&I%0B;BS*'W&K,%2L+6H%5HZUPUJKRU]@ N?X!+DUL;D;92YHBKZ4M)\0BU
MVSB35@=2@B^,75#M!.^LX4]^_3"EM"$_G[NFS-[PK7%R,J$B6@7V]OS%7^XN
M=AU;F'*+N>C]%W37$LLY.8Q]#"E>N05780H=Q[^)6:R&N[8-\*MJ^F8>.##I
M$:B"% O/J0CW)S\:LN2HSF=<?ZEWH*UWA8]VG^59)#R[JIRLB/;).=M%V: L
M!,=<P034U?*(3W_2LJSY! 3L5FX4G/?7RQTAXB<U"RZ47%>SFZ0S-HV.\:WD
MI\=V*\""[ZY-4);JW\Y3AE1^!,.S0:U/,8:NF/:KJPA\@KP^>_O@O<Z$,J"!
M1!V?(<N+"QI&[]OO^(N=7UYDP>:K#9.2?VK^ITH6*K+(<D3CG:B9$=\ZWPQ0
M\=]>@>&_RKO]AA%6YD7.51U@Y3;"LKIBK[RG#!.??7Z/:X<&-)]^D&E46KC!
M@UWMBUF:9_&-,ZD(!53TT,&^;R3DB.]-(QN-4=H[^C/[ZZW1\)%>-$ %JD$8
MXE;?D,B[2.7ZGQNH]J,/LB1E-Q%[9<-0"43KHW0XF-R]5GU+S_EMIUP<@KQB
M5,=9;/*\'G; V>4\,R!H'R4,14 )>KD#X^*RR/:;4#>-XB7IJ%2FAR?,,/V,
ME8O+['F (XV1$.]?1/A;[5?Z&&GLIH^\XQ-=JRH1^3T_K#ME*T85>">V<@ML
M"TRW8OZ3K@=BDXL&M&(GP+*FO&RB-%4/(W/V#8@0GH0NM(_%MUIH#XF;(ST\
M(KY'VO9"]]>N%T(V:.%E>TO'PF-VCZ -T=#V1D:4N]!- -8^G)RGM:HR0-9]
M/+TZ0H$X?/Z@"JE'P2&G\2JGYUG'HV.GGH[:T6U7=; _EVIXFKK<)X*DAY9W
M@X.&>I7*3Y"(N"G-LI#^O,E_5ZCA29/N;X4:]A[/BR!7FN=<UUT6-V(-AI?_
M@CN[\6/>X6GWHV;Z#8L3#E$5_^V!\U^6,S1<E"+7XP?ATU,N%LPUQ<_$4DI?
M48Q#:N_R$>^>K\)"@A_KV*I7).Z@<&)/* P<0GL*O-ZPP; GQ9YY/S"PS2ZN
M2"P<T =A5XVYWH30I"<3IPK[<:S>V0]*CWM"H[R3G?I>+;"^EP+?4&VY*GT.
MV:NQU-'JOG+X!U#[M<XW6O85%L4FBBL\%_H#)GL'1F56+SGW8;7H1FK^<\+,
M"D*B*8^4*0/KD5!5O[[AE7>69N'C6K[2!9#GMIO6ZD%6QZ/NAF%PVZ_G^R(8
MGWJW&\2Y"8CGQ%;XD#\31PS#IK-/^'><^_Y*PL-9Y; R_6LB[JH,..PYP'2=
M<Y6[0,XTT> MI?^2J$ O[H!:_'SWAL*N?SCAN3?E];K)PRWIAB6%P85DC<:1
M'#DK3NS?T4!+C)D?=_:^(KC.:=NV+9XKV>1]8.T6YQ?U$\WP"1"[Z-![GM9U
M!2FGU0*4BH\+9,10S#M<G/*(<6UO>5:O--8,/Z!2+5^='4EG1F7ZY93J<L^O
M:Z)86[GH(AXVS*'[])+Q6^)DG\'Y2BF)U;!K7BX9I:N=2$5==4GUZ-#:9N5I
M5P^-FZBZ]V!UBVZ:T"EH=_AAC_@PJF;F+O) P%* 7EQI^CP<*N *6'EDM:ML
MD3V<R.?+\==C&)QT[^T$ACV-Z?04[$6GO3L==90#0P^CE'HQ8$MI1CN7YDV9
MDH6*R48A[^U5U*NX6IFU954\9R-^8N_]6QW3ZK(/"1H8LR&<F#C\9PC.?S(L
MAEJZVV_%BG_9\G+C%T5AJ("^4DN0TRWZWQEXE?GMBT6<DLM@&-^VL8U4$\W[
M7!6.HWC]%/#:G-BCX4WO-=@YH<:YUWM7V+T>AL2VIUJ^QYF8-46A:(!]Z:SS
M9-N3QMQ[3X_O#4-C%6DU3:%;DD73&)CT'/K=R+F([/Z(MH7/':GR$5)Q\EZE
MU\SR*'UU>#-;E2Z<!KKH$*HA_EP9<WGB6GH DX86,S$H>IZZES9-^FVO %0)
M/SR8?LYW]\K]6/\&284>7@P1FG!;;'>>.A9O*;,;3ZO)+X'GS\U7%UA.4DZB
MP__S[F/+/NK_)H"1\!&+*$9B^TY^O%I<!,2ZD!=AE=?3^J<;;<E0TRSMK2*S
MJ@CZYZU"%H(GMT-;3C$I2N0$=03=UJ3NL9_6V\\ES%9W[Q2&%7^2X_LVH\\&
MN9AF10X([PE&/1:E??+FP1[N]9?J+F5=,/U9ILFZ73HX1;6'C*'_OFXHSMWU
M/2H_&UGC(ESP4\I-[Y'CARFZ[+M$OSYK\$:MDVA\)!@8_!YZ!Z]7W*CET0?%
MY(>1UJ1!32ND=5@J&\Y5PN5?\.JIRN\#;+(  3.FY+]E'^^=."*AEWBSJ*HS
MR?]X![T_5:>\NCY:T5-S3W7#[,5#AX1'2E"K)Z*90DK/8<EE_O8L+X#1_[8W
M,8X,J9!/P]5-\ZUTWQV,'3#GFKTO%?J5;=J;)!I,KN)IE)T$(WO@KWJ]1NCF
M-6NVL(E$((=&N>V9TXG8'MI^F-*H54M93Q-L9!M%,8I8+5^O5M55O(G&06I
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MTXT!L#O^&4#<_]<-+7KZ_P%02P,$%     @ 9(0#5_"&[]9.>   AZ<  !D
M  !S879A+3(P,C,P-C,P>#$P<6<P,#0N:G!G[+H%5!U-MR;<!W>"!'=WU^!N
MP=W=@D-P.81@P5V#)+@%=P($=X([">X>',X9WOFO?#/SS\S][KVS[LQ:MWKU
MJK/Z5'?UKMI[/\]37=!%Z&_@E:*L@BP @@$!9B\' -T #&1\[&T 0%D98 (
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M._)IU44+1;AI0]N][_W0HD(^1K+D>>@RW;>%\OWYBI(?U@2COJVALNV97L=
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MT@1H+?"7E04N$X8 'K';I!EHLO]\W>$Q>F5-Y687V64W<&I118.N>6!Q*SU
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M9%5%=R%,U ".Z2>!GETSE[/ZEE456/.'M%B,WQ'"I[1YSVW'!1]+Y-:#GJ!
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M533[G]&C^F&9#H$Q4YNAWCE#S(;M17OS"JJ,=EA]]>61['O/8T<"J:TP%+#
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M&9.'(U?DK:>S4UTN.JCVEZHL:;UBN%<>+7Q3Y83E0PU+@$M3/0?@#/+!]CF
MKUOM5PDXK4G.2044'5YR#+-,[B"&^T\R7 <5.F?\5,N/EJHWDP]ODJP<XX0Y
M\.!*H_X2[Z-='(1!$);TE[.GV')1,=G:;'LLU<G<488/FXQM;"[W$*^N6KUP
M+04]-H24ROF0 ,?3FQWH@IIZ3%JBVHGH77(8RZC8R[^3X4GHPNZGQ+Z7(K$T
M!0 /NDS@@C>MOO*EANGF)'5:@J<<2_T-79T]3-1IM9;!:6\)Y_EUW?'R0RT8
M<15=)$^P )C,K$_,NL>'CZL$,8)#K/;&^*?-* X9O,5"[R)4N=[TT!(0X9XJ
MYMNWV+#*T_^1L07Z8J7KSS\)5Z59NAS>7N_$KE?YHC,Q&^[_+AHCU%'T5??9
ML(!\TEPFM^)YT&S 7,#<5492XSO,I!<Z2F0YCT^3&3X[NI[(&YW,: Y?:<-O
M1".4)MC<0Q]-]](U! O1/%4]$P6+?E]/ -/-5&%(IVX$R;&'PK?P0\LCBG97
M2^3S95KS#FZ)S9OIS9MISG0'?NV<W_VI7] "?ZH7QC"Q1UTN_.>%'RR$M#Z_
M_P(#ZYC;;VUJ;HJ<"J.\$#MUB+<#E[Y3O#$0/O<@=B"\J;^R@5)E;\#EA-P1
MN>D2ID<Q,L.))1(^_,?SA3QJQI:VX(>\66$IOA1?QUNM4&JR/AN6(#95TQV?
MN&;[@BE5J%KCEJ>=>P82SG7Z89"\Y)$1Y2&;]>A6;=RQ/G5O!%E)J=JB!MGM
M.D7E0'K9X1QA;8N\ETQUIX@75]EH,Y@LLC0730N]^0L=_@&.'U,Q2P]4-/4[
M?-$YB4G(PW1-H$4 +  6&Q+FA7]BX^'\G2 >Z#'VX@_O_9^>P &/VI]Q>DHK
M)Z]2[V=X7]+HVVK#7]1?,+EAD^B:BVFXL?9X-EKA']XM)<CV[]L$MD5X"A?U
ML=*@LC2&2\,,WFL.$((R&VR7@Z^X W%1P\#=+/M8W,]_RK_YE5O:J%$S<)3/
MW@EL/O81/""(=8<'>X ".VK6]0]R/VT* S;FN6'FV^F?EO26VS:GX*8X:ZWS
M5-YVY967^)M'>XEU,;>-J_ 1\9\\2]B]2'#5RE5$EN:Q;>,1:793VL)E?AS?
M+G&QVHH$2K6[=D.*AZC64[9_VN9R8BTW=LQ#MPLG:,6:(!@B^/#-P706^,;X
MA9]QA+H--Y8QD<W)-BPAYAF?95B;K);@_"'9$'PGF6_"O['$$:]9#V04]4EC
MQ=>[L?D*ESV3@>Q&$"S]&>9@ V+J_;3C*Q[*N_]&G%^Q,7Q#AHX6!X*X)A<*
M()&H5,O0T=0NI+OEORJ?&;P4T4(G2H$DD$B[9RE9''0<@8VXD4"#_C,6L^'?
MR>7;SRF-5XW#4QTCD8#91.<4Q_=]'8=A%:Z]\:>OE6\P*&HZYR=]DJJ^%%PQ
M(6!^]!25NY4+%0'3AET"9?9O:B+M,$,4/DV6E+-K3DDTSH)\E9CG2O?<\+WY
MNXV$/1J/%3NKJOLMJ@*7E]T7Q2S48U;=6-_1F0AI,W=-]XC9:S0]@<?=^@9<
MO/G0P#K/VF_Z8UU#TU^Z>-6VM/+&8YNA]7,.NODAVXCA*%RX\-*1JF;["QUF
M[RJ:X3%T86,!YM*8;H6*&GZV/1Y,!%%BXNBY;IN].N"A"ALL\;-WT-5(>7D:
MZ9]+9-WC2_^FP7+*WN?M;RLO-,O*S[-V]?LV12]2'C0<?5FG.F3!YN;<&Y"@
MK$O<[BU9+THP A4ZQ4&#>V:^:NA$4LBI%S7W'+3(B=*UYJ7"1"Q!F+M( (_.
MK@.K?^;:AS[O2PKK5RM&B&I4'U4?Y:S0G7C KL^=Y?62&-')Q"YZ!Z2CI 9F
MM?U@B'N1)KQK*U;'7[,<6T/T>X.#X/RE]H75$,Y<(@G46V'UV:?5R@6F9RF0
MKKE!YRMR?+('=S^*/D?ITY(B@DH2*76T'(W\!;3*BH/-%DA$#(!\9^J[Q$/J
M^+QG]X?KG#N\O-OCK4"&6^#?E[:YR$VU[<M8_Z7CVFGR*6K3+Y=+;KI)-RJ*
M<V6XZ?;8#W(4K!.IDVV>-&FK9%=IRL"P'IG>[_4B0M_(QDV3G ZI(D];]=./
ML'G%T_E$;:Q1T^3D"7-__T#_CN<7$7=>E(;?@_$_,-23]",)V>1-9;@!TY06
M7Y?>P5ME-M!(88VWJ]&6GMR9S*%7B]S +,_'% #[\D[().U2H=>VI-QH)= U
M*XYN&*'1HYQ]U_G)$O."#_#D83NOF< G:H[IS0+[%Z $&>B*0"6)O%@7U7WO
M 0X9TF(FOOE/#%FW'9CB/%3[F8)'5G!_Z=3;5!"!U2]Y_2AW#,[ UENH-U 6
M2GLCLE7Y6F+-8U#6"H?ZV+F!: 8(S152A;<'N52$SQ<Z@I62D$"*6^XH@NU'
M:@T&NV'M;N1RG^NS(L?W/AW.9HA4'ZNY9INU8HT+\P7Z.3V.#J?VOJBH%?LN
MC+9RC#)%MLFB=BO'F(15T/F6T(GH,T$U"P+ISK$02::[^#L8RS'YOG*%)=\O
MPZ15' F5N/5XIU(#4GUS3L&_E</X]EBY.X#Q6W<7;5I:.U#_;M,_\^W\0=^I
M64?L"]+E\HA"2:A3JO% P]6I<5;<V2<GO#4W!8WW 4FX=25^5=4(S6.%*78C
MF SF;<IJ9>C"CI*[(A,2V(!JA.492Z/CN@I=!:OG/*ASAIER976_&4B!E2]5
M&K=#^J\KR];A_ 7W62BBC6'GBGX"8L>VQV/[_?EL$T4QRD<S0:<=F'TURN\Q
M,;I>7=ID[5P^IMHKTCRO5(JFS*302YTI]6TXN7WTH6M3L)WG6<HS]MQUI>-"
MLM[T -H X_1*#IZ2BMS.OR/K!.\17'!"1/L&AI,/@Z6H1(K)4/=GOV7 >R'K
M F?_W,BRPC1ST4YR&K^TM71R(M; ,G+LHWR0</[=ZEBUZ)!,](JR@GBODGB:
M=>7UL67'$4RJ]EC$ 508_TCXLGHP5X#2C-Q1 ('Y##SY(1;%@+G-GFR]N\(W
M@*'AZN+4\XW]]:<-'R=\J55NP3(QYIG,1V_V].M;P_Q9;D8W0\"]V.<.M+K5
M,P[3A\I)[$^<5M7[Q:$6 N8F4)T[HBS?@V6G#$[G["!G^R?B_#TF+,O,(F+L
MZ<63AG0-AJO3\48N#CZI'L7??I.[R<4CH]G=#4"C1N+3 Y<JZ"Z_Y&.);'6U
M$[00JQF.B"0'604-&>]C.6R:#YB%$;K[.Y(5)-@6T]($"E5BAC'<:,)C%1W.
M=V,$_<\C6WII9=>N:%EI-34 %H*^"MF?@W9^=SZLX)#;-SWE,&+2J%JW9YQT
MO;,RXR_GEO$4OY^A->VH%.I?QBF/6%V4*UO=2S7CGO&GL/G&WQ)\E7UKPM*W
M97>5:<'8A:/=%6EUE)Q/ARK</N3L1G(8&<Q5M<??E:4KE'I"B9M/Y8>I6GD
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M1K#8=BDO?&Q-KZ%+N UW>:<=.WUV9&J?I,/MZ;!GL7T191PX$3W)^XBE-Y-
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MK''W%@6R2GS*"!26__?!#/0N4?1N09_RGM8A),!6?DRX-1F([1@ ?7PS<\^
MGG2N<?8B.@:>-42E^W:5M8^]UF;:@ZGRRDM[*:J%84E$.]$\):X'](UE#0\=
M/H>SL^-9/#Z]>X@R8WMHCX($##8C&#^?&!CU$88@[EZMM@]V*""B?*D4;POC
MK4@M&ZW>5UR42]I=^)=<( $*H62$ U8]%?%J;:+N9?)P /-:RT/+4"10%XEY
MY]I!5UH0.EXAL$$,#GM?#!FK0X \;I5LX2Q"7[PC4_ 5B!7R-'))*EF@G>WP
M8;R;PI+MU+;D&N(L$Q%M+B3@RX\38PEL*-<  :53[]=4W=3C[<!9]T*_S70J
MSYIN*R7>*+'SGVB/5?*Y6T]_(+DW-/E,M?8"-[;['2N,4TIU1S<4]9B/K:C"
MAO<7=+9V>[AVBIDK<8OMH6EZWE*\MOWQK?9J7FKDEN)15(VMMDQ9CVRP8*\+
M+-GX')HK$>L*9>G/Y!NZ$:'SV5C:J]QMJ3X3E_IV-.@\B6CI)DI^%"-O4ZBE
M9S0SQ7C[O1A\_M+7ZMM\E)%+T>6W[<JM';:QCR\^;3FNU,1HA*FZ03]H8I.7
MB-M$)*0A-$Z-4Q;*VN2[7=A8*?C?K<SA=TWL:JDJY34;C:09C:<EEH^+BH8/
M#^ (T3?41E$'"VA$O7AZS1PHUEY8[H<?'O0+=A.F2Y6A6:Z.SZ_7NJ&6UY"X
MOL&X YVU+/KZ#Y0D^#/('9*?/[?[@"__5,X%ZTR&A&1/QL-D-C$$/5;*2D#Z
M\WJJHJ>5$16A_CU54\XZ>J4\ST3#K-0 T@#UY@#5-6(CC&DX)HOQY0NMQCI&
M]V;_/D^9@$_48N@O\AD @%1)RAO6-?6MW9^VU7?"]Q;Z4]GZ9N6-#W.2G#XB
M#+4IT1ROY7*?86MQ<X)L>3#[U6=[4A)<)A5>)@6G+W^WI=ZWLVE7&Q8*_?BV
M$0E\>=$O>"5+4M'\N%'K@OY  Z&]!.DH0,@,;Z:+AD$(N]7J:3&FIFQ]\RFC
M;8R30#[\>(>&WT]M3Y6C_L;*5T7LN>=T3Z?VE1'"G(A:E/F?4HWD.CK)JK1O
M?4F2HML?7DUM;]4<SUT(E14[11FPU;-_0S)A1$9B%4(6D:;SL79XR3+<+S0G
M\=N!;LZ=9P[E+1>.7L5W[P,=*^-'1K:/[.AJ].<5,"*&XC;-.>Z(Q%U5\_1_
M)7B,;LG2@1IY'Q@\@AG:$$,*=\@V&C-)-G1[SH8&'LHE".]OWD]>QZ35L)YZ
MV\6^DOX %Q$H$(,C"RZVRZ;EARN:K!,A@>QG<7V#7Q&)*-]]1I" R-))#!*(
MR$8=!EUM(H%T$-P0H'1# B/\\#4DL/H#.,E"^'1L42$!XN?HZ4C@Y*< $4 "
ME\V R!82R'2ZZD,"/:,H6^+P$]"P.((]$$\0"6RE(5R0P+$[\$?_0S[("JT8
M/^A\TN"E;UXI8>4,=A_Z:+2,F>I3:;MD&[[9T@Q>+J(O-9K.4XQ*=OLOE#@.
M%6W63ZV2;$&8;%K&]=8$/W>!-@FVCD-5(3Y=%HYY&EM$\>!M.*PP,-S_TD<^
MO37-[J1C#29V@=?CL2!6F:::'_GYU/\XTFH."6"]LQO&[-C<\?8*]Q@AM&Y.
MG.:?BYK)POVZJ-@=1H+&:\Y<E:@B3\06?+=^M>=CLAB%;=*V1I+@9-)4.PEO
MO=:8?L&UXYO2Y->P=$^"9 Z<H,_%(QGY6E&"BGR"3(Q,;@TVC)!#WESSLGB%
MR5KQ.SN+W/7U[<=2T.[IS%?*]UJ5/GD/,,DD05#:)C>^EP[.A]D05;-,YH<4
MAT5:A:>Y5+N$![#E.K7H'\!'WO99?7P57^[/+A7\GJ4DB5:K-C?/,F\R5TD8
MUJLG9<0[5?M.+W,IWZ:^F?S.C'+=C8@"_"DMB5B9U\;'"TNZ++V+)TJ\*6R\
MGUMC(,<"S9<[T>WL>26*9PEM*>;UX3 Y#EJ%?]LW:Y?_>8?LGW_X/7]8@>LO
M&PKW0-I7T4/V4*HW.5AEN4;Y1\(>^O)3!TRK#[EH?YOHMJ.W<?\%;=B"59V1
M&/E$@)?82-Q&040DT,XE+\HO3JWN(!L%L[?ONHUH+^VU<-[P3]9FO\B?,\F/
M\@7Z&!EOPSX2>,N%/JX4U*P,NK"KM%'(F]Z]WD.\NL%\[3K,H%2O3O^^3[?)
M9"N/X;HV.1EQQE< *TAKVFUF#+.'2P'-$_HC,9'[3TDPM^QRG/L7!]%\(Z/M
MOA=J$:7P/4N%:Y?\>.,6^765>RXZA#N]>"0?0<)^'#^N,,0_.YLF]F]$V#4;
M(H_G(7]H<4'/=<TEG@\H_)52,/PDB,'SJ3TD<)X/>/W[\"TSF"RH+#HG*?%(
MDNGN QD5:1Q XX-L=7W4DY!%C-4P^.3+,"(UB739DH?WWB@/ H[*O$"RD&AT
MLFY9^7(]MYE/R-,UML@U%RF#-4:28>X :U3I?[ :%RZ+TK%Y0\,C"'UUGU51
M6[=G#>O\.@<0AP0"\!)+"2#DW,T/,TTY2W;*^EZCGG$0U25_2>5F2ZV-[7QJ
ME[94TQIB4Q !:0C5AVS)MBMY'KY*T5P3S,8=^$?,DO^M,8\K*S&+19>^R_WE
M[@-OZG>==SW0_B7:FCT7[Z4HS#L]Q%=BU[36O/3MBO?F7:GW"[="(PX&;,2J
MTL9SZF#H;1\.OL J)X^1Z"NR]VT5! ;Q".-J)  9@_I2Y2Y?1C\.-YZ%2\J9
M.A]*:2VU?4BK2VLXD>HMN![Z(;>"!,)IF)! M;\FYOCA#*K?'>H$T<<)61Q>
MEI"7OF'H=TJ2N4=F35-JLD#5?[JZ;NE]0+99> 8/^=RS8KC$:KC3!:9W]//0
MBI*J>;=P=N;A3")K\1J#>OV![\^]]],N;^_;BA*HSTNUD\Z,XAN++I#]CSEF
M.&L)P1.@/2XS))!3!WCQ_GMTZQ]ZOP4=O_!2WH^$&FV;KF%B;F5O[=FZD,CJ
M2W61(%<&G=SDEYJRY;-O[RU\H0LTG.85WG?DJ%HPF"_/BWB0H3;57=$_<&":
M5#%+@PN!H85H1;I[OB8'/#3^L0)*_WMC8H<@G8 KHL_6/=6R()F#4G*#PLC]
M!]Y\0,^](U#&/!9L 5$U;O#X,:*-^M'4M3ES_IYJYVU^JV6+/(=T!]%88?%Q
M>^&RJ-KP^<[BXOCQ2I - ?HS6()068NVB<;]/;/!#L9[1!]Q<FG7+8*+\OD>
M#X\Y+NY>I'"'UZ>VB#D(,8!>CHU\<<T-SK"]]%!K-=NG*567C\P@T4P1<FTU
M+:2R.K0M?%I8?,$64 S_CS@D2M?ECU518:I3X@DDH%OU?[O>^^^.F&Q=SX15
M[N6UI4[JWZ;(V7FD"A)(IX+XS)*5V363""CBY%OXI<0NT(6EGZ(J] C!YX3U
M]?5BEHR$8SCG%PQ#Q^D7]L_M#!19R$L $B(O$I*C-!U4NU>3:@>]+)TT"V5Q
M'[@E'X:2S=C?RT_"$$1C8*/A9$8"G-2 )-LX=,211K==3O=C+:%TM@\ANX*(
M;8=/(*H@W2C:U%^)"_]8I1!! I/&2K>.&B"]_T.E"/_Q!E=?Y2BI/<>%;I^O
MVP7Z6&\32BK.L))-"^%V#,M7KU.E B<_H:$I?3?\G'7I!Y63]28_/Y>!/H0N
M=HAJ]J*W.D?Z/<M\J_*CB;XT\GAS%I^T0%Z4W'R;V!_G5;/ZCK <P^R:1Z9R
M])\^GEF:ZL:@TBVCO'U._%>@9@$0Q;+^]X1Y[0FN2VBO>/E?],]_B=#XO],X
M(T2H?DS+%/ %L" !A1RJZ?_3Y?+^RQL!$!7VG.Z-[;4$$AB(:OQ+9O"_+O"/
M]\K(7X%CO.&@'#T_.U)^1/J^]9_RHOYUC6LB'$C@"847XEL5:#M%-AMW^(]!
M]G\7&X6(T5VFR5<%82E$S,LZFDWQ^E"2L#^14^.;+*?WLI[M8F:5R+.DOA=)
M3/=T"/"E3"O5M>.\+51J#()1]/A#?-0T%KB2ELBX#TA(2/K[AP#KOU EIF!7
MU=9M0;\W07HZ&)5$'0)MY<(.[QN<AV4:$HIPATAK49/]H9^D^A<U!%FJM>HB
MBR&BSZS+>VG1'BZ[5R"%SH$][A \S/,6>UB2/ "LP#5/!5!>+"]A2RQ#*6>D
MZC;8:.X/1?K$D]=64_G063K9K]4![I-_GM-USC YUZG8T'"AS_Z+86@@[(#.
MAQBLI3G 5V;K=0"^79X===I]3J'XRXL.(8)\;.[-I53[.M*RZ(C7<S+E@">5
MQ0>$3^$MK&/E.?JLR4]OQ08)^%=>JJ"<ZX"V4D%++(B'0$ RU=5FUL4 $@@&
M_CG^G^/_.?[WCQ>DCN9)U%3?>8AZ?1](_@WQ^8>6[[@H[8S6JF75PD9YGA5F
MC7&G;:HT;P.U:'ST^F5PISPLN;F#I;7HF- "A=/L/E;2*$1XR>5\>B2['O4N
M-S>P_\>.?'5U[," +'40)EH@0S:NF<SQ*Z%3-46S>Y RXFI=60H"8NFP>C"7
M7%Y4-TOZ&J4/!35C.+#]XTY;V:%S?EZX@BO%)&L(MZP6<S4>LQRQ>2#Z<QU9
MHL X_ MJH.J_AY6%LH(@.T8"(:=;TXM;*M4F[*6L<=T)/:P-&/9[L3X/I(?H
M;J!Z?/BT!\X#W!( ZO#>WIDHK=+$J8.""N6CFL:ZUJ8&'\0$7@+O3((<44.:
M0Y$.\X+^')@PO[Q+ =]T^]P'6P:@#,NW587N2(OCVVI["M42ZM0E??FTUSYC
M/SU](#NAN4@6Y^;NN-9$QL[08.&M9OV>ZPNPOM^J;>7XXWPN3X4UDS-=@5Q;
MI63$B6'MD[-7K>!]:0HSTRYO4 +PX(<18P@3&X?Y3'YSO#+!SB.?%)70[G/Q
M[1ST.!(%*QF&:9UU+GR2>*)ZKA=C/<^)3HT)94J>1=B)AS*8IZE/[Q_(&W^-
M$9&_D)X?BN>LR#1]3("*]8)6U\R."SOS92@0?_F-R3U#9*18P0W%T!*@GJ:I
MRB@,VB<8L.$H:*O5A:=9/1\%.\-D&_ -:OF!1RIX.:UD& UCK+DW*I.Z#KE+
MG@T$AFS=+3)IS+^\R4X+:2W0"3:@"=:\#PCI_3>Q7O_,9G;:1WNI20-&\\:+
MVQ-TBI@W_+.&%%CH9+FM=<U1.IPWQZR.7_?CTIGO ;,3>RE*;QVF,A6;V.C>
M$\?-1H!I]S45QX5YOKQ\>2_TI=3/4S?PWVGM?T3O\G<V?VC1_=<,]3_>HY2_
MP1?_;<XPDZVQY:/Q@+KN9S<@[TUU#*RX:2ES9KP77MA;Z._"@?56K.)9'-)9
M F\Q+<Y@ D8"GA8Z'?0/%AOJAT3KV"IHRN]IZR;.\*J^BP9?\_+(L4'SY&NZ
M_3<LHC<UDRT2!A<]L7N7FAA--.D WV# ;<XH2>R35]'"G7CV7.\49G[N1"PS
M"VO-=NF[!W56_0)SRQYH@<\:%&\GD4#[/!*(&D5I=CHHO#U?@CL&XDR /,0/
MZY' FCO@F'93C 0"&I  63:J^Q)4^6:_XQ(*D!4@=D!+#DB@]P< Y;]01]PX
M(?B?HVUW-&==S(..FP'^?T[]SZG_!T[M2L)S4O)VKSNK_S,2$/I-R_T/W*!&
M'7]J9++ J7H]84QG7^K"5W$&8W^<JPC8:+KFM&O:)Y%0?$6G$U$%Y>M\I#81
MG0IMMPM.PEZF;UU'/2]V<M#I?3M-O<'0Z.]H+7DG#[6L=>9@G]W4A\BD*IG.
M>B3^A'>"N^7QRV+N@(POQ";)T+&K[K>ASU%&V&M*[!ZY*/LX5LTIBZ7PJA6%
M/6<KFL.G ONXC@>5Q['(.$1]<'_>J %,1&A-/LYO"WN+55])R_>U,>O.P-7K
M2'9'HG9G),"YB"_471).0TW4%\&G?T5K^&Q2(4)?H5C]PEA\3J-**EX!XG:_
M2.VS!,ZTOG"L \I748;?)$>O.X[EZ2Q[ NMXVV+^!E_9X!Z,E3M9OQ!W4,GA
MI5I_>E2![ -GB6RL9NW0,Z()HL_QV+,V8X:#,YGF\09.W$<5]"_"[]*_&F88
MC(K*>K* TN@O5<0+DRV]HR?I8>(X5BUK17/F("'V.DY5C[$)_6.:;Q!GL)<
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M*O?TV=A'%!?MET/FAZ@[DDAE6B.7ZWO(0L&=@CL!UG?._E_'IWY/" LY^[\
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MK*[B4[9YNQ>:Y<CT@:>E7T^.;YZO5)6I\%.%839EM-C_D0*.0GHL@+MLF4Y
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M4-COO+OO\E?"6W;ZJJ:BV'JM@S<L<NG'E(3]=X<)P0A=5W=68V]HAC>;"?^
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MPLQH*]UGE;?RK:FR[4K5F-\QZ[N5@W7MK_]',I=830#$AKK YQ&*QXD(]X^
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MM?'Q<44DGI;PTXSG&L0Q:^B<&Y%R5=6 -BKV-/!\]8U7W%[])-WV$$9EC-%
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M.B!4Z&CDTF'.]=UE1=$"$V]%Z%C%^*^:5&NI[B26X4^T=>9.SGC5_DY6)3*
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MEU =,Q;IEL*9+GNOZ;9;!WC;03*(#%@:RB.F=)^6QI#V2!0LI)N'?Q[-.!E
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M$@)'BUZ?"M.T)\I//MI#-%"X!@0$E=&]E=U9>=Z7_7A;4>S-6V.J3SKZIJ8
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M)RKC)V$W"7-/B[SJH+Q;PJ(U[=4S8I/8#OLV_\GWB3WZ.PE!<?J[^96A7'H
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MIRMX?.>[4(1_&5YC?ZBM^MI(:(N>QMYI0'.K^!RQ @;"&2_]3'#&^[Y4:#?
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M>.442P8\@,!/L]K02TB%,R&E<),,J&[H)(TX<0>=J?#-A;PRK4?EI\=YB/7
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MUG&TF8RU'>\3[=_]:&\: /9 )I3,F#>0 E&K<O)# KQ5/B[M&6K67O43*AM
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M8&#O*=23U0-Y$7>Z<BQJ6<U/RIHI+['=95B[\01*G28]]P_W=]SXI]UK<G#
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M-OHATD6D"0@2%:2*"(@4@:A(ERY=B J(= &!4*.@($A1$)"^  &1$NE20T=
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M6$0-U@Y&(C"@S0V&+@UVG!8^WO,I1L^S3L?':W@\,$6JBK&'[IS3,X61NU2
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MIW8P2+;W"ZEW8V_E:R>,77BQ2"R,$2;AX7$/R85J[AQM:QJ"%;6)# -*.<C
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MK70\$>P_]R(1[RG_4^]\DHZS\FNIKW>B!:,8C>0@W(1_V>5Q@B.>"A Z%U"
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M_8*D]]6^"O9&15"!,VJ.1%^"N2U6] RZ+F%^YFJ\&<JG:DST1.BB C!P)GG
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M"7=TRK8!]K->&NF[ )PE9:]CZASSHY8$W((TBF[E/@(O,BX;EH-I&!6LVNJ
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MNFZG_H8>=#,0.GH@/BFJ)59X/MW.YRX1YM^I6S;]V7I)H#5N'-<JSDV6;AL
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M&!-KHO5<0-+)30:1,J/(+C53++O4PL3_E9HT0W991?]?J0W4,*OA\_]*S3]
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MWJ]H?FEFI78Y#7BG8W:$A[NG"L<0H)V9Y<8#VXVS:,K:#3@?WO"^*SJ6/+S
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MY__&->P[E&Z,JJ:SX[IS%=(R8*)U]4F8.&0)/;P_BII"'XA3%-<I)%/@%#S
M@19##C.AU,1JJ,,XZR!&:./\SA^GN9Y!TIQC$JQ$H7,GE_0FKBT"J6NCNX.4
MU$7'H4LC5>!HU3]V?5Z<G>.S0VVFGPGB'0K?CWX[\;YEKDR%Q&OUZO?/FW@Q
MS$AQB91D%GJC*&>MN-+A;+)S>/(6@[_.SD'%%V9=L%S'O2[$#*-+0XCG_MW/
MB[C>&,3I33==AV\A?K7X.UH-I-WN7Y\53UKU1C;K[Z2A\!>;0!>)),P /\UD
MPG;%O'WFU'G(-;FI\:,=?WX&0YD3 OTW B'S;Y<:C,CY8#+R'4-EQE.O=>T
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M30&Y_XN]]XYJNNO612.H2!%4.@A106D"(KW&!@B(* J1&A61)B"]!:(@O41
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MYZ;N.> :4&*-#AA'3X!!S[9*XK/-#S,\VA7BP,M+_S2!/6P$=5@_M)&R<-W
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M*MU)H3 -YPVZOL(%0.]V+ZKUW=]FVC\;DT>QH_7)$[I(0600H6MVK^70JNV
M,P,_P;I[4J?_^$1=T,LM U)!U-8<=R<8FG CKNH[TDRM+N!#30?DY\'-'W1
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MC#8Q[_ _V'OOJ*:^=ETT"HIT03I"E*XTI2LE*@("8@3I501%0$!Z"X0B(%U
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M(/T1!1X'8Q *>.H[D_:@.LL;C5%M=I(=,6+ET7^]\@LSVL-3'?QS]R40E<U
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M[1>B,B<9ZZTW@H=OT[0G3M=.]W#V08M^'V9S1M@JL)3V77GOJGEFZOS-G>P
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M:2('%H8<.J^]L,/U,BT GR04JYCT^L+-WH9I@=OO?B\*N1HP<<7-9ZR+?5&
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M$^A<?RAF.SQV8,RM]/Q*7+9_!?W"Y"8C-F7!)FZS63W?3X.I^NOE*2N;=<6
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M=4^C*^E=MQ67!Y5XZ;75DHQ=:8*H\16"_V*_ Z]T.22PK "CB-96&0<IMH[
M.8F7:(7=IB S]KR\LU##[+:(C@^,_2%:5/'M9, 0VT?]5\<",6+YIL9D0#QT
MB9>23"?G8:3XY&_BT![$+B.6##@-IZA*S3XS\&+BP<^"ZAMBN3%C*>\(4W^.
M854?AF[+[UQRNFEF<3]?G<-3=3/$G4U[?":3@=DRD\D9N."VQ5=(V,$[5!$^
M%4]#;1T]'9/7TV_4S$&GGB4&[WQRVE8"W^WK?DE\0;"EW)IS#3W=^#7% 5KJ
MYP9NN6W5M=8\Q6W'.W5F_N;NZ$J/II*@*$@.9='_YY.MIN)T34K8I@;Z2:<9
M5N1OMLLG+SXRU@RICX)<K5R1NI2)1S?K84<?8]&=0Y<L.\]];3QN5KQD44:T
M&'1W*N$10XOW^J"X')+/; 1+!(_RY$2V2JC/VYPCW /S^A50G+-E\=OB2>(C
M^&AY["MUH0'87K77G0:DJGCH:=W.YC9H_F-&=&C>#?3+8QVSZW%'9:,6_K8T
MGC_C AS@CL%#TV4@5UB<PG&>4,8 2C0J7QN ,=3U9WWQB*9_A7WSUA9XP,2W
M\C<94(U$_E93\8,:.LJ5PIB=27R((&FSX6U[,^'1[4N9--9\7!>-D RR:];A
M-FJD 0/ZH6EI?'0#W-Y%"?WRG4@7ZER7#T,U_O)V3U"[ZJX'PI4,N-"YN!.'
MH/*R^+@CN24O&; [MX0:^-DG).D$Z3TL9J#ZNO3JHD]#P1AD;FNHX#<LMEGZ
M1,I/ 3S=V44&,)N &Z+:=!=B70+ S!I!,K\LK8]:'Z2.0@<C?!:5^J@3SKE_
M(\ ,"+Y8,)+R:R\]\Y/[/R]AQJQ9ZYHL/O*X !_6/]]C512J*KJ@!=L!-A3:
M>AZ"[OR&)8!>NDWIMH, P4)$5@0VHCF#UY)P"*YI_*;;9Y_X^,C>]O7ZMJ=0
MH,Y.C_NMOB63X9P:,B!1'A@)K*Z+AZCG,Q,^KO'(#PZ6LL\()MDI>2A'G* C
M!& M/[9C",AN:!7T#43ZA+4/Q_]][TDXAJ\P<K2K#S.T=8LTZ^Z_1$O";[+Y
M*)]EB;NQ,WB7)J1F!X7$CV&5_2:&*[;DF</3;F_A<U;D'L_\F(Q3Z&6)-#+W
M:'/@30T2^]8PA2]G?W+WYQ;DYI>IM=J;_ASF$%H7-P[,G.7++T8>VJ* ,\F>
MQFL<IL-DP)*D,QE@E7(4T[*X<\0O#SW^\\A775Z+(OC>P6&G/N"5ZX>)B"6_
M<3)@8]?FE&'"9A<7 $VRL>^C4$Z#_[ LM$3A*3&?9'Y":D7@-6#\,-M3"M=9
M,FXE V"PTR3GJ)LD*H4ON.PH2D'XD87DQ4V3M)?0!RC0JC6O]?+?_B*9$8$?
MN]\2PF+$8/?;_C-OE!(/Z"=I5WPA VPO@/9IQ<_7E2&6,M:!^(OA9,"=Y*K2
MJ@.;C_HW7E)@X=T_']S^'PYR0PBR9(#0Y,-C2AW/XV]F:MF;'R*F6,FNB9+B
M O9DP0O2-GNW;U"*TYB^!OL"7]3'X!$;W#*EF".D=\UW8PZ@*%V22DW.X3))
MUUK?1HMBY#,0,D VK*[GSQMJ1O^'D^/_?)7O1 )WU=;0!S_)@-\BWYP#%Z*(
MB8V^IUZ@8]JR4BB3=5P1Y$'[?\HG_Y.+/AA(\?=!^BF$XO<O=,<O6E]0<(@8
M58;8P(!.+YB,RF-6FI KW@NUMA1')7M%L&.EMY8I20LC*H")QC;8=V3 ,^BS
M]J83SKX3"B+GN*J@T]U@ ;^AMBVTY21A0O))^T5"#W.D+X]0KK;\DL:)WJ\V
M7@;U_A<VGU*7I.;!5X AA4@F_[*J<0UEO8YUW[0<1V3Z@T,("I@[-B_,\/76
MIXI).;;-A9<;>,,C>/KS?E@2?I#]2 .+(+$#B0)D ,X<VH$DH?8L0+]RGIU(
MI_>@#Q *VPU;(RUY^)YA%5$*2$?: .9G,2)8YZE9R]4;6>#-JEAM]Y\:*Y1_
MS0[!S/>^M0HV_KI>C[;CO:LQC9H]&8T+VO&<A>\$^52N/6N6,70?^Z8VY_LI
M&5%5=6A[+1#1? ASMM#;&4'.U9AT :LYFK"+"Y,1)$&__H6?N-'U.?Z??%8J
M=UQ44E84EJY?Y1924;^EU!/D-T[0/Z$V#_Z)IB\CNF,2N0@9B]US0B%SW3[)
M@EJO=# 7OW^WPC]]71'.930=-PF+Q&P:7V>;8&8H,4Q^7U8B9<1VY#:P6.JF
M:S&>K28>_KI>>\QO1K?PD=3-IORCS$S_\MZ"7/T)XJR7UI2A21<:.T*2IRQ=
M8!<$+R #WJ206(<(ZHA:E8D3</KRT1P%>%L0P";T8>70W%%IY9_M?M<A+-K\
M)WSHK-^BR2A1R]&;=YW3E^#GD'CEN['2N'8?]9'KLBE?0=1<N:/[\U<FXOW?
M?N0NQQ7LB-7O6?>)XN0=@@SVQCI@-,,=GA+];,5JCIK\&\GIPA73-G2^QL,(
M2>82,5@FA"$?VOZH^3G2YD*/%F+(P;!9E'T?@7T,CK5[:)^HK\89X<+7HR]R
M [4IJF+G(UY]:D^ >K<X&J"/#',49OU]]F8P9("Q?/J.SQ>>::ALS#*Z4+%[
MN7)_EOWH4P'!N>.8HT: $%U*?(3E[!KU.-0K'[K04!T7)9&R];A.PL+Q3N^
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M8?(I2@HUDV7& CCE,OT(52N0?SA<G<UNV<FXDQAU,B=FXX8 /Z.._KS8HUF
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MU+_M@*>=1$7X&@_PETSCHX...RLT1 Q=^W!S()F[BD/E2[&<Y!/ 88F(\8E
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M2JC9R\E^%N%3^ZDKH80Q^C5*E\/9"5JU1,G1%1;@JE7H3>Z?+Y>O&7Y-MSG
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M93PANTO9W=:K0,0/:C$+,#J#VI7\HO<_S>(H9P'28H?H,7N*9B*6]LDBED:
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MOUBD@6L<QZQAL!5F&A"&&GI[4E@<K_B"W"-49*A=7"QF^C2M#O[;\^8!/'^
MZ2M.!49+-3G=NPLR;AVYPBTG0:]]/>N1!,>=)"!)T#P!$<8-3!$"^6GJTTK9
M23-&JR89Y:J![D>&M7,V$F]B0A4,U(+ T,P?.7Z5>V>C#[&F),7^$XA"K;O8
M1&HDO8"B'3IL.8Y"+#H9R=*K?3-L^?T]W/614DGQ-;F+*T=\HE<%2KFQL!W*
M"G@JR0W\_W1G$*:1V#HXVA8CV+YA++9L9/VKG:3XED__#,;,8MN[6&!,^>T8
MC>F)N4]D,9!*XLS,Y(O0WP(#<)("06/;CKJ?NB@LQI&:>+IF5U=)Y>5-/X>8
M ;+X>GNP0]E!NUZ$'D3$$ MBA;!(/L6"L)]G<!V:F%2^PU^&&(6ZO'Q^>7G)
M#C?;07@C./ I@9G'2>IZJI-!\]*D-B70L\Q:+\OFOQLJ[6>@0NCYMPW(%=B(
MN0XEU@4\=9#Z?J\TK"X5',GO"AX#U1V(J?(8##A3QF)8/^P.OM=+B-'=.B<W
M%'&X"W]QAO->E%4MCJ5':1,".("L?;_462/4#J>,K5.S;@W2/#,&PF_.&B.[
M8AG:(KOXP7F,[]3*2Z=;LZ/8W %)D0ZJEJP,SZ><1G.P6N[U;$Z)WG4D5?QC
M]05PQ#!JDL*+QL!ZM7?-&YD!YY55=>GX*\V!/]Z<J73I^$NFXV\P!YME8<NY
M4@K<9JZ[*0V(=_4E*)?.?,&A@ED9?+?\-;*N$R2GU73/GDVK(E/O!CNP8VPI
M'F ?>GUL?Z1>["6JB*& "GW1-*JBHH D#V]P@,">:QD] ,T@DE=]5<ZZB*S-
M:A,"*B&7 M%8891/0_<6U.]U2R]NDOVPNPC5S'7';T0YP#++OI 188ZGO'R:
MNN,N*)+2.">T83_P KCLJ'CF::V5$U]9W@+?:7G.\JPX2>3Q@FP$&CV(4@(-
MH5QK9I8TW&('LS9_5RD3A"P'[@7#WY]6,I)S1T+A>(V*68)<XF*>E*DLX^_5
M[+W]ER_V#HYU]M[B,$"YM6VNLMC9! -\1M.AER?H@4.7U4DZ1O-+QK,;]F*A
M>\$=O[J66]=]E]_5N%U)&!^\VGU58*Y,]73A76*-SJJ NW.47+*U,MS"DO#.
MD?(KUSQ4O8YDWN/]H_T-2>9]L9O9-X\F/F'\9$9?9$E'HV-BF)I=.]0@%V5-
M*;,9UE4A<$.NG4PEQ_JM<K4,P8GQD,O)E513 36"J\=:@/JAG-3464CL_"X(
MD=8)1THHW5Z",!2_*E^AEUW&>34'+#E#N.K-^I.*R=3:?&315>;,''J$!#?D
M%=,U1[)IKJ)F7.W\'_\^.SAD5/>BWH81E4+;@L.]Y2>6<UWDYQ.%AR9]PX/B
M% 3M3%@#(WZL?7?1.YF5%K(3PEFTL]JF8)74$9.7P1DI![)IE)+!R@=L4CK
M>M98(,16XI7B_,$A609VU"1SOHP27?!]>!CKEJ8W&<6'9L/1PDUYF4K5?2LO
MY[A7>A<_OROW!(RDJT,6#YH#V;/!! !^06@FQ4U/U\+&[XI/O,2-4H8(O@0T
M"T5!\]5=9(-E$H]-(5!]PLBM04>67O.0J<KBUIBR^=[,)F80)[5P)8(@.[A"
MIRG.0CMDHB_6/,@,^#;+7;1^6)P&@"))KKDN3 ]$#K?MI=;.!1"UD^K,&IT0
M9-*!RGLU_Q6W(YR8F8+B[T\U!@6J_=9;;[WWI)5ARD*CO$_.PWVE AM3<.^
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MKT!@R #[1C\D]VME/G.'">.2G1 X)NP^75HS]EP,'R-3F]0P"O--+XD&A5+
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MW56D45>D 50'[+ 7^Z/W"'NHP^#]_P%02P,$%     @ 9(0#5\\/^;$;"@
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MVSMH%M]Q]S]02P$"% ,4    " !DA -7"M:8@=L,  !C?0  $0
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M9S P,BYJ<&=02P$"% ,4    " !DA -7FT[(,2V   #^M   &0
M    @ $+_P, <V%V82TR,#(S,#8S,'@Q,'%G,# S+FIP9U!+ 0(4 Q0    (
M &2$ U?PAN_63G@  (>G   9              "  6]_! !S879A+3(P,C,P
M-C,P>#$P<6<P,#0N:G!G4$L! A0#%     @ 9(0#5VO':8;DE@  N[$  !D
M             ( !]/<$ '-A=F$M,C R,S V,S!X,3!Q9S P-2YJ<&=02P$"
M% ,4    " !DA -7DQJ[*1DG 0 E;0$ &0              @ $/CP4 <V%V
M82TR,#(S,#8S,'@Q,'%G,# V+FIP9U!+ 0(4 Q0    ( &2$ U?)EG(+FCH
M )5E @ 8              "  5^V!@!S879A+3(P,C,P-C,P>&5X,3!?,BYH
M=&U02P$"% ,4    " !DA -7B"2O3" 2   WR0  &               @ $O
M\08 <V%V82TR,#(S,#8S,'AE>#$P7S,N:'1M4$L! A0#%     @ 9(0#5\\/
M^;$;"@  HV,  !@              ( !A0,' '-A=F$M,C R,S V,S!X97@S
M,5\Q+FAT;5!+ 0(4 Q0    ( &2$ U>#VG[2%0H  /=B   8
M  "  =8-!P!S879A+3(P,C,P-C,P>&5X,S%?,BYH=&U02P$"% ,4    " !D
MA -7?]7AV!('  !<3P  &               @ $A& < <V%V82TR,#(S,#8S
B,'AE>#,R7S$N:'1M4$L%!@     1 !$ E@0  &D?!P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
